Citrus Sinensis ID: 046877
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.98 | 0.412 | 0.573 | 1e-113 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.828 | 0.353 | 0.478 | 3e-75 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.84 | 0.354 | 0.440 | 2e-73 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.922 | 0.370 | 0.397 | 6e-68 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.845 | 0.357 | 0.424 | 3e-67 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.817 | 0.327 | 0.394 | 5e-62 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.822 | 0.361 | 0.426 | 6e-62 | |
| Q8H199 | 658 | Cysteine-rich receptor-li | no | no | 0.9 | 0.478 | 0.389 | 2e-58 | |
| Q8GWJ7 | 645 | Cysteine-rich receptor-li | no | no | 0.871 | 0.472 | 0.390 | 5e-57 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.934 | 0.496 | 0.388 | 6e-57 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 407 bits (1045), Expect = e-113, Method: Compositional matrix adjust.
Identities = 202/352 (57%), Positives = 255/352 (72%), Gaps = 9/352 (2%)
Query: 3 AGSVLLGSSVFVNFALVCAV-----GLGFFFIYKKKWIRNSPGDGTIETKSRCFSYKELE 57
A SVLLG+S FV F C+ + R + E R F+Y EL
Sbjct: 468 ACSVLLGTSAFVIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELA 527
Query: 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH 117
EAT +F EE+GRG+FGI+YKG ++ S VAVKKLDR+ D EKEFKNEV VIGQ H
Sbjct: 528 EATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIH 587
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHE 177
HKNLVRL+GFC+EGQ++++ YEFL GTLA+FLF +P+W R NIA IAR +LYLHE
Sbjct: 588 HKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLHE 647
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
+CS QIIHCDIKPQNILL++ Y RISDFGLAKLL +NQ T+ T IRGTKGYVAPEWFR
Sbjct: 648 ECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTL-TNIRGTKGYVAPEWFR 706
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297
S I++KVDVYS+GV+LLEI+ C+K+ D+ E+ IL +WA+DC+R G+L+DL E D E
Sbjct: 707 NSPITSKVDVYSYGVMLLEIVCCKKAVDL---EDNVILINWAYDCFRQGRLEDLTEDDSE 763
Query: 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNPSPFS 349
AMND++ VE+ + I+IWCIQE+ +RP MR V+QML+ V++V PPNPSP+S
Sbjct: 764 AMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNPSPYS 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 282 bits (722), Expect = 3e-75, Method: Compositional matrix adjust.
Identities = 144/301 (47%), Positives = 204/301 (67%), Gaps = 11/301 (3%)
Query: 51 FSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV 110
F+YK+L+ AT+NF ++G+G FG +Y+G T + +AVKKL+ + Q G+KEF+ EV
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEG----TLPDGSRLAVKKLEGIGQ-GKKEFRAEV 537
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAF 166
+IG HH +LVRL GFC EG +RLLAYEFL+ G+L ++F G++ +W+ R NIA
Sbjct: 538 SIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIAL 597
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG 226
A+ L YLHEDC ++I+HCDIKP+NILL+D +NA++SDFGLAKL+T Q T +RG
Sbjct: 598 GTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVF-TTMRG 656
Query: 227 TKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 286
T+GY+APEW IS K DVYS+G++LLE+I RK++D E +AF G
Sbjct: 657 TRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEG 716
Query: 287 KLDDLVEGDMEAMNDI-KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNP 345
KL D+V+G M+ ++ + V++ + ++WCIQED RP+M KV QML+ V V PP+
Sbjct: 717 KLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSS 776
Query: 346 S 346
S
Sbjct: 777 S 777
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 134/304 (44%), Positives = 200/304 (65%), Gaps = 10/304 (3%)
Query: 51 FSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV 110
F+YKEL+ T +FKE++G G FG +Y+GV+ T+ T VAVK+L+ + Q GEK+F+ EV
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVL----TNRTVVAVKQLEGIEQ-GEKQFRMEV 528
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP---NWNLRTNIAFQ 167
I THH NLVRL+GFC +G++RLL YEF+ NG+L +FLF W R NIA
Sbjct: 529 ATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALG 588
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGT 227
A+ + YLHE+C I+HCDIKP+NIL++D + A++SDFGLAKLL + +++RGT
Sbjct: 589 TAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGT 648
Query: 228 KGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287
+GY+APEW I++K DVYS+G++LLE++S +++FD+ + + WA++ + G
Sbjct: 649 RGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGN 708
Query: 288 LDDLVEGDM--EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNP 345
+++ + + D++ V +++ S WCIQE P RPTM KV QML+ + E+ P P
Sbjct: 709 TKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCP 768
Query: 346 SPFS 349
S
Sbjct: 769 KTIS 772
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 6e-68, Method: Compositional matrix adjust.
Identities = 134/337 (39%), Positives = 202/337 (59%), Gaps = 14/337 (4%)
Query: 18 LVCAVGLGFFFIY---KKKWIRNSPGDGTIETKSR-CFSYKELEEATDNFKEEVGRGSFG 73
LV LG Y +K+ ++ + + I S F+Y++L+ T+NF + +G G FG
Sbjct: 483 LVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNFSQLLGSGGFG 542
Query: 74 IIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133
+YKG T T VAVK+LDR GE+EF EV IG HH NLVRL G+C E +
Sbjct: 543 TVYKG----TVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSH 598
Query: 134 RLLAYEFLNNGTLASFLFGNLKP----NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIK 189
RLL YE++ NG+L ++F + + +W R IA A+ + Y HE C ++IIHCDIK
Sbjct: 599 RLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIK 658
Query: 190 PQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYS 249
P+NILL+D + ++SDFGLAK++ + + T IRGT+GY+APEW I+ K DVYS
Sbjct: 659 PENILLDDNFCPKVSDFGLAKMMG-REHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYS 717
Query: 250 FGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLL 309
+G+LLLEI+ R++ D+ E WA+ NG V+ ++ + + + V K L
Sbjct: 718 YGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKAL 777
Query: 310 MISIWCIQEDPSLRPTMRKVSQMLQEVV-EVDVPPNP 345
++ WCIQ++ S+RP+M +V ++L+ E+++PP P
Sbjct: 778 KVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 255 bits (652), Expect = 3e-67, Method: Compositional matrix adjust.
Identities = 133/313 (42%), Positives = 199/313 (63%), Gaps = 17/313 (5%)
Query: 40 GDGTIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF 99
GDGT+ FSY+EL+ AT NF +++G G FG ++KG + ++ +AVK+L+ +
Sbjct: 476 GDGTLSA----FSYRELQNATKNFSDKLGGGGFGSVFKGAL----PDSSDIAVKRLEGIS 527
Query: 100 QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN-----L 154
Q GEK+F+ EV+ IG H NLVRL GFC EG +LL Y+++ NG+L S LF N +
Sbjct: 528 Q-GEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKI 586
Query: 155 KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214
W LR IA AR L YLH++C IIHCDIKP+NILL+ ++ +++DFGLAKL+
Sbjct: 587 VLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGR 646
Query: 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 274
+ + + T +RGT+GY+APEW I+AK DVYS+G++L E++S R++ + E+
Sbjct: 647 DFSRVL-TTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRF 705
Query: 275 LTDWAFDCY-RNGKLDDLVEGDMEA-MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332
WA ++G + LV+ +E DI+ V + ++ WCIQ++ S RP M +V Q+
Sbjct: 706 FPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQI 765
Query: 333 LQEVVEVDVPPNP 345
L+ V+EV+ PP P
Sbjct: 766 LEGVLEVNPPPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 238 bits (607), Expect = 5e-62, Method: Compositional matrix adjust.
Identities = 124/314 (39%), Positives = 181/314 (57%), Gaps = 28/314 (8%)
Query: 51 FSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV 110
F ++ELE+AT+NFK ++G G FG +YKG T T +AVKK+ G +EF E+
Sbjct: 505 FEFEELEQATENFKMQIGSGGFGSVYKG----TLPDETLIAVKKITNHGLHGRQEFCTEI 560
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQI 168
+IG H NLV+L GFC G+ LL YE++N+G+L LF P W R +IA
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGT 620
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK 228
AR L YLH C +IIHCD+KP+NILL+D + +ISDFGL+KLL + ++ T +RGT+
Sbjct: 621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLN-QEESSLFTTMRGTR 679
Query: 229 GYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD----------- 277
GY+APEW + IS K DVYS+G++LLE++S RK+ ++ D
Sbjct: 680 GYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFR-SRSNSVTEDNNQNHSSTTTT 738
Query: 278 ---------WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRK 328
+A D + G+ +L + +E + EKL+ I++ C+ E+P+LRPTM
Sbjct: 739 STGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAA 798
Query: 329 VSQMLQEVVEVDVP 342
V M + + + P
Sbjct: 799 VVGMFEGSIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (606), Expect = 6e-62, Method: Compositional matrix adjust.
Identities = 130/305 (42%), Positives = 184/305 (60%), Gaps = 17/305 (5%)
Query: 41 DGTIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ 100
DG + FS+KEL+ AT+ F ++VG G FG ++KG T S+T VAVK+L+R
Sbjct: 441 DGFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKG---TLPGSSTFVAVKRLERP-G 496
Query: 101 DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP---N 157
GE EF+ EV IG H NLVRL GFC E +RLL Y+++ G+L+S+L P +
Sbjct: 497 SGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL-SRTSPKLLS 555
Query: 158 WNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217
W R IA A+ + YLHE C IIHCDIKP+NILL+ YNA++SDFGLAKLL +
Sbjct: 556 WETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFS 615
Query: 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIE---MGEEYAI 274
+ + T +RGT GYVAPEW I+ K DVYSFG+ LLE+I R++ + +GE+
Sbjct: 616 RVLAT-MRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETE 674
Query: 275 LTDWAFDCYR-----NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
W F + G +D +V+ + + + V ++ ++IWCIQ++ +RP M V
Sbjct: 675 PEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTV 734
Query: 330 SQMLQ 334
+ML+
Sbjct: 735 VKMLE 739
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 226 bits (576), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 128/329 (38%), Positives = 197/329 (59%), Gaps = 14/329 (4%)
Query: 11 SVFVNFALVCAVGLGFFFIYKKKWIRNSPGDGTIETKSRCFSYKELEEATDNFKEE--VG 68
+V V F ++ A LGF ++K + S D TI T S F +K +E+AT+ F E +G
Sbjct: 288 TVIVVFLVLLA--LGFVVYRRRKSYQGSSTDITI-THSLQFDFKAIEDATNKFSESNIIG 344
Query: 69 RGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFC 128
RG FG ++ GV+ + T VA+K+L + + G +EFKNEV+V+ + HH+NLV+LLGFC
Sbjct: 345 RGGFGEVFMGVL-----NGTEVAIKRLSKASRQGAREFKNEVVVVAKLHHRNLVKLLGFC 399
Query: 129 DEGQNRLLAYEFLNNGTLASFLFGNLKP---NWNLRTNIAFQIARVLLYLHEDCSSQIIH 185
EG+ ++L YEF+ N +L FLF K +W R NI I R +LYLH+D IIH
Sbjct: 400 LEGEEKILVYEFVPNKSLDYFLFDPTKQGQLDWTKRYNIIRGITRGILYLHQDSRLTIIH 459
Query: 186 CDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKV 245
D+K NILL+ N +I+DFG+A++ ++Q I GT+GY+ PE+ R+ S +
Sbjct: 460 RDLKASNILLDADMNPKIADFGMARIFGIDQSGANTKKIAGTRGYMPPEYVRQGQFSTRS 519
Query: 246 DVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 304
DVYSFGVL+LEII R + I + L +A+ +RN +LV+ + + +
Sbjct: 520 DVYSFGVLVLEIICGRNNRFIHQSDTTVENLVTYAWRLWRNDSPLELVDPTISENCETEE 579
Query: 305 VEKLLMISIWCIQEDPSLRPTMRKVSQML 333
V + + I++ C+Q +P+ RP++ ++ ML
Sbjct: 580 VTRCIHIALLCVQHNPTDRPSLSTINMML 608
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 221 bits (564), Expect = 5e-57, Method: Compositional matrix adjust.
Identities = 123/315 (39%), Positives = 183/315 (58%), Gaps = 10/315 (3%)
Query: 40 GDGTIETKSRCFSYKELEEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR 97
G+ S F +K +E AT+ F ++G+G FG +YKG T +S VAVK+L +
Sbjct: 303 GNDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKG----TLSSGLQVAVKRLSK 358
Query: 98 VFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN---L 154
GEKEF+NEV+V+ + H+NLV+LLG+C EG+ ++L YEF+ N +L FLF + +
Sbjct: 359 TSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKM 418
Query: 155 KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214
K +W R I IAR +LYLH+D IIH D+K NILL+D N +I+DFG+A++ +
Sbjct: 419 KLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGM 478
Query: 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDI-EMGEEYA 273
+Q + + + GT GY++PE+ S K DVYSFGVL+LEIIS K+ + +M E
Sbjct: 479 DQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVG 538
Query: 274 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333
L + + + NG +LV+ + + + I++ C+QED RPTM + QML
Sbjct: 539 NLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQML 598
Query: 334 QEVVEVDVPPNPSPF 348
+ P P F
Sbjct: 599 TTSLIALAEPRPPGF 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 6e-57, Method: Compositional matrix adjust.
Identities = 132/340 (38%), Positives = 190/340 (55%), Gaps = 13/340 (3%)
Query: 18 LVCAVGLGFFFIYKKKWIRNSPG---DGTIETKSRCFSYKELEEATDNFKE--EVGRGSF 72
L+ G FF KK +P D +S Y+ ++ AT++F E ++GRG F
Sbjct: 288 LIFIAGYCFFAKRAKKTYGTTPALDEDDKTTIESLQLDYRAIQAATNDFSENNKIGRGGF 347
Query: 73 GIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ 132
G +YKG T ++ T VAVK+L + + G+ EFKNEV+V+ HKNLVR+LGF E +
Sbjct: 348 GDVYKG----TFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIERE 403
Query: 133 NRLLAYEFLNNGTLASFLFGNLKPN---WNLRTNIAFQIARVLLYLHEDCSSQIIHCDIK 189
R+L YE++ N +L +FLF K W R +I IAR +LYLH+D IIH D+K
Sbjct: 404 ERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLK 463
Query: 190 PQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYS 249
NILL+ N +I+DFG+A++ ++Q + + I GT GY++PE+ + S K DVYS
Sbjct: 464 ASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYS 523
Query: 250 FGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLL 309
FGVL+LEIIS RK+ ++ L A+ +RNG DLV+ + V +
Sbjct: 524 FGVLVLEIISGRKNNSFIETDDAQDLVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCT 583
Query: 310 MISIWCIQEDPSLRPTMRKVSQML-QEVVEVDVPPNPSPF 348
I + C+QEDP RP M +S ML + + P P F
Sbjct: 584 HIGLLCVQEDPVKRPAMSTISVMLTSNTMALPAPQQPGFF 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | ||||||
| 224143655 | 417 | predicted protein [Populus trichocarpa] | 0.908 | 0.762 | 0.686 | 1e-127 | |
| 224143661 | 691 | predicted protein [Populus trichocarpa] | 0.877 | 0.444 | 0.713 | 1e-125 | |
| 224073224 | 699 | predicted protein [Populus trichocarpa] | 0.86 | 0.430 | 0.721 | 1e-124 | |
| 224099309 | 801 | predicted protein [Populus trichocarpa] | 0.937 | 0.409 | 0.656 | 1e-124 | |
| 359487487 | 808 | PREDICTED: G-type lectin S-receptor-like | 0.974 | 0.422 | 0.626 | 1e-124 | |
| 356575025 | 800 | PREDICTED: G-type lectin S-receptor-like | 0.954 | 0.417 | 0.627 | 1e-121 | |
| 255544746 | 800 | ATP binding protein, putative [Ricinus c | 0.945 | 0.413 | 0.646 | 1e-120 | |
| 224103119 | 799 | predicted protein [Populus trichocarpa] | 0.971 | 0.425 | 0.632 | 1e-119 | |
| 224120872 | 704 | predicted protein [Populus trichocarpa] | 0.868 | 0.431 | 0.664 | 1e-118 | |
| 356532279 | 813 | PREDICTED: G-type lectin S-receptor-like | 0.957 | 0.412 | 0.605 | 1e-116 |
| >gi|224143655|ref|XP_002336065.1| predicted protein [Populus trichocarpa] gi|222869873|gb|EEF07004.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 462 bits (1189), Expect = e-127, Method: Compositional matrix adjust.
Identities = 221/322 (68%), Positives = 264/322 (81%), Gaps = 4/322 (1%)
Query: 28 FIYKKKWIRNSPGDGTIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTST 87
FIY+ K + N + +E+ R F+YKEL EAT+ FK+E+GRG+FG +YKG I+T T+
Sbjct: 95 FIYRNK-VANVREENNVESNLRSFTYKELTEATEGFKDELGRGAFGGVYKGAIKTGFTN- 152
Query: 88 TAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLA 147
+AVKKLD V + GEKEFK EV VIGQTHHKNLVRLLGFCDEGQ+RLL YEFL+NGTLA
Sbjct: 153 -FIAVKKLDGVVEHGEKEFKTEVTVIGQTHHKNLVRLLGFCDEGQHRLLVYEFLSNGTLA 211
Query: 148 SFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207
FLFG+L+P+W RT IAF IAR LLYLHE+CS+QIIHCDIKPQNIL++D YNARISDFG
Sbjct: 212 DFLFGSLRPSWKQRTQIAFGIARGLLYLHEECSTQIIHCDIKPQNILIDDYYNARISDFG 271
Query: 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIE 267
LAKLL +NQ +T KTAIRGTKGYVAPEWFR + ++ KVDVYSFGVLLLEII CR+S D+E
Sbjct: 272 LAKLLAINQSQT-KTAIRGTKGYVAPEWFRNTPVTVKVDVYSFGVLLLEIICCRRSVDLE 330
Query: 268 MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMR 327
+ AIL DWA+DCYR+G LD L+E DMEAMND+ +E+ + ++IWCIQE PSLRPTMR
Sbjct: 331 ISGTGAILIDWAYDCYRHGTLDALIEDDMEAMNDVSTLERAMKVAIWCIQEVPSLRPTMR 390
Query: 328 KVSQMLQEVVEVDVPPNPSPFS 349
KV+QML+ VVEV PPNP PFS
Sbjct: 391 KVTQMLEGVVEVPAPPNPFPFS 412
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143661|ref|XP_002336066.1| predicted protein [Populus trichocarpa] gi|222869874|gb|EEF07005.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1169), Expect = e-125, Method: Compositional matrix adjust.
Identities = 222/311 (71%), Positives = 255/311 (81%), Gaps = 4/311 (1%)
Query: 40 GDGTIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF 99
G +ET R F+YKEL EAT++FK+EVGRG FG++YKG IQ ST VAVKKLD+V
Sbjct: 381 GGSGLETNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAG--STRVVAVKKLDKVV 438
Query: 100 QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWN 159
QDGEKEFK EV VIGQTHHKNLVRLLGFCDEGQNRLL YEFL+NGTLA+FLFG KPNW
Sbjct: 439 QDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNWK 498
Query: 160 LRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219
RT IAF IAR LLYLHE+C +QIIHCDIKPQNILL++ YNARISDFGLAKLL ++Q KT
Sbjct: 499 QRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKT 558
Query: 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDW 278
+TAIRGTKGYVAPEWFR I+ KVDVYSFGV+LLEII CR++ D+E+GE E +LTDW
Sbjct: 559 -QTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTDW 617
Query: 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
A+DCY +G LD L+ D EA NDI +E+LL + IWCIQEDPSLRPTMRKV+QML+ VVE
Sbjct: 618 AYDCYMDGSLDVLIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVVE 677
Query: 339 VDVPPNPSPFS 349
V PNP P+S
Sbjct: 678 VPAAPNPFPYS 688
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224073224|ref|XP_002304031.1| predicted protein [Populus trichocarpa] gi|222841463|gb|EEE79010.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1159), Expect = e-124, Method: Compositional matrix adjust.
Identities = 220/305 (72%), Positives = 252/305 (82%), Gaps = 4/305 (1%)
Query: 46 TKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE 105
T R F+YKEL EAT++FK+EVGRG FG++YKG IQ ST VAVKKLD+V QDGEKE
Sbjct: 391 TNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAG--STRVVAVKKLDKVVQDGEKE 448
Query: 106 FKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA 165
FK EV VIGQTHHKNLVRLLGFCDEGQNRLL YEFL+NGTLA+FLFG KPNW RT IA
Sbjct: 449 FKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNWKQRTQIA 508
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
F IAR LLYLHE+C +QIIHCDIKPQNILL++ YNARISDFGLAKLL ++Q KT +TAIR
Sbjct: 509 FGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKT-QTAIR 567
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDWAFDCYR 284
GTKGYVAPEWFR I+ KVDVYSFGV+LLEII CR++ D+E+GE E +LTDWA+DCY
Sbjct: 568 GTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTDWAYDCYM 627
Query: 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPN 344
+G LD L+ D EA NDI +E+LL + IWCIQEDPSLRPTMRKV+QML+ VVEV PN
Sbjct: 628 DGSLDVLIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVVEVPAAPN 687
Query: 345 PSPFS 349
P P+S
Sbjct: 688 PFPYS 692
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1159), Expect = e-124, Method: Compositional matrix adjust.
Identities = 218/332 (65%), Positives = 266/332 (80%), Gaps = 4/332 (1%)
Query: 4 GSVLLGSSVFVNFALVCAVGLGFFFIYKKKWIRNSPGDGTIETKSRCFSYKELEEATDNF 63
GSV LG SVFVNF LVCA+ + FFFIY+++ R DG +ET RCF+Y+EL EAT+ F
Sbjct: 455 GSVFLGCSVFVNFLLVCAIFMCFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGF 514
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
KEE+GRG+FG++YKGV+ S+ VAVKKL+ V +D +EFK EV VIGQTHHKNLVR
Sbjct: 515 KEELGRGAFGVVYKGVVHIG--SSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVR 572
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
LLGFC+EG RLL YEF++NG+L+SF+F + KP W +R IAF +AR LLYLHE+CS+QI
Sbjct: 573 LLGFCEEGDQRLLVYEFMSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQI 632
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
IHCDIKPQNILL++ YNARISDFGLAKLL L+Q +T TAIRGTKGYVAPEWFR ++
Sbjct: 633 IHCDIKPQNILLDEYYNARISDFGLAKLLLLDQSQT-HTAIRGTKGYVAPEWFRNLPVTV 691
Query: 244 KVDVYSFGVLLLEIISCRKSFDIEMG-EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 302
KVDVYS+GVLLLEII CR++ D + EE AILTDWA+DCYR G LD LV D A++DI
Sbjct: 692 KVDVYSYGVLLLEIICCRRNVDSKATIEEQAILTDWAYDCYREGTLDALVGSDTGALDDI 751
Query: 303 KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
+ +E+ LMI+ WCIQEDPSLRPTMRKV+QML+
Sbjct: 752 EKLERFLMIAFWCIQEDPSLRPTMRKVTQMLE 783
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487487|ref|XP_002269067.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1156), Expect = e-124, Method: Compositional matrix adjust.
Identities = 216/345 (62%), Positives = 276/345 (80%), Gaps = 4/345 (1%)
Query: 4 GSVLLGSSVFVNFALVCAVGLGFFFIYKKKWIRNSPGDGTIETKSRCFSYKELEEATDNF 63
GS+LLGSSVF+NF LV A+ L + +K+ + +ET R F+Y+EL++A D F
Sbjct: 462 GSILLGSSVFLNFLLVAAISLVRSYPSQKR-RELTRASSILETNIRSFTYEELKQAADGF 520
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
+EE+GRG+FG +YKGV+ ++++S T VAVKKLD++ Q+GE+EFK EV I THHKNLVR
Sbjct: 521 REELGRGAFGTVYKGVL-SSSSSGTQVAVKKLDKLVQEGEREFKTEVRTIAMTHHKNLVR 579
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
L+GFCDEG ++LL YEF+ NGTLASFLFG+ P+W +RT +AF +AR L+YLHE+CS+QI
Sbjct: 580 LIGFCDEGPHKLLVYEFMCNGTLASFLFGSSAPDWKIRTQMAFGVARGLMYLHEECSTQI 639
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
IHCDIKPQN+LL+D + ARISDFGLAKLL +Q +T+ TAIRGTKGYVAPEWFR I+A
Sbjct: 640 IHCDIKPQNVLLDDSFTARISDFGLAKLLMSDQTRTL-TAIRGTKGYVAPEWFRSKPITA 698
Query: 244 KVDVYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 302
KVDVYS+GV+LLEIISCRK D + EE AILTDWA+DCYR +LD LVE D +A ND+
Sbjct: 699 KVDVYSYGVMLLEIISCRKCIDFQTENEEEAILTDWAYDCYRGHRLDKLVENDDDARNDM 758
Query: 303 KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNPSP 347
+ +EKL+M++IWCIQEDPSLRP+MR V+QML+ VVEV +PP P P
Sbjct: 759 RRLEKLVMVAIWCIQEDPSLRPSMRNVTQMLEGVVEVPMPPCPFP 803
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575025|ref|XP_003555643.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1137), Expect = e-121, Method: Compositional matrix adjust.
Identities = 217/346 (62%), Positives = 273/346 (78%), Gaps = 12/346 (3%)
Query: 5 SVLLGSSVFVNFALVCAVGLGFFFIYKKKWIRNSPGDGTIETKSRCFSYKELEEATDNFK 64
SVLLG SVF F LV AV +GF+F Y KK +S E+ F++ EL +ATDNFK
Sbjct: 459 SVLLGGSVF--FNLVSAVWVGFYFYYNKK---SSTNKTATESNLCSFTFAELVQATDNFK 513
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
EE+GRGS GI+YKG TT+ +AVKKLD+V +D +KEFK EV VIGQTHHK+LVRL
Sbjct: 514 EELGRGSCGIVYKG-----TTNLATIAVKKLDKVLKDCDKEFKTEVNVIGQTHHKSLVRL 568
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
LG+CDE Q+R+L YEFL+NGTLA+FLFG+ KPNWN R IAF IAR L+YLHE+C +QII
Sbjct: 569 LGYCDEEQHRILVYEFLSNGTLANFLFGDFKPNWNQRVQIAFGIARGLVYLHEECCTQII 628
Query: 185 HCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAK 244
HCDIKPQNILL+++YNARISDFGL+KLL +N+ T +T IRGTKGYVAP+WFR + I+ K
Sbjct: 629 HCDIKPQNILLDEQYNARISDFGLSKLLKINESHT-ETGIRGTKGYVAPDWFRSAPITTK 687
Query: 245 VDVYSFGVLLLEIISCRKSFDIEMG-EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 303
VDVYSFGVLLLEII CR++ D E+G EE AILTDWA+DCYR G++D L+E D EA++D
Sbjct: 688 VDVYSFGVLLLEIICCRRNVDGEVGNEEKAILTDWAYDCYRAGRIDILLENDDEAIDDTN 747
Query: 304 CVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNPSPFS 349
+E+ +M++IWC+QEDPSLRP M+KV ML+ + V +PP+PSP++
Sbjct: 748 RLERFVMVAIWCLQEDPSLRPPMKKVMLMLEGIAPVTIPPSPSPYT 793
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544746|ref|XP_002513434.1| ATP binding protein, putative [Ricinus communis] gi|223547342|gb|EEF48837.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1123), Expect = e-120, Method: Compositional matrix adjust.
Identities = 218/337 (64%), Positives = 264/337 (78%), Gaps = 6/337 (1%)
Query: 5 SVLLGSSVFVNFALVCAVGLGFFFIYKKKWIRNSPGDGTIETKSRCFSYKELEEATDNFK 64
SVLLGSSVF+NF L+ V F F Y KK G+ ++ RCFSYKEL EAT FK
Sbjct: 457 SVLLGSSVFINFILIGLVTFCFLFFYHKKSTGIPQGE---KSNLRCFSYKELVEATKGFK 513
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
EE+GRGSFGI+YKG+I+ TT VAVKKLDRV + GEKE+K EV IGQTHHKNLV+L
Sbjct: 514 EELGRGSFGIVYKGLIEMGTT--VPVAVKKLDRVVEYGEKEYKAEVKAIGQTHHKNLVQL 571
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
LGFCDEGQ +LL YE L+NGTLA+FLFG+ K +W RT IAF IAR L+YLHE+C++QII
Sbjct: 572 LGFCDEGQQKLLVYELLSNGTLANFLFGDTKLSWKQRTQIAFGIARGLVYLHEECNTQII 631
Query: 185 HCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAK 244
HCDIKPQNIL+++ Y+A+ISDFGLAKLL L+Q +T T IRGTKGYVAPEWFR I+ K
Sbjct: 632 HCDIKPQNILVDEYYDAKISDFGLAKLLLLDQSQTF-TTIRGTKGYVAPEWFRNVPITVK 690
Query: 245 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 304
VD YSFGVLLLEII R+S D E+ E AILTDWA+DCY G++DDLVE D EA++D+K
Sbjct: 691 VDAYSFGVLLLEIICSRRSVDTEISGERAILTDWAYDCYMEGRIDDLVENDEEALSDLKK 750
Query: 305 VEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDV 341
VE+ LM++IWCIQEDP+LRPTM+ V ML+ +++V V
Sbjct: 751 VERFLMVAIWCIQEDPTLRPTMKTVILMLEGIIQVAV 787
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 434 bits (1117), Expect = e-119, Method: Compositional matrix adjust.
Identities = 219/346 (63%), Positives = 271/346 (78%), Gaps = 6/346 (1%)
Query: 4 GSVLLGSSVFVNFALVCAVGLGFFFIYKKKWIRNSPGDGTIETKSRCFSYKELEEATDNF 63
GSV LG SVFVNF LVCA+ +GFFFIY+++ R DG +ET RCF+Y+EL EAT+ F
Sbjct: 455 GSVFLGCSVFVNFLLVCAICMGFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGF 514
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
KEE+GRG+FG++Y+GV+ S+ VAVKKL+ V +D +EFK EV VIGQTHHKNLVR
Sbjct: 515 KEELGRGAFGVVYRGVVHIG--SSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVR 572
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
LLGFC+EG RLL YEF++NG+L+SF+F + KP W +R IAF +AR LLYLHED SQI
Sbjct: 573 LLGFCEEGDQRLLVYEFMSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHED--SQI 630
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
IHCDIKPQNILL++ NARISDFGLAKLL +Q KT TAIRGTKGYVAPEWF+ ++
Sbjct: 631 IHCDIKPQNILLDESLNARISDFGLAKLLKTDQTKTT-TAIRGTKGYVAPEWFKNLPVTT 689
Query: 244 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWAFDCYRNGKLDDLVEGDMEAMNDI 302
KVD YSFG+LLLE++ CRK+F+I +E+ I L DWA DC + GKL+ LVE D EAM D+
Sbjct: 690 KVDTYSFGILLLELVCCRKNFEINAMQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDM 749
Query: 303 KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNPSPF 348
K VE+ +M++IWCIQEDPSLRP M+KV QML+ V+V VPP+PS F
Sbjct: 750 KRVERFVMVAIWCIQEDPSLRPGMKKVVQMLEGGVQVSVPPDPSSF 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120872|ref|XP_002330847.1| predicted protein [Populus trichocarpa] gi|222872669|gb|EEF09800.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 432 bits (1110), Expect = e-118, Method: Compositional matrix adjust.
Identities = 204/307 (66%), Positives = 249/307 (81%), Gaps = 3/307 (0%)
Query: 44 IETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE 103
+ET R F+YK+L+EATD FKE++GRGSFG +YKG++ T+ +S VAVKKL+R+ Q+GE
Sbjct: 398 LETNLRSFTYKDLKEATDGFKEQLGRGSFGTVYKGLL-TSQSSRNYVAVKKLERMVQEGE 456
Query: 104 KEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN 163
KEFK E I +THHKNLVRLLGFCDEG NRLL YEF++NGTLA FLFG +P+WN R
Sbjct: 457 KEFKTEASAIAKTHHKNLVRLLGFCDEGPNRLLVYEFMSNGTLAGFLFGISRPDWNKRIQ 516
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223
+AF IAR L YLHE+CS+QIIHCDIKPQNILL+ + ARISDFGLAKLL +N++ TA
Sbjct: 517 MAFGIARALTYLHEECSTQIIHCDIKPQNILLDGTFTARISDFGLAKLL-MNEQTRTHTA 575
Query: 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDC 282
IRGT+GYVAPEWFR I+AKVDVYS+G++LLEII CRKS D+E EE IL DWA DC
Sbjct: 576 IRGTRGYVAPEWFRNMPITAKVDVYSYGIMLLEIICCRKSLDMENEKEEEIILADWAHDC 635
Query: 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342
Y+ GKLD+LV+ D EA ND+K +E L+M+SIWCIQEDPSLRP+MR V+QML+ +V+V P
Sbjct: 636 YKGGKLDELVKADEEAKNDMKTLETLVMVSIWCIQEDPSLRPSMRTVTQMLEGIVQVSAP 695
Query: 343 PNPSPFS 349
P PSPFS
Sbjct: 696 PCPSPFS 702
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532279|ref|XP_003534701.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1094), Expect = e-116, Method: Compositional matrix adjust.
Identities = 207/342 (60%), Positives = 257/342 (75%), Gaps = 7/342 (2%)
Query: 5 SVLLGSSVFVNFALVCAVGLGFFFIYKKKWIRNSP-GDGTIETKSRCFSYKELEEATDNF 63
S+LLGSSVF+N L A+ + FF Y K+ + N TI R F+YKELEEAT F
Sbjct: 464 SILLGSSVFLNVLLFVALFVAFFIFYHKRLLNNPKLSAATI----RSFTYKELEEATTGF 519
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
K+ +GRG+FG +YKGV+ T+ ++ VAVK+LD+V Q+GEKEFK EV VIGQTHH+NLVR
Sbjct: 520 KQMLGRGAFGTVYKGVL--TSDTSRYVAVKRLDKVVQEGEKEFKTEVSVIGQTHHRNLVR 577
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
LLG+CDEG++RLL YE ++NG+LASFLFG +P+WN R IA IAR L YLHE+CS+QI
Sbjct: 578 LLGYCDEGEHRLLVYEHMSNGSLASFLFGISRPHWNQRVQIALGIARGLTYLHEECSTQI 637
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
IHCDIKPQNILL++ + RI+DFGLAKLL Q K KT +RGT GY APEWFRK++I+
Sbjct: 638 IHCDIKPQNILLDELFTPRIADFGLAKLLLAEQSKAAKTGLRGTIGYFAPEWFRKASITT 697
Query: 244 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 303
K+DVYSFGV+LLEII C+ S M + L DWA+ CY GK+ LVE D EA NDIK
Sbjct: 698 KIDVYSFGVVLLEIICCKSSVAFAMANDEEALIDWAYRCYSQGKVAKLVENDEEAKNDIK 757
Query: 304 CVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNP 345
VEK +M++IWCIQEDPSLRP+M+KV+QML+ V V VPP P
Sbjct: 758 RVEKHVMVAIWCIQEDPSLRPSMKKVTQMLEGVTTVSVPPRP 799
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | ||||||
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.925 | 0.394 | 0.443 | 5.5e-70 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.84 | 0.354 | 0.437 | 3.1e-67 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.94 | 0.397 | 0.409 | 1.8e-64 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.594 | 0.238 | 0.469 | 1.2e-57 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.948 | 0.499 | 0.377 | 3.8e-53 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.888 | 0.288 | 0.4 | 8.7e-53 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.828 | 0.449 | 0.399 | 1.3e-52 | |
| TAIR|locus:2083986 | 715 | AT3G53380 [Arabidopsis thalian | 0.922 | 0.451 | 0.353 | 1.7e-52 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.928 | 0.493 | 0.391 | 2.1e-52 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.908 | 0.682 | 0.369 | 3.5e-52 |
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 5.5e-70, P = 5.5e-70
Identities = 153/345 (44%), Positives = 219/345 (63%)
Query: 16 FALVCAVGLGFFFIYKKKWIRNSPG-----DGTIETKSRC---FSYKELEEATDNFKEEV 67
F + + + F +KK I +P D +E S F+YK+L+ AT+NF ++
Sbjct: 440 FIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKL 499
Query: 68 GRGSFGIIYKGVIQXXXXXXXAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGF 127
G+G FG +Y+G + +AVKKL+ + Q G+KEF+ EV +IG HH +LVRL GF
Sbjct: 500 GQGGFGSVYEGTLPDGSR----LAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGF 554
Query: 128 CDEGQNRLLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
C EG +RLLAYEFL+ G+L ++F G++ +W+ R NIA A+ L YLHEDC ++I
Sbjct: 555 CAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARI 614
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
+HCDIKP+NILL+D +NA++SDFGLAKL+T Q T +RGT+GY+APEW IS
Sbjct: 615 VHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVF-TTMRGTRGYLAPEWITNYAISE 673
Query: 244 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI- 302
K DVYS+G++LLE+I RK++D E +AF GKL D+V+G M+ + D+
Sbjct: 674 KSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNV-DVT 732
Query: 303 -KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNPS 346
+ V++ + ++WCIQED RP+M KV QML+ V V PP+ S
Sbjct: 733 DERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSS 777
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 683 (245.5 bits), Expect = 3.1e-67, P = 3.1e-67
Identities = 133/304 (43%), Positives = 199/304 (65%)
Query: 51 FSYKELEEATDNFKEEVGRGSFGIIYKGVIQXXXXXXXAVAVKKLDRVFQDGEKEFKNEV 110
F+YKEL+ T +FKE++G G FG +Y+GV+ VAVK+L+ + Q GEK+F+ EV
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVL----TNRTVVAVKQLEGIEQ-GEKQFRMEV 528
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF--GNLK-PNWNLRTNIAFQ 167
I THH NLVRL+GFC +G++RLL YEF+ NG+L +FLF + K W R NIA
Sbjct: 529 ATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALG 588
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGT 227
A+ + YLHE+C I+HCDIKP+NIL++D + A++SDFGLAKLL + +++RGT
Sbjct: 589 TAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGT 648
Query: 228 KGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287
+GY+APEW I++K DVYS+G++LLE++S +++FD+ + + WA++ + G
Sbjct: 649 RGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGN 708
Query: 288 LDDLVEGDM--EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNP 345
+++ + + D++ V +++ S WCIQE P RPTM KV QML+ + E+ P P
Sbjct: 709 TKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCP 768
Query: 346 SPFS 349
S
Sbjct: 769 KTIS 772
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 657 (236.3 bits), Expect = 1.8e-64, P = 1.8e-64
Identities = 143/349 (40%), Positives = 213/349 (61%)
Query: 4 GSVLLGSSVFVNFALVCAVGLGFFFIYKKKWIRNSPGDGTIETKSRCFSYKELEEATDNF 63
G+VL V V LV + L + ++K +R GDGT+ FSY+EL+ AT NF
Sbjct: 443 GAVLGSLGVIVLVLLVVILILRY---RRRKRMRGEKGDGTLSA----FSYRELQNATKNF 495
Query: 64 KEEVGRGSFGIIYKGVIQXXXXXXXAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
+++G G FG ++KG + +AVK+L+ + Q GEK+F+ EV+ IG H NLVR
Sbjct: 496 SDKLGGGGFGSVFKGALPDSSD----IAVKRLEGISQ-GEKQFRTEVVTIGTIQHVNLVR 550
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARVLLYLHED 178
L GFC EG +LL Y+++ NG+L S LF N + W LR IA AR L YLH++
Sbjct: 551 LRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDE 610
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
C IIHCDIKP+NILL+ ++ +++DFGLAKL+ + + + T +RGT+GY+APEW
Sbjct: 611 CRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVL-TTMRGTRGYLAPEWISG 669
Query: 239 STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY-RNGKLDDLVEGDME 297
I+AK DVYS+G++L E++S R++ + E+ WA ++G + LV+ +E
Sbjct: 670 VAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLE 729
Query: 298 A-MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNP 345
DI+ V + ++ WCIQ++ S RP M +V Q+L+ V+EV+ PP P
Sbjct: 730 GDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 526 (190.2 bits), Expect = 1.2e-57, Sum P(2) = 1.2e-57
Identities = 101/215 (46%), Positives = 141/215 (65%)
Query: 51 FSYKELEEATDNFKEEVGRGSFGIIYKGVIQXXXXXXXAVAVKKLDRVFQDGEKEFKNEV 110
F ++ELE+AT+NFK ++G G FG +YKG + +AVKK+ G +EF E+
Sbjct: 505 FEFEELEQATENFKMQIGSGGFGSVYKGTLPDETL----IAVKKITNHGLHGRQEFCTEI 560
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQI 168
+IG H NLV+L GFC G+ LL YE++N+G+L LF P W R +IA
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGT 620
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK 228
AR L YLH C +IIHCD+KP+NILL+D + +ISDFGL+KLL + ++ T +RGT+
Sbjct: 621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLN-QEESSLFTTMRGTR 679
Query: 229 GYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS 263
GY+APEW + IS K DVYS+G++LLE++S RK+
Sbjct: 680 GYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 3.8e-53, P = 3.8e-53
Identities = 132/350 (37%), Positives = 203/350 (58%)
Query: 12 VFVNFALVCAVGLGFFFIYKKKWIRNSP-GDGTIETKS--RCFSYKELEEATDNFKEEVG 68
V V+ AL + + I + K +RNS D +E + + +SY +++ T++F +G
Sbjct: 279 VGVSAALTLMILIVVVIIVRTKNMRNSEWNDQNVEAVAMLKRYSYTRVKKMTNSFAHVLG 338
Query: 69 RGSFGIIYKGVIQXXXXXXXAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFC 128
+G FG +YKG + VAVK L +V + +EF NEV + +T H N+V LLGFC
Sbjct: 339 KGGFGTVYKGKLADSGRD---VAVKIL-KVSEGNGEEFINEVASMSRTSHVNIVSLLGFC 394
Query: 129 DEGQNRLLAYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHC 186
E R + YEF+ NG+L ++ N+ K W ++A I+R L YLH C ++I+H
Sbjct: 395 YEKNKRAIIYEFMPNGSLDKYISANMSTKMEWERLYDVAVGISRGLEYLHNRCVTRIVHF 454
Query: 187 DIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA-IRGTKGYVAPEWFRKS--TISA 243
DIKPQNIL+++ +ISDFGLAKL N+ I +RGT GY+APE F K+ +S
Sbjct: 455 DIKPQNILMDENLCPKISDFGLAKLCK-NKESIISMLHMRGTFGYIAPEMFSKNFGAVSH 513
Query: 244 KVDVYSFGVLLLEIISCRKSFDIEM-GEEYAIL--TDWAFDCYRNGKLDDLVEGDMEAMN 300
K DVYS+G+++LE+I + +E G + +W + + G++ + GD
Sbjct: 514 KSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWVYKDFEKGEITRIF-GDSITDE 572
Query: 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE-VDVPPNPSPFS 349
+ K +KL+++++WCIQ +PS RP M KV +ML+ +E + VPPNP FS
Sbjct: 573 EEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEALQVPPNPLLFS 622
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 8.7e-53, P = 8.7e-53
Identities = 130/325 (40%), Positives = 186/325 (57%)
Query: 22 VGLGFFFIYKKKW-IRNSPGDGTIETKSRCFSYKELEEATDNFK--EEVGRGSFGIIYKG 78
V L F + W I S DG K FS ++L+ ATD+F ++G G FG +YKG
Sbjct: 638 VSLSFLILGALYWRICVSNADGE---KRGSFSLRQLKVATDDFNPLNKIGEGGFGSVYKG 694
Query: 79 VIQXXXXXXXAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138
+ +AVKKL G KEF NE+ +I H NLV+L G C E LL Y
Sbjct: 695 RLPNGTL----IAVKKLSSKSCQGNKEFINEIGIIACLQHPNLVKLYGCCVEKTQLLLVY 750
Query: 139 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196
E+L N LA LFG LK +W R I IAR L +LHED + +IIH DIK NILL+
Sbjct: 751 EYLENNCLADALFGRSGLKLDWRTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNILLD 810
Query: 197 DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLE 256
N++ISDFGLA+L +Q I T + GT GY+APE+ + ++ K DVYSFGV+ +E
Sbjct: 811 KDLNSKISDFGLARLHEDDQSH-ITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAME 869
Query: 257 IISCRKSFDIEMGEEYAI-LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWC 315
I+S + + + E + L DWAF + G D++++ +E + D+ E+++ +S+ C
Sbjct: 870 IVSGKSNANYTPDNECCVGLLDWAFVLQKKGAFDEILDPKLEGVFDVMEAERMIKVSLLC 929
Query: 316 IQEDPSLRPTMRKVSQMLQEVVEVD 340
+ P+LRPTM +V +ML+ E++
Sbjct: 930 SSKSPTLRPTMSEVVKMLEGETEIE 954
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 1.3e-52, P = 1.3e-52
Identities = 123/308 (39%), Positives = 183/308 (59%)
Query: 51 FSYKELEEATDNFK--EEVGRGSFGIIYKGVIQXXXXXXXAVAVKKLDRVFQDGEKEFKN 108
F +K +E AT+ F ++G+G FG +YKG + VAVK+L + GEKEF+N
Sbjct: 314 FDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQ----VAVKRLSKTSGQGEKEFEN 369
Query: 109 EVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN---LKPNWNLRTNIA 165
EV+V+ + H+NLV+LLG+C EG+ ++L YEF+ N +L FLF + +K +W R I
Sbjct: 370 EVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKII 429
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
IAR +LYLH+D IIH D+K NILL+D N +I+DFG+A++ ++Q + + +
Sbjct: 430 GGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVV 489
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDI-EMGEEYAILTDWAFDCYR 284
GT GY++PE+ S K DVYSFGVL+LEIIS K+ + +M E L + + +
Sbjct: 490 GTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWS 549
Query: 285 NGKLDDLVE---GDMEAMNDI-KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340
NG +LV+ GD ++I +C+ I++ C+QED RPTM + QML +
Sbjct: 550 NGSPSELVDPSFGDNYQTSEITRCIH----IALLCVQEDAEDRPTMSSIVQMLTTSLIAL 605
Query: 341 VPPNPSPF 348
P P F
Sbjct: 606 AEPRPPGF 613
|
|
| TAIR|locus:2083986 AT3G53380 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 544 (196.6 bits), Expect = 1.7e-52, P = 1.7e-52
Identities = 121/342 (35%), Positives = 188/342 (54%)
Query: 16 FALVCAVGLGFFFIYKKKWIRNSPGDG---TIETKSRCFSYKELEEATDNFKEE--VGRG 70
F L G F++Y KK+ R D I + FSYKEL+ T NF E +G G
Sbjct: 327 FFLALFAG-ALFWVYSKKFKRVERSDSFASEIIKAPKEFSYKELKAGTKNFNESRIIGHG 385
Query: 71 SFGIIYKGVIQXXXXXXXAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE 130
+FG++Y+G++ VAVK+ QD + EF +E+ +IG H+NLVRL G+C E
Sbjct: 386 AFGVVYRGILPETGDI---VAVKRCSHSSQDKKNEFLSELSIIGSLRHRNLVRLQGWCHE 442
Query: 131 GQNRLLAYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIK 189
LL Y+ + NG+L LF W+ R I +A L YLH +C +Q+IH D+K
Sbjct: 443 KGEILLVYDLMPNGSLDKALFESRFTLPWDHRKKILLGVASALAYLHRECENQVIHRDVK 502
Query: 190 PQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYS 249
NI+L++ +NA++ DFGLA+ + + + T GT GY+APE+ S K DV+S
Sbjct: 503 SSNIMLDESFNAKLGDFGLARQIE-HDKSPEATVAAGTMGYLAPEYLLTGRASEKTDVFS 561
Query: 250 FGVLLLEIISCRKSFDIEMG-EEYAI-----LTDWAFDCYRNGKLDDLVEGDMEAMNDIK 303
+G ++LE++S R+ + ++ + + + L +W + Y+ GK+ + +E D
Sbjct: 562 YGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNLVEWVWGLYKEGKVSAAADSRLEGKFDEG 621
Query: 304 CVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNP 345
+ ++L++ + C DP+ RPTMR V QML + E DVP P
Sbjct: 622 EMWRVLVVGLACSHPDPAFRPTMRSVVQML--IGEADVPVVP 661
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 2.1e-52, P = 2.1e-52
Identities = 134/342 (39%), Positives = 190/342 (55%)
Query: 18 LVCAVGLGFFFIYKKKWIRNSPG---DGTIETKSRCFSYKELEEATDNFKE--EVGRGSF 72
L+ G FF KK +P D +S Y+ ++ AT++F E ++GRG F
Sbjct: 288 LIFIAGYCFFAKRAKKTYGTTPALDEDDKTTIESLQLDYRAIQAATNDFSENNKIGRGGF 347
Query: 73 GIIYKGVIQXXXXXXXAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ 132
G +YKG VAVK+L + + G+ EFKNEV+V+ HKNLVR+LGF E +
Sbjct: 348 GDVYKGTFSNGTE----VAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIERE 403
Query: 133 NRLLAYEFLNNGTLASFLFGNLKPN---WNLRTNIAFQIARVLLYLHEDCSSQIIHCDIK 189
R+L YE++ N +L +FLF K W R +I IAR +LYLH+D IIH D+K
Sbjct: 404 ERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLK 463
Query: 190 PQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYS 249
NILL+ N +I+DFG+A++ ++Q + + I GT GY++PE+ + S K DVYS
Sbjct: 464 ASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYS 523
Query: 250 FGVLLLEIISCRK--SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEK 307
FGVL+LEIIS RK SF IE + ++T A+ +RNG DLV+ + V +
Sbjct: 524 FGVLVLEIISGRKNNSF-IETDDAQDLVTH-AWRLWRNGTALDLVDPFIADSCRKSEVVR 581
Query: 308 LLMISIWCIQEDPSLRPTMRKVSQML-QEVVEVDVPPNPSPF 348
I + C+QEDP RP M +S ML + + P P F
Sbjct: 582 CTHIGLLCVQEDPVKRPAMSTISVMLTSNTMALPAPQQPGFF 623
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 3.5e-52, P = 3.5e-52
Identities = 123/333 (36%), Positives = 186/333 (55%)
Query: 19 VCAVGLGFFFIYKKKWIRNSPGDGTIETK---SRCFSYKELEEATDNFKEE--VGRGSFG 73
+C +Y+ SP G E+ F+ ++LE AT+ F +E +G G +G
Sbjct: 110 LCVANRSTSSLYEMATPSPSPLSGLPESHLGWGHWFTLRDLEIATNRFSKENVIGEGGYG 169
Query: 74 IIYKGVIQXXXXXXXAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133
++Y+G + VAVKK+ EKEF+ EV IG HKNLVRLLG+C EG N
Sbjct: 170 VVYRGEL----VNGSLVAVKKILNHLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGTN 225
Query: 134 RLLAYEFLNNGTLASFLFGNLKPN----WNLRTNIAFQIARVLLYLHEDCSSQIIHCDIK 189
R+L YE++NNG L +L G +K + W R + ++ L YLHE +++H DIK
Sbjct: 226 RILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHRDIK 285
Query: 190 PQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYS 249
NIL++DR+NA+ISDFGLAKLL + + + T + GT GYVAPE+ ++ K DVYS
Sbjct: 286 SSNILIDDRFNAKISDFGLAKLLG-DGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYS 344
Query: 250 FGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLL 309
FGVL+LE I+ R D L +W + +L+++++ ++ + ++++L
Sbjct: 345 FGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGSKRLEEVIDPNIAVRPATRALKRVL 404
Query: 310 MISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342
+ ++ CI D RP M +V +ML E E VP
Sbjct: 405 LTALRCIDPDSEKRPKMSQVVRML-ESEEYPVP 436
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 350 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-45 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 4e-47
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FKNEVIVIGQTHHKNLVRLL 125
+G G FG +Y + T VA+K + + E E+ ++ + +H N+V+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKK---VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 126 GFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLHEDCSSQII 184
G ++ + L E+ G+L L N + + I QI L YLH S+ II
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGII 114
Query: 185 HCDIKPQNILLNDR-YNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE-WFRKSTIS 242
H D+KP+NILL+ +++DFGL+KLLT ++ I GT Y+APE K S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL--KTIVGTPAYMAPEVLLGKGYYS 172
Query: 243 AKVDVYSFGVLLLEIISCRK 262
K D++S GV+L E+ +
Sbjct: 173 EKSDIWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 7e-46
Identities = 81/280 (28%), Positives = 134/280 (47%), Gaps = 34/280 (12%)
Query: 63 FKEEVGRGSFGIIYKGV-IQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKN 120
+++G G+FG +YKG VAVK L + + +EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHED 178
+V+LLG C E + + E++ G L S+L +P +L + A QIAR + YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA---IRGTKGYVAPEW 235
S IH D+ +N L+ + +ISDFGL++ L + + IR ++APE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPES 174
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 294
++ ++K DV+SFGVLL EI + +GE+ Y +++ + L G
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT--------LGEQPYPGMSN--EEVLE-----YLKNG 219
Query: 295 D-MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333
+ C +L + + C EDP RPT ++ ++L
Sbjct: 220 YRLPQPP--NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 82/280 (29%), Positives = 136/280 (48%), Gaps = 33/280 (11%)
Query: 63 FKEEVGRGSFGIIYKGV-IQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKN 120
+++G G+FG +YKG VAVK L + + +EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHED 178
+V+LLG C E + ++ E++ G L +L N +L + A QIAR + YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA---IRGTKGYVAPEW 235
S IH D+ +N L+ + +ISDFGL++ L + +K IR ++APE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPES 175
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 294
++ ++K DV+SFGVLL EI + +GEE Y +++ + L +G
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT--------LGEEPYPGMSN--AEVLE-----YLKKG 220
Query: 295 D-MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333
+ + C +L + + C EDP RPT ++ ++L
Sbjct: 221 YRLPKPPN--CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 81/282 (28%), Positives = 127/282 (45%), Gaps = 41/282 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE--FKNEVIVIGQTHHKN 120
++G GSFG +YK + T VAVK L + + +K+ + E+ ++ + H N
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKI---VAVKILKKRSEKSKKDQTARREIRILRRLSHPN 59
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCS 180
+VRL+ ++ + L E+ G L +L + + IA QI R L YLH +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN-- 117
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
IIH D+KP+NILL++ +I+DFGLAK L + T GT Y+APE
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGN 174
Query: 241 -ISAKVDVYSFGVLLLEIISCRKSFD----------IEMGEEYAILTDWAFDCYRNGKLD 289
KVDV+S GV+L E+++ + F I + D + +
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331
DL++ C+ +DPS RPT ++ Q
Sbjct: 235 DLIK--------------------KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 3e-45
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 33/276 (11%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FKNEVIVIGQTHHKNL 121
E++G GSFG +Y T VA+K + + ++E E+ ++ + H N+
Sbjct: 3 ILEKLGEGSFGKVYL-ARDKKTGKL--VAIKVIKKKKIKKDRERILREIKILKKLKHPNI 59
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
VRL ++ L E+ G L L G L + QI L YLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE--ARFYLRQILSALEYLH--- 114
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
S I+H D+KP+NILL++ + +++DFGLA+ L ++ T T + GT Y+APE
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYMAPEVLLGK 171
Query: 240 TISAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDC-YRNGKLDDLVEGDM 296
VD++S GV+L E+++ + F D ++ E + + +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP------ 225
Query: 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332
EA + I+ + +DP R T + Q
Sbjct: 226 EAKDLIRK----------LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 6e-44
Identities = 85/288 (29%), Positives = 137/288 (47%), Gaps = 44/288 (15%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE-KEFKNEVIVIGQTHHKNLVR 123
+++G G+FG +YKG ++ TT VAVK L + E K+F E V+ + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFL------FGNLKPN---WNLRTNIAFQIARVLLY 174
LLG C E + L E++ G L +L F + + + + A QIA+ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA----IRGTKGY 230
L S + +H D+ +N L+ + +ISDFGL++ + + KT IR +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 231 VAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKL 288
+APE + ++K DV+SFGVLL EI + +G + + + R G
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT--------LGATPYPGLSNEEVLEYLRKGYR 225
Query: 289 DDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQ 334
+ C ++L LM+S W Q DP RPT ++ + L+
Sbjct: 226 -------LPKP--EYCPDELYELMLSCW--QLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 8e-44
Identities = 81/281 (28%), Positives = 134/281 (47%), Gaps = 35/281 (12%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTST-TAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKN 120
+++G G+FG +YKG ++ T T VAVK L + E+ EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARVLLYLHE 177
+VRLLG C +G+ + E++ G L FL L +A QIA+ + YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE- 119
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN----QRKTIKTAIRGTKGYVAP 233
S +H D+ +N L+ + +ISDFGL++ + + +R K I+ ++AP
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAP 173
Query: 234 EWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292
E + ++K DV+SFGVLL EI + + + EE + + D YR
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLELLEDGYR-------- 222
Query: 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333
+ + C ++L + + C DP RPT ++ + L
Sbjct: 223 ---LPRPEN--CPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 77/287 (26%), Positives = 124/287 (43%), Gaps = 53/287 (18%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKK--LDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
E +GRGSFG +Y + +AVK L ++ + + E+ ++ H N+V
Sbjct: 6 ELLGRGSFGSVYLA---LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 123 RLLGFC-DEGQNRLLAY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHED 178
R G DE +N L + E+++ G+L+S L FG L +R QI L YLH
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIR-KYTRQILEGLAYLH-- 118
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S+ I+H DIK NIL++ +++DFG AK L + ++RGT ++APE R
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 239 STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298
D++S G ++E+ + + + E+G A A
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWS-ELGNPMA------------------------A 212
Query: 299 MNDIKCVEKLLMISIW-----------CIQEDPSLRPTMRKVSQMLQ 334
+ I + I C++ DP RPT ++LQ
Sbjct: 213 LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT---ADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 9e-31
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
E++G+G FG +YK T VA+K + ++ +++ NE+ ++ + H N+V+
Sbjct: 5 LEKIGKGGFGEVYK-ARHKRTGKE--VAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNL-RTNIAFQIARVLL---YLHEDC 179
G + + EF + G+L L + L + IA+ +L YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLH--- 115
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
S+ IIH DIK NILL ++ DFGL+ L+ K T + GT ++APE
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMV-GTPYWMAPEVINGK 172
Query: 240 TISAKVDVYSFGVLLLE 256
K D++S G+ +E
Sbjct: 173 PYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 45/281 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+G+G FG + G + VAVK L + F E V+ H NLV
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQK-----VAVKCLKDD-STAAQAFLAEASVMTTLRHPNLV 63
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARVLLYLHEDCS 180
+LLG +G + E++ G+L +L + L + A + + YL E
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE--- 120
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+H D+ +N+L+++ A++SDFGLAK + Q + K ++ T APE R+
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-DSGKLPVKWT----APEALREKK 175
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG-----D 295
S K DV+SFG+LL EI S + Y L D+V
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRV------------------PYPRIPLKDVVPHVEKGYR 217
Query: 296 MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQ 334
MEA C ++ +M W + DP+ RPT +++ + L
Sbjct: 218 MEAPE--GCPPEVYKVMKDCWEL--DPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 5e-29
Identities = 89/339 (26%), Positives = 158/339 (46%), Gaps = 32/339 (9%)
Query: 10 SSVFVNFALVCAVGLGFFFIYKKKWI---RNSPGDGTIETK---SRCFSYKELEEATDNF 63
+ F ++ V GF FI + + R DGT E + S+ + + +
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL 692
Query: 64 KEE--VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
KEE + RG G YKG + + VK+++ V E + +G+ H N+
Sbjct: 693 KEENVISRGKKGASYKG---KSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNI 745
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
V+L+G C + L +E++ L+ L +W R IA IA+ L +LH CS
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
++ ++ P+ I+++ + + L LL + + I +A YVAPE I
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------YVAPETRETKDI 855
Query: 242 SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL----DDLVEGDME 297
+ K D+Y FG++L+E+++ + D E G +I+ +WA CY + L D + GD+
Sbjct: 856 TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV-EWARYCYSDCHLDMWIDPSIRGDV- 913
Query: 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336
++N + VE ++ +++ C DP+ RP V + L+
Sbjct: 914 SVNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 1e-28
Identities = 79/287 (27%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---FKNEVIVIGQ-TH 117
++G GSFG +Y VA+K L + + KE F E+ ++ H
Sbjct: 3 RILRKLGEGSFGEVYLAR------DRKLVALKVLAKKLESKSKEVERFLREIQILASLNH 56
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL-----FGNLKPNWNLRTNIAFQIARVL 172
N+V+L F + + L E+++ G+L L G L + L I QI L
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF--ILAQILSAL 114
Query: 173 LYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLNQRKTI----KTAIRGT 227
YLH IIH DIKP+NILL+ D ++ DFGLAKLL + + GT
Sbjct: 115 EYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 228 KGYVAPEWFRKST---ISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWA 279
GY+APE + S+ D++S G+ L E+++ F+ E I+ +
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 280 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTM 326
+ E +A +D+ ++KLL +DP R +
Sbjct: 232 TPSLASPLSPSNPELISKAASDL--LKKLL-------AKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVFQDGEKEFKNEVIVIGQTHHKN 120
+ +GRG+FG++YKG+ T VA+K++ ++ ++ K E+ ++ H N
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDF---VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHED 178
+V+ +G + + + E+ NG+L + FG +L +Q+ + L YLHE
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF--PESLVAVYVYQVLQGLAYLHE- 117
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
+IH DIK NIL +++DFG+A LN ++ GT ++APE
Sbjct: 118 --QGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 239 STISAKVDVYSFGVLLLEIISCRKS-FDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDM 296
S S D++S G ++E+++ +D+ M + I+ D D L EG
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---DHPP------LPEGIS 224
Query: 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRK 328
+ D LM C Q+DP+LRPT ++
Sbjct: 225 PELKD------FLMQ---CFQKDPNLRPTAKQ 247
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-28
Identities = 68/198 (34%), Positives = 101/198 (51%), Gaps = 8/198 (4%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
+E+G G+FG + KGV + VAVK L G+KEF E V+ Q H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARVLLYLHEDCSSQ 182
L+G C +G+ +L E G L +L + P +L +A Q+A + YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-KELAHQVAMGMAYLES---KH 115
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLL-TLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
+H D+ +N+LL +R+ A+ISDFG+++ L + TA R + APE
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 242 SAKVDVYSFGVLLLEIIS 259
S+K DV+S+GV L E S
Sbjct: 176 SSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 65/216 (30%), Positives = 111/216 (51%), Gaps = 26/216 (12%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTA-VAVKKLDRVFQDGE----KEFKNEVIVIGQTH 117
F +++G G FG + +T VAVK L+ GE +F+ E+ ++
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH---SGEEQHRSDFEREIEILRTLD 64
Query: 118 HKNLVRLLGFCDE--GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARVLL 173
H+N+V+ G C++ G++ L E+L +G+L +L + + NL+ + + QI + +
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMD 123
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ-----RKTIKTAIRGTK 228
YL S + IH D+ +NIL+ +ISDFGLAK+L ++ ++ ++ I
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF--- 177
Query: 229 GYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKS 263
+ APE R S S+ DV+SFGV L E+ + S
Sbjct: 178 -WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 3e-26
Identities = 69/278 (24%), Positives = 128/278 (46%), Gaps = 36/278 (12%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK---NEVIVIGQTHHKN 120
+++G+GSFG +Y ++ + +K++D + EKE + NEV ++ + +H N
Sbjct: 5 IKQIGKGSFGKVYL--VRRKSDGKL-YVLKEID-LSNMSEKEREDALNEVKILKKLNHPN 60
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT----NIAFQIARVLLYLH 176
+++ +E + E+ + G L+ + K + Q+ L YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
S +I+H DIKPQNI L ++ DFG++K+L+ KT + GT Y++PE
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA-KTVV-GTPYYLSPELC 175
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR--NGKLDDLVEG 294
+ + K D++S G +L E+ + + F+ GE L + G+ +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLEL------ALKILKGQYPPIPSQ 226
Query: 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332
+ ++ V LL Q+DP RP++ ++ Q
Sbjct: 227 YSSELRNL--VSSLL-------QKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 68/230 (29%), Positives = 112/230 (48%), Gaps = 34/230 (14%)
Query: 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTT--STTAVAVKKL-DRVFQDGEKEFKNEVI 111
E+ + F EE+G G+FG +YKG + S T+VA+K L + ++EF+ E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 112 VIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--------- 162
++ H N+V LLG C + Q + +E+L +G L FL N P+ ++
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRN-SPHSDVGAESGDETVKS 119
Query: 163 --------NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214
+IA QIA + YL S +H D+ +N L+ + +ISDFGL++ +
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176
Query: 215 N-----QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
Q K++ +R ++ PE + + D++SFGV+L EI S
Sbjct: 177 ADYYRVQSKSL-LPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 49/284 (17%)
Query: 63 FKEEVGRGSFGII----YKGVIQTTTTSTTAVAVKKLDRVFQDG---EKEFKNEVIVIGQ 115
F +E+G G FG++ ++G I VA+K + ++G E +F E V+ +
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID--------VAIKMI----REGAMSEDDFIEEAKVMMK 55
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARVL 172
H NLV+L G C + + + E++ NG L ++L G L W L ++ + +
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCSDVCEAM 113
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK---G 229
YL + IH D+ +N L+ + ++SDFGLA+ + +Q T+ +GTK
Sbjct: 114 EYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----TSSQGTKFPVK 166
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289
+ PE F S S+K DV+SFGVL+ E+ S K ++ + N ++
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM---------------PYERFSNSEVV 211
Query: 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333
+ V ++ I C E P RP +K+ L
Sbjct: 212 ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 82/289 (28%), Positives = 131/289 (45%), Gaps = 39/289 (13%)
Query: 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIV 112
E+E K ++G G +G +Y+GV + + + VAVK L +D +EF E V
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLK---EDTMEVEEFLKEAAV 55
Query: 113 IGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIAR 170
+ + H NLV+LLG C + EF+ G L +L + N +A QI+
Sbjct: 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK-- 228
+ YL IH D+ +N L+ + + +++DFGL++L+T TA G K
Sbjct: 116 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFP 168
Query: 229 -GYVAPEWFRKSTISAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAILTDWAFDCYRN 285
+ APE + S K DV++FGVLL EI + I++ + Y +L
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EK 220
Query: 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
G + EG C K+ + C Q +PS RP+ ++ Q +
Sbjct: 221 GYRMERPEG---------CPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 25/269 (9%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLG 126
G+GS G++YK + T A+KK+ + K+ E+ + +V+ G
Sbjct: 10 GQGSSGVVYKVRHKPTGK---IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 127 -FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIH 185
F EG+ + E+++ G+LA L K + IA QI + L YLH IIH
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIH 123
Query: 186 CDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKV 245
DIKP N+L+N + +I+DFG++K L GT Y++PE + + S
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 246 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCV 305
D++S G+ LLE + F + L + + +G ++ +
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFEL------------MQAICDGPPPSLPAEEFS 229
Query: 306 EKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
+ C+Q+DP RP+ +++LQ
Sbjct: 230 PEFRDFISACLQKDPKKRPS---AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-24
Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 43/289 (14%)
Query: 66 EVGRGSFGIIYKGVIQTTTTST--TAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNLV 122
E+G+GSFG++Y+G+ + T VA+K ++ E+ EF NE V+ + + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFL--------FGNLK--PNWNLRTNIAFQIARVL 172
RLLG GQ L+ E + G L S+L P +A +IA +
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTA--IRGTK 228
YL + +H D+ +N ++ + +I DFG+ + + T RK K +R
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 229 GYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILT-DWAFDCYRNG 286
++APE + + K DV+SFGV+L E+ + + E+ Y L+ + +G
Sbjct: 187 -WMAPESLKDGVFTTKSDVWSFGVVLWEMAT--------LAEQPYQGLSNEEVLKFVIDG 237
Query: 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
DL E C +KLL + C Q +P +RPT ++ L++
Sbjct: 238 GHLDLPEN---------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-24
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQ-THH 118
F + +G GSF + + T A+K LD+ + K K E V+ + H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKE---YAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 119 KNLVRLLG-FCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYL 175
+++L F DE +N E+ NG L ++ +G+L + A +I L YL
Sbjct: 62 PGIIKLYYTFQDE-ENLYFVLEYAPNGELLQYIRKYGSL--DEKCTRFYAAEILLALEYL 118
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR---------KTIKTAIR- 225
H S IIH D+KP+NILL+ + +I+DFG AK+L N +
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 226 --------GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFD 265
GT YV+PE + D+++ G ++ ++++ + F
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
E++G G+ G +YK + T VA+KK+ R+ + ++ NE++++ H N+
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKE---VAIKKM-RLRKQNKELIINEILIMKDCKHPNI 77
Query: 122 VRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARV-------LL 173
V + L + E+++ G+L + N QIA V L
Sbjct: 78 VDYYD-SYLVGDELWVVMEYMDGGSLTDII------TQNFVRMNEPQIAYVCREVLQGLE 130
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAP 233
YLH S +IH DIK NILL+ + +++DFG A LT + K + ++ GT ++AP
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAP 185
Query: 234 EWFRKSTISAKVDVYSFGVLLLEII 258
E ++ KVD++S G++ +E+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 7e-24
Identities = 75/286 (26%), Positives = 131/286 (45%), Gaps = 32/286 (11%)
Query: 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIG 114
E++ + ++G G FG +++G+ +TT VAVK L D K+F E ++
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGL----WNNTTPVAVKTLKPGTMD-PKDFLAEAQIMK 56
Query: 115 QTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVL 172
+ H L++L C + + E + G+L +L G L ++A Q+A +
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK---G 229
YL + IH D+ +N+L+ + +++DFGLA+++ + I A G K
Sbjct: 117 AYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIK 169
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289
+ APE + S K DV+SFG+LL EI++ + Y +T N ++
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM-------PYPGMT--------NAEVL 214
Query: 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
V+ C ++L I + C +EDP RPT + L++
Sbjct: 215 QQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 45/283 (15%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE----KEFKNEVIVIGQTHHKNLV 122
+G G+FG +Y V + +AVK++ QD + KE +E+ V+ H NLV
Sbjct: 8 IGGGTFGKVYTAV---NLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
+ G + + E+ + GTL L G + +R Q+ L YLH S
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-YTLQLLEGLAYLH---SH 118
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK--TIKTAIRGTKGYVAPEWFRKS 239
I+H DIKP NI L+ ++ DFG A L N ++ GT Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 240 TISAK---VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-----KLDDL 291
D++S G ++LE+ + ++ + E+ E+ I+ + G + D
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWS-ELDNEFQIM-------FHVGAGHKPPIPDS 230
Query: 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
++ E + + C++ DP RPT S++LQ
Sbjct: 231 LQLSPEGKDFLD----------RCLESDPKKRPT---ASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-23
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
+ ++G G FG ++ G T TT VAVK L E F E ++ + H LV+
Sbjct: 11 ERKLGAGQFGEVWMG----TWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQ 65
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCSS 181
L C E + + E+++ G+L FL L ++A QIA + YL S
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SR 122
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK---GYVAPEWFRK 238
IH D+ +NIL+ + +I+DFGLA+L+ + TA G K + APE
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDD----EYTAREGAKFPIKWTAPEAANY 178
Query: 239 STISAKVDVYSFGVLLLEIIS 259
+ K DV+SFG+LL EI++
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+E+G G FG+++ G VA+K + E++F E V+ + H LV
Sbjct: 8 LVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLV 62
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCS 180
+L G C E L +EF+ +G L+ +L + ++ T + + + YL
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN- 120
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+IH D+ +N L+ + ++SDFG+ + + L+ + T T + + +PE F S
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 241 ISAKVDVYSFGVLLLEIIS 259
S+K DV+SFGVL+ E+ S
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
++G G FG +++G+ + VA+K L +++F+ EV + + HK+L+ L
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVR----VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT----NIAFQIARVLLYLHEDCS 180
C G+ + E + G+L +FL L ++A Q+A + YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE--- 122
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
IH D+ +NIL+ + +++DFGLA+L+ + + I + APE T
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGT 180
Query: 241 ISAKVDVYSFGVLLLEIIS 259
S K DV+SFG+LL E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-22
Identities = 78/283 (27%), Positives = 131/283 (46%), Gaps = 36/283 (12%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNLVR 123
+ +G G FG + +G ++ VA+K L D ++ +F E ++GQ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQ 182
L G + + ++ E++ NG+L FL N K + IA + YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLL-----TLNQRKTIKTAIRGTKGYVAPE--W 235
+H D+ +NIL+N ++SDFGL++ L T + K IR T APE
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGG-KIPIRWT----APEAIA 181
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 294
+RK T ++ DV+SFG+++ E++S GE Y D + N + VE
Sbjct: 182 YRKFTSAS--DVWSFGIVMWEVMS--------YGERPYW---DMS-----NQDVIKAVED 223
Query: 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337
+ C L + + C Q+D + RPT ++ L +++
Sbjct: 224 GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 8e-22
Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 45/294 (15%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTST--TAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHH 118
E+G+GSFG++Y+G + T VAVK ++ E+ EF NE V+
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQI 168
++VRLLG +GQ L+ E + +G L S+L G P +A +I
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRG 226
A + YL+ + + +H D+ +N ++ + +I DFG+ + + T RK G
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK-------G 178
Query: 227 TKG-----YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 281
KG ++APE + + D++SFGV+L EI S L + +
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQ 223
Query: 282 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
N ++ V C E++ + C Q +P +RPT ++ +L++
Sbjct: 224 GLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 67 VGRGSFGIIYKGVI--QTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVR 123
+G G+FG +Y+G+ + VAVK L + E +F E +++ + +H+N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--------NIAFQIARVLLYL 175
L+G E R + E + G L SFL N +P + A +A+ YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLREN-RPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNAR---ISDFGLAKLL--TLNQRKTIKTAIRGTKGY 230
E + IH DI +N LL + R I+DFG+A+ + RK + A+ K +
Sbjct: 133 EE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR-AMLPIK-W 187
Query: 231 VAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
+ PE F ++K DV+SFGVLL EI S
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 68 GRGSFGIIYKGV-IQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
G G+FG +YKGV I VA+K L + KE +E V+ H ++VRLL
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 126 GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCSSQI 183
G C L + + G L ++ + K N + N QIA+ + YL E ++
Sbjct: 76 GIC-LSSQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEE---KRL 130
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
+H D+ +N+L+ + +I+DFGLAKLL +++++ + ++A E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 244 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-GDMEAMNDI 302
K DV+S+GV + E+++ G + ++ ++ DL+E G+ I
Sbjct: 191 KSDVWSYGVTVWELMT--------FGAK-------PYEGIPAVEIPDLLEKGERLPQPPI 235
Query: 303 KCVEKLLMISIWCIQEDPSLRPTMRKVS 330
C + M+ + C D RPT +++
Sbjct: 236 -CTIDVYMVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-21
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVI----VIGQTHHKNL 121
E+G G+FG + KG+ + + T VAVK L + + K+E++ V+ Q + +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKT-VAVKILKN--DNNDPALKDELLREANVMQQLDNPYI 58
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
VR++G C E ++ +L E G L FL N T + Q++ + YL E +
Sbjct: 59 VRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---T 114
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR-KTIKTAIRGTKGYVAPEWFRKST 240
+H D+ +N+LL ++ A+ISDFGL+K L ++ KT + + APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 241 ISAKVDVYSFGVLLLEIIS 259
S+K DV+SFGVL+ E S
Sbjct: 175 FSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 71/285 (24%), Positives = 116/285 (40%), Gaps = 44/285 (15%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD-RVFQDGEKE-FKNEVIVIGQTHHKNLV 122
E +G+GSFG + K V + + + K++D + EK+ +EV ++ + H N+V
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKI--LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 123 RLLG-FCDEGQNRLLAY-EFLNNGTLASFLFGNLKPN---------WNLRTNIAFQIARV 171
R D L E+ G LA + K W I Q+
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEFIWR----ILTQLLLA 117
Query: 172 LLYLH--EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
L H D + ++H D+KP NI L+ N ++ DFGLAK+L + KT + GT
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA-KTYV-GTPY 175
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289
Y++PE + K D++S G L+ E+ + F L + GK
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKI----KEGKFR 228
Query: 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
+ +N++ I + DP RP+ ++LQ
Sbjct: 229 RIPYRYSSELNEV--------IKS-MLNVDPDKRPS---TEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-21
Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 33/273 (12%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E +G G FG + +G T AV K D Q F E V+ + HHKNLVRL
Sbjct: 12 EIIGEGEFGAVLQG---EYTGQKVAVKNIKCDVTAQ----AFLEETAVMTKLHHKNLVRL 64
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQ 182
LG + E ++ G L +FL G + + +A + YL S +
Sbjct: 65 LGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKK 120
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTIS 242
++H D+ +NIL+++ A++SDFGLA++ + + K + APE + S
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVK-WTAPEALKHKKFS 175
Query: 243 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 302
+K DV+S+GVLL E+ S ++ +M + + + YR ME
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKGYR-----------MEPPEGC 222
Query: 303 KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
+LM S W + +P RP+ K+ + L++
Sbjct: 223 PADVYVLMTSCW--ETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 8e-21
Identities = 70/290 (24%), Positives = 133/290 (45%), Gaps = 53/290 (18%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNLVRLL 125
+G G FG +++G+++ AVA+K L + + ++ +F +E ++GQ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 126 GFCDEGQNRLLAYEFLNNGTLASFL------FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
G + + ++ E++ NG L +L F + + LR IA + YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG-----IAAGMKYLSD-- 125
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA-----IRGTKGYVAPE 234
+H D+ +NIL+N ++SDFGL+++L + T T+ IR T APE
Sbjct: 126 -MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT----APE 180
Query: 235 WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294
++ DV+SFG+++ E++S + +M
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV--------------------- 219
Query: 295 DMEAMND-------IKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337
M+A+ND + C + + + C Q+D + RP + +L +++
Sbjct: 220 -MKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 55 ELEEATDNFKEEV--GRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIV 112
E E D E V G+G++GI+Y +T +A+K++ + E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVR---IAIKEIPERDSRYVQPLHEEIAL 58
Query: 113 IGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIA 169
H+N+V+ LG E + E + G+L++ L +G LK N QI
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA--RISDFGLAKLLT-LNQRKTIKTAIRG 226
L YLH++ QI+H DIK N+L+N Y+ +ISDFG +K L +N G
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGIN---PCTETFTG 171
Query: 227 TKGYVAPEWFRKST--ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 273
T Y+APE K A D++S G ++E+ + + F IE+GE A
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF-IELGEPQA 219
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 32/272 (11%)
Query: 67 VGRGSFGIIYKGV-IQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+G G FG ++KG+ I + VA+K + DR + +E + ++ +G H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
LG C G + L + G+L + +L P N QIA+ + YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQ--RLLNWCVQIAKGMYYLEEHR-- 129
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE--WFRKS 239
++H ++ +NILL +I+DFG+A LL + +K + + ++A E F +
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 240 TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-GDMEA 298
T + DV+S+GV + E++S E YA + R ++ DL+E G+ A
Sbjct: 189 T--HQSDVWSYGVTVWEMMSYG-------AEPYAGM--------RPHEVPDLLEKGERLA 231
Query: 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330
I C + M+ + C D ++RPT ++++
Sbjct: 232 QPQI-CTIDVYMVMVKCWMIDENVRPTFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 68/226 (30%), Positives = 112/226 (49%), Gaps = 27/226 (11%)
Query: 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIV 112
Y LE F++ +G G+FG + K I+ A + + +D ++F E+ V
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 113 IGQT-HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA-- 169
+ + HH N++ LLG C+ LA E+ +G L FL + + L T+ AF IA
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANS 116
Query: 170 -------RVLLYLHEDCS--------SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214
+ LL+ D + Q IH D+ +NIL+ + Y A+I+DFGL++ +
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 215 NQRKTI-KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
+KT+ + +R ++A E S + DV+S+GVLL EI+S
Sbjct: 177 YVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 76/291 (26%), Positives = 137/291 (47%), Gaps = 47/291 (16%)
Query: 66 EVGRGSFGIIYKGVIQTTTTST--TAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNLV 122
E+G+GSFG++Y+G+ + T VA+K ++ E+ EF NE V+ + + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQIARVL 172
RLLG +GQ L+ E + G L S+L P+ +A +IA +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKG- 229
YL+ +++ +H D+ +N ++ + + +I DFG+ + + T RK G KG
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-------GGKGL 182
Query: 230 ----YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285
+++PE + + DV+SFGV+L EI A L + + N
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGMSN 227
Query: 286 GK-LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
+ L ++EG + D C + L + C Q +P +RP+ ++ ++E
Sbjct: 228 EQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-20
Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKL--DRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
VGRG+FGI++ + V +K++ +++ +D +NE V+ H N++
Sbjct: 8 VGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
E + ++ E+ GTLA ++ + T + F ++LL LH + I+
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF-FVQILLALHHVHTKLIL 123
Query: 185 HCDIKPQNILLNDRYN-ARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
H D+K QNILL+ +I DFG++K+L+ K+ + GT Y++PE +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 244 KVDVYSFGVLLLEIISCRKSFDIE 267
K D+++ G +L E+ S +++F+
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-20
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 8/199 (4%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
+++G GSFG++ +G T+ VAVK L D +F E ++ H+NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCSS 181
L G ++ E G+L L + ++ + T + A QIA + YL S
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK-GYVAPEWFRKST 240
+ IH D+ +NILL +I DFGL + L N+ + + APE R T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 241 ISAKVDVYSFGVLLLEIIS 259
S DV+ FGV L E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-20
Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 53/292 (18%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD-------RVFQDGEKEFKNEV----IVI 113
E +G G+FG +YK ++ +A+K+++ + ++ +K + V I+
Sbjct: 6 EHLGSGAFGCVYK--VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63
Query: 114 GQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPN---------WNLRTNI 164
Q H N+VR E + + + L F +LK WN I
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWN----I 118
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224
Q+ L YLH++ +I+H D+ P NI+L + I+DFGLAK Q ++ T++
Sbjct: 119 FVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSV 173
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284
GT Y PE + K DV++FG +L ++ + + F Y
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF------------------YS 215
Query: 285 NGKLD---DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333
L +VE E + + E + + C+ D RP + +VS M+
Sbjct: 216 TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 82/300 (27%), Positives = 131/300 (43%), Gaps = 56/300 (18%)
Query: 67 VGRGSFGIIYKGVIQTT--TTSTTAVAVKKL--DRVFQDGEKEFKN-----EVI-VIGQT 116
+G G+FG + K T+ VAVK L D EK+ + E++ +IG+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT----EKDLSDLVSEMEMMKMIGK- 74
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNI------------ 164
HKN++ LLG C + + E+ +G L FL P +
Sbjct: 75 -HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 165 ----AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RK 218
A+Q+AR + +L S + IH D+ +N+L+ + + +I+DFGLA+ + RK
Sbjct: 134 LVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTD 277
T T R ++APE + + DV+SFGVLL EI + G Y I +
Sbjct: 191 T--TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-------GSPYPGIPVE 241
Query: 278 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337
F + G ME C ++L + C E PS RPT +++ + L ++
Sbjct: 242 ELFKLLKEGY-------RME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-20
Identities = 73/277 (26%), Positives = 121/277 (43%), Gaps = 33/277 (11%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
E +GRG+FG ++ G ++ T VAVK + + D + +F E ++ Q H N+VR
Sbjct: 1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARVLLYLHEDCSS 181
L+G C + Q + E + G +FL P ++ I A + YL
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHC- 115
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK----GYVAPEWFR 237
IH D+ +N L+ ++ +ISDFG+++ + + + G K + APE
Sbjct: 116 --IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297
S++ DV+SFG+LL E S YA L+ N + + +E +
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAV-------PYANLS--------NQQTREAIEQGVR 214
Query: 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
C + + + C + DP RP+ V Q LQ
Sbjct: 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-20
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 34/214 (15%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN---EVIVIGQTHHKNLVR 123
+G+G+FG + ++Q T A+K +++ + +N E ++ + +H LV
Sbjct: 8 IGKGAFGKVC--IVQKRDTKKM-FAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 124 L-LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARV----------L 172
L F DE +N L + L G L ++L + F +V L
Sbjct: 65 LWYSFQDE-ENMYLVVDLLLGGDL----------RYHLSQKVKFSEEQVKFWICEIVLAL 113
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
YLH S IIH DIKP NILL+++ + I+DF +A +T T+ T+ GT GY+A
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTSTSGTPGYMA 167
Query: 233 PEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDI 266
PE + S VD +S GV E + ++ +
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-20
Identities = 74/288 (25%), Positives = 135/288 (46%), Gaps = 41/288 (14%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE-KEFKNEVIVIGQTHHKNLV 122
+E +G G FG + +G ++ VA+K L + + + ++F +E ++GQ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFL------FGNLKPNWNLRTNIAFQIARVLLYLH 176
L G + + ++ EF+ NG L SFL F ++ LR IA + YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG-----IAAGMKYLS 123
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK---GYVAP 233
E +H D+ +NIL+N ++SDFGL++ L + T+ G K + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 234 E--WFRKSTISAKVDVYSFGVLLLEIISC--RKSFDIEMGEEYAILTDWAFDCYRNGKLD 289
E +RK T ++ DV+S+G+++ E++S R +D+ N +
Sbjct: 181 EAIAYRKFTSAS--DVWSYGIVMWEVMSYGERPYWDMS-----------------NQDVI 221
Query: 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337
+ +E D + C L + + C Q+D + RP ++ L +++
Sbjct: 222 NAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-20
Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
E++G+G+FG +YKGV++ T VAVK + D +++F E ++ Q H N+V+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE----VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI----ARVLLYLHEDC 179
L+G C + Q + E + G+L +FL K L Q+ A + YL
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK----GYVAPEW 235
IH D+ +N L+ + +ISDFG+++ + I T G K + APE
Sbjct: 114 C---IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295
+++ DV+S+G+LL E S L D + N + + +E
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFS---------------LGDTPYPGMSNQQTRERIESG 211
Query: 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
C E++ + + C DP RP+ ++ LQ
Sbjct: 212 YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-19
Identities = 57/200 (28%), Positives = 107/200 (53%), Gaps = 12/200 (6%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE-KEFKNEVIVIGQTHHKNLVRLL 125
+G+G FG +Y G + + AVK L+R+ E ++F E I++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 126 GFC--DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARVLLYLHEDCSS 181
G C EG L+ ++ +G L +F+ + N ++ I F Q+A+ + YL S
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI--KTAIRGTKGYVAPEWFRKS 239
+ +H D+ +N +L++ + +++DFGLA+ + + ++ T + ++A E +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 240 TISAKVDVYSFGVLLLEIIS 259
+ K DV+SFGVLL E+++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-19
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 64 KEEVGRGSFGIIYKGV-IQTTTTSTTAVAVKKLDRVFQDGEKE--FKN---EVIVIGQTH 117
E++G G++G++YK +T VA+KK + D E+E E+ ++ +
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEI----VALKK---IRLDNEEEGIPSTALREISLLKELK 56
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARVLLY 174
H N+V+LL + L +E+ + L +L G L PN +++ I +Q+ R L Y
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-IKS-IMYQLLRGLAY 113
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE 234
H S +I+H D+KPQNIL+N +++DFGLA+ + R + T Y APE
Sbjct: 114 CH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPE 168
Query: 235 WFRKSTI-SAKVDVYSFGVLLLEII 258
S S VD++S G + E+I
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 54/288 (18%)
Query: 62 NFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHK 119
+FK +++G+GS+G +YK V + + A+ L + Q ++ NE+ ++ +H
Sbjct: 1 DFKVLKKLGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP 59
Query: 120 NLVR-----LLGFCDEGQNRL-LAYEFLNNGTLASFL-----FGNLKPN---WNLRTNIA 165
N++ L G N+L + E+ G L+ + L P W I
Sbjct: 60 NIISYKEAFLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IF 109
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
Q+ R L LHE +I+H D+K NILL +I D G++K+L N KT
Sbjct: 110 IQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---- 162
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCY 283
GT Y+APE ++ S K D++S G LL E+ + F+ ++ Y +
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------- 215
Query: 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331
GK + + + + I +Q P LRP K+
Sbjct: 216 --GKYPPIPPIYSQDLQN--------FIR-SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 2e-19
Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEF-KNEVIVIGQTHHKNLVRLL 125
+G+GSFG + V + T A+ V K ++ + E E E ++ + +H +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 126 -GFCDEGQNRL-LAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLL---YLHED 178
F E +L L E+ G L S L G F A ++L YLH
Sbjct: 60 YAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEER-----ARFYAAEIVLALEYLH-- 110
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S II+ D+KP+NILL+ + +++DFGLAK L ++ T GT Y+APE
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFC-GTPEYLAPEVLLG 167
Query: 239 STISAKVDVYSFGVLLLEIIS 259
VD +S GVLL E+++
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 61/214 (28%), Positives = 114/214 (53%), Gaps = 25/214 (11%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKK--LDRVFQDGEKE-------FKNEVIVIGQTH 117
+G GSFG +Y G+ +S +AVK+ L V + E+ ++ +
Sbjct: 8 IGSGSFGSVYLGM---NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 118 HKNLVRLLGFCDEGQNRLLAY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLY 174
H+N+V+ LG + L + E++ G++A+ L +G + L N QI + L Y
Sbjct: 65 HENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEET--LVRNFVRQILKGLNY 121
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN----QRKTIKTAIRGTKGY 230
LH + IIH DIK NIL++++ +ISDFG++K L N + + +++G+ +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 231 VAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
+APE ++++ + K D++S G L++E+++ + F
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 37/299 (12%)
Query: 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTS-TTAVAVKKLDRVFQDGE-KEFKNEVIV 112
EL + F EE+G +FG IYKG + VA+K L + + EF+ E +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 113 IGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF---------------GNLKPN 157
+ + HH N+V LLG + Q + +E+LN G L FL G +K +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 158 WNLRT--NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215
+ +IA QIA + YL S +H D+ +NIL+ ++ + +ISD GL++ +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 275
++ ++ PE S+ D++SFGV+L EI F + Y
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI------FSFGLQPYYGFS 231
Query: 276 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
+ R +L E C ++ + C QE PS RP + + L+
Sbjct: 232 NQEVIEMVRKRQLLPCSE---------DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 80/282 (28%), Positives = 131/282 (46%), Gaps = 45/282 (15%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE---KEFKNEVIVIGQTHHKNL 121
E +G GSFG +Y+G + AV L Q G+ K+ + E+ ++ + H N+
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLK-PNWNLRTNIAFQIARVLLYLHED 178
V+ LG E N + E + G+LA L +G+ P L T QI L YLH
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLH-- 119
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAK-LLTLNQRKTIKTAIRGTKGYVAPEWF- 236
+H DIK NIL++ +++DFG+AK ++ + K+ K G+ ++APE
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK----GSPYWMAPEVIA 174
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL----DDLV 292
++ D++S G +LE+ + + + E A + F R+ +L D L
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQL--EGVAAV----FKIGRSKELPPIPDHL- 227
Query: 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
EA + I + C+Q DPSLRPT +++L+
Sbjct: 228 --SDEAKDFI----------LKCLQRDPSLRPT---AAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-19
Identities = 75/297 (25%), Positives = 127/297 (42%), Gaps = 49/297 (16%)
Query: 63 FKEEVGRGSFGIIYKG--VIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHK 119
K E+G G+FG ++ G VAVK L + D K+F+ E ++ H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN---------------I 164
N+V+ G C EG ++ +E++ +G L FL + P+ + I
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSH-GPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA- 223
A QIA ++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 224 ---IRGTKGYVAPE--WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 278
IR ++ PE +RK T + DV+SFGV+L EI + K + E I
Sbjct: 185 MLPIR----WMPPESIMYRKFTTES--DVWSFGVVLWEIFTYGKQPWYGLSNEEVI---- 234
Query: 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
+C G+L C ++ I + C + DP R ++ + + LQ+
Sbjct: 235 --ECITQGRLLQRPRT---------CPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 24/284 (8%)
Query: 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTA-VAVKKLDRVFQDGEKEFKNEVIVIGQ 115
EE F +++G+G+FG + +T VAVKKL + ++F+ E+ ++
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 116 THHKNLVRLLGFC-DEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARV 171
H N+V+ G C G+ L L E+L G+L +L + + + R + + QI +
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKG 120
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR-KTIKTAIRGTKGY 230
+ YL S + +H D+ +NIL+ +I DFGL K+L ++ ++ +
Sbjct: 121 MEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 231 VAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKS------FDIEMGEEYAILTDWAFDCY 283
APE +S S DV+SFGV+L E+ + KS F MG + Y
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND----KQGQMIVY 233
Query: 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMR 327
L +L++ + C ++ I C DPS RP+
Sbjct: 234 H---LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-19
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+++G G FG ++ G T VA+K L + E F E ++ Q H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYYN----GHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRL 66
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQ 182
+ + + E++ NG+L FL +K N ++A QIA + ++
Sbjct: 67 YAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KN 122
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK---GYVAPEWFRKS 239
IH D++ NIL+++ +I+DFGLA+L+ N+ TA G K + APE
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYG 178
Query: 240 TISAKVDVYSFGVLLLEIIS 259
T + K DV+SFG+LL EI++
Sbjct: 179 TFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH 117
E D+F + +G GS GI+ I T + VAVKK+D Q + NEV+++ H
Sbjct: 22 EYLDSFIK-IGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHE 177
H+N+V + G + EFL G L + + + N + + R L YLH
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLH- 135
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
+ +IH DIK +ILL ++SDFG ++ K + ++ GT ++APE
Sbjct: 136 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVIS 191
Query: 238 KSTISAKVDVYSFGVLLLEII 258
+ +VD++S G++++E+I
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-19
Identities = 72/277 (25%), Positives = 126/277 (45%), Gaps = 43/277 (15%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
F +E+G G FG++ G + VA+K + + E EF E V+ + H+ LV
Sbjct: 8 FLKELGTGQFGVVKYGKWR----GQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLV 62
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC--- 179
+L G C + + + E+++NG L ++L + K FQ +++L + C
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK---------RFQPSQLLEMCKDVCEGM 113
Query: 180 ----SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV---A 232
S Q IH D+ +N L++D+ ++SDFGL++ + ++ T+ G+K V
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSP 169
Query: 233 PEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292
PE S S+K DV++FGVL+ E+ S L ++ + N + + V
Sbjct: 170 PEVLLYSKFSSKSDVWAFGVLMWEVYS---------------LGKMPYERFNNSETVEKV 214
Query: 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ EK+ I C E RPT +++
Sbjct: 215 SQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-19
Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN 120
DNF + +G GS GI+ I T ++ VAVKK+D Q + NEV+++ H N
Sbjct: 22 DNFVK-IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCS 180
+V + G + EFL G L + + + N + + + L +LH +
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLH---A 133
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLT--LNQRKTIKTAIRGTKGYVAPEWFRK 238
+IH DIK +ILL ++SDFG ++ + +RK++ GT ++APE +
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISR 189
Query: 239 STISAKVDVYSFGVLLLEII 258
+VD++S G++++E++
Sbjct: 190 LPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-19
Identities = 60/274 (21%), Positives = 120/274 (43%), Gaps = 34/274 (12%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+G+G+FG + T + V K+++ R+ + ++ NE++++ H N++
Sbjct: 8 LGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA--FQIARVLLYLHEDCSSQ 182
+ L+ E+ N GTL + + + FQI + Y+H+ +
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AG 121
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTIS 242
I+H DIK NI L ++ DFG++K+ L ++ + GT Y++PE + +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYN 179
Query: 243 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME-AMND 301
K D+++ G +L E+++ +++FD +LV ++
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDAT-------------------NPLNLVVKIVQGNYTP 220
Query: 302 IKCVEKLLMISIW--CIQEDPSLRPTMRKVSQML 333
+ V +IS+ +Q+DP RPT +V
Sbjct: 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN 120
DNF + +G GS GI+ I T +S VAVKK+D Q + NEV+++ H+N
Sbjct: 23 DNFIK-IGEGSTGIV---CIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCS 180
+V + G + EFL G L + + + N + + + L LH +
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLH---A 134
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+IH DIK +ILL ++SDFG +++ + ++ GT ++APE +
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 241 ISAKVDVYSFGVLLLEII 258
+VD++S G++++E++
Sbjct: 193 YGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E +G+GSFG +YKG I T A+ + L+ +D ++ + E+ V+ Q + R
Sbjct: 10 ERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRY 67
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARVLLYLHEDCSS 181
G +G + E+L G+ L KP T IA +I + L YLH S
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLH---SE 120
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
+ IH DIK N+LL+++ + +++DFG+A LT Q K + GT ++APE ++S
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAY 178
Query: 242 SAKVDVYSFGVLLLEI 257
K D++S G+ +E+
Sbjct: 179 DFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-18
Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 31/275 (11%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
F +E+G G FG+++ G + + VA+K + E++F E V+ + H LV
Sbjct: 8 FMKELGSGQFGVVHLGKWR----AQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
+L G C + + + EF+ NG L ++L G L + L ++ + + YL
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL--SMCQDVCEGMEYLER-- 118
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
+ IH D+ +N L++ ++SDFG+ + + L+ T + + + PE F S
Sbjct: 119 -NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 240 TISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298
S+K DV+SFGVL+ E+ + + F+ + E + F YR KL A
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP-KL---------A 226
Query: 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333
+ V M S W E P RPT ++ + +
Sbjct: 227 SMTVYEV----MYSCW--HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 14/209 (6%)
Query: 64 KEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
++G+GSFG+++K V + + + + K++R ++ E +E V+ + +
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE---EAIDEARVLAKLDSSYI 61
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARVLLYLHED 178
+R + + E+ NG L L G P + QI L +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPE-DQVWRFFIQILLGLAHLH-- 118
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S +I+H DIK N+ L+ N +I D G+AKLL+ N I GT Y++PE
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELCED 175
Query: 239 STISAKVDVYSFGVLLLEIISCRKSFDIE 267
+ K DV++ GV+L E + + FD
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVK--KLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+G G FG + +G + S VAVK KLD +EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 125 LGFCDEGQNR------LLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAF--QIARVL 172
+G C E + ++ F+ +G L SFL G L L+T + F IA +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL----TLNQRKTIKTAIRGTK 228
YL + IH D+ +N +L + ++DFGL+K + Q + K ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK--- 180
Query: 229 GYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288
++A E ++K DV++FGV + EI + G+ + N ++
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWEIAT--------RGQT-------PYPGVENHEI 224
Query: 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336
D + C+++L + C + DP RPT K+ ++L+ +
Sbjct: 225 YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---FKNEVIVIGQTHHKNL 121
E +G+GSFG +YK + + T VA+K +D ++ E E + E+ + Q +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQ---VVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLL---YLHED 178
+ G +G + E+ G+ L KP T IAF + VLL YLHE+
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
IH DIK NILL++ + +++DFG++ LT K GT ++APE ++
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTPFWMAPEVIKQ 172
Query: 239 STISAKVDVYSFGVLLLEII 258
S K D++S G+ +E+
Sbjct: 173 SGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHH---KNL 121
E +GRG++G +Y+G T A+ + LD D + + EV ++ Q N+
Sbjct: 7 ELIGRGAYGAVYRG-KHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNI 64
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLL---YLHED 178
+ G +G + E+ G++ + + K I+ I VL+ Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH-- 118
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
+IH DIK NIL+ + N ++ DFG+A LL N K ++ GT ++APE +
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITE 175
Query: 239 -STISAKVDVYSFGVLLLEIIS 259
K D++S G+ + E+ +
Sbjct: 176 GKYYDTKADIWSLGITIYEMAT 197
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-18
Identities = 56/193 (29%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E +G+GSFG ++KG I T A+ + L+ +D ++ + E+ V+ Q + +
Sbjct: 10 ERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
G +G + E+L G+ L + + T + +I + L YLH S + I
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLH---SEKKI 123
Query: 185 HCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAK 244
H DIK N+LL+++ + +++DFG+A LT Q K + GT ++APE ++S +K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 245 VDVYSFGVLLLEI 257
D++S G+ +E+
Sbjct: 182 ADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 49/304 (16%)
Query: 51 FSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTST--TAVAVKKLDRV-FQDGEKEFK 107
F L+E T +GRG FG ++ + T V VK L + ++ + EF+
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 108 NEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN------LKP---NW 158
E+ + + HKN+VRLLG C E + + E+ + G L FL LKP +
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 159 NLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR- 217
+ + QIA + +L +++ +H D+ +N L++ + ++S L+K N
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEY 172
Query: 218 ---KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YA 273
+ +R ++APE ++ S K DV+SFGVL+ E+ + GE +
Sbjct: 173 YKLRNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT--------QGELPFY 220
Query: 274 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQ 331
L+D L+ L G +E C +L LM W + +P RP+ ++
Sbjct: 221 GLSDEEV-------LNRLQAGKLELPVPEGCPSRLYKLMTRCWAV--NPKDRPSFSELVS 271
Query: 332 MLQE 335
L E
Sbjct: 272 ALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-18
Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 44/290 (15%)
Query: 67 VGRGSFGIIYKGV---IQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNLV 122
+G G+FG +Y+G I + VAVK L + D EK EF E ++ +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLK-----PNWNLR--TNIAFQIARVLLYL 175
+LLG C + + + E + G L S+L P L+ +I +A+ +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 176 HEDCSSQIIHCDIKPQNILLNDR-YNAR----ISDFGLAKLLTLN----QRKTIKTAIRG 226
+ IH D+ +N L++++ Y+A I DFGLA+ + + + +R
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 227 TKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRN 285
++APE + + DV+SFGVL+ EI++ +G++ Y L + + ++
Sbjct: 179 ---WMAPESLLDGKFTTQSDVWSFGVLMWEILT--------LGQQPYPALNN--QEVLQH 225
Query: 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
G ++ + C +K+ + C +DPS RPT ++ ++LQ
Sbjct: 226 VT----AGGRLQKPEN--CPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 7e-18
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 45/223 (20%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+ +G G++G +YK T A+ V KL+ D + + E+ ++ + H N+V
Sbjct: 7 LIQRIGSGTYGDVYKARD-IATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIV 63
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARV-------L 172
G + E+ G+L T QIA V L
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIY---------QVTRGPLSELQIAYVCRETLKGL 114
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKGY 230
YLHE + IH DIK NILL + + +++DFG++ L T+ +RK+ I GT +
Sbjct: 115 AYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF---I-GTPYW 167
Query: 231 VAPEWF---RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGE 270
+APE RK K D+++ G I+ IE+ E
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALG------ITA-----IELAE 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-18
Identities = 70/270 (25%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 67 VGRGSFGIIYKGV-IQTTTTSTTAVAVKKLDRVFQDGEK---EFKNEVIVIGQTHHKNLV 122
+G G+FG +YKG+ + T VA+K L+ G K EF +E +++ H +LV
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASMDHPHLV 72
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNW--NLRTNIAFQIARVLLYLHEDCS 180
RLLG C +L+ + + +G L ++ + K N L N QIA+ ++YL E
Sbjct: 73 RLLGVCLSPTIQLVT-QLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE--- 127
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+++H D+ +N+L+ + +I+DFGLA+LL ++++ + ++A E
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300
+ + DV+S+GV + E+++ G+ Y D ++ DL+E
Sbjct: 188 FTHQSDVWSYGVTIWELMTFG-------GKPY--------DGIPTREIPDLLEKGERLPQ 232
Query: 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330
C + M+ + C D RP ++++
Sbjct: 233 PPICTIDVYMVMVKCWMIDADSRPKFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 28/288 (9%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTST-TAVAVKKLDR-VFQDGEKEFKNEVIVIGQTHHKNLV 122
+G G FG + T VAVK L R Q +K E+ ++ +H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 123 RLLGFCDE--GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARVLLYLHED 178
+ G C E G+ L E++ G+L +L K NL + F QI + YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLH-- 124
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL-TLNQRKTIKTAIRGTKGYVAPEWFR 237
S IH D+ +N+LL++ +I DFGLAK + ++ ++ + A E +
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 238 KSTISAKVDVYSFGVLLLEII-------SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290
++ S DV+SFGV L E++ S K F+ +G + +T +L +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV--------RLIE 235
Query: 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
L+E M C +++ ++ C + + RPT R + +L+E+
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 103 EKEFKNEVIVIGQTHHKNLVRLLG-FCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNL 160
+K+ E+ + +V+ G F DE + + +A E+ G+L S ++ +K
Sbjct: 43 QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKR-GG 100
Query: 161 RTN------IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214
R IA + + L YLH S +IIH DIKP NILL + ++ DFG++ L
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157
Query: 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
+ T GT Y+APE + S DV+S G+ LLE+ R F
Sbjct: 158 SLAGTFT----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 25/185 (13%)
Query: 89 AVAVKKLDRVFQDGEKE---FKNEVIVIGQTHHKNLVRLLGFCDEGQ---NRLLA-YEFL 141
VA+K L + E + F+ E + + +H N+V LL D G+ L A +E++
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFEYV 61
Query: 142 NNGTLASFLF--GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL---N 196
TL L G L R + Q+ L H I+H D+KPQNI++
Sbjct: 62 PGRTLREVLAADGALPAGETGR--LMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116
Query: 197 DRYNARISDFGLAKLL-----TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFG 251
R +A++ DFG+ LL T T + GT Y APE R ++ D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 252 VLLLE 256
++ LE
Sbjct: 177 LIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-17
Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 41/277 (14%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVK--KLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+G+G FG + G + VAVK K D Q F E V+ Q H NLV+L
Sbjct: 14 IGKGEFGDVMLGDYRGNK-----VAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQL 64
Query: 125 LGFCDEGQNRL-LAYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
LG E + L + E++ G+L +L G + + + + YL ++
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---AN 121
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
+H D+ +N+L+++ A++SDFGL K + Q T K ++ T APE R+
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWT----APEALREKKF 176
Query: 242 SAKVDVYSFGVLLLEIISC-RKSFD-IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299
S K DV+SFG+LL EI S R + I + + + G D +G +
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--------EKGYKMDAPDGCPPVV 228
Query: 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336
D+ M W + D + RP+ ++ + L+ +
Sbjct: 229 YDV-------MKQCWHL--DAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 33/275 (12%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
++G+G FG ++ G T TT VA+K L E F E V+ + H+ LV+L
Sbjct: 13 KLGQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLY 67
Query: 126 GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARVLLYLHEDCSSQI 183
E + + E+++ G+L FL G + L ++A QIA + Y+
Sbjct: 68 AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 123
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK---GYVAPEWFRKST 240
+H D++ NIL+ + +++DFGLA+L+ N+ TA +G K + APE
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGR 179
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300
+ K DV+SFG+LL E+ + + + N ++ D VE
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPC 224
Query: 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
+C E L + C +++P RPT + L++
Sbjct: 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 83/319 (26%), Positives = 130/319 (40%), Gaps = 64/319 (20%)
Query: 55 ELEEATDNFKEEVGRGSFGIIYK----GVIQTTTTSTTAVAVKKL-----DRVFQDGEKE 105
EL + +G G FG + G+ + VAVK L D+ D E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 106 FKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR---- 161
+ + +IG+ HKN++ LLG C + + E+ + G L +L P +
Sbjct: 68 ME-MMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 162 ------------TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209
+ A+Q+AR + YL S + IH D+ +N+L+ + +I+DFGLA
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 210 KLL--------TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCR 261
+ + T N R +K ++APE + + DV+SFGVLL EI +
Sbjct: 182 RDVHNIDYYKKTTNGRLPVK--------WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 233
Query: 262 KSFDIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDP 320
G Y I + F + G D C +L MI C P
Sbjct: 234 -------GSPYPGIPVEELFKLLKEGHRMD---------KPANCTHELYMIMRECWHAVP 277
Query: 321 SLRPTMRKVSQMLQEVVEV 339
S RPT +++ + L V+ V
Sbjct: 278 SQRPTFKQLVEDLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 64/291 (21%), Positives = 123/291 (42%), Gaps = 33/291 (11%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTA--VAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN 120
K E+G G+FG ++ VAVK L + K+F E ++ H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN-----LKPNWNLRT--------NIAFQ 167
+V+ G C EG ++ +E++ +G L FL + L N +IA Q
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGT 227
IA ++YL S +H D+ +N L+ + +I DFG+++ + +
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 228 KGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287
++ PE + + DV+S GV+L EI + K Y + + +C G+
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ------PWYQLSNNEVIECITQGR 239
Query: 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ C +++ + + C Q +P +R ++++ +LQ + +
Sbjct: 240 V---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 62/225 (27%), Positives = 112/225 (49%), Gaps = 24/225 (10%)
Query: 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKL-DRVFQDGEKEFKNEVI 111
E+ +T F EE+G FG +YKG + T T AVA+K L D+ +EFK+E +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 112 VIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF--------GNLKPNWNLRT- 162
+ + H N+V LLG + Q + + + ++ L FL G+ + +++
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 163 -------NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK-LLTL 214
+I QIA + +L S ++H D+ +N+L+ D+ N +ISD GL + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
+ K + ++ + +++PE S D++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 78/289 (26%), Positives = 129/289 (44%), Gaps = 42/289 (14%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVK--KLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
+G G FG +Y+GV + AVAVK K EK F E ++ Q H ++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARVLLYLHEDC 179
V+L+G E + E G L S+L N K + +L + I ++Q++ L YL
Sbjct: 70 VKLIGVITE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE--- 124
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLL---TLNQRKTIKTAIRGTKGYVAPEW- 235
S + +H DI +N+L++ ++ DFGL++ L + + K I+ ++APE
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPESI 180
Query: 236 -FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE- 293
FR+ T ++ DV+ FGV + EI+ F +N + +E
Sbjct: 181 NFRRFTSAS--DVWMFGVCMWEILMLGVK---------------PFQGVKNNDVIGRIEN 223
Query: 294 GDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340
G+ M C L LM W DPS RP ++ L ++++ +
Sbjct: 224 GERLPMPP-NCPPTLYSLMTKCWAY--DPSKRPRFTELKAQLSDILQEE 269
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-17
Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHK----NL 121
E+G G+FG + KGV + VA+K L + EK ++E++ + H+ +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQID-VAIKVLK---NENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA---FQIARVLLYLHED 178
VR++G C E + +L E + G L FL G K + +N+ Q++ + YL
Sbjct: 58 VRMIGVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEG- 113
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR-KTIKTAIRGTKGYVAPEWFR 237
+H D+ +N+LL +++ A+ISDFGL+K L + ++A + + APE
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 238 KSTISAKVDVYSFGVLLLEIIS 259
S++ DV+S+G+ + E S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQTHHKNLVR 123
+G+G FG + ++ T A KKLD+ + GE+ NE ++ + + +V
Sbjct: 1 LGKGGFGEVCACQVKATGK---MYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 124 LLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARVLLYLHEDCS 180
L + E ++ L L +N G L ++ +P + I A QI L +LH+
Sbjct: 58 L-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+I++ D+KP+N+LL+D N RISD GLA + L K IK GT GY+APE +
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRA-GTPGYMAPEVLQGEV 170
Query: 241 ISAKVDVYSFGVLLLEIISCRKSF 264
VD ++ G L E+I+ R F
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-17
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG-EKEFKN---EVIVIGQTHHKN 120
E +G+G++G +Y G+ T AV +LD EKE++ EV ++ H N
Sbjct: 6 EVLGKGAYGTVYCGL--TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHED 178
+V+ LG C + + EF+ G+++S L FG L P QI + YLH +
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPL-PEPVFCKYTK-QILDGVAYLHNN 121
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL---TLNQRKT-IKTAIRGTKGYVAPE 234
C ++H DIK N++L ++ DFG A+ L L+ + + ++ GT ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 235 WFRKSTISAKVDVYSFGVLLLEI 257
+S K D++S G + E+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 6e-17
Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E++G+GSFG ++KG I T A+ + L+ +D ++ + E+ V+ Q + +
Sbjct: 10 EKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARVLLYLHEDCSS 181
G + + E+L G+ L +P T IA +I + L YLH S
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SE 120
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
+ IH DIK N+LL++ +++DFG+A LT Q K + GT ++APE ++S
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAY 178
Query: 242 SAKVDVYSFGVLLLEI 257
+K D++S G+ +E+
Sbjct: 179 DSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 7e-17
Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE---KEFKNEVIVIGQTHHKNL 121
E++G G++G++YK + T + +A+KK+ R+ Q+ E E+ ++ + H N+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNET---IALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDC 179
VRL + L +E+L+ L + + N L +QI R + Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--- 119
Query: 180 SSQIIHCDIKPQNILLNDRYNA-RISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S +++H D+KPQN+L++ R NA +++DFGLA+ + R + T Y APE
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLG 177
Query: 239 S-TISAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 274
S S VD++S G + E+++ + F D E+ E + I
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216
|
Length = 294 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
+ +G++G ++ + +T A+ +KK D + ++ + E ++ Q +V+L
Sbjct: 1 ISKGAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 126 -GFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQ 182
F + +N L E+L G LAS L G+L + +I L YLH S+
Sbjct: 60 YSFQGK-KNLYLVMEYLPGGDLASLLENVGSLDEDV--ARIYIAEIVLALEYLH---SNG 113
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKL------LTLNQRKTIKTAIRGTKGYVAPEWF 236
IIH D+KP NIL++ + +++DFGL+K+ + LN + I GT Y+APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 237 RKSTISAKVDVYSFGVLLLEIIS 259
S VD +S G +L E +
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 29/217 (13%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQT-HHKN 120
F++ +G G+FG + + +I+ A A+K L + ++ ++F E+ V+ + HH N
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNA-AIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQ---------IARV 171
++ LLG C+ +A E+ G L FL + + L T+ AF ++
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFL----RKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 172 LLYLHEDCSS--------QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI-KT 222
LL D ++ Q IH D+ +N+L+ + ++I+DFGL++ + +KT+ +
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
+R ++A E S + K DV+SFGVLL EI+S
Sbjct: 181 PVR----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN---EVIVIGQTHHKNLV 122
E+G G+ G++ K + + T + K R+ + E K E+ ++ + + +V
Sbjct: 8 ELGAGNSGVVSKVLHR----PTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIV 62
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLHEDCSS 181
G + + E+++ G+L L + IA + + L YLHE
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--H 120
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
+IIH D+KP NIL+N R ++ DFG++ L ++ GT Y+APE + +
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV----NSLAKTFVGTSSYMAPERIQGNDY 176
Query: 242 SAKVDVYSFGVLLLEIISCR 261
S K D++S G+ L+E+ + R
Sbjct: 177 SVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 67/281 (23%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNLVRLL 125
+G G FG + G ++ VA+K L + + ++ +F +E ++GQ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 126 GFCDEGQNRLLAYEFLNNGTLASFL------FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
G + + ++ E++ NG+L +FL F ++ LR IA + YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG-----IASGMKYLSD-- 124
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK---GYVAPEWF 236
+H D+ +NIL+N ++SDFGL+++L + T RG K + APE
Sbjct: 125 -MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT--RGGKIPIRWTAPEAI 181
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296
++ DV+S+G+++ E++S + EM + I +E
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA---------------IEEGY 226
Query: 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337
+ C L + + C Q+D + RP ++ +L +++
Sbjct: 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
E++G GS+G +YK + VA+K + V +D + E E+ ++ Q +V
Sbjct: 7 ILEKLGEGSYGSVYKA---IHKETGQVVAIKVV-PVEEDLQ-EIIKEISILKQCDSPYIV 61
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARVLL------ 173
+ G + + + E+ G+++ + TN +IA +L
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIM---------KITNKTLTEEEIAAILYQTLKGL 112
Query: 174 -YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
YLH S++ IH DIK NILLN+ A+++DFG++ LT K T I GT ++A
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR-NTVI-GTPFWMA 167
Query: 233 PEWFRKSTISAKVDVYSFGVLLLEI 257
PE ++ + K D++S G+ +E+
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN--EVIVIGQTHHKNLV 122
++G G++G++YK + VA+KK+ F+ E+ ++ + +H N++
Sbjct: 5 GKIGEGTYGVVYKA---RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARVLLYLHEDCSS 181
+LL + L +EF++ L + + + +Q+ + L + H S
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE-WFRKST 240
I+H D+KP+N+L+N +++DFGLA+ R T T+ Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKG 175
Query: 241 ISAKVDVYSFGVLLLEIISCRKSF 264
S VD++S G + E++S R F
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 39/279 (13%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+++G G FG ++ G T T VAVK L E F E ++ + H LV+L
Sbjct: 12 KKLGNGQFGEVWMG----TWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQL 66
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFG----NLK-PNWNLRTNIAFQIARVLLYLHEDC 179
E + + E+++ G+L FL LK PN ++A Q+A + Y+
Sbjct: 67 YAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL---VDMAAQVAAGMAYIER-- 120
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK---GYVAPEWF 236
IH D++ NIL+ D +I+DFGLA+L+ N+ TA +G K + APE
Sbjct: 121 -MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY----TARQGAKFPIKWTAPEAA 175
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296
+ K DV+SFG+LL E+++ + + N ++ + VE
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRV---------------PYPGMNNREVLEQVERGY 220
Query: 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
C L + + C ++DP RPT + L++
Sbjct: 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 34/218 (15%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL----------DRVFQDGEKEFKNEVIVIG 114
E +G+G++G +Y + T+ +AVK++ D +D K ++E+ +
Sbjct: 7 ELIGKGTYGRVYLAL---NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK 63
Query: 115 QTHHKNLVRLLGFCDEGQNRLLAY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARV 171
H N+V+ LGF + + L + E++ G++ S L +G + L Q+
Sbjct: 64 DLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ--LVRFFTEQVLEG 120
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI-----KTAIRG 226
L YLH S I+H D+K N+L++ +ISDFG++K + I +++G
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYDNDQNMSMQG 172
Query: 227 TKGYVAPEWFRKST--ISAKVDVYSFGVLLLEIISCRK 262
+ ++APE + SAKVD++S G ++LE+ + R+
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 71/295 (24%), Positives = 122/295 (41%), Gaps = 65/295 (22%)
Query: 70 GSFGIIYKGV-IQTTTTSTTAVAVK---------KLDRVFQDGEKEFKNEVIVIGQTHHK 119
G+FG I+ G+ I V VK ++ + Q+ + G H+
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCL-------LYG-LSHQ 68
Query: 120 NLVRLLGFCDEGQNR-LLAYEFLNNGTLASFL-FGNLKPNWNLRT-------NIAFQIAR 170
N++ +L C E + Y ++N G L FL L N + ++A QIA
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK--------LLTLNQRKTIKT 222
+ YLH +IH DI +N ++++ +I+D L++ L N+ + +K
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK- 184
Query: 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 280
++A E S+ DV+SFGVLL E+++ ++ +I+ E A L D
Sbjct: 185 -------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-- 235
Query: 281 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
YR + I C ++L + C DP RP+ ++ Q L +
Sbjct: 236 --YRLAQ-------------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK----NEVIVIGQT---H 117
E+G G++G +YK + VA+KK+ E+ E+ ++ Q
Sbjct: 5 AEIGEGAYGTVYKA---RDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 118 HKNLVRLLGFC-----DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIAR 170
H N+VRLL C D L +E ++ LA++L KP T ++ Q+ R
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGY 230
+ +LH S +I+H D+KPQNIL+ +I+DFGLA++ + T++ T Y
Sbjct: 119 GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWY 172
Query: 231 VAPEWFRKSTISAKVDVYSFGVLLLEI 257
APE +S+ + VD++S G + E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK-NEVIVIGQ-THHKNLV 122
+++G G+FG +Y + T VA+KK+ + F E+ EV + + H N+V
Sbjct: 5 KQLGDGTFGSVYLARNKET---GELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLF-------GNLKPNWNLRTNIAFQIARVLLYL 175
+L E +E++ L+ G +R +I +QI + L ++
Sbjct: 62 KLKEVFRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIR-SIIYQILQGLAHI 115
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
H H D+KP+N+L++ +I+DFGLA+ + R T T+ Y APE
Sbjct: 116 H---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPY-TDYVSTRWYRAPEI 169
Query: 236 FRKST-ISAKVDVYSFGVLLLEIISCRKSF 264
+ST S+ VD+++ G ++ E+ + R F
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 14/210 (6%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNE-VIVIGQTHHKNLVR 123
+ + +G+FG +Y ++T +KK D + ++ K E I++ Q + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
L L E+LN G AS + G L +W + IA ++ + LH+
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQR--- 116
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
IIH DIKP+N+L++ + +++DFGL++ N++ GT Y+APE
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGD 170
Query: 242 SAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
D +S G ++ E + F E +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 64/289 (22%), Positives = 123/289 (42%), Gaps = 36/289 (12%)
Query: 63 FKEEVGRGSFGIIYKGVIQ--TTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN 120
K E+G G+FG ++ + T VAVK L K+F+ E ++ H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN------------LKPNWNL----RTNI 164
+V+ G C +G ++ +E++ +G L FL + + L +I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224
A QIA ++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284
++ PE + + DV+SFGV+L EI + K ++ I +C
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI------ECIT 239
Query: 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333
G++ + C +++ I + C Q +P R ++++ ++L
Sbjct: 240 QGRVLERPR---------VCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 72/299 (24%), Positives = 130/299 (43%), Gaps = 47/299 (15%)
Query: 67 VGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVFQDGE-KEFKNEVIVIGQTHHKNLVR 123
+G G FG + K T VAVK L E ++ +E ++ Q +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP------------------------NWN 159
L G C + LL E+ G+L SFL + K
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 160 LRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219
+ A+QI+R + YL E +++H D+ +N+L+ + +ISDFGL++ +
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDW 278
++ R ++A E + + DV+SFGVLL EI++ G Y I +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG-------GNPYPGIAPER 237
Query: 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337
F+ + G + E C E++ + + C +++P RPT +S+ L++++
Sbjct: 238 LFNLLKTGYRMERPE---------NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN----EVIVIGQTHHKN 120
VG G++G++ K + T VA+KK + +++ K EV V+ Q H+N
Sbjct: 7 GVVGEGAYGVVLKCRNKATGE---IVAIKKFKES--EDDEDVKKTALREVKVLRQLRHEN 61
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPN---WNLRTNIAFQIARVLLYLHE 177
+V L L +E++ TL L P + + +Q+ + + Y H
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVER-TLLELL--EASPGGLPPDAVRSYIWQLLQAIAYCH- 117
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
S IIH DIKP+NIL+++ ++ DFG A+ L + T T+ Y APE
Sbjct: 118 --SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELLV 174
Query: 238 KSTISAK-VDVYSFGVLLLEIISCRKSF 264
T K VDV++ G ++ E++ F
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-16
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
E +G+G+FG ++KG ++ T VAVK + + Q+ + +F +E ++ Q H N+V+
Sbjct: 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVK 56
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARVLLYLHEDC 179
L+G C + Q + E + G SFL K L+T A A + YL
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLE--- 110
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK----GYVAPEW 235
S IH D+ +N L+ + +ISDFG+++ Q + G K + APE
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEA 165
Query: 236 FRKSTISAKVDVYSFGVLLLEIIS 259
S++ DV+S+G+LL E S
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 75/296 (25%), Positives = 121/296 (40%), Gaps = 53/296 (17%)
Query: 52 SYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN--- 108
S ELE +G G+ G +YK VI T A+ V ++ + E +
Sbjct: 72 SLSELERV-----NRIGSGAGGTVYK-VIHRPTGRLYALKV-----IYGNHEDTVRRQIC 120
Query: 109 -EVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQ 167
E+ ++ +H N+V+ D + EF++ G+L G + ++A Q
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVARQ 176
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGT 227
I + YLH I+H DIKP N+L+N N +I+DFG++++ L Q + GT
Sbjct: 177 ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGT 231
Query: 228 KGYVAPEWFRKSTISAKV-----DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--- 279
Y++PE D++S GV +LE R F +G + DWA
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR--FPFGVGRQ----GDWASLM 285
Query: 280 -FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
C + E + I C C+Q +P+ R + Q+LQ
Sbjct: 286 CAICMSQPP-EAPATASREFRHFISC----------CLQREPAKRWS---AMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 53/194 (27%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E++G+G+ G +Y + T VA+K+++ Q ++ NE++V+ + H N+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQE---VAIKQMNLQQQPKKELIINEILVMRENKHPNIVNY 81
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
L G + E+L G+L + + + + + L +LH S+Q+I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 137
Query: 185 HCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAK 244
H DIK NILL + +++DFG +T Q K ++ + GT ++APE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 245 VDVYSFGVLLLEII 258
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 43/293 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN 120
K E+G G+FG ++ VAVK L + ++F+ E ++ H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLF-----------GNLKPNWNLR----TNIA 165
+VR G C EG+ L+ +E++ +G L FL G L IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKT- 222
QIA ++YL S +H D+ +N L+ +I DFG+++ + T R +T
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 223 -AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 281
IR ++ PE + + D++SFGV+L EI + K Y + A +
Sbjct: 186 LPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ------PWYQLSNTEAIE 235
Query: 282 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
C G+ E C ++ I C Q +P R ++ + LQ
Sbjct: 236 CITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKN----EVIVIGQTHHKN 120
VG GS+G++ K + VA+KK F + E K K E+ ++ Q H+N
Sbjct: 9 VGEGSYGMVMKC---KHKETGQIVAIKK----FLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPN---WNLRTNIAFQIARVLLYLHE 177
LV L+ + L +EF+++ L PN + FQI R + + H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCH- 117
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
S IIH DIKP+NIL++ ++ DFG A+ TL + T T+ Y APE
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 238 KSTISAK-VDVYSFGVLLLEIIS 259
T + VD+++ G L+ E+++
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 55/163 (33%), Positives = 76/163 (46%), Gaps = 16/163 (9%)
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
+VLL +H S +IH DIK NILL ++ DFG +K+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289
YVAPE +R+ S K D++S GVLL E+++ ++ FD E EE T G+ D
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-------LAGRYD 263
Query: 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332
L M +I V LL DP RP+ K+ M
Sbjct: 264 PLPPSISPEMQEI--VTALL-------SSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-16
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 29/213 (13%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQT-HHKNLVRL 124
+G G+FG + K I+ A A+K++ + +D ++F E+ V+ + HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQ---------IARVLLYL 175
LG C+ LA E+ +G L FL + + L T+ AF ++ LL+
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 176 HEDCSS--------QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI-KTAIRG 226
D + Q IH D+ +NIL+ + Y A+I+DFGL++ + +KT+ + +R
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 176
Query: 227 TKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
++A E S + DV+S+GVLL EI+S
Sbjct: 177 ---WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+++G G FG ++ G ++T VAVK L + + F E ++ H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYYN----NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRL 66
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARVLLYLHEDCSSQ 182
+ + + E++ G+L FL + L I F QIA + Y+
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KN 123
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK---GYVAPEWFRKS 239
IH D++ N+L+++ +I+DFGLA+++ N+ TA G K + APE
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAINFG 179
Query: 240 TISAKVDVYSFGVLLLEIIS 259
+ + K DV+SFG+LL EI++
Sbjct: 180 SFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 7e-16
Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 29/289 (10%)
Query: 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FKNEVIVI 113
EL+ + + +G G FG + +G ++ + VA+ L D ++ F E + +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 114 GQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIAR 170
GQ H N+VRL G G ++ E+++NG L SFL G L + + +A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM--GMLPGLAS 118
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG- 229
+ YL E +H + +L+N +IS F L ++ + I T + G
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPV 172
Query: 230 -YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288
+ APE + S+ DV+SFG+++ E++S + +M + I
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-------------- 218
Query: 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337
VE C L + + C Q++ RP ++ +L ++V
Sbjct: 219 -KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 72/303 (23%), Positives = 129/303 (42%), Gaps = 61/303 (20%)
Query: 66 EVGRGSFGIIYK----GVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKN 120
++G+G+FG +++ G++ T VAVK L + D + +F+ E ++ + H N
Sbjct: 12 DIGQGAFGRVFQARAPGLL--PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWN--------------------- 159
+V+LLG C G+ L +E++ G L FL P
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHR-SPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 160 --LRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL------AKL 211
+ IA Q+A + YL E + +H D+ +N L+ + +I+DFGL A
Sbjct: 129 CTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
++ I IR ++ PE + + + DV+++GV+L EI F M
Sbjct: 186 YKASENDAI--PIR----WMPPESIFYNRYTTESDVWAYGVVLWEI------FSYGMQPY 233
Query: 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331
Y + + R+G + + C +L + C + PS RP+ +++
Sbjct: 234 YGMAHEEVIYYVRDGNVLSCPDN---------CPLELYNLMRLCWSKLPSDRPSFASINR 284
Query: 332 MLQ 334
+LQ
Sbjct: 285 ILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 9e-16
Identities = 51/194 (26%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E++G+G+ G +Y + + VA+K+++ Q ++ NE++V+ + + N+V
Sbjct: 25 EKIGQGASGTVYTAI---DIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNY 81
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
L G + E+L G+L + + + + + L +LH S+Q+I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALDFLH---SNQVI 137
Query: 185 HCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAK 244
H DIK NILL + +++DFG +T Q K ++ + GT ++APE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 245 VDVYSFGVLLLEII 258
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 51/194 (26%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E++G+G+ G +Y + + VA+++++ Q ++ NE++V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAM---DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
L G + E+L G+L + + + + + L +LH S+Q+I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 138
Query: 185 HCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAK 244
H DIK NILL + +++DFG +T Q K ++ + GT ++APE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 245 VDVYSFGVLLLEII 258
VD++S G++ +E+I
Sbjct: 197 VDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 54/193 (27%), Positives = 95/193 (49%), Gaps = 9/193 (4%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
++G GS GI+ I S VAVK +D Q + NEV+++ H+N+V +
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 126 GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIH 185
G+ + EFL G L + + N + + + L YLH S +IH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLH---SQGVIH 140
Query: 186 CDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKV 245
DIK +ILL ++SDFG ++ + K + ++ GT ++APE ++ +V
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 246 DVYSFGVLLLEII 258
D++S G++++E++
Sbjct: 199 DIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 48/194 (24%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E++G+G+ G ++ + VA+K+++ Q ++ NE++V+ + + N+V
Sbjct: 25 EKIGQGASGTVFTA---IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNF 81
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
L G + E+L G+L + + + + + L +LH ++Q+I
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLH---ANQVI 137
Query: 185 HCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAK 244
H DIK N+LL + +++DFG +T Q K ++ + GT ++APE + K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 245 VDVYSFGVLLLEII 258
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 33/222 (14%)
Query: 56 LEEATDNF--KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVI 113
L + T F E +G G++G +YK + VA+K +D + +D E+E K E ++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKAR---HKKTGQLVAIKIMD-IIEDEEEEIKEEYNIL 56
Query: 114 GQ-THHKNLVRLLG-------FCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTN- 163
+ ++H N+ G ++ Q L L E G++ + G K L+
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQ--LWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114
Query: 164 IAF---QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL-AKLLTLNQRKT 219
IA+ + R L YLHE +++IH DIK QNILL ++ DFG+ A+L + R+
Sbjct: 115 IAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR- 170
Query: 220 IKTAIRGTKGYVAPEWF-----RKSTISAKVDVYSFGVLLLE 256
T I GT ++APE ++ A+ DV+S G+ +E
Sbjct: 171 -NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 63/212 (29%), Positives = 115/212 (54%), Gaps = 21/212 (9%)
Query: 64 KEEVGRGSFGIIYKGV-IQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQ-THH 118
+++G+G++GI++K + +T VA+KK+ F+ D ++ F+ E++ + + H
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEV----VALKKIFDAFRNATDAQRTFR-EIMFLQELGDH 66
Query: 119 KNLVRLLGF--CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
N+V+LL + ++ L +E++ L + + N+ + + R I +Q+ + L Y+H
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRY-IMYQLLKALKYIH 124
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT---LNQRKTIKTAIRGTKGYVAP 233
S +IH D+KP NILLN +++DFGLA+ L+ N + T T+ Y AP
Sbjct: 125 ---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 234 EWFRKSTISAK-VDVYSFGVLLLEIISCRKSF 264
E ST K VD++S G +L E++ + F
Sbjct: 182 EILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 35/287 (12%)
Query: 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIG 114
E+ + ++++G G FG ++ T T VAVK + E F E V+
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVW----MATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMK 56
Query: 115 QTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARV 171
H LV+L + ++ EF+ G+L FL G+ +P L + + QIA
Sbjct: 57 TLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEG 114
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTK 228
+ ++ + IH D++ NIL++ +I+DFGLA+++ N+ R+ K I+ T
Sbjct: 115 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT- 170
Query: 229 GYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288
APE + + K DV+SFG+LL+EI++ + Y ++ N ++
Sbjct: 171 ---APEAINFGSFTIKSDVWSFGILLMEIVTYGRI-------PYPGMS--------NPEV 212
Query: 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
+E C E+L I + C + P RPT + +L +
Sbjct: 213 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 56/178 (31%), Positives = 89/178 (50%), Gaps = 14/178 (7%)
Query: 90 VAVKKLDRVFQDGEK---EFKNEVIVIGQTHHKNLVRLLGFCDEGQNR--LLAYEFLNNG 144
VAVK L + G + K E+ ++ +H+N+V+ G C E L EFL +G
Sbjct: 36 VAVKSLKP--ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93
Query: 145 TLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNAR 202
+L +L N K NL+ A QI + + YL S Q +H D+ +N+L+ + +
Sbjct: 94 SLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 149
Query: 203 ISDFGLAKLLTLNQR-KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
I DFGL K + ++ T+K + + APE +S DV+SFGV L E+++
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 50/231 (21%)
Query: 49 RCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE--- 105
RC S E E+ +G G++GI+Y+ TTS VA+KK V D E++
Sbjct: 2 RCRSVTEFEKLN-----RIGEGTYGIVYRA---RDTTSGEIVALKK---VRMDNERDGIP 50
Query: 106 --FKNEVIVIGQTHHKNLVRLL---------------GFCDEGQNRLLAYEFLNNGTLAS 148
E+ ++ H N+V L +C++ LL +N
Sbjct: 51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----DNMP-TP 104
Query: 149 FLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208
F +K + Q+ R L YLHE+ IIH D+K N+LL D+ +I+DFGL
Sbjct: 105 FSESQVK-------CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGL 154
Query: 209 AKLLTLNQRKTIKTAIRGTKGYVAPE-WFRKSTISAKVDVYSFGVLLLEII 258
A+ L + + T Y APE +T + +D+++ G +L E++
Sbjct: 155 ARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 75/294 (25%), Positives = 143/294 (48%), Gaps = 51/294 (17%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE---KEFKNEVIVIGQTHHKNL 121
E++G G++G++YKG + T VA+KK+ R+ + E E+ ++ + H N+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQ---IVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 122 VRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARVLLYLH 176
V L + ++RL L +EFL+ L +L +L + + +QI + +L+ H
Sbjct: 62 VCLQDVLMQ-ESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
S +++H D+KPQN+L++++ +++DFGLA+ + R + T Y APE
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVL 173
Query: 237 RKST-ISAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI-----------------LT 276
S S VD++S G + E+ + + F D E+ + + I L
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233
Query: 277 DW--AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRK 328
D+ F ++ G L V+ +++ + + +EK+L+ DP+ R + +K
Sbjct: 234 DYKNTFPKWKKGSLRSAVK-NLDE-DGLDLLEKMLIY-------DPAKRISAKK 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 76/302 (25%), Positives = 139/302 (46%), Gaps = 42/302 (13%)
Query: 67 VGRGSFGIIYKGV-IQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+G G+FG +YKG+ I VA+K+L + KE +E V+ + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
LG C +L+ + + G L ++ N+ + L N QIA+ + YL E
Sbjct: 75 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEE---R 128
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
+++H D+ +N+L+ + +I+DFGLAKLL ++++ + ++A E
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 242 SAKVDVYSFGVLLLEIISC-RKSFD-IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299
+ + DV+S+GV + E+++ K +D I E +IL +G+
Sbjct: 189 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------------KGERLPQ 232
Query: 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKV----SQMLQE-----VVEVDVP---PNPSP 347
I C + MI + C D RP R++ S+M ++ V++ D P+P+
Sbjct: 233 PPI-CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 291
Query: 348 FS 349
+
Sbjct: 292 SN 293
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 81/306 (26%), Positives = 134/306 (43%), Gaps = 66/306 (21%)
Query: 67 VGRGSFGIIYK----GVIQTTTTSTTAVAVKKL-----DRVFQDGEKEFKNEVI-VIGQT 116
+G G FG + + G+ ++ T VAVK L D+ D E E++ +IG+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM--ELMKLIGK- 76
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNI------------ 164
HKN++ LLG C + + E+ G L FL P + +I
Sbjct: 77 -HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 165 ----AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL-------- 212
A+Q+AR + YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 272
T N R +K ++APE + + DV+SFG+L+ EI + G Y
Sbjct: 193 TSNGRLPVK--------WMAPEALFDRVYTHQSDVWSFGILMWEIFTLG-------GSPY 237
Query: 273 -AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331
I + F R G M+ ++ C +L M+ C P+ RPT +++ +
Sbjct: 238 PGIPVEELFKLLREGH-------RMDKPSN--CTHELYMLMRECWHAVPTQRPTFKQLVE 288
Query: 332 MLQEVV 337
L +V+
Sbjct: 289 ALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 6e-15
Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 33/275 (12%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
++G+G FG ++ G T TT VA+K L E F E ++ + H LV L
Sbjct: 13 KLGQGCFGEVWMG----TWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLY 67
Query: 126 GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARVLLYLHEDCSSQI 183
E + + EF+ G+L FL L ++A QIA + Y+
Sbjct: 68 AVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNY 123
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK---GYVAPEWFRKST 240
IH D++ NIL+ D +I+DFGLA+L+ N+ TA +G K + APE
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGR 179
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300
+ K DV+SFG+LL E+++ + + N ++ + VE
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRV---------------PYPGMVNREVLEQVERGYRMPC 224
Query: 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
C E L + C ++DP RPT + L++
Sbjct: 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-15
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKL--DRVFQDGEKE---FKNEVIVIGQTHHKNL 121
+G+G+FG +Y T +AVK++ D + +KE + E+ ++ H+ +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRE---LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
V+ G + + + E++ G++ L +G L + QI + YLH
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGAL--TETVTRKYTRQILEGVEYLH--- 121
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAK-LLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S+ I+H DIK NIL + N ++ DFG +K L T+ T ++ GT +++PE
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 239 STISAKVDVYSFGVLLLEIIS 259
K DV+S G ++E+++
Sbjct: 182 EGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 8e-15
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVR 123
+G+G FG + +Q T A KKLD+ + GEK E ++ + + +V
Sbjct: 1 LGKGGFGEVC--AVQVKNTGKM-YACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
L + + L +N G L ++ G + + QI +L+LH S
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
I++ D+KP+N+LL+D+ N R+SD GLA + L KTI T GT GY+APE ++
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI-TQRAGTNGYMAPEILKEEPY 171
Query: 242 SAKVDVYSFGVLLLEIISCRKSF 264
S VD ++ G + E+++ R F
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 8e-15
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-----FKNEVIVIGQTHHK 119
++G G++G +YK + T VA+KK+ + EKE E+ ++ + H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGE---LVALKKIR---MENEKEGFPITAIREIKLLQKLRHP 58
Query: 120 NLVRLLGFC-DEGQNRL-LAYEFLN---NGTLAS----FLFGNLKPNWNLRTNIAFQIAR 170
N+VRL +G+ + + +E+++ G L S F +K Q+
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK-------CYMKQLLE 111
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGY 230
L YLH S+ I+H DIK NIL+N+ +++DFGLA+ T + T T Y
Sbjct: 112 GLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVITLWY 167
Query: 231 VAPEWFRKSTI-SAKVDVYSFGVLLLEIIS 259
PE +T +VD++S G +L E+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 9/202 (4%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVI---VIGQTHHKNLVR 123
+G+G FG + ++ T A KKL++ K ++ ++ ++ + H + +V
Sbjct: 1 LGKGGFGEVSACQMRATGK---LYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLLYLHEDCSSQ 182
L + L +N G L ++ + N A F A+++ L +
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTIS 242
II+ D+KP+N+LL++ N RISD GLA L Q KT A GT G++APE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--GTPGFMAPELLQGEEYD 175
Query: 243 AKVDVYSFGVLLLEIISCRKSF 264
VD ++ GV L E+I+ R F
Sbjct: 176 FSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 24/214 (11%)
Query: 62 NFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-----FKNEVIVIG 114
NF+ E++G G++G++YK + T VA+KK+ R+ D E E E+ ++
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGE---VVALKKI-RL--DTETEGVPSTAIREISLLK 54
Query: 115 QTHHKNLVRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPN--WNLRTNIAFQIARV 171
+ +H N+V+LL +N+L L +EFL+ L F+ + L + FQ+ +
Sbjct: 55 ELNHPNIVKLLDVI-HTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231
L + H S +++H D+KPQN+L+N +++DFGLA+ + R + T Y
Sbjct: 113 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYR 167
Query: 232 APEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSF 264
APE S VD++S G + E+++ R F
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKK--LDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+G G+ GI++K + T VA+KK L R+ + E+ + H +V+L
Sbjct: 8 IGEGAHGIVFKAKDRETGE---TVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLL----YLHEDCS 180
L G +L E++ L+ L +P L R+LL Y+H
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVLRDEERP---LPEAQVKSYMRMLLKGVAYMHA--- 117
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE-WFRKS 239
+ I+H D+KP N+L++ +I+DFGLA+L + + + + T+ Y APE +
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 240 TISAKVDVYSFGVLLLEIISCRKSF----DIE 267
VD+++ G + E+++ F DIE
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGENDIE 208
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 22/231 (9%)
Query: 42 GTIETKSRCFSYKELEEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF 99
G S + L + TD ++ E +G+G++G +YK T + AVK LD +
Sbjct: 3 GLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYK---VTNKKDGSLAAVKILDPI- 58
Query: 100 QDGEKEFKNEV-IVIGQTHHKNLVRLLGF------CDEGQNRLLAYEFLNNGTLASFLFG 152
D ++E + E I+ +H N+V+ G GQ L E N G++ + G
Sbjct: 59 SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGGSVTELVKG 117
Query: 153 NLKPNWNL-RTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211
L L I++ + LL L +++IIH D+K NILL ++ DFG++
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 212 LTLNQRKTIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEI 257
LT + R T++ GT ++APE + A+ DV+S G+ +E+
Sbjct: 178 LT-STRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 60/226 (26%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLVRL 124
VG G++G + T VA+KKL R FQ K E+ ++ H+N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRK---VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGL 79
Query: 125 LG-------------------FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA 165
L N ++ + L++ + FL
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI-QFLV-------------- 124
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
+QI R L Y+H S+ IIH D+KP NI +N+ +I DFGLA+ + T
Sbjct: 125 YQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH--TDDEMT------ 173
Query: 226 GTKGYVAPEWFRKSTI-------SAKVDVYSFGVLLLEIISCRKSF 264
GYVA W+R I + VD++S G ++ E+++ + F
Sbjct: 174 ---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD-RVFQDGEKEFKNEVIVIGQTHHKN 120
E +G G+ ++Y + VA+K++D Q E + EV + Q +H N
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEK---VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVL---LYLHE 177
+V+ G L +L+ G+L + + IA + VL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH- 119
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL---TLNQRKTIKTAIRGTKGYVAPE 234
S+ IH DIK NILL + + +I+DFG++ L RK KT + GT ++APE
Sbjct: 120 --SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPE 176
Query: 235 WFRKST-ISAKVDVYSFGVLLLEII 258
+ K D++SFG+ +E+
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 77/302 (25%), Positives = 130/302 (43%), Gaps = 62/302 (20%)
Query: 60 TDNFKEE--VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN----EVIVI 113
NFK E +G+G F ++YK VA+KK+ ++F+ + + + E+ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---ICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLL 56
Query: 114 GQTHHKNLVRLL-GFCDEGQNRL-LAYEFLNNGTLASFL--FGNLKPNWNLRT--NIAFQ 167
Q H N+++ L F + N L + E + G L+ + F K RT Q
Sbjct: 57 KQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT-AIRG 226
+ L ++H S +I+H DIKP N+ + ++ D GL + + KT ++ G
Sbjct: 115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVG 168
Query: 227 TKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF------------DIEMGEEYAI 274
T Y++PE ++ + K D++S G LL E+ + + F IE +Y
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYPP 227
Query: 275 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
L D Y + +L DLV CI DP RP + V Q+ +
Sbjct: 228 LPA---DHY-SEELRDLVSR--------------------CINPDPEKRPDISYVLQVAK 263
Query: 335 EV 336
E+
Sbjct: 264 EM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV------FQDGEKEFKNEVIVIGQTHH 118
+++G G+F Y+ + T +AVK++ V ++ + + E+ ++ + +H
Sbjct: 6 QQLGTGAFSSCYQA---RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLH 176
+++R+LG E + L E++ G+++ L +G K + N Q+ R L YLH
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE--AVIINYTEQLLRGLSYLH 120
Query: 177 EDCSSQIIHCDIKPQNILLNDR-YNARISDFGLAKLLT--LNQRKTIKTAIRGTKGYVAP 233
E+ QIIH D+K N+L++ RI+DFG A L + + GT ++AP
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 234 EWFRKSTISAKVDVYSFGVLLLEI 257
E R DV+S G +++E+
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEM 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 78/307 (25%), Positives = 127/307 (41%), Gaps = 68/307 (22%)
Query: 67 VGRGSFGIIYK----GVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVI-------VIGQ 115
+G G FG + G+ + T VAVK L D ++ +++I +IG+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 82
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN------------ 163
HKN++ LLG C + + E+ + G L +L P N
Sbjct: 83 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 164 ----IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL------- 212
A+Q+AR + YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 213 -TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
T N R +K ++APE + + DV+SFGVLL EI + G
Sbjct: 198 KTTNGRLPVK--------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSP 242
Query: 272 Y-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330
Y + + F + G D C +L M+ C PS RPT +++
Sbjct: 243 YPGVPVEELFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293
Query: 331 QMLQEVV 337
+ L ++
Sbjct: 294 EDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 62/222 (27%), Positives = 111/222 (50%), Gaps = 26/222 (11%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-----FKNEVIVIGQTHHK 119
E++G G++G++YK + T VA+KK+ R+ + E E E+ ++ + +H
Sbjct: 5 EKIGEGTYGVVYKARDKLTGE---IVALKKI-RL--ETEDEGVPSTAIREISLLKELNHP 58
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNI----AFQIARVLLYL 175
N+VRLL L +EFL+ L ++ + P L + +Q+ + + Y
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
H S +++H D+KPQN+L++ +++DFGLA+ + R + T Y APE
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 170
Query: 236 FRKS-TISAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 274
S S VD++S G + E+++ R F D E+ + + I
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 62/304 (20%)
Query: 67 VGRGSFGIIYK----GVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEV---IVIGQTHH 118
+G G FG + G+ + VAVK L D + + +E+ +IG+ H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA------------- 165
KN++ LLG C + + E+ + G L +L P +IA
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 166 ---FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--------TL 214
+Q+AR + YL S + IH D+ +N+L+ + +I+DFGLA+ + T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-A 273
N R +K ++APE + + DV+SFGVL+ EI + G Y
Sbjct: 198 NGRLPVK--------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPG 242
Query: 274 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333
I + F + G D C +L M+ C PS RPT +++ + L
Sbjct: 243 IPVEELFKLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
Query: 334 QEVV 337
++
Sbjct: 294 DRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 32/271 (11%)
Query: 67 VGRGSFGIIYKGV-IQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+G G+FG +YKG+ I VA+K L + KE +E V+ + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
LG C +L+ + + G L ++ N + N QIA+ + YL E ++
Sbjct: 75 LGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI-- 241
+H D+ +N+L+ + +I+DFGLA+LL +++ T G V +W +I
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDE-----TEYHADGGKVPIKWMALESILH 185
Query: 242 ---SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298
+ + DV+S+GV + E++ +F + +D ++ DL+E
Sbjct: 186 RRFTHQSDVWSYGVTVWELM----TFGAK-----------PYDGIPAREIPDLLEKGERL 230
Query: 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
C + MI + C D RP R++
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSECRPRFREL 261
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 27/281 (9%)
Query: 63 FKEEVGRGSFGIIYKGVIQ--TTTTSTTAVAVKKLDRVFQDGEKE-FKNEVIVIGQT-HH 118
F + +G G+FG + + + + + VAVK L E+E +E+ ++ +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARVLLYLH 176
+N+V LLG C G L+ E+ G L +FL + L ++F Q+A+ + +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
S IH D+ +N+LL +I DFGLA+ + + +K R ++APE
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF-DCYRNGKLDDLVEG 294
+ + DV+S+G+LL EI S Y + D F + G E
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLG-------SNPYPGMPVDSKFYKLIKEGYRMAQPEH 268
Query: 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
+ DI M + W DP RPT +++ Q++ +
Sbjct: 269 APAEIYDI-------MKTCW--DADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 40/230 (17%)
Query: 54 KELEEATDNFKE--EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNE 109
K + E + ++ VG G++G + T + VAVKKL R FQ K E
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAF---DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 66
Query: 110 VIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFG----NLKPNWNLRTN-- 163
+ ++ H+N++ LL + + E N+ L + L G N+ L +
Sbjct: 67 LRLLKHMKHENVIGLLDVFTPAR----SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 122
Query: 164 --IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK 221
+ +QI R L Y+H S+ IIH D+KP N+ +N+ +I DFGLA+
Sbjct: 123 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----------H 169
Query: 222 TAIRGTKGYVAPEWFRKSTI-------SAKVDVYSFGVLLLEIISCRKSF 264
T T GYVA W+R I + VD++S G ++ E+++ R F
Sbjct: 170 TDDEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAV-AVKKLDR---VFQDGEKEFKNEVIVIGQTH 117
F + +G GSFG V+ + A+K L + V + NE ++
Sbjct: 4 EFIKTLGTGSFGR----VMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHE 177
H LV L G + N L E++ G L S L + + + A Q+ L YLH
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH- 118
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
S I++ D+KP+N+LL+ +I+DFG AK + + T + GT Y+APE
Sbjct: 119 --SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYT-LCGTPEYLAPEIIL 171
Query: 238 KSTISAKVDVYSFGVLLLEII 258
VD ++ G+L+ E++
Sbjct: 172 SKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 56/204 (27%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNLVR 123
+++G G++ ++KG + T VA+K++ ++G EV ++ H N+V
Sbjct: 11 DKLGEGTYATVFKGRSKLTEN---LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
L + L +E+L++ L +L GNL N++ FQ+ R L Y H+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHK---R 122
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST- 240
+I+H D+KPQN+L+N++ +++DFGLA+ ++ + + T Y P+ ST
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTE 180
Query: 241 ISAKVDVYSFGVLLLEIISCRKSF 264
S +D++ G +L E+ + R F
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK----NEVIVIGQTH---H 118
E+G G++G ++K + VA+K++ RV Q GE+ EV V+ H
Sbjct: 8 EIGEGAYGKVFKA--RDLKNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEH 63
Query: 119 KNLVRLLGFC-----DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARV 171
N+VRL C D L +E ++ L ++L +P T ++ FQ+ R
Sbjct: 64 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231
L +LH S +++H D+KPQNIL+ +++DFGLA++ + + T++ T Y
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYR 176
Query: 232 APEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
APE +S+ + VD++S G + E+ + F
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 66 EVGRGSFGIIYKGVIQTTTTST---TAVAVKKLDRVFQD------GEKEFKNEVIVIGQT 116
E+G+G++GI V T VA+KK+ VF +E K ++
Sbjct: 7 ELGQGAYGI----VCSARNAETSEEETVAIKKITNVFSKKILAKRALRELK---LLRHFR 59
Query: 117 HHKNLVRL--LGFCDEGQ-NRLLAYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARVL 172
HKN+ L + G N L YE L L + G + + ++ I +QI L
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCGL 118
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
Y+H S+ ++H D+KP N+L+N +I DFGLA+ + N + YVA
Sbjct: 119 KYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF----MTEYVA 171
Query: 233 PEWFRKSTI-------SAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 272
W+R I + +DV+S G +L E++ + F G++Y
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF---KGKDY 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 36/240 (15%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK----NEVIVIG---QTHH 118
E+G G++G +YK S VA+K + RV Q E EV ++ H
Sbjct: 7 EIGVGAYGTVYKA---RDPHSGHFVALKSV-RV-QTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 119 KNLVRLLGFC-----DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARV 171
N+VRL+ C D L +E ++ L ++L P T ++ Q R
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231
L +LH +C I+H D+KP+NIL+ +++DFGLA++ + + T + T Y
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYR 174
Query: 232 APEWFRKSTISAKVDVYSFGVLLLEIIS-----CRKSFDIEMGEEYAIL-----TDWAFD 281
APE +ST + VD++S G + E+ C S ++G+ + ++ DW D
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
+QI R L Y+H S+ ++H D+KP N+LLN + +I DFGLA++ T
Sbjct: 113 YQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL--- 166
Query: 226 GTKGYVAPEWFRKSTI-------SAKVDVYSFGVLLLEIISCRKSF 264
T+ YVA W+R I + +D++S G +L E++S R F
Sbjct: 167 -TE-YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-13
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ-THHKNLVR 123
E VG G++G +YKG T +A K+ V D E+E K E+ ++ + +HH+N+
Sbjct: 12 ELVGNGTYGQVYKG----RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 124 LLG-FCDEGQNRL-----LAYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARVLLY 174
G F + + L EF G++ L N K N IA+ +I R L +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKGYVA 232
LH+ ++IH DIK QN+LL + ++ DFG++ L T+ +R T GT ++A
Sbjct: 127 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI----GTPYWMA 179
Query: 233 PEWFR-----KSTISAKVDVYSFGVLLLEI 257
PE +T K D++S G+ +E+
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 71/307 (23%), Positives = 125/307 (40%), Gaps = 54/307 (17%)
Query: 63 FKEEVGRGSFGIIY----KGVIQTTTTSTTA-------VAVKKL-DRVFQDGEKEFKNEV 110
KE++G G FG ++ +G+ + VAVK L V + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNI----- 164
++ + + N++RLLG C + E++ NG L FL ++ + NI
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 165 ------AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218
A QIA + YL S +H D+ +N L+ + Y +I+DFG+++ L
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 278
I+ ++A E + DV++FGV L E+ + K + Y++L+D
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE------QPYSLLSD- 238
Query: 279 AFDCYRNGKLDDLVEGDMEAMNDIK----------CVEKLLMISIWCIQEDPSLRPTMRK 328
+ ++E E + C + + + C D RPT K
Sbjct: 239 ----------EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288
Query: 329 VSQMLQE 335
+ L+E
Sbjct: 289 IHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 26/210 (12%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNLVR 123
E++G G++ ++KG + T VA+K++ ++G EV ++ H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTEN---LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
L ++ L +E+L+ L ++ GN+ N++ + +QI R L Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCHR---R 123
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR---- 237
+++H D+KPQN+L+N+R +++DFGLA+ K++ T + V W+R
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNE--VVTLWYRPPDV 175
Query: 238 ---KSTISAKVDVYSFGVLLLEIISCRKSF 264
S S ++D++ G + E+ S R F
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 22/221 (9%)
Query: 67 VGRGSFGII----YKGVIQTTTTSTTAVAVKKLDRVFQDGEKEF-KNEVIVIGQT-HHKN 120
+G+GSFG + KG T AV V K D + QD + E E V+ H
Sbjct: 3 LGKGSFGKVLLAELKG-----TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 121 LVRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
L +L C + ++RL E++N G L + + + + A +I L +LHE
Sbjct: 58 LTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE-- 114
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
II+ D+K N+LL+ + +I+DFG+ K L T + GT Y+APE
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILSYQ 171
Query: 240 TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY---AILTD 277
VD ++ GVLL E+++ + F+ + E+ +IL D
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSILED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 78/323 (24%), Positives = 124/323 (38%), Gaps = 83/323 (25%)
Query: 62 NFKEEVGRGSFGIIY-------------KGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFK 107
NF E++G G FG ++ + VAVK L + ++F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 108 NEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL----------------- 150
EV ++ + N+ RLLG C + E++ NG L FL
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 151 -FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209
F L +A QIA + YL S +H D+ +N L+ Y +I+DFG++
Sbjct: 128 SFSTLL-------YMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 210 KLLTLNQRKTIK----TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSF 264
+ L + ++ IR ++A E + K DV++FGV L EI++ CR+
Sbjct: 178 RNLYSSDYYRVQGRAPLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-- 231
Query: 265 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK----------CVEKL--LMIS 312
+ Y LTD ++E D C + + LM+
Sbjct: 232 -----QPYEHLTD-----------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLE 275
Query: 313 IWCIQEDPSLRPTMRKVSQMLQE 335
W + D RPT R++ LQ
Sbjct: 276 CW--RRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---FKNEVIVIGQTHH 118
NF +G+GSFG + + T A+ + K D + QD + E + V+ +
Sbjct: 3 NFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 119 KNLVRLLGFCDEGQNRL-LAYEFLNNGTLASFL--FGNLKPNWNLRTNIAF---QIARVL 172
+ L C + +RL E++N G L + G K + F +IA L
Sbjct: 62 --FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFK-----EPHAVFYAAEIAIGL 114
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
+LH S II+ D+K N++L+ + +I+DFG+ K + KT +T GT Y+A
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFC-GTPDYIA 169
Query: 233 PEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
PE VD ++FGVLL E+++ + FD E +E
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ-THHKNLVR 123
E VG G++G +YKG T +A K+ V +D E+E K E+ ++ + +HH+N+
Sbjct: 22 EVVGNGTYGQVYKG----RHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 124 LLG-FCDE---GQNR--LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARVLLY 174
G F + G + L EF G++ L N K N IA+ +I R L +
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKGYVA 232
LH + ++IH DIK QN+LL + ++ DFG++ L T+ +R T GT ++A
Sbjct: 137 LH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI----GTPYWMA 189
Query: 233 PEWFR-----KSTISAKVDVYSFGVLLLEI 257
PE +T + D++S G+ +E+
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNLVR 123
+++G G++ +YKG + T VA+K++ ++G EV ++ H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDN---LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
L ++ L +E+L+ L +L GN N++ + FQ+ R L Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHR---R 123
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
+++H D+KPQN+L+N+R +++DFGLA+ K+I T + V W+R I
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNE--VVTLWYRPPDI 175
Query: 242 -------SAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
S ++D++ G + E+ + R F EE
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 67 VGRGSFGIIYKGVI-QTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
+G G FG + +G + Q + AV K+ + ++F +E + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 126 GFCDEGQNR------LLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAF--QIARVLL 173
G C + ++ F+ +G L SFL G+ + + F IA +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL----TLNQRKTIKTAIRGTKG 229
YL S IH D+ +N +LN+ N ++DFGL+K + Q + K ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK---- 179
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEI 257
++A E + K DV+SFGV + EI
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK--EFKNEVIVIGQTHHKNLVR 123
E+G G+FG +YK Q T A A K + + E+ +F E+ ++ + H N+V
Sbjct: 12 ELGDGAFGKVYK--AQHKETGLFA-AAKIIQ--IESEEELEDFMVEIDILSECKHPNIVG 66
Query: 124 LL-GFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLHEDCSS 181
L + E + +L EF + G L S + + + Q+ L +LH S
Sbjct: 67 LYEAYFYENKLWIL-IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SH 122
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGL-AKLLTLNQRKTIKTAIRGTKGYVAP-----EW 235
++IH D+K NILL + +++DFG+ AK + Q++ T I GT ++AP E
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD--TFI-GTPYWMAPEVVACET 179
Query: 236 FRKSTISAKVDVYSFGVLLLEI 257
F+ + K D++S G+ L+E+
Sbjct: 180 FKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 10/194 (5%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLL 125
VG G+FG ++ V + A+ V + V + E+ NE V+ + H ++RL
Sbjct: 9 VGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 126 GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIH 185
+ + + E++ G L S+L + + + + A +I L YLH S +I++
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVY 124
Query: 186 CDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKV 245
D+KP+NILL+ + +++DFG AK L + +T + GT Y+APE + + V
Sbjct: 125 RDLKPENILLDKEGHIKLTDFGFAKKL---RDRT--WTLCGTPEYLAPEVIQSKGHNKAV 179
Query: 246 DVYSFGVLLLEIIS 259
D ++ G+L+ E++
Sbjct: 180 DWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVR 123
+G+G FG + ++ T A KKL++ + GE NE ++ + + + +V
Sbjct: 8 LGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC---- 179
L + E ++ L L NG G+LK + F+ R + Y E C
Sbjct: 65 L-AYAYETKDALCLVLTLMNG-------GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 180 ---SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
+I++ D+KP+NILL+D + RISD GLA + + + +TIK + GT GY+APE
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMAPEVV 173
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSF 264
+ + D ++ G LL E+I+ + F
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 59/212 (27%), Positives = 110/212 (51%), Gaps = 20/212 (9%)
Query: 62 NFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK-NEVIVIGQTHH 118
NFK E++G G++ +YKG +TT VA+K++ ++G E+ ++ + H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKELKH 57
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL-----FGNLKPNWNLRTNIAFQIARVLL 173
+N+VRL +L +E+++ L ++ G L PN + +Q+ + +
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPN--TVKSFTYQLLKGIA 114
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAP 233
+ HE+ +++H D+KPQN+L+N R +++DFGLA+ + + T Y AP
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAP 169
Query: 234 EWFRKS-TISAKVDVYSFGVLLLEIISCRKSF 264
+ S T S +D++S G ++ E+I+ R F
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 9e-13
Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223
IA I + L YLH S +IH D+KP N+L+N ++ DFG++ L + KTI
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA- 164
Query: 224 IRGTKGYVAPEWF----RKSTISAKVDVYSFGVLLLEI 257
G K Y+APE + K DV+S G+ ++E+
Sbjct: 165 --GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLD-RVFQDGEKEF-KNEVIVIGQTHHKNLVRL 124
+G GSFG IY + + + +K++D EKE K EVI++ + H N+V
Sbjct: 8 IGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARVLLY 174
E + E+ + G L + N + + F QI+ L +
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRI--------NRQRGVLFSEDQILSWFVQISLGLKH 116
Query: 175 LHEDCSSQIIHCDIKPQNILLNDR-YNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAP 233
+H+ +I+H DIK QNI L+ A++ DFG+A+ LN + GT Y++P
Sbjct: 117 IHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSP 171
Query: 234 EWFRKSTISAKVDVYSFGVLLLEIISCRKSFD 265
E + + K D++S G +L E+ + + F+
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 66/265 (24%), Positives = 120/265 (45%), Gaps = 25/265 (9%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
++E +G G+ G +YK T AV V LD + + +K+ +E+ ++ + ++
Sbjct: 5 YQEILGHGNGGTVYK-AYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYII 62
Query: 123 RLLG-FCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCS 180
G F E NR+ + EF++ G+L ++ + P L IA + + L YL S
Sbjct: 63 GFYGAFFVE--NRISICTEFMDGGSLD--VYRKI-PEHVL-GRIAVAVVKGLTYL---WS 113
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+I+H D+KP N+L+N R ++ DFG++ L +I GT Y+APE
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQ 169
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300
DV+S G+ +E+ R + + +++ C +V+ D +
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC--------IVDEDPPVLP 221
Query: 301 DIKCVEKLLMISIWCIQEDPSLRPT 325
+ EK + C+++ P RP
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 21/224 (9%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---FKNEVIVIGQTHHKNLVR 123
+G+GSFG + ++ T A+KK D V +D + E + V+ + H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALA-WEHPFLTH 60
Query: 124 LLGFCDEGQNRLLAY--EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
L FC L + E+LN G L + + + + A +I L +LH
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KK 115
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
II+ D+K N+LL+ + +I+DFG+ K + K + GT Y+APE +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQKY 173
Query: 242 SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285
+ VD +SFGVLL E++ + F E +E FD N
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-------FDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 10/215 (4%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK-NEVIVIGQTHHKNLVRLL 125
+G+GSFG + ++ + AV V K D + QD + E E ++ + + L
Sbjct: 3 LGKGSFGKVMLARLKESG-RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 126 GFCDEGQNRLL-AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
C + +RL EF+N G L + + + + A +I L++LH+ II
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGII 118
Query: 185 HCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAK 244
+ D+K N+LL+ + +++DFG+ K N + T + GT Y+APE ++
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAPEILQEMLYGPS 176
Query: 245 VDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 277
VD ++ GVLL E++ F+ E ++ AIL D
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 54 KELEEATDNFKE--EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--EKEFKNE 109
K + E D +++ +VG G++G + + + VA+KKL R FQ K E
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSAL---DRRTGAKVAIKKLYRPFQSELFAKRAYRE 64
Query: 110 VIVIGQTHHKNLVRLLGF------CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN 163
+ ++ H+N++ LL D + L F+ GT L + K + +
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF 122
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223
+ +Q+ + L Y+H ++ IIH D+KP N+ +N+ +I DFGLA+ Q + T
Sbjct: 123 LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTG 174
Query: 224 IRGTKGYVAPE----WFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
T+ Y APE W + VD++S G ++ E+++ + F
Sbjct: 175 YVVTRWYRAPEVILNWMH---YTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
+G G FG + V + T A+ VKK V ++ +E ++ + +H +V+L
Sbjct: 1 LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 126 -GFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLL---YLHEDC 179
F D+ + + E+ G L + L G + R F IA V+L YLH
Sbjct: 60 RTFKDK-KYIYMLMEYCLGGELWTILRDRGLF-DEYTAR----FYIACVVLAFEYLH--- 110
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
+ II+ D+KP+N+LL+ ++ DFG AK L + +KT T GT YVAPE
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKT-WTFC-GTPEYVAPE----- 162
Query: 240 TISAK-----VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 277
I K VD +S G+LL E+++ R F + + I D
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQTHHKNLVRL 124
+G G+FG+++ T VA+KK+ VFQ+ K E+ ++ H N++
Sbjct: 8 IGYGAFGVVWS---VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARVLLYLHEDCS 180
L ++ + S L + L ++ +QI R L YLH S
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---S 121
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+ I+H DIKP N+L+N +I DFGLA++ ++ K + T T+ Y APE S
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM-TQEVVTQYYRAPEILMGSR 180
Query: 241 -ISAKVDVYSFGVLLLEIISCRKSF 264
++ VD++S G + E++ R F
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 49/210 (23%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVFQDGEKEFKNEVIVIGQTHHKNLV 122
+++G GSFG K ++ + +K+++ ++ +E + EV V+ H N+V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC--- 179
+ +E N + ++ G L + N + + F ++L + + C
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKI--------NAQRGVLFPEDQILDWFVQICLAL 114
Query: 180 ----SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
+I+H DIK QNI L ++ DFG+A++L + + +T I GT Y++PE
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCI-GTPYYLSPEI 172
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFD 265
+ K D+++ G +L E+ + + +F+
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
E+G G+FG +YK Q T A A K +D ++ +++ E+ ++ H N+V+LL
Sbjct: 12 ELGDGAFGKVYKA--QNKETGVLAAA-KVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 126 GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF-QIARVLLYLHEDCSSQII 184
N + EF G + + + +P + + Q L YLHE ++II
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 185 HCDIKPQNILLNDRYNARISDFGL-AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST--- 240
H D+K NIL + +++DFG+ AK QR + + GT ++APE T
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVVMCETSKD 182
Query: 241 --ISAKVDVYSFGVLLLEI 257
K DV+S G+ L+E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 38/224 (16%)
Query: 51 FSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--EKEFKN 108
F+ ++L++ E+GRG+FG + K + + S T +AVK++ R D +K
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKP---SGTIMAVKRI-RSTVDEKEQKRLLM 51
Query: 109 EVIVIGQTHH-KNLVRLLG---------FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNW 158
++ V+ ++ +V+ G C E L+ +++ LK
Sbjct: 52 DLDVVMRSSDCPYIVKFYGALFREGDCWICME----LMDISLDK---FYKYVYEVLKSVI 104
Query: 159 --NLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216
+ IA + L YL E+ +IIH D+KP NILL+ N ++ DFG++ L
Sbjct: 105 PEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL---V 159
Query: 217 RKTIKTAIRGTKGYVAPEWFRKSTISA---KVDVYSFGVLLLEI 257
KT G + Y+APE S + DV+S G+ L E+
Sbjct: 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNL 121
E +G G++G++ + T S VA+KK+ F ++ + E+ ++ H N+
Sbjct: 11 ENIGSGAYGVVCSAI---DTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNI 66
Query: 122 VRLLGFC----DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHE 177
+ + + ++ + + L L + + +Q+ R L Y+H
Sbjct: 67 IAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH- 124
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RKTIKTAIRGTKGYVAPE- 234
S+ +IH D+KP N+L+N+ RI DFG+A+ L+ + K T T+ Y APE
Sbjct: 125 --SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 235 WFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
+ +D++S G + E++ R+ F
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 48/216 (22%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN-EVIVIGQTHHKNLVRL- 124
+G GSFG++Y+ + T+ VA+KK V QD ++KN E++++ +H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEK---VAIKK---VLQD--PQYKNRELLIMKNLNHINIIFLK 125
Query: 125 --------------------LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNI 164
+ F + ++ + + NN L FL
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV----------KLY 175
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR-YNARISDFGLAKLLTLNQRKTIKTA 223
++Q+ R L Y+H S I H D+KPQN+L++ + ++ DFG AK L QR
Sbjct: 176 SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232
Query: 224 IRGTKGYVAPEWFRKST-ISAKVDVYSFGVLLLEII 258
R Y APE +T + +D++S G ++ E+I
Sbjct: 233 SR---FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV-IVIGQTHHKNLVR 123
E +G+G++G ++K V+ S AV K LD + D ++E + E I+ + H N+V+
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAV--KILDPI-HDIDEEIEAEYNILKALSDHPNVVK 79
Query: 124 LLGF-----CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN-IAFQIARVLLYLHE 177
G G L E N G++ + G LK + IA+ + L+ L
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
++ IH D+K NILL ++ DFG++ LT + R T++ GT ++APE
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSV-GTPFWMAPEVIA 197
Query: 238 -----KSTISAKVDVYSFGVLLLEI 257
ST A+ DV+S G+ +E+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 25/203 (12%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN---EVIVIGQTHHKNL 121
E++G G++G ++K + T VA+K++ R+ D E + E+ ++ + HKN+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHE---IVALKRV-RLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
VRL + L +E+ + F N + + + FQ+ + L + H S
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SH 118
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
++H D+KPQN+L+N +++DFGLA+ + +R V W+R +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGI--------PVRCYSAEVVTLWYRPPDV 170
Query: 242 -------SAKVDVYSFGVLLLEI 257
S +D++S G + E+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---FKNEVIVIGQTHHKNLVR 123
+G+GSFG ++ ++ T A+KK D V D + E + V+ + H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAW-EHPFLTH 60
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
L +N E+LN G L + K + T A +I L +LH S I
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGI 117
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
++ D+K NILL+ + +I+DFG+ K L KT GT Y+APE +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT--CTFCGTPDYIAPEILLGQKYNT 175
Query: 244 KVDVYSFGVLLLEIISCRKSF 264
VD +SFGVLL E++ + F
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 39/120 (32%), Positives = 60/120 (50%), Gaps = 10/120 (8%)
Query: 152 GNLKPNWNLRTNIAFQIARVLLYLHEDC-------SSQIIHCDIKPQNILLNDRYNARIS 204
G+LK + N F R + Y E +I++ D+KP+NILL+D + RIS
Sbjct: 85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRIS 144
Query: 205 DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
D GLA + + TI+ + GT GY+APE + + D + G L+ E+I + F
Sbjct: 145 DLGLAVEIPEGE--TIRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 64/284 (22%), Positives = 123/284 (43%), Gaps = 30/284 (10%)
Query: 62 NFKEE--VGRGSFGIIYKGVIQTTTTSTTAVAVKKL---DRVFQDGEKEFKNEVIVIGQT 116
NF+ E +GRG F +Y+ T VA+KK+ D + + E+ ++ Q
Sbjct: 3 NFRIEKKIGRGQFSEVYRA---TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 59
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAF--QIARVL 172
+H N+++ E + E + G L+ + F K +T + Q+ L
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
++H S +++H DIKP N+ + ++ D GL + + + T ++ GT Y++
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMS 174
Query: 233 PEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292
PE ++ + K D++S G LL E+ + + F + Y++ C + +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-------CKK------IE 221
Query: 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336
+ D + E+L + CI DP RP + V + + +
Sbjct: 222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-12
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 27/201 (13%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--EKEFKNEVIVIGQTHHKNLVRL 124
VG G+FG++ Q T VA+KK+ + F K E+ ++ H+N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQ---NVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 125 LG-FCDEGQNRLLAYEFLNNGT-LASFL-FGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
F ++ E L GT L L L+ + +QI R L Y+H S+
Sbjct: 75 SDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQF--IQYFLYQILRGLKYVH---SA 127
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE----WFR 237
++H D+KP NIL+N+ + +I DFGLA++ + T T+ Y APE W +
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 238 KSTISAKVDVYSFGVLLLEII 258
+VD++S G + E++
Sbjct: 183 ---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-12
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKL--------DRVFQDGEKEFKNEVIVIGQTHH 118
+G+GSFG ++ T + A+K L DRV K E ++ + +H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV------RTKMERDILAEVNH 57
Query: 119 KNLVRL-LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHE 177
+V+L F EG+ L+ +FL G L + L K ++ F +A + L L
Sbjct: 58 PFIVKLHYAFQTEGKLYLI-LDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDH 113
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
S II+ D+KP+NILL++ + +++DFGL+K +++K + GT Y+APE
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPEVVN 171
Query: 238 KSTISAKVDVYSFGVLLLEIIS 259
+ + D +SFGVL+ E+++
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 67/285 (23%), Positives = 130/285 (45%), Gaps = 32/285 (11%)
Query: 62 NFKEE--VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ----DGEKEFKNEVIVIGQ 115
NF+ E +GRG F +Y+ T VA+KK+ ++F+ ++ E+ ++ Q
Sbjct: 3 NFQIEKKIGRGQFSEVYRA---TCLLDRKPVALKKV-QIFEMMDAKARQDCVKEIDLLKQ 58
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAF--QIARV 171
+H N+++ L E + E + G L+ + F K RT + Q+
Sbjct: 59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231
+ ++H S +++H DIKP N+ + ++ D GL + + + T ++ GT Y+
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYM 173
Query: 232 APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291
+PE ++ + K D++S G LL E+ + + F G++ + + C + +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLFS----LCQK------I 220
Query: 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336
+ D + EKL + CI DP RP + V Q+ +++
Sbjct: 221 EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 14/215 (6%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN-EVIVIGQTHHKN 120
NF +G+GSFG + + T A+ + K D V QD + E E V+ +
Sbjct: 3 NFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 121 LVRLLGFCDEGQNRL-LAYEFLNNGTLASFL--FGNLK-PNWNLRTNIAFQIARVLLYLH 176
+ L C + +RL E++N G L + G K P+ A +IA L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH---AVFYAAEIAIGLFFLH 118
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
S II+ D+K N++L+ + +I+DFG+ K + T KT GT Y+APE
Sbjct: 119 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTTKTFC-GTPDYIAPEII 173
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
VD ++FGVLL E+++ + F+ E +E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVR 123
+G+G FG + ++ T A KKL++ + GE NE ++ + + + +V
Sbjct: 8 LGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 124 LLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQ 182
L + E ++ L L +N G L ++ P ++ + I F A + L + +
Sbjct: 65 L-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAI-FYAAELCCGLEDLQRER 122
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTIS 242
I++ D+KP+NILL+DR + RISD GLA + + + +T++ + GT GY+APE +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRV-GTVGYMAPEVINNEKYT 179
Query: 243 AKVDVYSFGVLLLEIISCRKSF 264
D + G L+ E+I + F
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-12
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 29/212 (13%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
+E+G G FG + G S V VK+L D + F EV + +H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGM-SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARVLLYLHED 178
LG C E LL EF G L ++L N ++ +A ++A LL+LH+
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA------IRGTKGYVA 232
+ IH D+ +N L + +I D+GLA L T +R ++A
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR----WLA 170
Query: 233 PEW-------FRKSTISAKVDVYSFGVLLLEI 257
PE + K +++S GV + E+
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 65 EEVGRGSFGIIYKG----VIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN 120
E +G+G+F I+KG V T V +K LD+ ++ + F ++ Q HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARVLLYLHE 177
LV G C G ++ E++ G+L ++L N + +W L +A Q+A L +L +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLED 118
Query: 178 DCSSQIIHCDIKPQNILL---NDRYNA-----RISDFGLAKLLTLNQRKTIKTAIRGTKG 229
+ H ++ +N+LL DR ++SD G++ +T+ ++ + I
Sbjct: 119 ---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP---- 169
Query: 230 YVAPEWFRKS-TISAKVDVYSFGVLLLEIIS 259
+V PE +S D +SFG L EI S
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLVRL 124
+G G+ GI+ T VAVKKL R FQ+ K E++++ +HKN++ L
Sbjct: 29 IGSGAQGIVCAAF---DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 125 LGF------CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHED 178
L +E Q+ L E ++ L + L + + + +Q+ + +LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMEL--DHERMSYLLYQMLCGIKHLH-- 140
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S+ IIH D+KP NI++ +I DFGLA+ N + T T+ Y APE
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILG 196
Query: 239 STISAKVDVYSFGVLLLEII 258
VD++S G ++ E++
Sbjct: 197 MGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 56/204 (27%), Positives = 104/204 (50%), Gaps = 26/204 (12%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
E+G G+FG +YK + T A A K ++ ++ +++ E+ ++ +H +V+LL
Sbjct: 19 ELGDGAFGKVYKA--KNKETGALAAA-KVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 126 G-FCDEGQNRLLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCS 180
G F +G+ ++ EF G + + + G +P + I Q+ L YLH S
Sbjct: 76 GAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLH---S 128
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLA--KLLTLNQRKTIKTAIRGTKGYVAP----- 233
+IIH D+K N+LL + +++DFG++ + TL +R + GT ++AP
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMC 184
Query: 234 EWFRKSTISAKVDVYSFGVLLLEI 257
E + + K D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 67/286 (23%), Positives = 122/286 (42%), Gaps = 36/286 (12%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVK--KLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+G+G FG + + +++ S VAVK K D +EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 125 LGFC--DEGQNRL----LAYEFLNNGTLASFLF----GNLKPNWNLRTNIAF--QIARVL 172
+G + RL + F+ +G L +FL G L+T + F IA +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
YL S IH D+ +N +LN+ ++DFGL+K + A + ++A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 233 PEWFRKSTISAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDD 290
E + + DV++FGV + EI++ ++ +E E Y
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY---------------- 227
Query: 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336
L++G+ C+E + + C +P RP+ + + L+ +
Sbjct: 228 LIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 52/208 (25%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 57 EEATDNFKE--EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVI--- 111
E D+F+ E+G G+ G++ K + + +KL + + + +N++I
Sbjct: 1 ELKDDDFERISELGAGNGGVVTK----VQHKPSGLIMARKL--IHLEIKPAIRNQIIREL 54
Query: 112 -VIGQTHHKNLVRLLG-FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA 169
V+ + + +V G F +G+ + E ++ G+L L + + ++ +
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVL 113
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
R L YL E QI+H D+KP NIL+N R ++ DFG++ L ++ + GT+
Sbjct: 114 RGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRS 167
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEI 257
Y++PE + + S + D++S G+ L+E+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 40 GDGTIETKSRCFSYK--ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR 97
+ TK S+K + E E +G GSFG + + T +KK +
Sbjct: 2 KAAYMFTKPDTSSWKLSDFE-----MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI 56
Query: 98 VFQDGEKEFKNEVIVIGQTHHKNLVRLL-GFCDEGQNRL-LAYEFLNNGTLASFLFGNLK 155
+ + E ++ + H +V ++ F DE NR+ EF+ G L F +L+
Sbjct: 57 LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGEL----FTHLR 110
Query: 156 PNWNLRTNIA-FQIARVLL---YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211
++A F A ++L YLH S II+ D+KP+N+LL+++ + +++DFG AK
Sbjct: 111 KAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK- 166
Query: 212 LTLNQRKTIKT-AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEII 258
+ +T + GT Y+APE + VD ++ GVLL E I
Sbjct: 167 -----KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 35/219 (15%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVFQDGEKEFKNEVIVIGQTHHKN 120
F VG+GS+G + +++ T V +KKL+ + K + E ++ Q H N
Sbjct: 4 FVRVVGKGSYGEV--SLVRHRTDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 121 LVR--------------LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF 166
+V ++GFC+ G Y L G L P N
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGD----LYHKLKEQK------GKLLPE-NQVVEWFV 109
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG 226
QIA L YLHE I+H D+K QN+ L ++ D G+A++L NQ T I G
Sbjct: 110 QIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLI-G 164
Query: 227 TKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFD 265
T Y++PE F + K DV++ G + E+ + + +F+
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN--------EVIVIGQTHH 118
+G G++ ++YK + T VA+KK + KE K+ E+ ++ + H
Sbjct: 8 LGEGTYAVVYKA--RDKETGRI-VAIKK---IKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 119 KNLVRLLGFCDEGQNRLLAYEFL--------NNGTLASFLFGNLKPNWNLRTNIAFQIAR 170
N++ LL N L +EF+ + ++ ++K + R
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI-VLTPADIK-------SYMLMTLR 113
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGY 230
L YLH S+ I+H D+KP N+L+ +++DFGLA+ RK + T+ Y
Sbjct: 114 GLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWY 168
Query: 231 VAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSF 264
APE + VD++S G + E++ R F
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224
+ Q+A+ + +L S IH D+ +N+LL D A+I DFGLA+ + + +K
Sbjct: 218 SSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 283
R ++APE + + DV+S+G+LL EI S KS Y IL + F Y
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS-------PYPGILVNSKF--Y 325
Query: 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
+ K G + D E + I C +P+ RPT ++SQ++Q
Sbjct: 326 KMVK-----RGYQMSRPDFAPPE-IYSIMKMCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 72/323 (22%), Positives = 130/323 (40%), Gaps = 85/323 (26%)
Query: 63 FKEEVGRGSFGIIY----KGV---------IQTTTTSTTAVAVKKL-DRVFQDGEKEFKN 108
FKE++G G FG ++ +G+ + + VAVK L + ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 109 EVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL------------------ 150
E+ ++ + N++RLL C + E++ NG L FL
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 151 FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210
+ L +A QIA + YL S +H D+ +N L+ Y +I+DFG+++
Sbjct: 129 YSTLI-------FMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI-----SAKVDVYSFGVLLLEIIS-CRKSF 264
L I+ + + W +I + DV++FGV L EI++ C++
Sbjct: 179 NLYSGDYYRIQ-----GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE-- 231
Query: 265 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK----------CVEKL--LMIS 312
+ Y+ L+D + ++E E D C + L LM+S
Sbjct: 232 -----QPYSQLSD-----------EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS 275
Query: 313 IWCIQEDPSLRPTMRKVSQMLQE 335
W + + RP+ +++ L E
Sbjct: 276 CW--RRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 38/215 (17%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQTHHKNLVRL 124
VG G++G + T VAVKKL R FQ + E+ ++ H+N++ L
Sbjct: 23 VGSGAYGSVCSAY---DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARVLLYLH 176
L + E N L + L G N+ L + +Q+ R L Y+H
Sbjct: 80 LDVFTPAT----SIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
S+ IIH D+KP N+ +N+ RI DFGLA + A GYVA W+
Sbjct: 136 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLA-----------RQADDEMTGYVATRWY 181
Query: 237 RKSTI-------SAKVDVYSFGVLLLEIISCRKSF 264
R I + VD++S G ++ E++ + F
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 46/280 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN---EVIVIGQTHHK 119
+E+G+G++G +YK V+ T T A+ +L+ E +F E+ ++ +
Sbjct: 5 VLDELGKGNYGSVYK-VLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSP 59
Query: 120 NLVRLLG-FCDEGQNRLLAYEFLNNGTLASFLFGNL----KPNWNLRTNIAFQIARVLLY 174
+V G F EG + E+++ G+L G + P LR I + + + L +
Sbjct: 60 YIVDFYGAFFIEGA-VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKF 117
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI-KTAIRGTKGYVAP 233
L E+ IIH D+KP N+L+N ++ DFG++ N ++ KT I G + Y+AP
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG----NLVASLAKTNI-GCQSYMAP 170
Query: 234 EWFR------KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-- 285
E + T + + DV+S G+ +LE+ R + E Y N
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--------------YANIF 216
Query: 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT 325
+L +V+GD + + ++ C+ + P+ RPT
Sbjct: 217 AQLSAIVDGDPPTLPSGYSDDAQDFVAK-CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKLDRVFQDGEKEFKN---EVIVIGQTHHKNLV 122
+G+GSFG V+Q T + A+K + + E + E V+ Q + +V
Sbjct: 1 IGKGSFG----KVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIV 56
Query: 123 RLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLLYLHEDCS 180
L F + +L L F+N G L F +L+ + A F A +L L
Sbjct: 57 PL-KFSFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHK 111
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT-AIRGTKGYVAPEWFRKS 239
+I+ D+KP+NILL+ + + + DFGL K LN + KT GT Y+APE
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCK---LNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 240 TISAKVDVYSFGVLLLEIISCRKSF-DIEMGEEY-AILTD 277
+ VD ++ GVLL E+++ F D + E Y IL +
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 43 TIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG 102
TI+ + +LE E+G G+ G +YK + +AVK++ R G
Sbjct: 4 TIDGQKYPADLNDLE-----NLGEIGSGTCGQVYK---MRFKKTGHVMAVKQMRRT---G 52
Query: 103 EKEFKNEVI----VIGQTHH-KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLK-- 155
KE ++ V+ ++H +V+ G+ + + E + T L ++
Sbjct: 53 NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGP 110
Query: 156 -PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214
P ++ + I + L YL E +IH D+KP NILL+ N ++ DFG++ L
Sbjct: 111 IPE-DILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167
Query: 215 NQRKTIKTAIRGTKGYVAPEWF----RKSTISAKVDVYSFGVLLLEI 257
++ KT ++A G Y+APE + DV+S G+ L+E+
Sbjct: 168 SKAKT-RSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 8/214 (3%)
Query: 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN-EVIVIGQTHH 118
NF +G+GSFG + + T A+ + K D V QD + E E V+
Sbjct: 1 DFNFLMVLGKGSFGKVML-AERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK 59
Query: 119 KNLVRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHE 177
+ L C + +RL E++N G L + K A +I+ L +LH
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
II+ D+K N++L+ + +I+DFG+ K ++ T GT Y+APE
Sbjct: 120 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT--RTFCGTPDYIAPEIIA 174
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
VD +++GVLL E+++ + FD E +E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--EKEFKNEVIVIGQTHHKNLVRL 124
VG G++G + + + T VA+KKL R FQ K E+ ++ H+N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEK---VAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN------IAFQIARVLLYLHED 178
L D + + EF + + ++ +L+ + + +Q+ L Y+H
Sbjct: 80 L---DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH-- 134
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S+ IIH D+KP N+ +N+ +I DFGLA + A GYV W+R
Sbjct: 135 -SAGIIHRDLKPGNLAVNEDCELKILDFGLA-----------RHADAEMTGYVVTRWYRA 182
Query: 239 STI-------SAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 272
+ + VD++S G ++ E+++ + F G++Y
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK---GKDY 220
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 53/177 (29%), Positives = 88/177 (49%), Gaps = 23/177 (12%)
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224
+FQ+AR + +L S + IH D+ +NILL++ +I DFGLA+ + + K +
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 282
R ++APE + + DV+SFGVLL EI S S +++ EE+ C
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---------C 287
Query: 283 YRNGKLDDLVEGD-MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
R L +G M A + +M++ W Q DP RPT + ++L ++++
Sbjct: 288 QR------LKDGTRMRAPENATPEIYRIMLACW--QGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224
A +IA L YLH S II+ D+KP+NILL+ + + ++DFGL K + +
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI--EHSKTTSTF 156
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
GT Y+APE RK VD + G +L E++
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 50/208 (24%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 57 EEATDNFKE--EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVI--- 111
E D+F++ E+G G+ G+++K + + + +KL + + + +N++I
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK----VSHKPSGLIMARKL--IHLEIKPAIRNQIIREL 54
Query: 112 -VIGQTHHKNLVRLLG-FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA 169
V+ + + +V G F +G+ + E ++ G+L L + + ++ +
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 113
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
+ L YL E +I+H D+KP NIL+N R ++ DFG++ L ++ + GT+
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRS 167
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEI 257
Y++PE + + S + D++S G+ L+E+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN---EVIVIGQTHHKNLV 122
E+G GSFG +Y T + + VAVKK+ + +++++ EV + Q H N +
Sbjct: 28 EIGHGSFGAVY---FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARVLLYLHEDCSS 181
G + L E+ G+ + L + KP + I + L YLH
Sbjct: 85 EYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE---WFRK 238
+IH DIK NILL + +++DFG A + + GT ++APE +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKS------SPANSFVGTPYWMAPEVILAMDE 194
Query: 239 STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298
KVDV+S G I+C IE+ E L F+ L + + D
Sbjct: 195 GQYDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNDSPT 239
Query: 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPP 343
+ + + +C+Q+ P RP ++ + + V D P
Sbjct: 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAEL--LRHDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 71/317 (22%), Positives = 123/317 (38%), Gaps = 65/317 (20%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTA-------------VAVKKL-DRVFQDGEKEFKN 108
FKE++G G FG ++ + T VAVK L ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 109 EVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN--------------- 153
EV ++ + N++RLLG C + + E++ NG L FL +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 154 ----LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209
+++ ++A QIA + YL S +H D+ +N L+ + +I+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEM 268
+ L I+ ++A E + DV++FGV L EI+ C++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE------ 239
Query: 269 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK----------CVEKLLMISIWCIQE 318
+ Y LTD + ++E E D C + L + + C
Sbjct: 240 -QPYGELTD-----------EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSR 287
Query: 319 DPSLRPTMRKVSQMLQE 335
D RP+ + L E
Sbjct: 288 DCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 44/212 (20%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQTHHKNLVRL 124
+G G+ GI+ T + VA+KKL R FQ+ K E++++ +HKN++ L
Sbjct: 24 IGSGAQGIV---CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 125 LG-FC-----DEGQNRLLAYEF------------LNNGTLASFLFGNLKPNWNLRTNIAF 166
L F +E Q+ L E L++ ++ L+
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLY--------------- 125
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG 226
Q+ + +LH S+ IIH D+KP NI++ +I DFGLA+ + + T
Sbjct: 126 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVV 179
Query: 227 TKGYVAPEWFRKSTISAKVDVYSFGVLLLEII 258
T+ Y APE VD++S G ++ E+I
Sbjct: 180 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 48/186 (25%), Positives = 85/186 (45%), Gaps = 18/186 (9%)
Query: 87 TTAVAVKKLDRVFQDGEKEFKNEVI----VIGQTHHKNLVRLLG-FCDEGQNRLLAYEFL 141
T V KK+ V + + +++ ++ + +V G F +E N + EF+
Sbjct: 29 TGTVMAKKV--VHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-NICMCMEFM 85
Query: 142 NNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY 199
+ G+L G + + IA + L YL+ +I+H DIKP NIL+N R
Sbjct: 86 DCGSLDRIYKKGGPIPVE--ILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRG 141
Query: 200 NARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
++ DFG++ L +I GT Y++PE + + K DV+S G+ ++E+
Sbjct: 142 QIKLCDFGVSGELI----NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL 197
Query: 260 CRKSFD 265
+ F
Sbjct: 198 GKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 8e-11
Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL--DRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+E+G G FG + G + + T V VK+L Q+ + +F E H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYT-PAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLL 58
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARVLLYLHE 177
+ LG C E LL EF G L +L + P+ +A +IA LL+LH+
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211
+ IH D+ +N LL +I D+GL+
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 9e-11
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLG 126
+G+G FG + ++ T ++K + GE NE ++ + + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 127 FCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC------ 179
+ E ++ L L +N G L ++ P F+ R L Y E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNP--------GFEEERALFYAAEILCGLEDL 118
Query: 180 -SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
++ D+KP+NILL+D + RISD GLA + + + ++I+ + GT GY+APE
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRV-GTVGYMAPEVLNN 175
Query: 239 STISAKVDVYSFGVLLLEIISCRKSF 264
+ D + G L+ E+I + F
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 41/213 (19%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE------KEFKNEVIVIGQTHH 118
++G GS+G+++K + VA+KK F + E K E+ ++ Q H
Sbjct: 7 SKIGEGSYGVVFKC---RNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQLKH 59
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLHE 177
NLV L+ + L +E+ ++ T+ + L N + +L I +Q + + + H
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH- 117
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG----YVAP 233
IH D+KP+NIL+ + ++ DFG A++LT G YVA
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILT------------GPGDDYTDYVAT 163
Query: 234 EWFRKSTI-------SAKVDVYSFGVLLLEIIS 259
W+R + VDV++ G + E+++
Sbjct: 164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEF-KNEVIVIGQTHHKNLVRLL 125
+GRGS+ + V T A+ V K + V D + ++ + E V Q + + L
Sbjct: 3 IGRGSYAKVLL-VRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 126 GFCDEGQNRLL-AYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARVLLYLHEDCSSQI 183
C + ++RL E++N G L + K P + R A +I+ L YLHE I
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGI 117
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
I+ D+K N+LL+ + +++D+G+ K T + GT Y+APE R
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEILRGEDYGF 175
Query: 244 KVDVYSFGVLLLEIISCRKSFDI 266
VD ++ GVL+ E+++ R FDI
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 17/103 (16%)
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR-KTIKT 222
+QI R L YLH S+ +IH D+KP NIL+N + +I DFGLA+ + ++ K T
Sbjct: 108 FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 223 AIRGTKGYVAPEWFRK-------STISAKVDVYSFGVLLLEII 258
YV W+R S + +D++S G + E++
Sbjct: 165 ------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK--NEVIVIGQTHHKNLV 122
E++G GS+ +YKG + + VA+K + R+ ++ F E ++ H N+V
Sbjct: 11 EKLGEGSYATVYKG---KSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARVLLYLHEDC 179
L + L +E+++ L ++ G L P N++ + FQ+ R L Y+H+
Sbjct: 67 LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPE-NVKLFL-FQLLRGLSYIHQ-- 121
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
I+H D+KPQN+L++D +++DFGLA+ ++ + T Y P+ S
Sbjct: 122 -RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGS 178
Query: 240 T-ISAKVDVYSFGVLLLEIISCRKSF 264
T S +D++ G + +E+I +F
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---FKNEVIVIGQTHHKNLVR 123
+G+G+FG +Y T AV + D + KE + E+ ++ H+ +V+
Sbjct: 10 LGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 124 LLGFCDEGQNRLLA--YEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
G + R L+ E + G++ L +G L N + QI + YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK--YTRQILEGVSYLH--- 123
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAK-LLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S+ I+H DIK NIL + N ++ DFG +K L T+ T ++ GT +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 239 STISAKVDVYSFGVLLLEIISCR 261
K D++S G ++E+++ +
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 59/216 (27%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE--FKNEVIVIGQTHHKNLVRL 124
+G+GSFG + ++ T A+ V K D + QD + + + I+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTD-EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 125 LGFCDEGQNRLL-AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
C + ++RL E++N G L + + K + A ++ L++LH +
Sbjct: 62 HC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GV 117
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
I+ D+K NILL+ + +++DFG+ K LN T T GT Y+APE ++
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTFCGTPDYIAPEILQELEYGP 175
Query: 244 KVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 277
VD ++ GVL+ E+++ + F+ + ++ +IL D
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 23/177 (12%)
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224
+FQ+AR + +L S + IH D+ +NILL++ +I DFGLA+ + + K
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 282
R ++APE + + DV+SFGVLL EI S S +++ EE+ C
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF---------C 286
Query: 283 YRNGKLDDLVEGD-MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
R L EG M A ++ I + C +P RPT ++ ++L ++++
Sbjct: 287 RR------LKEGTRMRAPE--YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV----IVIGQTHHKNLV 122
+G+GSFG K ++ + + AVK L + +KE + + +++ H LV
Sbjct: 3 IGKGSFG---KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARVLLYLHED 178
L + +++N G L F +L+ A ++A + YLH
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAEVASAIGYLH-- 113
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S II+ D+KP+NILL+ + + ++DFGL K + +T T GT Y+APE RK
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFC-GTPEYLAPEVLRK 170
Query: 239 STISAKVDVYSFGVLLLEII 258
VD + G +L E++
Sbjct: 171 EPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 50/234 (21%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FK----NEVIVIGQTHHKN 120
++G G++G +YK + T VA+KK V D EKE F E+ ++ Q +H+N
Sbjct: 14 QIGEGTYGQVYKARDKDTGE---LVALKK---VRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 121 LVRL----------LGFCDEGQNRLLAYEFLNN---GTLASFLFGNLKPNWNLRTNIAF- 166
+V L L F + L +E++++ G L S L +++ +F
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-----HFSEDHIKSFM 122
Query: 167 -QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
Q+ L Y H+ +H DIK NILLN++ +++DFGLA+L + R
Sbjct: 123 KQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-------R 172
Query: 226 GTKGYVAPEWFRKSTI-------SAKVDVYSFGVLLLEIISCRKSF--DIEMGE 270
V W+R + +DV+S G +L E+ + + F + E+ +
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 30/94 (31%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223
I+ + R L YL E +I+H D+KP NIL+N R ++ DFG++ L ++ +
Sbjct: 104 ISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANS 157
Query: 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEI 257
GT+ Y++PE + + + + D++S G+ L+E+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
+Q+ R L Y+H S+ ++H D+KP N+LLN + +I DFGLA+ T +++ T
Sbjct: 115 YQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYV 169
Query: 226 GTKGYVAPEWFRKST-ISAKVDVYSFGVLLLEII 258
T+ Y APE + + +DV+S G + E++
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---FKNEVIVIGQTHHKNLVR 123
+GRG+FG +Y T AV D Q+ KE + E+ ++ H +V+
Sbjct: 10 LGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 124 LLGFCDEGQNRLLA--YEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
G + + + L+ E++ G++ L +G L N R QI + + YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR--YTRQILQGVSYLH--- 123
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAK-LLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S+ I+H DIK NIL + N ++ DFG +K + T+ T ++ GT +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 239 STISAKVDVYSFGVLLLEIIS 259
K DV+S ++E+++
Sbjct: 184 EGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV----IVIGQTHHKNLV 122
+G+GSFG K ++ AVK L + KE K+ + +++ H LV
Sbjct: 3 IGKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLK-----PNWNLRTNIAFQIARVLLYLHE 177
L + +F+N G L F +L+ P R A +IA L YLH
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAA-EIASALGYLH- 113
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
S I++ D+KP+NILL+ + + ++DFGL K + Q T T GT Y+APE R
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDT-TTTFCGTPEYLAPEVIR 169
Query: 238 KSTISAKVDVYSFGVLLLEII 258
K VD + G +L E++
Sbjct: 170 KQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 8e-10
Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNL 121
E +G+GS+G++ + T + VA+KK++ VF+ D + + E+ ++ H ++
Sbjct: 6 EVIGKGSYGVVCSAI---DTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDI 61
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARVLLYLHE 177
V + R ++ + S L +K N +L +Q+ R L Y+H
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH- 120
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
++ + H D+KP+NIL N +I DFGLA++ + TAI T YVA W+R
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT----PTAIFWTD-YVATRWYR 173
Query: 238 K--------STISAKVDVYSFGVLLLEIISCRKSF 264
S + +D++S G + E+++ + F
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 21/178 (11%)
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224
+FQ+A+ + +L S + IH D+ +NILL++ +I DFGLA+ + + K
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 282
R ++APE + + DV+SFGVLL EI S S +++ EE+ C
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 292
Query: 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340
R L EG D E + + C +PS RPT ++ + L +++ +
Sbjct: 293 RR------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 57/226 (25%), Positives = 91/226 (40%), Gaps = 44/226 (19%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL---DRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+GRG+FG V T V A+K L D + ++ + E ++ +V
Sbjct: 9 IGRGAFGE----VWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 123 RLL-GFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
+L F DE ++ L E++ G L + L F IA ++L L
Sbjct: 65 KLYYSFQDE-EHLYLVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVH 118
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--------------------------- 212
IH DIKP NIL++ + +++DFGL K +
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEII 258
QR+ + GT Y+APE R + + D +S GV+L E++
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEF-KNEVIVIGQTHHKNLVRLL 125
+GRGS+ + V A+ V K + V D + ++ + E V Q + L
Sbjct: 3 IGRGSYAKVLL-VRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 126 GFCDEGQNRL-LAYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARVLLYLHEDCSSQI 183
C + +RL L E++N G L + K P + R A +I L +LHE I
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHE---RGI 117
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
I+ D+K N+LL+ + +++D+G+ K L T T GT Y+APE R
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFC-GTPNYIAPEILRGEEYGF 175
Query: 244 KVDVYSFGVLLLEIISCRKSFDI 266
VD ++ GVL+ E+++ R FDI
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 34/111 (30%), Positives = 48/111 (43%), Gaps = 12/111 (10%)
Query: 163 NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI--SDFGLAKLLTLNQRKTI 220
I Q+ L LH IIH DIK +N+L DR RI D+GL K
Sbjct: 113 KIIRQLVEALNDLH---KHNIIHNDIKLENVLY-DRAKDRIYLCDYGLCK------IIGT 162
Query: 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
+ GT Y +PE + D ++ GVL E+++ + F + EE
Sbjct: 163 PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 59/247 (23%), Positives = 106/247 (42%), Gaps = 39/247 (15%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAV-KKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
+GRG+FG + + V + T A+ + +K D + ++ + E ++ + +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 126 GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIH 185
+ N L EFL G + + L +K + F IA +L + IH
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124
Query: 186 CDIKPQNILLNDRYNARISDFGLAKLL-----------------------TLNQRKTIKT 222
DIKP N+LL+ + + ++SDFGL L +N ++ +T
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 223 AIR----------GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE- 271
R GT Y+APE F ++ + D +S GV++ E++ F E +E
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
Query: 272 YAILTDW 278
Y + +W
Sbjct: 245 YKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 47/180 (26%), Positives = 87/180 (48%), Gaps = 31/180 (17%)
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
+++L L E S +++H D+K NI L ++ DFG +K + + + ++ GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289
Y+APE + + S K D++S GV+L E+++ + F E I+ + GK D
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--IMQQVLY-----GKYD 289
Query: 290 DL---VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT---------MRKVSQMLQEVV 337
V M+A+ ++ LL ++P+LRPT ++ V+ + Q++V
Sbjct: 290 PFPCPVSSGMKAL-----LDPLL-------SKNPALRPTTQQLLHTEFLKYVANLFQDIV 337
|
Length = 478 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 67 VGRGSFGII---YKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNL 121
+G G+ GI+ Y V+ VA+KKL R FQ+ K E++++ +HKN+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 122 VRLLGF------CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYL 175
+ LL +E Q+ L E ++ L + ++ + + + +Q+ + +L
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 135
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
H S+ IIH D+KP NI++ +I DFGLA+ + + T T+ Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 189
Query: 236 FRKSTISAKVDVYSFGVLLLEII 258
VD++S G ++ E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 61/228 (26%), Positives = 108/228 (47%), Gaps = 44/228 (19%)
Query: 52 SYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK--NE 109
+YK+L++ +G GS+ +YKG + T VA+K++ R+ + F E
Sbjct: 6 TYKKLDK--------LGEGSYATVYKGRSKLTGQ---LVALKEI-RLEHEEGAPFTAIRE 53
Query: 110 VIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF---GNLKPNWNLRTNIAF 166
++ H N+V L + L +E+L+ L ++ G L + N+R F
Sbjct: 54 ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-NVRL-FLF 110
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG 226
Q+ R L Y H +++H D+KPQN+L+++R +++DFGLA+ K++
Sbjct: 111 QLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR------AKSVP----- 156
Query: 227 TKGY---VAPEWFRK------ST-ISAKVDVYSFGVLLLEIISCRKSF 264
+K Y V W+R ST S +D++ G + E+ + R F
Sbjct: 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 37/114 (32%), Positives = 55/114 (48%), Gaps = 15/114 (13%)
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG 226
QI L YLH + +IIH D+K +NI +ND I D G A Q + A G
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAA------QFPVVAPAFLG 215
Query: 227 TKGYV---APEWFRKSTISAKVDVYSFGVLLLEIISCRKS-FDIE--MGEEYAI 274
G V APE + ++K D++S G++L E+++ + F+ EEY
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269
|
Length = 357 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDGE-KEFKNEVIVIGQTHHKNL 121
+VG+G +G ++ + + VA+K++ + +F+ E + E ++ T + L
Sbjct: 7 TQVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLY---LH 176
V+LL + + LA E++ G + L G L + + F +A + LH
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----HARFYMAEMFEAVDALH 118
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
E IH D+KP+N L++ + +++DFGL+K + T ++ G+ Y+APE
Sbjct: 119 E---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-----TYANSVVGSPDYMAPEVL 170
Query: 237 RKSTISAKVDVYSFGVLLLEIIS 259
R VD +S G +L E +
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAV-KKLDRVFQDGEKEFKNEVIVIGQTHHKN 120
+ K VGRG FG + + V + T A+ V KK + Q+ F+ E ++ ++
Sbjct: 4 DVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLLYLHEDC 179
+ +L + N L E+ G L S L ++A F +A ++L +H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLAIHSVH 119
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR-- 237
+H DIKP+N+L++ + +++DFG A LT N+ K + GT Y+APE
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTM 178
Query: 238 ----KSTISAKVDVYSFGVLLLEIISCRKSF 264
K T + D +S GV+ E+I R F
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVK--KLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
VG GSFG + ++ S A+K +L + E K E +++ + H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK-EAVLLAKMKHPNIVAF 63
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFL---FGNLKP-----NWNLRTNIAFQIARVLLYLH 176
+ + + E+ + G L + G L P W ++ + Q ++H
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ------HIH 117
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
E +++H DIK +NI L ++ DFG A+LLT GT YV PE +
Sbjct: 118 E---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAYACTYVGTPYYVPPEIW 172
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSF 264
+ K D++S G +L E+ + + F
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIG--QTHHKNLVR 123
+GRG FG +Y G + T A+ R+ + GE NE I++ T +
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 124 LLGFCDEGQNRL-LAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDCS 180
+ + ++L + +N G L L G + F ++L L +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-----EKEMRFYATEIILGLEHMHN 115
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+++ D+KP NILL++ + RISD GLA + K A GT GY+APE +K T
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGT 171
Query: 241 I-SAKVDVYSFGVLLLEIISCRKSF 264
+ D +S G +L +++ F
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR---VFQDGEKEFKNEVIVIGQTHH 118
NF +G GSFG + + VA+K+ ++ + Q +E ++ +H
Sbjct: 33 NFIRTLGTGSFGRVI--LATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARVLLYLHE 177
V L G + L EF+ G +FL N + PN ++ A QI + YL
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-DVGCFYAAQIVLIFEYLQ- 148
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
S I++ D+KP+N+LL+ +++DFG AK++ T + GT Y+APE
Sbjct: 149 --SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILL 201
Query: 238 KSTISAKVDVYSFGVLLLEII 258
D ++ G+ + EI+
Sbjct: 202 NVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 43/280 (15%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK--EFKNEVIVIGQTHHKNLV 122
+ +G G++G +YK T A+ V KL + GE + E+I++ H N+V
Sbjct: 15 QRIGSGTYGDVYKAR-NVNTGELAAIKVIKL----EPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASF--LFGNLKPNWNLRTNIAF---QIARVLLYLHE 177
G + EF G+L + G L + IA+ + + L YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-----ESQIAYVSRETLQGLYYLH- 123
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKGYVAPEW 235
S +H DIK NILL D + +++DFG++ + T+ +RK+ GT ++APE
Sbjct: 124 --SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI----GTPYWMAPEV 177
Query: 236 F---RKSTISAKVDVYSFGVLLLEIISCRKS-FDIEMGEEYAILTDWAFDCYRNGKLDDL 291
RK + D+++ G+ +E+ + FD+ ++T F + KL D
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF---QPPKLKD- 233
Query: 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331
M+ N K+ + ++P RPT K+ Q
Sbjct: 234 ---KMKWSNSFHHFVKM------ALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 54/212 (25%), Positives = 104/212 (49%), Gaps = 30/212 (14%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK--NEVIVIGQTHHKNLV 122
E++G GS+ +YKG+ + + VA+K + ++G F E ++ H N+V
Sbjct: 11 EKLGEGSYATVYKGI---SRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIV 66
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARVLLYLHEDC 179
L + +E+++ LA ++ G L P +N+R FQ+ R L Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP-YNVRL-FMFQLLRGLAYIH--- 120
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
I+H D+KPQN+L++ +++DFGLA+ K+I + ++ V W+R
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSE--VVTLWYRPP 172
Query: 240 TI-------SAKVDVYSFGVLLLEIISCRKSF 264
+ S+ +D++ G + +E++ + +F
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 61/255 (23%), Positives = 112/255 (43%), Gaps = 41/255 (16%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAV-KKLDRVFQDGEKEFKNEVIVIGQTH 117
D+F+ + +GRG+FG + + V + T A+ + +K D + ++ + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD 59
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHE 177
+V++ + +N L EFL G + + L +K + F IA +L +
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDA 116
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLA------------KLLTLN---------- 215
IH DIKP N+LL+ + + ++SDFGL + LT N
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 216 -----------QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
R+ + + GT Y+APE F ++ + D +S GV++ E++ F
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 265 DIEMGEE-YAILTDW 278
E +E Y + +W
Sbjct: 237 CSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 67 VGRGSFGII---YKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNL 121
+G G+ GI+ Y +++ VA+KKL R FQ+ K E++++ +HKN+
Sbjct: 32 IGSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 122 VRLLGF------CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYL 175
+ LL +E Q+ + E ++ L + ++ + + + +Q+ + +L
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
H S+ IIH D+KP NI++ +I DFGLA+ + T T+ Y APE
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEV 196
Query: 236 FRKSTISAKVDVYSFGVLLLEII 258
VD++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 43/201 (21%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKK-LDRVFQDGEKEFK----NEVIVIGQT 116
++G G+FG +YK T VA+KK L +DG F E+ ++ +
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGR---VVALKKILMHNEKDG---FPITALREIKILKKL 64
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNN--GTLASF----------LFGNLK-PNWNLR-- 161
H N+V L+ +A E + S L G L+ P+ L
Sbjct: 65 KHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115
Query: 162 --TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219
Q+ + YLHE + I+H DIK NIL++++ +I+DFGLA+
Sbjct: 116 QIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 220 IKTAIRGTKGY---VAPEWFR 237
GT+ Y V W+R
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYR 193
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 6e-09
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 30/229 (13%)
Query: 46 TKSRCFSYKELEEATDNFKE----------EVGRGSFGIIYKGVIQTTTTSTTAVAVKKL 95
+ SR S K+ E A FKE E+G GSFG +Y + VA+KK+
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY---FARDVRTNEVVAIKKM 58
Query: 96 DRVFQDGEKEFKN---EVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFG 152
+ +++++ EV + + H N + G L E+ G+ + L
Sbjct: 59 SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEV 117
Query: 153 NLKPNWNLR-TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211
+ KP + I + L YLH S +IH DIK NILL + +++DFG A +
Sbjct: 118 HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174
Query: 212 LTLNQRKTIKTAIRGTKGYVAPE---WFRKSTISAKVDVYSFGVLLLEI 257
+ + GT ++APE + KVDV+S G+ +E+
Sbjct: 175 A------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---FKNEVIVIGQTHHKNLVR 123
+G+GSFG + ++ A+KK D V D + E + V+ + + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKK-DVVLIDDDVECTMVEKRVLALAW-ENPFLTH 60
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
L ++ EFLN G L + + + T A +I L +LH S I
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGI 117
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA 243
I+ D+K N++L+ + +I+DFG+ K + + GT Y+APE + +
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTF 175
Query: 244 KVDVYSFGVLLLEIISCRKSF 264
VD +SFGVLL E++ + F
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 8e-09
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---FKNEVIVIGQTHHKNLVR 123
+G+G+FG +Y T A + D + KE + E+ ++ H+ +V+
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 124 LLG-FCDEGQNRLLAY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
G D + L + E++ G++ L +G L + + QI + YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTES--VTRKYTRQILEGMSYLH--- 123
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAK-LLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S+ I+H DIK NIL + N ++ DFG +K L T+ T ++ GT +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 239 STISAKVDVYSFGVLLLEIIS 259
K DV+S G ++E+++
Sbjct: 184 EGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK--EFKNEVIVIGQ-THHKNLVR 123
+GRGS+ + ++ T +KK + D E + E V ++H LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKK--ELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 124 LLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARVLLYLHEDCSS 181
L C + ++RL EF++ G L + K P + R A +I+ L +LHE
Sbjct: 61 LHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHE---R 115
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR-GTKGYVAPEWFRKST 240
II+ D+K N+LL+ + +++D+G+ K R T+ GT Y+APE R
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE---GIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDI 266
VD ++ GVL+ E+++ R FDI
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 163 NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT 222
+ ++Q+A+ + +L S IH D+ +NILL +I DFGLA+ + + +K
Sbjct: 218 SFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF- 280
R ++APE + + DV+S+G+LL EI S S Y + D F
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSS-------PYPGMPVDSKFY 327
Query: 281 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
+ G E M DI M S W DP RPT +++ Q++++
Sbjct: 328 KMIKEGYRMLSPECAPSEMYDI-------MKSCW--DADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 36/228 (15%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE---KEFKNEVIVIGQTHHKNLVR 123
+G+G G +Y + VA+KK+ + K F E + H +V
Sbjct: 10 IGKGGMGEVYLAY---DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFG-----NLKPNWNLRTNI-AF-----QIARVL 172
+ C +G ++ TL S L +L +T++ AF +I +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---------------- 216
Y+H S ++H D+KP NILL I D+G A L +
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
TI I GT Y+APE S D+Y+ GV+L ++++ +
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV----IVIGQTHHKNLV 122
+G+GSFG K ++ AVK L + +KE K+ + +++ H LV
Sbjct: 3 IGKGSFG---KVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 123 RLLGFCDEGQNRL-LAYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARVLLYLHED 178
L F + ++L +++N G L L L+P A +IA L YLH
Sbjct: 60 GL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYLH-- 113
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S I++ D+KP+NILL+ + + ++DFGL K + T T GT Y+APE K
Sbjct: 114 -SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFC-GTPEYLAPEVLHK 170
Query: 239 STISAKVDVYSFGVLLLEII 258
VD + G +L E++
Sbjct: 171 QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 41/179 (22%), Positives = 72/179 (40%), Gaps = 57/179 (31%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN--------EVIVIGQTH 117
+GRG++G +YK + A+KK G+KE E+ ++ +
Sbjct: 7 CIGRGTYGRVYKAKRKNGKD-GKEYAIKKF-----KGDKEQYTGISQSACREIALLRELK 60
Query: 118 HKNLVRLLGFCDEGQNRL--LAYEF-------------------LNNGTLASFLFGNLKP 156
H+N+V L+ E ++ L +++ + + S L
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL------ 114
Query: 157 NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL----NDRYNARISDFGLAKL 211
+QI + YLH S+ ++H D+KP NIL+ +R +I D GLA+L
Sbjct: 115 ---------WQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE----KEFKNEVIVIG 114
D ++ E++G G++G +YK + T VA+KK R+ D E + ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGK---LVALKK-TRLEMDEEGIPPTALREISLLQM 56
Query: 115 QTHHKNLVRLLGF----CDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWN-LRTNIA--- 165
+ +VRLL G+ L L +E+L++ L F+ N + L
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 166 -FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA-RISDFGLAKLLTLNQRKTIKTA 223
+Q+ + + + H ++H D+KPQN+L++ + +I+D GL + ++ +
Sbjct: 116 MYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 224 IRGTKGYVAPEWFRKST-ISAKVDVYSFGVLLLEII 258
+ T Y APE ST S VD++S G + E+
Sbjct: 173 V--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR---VFQDGEKEFKNEVIVIGQTHHKNLVR 123
+G+G+FG K ++ S A+K L + + +D E V+ T H L
Sbjct: 3 LGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 124 LLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQ 182
L + + ++RL E++N G L L + + +I L YLH S +
Sbjct: 60 L-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGK 115
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTIS 242
I++ D+K +N++L+ + +I+DFGL K + T+KT GT Y+APE +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 243 AKVDVYSFGVLLLEIISCRKSF 264
VD + GV++ E++ R F
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL-LTLNQRKTIKT 222
I + R + YLHE+ +IIH DIK +NI +N + + DFG A + +N K
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
A GT APE + VD++S G++L E+ +C S
Sbjct: 244 A--GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
F A ++L L + +++ D+KP NILL++ + RISD GLA + K A
Sbjct: 101 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASV 156
Query: 226 GTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEII 258
GT GY+APE +K + D +S G +L +++
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 54/230 (23%), Positives = 100/230 (43%), Gaps = 43/230 (18%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAV-KKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
+GRG+FG + + V + T A+ +K + + ++ + E ++ + + +V+L
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 126 -GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
F DE L E+L G + + L +K + F IA +L + I
Sbjct: 68 YSFQDE-NYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 185 HCDIKPQNILLNDRYNARISDFGLAKLL--------------------------TLNQRK 218
H DIKP N+LL+ + + ++SDFGL L ++ ++
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 219 TIKTAIR----------GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEII 258
+T R GT Y+APE F ++ + + D +S GV++ E++
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN---EVIVIGQTHHKNLV 122
E+G GSFG +Y ++ VA+KK+ + +++++ EV + + H N +
Sbjct: 22 EIGHGSFGAVY---FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARVLLYLHEDCSS 181
+ G L E+ G+ + L + KP + + + L YLH S
Sbjct: 79 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE---WFRK 238
+IH D+K NILL++ ++ DFG A ++ GT ++APE +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDE 188
Query: 239 STISAKVDVYSFGVLLLEI 257
KVDV+S G+ +E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 14/173 (8%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+ VG G++G +YK T AV + KL+ D + E+ ++ + H N+V
Sbjct: 15 QRVGSGTYGDVYKAR-NLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARVLLYLHEDCSS 181
G + + E+ G+L ++ P L+ IA+ + + L YLH S
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQ--IAYVCRETLQGLAYLH---SK 125
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE 234
+H DIK NILL D + +++DFG+A +T K + + GT ++APE
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (130), Expect = 6e-08
Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 36/187 (19%)
Query: 109 EVIVIGQTHHKNLVRLLG-FCDEGQNRL-LAYEFLNNGTLASF------LFGNLKPNWNL 160
EV V+ + HKN+VR + F ++ +L + EF + G L+ +FG ++ +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH--A 119
Query: 161 RTNIAFQIARVLLYLHE----DCSSQIIHCDIKPQNIL-----------------LNDRY 199
+I Q+ L Y H +++H D+KPQNI LN R
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 200 NARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTIS--AKVDVYSFGVLLLEI 257
A+I DFGL+K + + +++ + GT Y +PE T S K D+++ G ++ E+
Sbjct: 180 IAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 258 ISCRKSF 264
S + F
Sbjct: 237 CSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 20/199 (10%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEK--EFKNEVIVIGQTHHKNLV 122
E+G GSFG +Y + VA+KK+ Q EK + EV + Q H N +
Sbjct: 22 EIGHGSFGAVY---FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI 78
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARVLLYLHEDCSS 181
G L E+ G+ + L + KP + I + L YLH S
Sbjct: 79 EYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SH 134
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE---WFRK 238
+ IH DIK NILL + +++DFG A L++ + GT ++APE +
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------SFVGTPYWMAPEVILAMDE 188
Query: 239 STISAKVDVYSFGVLLLEI 257
KVDV+S G+ +E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 8e-08
Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 3/93 (3%)
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
F IA ++L L I++ D+KP+NILL+ + + DFGL+K L KT T
Sbjct: 100 FYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFC- 157
Query: 226 GTKGYVAPE-WFRKSTISAKVDVYSFGVLLLEI 257
GT Y+APE + + VD +S GVL+ E+
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 35/111 (31%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 166 FQIARVLLYLHE-----DCSSQ--IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218
F + V +Y+ E D Q II+ DIK +NILL+ + ++DFGL+K + +
Sbjct: 102 FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 219 TIKTAIRGTKGYVAPEWFRKSTI--SAKVDVYSFGVLLLEIISCRKSFDIE 267
+ GT Y+APE R + VD +S GVL E+++ F ++
Sbjct: 162 RAYSFC-GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 3/108 (2%)
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223
+ F ++L L I++ DIK +NILL+ + ++DFGL+K L++ K +
Sbjct: 107 VRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYS 165
Query: 224 IRGTKGYVAPEWFRKSTISAK-VDVYSFGVLLLEIISCRKSFDIEMGE 270
GT Y+APE R K VD +S G+L+ E+++ F +E GE
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE-GE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 49/197 (24%), Positives = 76/197 (38%), Gaps = 44/197 (22%)
Query: 93 KKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFG 152
K+ RV E+E ++ H L L L ++ G L L
Sbjct: 43 NKVKRVLT--EQE------ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL-- 92
Query: 153 NLKPNWNLRTNIA-FQIARVLL---YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208
+P L +A F A VLL YLH I++ D+KP+NILL++ + +SDF L
Sbjct: 93 QRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDL 149
Query: 209 AKLLTLNQRKTIKTAIR---------------------------GTKGYVAPEWFRKSTI 241
+K + K + GT+ Y+APE
Sbjct: 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209
Query: 242 SAKVDVYSFGVLLLEII 258
+ VD ++ G+LL E++
Sbjct: 210 GSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 34/215 (15%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTST-------TAVAVKKLDRVFQDGEKEFKNEVIVIGQTH 117
E +G+G+F IYKGV++ + +V +K L +D F ++ Q
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLS 59
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARVLLY 174
HK+LV+L G C +N ++ E++ G L FL N+ +W L ++A Q+A L Y
Sbjct: 60 HKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKL--DVAKQLASALHY 116
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYN--------ARISDFGLAKLLTLNQRKTIKTAIRG 226
L + +++H ++ +NIL+ RY ++SD G+ +T+ R+ I
Sbjct: 117 LEDK---KLVHGNVCGKNILVA-RYGLNEGYVPFIKLSDPGIP--ITVLSREERVERIP- 169
Query: 227 TKGYVAPEWFR--KSTISAKVDVYSFGVLLLEIIS 259
++APE R +++++ D +SFG LLEI S
Sbjct: 170 ---WIAPECIRNGQASLTIAADKWSFGTTLLEICS 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 65 EEVGRGSFGIIYKGVIQ---------TTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ 115
E +GRG+ IY G++ + V +K LD +D F ++ Q
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARVL 172
HK++V L G C ++ EF+ G L F+ L W +A Q+A L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASAL 118
Query: 173 LYLHEDCSSQIIHCDIKPQNILL-----NDRYNA--RISDFGLAKLLTLNQRKTIKTAIR 225
YL ED ++H ++ +NILL + ++SD G+ +T+ R+ I
Sbjct: 119 SYL-ED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERIP 173
Query: 226 GTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEI 257
++APE S +S D +SFG L EI
Sbjct: 174 ----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK-NEVIVIGQ-THHKNLVRLL 125
G G+F + K Q+ T A+K + + F+ E+ E+ + + + H N++RL+
Sbjct: 8 GEGTFSEVLK--AQSRKTGKY-YAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 126 GFC-DEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRT-NIAFQIARVLLYLHEDCSSQ 182
D RL L +E L + L + G +P R + +Q+ + L ++H +
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNG 120
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI- 241
I H DIKP+NIL+ D +++DFG + + + I T+ Y APE
Sbjct: 121 IFHRDIKPENILIKD-DILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLLTDGYY 176
Query: 242 SAKVDVYSFGVLLLEIIS 259
K+D+++ G + EI+S
Sbjct: 177 GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 34/106 (32%), Positives = 47/106 (44%), Gaps = 7/106 (6%)
Query: 163 NIAFQIARVLL----YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218
A I R LL YLH IIH D+K +NI L++ NA + DFG A L +
Sbjct: 185 EQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
GT +PE AK D++S G++L E+ +
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLG 126
+GRG+FG + +++ + K + + + F E ++ + +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 127 FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLLYLHEDCSSQIIH 185
+ + + E++ G L NL N+++ A F A V+L L S +IH
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLV-----NLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH 165
Query: 186 CDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST----I 241
D+KP N+LL+ + +++DFG + TA+ GT Y++PE +
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 242 SAKVDVYSFGVLLLEII 258
+ D +S GV L E++
Sbjct: 225 GRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDGEKE-FKNE--VIVIGQTHHKNL 121
+GRG+FG + V++ T A+K L++ + + E F+ E V+V G
Sbjct: 9 IGRGAFGEV--AVVKMKHTERI-YAMKILNKWEMLKRAETACFREERNVLVNGDCQ---W 62
Query: 122 VRLLGFCDEGQNRL-LAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHED 178
+ L + + +N L L ++ G L + L F + P R F IA ++L +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSI 118
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR-GTKGYVAPEWFR 237
+H DIKP N+LL+ + R++DFG L +NQ T+++++ GT Y++PE +
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 238 K-----STISAKVDVYSFGVLLLEIISCRKSFDIE 267
+ D +S GV + E++ F E
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLG 126
+GRG+FG + ++T + K + + + F E ++ + +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 127 FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLLYLHEDCSSQIIH 185
+ + + E++ G L NL N+++ A F A V+L L S IH
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH 165
Query: 186 CDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK--TAIRGTKGYVAPEWFRKST--- 240
D+KP N+LL+ + +++DFG + +N+ ++ TA+ GT Y++PE +
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 241 -ISAKVDVYSFGVLLLEII 258
+ D +S GV L E++
Sbjct: 223 YYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 48/231 (20%), Positives = 92/231 (39%), Gaps = 56/231 (24%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT---------- 116
+G G++G + K T + VA+KK+ + + + + ++G
Sbjct: 17 LGEGTYGKVEKAY---DTLTGKIVAIKKVKII--EISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 117 ------HHKNLVRLLG-FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN------ 163
H+N++ L+ + + F+N + + +LK + +
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGD--------FIN--LVMDIMASDLKKVVDRKIRLTESQV 121
Query: 164 --IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK-------LLTL 214
I QI L LH +H D+ P NI +N + +I+DFGLA+ TL
Sbjct: 122 KCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 215 NQRKTIKTAIRGTKG-----YVAPEWFRKST-ISAKVDVYSFGVLLLEIIS 259
++ +T++ T Y APE + VD++S G + E+++
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKN----EVIVIGQTHHKN 120
VG G++G++ K + T VA+KK F+D E +E K E+ ++ +N
Sbjct: 9 VGEGAYGVVLKCRHKETKE---IVAIKK----FKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
+V L L +E++ L N P +R+ I +Q+ + + + H++
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN- 119
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
I+H DIKP+N+L++ ++ DFG A+ L+ T T+ Y +PE +
Sbjct: 120 --DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGA 176
Query: 240 TISAKVDVYSFGVLLLEI 257
VD++S G +L E+
Sbjct: 177 PYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG 226
+I L YLH S +++ DIK +N++L+ + +I+DFGL K ++ T+KT G
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-G 157
Query: 227 TKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
T Y+APE + VD + GV++ E++ R F
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL----LTLN---------QRK 218
L YLH + I+H D+KP N+L+ + +++DFGL+K+ LT N R+
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEII 258
+ + GT Y+APE + VD ++ G++L E +
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 24/153 (15%)
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAP 233
Y+H+ +I+H D+K +NI L + +I DFG+++LL + T GT Y++P
Sbjct: 121 YMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFTGTPYYMSP 174
Query: 234 EWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293
E + +K D++S G +L E+ +F E L+ + +VE
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAF-----EGQNFLS----------VVLRIVE 219
Query: 294 GDMEAMNDIKCVE-KLLMISIWCIQEDPSLRPT 325
G ++ + + +M S+ + +DPSLRP+
Sbjct: 220 GPTPSLPETYSRQLNSIMQSM--LNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 2/102 (1%)
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
F ++ + L L II+ D+KP+NILL+ + + +++DFGL K T
Sbjct: 104 FYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT--HTFC 161
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIE 267
GT Y+APE +S VD +S G L+ ++++ F E
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG 226
+I L YLH S +++ D+K +N++L+ + +I+DFGL K ++ T+KT G
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-G 157
Query: 227 TKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
T Y+APE + VD + GV++ E++ R F
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 10/117 (8%)
Query: 166 FQIARVLL---YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT 222
F A V+L YLHE+ +I++ D+K N+LL+ +I+DFGL K +T +
Sbjct: 105 FYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--S 159
Query: 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 277
GT ++APE +++ + VD + GVL+ E++ F + EE +I+ D
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDGEKE-FKNEVIVIGQTHHKNLVR 123
+GRG+FG + + + A+K L++ + + E F+ E V+ ++ +
Sbjct: 9 IGRGAFGEV---AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
L + N L ++ G L + L F + P R F +A +++ +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVIAIDSVHQL 121
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR-GTKGYVAPEWFR--- 237
+H DIKP NIL++ + R++DFG L L + T+++++ GT Y++PE +
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 238 --KSTISAKVDVYSFGVLLLEIISCRKSFDIE 267
K + D +S GV + E++ F E
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 4/98 (4%)
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG 226
+I L YLH + +++ D+K +N++L+ + +I+DFGL K + T+KT G
Sbjct: 103 EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-G 158
Query: 227 TKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
T Y+APE + VD + GV++ E++ R F
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 38/190 (20%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FK----NEVIVIGQTHHKNL 121
+G+G+FG ++K + T VA+KK V + EKE F E+ ++ H+N+
Sbjct: 20 IGQGTFGEVFKARHKKTKQ---IVALKK---VLMENEKEGFPITALREIKILQLLKHENV 73
Query: 122 VRLLGFCD---EGQNR-----LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARV-- 171
V L+ C NR L +EF + LA L N N++ ++ +I +V
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-----SNKNVKFTLS-EIKKVMK 126
Query: 172 -----LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL--NQRKTIKTAI 224
L Y+H ++I+H D+K NIL+ +++DFGLA+ +L N + T
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 225 RGTKGYVAPE 234
T Y PE
Sbjct: 184 VVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARVLLYLHEDCSSQIIHCDIKP 190
+R +Y+ N+ + + L + ++F Q+AR + +L S +H D+
Sbjct: 209 DRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAA 265
Query: 191 QNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSF 250
+N+LL +I DFGLA+ + + K + ++APE + + DV+S+
Sbjct: 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325
Query: 251 GVLLLEIISCRKSFDIEMGEEY-AILTDWAF-----DCYRNGKLDDLVEGDMEAMNDIKC 304
G+LL EI S G Y ++ D F YR K D A ++
Sbjct: 326 GILLWEIFSLG-------GTPYPGMIVDSTFYNKIKSGYRMAKPD-------HATQEVYD 371
Query: 305 VEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337
+ M+ W +P RP+ +S +++ ++
Sbjct: 372 I----MVKCW--NSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 29/217 (13%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLVRL 124
+G GS G+++ V + VAVKK+ V D + K E+ +I + H N+V++
Sbjct: 13 LGCGSNGLVFSAV---DSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKV 67
Query: 125 LGFCDEGQNRL--------------LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR 170
+ L + E++ LA+ L + R +Q+ R
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL-FMYQLLR 125
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLN-QRKTIKTAIRGTK 228
L Y+H S+ ++H D+KP N+ +N + +I DFGLA+++ + K + TK
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 229 GYVAPEWFRKSTISAK-VDVYSFGVLLLEIISCRKSF 264
Y +P K +D+++ G + E+++ + F
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 22/179 (12%)
Query: 90 VAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASF 149
V +K LD +D F ++ Q H +L + G C G ++ EF+ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 150 LF---GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA----- 201
L G + W + +A Q+A L YL ED ++H ++ +NILL A
Sbjct: 107 LRKEKGRVPVAWKI--TVAQQLASALSYL-ED--KNLVHGNVCAKNILLARLGLAEGTSP 161
Query: 202 --RISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEI 257
++SD G++ T R+ I ++APE +++S D +SFG LLEI
Sbjct: 162 FIKLSDPGVS--FTALSREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 11/140 (7%)
Query: 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL 195
L +++N G L + L + + +I L +LH+ II+ DIK +NILL
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILL 138
Query: 196 NDRYNARISDFGLAK--LLTLNQRKTIKTAIRGTKGYVAPEWFR--KSTISAKVDVYSFG 251
+ + ++DFGL+K +R + GT Y+AP+ R VD +S G
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVER---AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMG 195
Query: 252 VLLLEIISCRKSFDIEMGEE 271
VL+ E+++ F ++ GE+
Sbjct: 196 VLMYELLTGASPFTVD-GEK 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 7e-06
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG 226
Q+ + +LH++ I+H D+K N+LLN+R +I DFGLA+ + T +
Sbjct: 114 QLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVV 168
Query: 227 TKGYVAPE-WFRKSTISAKVDVYSFGVLLLEIIS 259
T Y APE S +D++S G + E+++
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
F +A ++L + +H DIKP N+LL+ + R++DFG L L T+++ +
Sbjct: 106 FYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVA 163
Query: 226 -GTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEII 258
GT Y++PE + K + D +S GV + E++
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 18/164 (10%)
Query: 105 EFKNEVIVIGQTHHKNLVRL---LGFCDEGQNRLLAYEFLNNGTLASFLF-GNLKPN--- 157
+ +NE++ +G+ +H+N++++ L Y+F L SF++
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264
Query: 158 --WNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215
R I Q+ + Y+H ++IH DIK +NI LN + DFG A
Sbjct: 265 LLKQTRA-IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-K 319
Query: 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
+R+ GT +PE D++S G++LL+++S
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 40/222 (18%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH----HKN 120
+E+G G FG + I T T V VK+L KE +NE + G + H N
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVV-VKELKA--NASSKE-QNEFLQQGDPYRILQHPN 56
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN-------IAFQIARVLL 173
+++ LG C E LL +E+ G L S+L + W+ R + +A +IA +
Sbjct: 57 ILQCLGQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA------KLLTLNQRKTIKTAIRGT 227
++H+ +H D+ +N L ++ D+G+ + K + +R
Sbjct: 114 HMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV--PLR-- 166
Query: 228 KGYVAPEW---FRKSTISAK----VDVYSFGVLLLEIISCRK 262
++APE F I+A+ +V++ GV L E+
Sbjct: 167 --WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA 206
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 41/168 (24%), Positives = 64/168 (38%), Gaps = 52/168 (30%)
Query: 136 LAYEFLNNGTLASFLFGNLKPNWNLRTN--IAFQIARVLLYLHEDCSSQIIHCDIKPQNI 193
L EFL G L + L ++ + F +A +L + IH DIKP NI
Sbjct: 78 LIMEFLPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNI 132
Query: 194 LLNDRYNARISDFGLA-------------KL----------------------LTLNQRK 218
L++ + ++SDFGL+ KL LT++ +
Sbjct: 133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKD 192
Query: 219 TIKTAIR----------GTKGYVAPEWFRKSTISAKVDVYSFGVLLLE 256
I T + GT Y+APE F + + D +S G ++ E
Sbjct: 193 QIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 3/95 (3%)
Query: 162 TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK 221
T +A Q+ + Y+H IIH DIK +N+L+N + + DFG A +
Sbjct: 263 TAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319
Query: 222 TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLE 256
I GT APE + VD++S G+++ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVA-------VKKLDRVFQDGEKEFKNEVIVIGQTHHK 119
+GRG+FG + + V ++ A+ +K+ D F F E ++ + +
Sbjct: 51 IGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF------FWEERDIMAHANSE 103
Query: 120 NLVRL-LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLLYLHE 177
+V+L F D+ + + E++ G L NL N+++ A F A V+L L
Sbjct: 104 WIVQLHYAFQDD-KYLYMVMEYMPGGDLV-----NLMSNYDIPEKWARFYTAEVVLALDA 157
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
S IH D+KP N+LL+ + +++DFG + N TA+ GT Y++PE +
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLK 216
Query: 238 KSTISA----KVDVYSFGVLLLEII 258
+ D +S GV L E++
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224
++Q+A + +L S +H D+ +N+L+ + +I DFGLA+ + + K +
Sbjct: 245 SYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
++APE + + DV+SFG+LL EI +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 33/127 (25%), Positives = 54/127 (42%), Gaps = 11/127 (8%)
Query: 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNIL 194
LL N + + K L NI + L Y+HE I H DIKP+NI+
Sbjct: 105 LLEKLVENTKEIFKRIKCKNKK---LIKNIMKDMLTTLEYIHE---HGISHGDIKPENIM 158
Query: 195 LNDRYNARISDFGLAKLLTLNQR-----KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYS 249
++ I D+G+A ++ + K K RGT Y + + ++ + D+ S
Sbjct: 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLES 218
Query: 250 FGVLLLE 256
G +L+
Sbjct: 219 LGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 53/244 (21%), Positives = 94/244 (38%), Gaps = 50/244 (20%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLG 126
+G G+FG + T ++K D + ++ K E ++ + ++ +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 127 FCDEGQNRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIH 185
+ N +++ G + S L + P R F IA + L + IH
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLAR----FYIAELTLAIESVHKMGFIH 124
Query: 186 CDIKPQNILLNDRYNARISDFGLA------------------------------------ 209
DIKP NIL++ + +++DFGL
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184
Query: 210 ---KLLTLNQRKT------IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISC 260
+L TL QR T + ++ GT Y+APE + + D +S GV+L E++
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244
Query: 261 RKSF 264
+ F
Sbjct: 245 QPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLG 126
+ RG+FG +Y G + + VKK D + ++ + + E + + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 127 FCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
N L E+L G + S L +G ++ I+ ++A L YLH II
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-IS-EVALALDYLHR---HGII 126
Query: 185 HCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216
H D+KP N+L+++ + +++DFGL+K +TLN+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 50/249 (20%), Positives = 93/249 (37%), Gaps = 60/249 (24%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLG 126
+G G+FG + T ++K D + ++ K E ++ + ++ +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 127 FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNI------AFQIARVLLYLHEDCS 180
+ N +++ G + S L +R I F IA + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL---------IRMGIFPEDLARFYIAELTCAVESVHK 119
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLA------------------------------- 209
IH DIKP NIL++ + +++DFGL
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 210 --------KLLTLNQR------KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLL 255
+L L +R + + ++ GT Y+APE ++ + D +S GV+L
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 256 EIISCRKSF 264
E++ + F
Sbjct: 240 EMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 36/144 (25%), Positives = 59/144 (40%), Gaps = 32/144 (22%)
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN----------------DRYNARISDFG 207
I FQ L Y H + ++H D+KP+NIL+ D RI D G
Sbjct: 236 IIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIE 267
++R + +TAI T+ Y +PE D++S G ++ E+ + + +D
Sbjct: 294 GC----CDERHS-RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348
Query: 268 MGEEYAIL---------TDWAFDC 282
E+ L ++WA C
Sbjct: 349 DNLEHLHLMEKTLGRLPSEWAGRC 372
|
Length = 467 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 32/140 (22%), Positives = 55/140 (39%), Gaps = 41/140 (29%)
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL----------------- 208
F IA + + IH DIKP NIL++ + +++DFGL
Sbjct: 105 FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164
Query: 209 ------------------AKLLTLNQR------KTIKTAIRGTKGYVAPEWFRKSTISAK 244
+L L +R + + ++ GT Y+APE ++ +
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224
Query: 245 VDVYSFGVLLLEIISCRKSF 264
D +S GV+L E++ + F
Sbjct: 225 CDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 12/96 (12%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTT------TSTTAVAVKKLDRVFQDGEKE-FKNEVIVIGQ 115
F + +G G+FG V++ T + VAVK L E+E +E+ ++
Sbjct: 42 FGKTLGAGAFG----KVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 116 T-HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL 150
HKN+V LLG C G L+ E+ G L +FL
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 5/89 (5%)
Query: 67 VGRGSFGIIYK----GVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+GRG+FG + + G+ +T T T AV + K + I+I HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 123 RLLGFCDE-GQNRLLAYEFLNNGTLASFL 150
LLG C + G ++ EF G L+++L
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 44/204 (21%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 74 IIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK----EFKNEVIVIGQTHHKNLVRLLGF-- 127
IYKG+ + V ++ + F G K +NE+ + + N++++ GF
Sbjct: 35 SIYKGIF-----NNKEVIIRTFKK-FHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88
Query: 128 --CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIH 185
D+ L E+ G L L ++ + ++A + L L++ + +
Sbjct: 89 DIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--Y 146
Query: 186 CDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW----FRKSTI 241
++ + L+ + Y +I GL K+L+ K + + Y + + F + TI
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTI 201
Query: 242 SAKVDVYSFGVLLLEIISCRKSFD 265
K D+YS GV+L EI + + F+
Sbjct: 202 --KDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 45/213 (21%), Positives = 81/213 (38%), Gaps = 34/213 (15%)
Query: 66 EVGRGSFGI----IYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHK 119
+G+ + + K + T VAVKK++ E K + E+I Q H
Sbjct: 5 LIGKCFEDLMIVHLAK-----HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARV---LLYLH 176
N++ + + + G+ L P IAF + V L Y+H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH 118
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG-TKG------ 229
S IH +K +ILL+ +S GL +++ + + + K
Sbjct: 119 ---SKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 230 YVAPEWFRKSTI--SAKVDVYSFGVLLLEIISC 260
+++PE +++ + K D+YS G I +C
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVG-----ITAC 201
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.84 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.71 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.43 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.35 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.35 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.34 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.23 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.18 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.1 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.05 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.0 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.87 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.76 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.68 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.39 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.32 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.21 | |
| PLN02236 | 344 | choline kinase | 96.99 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.82 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.8 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.77 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.73 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.73 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.69 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.66 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.65 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.6 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.49 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.48 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.33 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.0 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.63 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.19 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.9 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.72 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.65 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.61 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.35 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.67 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.64 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-53 Score=379.38 Aligned_cols=287 Identities=44% Similarity=0.738 Sum_probs=247.8
Q ss_pred cccccCHHHHHHHhhhhh--hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeee
Q 046877 47 KSRCFSYKELEEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124 (350)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~--~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 124 (350)
..+.|++.++..+|+.|. ..||+|+||.||+|...++ ..||||++.........+|.+|+.++.+++|||++++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~----~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG----TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC----CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccE
Confidence 456789999999999998 5799999999999998764 4599998765433215569999999999999999999
Q ss_pred cceeecCC-eeEEEEecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCce
Q 046877 125 LGFCDEGQ-NRLLAYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA 201 (350)
Q Consensus 125 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~ 201 (350)
+|||.+.+ +.++|+||+++|+|.+++.... .++|..+.+|+.++|+||+|||+.+...|+||||||+|||+|+++++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99999998 5999999999999999998665 78999999999999999999999877789999999999999999999
Q ss_pred EEeecccccccccCcccceeecc-ccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH
Q 046877 202 RISDFGLAKLLTLNQRKTIKTAI-RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 280 (350)
Q Consensus 202 kl~Dfg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 280 (350)
||+|||++.......... ... .||.+|+|||....+..+.|+||||||+++.|++||+.+.+.........+..|..
T Consensus 217 KlsDFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EccCccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 999999996544311111 111 79999999999998999999999999999999999999988665445555888999
Q ss_pred HHhhcCCcchhcccccc-CCCcH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 281 DCYRNGKLDDLVEGDME-AMNDI-KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
..+..+.+.+++++.+. ..... .....+..++.+|++.+|.+||+|.+|++.|+.+...
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999999999876 44443 6778899999999999999999999999999766544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-53 Score=358.87 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=209.8
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-ccccHHHHHHHHHHHhcCCCCceeeecceeecCC-eeEEEEec
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ-NRLLAYEF 140 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~ 140 (350)
..+.||+|..|+||++.++.++ +.+|+|.+... .+...+++.+|+++++..+||+||++++.|..+. .+.++|||
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~---~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTG---KIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCC---eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3567999999999999998774 67999998433 3445678999999999999999999999999988 59999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
|++|+|.+++...+++++....+++.++++||.|||+ ..+|+||||||+|+|++..|++||||||.+..+.+. .
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~ 233 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----I 233 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----h
Confidence 9999999999888899999999999999999999996 369999999999999999999999999999877543 3
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
...++||..|||||.+++..|+.++||||||++++|+.+|+.||....+.....+. . +..+++.......
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~--L--------l~~Iv~~ppP~lP 303 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE--L--------LCAIVDEPPPRLP 303 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH--H--------HHHHhcCCCCCCC
Confidence 35678999999999999999999999999999999999999999765222211111 0 1122222222222
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+++++++|+.+||++||.+|||+.++++
T Consensus 304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2258899999999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-53 Score=373.80 Aligned_cols=264 Identities=28% Similarity=0.432 Sum_probs=227.7
Q ss_pred HHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCC
Q 046877 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ 132 (350)
Q Consensus 53 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 132 (350)
.+++......+.+.||+|-||.||.|.++...+ |++|.+... ....+.|.+|+++|++|+|+|||+++++|..+.
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~----vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTK----VAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCCCc----ccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 345556666788999999999999999987643 788887654 445678899999999999999999999999998
Q ss_pred eeEEEEecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
.++|||||++.|+|.++++. ...+...+.+.++.|||+||+||+ ++++|||||..+||||+++..+||+|||+++
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccc
Confidence 99999999999999999986 567889999999999999999999 6699999999999999999999999999999
Q ss_pred ccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
.... +.+.......-+..|.|||++..+.++.||||||||++||||+| |+.||.+....+ +.
T Consensus 352 ~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~ 414 (468)
T KOG0197|consen 352 LIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VL 414 (468)
T ss_pred ccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HH
Confidence 4443 33444455556789999999999999999999999999999998 888887555433 34
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCC
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDV 341 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~ 341 (350)
+.++.+.+.+.+..||++++++|..||..+|++|||++.+...|+++.....
T Consensus 415 ~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 415 ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 4567788888888999999999999999999999999999999998876544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=364.51 Aligned_cols=256 Identities=32% Similarity=0.515 Sum_probs=213.0
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc--HHHHHHHHHHHhcCCCCceeeecceeecCC-eeEEEEe
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--EKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ-NRLLAYE 139 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 139 (350)
+.+.||+|+||+||+|.+..+. .||+|.+.....+. .+.|.+|+.++.+++||||++++|.+.+.. ..++|||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~----~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTD----VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhcccCCceeEEEEEeCCce----eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 4456999999999999986552 38999987543222 458999999999999999999999999887 7999999
Q ss_pred cCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCeEEcCCC-ceEEeecccccccccC
Q 046877 140 FLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQ-IIHCDIKPQNILLNDRY-NARISDFGLAKLLTLN 215 (350)
Q Consensus 140 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~-i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 215 (350)
|+++|+|..++.. ...+++..+..|+.||+.||.|||+ .+ ||||||||+|+|++.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999987 6889999999999999999999995 47 99999999999999998 9999999999866543
Q ss_pred cccceeeccccCCCccCccccc--CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFR--KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
. ...+...||..|||||++. ...++.|+||||||+++|||+||+.||......... .....
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~---------------~~v~~ 260 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA---------------SAVVV 260 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH---------------HHHHh
Confidence 2 2223467999999999999 568999999999999999999999999866552211 11222
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCC
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~ 342 (350)
...+...+..++..+..+|.+||..||+.||++.+++..|+.+......
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 3333443445889999999999999999999999999999987654443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=361.06 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=209.4
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
.+|...+.||+|||+.||.+++.+++ ..+|+|++.+.. ....+.+.+|+++.+.++|||||+++++|++.++.|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tg---e~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTG---EVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCC---cEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 45666788999999999999975554 569999987632 345577999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++.|+|..++|..+++.+..+++.+++.+++||+.|+.||| +.+|+|||||..|+|++++.++||+|||+|..+...
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999999998999999999999999999999999 569999999999999999999999999999988644
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... .....||+-|.|||++....++..+||||+||++|-|++|++||+...-.+. +..++.. .
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-------y~~Ik~~--------~ 234 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-------YNKIKLN--------E 234 (592)
T ss_pred ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-------HHHHHhc--------C
Confidence 222 2456799999999999999999999999999999999999999985433221 1111111 1
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. .+...+.+..+||.++|+.||.+|||+++++.
T Consensus 235 Y~--~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 YS--MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cc--cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 11135678899999999999999999999983
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-51 Score=348.85 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=209.6
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-------ccHHHHHHHHHHHhcCCCCceeeecc
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-------DGEKEFKNEVIVIGQTHHKNLVRLLG 126 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~ 126 (350)
.+.....|...+.||+|+||.|-+|..+.+ ++.||+|++++... ......++|+.+|++++|||||++++
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~t---gk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d 243 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKT---GKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKD 243 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEccc---CcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEee
Confidence 344556667778999999999999987666 45699999864321 12334689999999999999999999
Q ss_pred eeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CceEE
Q 046877 127 FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR---YNARI 203 (350)
Q Consensus 127 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~---~~~kl 203 (350)
+++..+..||||||++||.|.+++..++.+.+...+.+++|++.|+.||| +.||+||||||+|||++.+ ..+||
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEe
Confidence 99999999999999999999999999999999999999999999999999 5599999999999999765 78999
Q ss_pred eecccccccccCcccceeeccccCCCccCcccccCCC---CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH
Q 046877 204 SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST---ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 280 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 280 (350)
+|||+|...+.. .......||+.|.|||++.+.. +..++|+||+||+||-+++|.+||......... .
T Consensus 321 tDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl------~ 391 (475)
T KOG0615|consen 321 TDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL------K 391 (475)
T ss_pred cccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH------H
Confidence 999999987632 3346678999999999997653 344889999999999999999999755443311 1
Q ss_pred HHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 281 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+.+..|.... ........+++..++|.+||..||++|||+.|+++
T Consensus 392 eQI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 392 EQILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1122222211 12334467899999999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=345.62 Aligned_cols=203 Identities=30% Similarity=0.493 Sum_probs=181.6
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|.+.+.||+|+|++||+|+++.++ ..||||.+.+. .....+.+..|+++|+.++|||||.+++++...+.+|+||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~---~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSG---TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCC---ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 445667999999999999998775 57999999765 4555677899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC------CceEEeeccccccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR------YNARISDFGLAKLL 212 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~------~~~kl~Dfg~~~~~ 212 (350)
|||+||+|.+|++..+.+++..++.++.|++.|+++|| .++|+||||||.|||++.+ -.+||+|||+++.+
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999999999999999999999999999999 5599999999999999764 45899999999988
Q ss_pred ccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhh
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 272 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~ 272 (350)
.+..- .....|++-|||||++...+|+.|+|+||+|+++|++++|+.||+.....+.
T Consensus 166 ~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 166 QPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred CchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 75432 2456799999999999999999999999999999999999999987666554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=376.57 Aligned_cols=265 Identities=27% Similarity=0.469 Sum_probs=225.3
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCC
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ 132 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 132 (350)
+....-.+.+.||+|.||.||+|+...-. +....||||.++..... ...+|++|+.++..++|||||+++|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 33444467788999999999999866433 45678999999876655 6778999999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCC----------C----CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 046877 133 NRLLAYEFLNNGTLASFLFGN----------L----KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR 198 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~----------~----~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~ 198 (350)
..++|+|||..|+|..|+..+ . +++..+.+.|+.|||.||.||. +..+|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccc
Confidence 999999999999999999532 2 2677889999999999999999 6699999999999999999
Q ss_pred CceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHH
Q 046877 199 YNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD 277 (350)
Q Consensus 199 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~ 277 (350)
..|||+|||+++..-..+++.......-+.+|||||.+..++|+++||||||||+|||+++ |+.||.+...++-
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV----- 714 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV----- 714 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-----
Confidence 9999999999998777777766545556789999999999999999999999999999996 9999987655442
Q ss_pred HHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 278 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
.+.+++| ...+.+.+||.++++||..||+.+|.+||+++||-.+|+....-
T Consensus 715 --Ie~i~~g---------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 --IECIRAG---------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred --HHHHHcC---------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 2222233 33555668999999999999999999999999999999877543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=330.50 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=208.9
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeec--cccccHHHHHHHHHHHhcCCCCceeeecc-eeecCC
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDGEKEFKNEVIVIGQTHHKNLVRLLG-FCDEGQ 132 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~ 132 (350)
..-+.+++.+.||+|.||+||++....++ +.+|.|.++- ........+..|+.+|+.++||||+++++ .+.++.
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g---~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDG---KLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCc---chhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 34456777889999999999999876664 5688888762 22333456889999999999999999998 455554
Q ss_pred e-eEEEEecCCCCChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCCeEEcCCCceEEeec
Q 046877 133 N-RLLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDC-SSQIIHCDIKPQNILLNDRYNARISDF 206 (350)
Q Consensus 133 ~-~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-~~~i~H~dlkp~Nill~~~~~~kl~Df 206 (350)
. ++++||||.+|+|...+. +...+++..+|+++.|++.||..+|... ...|+||||||.||+++.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 889999999999999885 4567899999999999999999999631 234999999999999999999999999
Q ss_pred ccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 046877 207 GLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 286 (350)
Q Consensus 207 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 286 (350)
|+++.+.... ......+|||.||+||.+.+..|+.||||||+||++|||+.-..||.+.+-.+ ....+..+
T Consensus 173 GL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qg 243 (375)
T KOG0591|consen 173 GLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQG 243 (375)
T ss_pred hhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcC
Confidence 9999776433 33357789999999999999999999999999999999999999998763222 22333344
Q ss_pred CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
+...+ ...-++..+..++..|+..||+.||+...++..+..
T Consensus 244 d~~~~--------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 DYPPL--------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCCC--------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 32222 224578899999999999999999996666555543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=321.70 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=210.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|+....+|+|+||.||+++++++ ++.||||++-.... ...+-..+|+++|++++|+|+|.++.+|......++|+
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~T---gqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDT---GQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred HhhhhccccCcceEEEEeccCCc---ccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 34456799999999999998777 46899999864332 22345789999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc-cCcc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT-LNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~-~~~~ 217 (350)
|||+..-|..+-......+...+.++++|++.|+.|+| +++++||||||+|||++.+|.+||||||+|+.+. +.+.
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 99999667666666677889999999999999999999 6699999999999999999999999999999876 3322
Q ss_pred cceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH--------hh-cCC
Q 046877 218 KTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC--------YR-NGK 287 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~--------~~-~~~ 287 (350)
.+.++.|.+|+|||.+.+ .+|+.++||||+||++.||++|.+.|.+..+.++.+........ +. ++-
T Consensus 158 ---YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 158 ---YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred ---hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 256778999999999988 58999999999999999999999999888877765544332211 11 122
Q ss_pred cchhccccccCCC-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 288 LDDLVEGDMEAMN-----DIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 288 ~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
+..+.-+..+.+. ..+.+.-+.+++..||..||++|++-++++
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 2222222222222 134556899999999999999999999887
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=362.96 Aligned_cols=270 Identities=24% Similarity=0.426 Sum_probs=232.2
Q ss_pred cccCHHHHHHHhhhhh-----------hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-cHHHHHHHHHHHhcC
Q 046877 49 RCFSYKELEEATDNFK-----------EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQT 116 (350)
Q Consensus 49 ~~~~~~~~~~~~~~~~-----------~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l 116 (350)
..++|+|+.++..+|. +.||.|.||.|++|.++..++....||||-++.-... +..+|+.|..+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 4557777777766654 4599999999999999988888889999999765543 445799999999999
Q ss_pred CCCceeeecceeecCCeeEEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 046877 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL 195 (350)
Q Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill 195 (350)
+||||+++.|+........++.|||++|+|..|++.+ +.+++.+...|+++|+.||+||.+ .++|||||..+|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheee
Confidence 9999999999999999999999999999999999754 778999999999999999999995 599999999999999
Q ss_pred cCCCceEEeecccccccccCccccee-eccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhh
Q 046877 196 NDRYNARISDFGLAKLLTLNQRKTIK-TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 273 (350)
Q Consensus 196 ~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~ 273 (350)
+.+..+|++|||+++........... ....-+.+|.|||.+...+++.+|||||+|+++||.++ |..||=...
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS----- 839 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----- 839 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----
Confidence 99999999999999976443322111 11222569999999999999999999999999999995 888984322
Q ss_pred hHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 274 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
+.++.+.++.+.+.+.+++||..|++||+.||++|..+||.+.+++..|++++
T Consensus 840 -----------NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 840 -----------NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred -----------hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 23345667889999999999999999999999999999999999999999886
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=334.01 Aligned_cols=266 Identities=22% Similarity=0.218 Sum_probs=212.6
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC--Ce
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--QN 133 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 133 (350)
...++-.++||+|+||.||+|+...+ ++.||+|++.... +.......+|+.+|++++||||+++.+...+. ..
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~t---gkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLET---GKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeeccc---CcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 34455567899999999999996655 5679999987544 33445678999999999999999999988766 78
Q ss_pred eEEEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
+|||+|||+. +|..++.. ...+++.++..++.|+++||+|+| +++|+|||||.+|||||++|.+||+|||+|+++
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999999998 88888764 468999999999999999999999 669999999999999999999999999999988
Q ss_pred ccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc--
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD-- 289 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 289 (350)
....... .+..+-|.+|+|||.+.+. .|+.++|+||.||++.||++|++.|.+.+..++.......+.......|.
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 7655443 3667789999999999875 89999999999999999999999999887766654433333322222232
Q ss_pred hhcc-cccc--CCC-------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 DLVE-GDME--AMN-------DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ~~~~-~~~~--~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
++.. ...+ ... -...+....+|+..+|..||++|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1110 0001 110 1235678889999999999999999999873
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=327.70 Aligned_cols=242 Identities=26% Similarity=0.323 Sum_probs=203.5
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..+++.+.||+|+||.|+.++.+++ ++.+|+|.+++.. ....+...+|..+|..++||+||++...|+++..+|
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt---~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDT---GKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEccc---CceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 3445678999999999999998765 4679999887543 234567899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+|+||+.||.|..++.+.+.++++.++.++..|+.||.||| +.+|+||||||+|||+|.+|+++|+|||++...-..
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999999999999999999999999999999999 569999999999999999999999999999855433
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......||+.|||||++.+..|+..+|.||||+++|||++|.+||...+..... +.+..++
T Consensus 179 ~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~-------~~I~~~k-------- 241 (357)
T KOG0598|consen 179 GD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY-------DKILKGK-------- 241 (357)
T ss_pred CC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH-------HHHhcCc--------
Confidence 22 224578999999999999999999999999999999999999999866643321 1111222
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRP 324 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 324 (350)
....+.-.+.+.++++.+.|..||++|.
T Consensus 242 -~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1111222567889999999999999996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=338.16 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=208.9
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcC-CCCceeeecceeecCCee
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 134 (350)
..+.|.+.||.|+|++|++|..+.+ .+.+|+|++++..- ...+-+..|-..|..| +||.|++++..|+++..+
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t---~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKAT---GKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred hhcchhheeccccceeEEEeeecCC---CceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3456889999999999999997665 46799999875432 2234467788888888 899999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
|+|+||+++|+|.+++.+.+.+++...+.++.+|+.|++||| ++|||||||||+|||+|++|.++|.|||.+..+++
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999999999999999999999999999999999 67999999999999999999999999999998765
Q ss_pred Cccc---------ce--eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh
Q 046877 215 NQRK---------TI--KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 283 (350)
Q Consensus 215 ~~~~---------~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 283 (350)
.... .. ...++||..|.+||++..+..+..+|+|+|||++|+|+.|.+||...+.--..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF---------- 296 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF---------- 296 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH----------
Confidence 3222 11 14588999999999999999999999999999999999999999865432211
Q ss_pred hcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
.++..-. -..+.++++.+.+|+.+.|..||.+|+|.+++.+-
T Consensus 297 -----qkI~~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 -----QKIQALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----HHHHHhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111111 11223456889999999999999999999888753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=327.33 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=200.8
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCC--eeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ--NRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 138 (350)
....+.||+|+||+||++.+.++ +...|+|..........+.+.+|+.+|+.++|||||+++|...... ..++.|
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~---g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKT---GELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhccccCccceEEEEEEecCC---CcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 34567899999999999998765 3568999886543333667999999999999999999999854444 688999
Q ss_pred ecCCCCChhhhhcCCC-CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEeeccccccccc-C
Q 046877 139 EFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND-RYNARISDFGLAKLLTL-N 215 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~-~ 215 (350)
||+++|+|.+++.+.+ .++++.++.+.+|+++|++||| +++++||||||+|||++. ++.+||+|||++..... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998766 7999999999999999999999 669999999999999999 79999999999986653 1
Q ss_pred cccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..........||+.|||||++..+ ....++||||+||++.||+||+.||....... .+...........
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~-----~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA-----EALLLIGREDSLP----- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH-----HHHHHHhccCCCC-----
Confidence 111223457799999999999853 34458999999999999999999997531111 1111111111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
..+...+++..+|+..|+..||++|||++++++.-.
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 223347789999999999999999999999986543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=305.00 Aligned_cols=264 Identities=21% Similarity=0.254 Sum_probs=211.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+|.-.+.||+|.||.||+|++..+ ++.||+|++.... ........+|++.|+.++|+||+.+++.|...+.+.+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t---~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTET---GKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCC---CcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 344557799999999999996555 4679999987432 22245688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+||++. +|...++.. ..++...+..++.++++|++||| +..|+||||||+|+|++.+|.+||+|||+++..++.+
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 999987 999999754 56788999999999999999999 5599999999999999999999999999999887665
Q ss_pred ccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc--
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-- 293 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 293 (350)
... +..+.|.+|+|||.+.|. .|+..+|+||.||++.||+-|.+-|.+..+-++....-.........++.++..
T Consensus 156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 433 334689999999998875 799999999999999999999999988877666544333333333333333221
Q ss_pred -c---c-c----cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 294 -G---D-M----EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 294 -~---~-~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
. . . ....-..++..+.+++..+|..||.+|+|++++++.
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 0 0 000112356778999999999999999999998753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=330.97 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=209.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-cHHHHHHHHHHHhcCC-CCceeeecceeecCC-eeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQ-NRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~ 135 (350)
.+|...++||.|+||.||+|+.+.++ ..||+|+.++.... .+..-.+|++.|++++ ||||+++.+++.+.+ .++
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~---~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETG---ELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCC---ceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45677889999999999999976664 45999998765433 2334578999999998 999999999998888 999
Q ss_pred EEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
+|||||+. +|..++..+ ..+++..++.|+.||++||+|+| .+|++|||+||+|||+..+..+||+|||+|+....
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999987 999988654 66899999999999999999999 55999999999999999888999999999997765
Q ss_pred CcccceeeccccCCCccCccccc-CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC-------
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFR-KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG------- 286 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~------- 286 (350)
...+ +.++.|.+|+|||++. ...|+.+.|+||+||+++|+.+-++.|.+.+.-++.+..-.+.......
T Consensus 163 kpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 KPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred CCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 4433 6678899999999975 5679999999999999999999999998776655433221111111111
Q ss_pred -------CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 287 -------KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 287 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
.+.......+.... .+++.+..++|.+|+..||++|||++++++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111122222 2378899999999999999999999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=332.73 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=208.0
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc----cc-ccHHHHHHHHHHHhcCC-CCceeeecceeec
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV----FQ-DGEKEFKNEVIVIGQTH-HKNLVRLLGFCDE 130 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 130 (350)
....+.+.+.||+|+||+|+.|.+..++ ..||+|.++.. .. ...+.+.+|+.+++.++ ||||++++.++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~---~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTG---EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCC---CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 3345667788999999999999987665 55899976653 12 34567788999999998 9999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEeecccc
Q 046877 131 GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR-YNARISDFGLA 209 (350)
Q Consensus 131 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~ 209 (350)
...+++||||+.||+|.+++...+++.+..++.+++|++.|++|+| +.+|+||||||+|++++.+ +++||+|||++
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999999998899999999999999999999999 6699999999999999999 99999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCC-CC-CCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKST-IS-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
.... ..........|++.|+|||++.+.. |+ .++||||+|++||.|++|..||+..+..... ..+..+
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~-------~ki~~~- 238 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY-------RKIRKG- 238 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH-------HHHhcC-
Confidence 8774 1122235667999999999999877 75 6799999999999999999999863332221 111111
Q ss_pred cchhccccccCCCcHHH-HHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 288 LDDLVEGDMEAMNDIKC-VEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
....+. .+ +.++..++.+||..||.+|+|+.+++ .-.-..
T Consensus 239 -------~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 239 -------EFKIPS--YLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred -------CccCCC--CcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 111111 12 67899999999999999999999998 444333
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=336.70 Aligned_cols=264 Identities=27% Similarity=0.383 Sum_probs=204.0
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecC-
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG- 131 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 131 (350)
....+++.+.||+|+||.||+|.+.. .......||+|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 34456778899999999999997532 22334569999886432 22345688999999999 899999999988654
Q ss_pred CeeEEEEecCCCCChhhhhcCC----------------------------------------------------------
Q 046877 132 QNRLLAYEFLNNGTLASFLFGN---------------------------------------------------------- 153 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 153 (350)
...+++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4578999999999999988542
Q ss_pred ----CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCC
Q 046877 154 ----LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229 (350)
Q Consensus 154 ----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 229 (350)
..+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++................++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23567788899999999999999 55999999999999999999999999999976543322222223345678
Q ss_pred ccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHH
Q 046877 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL 308 (350)
Q Consensus 230 y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 308 (350)
|+|||++.+..++.++||||||+++|||++ |..||......+.. ......+.. ...+..++..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF------CQRLKDGTR---------MRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH------HHHHhcCCC---------CCCCCCCCHHH
Confidence 999999998899999999999999999997 99999754432211 111111111 11122456789
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 309 LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 309 ~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.+++.+||+.||++|||+.++++.|++++.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=361.58 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=216.9
Q ss_pred hhhhccCCCccceEEEEEEcCCCcc--eeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTS--TTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~--~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.+.||+|.||.||.|...+...+ ...||+|.+.... .....+|.+|..++++++||||++++|++-+....++++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 4456799999999999998876544 5679999987653 445678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC-------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 139 EFLNNGTLASFLFGN-------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 139 e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
|||++|+|..|+++. ..++....+.++.|+|+|+.||+ ++++|||||..+|+||++...+||+|||+|+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999754 45678889999999999999999 55999999999999999999999999999996
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
....+++.......-+..|||||.+....++.|+|||||||++||++| |..||...+..+... .
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~---------------~ 916 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL---------------D 916 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH---------------H
Confidence 555555444333345679999999999999999999999999999998 888886544433211 1
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
....+ +...+..||+.++++|.+||+.+|++||++..+++++..+..
T Consensus 917 ~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 917 VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 22222 666777899999999999999999999999999999987763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=329.82 Aligned_cols=244 Identities=25% Similarity=0.384 Sum_probs=207.9
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
+.||+|+.|.||.|....++ ..||+|+++.......+-+.+|+.+|+..+|+|||++++.|...+.+|+||||++||
T Consensus 279 ~kigqgaSG~vy~A~~~~~~---~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~gg 355 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTK---QEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGG 355 (550)
T ss_pred hhhccccccceeeeeeccCC---ceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCC
Confidence 56999999999999865554 559999998765666677999999999999999999999998889999999999999
Q ss_pred ChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeecc
Q 046877 145 TLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224 (350)
Q Consensus 145 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 224 (350)
+|.+.+. ...+++.++..+++.+++||+||| ..+|+|||||.+|||++.+|.+||+|||++..+..... .....
T Consensus 356 sLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~Tm 429 (550)
T KOG0578|consen 356 SLTDVVT-KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTM 429 (550)
T ss_pred chhhhhh-cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccc
Confidence 9999985 445899999999999999999999 56999999999999999999999999999988765543 23567
Q ss_pred ccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHH
Q 046877 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 304 (350)
Q Consensus 225 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
+||+.|||||+.....|++|.||||||++.+||+-|.+||-.++.....++. . .....+.......
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-------a-------~ng~P~lk~~~kl 495 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------A-------TNGTPKLKNPEKL 495 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-------h-------hcCCCCcCCcccc
Confidence 8999999999999999999999999999999999999999754433222111 1 1222333444567
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 305 VEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 305 ~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+..+.+|+.+||+.|+++|+++.|+|+
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 889999999999999999999999985
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=332.97 Aligned_cols=265 Identities=28% Similarity=0.424 Sum_probs=211.6
Q ss_pred CHHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceee
Q 046877 52 SYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCD 129 (350)
Q Consensus 52 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 129 (350)
..+|+.-....+.+.||+|.||+||+|++-.+ ||||.++... .+..+.|++|+..+++-+|.||+-+.|++.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 44555555556678899999999999998766 9999997543 344567999999999999999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 130 EGQNRLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
+... .+|.-+|+|.+|..+++.. .+++..+.+.|+.|+++||.||| .++|+|+|||..|||+.+++.|||+|||+
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccc
Confidence 9877 9999999999999999743 56888999999999999999999 55999999999999999999999999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccC---CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRK---STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
+..-.......-....-|...|||||+++. .+|++.+||||||+++|||+||..||.....+.....++ .
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG-------r 607 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG-------R 607 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec-------c
Confidence 976544322222223346678999999964 368999999999999999999999998433333222211 0
Q ss_pred CCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
|- ..++ ......+|+.++.+|+..||..++++||++.+++..|++++.
T Consensus 608 G~----l~pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 608 GY----LMPD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cc----cCcc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 00 0000 011223688899999999999999999999999998888765
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=335.91 Aligned_cols=267 Identities=28% Similarity=0.388 Sum_probs=217.0
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeE-EEEEeeec---cccccHHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTA-VAVKKLDR---VFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~-vavk~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
+.-..-.+.+.||+|+||.||+|.++........ ||+|.... .......++.+|.++++.++||||++++|++..+
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 3333334557899999999999999876542223 89998874 3355667899999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCC-CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
..+++|||+|+||+|.+++.+.. .++..+...++.+.+.||+||| +.+++||||..+|+|++.++.+||+|||++.
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999998776 4899999999999999999999 5699999999999999999999999999987
Q ss_pred ccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
.... .........-+.+|+|||.+...-++.++|||||||++||+++ |..||.+....+.. .
T Consensus 311 ~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---------------~ 373 (474)
T KOG0194|consen 311 AGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---------------A 373 (474)
T ss_pred CCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---------------H
Confidence 5541 1111112245779999999999999999999999999999998 88899765543221 1
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCC
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~ 342 (350)
.+.....+...+...|.++..++.+||..+|++||||.++.+.|+.+.....+
T Consensus 374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11122333333335678999999999999999999999999999988766554
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=317.69 Aligned_cols=260 Identities=21% Similarity=0.361 Sum_probs=208.4
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
....+++.+.||+|+||.||+|.++........+++|.++.... .....+.+|+..++.++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 34556778899999999999998776555667899998875432 23456889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+++|+|.+++... ..+++..++.++.|++.|++||| ..+++|+||||+||+++.++.++++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999998653 56899999999999999999999 45999999999999999999999999998765432
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.... ......++..|+|||.+.+..++.++|||||||++|++++ |..||......+. ...+..+
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~-------~~~~~~~------- 224 (266)
T cd05064 160 EAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-------IKAVEDG------- 224 (266)
T ss_pred cchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHHCC-------
Confidence 2111 1112234568999999998899999999999999999875 9999975433221 1111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
...+.+..++..+.+++.+||+.+|++|||++++.+.|+++
T Consensus 225 --~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 --FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122335678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=317.97 Aligned_cols=246 Identities=19% Similarity=0.271 Sum_probs=199.5
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc---HHHHHHHHHHHhcCCCCceeeecceeec----CCeeEEE
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG---EKEFKNEVIVIGQTHHKNLVRLLGFCDE----GQNRLLA 137 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 137 (350)
..||+|+++.||+|.+. +..||+|.+....... .+.+.+|+.++++++||||+++++++.+ ....+++
T Consensus 26 ~~i~~g~~~~v~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-----NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred eEEeeCCceEEEEEEEC-----CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence 35999999999999873 3468999886543333 4567899999999999999999999866 4568899
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++|+|.+++.....+++....+++.|++.|+.|||+ ..+++||||||+||++++++.+||+|||++.......
T Consensus 101 ~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 101 LEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred EEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999999999888889999999999999999999995 2478899999999999999999999999987654321
Q ss_pred cceeeccccCCCccCcccccC--CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRK--STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. .... ...
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~-------~~i~--------~~~ 238 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY-------DLII--------NKN 238 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHH--------hcC
Confidence 22357889999999976 67899999999999999999999999754432211 1110 111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.+...+..++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111222246789999999999999999999999999998764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=330.78 Aligned_cols=265 Identities=26% Similarity=0.405 Sum_probs=206.0
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeec
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDE 130 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 130 (350)
......+++.+.||+|+||.||+|.....+ .....||+|.+.... .+....+.+|+.+++.+ +|+||+++++.+..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345566778899999999999999864322 234569999986432 33345688999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhcCC---------------------------------------------------------
Q 046877 131 GQNRLLAYEFLNNGTLASFLFGN--------------------------------------------------------- 153 (350)
Q Consensus 131 ~~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------- 153 (350)
....+++|||+++|+|.+++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999987432
Q ss_pred -------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 154 -------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 154 -------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
..+++..+++++.|+++|++||| +.+++||||||+||++++++.+||+|||++...........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 13567788999999999999999 55999999999999999999999999999976543322222
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||......... ......+ ....
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~------~~~~~~~---------~~~~ 335 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF------YKMVKRG---------YQMS 335 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH------HHHHHcc---------cCcc
Confidence 222335668999999988899999999999999999997 99999754332211 0111111 1111
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.+...+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11123578999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=325.04 Aligned_cols=245 Identities=27% Similarity=0.409 Sum_probs=208.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|.+.+.||+|+||.||+|+.+.+ .+.||+|.+.+.. ....+.+.+|+++++.++||||+.++++|+...+.++|.
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t---~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYT---IQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred hhHHHHhcCCccceeeecccccc---eeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 45668899999999999986655 5679999987643 333567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+.| +|+.++...+.++++.++.++.+++.|+.||| +..|.|||+||.|||++.+|.+|+||||+++..+. ..
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence 99988 99999999999999999999999999999999 66999999999999999999999999999997764 34
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
...+...||+.|||||...+.+|+..+|.||+||++||+++|++||....-.. .. ..+......
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~------Lv---------~~I~~d~v~- 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ------LV---------KSILKDPVK- 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH------HH---------HHHhcCCCC-
Confidence 44567789999999999999999999999999999999999999996322111 11 111111111
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+.+.+..+.+++...|.+||.+|.|..+++.
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 22367789999999999999999999998873
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=329.43 Aligned_cols=262 Identities=26% Similarity=0.393 Sum_probs=203.2
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecCC
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQ 132 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 132 (350)
....+.+.+.||+|+||.||+|.... .......||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34456778899999999999997532 22334579999886432 23345688999999999 8999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCC-----------------------------------------------------------
Q 046877 133 NRLLAYEFLNNGTLASFLFGN----------------------------------------------------------- 153 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------------- 153 (350)
..+++|||+++|+|.+++...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 999999999999999888532
Q ss_pred ----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 154 ----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 154 ----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
..+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 13567788999999999999999 45999999999999999999999999999986643332
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ...+..+.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~------~~~~~~~~--------- 334 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF------YKMIKEGY--------- 334 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH------HHHHHhCc---------
Confidence 222222334667999999998899999999999999999998 88888643322211 11111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
....+...+.++.+++.+||+.||++|||+.++++.|++.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111112356899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=318.53 Aligned_cols=265 Identities=25% Similarity=0.386 Sum_probs=201.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCC-------------cceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeee
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTT-------------TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRL 124 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~-------------~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~ 124 (350)
..+.+.+.||+|+||.||+|.+.... ..+..+|+|.+.... .....++.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 34566788999999999999865422 234568999886532 2334578999999999999999999
Q ss_pred cceeecCCeeEEEEecCCCCChhhhhcCC-------------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 046877 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGN-------------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIH 185 (350)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H 185 (350)
++++.+.+..+++|||+++++|.+++... ..+++..+.+++.|++.|+.||| +.+++|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 99999999999999999999999988532 13567788999999999999999 459999
Q ss_pred cCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh--CCCC
Q 046877 186 CDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS--CRKS 263 (350)
Q Consensus 186 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~p 263 (350)
+||||+||+++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999976544332222233345778999999988889999999999999999987 5567
Q ss_pred CCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 264 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 264 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
|......... ............... ...+..++..+.+++.+||+.||++|||++++.+.|++
T Consensus 242 ~~~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVI---ENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHH---HHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7644332211 111111111110000 11112356789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=295.25 Aligned_cols=263 Identities=23% Similarity=0.242 Sum_probs=210.8
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecC-----C
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-----Q 132 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 132 (350)
+.+|.+.+.||+|||+.||+++...+ ...+|+|++.-...+..+...+|+...++++|||+++++++...+ .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~---~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLST---GHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCc---ccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 34567788999999999999985544 456999999877667788899999999999999999999987433 3
Q ss_pred eeEEEEecCCCCChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 133 NRLLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
..|++++|...|+|.+.+. ++..+++.+++.|+.++++||++||+. ...++||||||.||++++++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 4899999999999999985 345689999999999999999999976 34599999999999999999999999999
Q ss_pred ccccccCcccc-------eeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHH
Q 046877 209 AKLLTLNQRKT-------IKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 278 (350)
Q Consensus 209 ~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 278 (350)
+....-.-... -......|..|+|||.+. +...++++|||||||++|+|+.|..||+..-.....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS----- 250 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS----- 250 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-----
Confidence 97653221110 012334688999999985 456789999999999999999999999743322211
Q ss_pred HHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
-.-.....+...+....+++.+.+++.+|++.||.+||++.+++..++.+.
T Consensus 251 --------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 --------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 011222334444444558899999999999999999999999999998764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=328.53 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=205.6
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+.+.||.|+.|.|.+|++..++ +..|||++.+. .......+.+|+.+|+.+.|||++.++++++++.++|++.|
T Consensus 16 LgkTLG~Gstg~vrlakh~~TG---qlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETG---QLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ccccccCCCCceehhhhccccc---ceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4577999999999999987764 56899988655 23345568999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++|.|++++...+++++....++++||+.|+.|+| ..+|+||||||+|+|+|..+++||+|||+|....+..
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--- 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--- 166 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc---
Confidence 9999999999999999999999999999999999999 5599999999999999999999999999998654432
Q ss_pred eeeccccCCCccCcccccCCCCC-CCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTIS-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
......|.+.|.+||++.+.+|. .++||||.|++||.|+||+.||++++-...... ...|.++
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlK-------V~~G~f~--------- 230 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLK-------VQRGVFE--------- 230 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHH-------HHcCccc---------
Confidence 22456799999999999999884 589999999999999999999985443332211 1222211
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+.+.+.+..+|+.+|+..||..|.|+++|++
T Consensus 231 -MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 231 -MPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred -CCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 12346789999999999999999999999976
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=311.24 Aligned_cols=267 Identities=21% Similarity=0.319 Sum_probs=209.6
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
....|++.+.||.|..++||+|....++ ..||||+++-...+ ..+.+.+|++.++.++||||++++..|..+..+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~---e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTN---EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccC---CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 3445677889999999999999987664 56999999754333 2578999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 136 LAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
+||.||.+|++.+.+... ..+++..+..+++++++||.|||+ +|.+|||+|+.||||+.+|.|||+|||.+....
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999998642 458899999999999999999995 599999999999999999999999999887654
Q ss_pred cCc-cccee-eccccCCCccCcccccC--CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 214 LNQ-RKTIK-TAIRGTKGYVAPEWFRK--STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 214 ~~~-~~~~~-~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
... ..... ....|+++|||||++.. ..|+.|+||||||++..||.+|..||....+-..... . -.+...
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~------t-Lqn~pp 250 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL------T-LQNDPP 250 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH------H-hcCCCC
Confidence 332 22222 45689999999999643 4799999999999999999999999964433221110 0 011221
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcc
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEV 336 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~ 336 (350)
...-..........++..+.+++..||++||.+|||++++++ +++..
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 111122222333456668999999999999999999999984 44443
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=317.03 Aligned_cols=252 Identities=31% Similarity=0.523 Sum_probs=198.6
Q ss_pred hhhccCCCccceEEEEEEc-CCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 63 FKEEVGRGSFGIIYKGVIQ-TTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~-~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.+.||.|.||.||+|.+. ........|++|.+..... ...+.+.+|++.+++++||||+++++++...+..++++||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3467999999999999998 5556678899999965322 3367899999999999999999999999988889999999
Q ss_pred CCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 141 LNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 141 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
+++|+|.+++... ..+++..+..|+.|+++||.|||+ .+++|++|+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999765 778999999999999999999995 48999999999999999999999999999876333332
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
...........|+|||.+....++.++||||||+++||+++ |+.||......+.. ..+.. ...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~-------~~~~~---------~~~ 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII-------EKLKQ---------GQR 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH-------HHHHT---------TEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccc---------ccc
Confidence 33333456778999999988889999999999999999999 67888654332211 11111 111
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
...+..++..+.+++.+||..||++|||++++++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 222334678899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=320.57 Aligned_cols=261 Identities=24% Similarity=0.384 Sum_probs=214.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccH-HHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE-KEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.-.|.+.||+|-||.|.+++... +..||+|+++....... .+|.+|+++|.+++||||++++++|...+.+++++
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg----~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEG----PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred heehhhhhcCcccceeEEEEecC----ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 33577889999999999998654 35699999986655444 78999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCC--cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||++.|+|..|+.++.. .......+|+.||+.||+||. +.+++|||+.++|+|++.++++||+|||+++-+-..+
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999976633 344566789999999999999 7799999999999999999999999999999776666
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh--CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
++......+-+.+|||||.+..++++.+||+|+||+++||+++ ...||....++.... ...+.+..+...
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve---n~~~~~~~~~~~----- 763 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE---NAGEFFRDQGRQ----- 763 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH---hhhhhcCCCCcc-----
Confidence 6666666667889999999999999999999999999999875 667887554443211 111111111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.-...+.-|+.+++++|.+||..|-.+|||++++...|++.
T Consensus 764 -~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 -VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11233456889999999999999999999999999988764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=319.47 Aligned_cols=244 Identities=25% Similarity=0.376 Sum_probs=209.2
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
.+.||+|.||.||+|.+..+ .+.||+|.++... .+..+.+++|+.++..++++||.++++.+..+..++++||||.
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t---~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKT---KKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred chhccccccceeeeeeeccc---cceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 36799999999999996655 4679999997543 4556789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceee
Q 046877 143 NGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT 222 (350)
Q Consensus 143 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 222 (350)
||++.+.+.....+.+..+.-+++.+..|+.||| +.+.+|||||+.||++..+|.+|++|||.+.......... .
T Consensus 95 gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~ 169 (467)
T KOG0201|consen 95 GGSVLDLLKSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--K 169 (467)
T ss_pred CcchhhhhccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc--c
Confidence 9999999988777788888999999999999999 5699999999999999999999999999998876554433 5
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcH
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 302 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
.++||+.|||||++....|+.|+||||||++.+||++|.+|+....+. ....++.+........
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP~L~~ 233 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPPRLDG 233 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCCcccc
Confidence 678999999999999889999999999999999999999999644431 1222233333333333
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 303 KCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 303 ~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.++..+.+|+..||.+||+.|||+.++++
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 78889999999999999999999999984
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=313.45 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=206.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+++.+.||+|+||.||+|...... .....+++|.+.... ......+.+|+..++.++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 4566788999999999999876543 334568999876432 2334568899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 046877 137 AYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN 200 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~ 200 (350)
+|||+++++|.+++... ..+++..++.++.|++.|+.|||+ .+++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 99999999999998643 346778889999999999999994 59999999999999999999
Q ss_pred eEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHH
Q 046877 201 ARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 279 (350)
Q Consensus 201 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 279 (350)
++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~------ 236 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI------ 236 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH------
Confidence 99999999976543332222233446788999999988889999999999999999998 99999754432211
Q ss_pred HHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 280 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
..+..+. ....+..++.++.+++.+||+.||.+||+++++++.|+++
T Consensus 237 -~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 -EMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111111 1122345778999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=297.14 Aligned_cols=234 Identities=26% Similarity=0.323 Sum_probs=200.0
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
++.+.||.|+||.|.+++.+.+ +..+|+|++++.. ..+.+...+|..+|+.+.||+++++.+.+.+.+..+|||
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~~---g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKHS---GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hheeeeccCccceEEEEEEccC---CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4567899999999999997766 4569999987543 334566889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||.+||.|.+++++.+++++..++.++.|++.|++||| +.+|++|||||+|||+|.+|.+||.|||++..+...
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999999999999999999999999999999999 679999999999999999999999999999977533
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.-...||+.|+|||+++...++.++|.||||+++|||+.|.+||...+... .++.+-+++ ...
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~--------v~f 260 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGK--------VKF 260 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCc--------ccC
Confidence 245679999999999999999999999999999999999999998666522 122222222 222
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCC
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLR 323 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~R 323 (350)
+ .-++.++.+|+...|+.|-.+|
T Consensus 261 P--~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 P--SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred C--cccCHHHHHHHHHHHhhhhHhh
Confidence 1 1245788999999999999999
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=312.58 Aligned_cols=259 Identities=26% Similarity=0.466 Sum_probs=206.9
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
..++.+.+.||+|+||.||+|..... ......+++|.+...... ....+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 34566778999999999999987543 233467999988654433 456899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCC--------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 046877 135 LLAYEFLNNGTLASFLFGN--------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN 200 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~ 200 (350)
+++|||+++++|.+++... ..+++..+..++.|++.|++||| ..+++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 9999999999999998643 34678888999999999999999 559999999999999999999
Q ss_pred eEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHH
Q 046877 201 ARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 279 (350)
Q Consensus 201 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 279 (350)
++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~------ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI------ 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH------
Confidence 99999999976543322222223345678999999998899999999999999999998 99999754433211
Q ss_pred HHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 280 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
.....+... ..+..++..+.+++.+||+.||++|||+.++++.|++
T Consensus 235 -~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 -ECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111122111 1122456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=325.04 Aligned_cols=237 Identities=27% Similarity=0.422 Sum_probs=203.3
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
+=||+|+.|.||+|+..+. .||||+++... ..+++-|++|+||||+.|.|+|...--+||+||||..|
T Consensus 130 eWlGSGaQGAVF~Grl~ne-----tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNE-----TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhccCcccceeeeeccCc-----eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3499999999999998765 39999875421 34688899999999999999999999999999999999
Q ss_pred ChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeecc
Q 046877 145 TLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224 (350)
Q Consensus 145 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 224 (350)
.|...++....++......|..+|+.||.||| ...|||||||.-||||+.+..|||+|||-++..... ..+-.+
T Consensus 198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred cHHHHHhccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 99999999999999999999999999999999 459999999999999999999999999999866543 233457
Q ss_pred ccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHH
Q 046877 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 304 (350)
Q Consensus 225 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
.||..|||||++.+.++++|+|||||||+||||+||..||...+..... -..-...+..+.+..|
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---------------wGVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---------------WGVGSNSLHLPVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---------------EeccCCcccccCcccC
Confidence 7999999999999999999999999999999999999999643322211 0111233445566789
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 305 VEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 305 ~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
|+.+.-|+.+||+..|..||++++++.-|+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 999999999999999999999999998885
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=320.12 Aligned_cols=265 Identities=21% Similarity=0.302 Sum_probs=203.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
..++..+.||+|+||.||++....++ ..+++|.+.... .....++.+|+++++.++||||+++++++...+..+++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSG---LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCC---cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 34566788999999999999976553 458888876432 23346799999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.+++.....+++..+..++.|++.|+.|||+. .+++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 99999999999998878889999999999999999999952 369999999999999999999999999987553221
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC----------
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---------- 287 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---------- 287 (350)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||......+..............+.
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 1334589999999999988999999999999999999999999975443222111000000000000
Q ss_pred ---------------------cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 288 ---------------------LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 288 ---------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
...+............++.++.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000111111122356789999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=335.11 Aligned_cols=260 Identities=20% Similarity=0.275 Sum_probs=212.6
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecce-eec------CC
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGF-CDE------GQ 132 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~------~~ 132 (350)
..+.+.|.+|||+.||+|++...+ ..+|+|+.-.......+.+.+|+.+|++| +|+|||.+++. ... .-
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~---~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGG---KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCC---ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 345678999999999999976553 55899988766677778899999999999 49999999993 211 13
Q ss_pred eeEEEEecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
..+|.||||+||.|-++++. ...+++.++++|+.|+++|+++||.. +..|||||||-+||||+.+|+.||||||.+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 46799999999999999973 35689999999999999999999976 7779999999999999999999999999997
Q ss_pred ccccCcccceee-------ccccCCCccCcccc---cCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH
Q 046877 211 LLTLNQRKTIKT-------AIRGTKGYVAPEWF---RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 280 (350)
Q Consensus 211 ~~~~~~~~~~~~-------~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 280 (350)
............ ...=|+.|+|||.+ .+...++|+|||||||+||.||....||+...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------ 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------ 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence 543322111000 11138899999987 46689999999999999999999999997321
Q ss_pred HHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCCC
Q 046877 281 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPP 343 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~~ 343 (350)
...++......+...+++..+.+||..||+.||++||++-++++.+.++...+.|-
T Consensus 263 -------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 263 -------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred -------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 23455566666666789999999999999999999999999999998888766553
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=310.78 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=201.3
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--------------ccHHHHHHHHHHHhcCCCCceeee
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--------------DGEKEFKNEVIVIGQTHHKNLVRL 124 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~ 124 (350)
..|++.+.||+|.||.|-+|....+ ++.+|+|++.+... ...+.+.+|+.++++++|||||++
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~---~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVD---GKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCC---CcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3456678899999999999985544 57799999864311 113578999999999999999999
Q ss_pred cceeec--CCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceE
Q 046877 125 LGFCDE--GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNAR 202 (350)
Q Consensus 125 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~k 202 (350)
+.+..+ .+.+|||+|||..|.+..---....+++.++++++++++.||.||| .++|+||||||+|+||+++|.+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEE
Confidence 999855 4679999999999987655433334899999999999999999999 56999999999999999999999
Q ss_pred EeecccccccccCc---ccceeeccccCCCccCcccccCCC----CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhH
Q 046877 203 ISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWFRKST----ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 275 (350)
Q Consensus 203 l~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~ 275 (350)
|+|||.+....... .........||++|+|||...++. .+.+.||||+|++||.|+.|+.||..+...+.
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l--- 327 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL--- 327 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH---
Confidence 99999998652221 111123367999999999987632 35678999999999999999999975544332
Q ss_pred HHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 276 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
..+++...+..+...+..+.+.++|.++|.+||++|.+..+|..-.
T Consensus 328 ------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 328 ------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 2344455555555556778999999999999999999999885433
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=307.27 Aligned_cols=259 Identities=24% Similarity=0.408 Sum_probs=207.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.+.+.||+|+||.||+|.+..+......+++|.+.... ......+.+|+..++.++||||+++++++.+.+..+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 3556788999999999999987665555678999876433 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 85 EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999998653 46889999999999999999999 55999999999999999999999999999987652222
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...+..+ .
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-------~~~~~~~---------~ 225 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-------IKAVEDG---------Y 225 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-------HHHHHcC---------C
Confidence 221122334678999999998889999999999999999998 9999864332221 1111111 1
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
..+.+..++..+.+++.+||+.+|++||+++++++.|++++
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11112245678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=305.24 Aligned_cols=254 Identities=20% Similarity=0.341 Sum_probs=211.3
Q ss_pred CHHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeeccee
Q 046877 52 SYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFC 128 (350)
Q Consensus 52 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 128 (350)
.-....+-+|++.+.||+|+||.|-+|... ..+..||+|.+.+..- ...-.+.+|+.+++.++||||+.++.+|
T Consensus 46 hhkhnlkHRyE~~etLGkGTYGKVk~A~e~---~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 46 HHKHNLKHRYEITETLGKGTYGKVKLAYEH---KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred CcccchhhHHHHHHHhcCCcccceeehhhc---cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 344566778889999999999999999743 3457799998875432 2234588999999999999999999999
Q ss_pred ecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 129 DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 129 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
++.+.+.+||||..+|.|.+|+.+++.+++...+.+++||+.|+.|+| .++++|||||.+|||+|.|+++||+|||+
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccch
Confidence 999999999999999999999999999999999999999999999999 55999999999999999999999999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
+..+... .....+.|.+-|.+||++.+.+| ++.+|.||||++||-|+.|..||++.+.... ...+..|.
T Consensus 200 SNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l-------vrQIs~Ga 269 (668)
T KOG0611|consen 200 SNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL-------VRQISRGA 269 (668)
T ss_pred hhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH-------HHHhhccc
Confidence 9877543 23356789999999999999888 5679999999999999999999987654321 12222222
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
..+- +.|....-+|++||..||+.|.|++++..-
T Consensus 270 YrEP-----------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 270 YREP-----------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ccCC-----------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 2221 123456779999999999999999998653
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=312.08 Aligned_cols=260 Identities=24% Similarity=0.442 Sum_probs=208.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.+.+.+.||+|+||.||+|+.... ......+++|..........+.+.+|+..++.++||||+++++++......+++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 345667899999999999986542 234456888887655444556799999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCce
Q 046877 138 YEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA 201 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~ 201 (350)
|||+++++|.+++... ..+++..++.++.|++.|++||| ..+++|+||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence 9999999999998643 23688899999999999999999 5599999999999999999999
Q ss_pred EEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHH
Q 046877 202 RISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF 280 (350)
Q Consensus 202 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 280 (350)
+|+|||++................++..|+|||.+.+..++.++||||||+++|+|+| |..||........ .
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------~ 235 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-------I 235 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------H
Confidence 9999999976543322222233446778999999988889999999999999999999 9999865443221 1
Q ss_pred HHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 281 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
+....+.... ....++..+.+++.+||+.+|++|||++++++.|+++.+
T Consensus 236 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 ECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1112222111 112356789999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=317.45 Aligned_cols=242 Identities=22% Similarity=0.258 Sum_probs=197.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
+.||+|+||.||++....++ ..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATG---KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 35899999999999876553 568999886432 223456788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccccee
Q 046877 142 NNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK 221 (350)
Q Consensus 142 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 221 (350)
++++|.+++.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 152 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence 99999999988888999999999999999999999 55999999999999999999999999999875322211 11
Q ss_pred eccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 222 TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 222 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
....|++.|+|||++.+..++.++||||+||++|+|++|..||...+..... ..+..+.. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-------~~~~~~~~----------~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEEI----------RFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-------HHHHcCCC----------CCC
Confidence 3456899999999999889999999999999999999999999754332211 11111111 111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
...+.++.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 23567899999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=313.56 Aligned_cols=263 Identities=19% Similarity=0.305 Sum_probs=210.7
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+..+.||+|+||.||+|+-++++ ..+|+|++.+.. ..+...+..|-.+|...++|.||+++..|++.+.+||||
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg---~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTG---EIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred hhheeeccccceeEEEEEEccCC---cEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 34567999999999999977774 579999997654 345567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc----
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL---- 214 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---- 214 (350)
||++||++..++...+.+++..++.++.+++.|+..+| ..|++||||||+|+|||..|++||+|||++.-...
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999999999999999999999999999999999 55999999999999999999999999999853311
Q ss_pred ------------------Ccccc-----------------------eeeccccCCCccCcccccCCCCCCCCcchhHHHH
Q 046877 215 ------------------NQRKT-----------------------IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVL 253 (350)
Q Consensus 215 ------------------~~~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~ 253 (350)
.+... .....+|||-|+|||++.+..|+..+|.|||||+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 00000 0012358999999999999999999999999999
Q ss_pred HHHHHhCCCCCCcccchhhh-hHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCC---HHHH
Q 046877 254 LLEIISCRKSFDIEMGEEYA-ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT---MRKV 329 (350)
Q Consensus 254 l~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~v 329 (350)
+||||.|.+||..++..+.- .+..| ...+..+....++++..++|.+|+. ||++|.- ++||
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nw--------------r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNW--------------RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHH--------------hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 99999999999877665432 22222 1122333334456899999999999 9999986 4444
Q ss_pred HHH-------HhcccCCCCCCCC
Q 046877 330 SQM-------LQEVVEVDVPPNP 345 (350)
Q Consensus 330 l~~-------L~~~~~~~~~~~~ 345 (350)
.+. -+.+.++++|=.|
T Consensus 443 K~HPfF~~v~W~~l~~~~apfvP 465 (550)
T KOG0605|consen 443 KKHPFFKGVDWDHLREMPAPFVP 465 (550)
T ss_pred hcCCccccCCcchhhcCCCCCCC
Confidence 321 1455677766444
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=310.78 Aligned_cols=262 Identities=23% Similarity=0.448 Sum_probs=208.4
Q ss_pred HhhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
..+.+.+.||+|+||.||++..... ......+++|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3455678899999999999976442 23345688998876555556679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC-------------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEE
Q 046877 137 AYEFLNNGTLASFLFGNL-------------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI 203 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl 203 (350)
+|||+++++|.+++.... .+++..++.++.|++.|++||| ..+++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 4788999999999999999999 459999999999999999999999
Q ss_pred eecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHH
Q 046877 204 SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 282 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 282 (350)
+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-------~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------IEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH
Confidence 99999976543322222223335678999999988889999999999999999998 8999865443221 111
Q ss_pred hhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
+..+.... .+..++..+.+++.+||+.||.+|||++++.+.|+++...
T Consensus 235 i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 12222111 1113456899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=304.14 Aligned_cols=261 Identities=24% Similarity=0.320 Sum_probs=205.5
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc--cHHHHHHHHHHHhcCCCCceeeecceeec-----CCeeEE
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQTHHKNLVRLLGFCDE-----GQNRLL 136 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 136 (350)
.+.||.|+||.|+.+.+..++ ..||+|++.....+ ..++..+|+++|+.++|+||+.+.+.+.. -...|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~---~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTG---EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred cccccCcceeeEEEEEEcCCC---CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 467999999999999977665 56999999744333 34678899999999999999999998854 467899
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|+|+|+. +|...++.+..++...+..++.|++.|+.|+| +.+|+||||||+|++++.++.+||||||+|+......
T Consensus 104 V~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 104 VFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred ehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 9999954 99999988888999999999999999999999 6799999999999999999999999999999876543
Q ss_pred ccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------HHHhhcCC
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRNGK 287 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~~ 287 (350)
.....+..+.|.+|+|||++.+ ..|+...||||.||++.||++|++.|.+.+...+..+.... ...+.+..
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 3344467788999999998754 58999999999999999999999999776654443222211 11112111
Q ss_pred cchhccccccC---C---CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 LDDLVEGDMEA---M---NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ~~~~~~~~~~~---~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....+...... + .-.+..+...+++.+||.+||.+|+|++++++
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111111100 0 01245678899999999999999999999874
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=317.00 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=210.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCe-eEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN-RLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~l 136 (350)
.|.+.+++|+|+||.+++++++... +.+++|++.... ....+...+|+.++++++||||+.+.+.|.+++. .+|
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~---~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDD---KLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCC---ceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4667889999999999999876654 358888886432 3334468899999999999999999999999888 999
Q ss_pred EEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 137 AYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
+|+||+||+|.+.+.+. ..++++.+..|+.|++.|+.||| ...|+|||||+.|||++.++.+||+|||+++..++
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999999654 46789999999999999999999 45999999999999999999999999999999886
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ......||+.|+.||.+.+.+|+.|+|||||||++|||++-+++|...+...... ++. .
T Consensus 159 ~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~---------------ki~-~ 220 (426)
T KOG0589|consen 159 EDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL---------------KIN-R 220 (426)
T ss_pred chh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH---------------HHh-h
Confidence 652 2256789999999999999999999999999999999999999998655444321 111 1
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
..-.+.+..++.++..++..|++.+|+.||++.+++..
T Consensus 221 ~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11234445678899999999999999999999999865
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=314.38 Aligned_cols=242 Identities=23% Similarity=0.259 Sum_probs=194.6
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
||+|+||.||+|....++ ..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++|||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQ---RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 799999999999976553 468999886432 23345678899999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeec
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 223 (350)
|+|.+++.....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........ ....
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 999999988888999999999999999999999 55999999999999999999999999999875432221 1234
Q ss_pred cccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHH
Q 046877 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 303 (350)
Q Consensus 224 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (350)
..|++.|+|||++.+..++.++||||+||++|+|++|..||......... .....+. ...+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-------~~~~~~~----------~~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-------RKILQEP----------LRFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH-------HHHHcCC----------CCCCCc
Confidence 46899999999999989999999999999999999999999754332211 1111111 111223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 304 CVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 304 ~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
.+..+.+++.+||..||.+||++..+.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 567899999999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=310.69 Aligned_cols=264 Identities=20% Similarity=0.240 Sum_probs=200.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+.+.+.||+|+||.||++..+.++ ..+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETK---EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCC---cEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 456788999999999999976553 458898876432 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||++++.+..+......+++..++.++.|++.|+.||| +.+++|+||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99999877766655567899999999999999999999 559999999999999999999999999999865432221
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH--------H-HhhcCCcc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------D-CYRNGKLD 289 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~-~~~~~~~~ 289 (350)
......++..|+|||++.+..++.++||||+||++|+|++|+.||......+......... . ........
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 -NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred -cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 1123457899999999988889999999999999999999999997654332211111000 0 00000011
Q ss_pred hhccccccC------CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 DLVEGDMEA------MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....+.... ......+..+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 110000000 001125678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=315.03 Aligned_cols=245 Identities=24% Similarity=0.304 Sum_probs=198.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||++....+...+..+|+|.+.... ......+.+|+.+++.++||||+++++.+..++..+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999876554556789999886432 12234578899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++++|.+++.....+.+..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--V 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--c
Confidence 999999999988888889999999999999999999 55999999999999999999999999999875432221 1
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||........ ...+..+.. ..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-------~~~~~~~~~----------~~ 219 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-------IDKILKGKL----------NL 219 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC----------CC
Confidence 1334689999999999988899999999999999999999999975443221 111111111 11
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
+...+..+.+++.+||+.||++|| +++++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 123457889999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=322.68 Aligned_cols=263 Identities=22% Similarity=0.355 Sum_probs=204.9
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeecccc-ccHHHHHHHHHHHhcCC-CCceeeecceeecCCe
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQN 133 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 133 (350)
...+.+.+.||+|+||.||+|.+.... .....||+|.+..... ...+.+.+|+++++.++ ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 445566789999999999999865332 2235689998864332 23457899999999995 9999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCC------------------------------------------------------------
Q 046877 134 RLLAYEFLNNGTLASFLFGN------------------------------------------------------------ 153 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~------------------------------------------------------------ 153 (350)
.+++|||+++|+|.+++..+
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999887532
Q ss_pred ------------------------------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 046877 154 ------------------------------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND 197 (350)
Q Consensus 154 ------------------------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~ 197 (350)
..+++..+..++.|+++|++||| +.+++|+||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 13566777899999999999999 559999999999999999
Q ss_pred CCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHH
Q 046877 198 RYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT 276 (350)
Q Consensus 198 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~ 276 (350)
++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--- 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--- 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH---
Confidence 99999999999986543322222223345678999999988889999999999999999997 88998643322111
Q ss_pred HHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 277 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
......+ .....+..++.++.+++.+||+.||++|||+.++.+.|+++.+
T Consensus 350 ---~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 ---YNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111111 1111223467889999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=316.95 Aligned_cols=252 Identities=19% Similarity=0.266 Sum_probs=203.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.++..++||||+++++++.+.+..+++
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTG---EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCC---CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 456688999999999999976654 458999886432 23345688899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.+++.....+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999999987788899999999999999999999 45999999999999999999999999999975543
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||......+... .+... .........
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-------~i~~~--~~~~~~~~~ 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-------NLKYW--KETLQRPVY 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH-------HHHhc--cccccCCCC
Confidence 1234568999999999998899999999999999999999999997654333211 00000 000110001
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
.......+.++.+++.+||..+|++||+++++++.
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11112457789999999999999999999999854
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=315.57 Aligned_cols=261 Identities=20% Similarity=0.329 Sum_probs=201.7
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
....|++.+.||+|+||.||++.+..++ ..+++|.+.... ......+.+|+++++.++||||+++++++.+.+..+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSG---LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCC---cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 3456677889999999999999876553 457888776432 233467899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++|||+++++|.+++.....+++..+..++.|++.|+.|||+ ..+++|+||||+||+++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999999877788999999999999999999995 247999999999999999999999999998755322
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc-------
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL------- 288 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------- 288 (350)
. .....++..|+|||++.+..++.++|+|||||++|+|++|+.||............. ....+..
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 229 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG----CPVEGDPAESETSP 229 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhc----CcccCCccccccCc
Confidence 1 123457889999999998889999999999999999999999997543322111000 0000000
Q ss_pred --------------------------chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 289 --------------------------DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 289 --------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
................+.++.+++.+||+.||++|||+.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell 297 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLM 297 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHh
Confidence 000000000000112456789999999999999999999996
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=312.03 Aligned_cols=244 Identities=24% Similarity=0.245 Sum_probs=199.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+++.+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISE---HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCC---CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 456788999999999999876553 468999886432 22345688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.+++.....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999999988888999999999999999999999 5599999999999999999999999999987654221
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
....|++.|+|||++.+..++.++|||||||++|+|++|..||......... ..+..+..
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~~--------- 215 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-------EKILAGKL--------- 215 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCc---------
Confidence 2345889999999999888999999999999999999999999754432211 11111111
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPT-----MRKVSQM 332 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~vl~~ 332 (350)
..+...+..+.+++.+||+.||.+||+ ++++++.
T Consensus 216 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111223568899999999999999995 8887643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=314.46 Aligned_cols=242 Identities=23% Similarity=0.251 Sum_probs=195.9
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
+.||+|+||.||++....+ +..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCC---CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 3689999999999987655 3568999886432 223456778999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccccee
Q 046877 142 NNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK 221 (350)
Q Consensus 142 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 221 (350)
++|+|..++.....+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........ ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 99999999988888999999999999999999999 55999999999999999999999999999875322111 11
Q ss_pred eccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 222 TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 222 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+...... ....+.. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-------~~~~~~~----------~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-------LILMEEI----------RFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH-------HHhcCCC----------CCC
Confidence 33468999999999998899999999999999999999999997544322111 1111110 011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
..++.++.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 23567899999999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=313.48 Aligned_cols=262 Identities=24% Similarity=0.373 Sum_probs=204.8
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcc-eeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTS-TTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~-~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
....++..+.||+|+||.||+|.+..++.. ...+++|.+.... .....++.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 344566678899999999999987654432 3458899886432 23456788999999999999999999998765 56
Q ss_pred EEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
+++++|+++|+|.+++... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 7999999999999998754 45788899999999999999999 5599999999999999999999999999998765
Q ss_pred cCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.............+..|+|||.+.+..++.++||||||+++|||++ |..||+.....+.. ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-------~~~~-------- 225 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILE-------- 225 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHh--------
Confidence 4332222122234668999999998899999999999999999998 99999754322211 1111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.....+.+..++.++.+++.+||..||++|||+.+++..|..+..
T Consensus 226 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 226 -KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 111111222355788999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=314.07 Aligned_cols=242 Identities=22% Similarity=0.260 Sum_probs=196.5
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
+.||+|+||.||++....++ ..+|+|.+.... ......+.+|+.+++.++||||+++.+++...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASG---KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 35899999999999876553 568999886432 233456788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccccee
Q 046877 142 NNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK 221 (350)
Q Consensus 142 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 221 (350)
++|+|.+++.....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........ ..
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 152 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM 152 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence 99999999987788999999999999999999999 55999999999999999999999999999875322111 11
Q ss_pred eccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 222 TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 222 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..... .....+. . ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-------~~~~~~~--------~--~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMED--------I--KFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-------HHhccCC--------c--cCC
Confidence 3346899999999999889999999999999999999999999754332211 0111111 0 111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
...+.++.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 23567899999999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=316.57 Aligned_cols=244 Identities=23% Similarity=0.288 Sum_probs=199.6
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..+.+.+.||+|+||.||+|....++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTG---EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCC---CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34567788999999999999976654 468999886432 223456889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++|||+.+++|.+++.....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999999988888899999999999999999999 559999999999999999999999999999865432
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
. ....|++.|+|||++.+..++.++|||||||++|+|++|..||........ ...+..+..
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~~------- 232 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-------YEKILAGRL------- 232 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcCCc-------
Confidence 2 234589999999999988899999999999999999999999975432211 111112211
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCC-----HHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPT-----MRKVS 330 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~vl 330 (350)
. .+..++..+.+++.+||+.||.+||+ +++++
T Consensus 233 -~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 233 -K--FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred -C--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1 11124567899999999999999997 57765
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=306.23 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=203.5
Q ss_pred hhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
...+.+.||+|+||.||++.... .......+++|.+..........+.+|+++++.++|+||+++++++......+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 34567889999999999997543 2234566888887766555567899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC---------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceE
Q 046877 138 YEFLNNGTLASFLFGN---------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNAR 202 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~k 202 (350)
|||+++++|.+++... ..+++..++.++.|++.|++||| +.+++|+||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEE
Confidence 9999999999998643 24688899999999999999999 55999999999999999999999
Q ss_pred EeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHH
Q 046877 203 ISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD 281 (350)
Q Consensus 203 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 281 (350)
|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.. .
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~ 235 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI-------E 235 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH-------H
Confidence 999999875543322222222334678999999988889999999999999999998 89998643332211 0
Q ss_pred HhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 282 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
....+ .....+..++..+.+++.+||+.||++||+++++.+.|++
T Consensus 236 ~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 01111 1111122456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=306.54 Aligned_cols=260 Identities=25% Similarity=0.440 Sum_probs=202.0
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
....+++.+.||+|+||.||+|..... ......+++|.+.... .....++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 445567788999999999999986532 2334669999875432 2234568899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCC----------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEE
Q 046877 134 RLLAYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI 203 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl 203 (350)
.+++|||+++++|.+++... ..+++..+..++.|+++|+.||| +.+++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998542 22467788899999999999999 459999999999999999999999
Q ss_pred eecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHH
Q 046877 204 SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 282 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 282 (350)
+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~-------~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL-------RF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HH
Confidence 99999876543322221122334678999999988889999999999999999999 68888654332211 11
Q ss_pred hhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
...+... ..+..++..+.+++.+||+.||++|||+.++++.|++
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111 1112356789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=318.06 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=221.8
Q ss_pred hhhhccCCCccceEEEEEEcCC-CcceeEEEEEeeec-cccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTT-TTSTTAVAVKKLDR-VFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~-~~~~~~vavk~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
...+.||.|-||.||+|.+.+- +.....||||..+. ...+..+.|..|..+++.++||||++++|+|.+. ..|+|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 4557799999999999988765 34456799998876 4455677899999999999999999999999875 7899999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
.++.|.|..|+..+ ..++......++.||+.||+||| +...|||||..+|||+.....+||+|||+++......++
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 99999999999754 56788888899999999999999 669999999999999999999999999999998877666
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ...-+.-|||||.+.-..++.+||||.||+++||++. |..||.+.. +.++...++.+.+
T Consensus 548 kaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk----------------NsDVI~~iEnGeR 610 (974)
T KOG4257|consen 548 KAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK----------------NSDVIGHIENGER 610 (974)
T ss_pred hcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc----------------ccceEEEecCCCC
Confidence 543 3334668999999998899999999999999999985 889997543 3344556778888
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.+.+.+||+.|+.++.+||..||.+||.+.++...|++++.
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 89999999999999999999999999999999999988765
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=314.96 Aligned_cols=263 Identities=27% Similarity=0.388 Sum_probs=203.8
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeec-CC
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDE-GQ 132 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~ 132 (350)
...+++.+.||+|+||.||+|....+. ..++.|++|++.... ......+.+|+.++..+ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 446778899999999999999754322 334679999886432 22345678899999999 89999999998754 46
Q ss_pred eeEEEEecCCCCChhhhhcCC-----------------------------------------------------------
Q 046877 133 NRLLAYEFLNNGTLASFLFGN----------------------------------------------------------- 153 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------------- 153 (350)
..+++|||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999988432
Q ss_pred --CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCcc
Q 046877 154 --LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231 (350)
Q Consensus 154 --~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 231 (350)
..+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25688889999999999999999 5599999999999999999999999999998654332222222334567899
Q ss_pred CcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHH
Q 046877 232 APEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLM 310 (350)
Q Consensus 232 aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 310 (350)
|||++.+..++.++|||||||++|+|++ |..||......+. ....+..+.. ...+...+.++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTR---------MRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCC---------CCCCccCCHHHHH
Confidence 9999999999999999999999999998 9999965332221 0111111111 1112234578999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 311 ISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 311 li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
++.+||+.+|++||++.++++.|++++.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=306.34 Aligned_cols=259 Identities=26% Similarity=0.381 Sum_probs=204.3
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
...+.+.+.||+|+||.||+|....+ ......+++|.+...... ..+.+.+|..+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 34567788999999999999987653 234567999998644322 235688999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 046877 135 LLAYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR 198 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~ 198 (350)
++++||+.+++|.+++... ..+++..+..++.|++.|++||| +.+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCC
Confidence 9999999999999998421 34677888999999999999999 5599999999999999999
Q ss_pred CceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHH
Q 046877 199 YNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD 277 (350)
Q Consensus 199 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~ 277 (350)
+.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----- 235 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV----- 235 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 9999999999876543332222223345678999999988889999999999999999998 8888865433221
Q ss_pred HHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 278 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
...+..+.. ...+..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 236 --~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 --IEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111112211 11223567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=302.95 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=201.5
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCe------
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN------ 133 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 133 (350)
.+.+.||+|+||.||+|....+......+++|.+.... ......+.+|+..++.++|||++++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 35678999999999999987665556779999886432 2234578999999999999999999998765544
Q ss_pred eEEEEecCCCCChhhhhcC------CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecc
Q 046877 134 RLLAYEFLNNGTLASFLFG------NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 207 (350)
.++++||+++++|..++.. ...+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 7899999999999988732 2357888999999999999999994 599999999999999999999999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcC
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG 286 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 286 (350)
++................++..|+|||.+.+..++.++||||||+++|||++ |..||........ ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~-------~~~~~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI-------YDYLRHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcC
Confidence 9986644332222122234668999999988889999999999999999999 8888864432221 1111111
Q ss_pred CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.. ...+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 232 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 112234567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=315.91 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=201.8
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
....+.+.+.||+|+||.||+|.+..+. ...+++|.+.... ......+.+|+.+++.++||||+++++++.+++.
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNED--FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCC--CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 3345667789999999999999865443 2468999876432 2334568889999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.+++|||+++|+|.+++.....+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999999988888999999999999999999999 5599999999999999999999999999997654
Q ss_pred cCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
... ....||+.|+|||++.+..++.++||||+||++|+|++|..||...+.... ...+..+..
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~i~~~~~----- 245 (340)
T PTZ00426 183 TRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQKILEGII----- 245 (340)
T ss_pred CCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHHHhcCCC-----
Confidence 221 234689999999999988899999999999999999999999975443211 111111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQM 332 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~~ 332 (350)
. .+...+..+.+++.+||+.||++|+ +++++++.
T Consensus 246 ---~--~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ---Y--FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---C--CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 1112456788999999999999995 88887653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=328.31 Aligned_cols=250 Identities=21% Similarity=0.266 Sum_probs=200.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
|.+.+.||+|+||.||+|....+. ...+++|............+.+|+.+++.++||||+++++++..++..+++|||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~--~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDP--KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCC--CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 667788999999999999865442 245777766544444455688899999999999999999999999999999999
Q ss_pred CCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 141 LNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 141 ~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+++|+|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999987743 346788899999999999999999 5599999999999999999999999999998765433
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.. .....+...
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~-------~~~~~~~~~------- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM-------QQVLYGKYD------- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC-------
Confidence 222234456899999999999889999999999999999999999999754332211 111111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..++.++.+++.+||..||++||++.+++.
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112235678999999999999999999998864
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=306.68 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=202.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCC-cceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTT-TSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
...++.+.||+|+||.||+|.....+ .....+++|.+..... .....+.+|+.+++.++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 34567788999999999999864332 3456789998864332 233578899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCC-----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 046877 137 AYEFLNNGTLASFLFGN-----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY 199 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~ 199 (350)
+|||+++++|.+++... ..+++.....++.|++.|+.|||+ .+++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 99999999999998422 236778889999999999999994 5999999999999999999
Q ss_pred ceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHH
Q 046877 200 NARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 278 (350)
Q Consensus 200 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~ 278 (350)
.+||+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~----- 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI----- 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence 999999999986644332222233345678999999988889999999999999999998 88898654322211
Q ss_pred HHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
+....... ...+..++.++.+++.+||+.||++||++.++.+.|..
T Consensus 237 --~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 --EMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 11222456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=300.14 Aligned_cols=253 Identities=30% Similarity=0.464 Sum_probs=202.5
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+.||+|+||.||+|.+.........+++|....... ...+++.+|+++++.++|||++++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998766654456799998865433 24567899999999999999999999876 4567999999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc-eee
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT-IKT 222 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~ 222 (350)
++|.+++.....+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++.......... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9999999877788999999999999999999994 589999999999999999999999999998664432211 111
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
...++..|+|||.+.+..++.++||||||+++|++++ |..||........ . ..+..+. ....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~----~~~~~~~---------~~~~~ 220 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---I----AMLESGE---------RLPRP 220 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---H----HHHHcCC---------cCCCC
Confidence 2223467999999988889999999999999999998 9999975443221 1 1111111 11222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
..++..+.+++.+||..+|++|||+.++++.|++..
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=306.22 Aligned_cols=249 Identities=24% Similarity=0.284 Sum_probs=197.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+...+.||+|+||.||++....++ ..+|+|.+.... ......+.+|+.+++.++|+|++++.+++.+.+..+++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCC---ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 345678999999999999876654 468999876432 22334678899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||+++|+|.+++.. ...+++..+..++.|++.|++||| +.+++||||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999999888753 345788999999999999999999 559999999999999999999999999999765322
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. .....|+..|+|||++.+..++.++||||+||++|+|++|+.||........... ........
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~--------- 220 (285)
T cd05631 156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKED--------- 220 (285)
T ss_pred Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhcc---------
Confidence 11 1334689999999999998999999999999999999999999976543221100 00000000
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPT-----MRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~vl~ 331 (350)
....+...+..+.+++.+||+.||++||+ ++++++
T Consensus 221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11112235678999999999999999997 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=317.50 Aligned_cols=241 Identities=24% Similarity=0.288 Sum_probs=203.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 135 (350)
...+.+.||+|.||+|+++..+.+++ .+|||.+++. ..+..+....|.+++... +||.+++++.+|++++++|
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e---~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNE---YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCc---EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 34567889999999999999887764 5777777653 356677888999998888 5999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+||||+.||++ .++.+...+++..++.++..++.||.|||++ +||+||||.+|||+|.+|.+||+|||+++..-..
T Consensus 446 fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 446 FVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99999999994 4445678999999999999999999999954 9999999999999999999999999999865322
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......||+.|+|||++.+..|+..+|.|||||+||||+.|..||.+++.++... .++.
T Consensus 522 g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd---------------sI~~-- 582 (694)
T KOG0694|consen 522 GD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD---------------SIVN-- 582 (694)
T ss_pred CC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHhc--
Confidence 22 2356889999999999999999999999999999999999999999877666432 1111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
.+...+..++.+..+++.++|.+||++|.-+
T Consensus 583 d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1223344577899999999999999999866
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=301.02 Aligned_cols=255 Identities=26% Similarity=0.431 Sum_probs=203.6
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
....+.+.+.||+|++|.||+|....+ ..+++|.+.... ...+++.+|+.+++.++|||++++++++...+..++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNT----TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCC----eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 344566778999999999999985433 458999886432 345678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 137 AYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
+|||+++++|.+++.... .+++..+..++.|++.|+.+||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999999986543 68899999999999999999994 5999999999999999999999999999987653
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.... .......+..|+|||.+.+..++.++||||||+++|+|+| |+.||......... .....+
T Consensus 156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~------- 220 (261)
T cd05068 156 DIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-------QQVDQG------- 220 (261)
T ss_pred Cccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcC-------
Confidence 2111 1111223457999999998889999999999999999999 99999654322211 111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 221 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 221 --YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11112224567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=303.18 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=200.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcc-eeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTS-TTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~-~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+++.+.||+|+||.||+|.+..++.. ...+++|....... ....++..|+..++.++||||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence 44567899999999999987655432 23477777754322 223567788889999999999999998754 4578899
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++|+|.+++.. ...+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 99999999999965 4567899999999999999999994 5899999999999999999999999999986644332
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
........++..|+|||.+.+..++.++||||||+++||+++ |..||......... ..+..+.
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~--------- 228 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-------DLLEKGE--------- 228 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCC---------
Confidence 222233446778999999988889999999999999999998 99999754332211 1111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
....+..++..+.+++.+||..||++|||+.++++.|..+..
T Consensus 229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111111245678899999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=299.17 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=196.5
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+.||+|+||.||+|....++ ..+++|...... .+....+.+|+++++.++||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADN---TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCC---ceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 46999999999999876543 468898765432 33456789999999999999999999999999999999999999
Q ss_pred CChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceee
Q 046877 144 GTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT 222 (350)
Q Consensus 144 g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 222 (350)
++|.+++... ..+++..++.++.|+++|+.||| +.+++|+||+|+||+++.++.+||+|||++.............
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999998654 45789999999999999999999 5599999999999999999999999999987543221111111
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
....+..|+|||.+.+..++.++||||||+++|+|++ |..||......... ..... ......+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-------~~~~~---------~~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-------EAIEQ---------GVRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-------HHHHc---------CCCCCCc
Confidence 1123456999999988889999999999999999998 88888643322211 11111 1111222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
..++..+.+++.+||+.+|++|||++++.+.|+.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 3456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=301.90 Aligned_cols=259 Identities=23% Similarity=0.442 Sum_probs=206.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+...+.||+|+||.||+|....+++....+++|.+.... ......+.+|+++++.++|||++++.+++...+..+++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 4455678999999999999987666555678999886542 233457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++++|.+++.. ...+++..+..++.|++.|++||| +.+++|+||||+||++++++.+|++|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 99999999999865 356889999999999999999999 45999999999999999999999999999876543322
Q ss_pred ccee-eccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 218 KTIK-TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 218 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.... .....+..|+|||.+.+..++.++||||||+++|++++ |..||......+. ...+..+
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~-------~~~i~~~--------- 226 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-------MKAINDG--------- 226 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-------HHHHhcC---------
Confidence 1111 11123457999999988889999999999999999997 9999965433221 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
...+....++..+.+++.+||+.+|++||++.++++.|++++
T Consensus 227 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111222245678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=299.17 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=198.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.+.||+|+||.||++..+.. ..+++|.+... .....++.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~----~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQ----IKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccC----ceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 345667899999999999986543 34888877533 3345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++|+|.+++.. ...+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.+|++|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999999864 3467899999999999999999994 59999999999999999999999999998765432211
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+.. ..+..+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~-------~~i~~~~~--------- 219 (256)
T cd05114 157 -SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-------EMISRGFR--------- 219 (256)
T ss_pred -ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCC---------
Confidence 1122234568999999988889999999999999999999 89999754432211 11111111
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
...+...+..+.+++.+||+.+|++|||++++++.|+
T Consensus 220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=314.60 Aligned_cols=277 Identities=22% Similarity=0.330 Sum_probs=201.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC-----Ce
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-----QN 133 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 133 (350)
|.+.+.||+|+||.||+|....++ ..|++|.+.... .....++.+|+.+++.++||||+++++++... ..
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCC---CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 456688999999999999876553 568999876432 22345688999999999999999999987543 34
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.+++|||+. ++|.+++.....+++..+..++.|+++||.||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 799999996 589999887788999999999999999999999 5599999999999999999999999999997543
Q ss_pred cCccc-ceeeccccCCCccCcccccC--CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHH--------HHHH
Q 046877 214 LNQRK-TIKTAIRGTKGYVAPEWFRK--STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW--------AFDC 282 (350)
Q Consensus 214 ~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~--------~~~~ 282 (350)
..... .......++..|+|||++.+ ..++.++|||||||++|+|+||+.||.............. ....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 22111 11134568999999999875 5789999999999999999999999975543221110000 0000
Q ss_pred hhcCCcchhcccc---ccCC---CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcccCCCCCCC
Q 046877 283 YRNGKLDDLVEGD---MEAM---NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVVEVDVPPN 344 (350)
Q Consensus 283 ~~~~~~~~~~~~~---~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~~~~~~~~ 344 (350)
+............ .... ...+.+..+.+++.+||+.||++|||++++++ .++++......+.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~ 304 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPS 304 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccc
Confidence 1111111111000 0000 00124567899999999999999999999984 3555544443333
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=300.85 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=206.7
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
...+.+.+.||.|+||.||+|.... ...+++|.+..........+.+|+.+++.++||||+++++++.+....+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3456778899999999999998765 245888888765554567899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||+++++|.+++... ..+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999999643 457899999999999999999995 58999999999999999999999999999765432
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+... ... .
T Consensus 158 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~-------~~~---------~ 219 (261)
T cd05148 158 VYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD-------QIT---------A 219 (261)
T ss_pred ccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-------HHH---------h
Confidence 211 123345678999999988889999999999999999998 899997544322111 111 1
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
......+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111222334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=306.54 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=205.5
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecCCe
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 133 (350)
...+++.+.||+|+||.||++...... .....+++|...... .....++.+|+.+++.+ +|+||+++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 334556678999999999999876543 344678999876432 22345688899999999 89999999999999999
Q ss_pred eEEEEecCCCCChhhhhcC----------------CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 046877 134 RLLAYEFLNNGTLASFLFG----------------NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND 197 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~----------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~ 197 (350)
.+++|||+++|+|..++.. ...+++..++.++.|++.|++|||+ .+++|+||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcC
Confidence 9999999999999999853 2457888999999999999999994 59999999999999999
Q ss_pred CCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHH
Q 046877 198 RYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT 276 (350)
Q Consensus 198 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~ 276 (350)
++.+||+|||++................++..|+|||.+.+..++.++|||||||++|++++ |..||......+..
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--- 244 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--- 244 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH---
Confidence 99999999999986654332222222334668999999988889999999999999999997 88998643322211
Q ss_pred HHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 277 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.....+. ....+..++..+.+++.+||..||++|||+.++++.|++++
T Consensus 245 ----~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 ----KLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----HHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111 11122245678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=314.80 Aligned_cols=242 Identities=24% Similarity=0.261 Sum_probs=196.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
+.||+|+||.||+++.......+..+++|.+..... .....+..|+.++++++||||+++++++.+++..+++|||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 569999999999998654444567799998865322 223457789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceee
Q 046877 143 NGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT 222 (350)
Q Consensus 143 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 222 (350)
+++|.+++.....+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........ ...
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAY 156 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--cee
Confidence 9999999987788999999999999999999999 55999999999999999999999999999876543221 113
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcH
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 302 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
...|+..|+|||.+.+..++.++|||||||++|+|++|+.||......... ..+..... ..+.
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-------~~i~~~~~----------~~p~ 219 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM-------TMILKAKL----------GMPQ 219 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH-------HHHHcCCC----------CCCC
Confidence 456899999999999888899999999999999999999999754432211 11111111 1112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHH
Q 046877 303 KCVEKLLMISIWCIQEDPSLRPTMRK 328 (350)
Q Consensus 303 ~~~~~l~~li~~cl~~dp~~Rps~~~ 328 (350)
..+..+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 34578899999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=301.18 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=203.1
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
..+.+.+.||+|+||.||+|..+.++ ..+++|..... ......+.+|++.++.++||||+++++++...+..+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~---~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCC---ceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 34556788999999999999876543 45888887643 333567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+++++|.+++... ..+++..++.++.|+++|++||| +.+++|+||||+||++++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999998643 45788899999999999999999 4599999999999999999999999999997654322
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. .......+..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. .....+
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~--------- 221 (263)
T cd05052 159 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKG--------- 221 (263)
T ss_pred ee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCC---------
Confidence 11 1112223567999999988889999999999999999998 89998754332211 111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.....+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112223567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=312.58 Aligned_cols=254 Identities=20% Similarity=0.224 Sum_probs=199.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 135 (350)
+++.+.||+|+||.||+++.......+..+|+|.+.... ....+.+..|+.+++.+ +||||+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 456788999999999999876555556789999886432 22345678899999999 6999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++|||+++|+|.+++.....+++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++......
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 99999999999999988888999999999999999999999 559999999999999999999999999999765332
Q ss_pred cccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.... .....||..|+|||++.+. .++.++|||||||++|+|+||..||........... ........
T Consensus 159 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---~~~~~~~~-------- 226 (332)
T cd05614 159 EKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE---VSRRILKC-------- 226 (332)
T ss_pred CCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH---HHHHHhcC--------
Confidence 2211 1234689999999999865 478899999999999999999999975433221110 00111000
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
....+...+..+.+++.+||+.||++|| +++++++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 --DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0111123457889999999999999999 6677764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=293.47 Aligned_cols=264 Identities=24% Similarity=0.305 Sum_probs=204.1
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCc-eeeecceeecCC----
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKN-LVRLLGFCDEGQ---- 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~---- 132 (350)
.+...+.||+|+||+||+|+.+.++ ..||+|++..... .......+|+.+++.++|+| |+.+++++...+
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g---~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTG---KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCC---CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 3445567999999999999987775 5699999975543 24566789999999999999 999999997776
Q ss_pred --eeEEEEecCCCCChhhhhcCCC----CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeec
Q 046877 133 --NRLLAYEFLNNGTLASFLFGNL----KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDF 206 (350)
Q Consensus 133 --~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 206 (350)
..++++||++. +|..++.... ..+...++.+++||+.|++||| +.+|+||||||.|++++++|.+||+||
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeecc
Confidence 78999999976 9999997554 4566789999999999999999 669999999999999999999999999
Q ss_pred ccccccccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 207 GLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 207 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
|+|+....... ..+..++|.+|+|||++.+. .|+...||||+||++.||++++..|.+..+.++....-........
T Consensus 165 GlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 165 GLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred chHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 99986653322 23556789999999999887 7999999999999999999999999877764433222112222222
Q ss_pred CCcchhc---cccc---cCCCc-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 286 GKLDDLV---EGDM---EAMND-------IKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 286 ~~~~~~~---~~~~---~~~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
..+.... +... ....+ .+......+++.+||+.+|.+|.|++.+++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 2222221 1110 00001 1112478899999999999999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=300.45 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=202.5
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
...+++.+.||+|+||.||+|....+ ..+++|.+... ....+.+.+|+.+++.++|+||+++++.+.+.+..+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNS----TKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCC----ceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 44566778999999999999986543 34888887543 23456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||+++++|.+++.. ...+++..+..++.|+++|++||| ..+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999999864 356788889999999999999999 459999999999999999999999999999865432
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ......++..|+|||.+.+..++.++||||||+++|+|+| |..||......... ..+..+
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~-------- 220 (261)
T cd05072 157 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM-------SALQRG-------- 220 (261)
T ss_pred cee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH-------HHHHcC--------
Confidence 211 1122335668999999988889999999999999999998 99999654332211 111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
...+....++.++.+++.+||..+|++|||++++.+.|+++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 221 -YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11111223567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=300.74 Aligned_cols=258 Identities=24% Similarity=0.427 Sum_probs=205.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+++.+.||+|+||.||+|....+++....+++|.+.... .....++..|+.+++.++||||+++++++.++...+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 3556788999999999999988776656679999886542 334567999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++++|.+++.. ...+++..++.++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999864 3567899999999999999999994 5999999999999999999999999999876543222
Q ss_pred cceeec-c--ccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 218 KTIKTA-I--RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 218 ~~~~~~-~--~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... . ..+..|+|||.+.+..++.++||||+|+++||+++ |..||......... ....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~-------~~i~--------- 225 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-------NAIE--------- 225 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH-------HHHH---------
Confidence 111111 1 12347999999998889999999999999999986 99999654322211 0010
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.....+.+..++..+.+++.+||+.+|++||+++++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111122234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=306.11 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=195.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
|.+.+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++||||+++++++.++...+++||
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTE---NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCC---CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 556788999999999999876553 468999876432 2234567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++ +|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 9986 888887644 44688899999999999999999 55999999999999999999999999999875432221
Q ss_pred ceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH-----Hhh----cCCc
Q 046877 219 TIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-----CYR----NGKL 288 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~-----~~~----~~~~ 288 (350)
......++..|+|||.+.+ ..++.++||||+||++|+|+||+.||......+.......... .+. ...+
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 1133457889999999875 4688999999999999999999999976543332111100000 000 0001
Q ss_pred chhccccccCCC----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDLVEGDMEAMN----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+...... ....+.++.+++.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111111110000 1124567899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=297.98 Aligned_cols=249 Identities=29% Similarity=0.422 Sum_probs=197.8
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
.||+|+||.||+|.+.... ....+++|.+.... ....+.+.+|+.+++.++||||+++++++.. +..+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK-SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCC-CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 5899999999999765332 34569999875432 2234678899999999999999999998754 567899999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce-ee
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI-KT 222 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~ 222 (350)
++|.+++.....+++..+..++.|++.|++||| +.+++|+||||+||++++++.+||+|||++........... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999987778899999999999999999999 45999999999999999999999999999986644322111 12
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
...++..|+|||.+....++.++|+||||+++|||++ |..||......+.. ..+..+. ....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~i~~~~---------~~~~~ 220 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-------QMIESGE---------RMECP 220 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHCCC---------CCCCC
Confidence 2233568999999988888999999999999999998 99999754332211 1111111 11122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
..++.++.+++.+||+.||++||++++|.+.|++
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2466789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=302.68 Aligned_cols=267 Identities=27% Similarity=0.380 Sum_probs=202.7
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC--CCCceeeecceeecCC----eeE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT--HHKNLVRLLGFCDEGQ----NRL 135 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~ 135 (350)
++.+.+|+|.||.||+|++.+ +.||||++. ......+++|..+.+.. +|+||+++++..+... ..+
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-----~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-----RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred hhHHHhhcCccceeehhhccC-----ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 456789999999999999876 359999975 34566799999988875 7999999999887666 789
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHED------CSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~------~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
+|++|.+.|+|.+|+. ....+|....+++..+++||+|||+. .+..|+|||||..||||.++++..|+|||+|
T Consensus 285 LVt~fh~kGsL~dyL~-~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK-ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EEeeeccCCcHHHHHH-hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999999994 56789999999999999999999963 3678999999999999999999999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCC-CCC-----CCCcchhHHHHHHHHHhCCCCCCc-ccchhhhhH-------
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-TIS-----AKVDVYSFGVLLLEIISCRKSFDI-EMGEEYAIL------- 275 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~-----~~~DiwslG~~l~~lltg~~pf~~-~~~~~~~~~------- 275 (350)
..+.+.....-....+||.+|||||++.+. ++. .+.||||+|.+||||++...-++. ..++-....
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 988765444444557899999999999754 222 369999999999999986654431 111000000
Q ss_pred ---HHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCC
Q 046877 276 ---TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDV 341 (350)
Q Consensus 276 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~ 341 (350)
.+...-..+...-..+.+.-..+ ..+.-+.+.+..||+.||+.|.|+.=+-+++.++.....
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 00000001111111111111111 345678999999999999999999999999988765554
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=302.68 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=205.0
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
....+.+.+.||+|+||.||+|...... .....+++|...... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3445667788999999999999876543 344679999876432 2334568899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCC----------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEE
Q 046877 134 RLLAYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI 203 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl 203 (350)
.+++|||+++++|.+++... ..+++..+..++.|++.|+.||| ..+++|+||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEE
Confidence 99999999999999998532 23577889999999999999999 559999999999999999999999
Q ss_pred eecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHH
Q 046877 204 SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 282 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 282 (350)
+|||++................++..|+|||.+.+..++.++||||||+++|+++| |..||......... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-------~~ 233 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL-------KF 233 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH-------HH
Confidence 99999876544332222233345778999999988889999999999999999998 89998654332211 11
Q ss_pred hhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
...+... ..+..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111 1122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=302.54 Aligned_cols=271 Identities=25% Similarity=0.356 Sum_probs=203.2
Q ss_pred hhhhccCCCccceEEEEEEcC-CCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecC--CeeEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQT-TTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--QNRLLA 137 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~-~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 137 (350)
.+.+.||+|+||.||++.... ....+..+++|.+..... .....+.+|+.+++.++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 566889999999999876542 223456789998865322 2356788999999999999999999987653 457899
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||||+||++++++.++|+|||++........
T Consensus 87 ~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999864 468999999999999999999995 5999999999999999999999999999986643222
Q ss_pred cc-eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 218 KT-IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 218 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. ......++..|+|||.+.+..++.++||||||+++|+|+||..||........... .............+......
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-cccccccchhhhhhhhhcCC
Confidence 11 11222345679999999888899999999999999999999999864332111000 00000000111112222222
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
....+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22233456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=315.17 Aligned_cols=266 Identities=23% Similarity=0.376 Sum_probs=205.4
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCC-CCceeeecceee
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTH-HKNLVRLLGFCD 129 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 129 (350)
.++......+.+.||+|+||.||+|.+... ......||+|.+..... .....+.+|++++..+. ||||+++++.+.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 345555566778999999999999987532 23346799999875422 22346889999999997 999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhhcCCC-------------------------------------------------------
Q 046877 130 EGQNRLLAYEFLNNGTLASFLFGNL------------------------------------------------------- 154 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 154 (350)
..+..+++|||+++|+|.+++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999985421
Q ss_pred -------------------------------------------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046877 155 -------------------------------------------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQ 191 (350)
Q Consensus 155 -------------------------------------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~ 191 (350)
.+++..++.++.|++.|++||| ..+++|+||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 2455667889999999999999 559999999999
Q ss_pred CeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccch
Q 046877 192 NILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGE 270 (350)
Q Consensus 192 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~ 270 (350)
||++++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999976532222111122345778999999988889999999999999999998 88898643322
Q ss_pred hhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 271 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
+.. ......+ .....+..++.++.+++.+||..+|++||+++++++.|++++
T Consensus 349 ~~~------~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQF------YNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHH------HHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 211 1111111 111122235678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=308.93 Aligned_cols=237 Identities=23% Similarity=0.359 Sum_probs=191.7
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|+.+.++ ..+|+|.+.... ......+..|..++..+ +||||+++++++...+..+++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESG---RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCC---CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 36899999999999976553 568999886432 23345667788888776 799999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++|+|.+++.....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 999999999988888999999999999999999999 55999999999999999999999999999875322211 1
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....|++.|+|||++.+..++.++||||+||++|+|++|+.||......... ..+..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-------~~i~~~~~----------~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF-------EAILNDEV----------VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-------HHHhcCCC----------CC
Confidence 23346899999999999888999999999999999999999999755432211 11111111 11
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
+...+.++.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11245788999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=297.07 Aligned_cols=251 Identities=31% Similarity=0.488 Sum_probs=205.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc-HHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG-EKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+.||+|+||.||+|...........+++|.+....... ...+.+|++.++.++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999987543335668999887544332 57889999999999999999999999999999999999999
Q ss_pred CChhhhhcCC---------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 144 GTLASFLFGN---------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 144 g~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|.+++... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765 77899999999999999999999 56999999999999999999999999999987655
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...........++..|+|||.+.+..++.++||||+|+++|+|++ |..||........ ......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~-------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------LEYLRK-------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHc--------
Confidence 432222234456889999999988889999999999999999999 6999976532221 111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
......+..++.++.+++.+||..+|++|||+.++++.|+
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111222345788999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=303.39 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=201.3
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCC-----------cceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeec
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTT-----------TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLL 125 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-----------~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~ 125 (350)
...+++.+.||+|+||.||++....+. .....+++|...... ......+.+|+++++.++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 445677789999999999998764321 223458899886432 23345789999999999999999999
Q ss_pred ceeecCCeeEEEEecCCCCChhhhhcCC------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046877 126 GFCDEGQNRLLAYEFLNNGTLASFLFGN------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNI 193 (350)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni 193 (350)
+++...+..+++|||+++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 9999999999999999999999988532 13577888999999999999999 55999999999999
Q ss_pred EEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh--CCCCCCcccchh
Q 046877 194 LLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS--CRKSFDIEMGEE 271 (350)
Q Consensus 194 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~pf~~~~~~~ 271 (350)
++++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ +..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999976543322222222334678999999988889999999999999999998 667776543322
Q ss_pred hhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
.... ............. ...+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 241 ~~~~---~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIEN---TGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHH---HHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1110 0111111000000 11111246789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=304.57 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=202.0
Q ss_pred hhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
++.+.||+|+||.||+|...... .....+++|.+..... ....++.+|+.+++.++||||+++++.+...+..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45678999999999999865422 2235688887754322 23457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC------------------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 046877 139 EFLNNGTLASFLFGN------------------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNIL 194 (350)
Q Consensus 139 e~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil 194 (350)
||+.+++|.+++... ..+++..++.++.|++.|+.||| ..+++|+||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEE
Confidence 999999999987532 24678888999999999999999 459999999999999
Q ss_pred EcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhh
Q 046877 195 LNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 273 (350)
Q Consensus 195 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~ 273 (350)
+++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|+| |..||.........
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999976543322111122335678999999988889999999999999999998 99999654322211
Q ss_pred hHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 274 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
..... ......+..++.++.+++.+||+.+|++||++.++++.|++++.
T Consensus 240 -------~~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 240 -------NLLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -------HHHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111 11112223456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=303.47 Aligned_cols=265 Identities=25% Similarity=0.389 Sum_probs=204.9
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCc-------------ceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeee
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTT-------------STTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRL 124 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~-------------~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~ 124 (350)
..+++.+.||+|+||.||+|.+..... ....+++|.+.... ......+.+|+++++.++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 345677899999999999998765432 23568899876432 2345678899999999999999999
Q ss_pred cceeecCCeeEEEEecCCCCChhhhhcCCC-----------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046877 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNL-----------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNI 193 (350)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni 193 (350)
++++..++..+++|||+++++|.+++.... .+++..++.++.|++.|++||| +.+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence 999999999999999999999999986554 6789999999999999999999 45999999999999
Q ss_pred EEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh--CCCCCCcccchh
Q 046877 194 LLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS--CRKSFDIEMGEE 271 (350)
Q Consensus 194 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~pf~~~~~~~ 271 (350)
+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ +..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999876543332222233445778999999988889999999999999999998 677876433222
Q ss_pred hhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
. .......+....... ....+..++.++.+++.+||+.||++|||+.++++.|++
T Consensus 242 ~---~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 V---IENAGHFFRDDGRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred H---HHHHHhccccccccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 111111111111110 111122356789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=289.59 Aligned_cols=261 Identities=20% Similarity=0.216 Sum_probs=201.0
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc--HHHHHHHHHHHhcCCCCceeeecceeec--CCeeEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--EKEFKNEVIVIGQTHHKNLVRLLGFCDE--GQNRLLA 137 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 137 (350)
+....|++|+||.||+|+++.+ ...||+|+++...... .-.-.+|+.+|.+.+|||||.+..+... -+.+|+|
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t---~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKT---DEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHhhcccCcceeEEEeccCCc---ceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 3445699999999999996655 4679999987532111 1235789999999999999999988744 4679999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||||+. +|..++... .++...+++.++.|+++|++||| ...|+||||||+|+|+++.|.+||+|||+|+.++...
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999988 899988655 48899999999999999999999 5599999999999999999999999999999887653
Q ss_pred ccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc--
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-- 293 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 293 (350)
. ..+..+-|.+|+|||.+.+. .|+++.|+||+||++.|++++++.|.+....++....-.......+..+..+..
T Consensus 232 k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 K--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 2 23566789999999999876 699999999999999999999999987765554332221112111222222211
Q ss_pred ------------ccccCCCcH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 ------------GDMEAMNDI-KCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ------------~~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..++..... ..++.-++++...|..||.+|.|+++.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 111111111 14577889999999999999999999874
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=305.18 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=205.5
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecC
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG 131 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 131 (350)
+....+.+.+.||+|+||.||++..... ......+++|.+.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3444566778999999999999975422 2334568999876432 22345688999999999 799999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
+..+++|||+++++|.+++.... .+++.++..++.|++.|++||| +.+++|+||||+||+++.++.++++|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999986432 3789999999999999999999 459999999999999999999999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
................++..|+|||.+.+..++.++||||+|+++|+|++ |..||......+.. ......+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~------~~~~~~~-- 260 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKLIKEG-- 260 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH------HHHHHcC--
Confidence 76543322222223345678999999988889999999999999999998 99998654332211 1111111
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.....+...+.++.+++.+||..+|++|||+.++++.|+++
T Consensus 261 -------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 -------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111123457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=306.55 Aligned_cols=267 Identities=25% Similarity=0.400 Sum_probs=208.7
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcC----CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeeccee
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQT----TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFC 128 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 128 (350)
++....+.+.+.||+|+||.||+|+... +......+++|...... ......+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 3445566677899999999999997532 23344578999876432 23346789999999999 899999999999
Q ss_pred ecCCeeEEEEecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046877 129 DEGQNRLLAYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQN 192 (350)
Q Consensus 129 ~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N 192 (350)
......+++|||+++++|.+++... ..+++..+..++.|+++|+.||| +.+++|+||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccce
Confidence 9999999999999999999998643 24567788999999999999999 4599999999999
Q ss_pred eEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchh
Q 046877 193 ILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 271 (350)
Q Consensus 193 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~ 271 (350)
|++++++.+||+|||++................++..|+|||++.+..++.++||||||+++|++++ |..||......+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 9999999999999999986654332222223345678999999988889999999999999999998 788886433222
Q ss_pred hhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
. ......+. ....+..++..+.+++.+||+.+|++|||+.++++.|+++....
T Consensus 248 ~-------~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 L-------FKLLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred H-------HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 1 11111111 11112346678999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=343.01 Aligned_cols=260 Identities=26% Similarity=0.512 Sum_probs=204.1
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCC
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
..+.||+|+||.||+|....++ ..||+|.+..... ...+|++.+++++||||+++++++.+....++||||++
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNG---MQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred cccEEccCCCeeEEEEEECCCC---cEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 3457999999999999875543 5689998764322 12346888999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceee
Q 046877 143 NGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT 222 (350)
Q Consensus 143 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 222 (350)
+|+|.+++. .+++..+.+++.|+++|++|||+.++.+++|||+||+||+++.++..++. ||........ .
T Consensus 767 ~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~ 836 (968)
T PLN00113 767 GKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------T 836 (968)
T ss_pred CCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------C
Confidence 999999995 47899999999999999999997667799999999999999998888775 5554432211 2
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC--CC
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA--MN 300 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 300 (350)
...++..|+|||++.+..++.++|||||||++|||+||+.||+...+.. .....|..............++.... ..
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 2357889999999998899999999999999999999999996443322 22344444433333333334433322 23
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
..+...++.+++.+||+.||++|||++++++.|+++....
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 4466778999999999999999999999999999886643
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=287.04 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=205.4
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeee--ccccccHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
....+++.+.||+|.|+.|+++.+..++. .+++|+++ +......+.+.+|+++-+.++||||+++.+...+....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~---~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchH---HHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 34456677899999999999998766543 46777664 23344677899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCceEEeecccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN---DRYNARISDFGLAKL 211 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~ 211 (350)
|+|+|+++|++|..-+..+..+++..+...++||++++.|+| .++|+|||+||+|+++. ...-+||+|||++..
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999999877766666788888999999999999999 55999999999999994 344599999999998
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
++. ...-....|||+|+|||++...+|+.++|||+.|++||-|+.|++||.+.+.... ++.+..+..
T Consensus 163 l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl-------ye~I~~g~y--- 229 (355)
T KOG0033|consen 163 VND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YEQIKAGAY--- 229 (355)
T ss_pred eCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH-------HHHHhcccc---
Confidence 872 2223567899999999999999999999999999999999999999976543332 222223222
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....+...+.+++..+++.+||..||.+|.|+.|.+.
T Consensus 230 ---d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 ---DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1222233456789999999999999999999998763
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=287.19 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=201.4
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc----ccH----HHHHHHHHHHhcC-CCCceeeecceeecCCe
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ----DGE----KEFKNEVIVIGQT-HHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~----~~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 133 (350)
-.+.||.|..+.|.++.++.+++ ..++|++..... ... +.-..|+.+|+++ .||+|+++.++++....
T Consensus 21 pkeilgrgvss~vrRci~k~t~~---e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGK---EFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hHHHhcccchhhhhhhhhccccc---ceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 34679999999999999877754 477777753221 112 2345688999998 89999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.++|+|.|+.|.|.|++...-.+++...+++++|+.+|++||| ..+|+||||||+|||++++.++||+|||+++...
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999999999999999999999999999999 5599999999999999999999999999999887
Q ss_pred cCcccceeeccccCCCccCccccc------CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFR------KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
+.... +...||++|+|||.+. ...|+..+|+||+|+++|-|+.|.+||-....- .....+..|+
T Consensus 175 ~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-------lMLR~ImeGk 244 (411)
T KOG0599|consen 175 PGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-------LMLRMIMEGK 244 (411)
T ss_pred CchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-------HHHHHHHhcc
Confidence 65443 4567999999999884 335888999999999999999999999532211 1222233333
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. ...+...+.++...++|.+||+.||.+|.|++|++.
T Consensus 245 yq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 245 YQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 22 122334567889999999999999999999999884
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=313.89 Aligned_cols=258 Identities=20% Similarity=0.228 Sum_probs=194.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.|.+.+.||+|+||.||++....++ ..||+|... ...+.+|+++++.++||||+++++++..+...++++|
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~---~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTC---EHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCC---CEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 4566788999999999999876554 458998643 2356789999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
++. ++|..++.....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........ .
T Consensus 164 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~ 238 (391)
T PHA03212 164 RYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N 238 (391)
T ss_pred cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence 986 588888877778899999999999999999999 55999999999999999999999999999965432211 1
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhh----hHHHHHHHHhhc----------
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA----ILTDWAFDCYRN---------- 285 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~----~~~~~~~~~~~~---------- 285 (350)
......||+.|+|||++.+..++.++||||+||++|+|++|..||......... ............
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 113456899999999999889999999999999999999999887543221100 000000000000
Q ss_pred CCcchhc---------ccccc--CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 286 GKLDDLV---------EGDME--AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 286 ~~~~~~~---------~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....... .+..+ .......+.++.+++.+||+.||++|||++++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000 0011245678999999999999999999999983
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=311.08 Aligned_cols=243 Identities=21% Similarity=0.245 Sum_probs=195.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
+.||+|+||.||++....+ +..+++|.+.... ......+.+|+++++.++||||+++.+++...+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCC---CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 3689999999999987655 3568999886532 223456778999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccccee
Q 046877 142 NNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK 221 (350)
Q Consensus 142 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 221 (350)
++|+|..++.....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||++........ ..
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TM 153 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cc
Confidence 999999999877889999999999999999999994 15899999999999999999999999999874322211 11
Q ss_pred eccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 222 TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 222 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
....|+..|+|||++.+..++.++|||||||++|+|+||..||.......... ....+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~-------~i~~~~~----------~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------LILMEEI----------RFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH-------HHhcCCC----------CCC
Confidence 23458999999999998899999999999999999999999997544322111 1111110 011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
...+.++.+++.+||+.||++|+ ++.++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 23457889999999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=306.35 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=201.7
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-ccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 136 (350)
..+++.+.||+|+||.||+|.++.++. ...+++|..... .......+.+|+.++.++ +||||+++++++...+..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCc-eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 345677889999999999999765432 234577766532 233445788999999999 89999999999999999999
Q ss_pred EEecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 046877 137 AYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN 200 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~ 200 (350)
+|||+++++|.+++... ..+++..++.++.|++.|++||| +.+++||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 99999999999998643 24678889999999999999999 559999999999999999999
Q ss_pred eEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHH
Q 046877 201 ARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 279 (350)
Q Consensus 201 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 279 (350)
+||+|||++........ ......+..|+|||.+.+..++.++||||||+++|+|+| |..||......+..
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------ 233 (303)
T cd05088 163 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------ 233 (303)
T ss_pred EEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH------
Confidence 99999999863321111 111223567999999988888999999999999999998 99999644332211
Q ss_pred HHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCC
Q 046877 280 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDV 341 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~ 341 (350)
.....+ .....+..++..+.+++.+||+.+|++||+++++++.|+++.+...
T Consensus 234 -~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 234 -EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred -HHHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 111111 1111122356788999999999999999999999999988765544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=296.24 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=202.4
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+.||+|++|.||+|.+.........+++|.+..... ...+.+.+|+..++.++||||+++++.+.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999876544455689999876554 456789999999999999999999999988 889999999999
Q ss_pred CChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc-ce
Q 046877 144 GTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK-TI 220 (350)
Q Consensus 144 g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~ 220 (350)
++|.+++.... .+++..++.++.|+++|++||| +.+++|+||+|+||+++.++.+||+|||++......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999986653 6789999999999999999999 559999999999999999999999999999876543221 11
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... ..... ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~------~~~~~---------~~~~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK------IDKEG---------ERLE 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHhcC---------CcCC
Confidence 123346778999999988889999999999999999998 9999965443321110 00000 1111
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
.+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12235678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=305.81 Aligned_cols=241 Identities=27% Similarity=0.329 Sum_probs=192.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhc-CCCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQ-THHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|....++ ..+|+|.+.... .........|..++.. ++||||+++++++.+.+..+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTN---QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 36999999999999976553 458999886532 2334456667777775 4999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++|+|.+++.....+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence 999999999987778899999999999999999999 55999999999999999999999999999875322211 1
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....||..|+|||++.+..++.++||||+||++|+|++|..||......+.. .....+. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-------~~i~~~~----------~~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF-------QSIRMDN----------PCY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC----------CCC
Confidence 13346899999999999889999999999999999999999999754432211 1111110 001
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMR-KVS 330 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~-~vl 330 (350)
+...+.++.+++.+||+.||++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 112456789999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=300.60 Aligned_cols=257 Identities=28% Similarity=0.378 Sum_probs=199.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+.+.+.||+|+||.||+|.+.... .....+++|...... ......+.+|+.+++.++|+||+++++++.+....++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 4556688999999999999876521 134568888875433 2234568899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC-------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---ceEEeec
Q 046877 137 AYEFLNNGTLASFLFGNL-------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY---NARISDF 206 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~Df 206 (350)
+|||+++++|.+++.... .+++..+..++.|++.|++|||+ .+++|+||||+||+++.++ .+||+||
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999986442 47888999999999999999994 5899999999999998654 5999999
Q ss_pred ccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 207 GLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 207 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
|++.................+..|+|||++.+..++.++|||||||++|+|++ |..||.......... ....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~-------~~~~ 236 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-------FVTG 236 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHc
Confidence 99986533222111112223567999999988889999999999999999997 999997544332111 1111
Q ss_pred CCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
......+..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus 237 ---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 237 ---------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred ---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11111223456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=309.48 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=191.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+++.+.||+|+||.||+|.+..++ +.|++|.+..... .....+.+|+++++.++|+||+++++++...+..+++||
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTG---RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCC---CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 345678999999999999876553 4689998854322 234578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++++|.+.. ..++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||++........
T Consensus 153 ~~~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 153 FMDGGSLEGTH----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred cCCCCcccccc----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 99999986543 3466778899999999999999 45999999999999999999999999999976543211
Q ss_pred eeeccccCCCccCcccccC-----CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 220 IKTAIRGTKGYVAPEWFRK-----STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
......|+..|+|||.+.. ...+.++|||||||++|+|++|+.||......+...... . .. .
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~-~~---------~ 290 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---A-IC---------M 290 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---H-Hh---------c
Confidence 1123468999999998743 234568999999999999999999997433222111100 0 00 0
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
.........++.++.+++.+||+.||++|||+.++++.
T Consensus 291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111223456789999999999999999999999864
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=306.18 Aligned_cols=265 Identities=26% Similarity=0.389 Sum_probs=205.7
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcCCC----cceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeeccee
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTT----TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFC 128 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 128 (350)
++....+.+.+.||+|+||.||++...... .....+++|.+.... .....++.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 334456778899999999999999864322 233568999886432 23345688899999999 799999999999
Q ss_pred ecCCeeEEEEecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046877 129 DEGQNRLLAYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQN 192 (350)
Q Consensus 129 ~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N 192 (350)
...+..+++|||+++++|.+++... ..+++..+++++.|++.|++||| ..+++|+||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHh
Confidence 9999999999999999999999643 23678889999999999999999 4599999999999
Q ss_pred eEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchh
Q 046877 193 ILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 271 (350)
Q Consensus 193 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~ 271 (350)
|+++.++.+||+|||.+................++..|+|||.+.+..++.++||||+|+++|+|++ |..||......+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999999876543222111122234568999999988889999999999999999998 888886433221
Q ss_pred hhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.. .....+. ....+..++.++.+++.+||..+|++|||+.++++.|+++.+
T Consensus 251 ~~-------~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 251 LF-------KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HH-------HHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11 1111111 111222456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=305.69 Aligned_cols=241 Identities=25% Similarity=0.306 Sum_probs=191.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhc-CCCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQ-THHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|....++ ..||+|.+.... ......+..|..++.. .+||||+++++++..++..+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTN---EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 35999999999999976653 458999886432 2223445556666665 4899999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++|+|.+++.....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ..
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 9999999999877889999999999999999999994 599999999999999999999999999997543222 11
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....||..|+|||.+.+..++.++|||||||++|+|++|..||...+..... ..+... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~----------~~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-------DSILND----------RPHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcC----------CCCC
Confidence 23446899999999999888999999999999999999999999765432211 111110 0111
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMR-KVS 330 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~-~vl 330 (350)
+..++.++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223456889999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=297.34 Aligned_cols=258 Identities=22% Similarity=0.411 Sum_probs=205.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.+.+.||+|+||.||+|....+++....+++|.+.... ......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 4456788999999999999877665555678899876432 223457899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++++|||++........
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999998654 46788999999999999999999 45999999999999999999999999999986643322
Q ss_pred ccee-eccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 218 KTIK-TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 218 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+.. ..+..+
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~-------~~~~~~--------- 225 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-------KAIEEG--------- 225 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH-------HHHhCC---------
Confidence 1111 11223567999999998889999999999999999886 99999654332211 111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
...+....++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11122234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=300.76 Aligned_cols=263 Identities=23% Similarity=0.365 Sum_probs=206.5
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCC-cceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeec-CCe
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTT-TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE-GQN 133 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 133 (350)
....+.+.+.||+|+||.||+|.+..+. .....+++|.+.... ......+.+|+.+++.++|||++++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3455667788999999999999976532 234668888875432 3335668899999999999999999998755 567
Q ss_pred eEEEEecCCCCChhhhhcCC--------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEee
Q 046877 134 RLLAYEFLNNGTLASFLFGN--------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISD 205 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D 205 (350)
.+++++|+++++|.+++... ..+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+|++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998543 457889999999999999999994 5999999999999999999999999
Q ss_pred cccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhh
Q 046877 206 FGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 206 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
||+++...............++..|+|||.+.+..++.++||||||+++|++++ |+.||......+. . ..+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~----~~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---A----AYLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---H----HHHH
Confidence 999986544332222223345678999999988889999999999999999999 9999975433221 1 1111
Q ss_pred cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.+ ........+++.+.+++.+||..||++|||+.++++.|+.+.+
T Consensus 234 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 1111222356789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=295.95 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=198.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.+.||+|+||.||++..... ..+++|.+... ......+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~----~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCC----CcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 345678899999999999976543 24889987643 2335678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+.+++|.+++... ..+++..++.++.|++.|++||| ..+++|+||+|+||++++++.+||+|||.+.........
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999998653 46799999999999999999999 459999999999999999999999999998765432211
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||......... .....+...
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~~-------- 220 (256)
T cd05113 157 -SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV-------EKVSQGLRL-------- 220 (256)
T ss_pred -ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHhcCCCC--------
Confidence 1122335668999999988889999999999999999998 99998644432211 111111111
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111124578999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=295.22 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=198.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
...+.+.||+|+||.||++.+... ..+++|.+... ......+.+|+.+++.++||||+++++++...+..+++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~----~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGK----IDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCC----ccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 345678899999999999986432 34788887543 2234578889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|.+++.. ...+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999999864 3467899999999999999999994 58999999999999999999999999998765432211
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
......++..|+|||.+.+..++.++|+||||+++|++++ |..||......+.. .....+ ..
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~---------~~ 219 (256)
T cd05059 157 -SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-------ESVSAG---------YR 219 (256)
T ss_pred -ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-------HHHHcC---------Cc
Confidence 1111223457999999998889999999999999999999 89999754332211 111111 11
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
...+..++.++.+++.+||..+|++|||+.++++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1112235778999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.71 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=202.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcc-eeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTS-TTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~-~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
...++.+.||+|+||.||+|.+..++.. ...|++|...... ......+.+|..+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 3445678899999999999987655432 2347889876432 33356788999999999999999999998754 5679
Q ss_pred EEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 137 AYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+++|+++|+|.+++... ..+++..++.++.|++.|++||| +.+++|+||||+||++++++.+||+|||++......
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999753 56899999999999999999999 559999999999999999999999999999866433
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..........++..|+|||.+.+..++.++||||||+++|||++ |..||......... ..+..+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~-------- 227 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-------DLLEKG-------- 227 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCC--------
Confidence 22111122234668999999988889999999999999999998 88998643322211 111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
.....+..++..+.+++.+||..||++||++.++++.|+++...
T Consensus 228 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 228 -ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred -CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11111224567899999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=306.94 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=191.3
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||++....++ ..+|+|.+.... ......+..|..++..+ +||||+++++++...+..+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTE---RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 36999999999999976654 468899886532 22334577888888776 899999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++|+|..++.....+++..++.++.|++.|+.||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~ 152 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 152 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence 999999999887888999999999999999999999 45999999999999999999999999999875322111 1
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchh--hhhHHHHHHHHhhcCCcchhccccccC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ......+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 133568999999999999999999999999999999999999996322111 11111111111111111
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
..+...+..+.+++.+||+.||++||++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1122345788999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=307.40 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=194.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||++....++ ..+|+|.+.... ......+..|..++..+ +||||+++++++.+.+..+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTR---RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 35899999999999976654 468999886532 22334578899999888 799999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++|+|.+++.....+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T 152 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence 999999999987788999999999999999999999 55999999999999999999999999999864321111 1
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchh--hhhHHHHHHHHhhcCCcchhccccccC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.....|+..|+|||++.+..++.++|+||+||++|+|++|+.||+...... ......+......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~- 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------IR- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------CC-
Confidence 134568999999999999899999999999999999999999997432211 1111111112111111 11
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCC------HHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPT------MRKVS 330 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps------~~~vl 330 (350)
.+..++.++.+++.+||+.||.+||| +++++
T Consensus 224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 11234578899999999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=306.85 Aligned_cols=242 Identities=22% Similarity=0.338 Sum_probs=194.7
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|+...++ ..+|+|.+.... ......+..|.+++..+ +||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTD---EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCC---CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 35999999999999876553 468999886432 23344567788888866 899999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++++|..++.....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 999999999988888999999999999999999999 45999999999999999999999999999875432221 1
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....|+..|+|||++.+..++.++||||+||++|+|++|+.||......... ..+..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-------~~i~~~~~----------~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF-------ESILHDDV----------LY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCC----------CC
Confidence 23456899999999999889999999999999999999999999765433211 11111111 01
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRP-------TMRKVSQ 331 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rp-------s~~~vl~ 331 (350)
+..++.++.+++.+||+.||++|| +++++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 112457889999999999999999 7777763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=302.62 Aligned_cols=274 Identities=24% Similarity=0.374 Sum_probs=201.5
Q ss_pred hhhhhhccCCCccceEEEEEEcC-CCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeec--CCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQT-TTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE--GQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 136 (350)
.+++.+.||+|+||.||++.... ....+..+++|.+..........+.+|+++++.++|||++++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 34567889999999999998642 223456799999876555556788999999999999999999997643 356889
Q ss_pred EEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 137 AYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+|||+++++|.+++... ..+++..+..++.|++.|++|||+ .+++|+||||+||++++++.++|+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999998653 467899999999999999999994 59999999999999999999999999999866433
Q ss_pred cccc-eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKT-IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.... ......++..|+|||.+.+..++.++||||||+++|||++|..|+.......................+.+....
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 2211 111122344699999998888999999999999999999988775422111000000000000000000011111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.........++..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 112222334567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=297.34 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=197.5
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCC-----eeEEEE
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ-----NRLLAY 138 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~ 138 (350)
.+.+|+|+||.||+|....+ ...+|||+.-.... --.+|+++|+.++||||+++..+|.... ...+||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~---~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRET---EEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred eEEEeecccceEEEEEEcCC---CceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 46799999999999998776 34699998743221 2346899999999999999998874332 234899
Q ss_pred ecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEeecccccccc
Q 046877 139 EFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR-YNARISDFGLAKLLT 213 (350)
Q Consensus 139 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 213 (350)
||++. +|..++++ +..++...++-+.+||.+|++||| +.+|+||||||.|+|+|.+ |.+||||||.|+..-
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 89888863 577788888899999999999999 5699999999999999965 899999999999876
Q ss_pred cCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH-----HHhhcCC
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----DCYRNGK 287 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-----~~~~~~~ 287 (350)
..... ..+..+..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+.++.++....-... +.+...+
T Consensus 178 ~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 178 KGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred cCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 54433 334568899999998875 79999999999999999999999998876655432211111 1111111
Q ss_pred -------cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH--HHHhcccCC
Q 046877 288 -------LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS--QMLQEVVEV 339 (350)
Q Consensus 288 -------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl--~~L~~~~~~ 339 (350)
..++.............+.++.+++.++|+.+|.+|.++.+++ ..++++.+.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1111111111112334678999999999999999999999998 456666544
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=306.76 Aligned_cols=241 Identities=25% Similarity=0.292 Sum_probs=193.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCC-CceeeecceeecCCeeEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHH-KNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~l 136 (350)
+.+.+.||+|+||.||+|....++ ..+|+|.+.... ....+.+..|..++..++| ++|+++++++.+.+..++
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTD---ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 456788999999999999876553 468999886432 2334567788999998865 568889999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+++|+|.+++.....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999999988788899999999999999999999 4599999999999999999999999999986432211
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. ......|+..|+|||++.+..++.++||||+||++|+|+||+.||......+.. ..+....
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-------~~i~~~~--------- 217 (324)
T cd05587 156 K--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------QSIMEHN--------- 217 (324)
T ss_pred C--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCC---------
Confidence 1 123456899999999999989999999999999999999999999754432211 1111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
...+...+.++.+++.+||..||.+|++.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01112345788999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=300.45 Aligned_cols=265 Identities=23% Similarity=0.360 Sum_probs=201.2
Q ss_pred HhhhhhhccCCCccceEEEEEEcC-------------CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeee
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQT-------------TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRL 124 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~-------------~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~ 124 (350)
..+++.+.||+|+||.||++.... .......+++|...... .....++.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 446777889999999999986442 22234568999886432 2334678999999999999999999
Q ss_pred cceeecCCeeEEEEecCCCCChhhhhcCCC-----------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046877 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNL-----------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNI 193 (350)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni 193 (350)
++++...+..+++|||+++++|.+++.... .+++..+..++.|++.|++|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 999999999999999999999999986432 35567899999999999999994 5999999999999
Q ss_pred EEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh--CCCCCCcccchh
Q 046877 194 LLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS--CRKSFDIEMGEE 271 (350)
Q Consensus 194 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~pf~~~~~~~ 271 (350)
+++.++.++|+|||++.................+..|+|||...+..++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999876543322221122234568999999888889999999999999999998 778886443322
Q ss_pred hhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
... .....+....... ..+.+..++..+.+++.+||+.||++|||+.++++.|++
T Consensus 242 ~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIE---NTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHH---HHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111 0111111110000 111122356789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=301.56 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=202.3
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
....+.+.+.||+|+||.||+|..++ +......+++|.+.... ......+.+|+..++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34556777899999999999997653 23334678999875432 2223457889999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCC----------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEE
Q 046877 134 RLLAYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI 203 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl 203 (350)
.+++|||+++|+|.+++... ...++..+..++.|++.|+.||| +.+++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999532 23356678899999999999999 559999999999999999999999
Q ss_pred eecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHH
Q 046877 204 SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 282 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 282 (350)
+|||++................++..|+|||.+.+..++.++|+|||||++|||++ |..||......+.. ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~-------~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL-------KF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HH
Confidence 99999875543222221122234678999999988889999999999999999998 78888654332211 11
Q ss_pred hhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
...+... ..+..++..+.+++.+||+.||++|||+.++++.|++..
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111111 111234578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=296.96 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=201.5
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
...+++.+.||+|+||.||+|....++ ..+++|............+.+|+.+++.++||||+++++++..++..+++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~---~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTG---ELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCC---eEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 345667789999999999999875553 56899988655444556788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.+++.....+++..+..++.|++.|+.||| +.+++|+|++|+||+++.++.++|+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999999999977778899999999999999999999 45999999999999999999999999999986543221
Q ss_pred cceeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
......++..|+|||.+. ...++.++|+||+|+++|+|++|+.||.......... ...... ...
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~---~~~- 228 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN---FQP- 228 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC---CCC-
Confidence 112345788999999884 3457889999999999999999999986433211100 000000 000
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
.........+..+.+++.+||..+|++|||++++++.|
T Consensus 229 -~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 -PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01111223567899999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=313.29 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=197.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||+|....++ ..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTH---ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 445678999999999999876653 569999986532 22345688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++|+|.+++.....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999999988788899999999999999999999 55999999999999999999999999999753311000
Q ss_pred ---------------------------------------------cceeeccccCCCccCcccccCCCCCCCCcchhHHH
Q 046877 218 ---------------------------------------------KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGV 252 (350)
Q Consensus 218 ---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 252 (350)
........||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012346899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHh--ccCCCCCCCCCHHHHH
Q 046877 253 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIW--CIQEDPSLRPTMRKVS 330 (350)
Q Consensus 253 ~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dp~~Rps~~~vl 330 (350)
++|||+||..||......+... ..... ......+.....+.++.+++.+ |+..+|..||++++++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~------~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL------KVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH------HHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999997654332211 00000 0011111122346788888887 5566777799999998
Q ss_pred H
Q 046877 331 Q 331 (350)
Q Consensus 331 ~ 331 (350)
.
T Consensus 304 ~ 304 (381)
T cd05626 304 A 304 (381)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=295.47 Aligned_cols=255 Identities=21% Similarity=0.359 Sum_probs=202.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++|||++++++++.+.+..+++
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDR---KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCC---CEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 456788999999999999876554 458888765322 23345688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 138 YEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 138 ~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
+||+++++|.+++. ....+++..+..++.|++.|+.||| ..+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999998874 2345788899999999999999999 5599999999999999999999999999987654
Q ss_pred cCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
..... .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......... . .......
T Consensus 158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~-~----~~~~~~~------ 224 (267)
T cd08228 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL-C----QKIEQCD------ 224 (267)
T ss_pred chhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH-H----HHHhcCC------
Confidence 32211 123357889999999988889999999999999999999999986433221111 0 1111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.........+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 225 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11112234567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=304.80 Aligned_cols=241 Identities=25% Similarity=0.307 Sum_probs=191.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|....++ ..+|+|.+.... .........|..++... +||||+++++++.+.+..+++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKG---EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 36999999999999977654 468999886432 22344566677777654 899999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++|+|..++.....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++....... ..
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999999999987788899999999999999999999 5599999999999999999999999999986432211 11
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....|+..|+|||++.+..++.++||||+||++|+|++|..||......... +.+..+. . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~-------~~~~~~~--------~--~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF-------ESIRVDT--------P--HY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC--------C--CC
Confidence 23456899999999999989999999999999999999999999754432211 1111110 0 01
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMR-KVS 330 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~-~vl 330 (350)
+...+.++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 112456889999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=313.65 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=202.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||+|....++ ..+|+|.+.... ......+.+|+.++..++||||+++++.+.+++..++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTG---QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCC---CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 456688999999999999976553 568999886432 23445688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc-
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ- 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 216 (350)
|||+++++|.+++.....+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999987788999999999999999999999 5699999999999999999999999999997654332
Q ss_pred --------------------------ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccch
Q 046877 217 --------------------------RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGE 270 (350)
Q Consensus 217 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~ 270 (350)
.........||+.|+|||.+.+..++.++|||||||++|+|++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001123346899999999999999999999999999999999999999765532
Q ss_pred hhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 046877 271 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT-MRKVSQM 332 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~vl~~ 332 (350)
... ..+... . .....+....++.++.+++.+||. ||.+||+ ++++++.
T Consensus 237 ~~~-------~~i~~~--~----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETY-------NKIINW--K----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH-------HHHhcc--C----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211 001110 0 111111111256789999999998 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=297.20 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=196.3
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceeecC------Cee
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG------QNR 134 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~ 134 (350)
+.+.||+|+||.||+|.+..+.. ...+++|.+... .......+.+|+.+++.++||||+++++++... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~-~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDS-ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cccccCcccCceEEEeEEccCCC-eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45789999999999998765533 345788877543 233356788999999999999999999976432 246
Q ss_pred EEEEecCCCCChhhhhc------CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 135 LLAYEFLNNGTLASFLF------GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
+++|||+++|+|.+++. ....+++.....++.|++.|++|||+ .+++|+||||+||++++++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998873 12346888999999999999999995 5999999999999999999999999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
+................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCC
Confidence 987643322111122235678999999998889999999999999999999 788986533221 111122221
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.. .....++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 11223567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=313.77 Aligned_cols=251 Identities=21% Similarity=0.263 Sum_probs=198.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+++.+.||+|+||.||+|+...++ ..+|+|.+.... ......+.+|+.++..++||||+++++++.+++..+++
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTG---HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 456688999999999999976654 468999986432 22345678899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++|+|.+++.....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999999988888999999999999999999999 55999999999999999999999999999875432110
Q ss_pred cc------------------------------------eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCC
Q 046877 218 KT------------------------------------IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCR 261 (350)
Q Consensus 218 ~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~ 261 (350)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 001235899999999999889999999999999999999999
Q ss_pred CCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 046877 262 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT---MRKVSQ 331 (350)
Q Consensus 262 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~vl~ 331 (350)
.||......+.. ..+.... .....+.....++.+.+++.+|+. +|.+|++ ++++++
T Consensus 237 ~Pf~~~~~~~~~-------~~i~~~~------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQETY-------RKIINWK------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHHHH-------HHHHcCC------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999755432211 0011100 011111112346788999999997 9999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=303.19 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=203.6
Q ss_pred HHhhhhhhccCCCccceEEEEEEcC----CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecC
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQT----TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG 131 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 131 (350)
...+.+.+.||+|+||.||+++... .......+++|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 3455677889999999999997642 22334568888876432 23345688999999999 699999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 046877 132 QNRLLAYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL 195 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill 195 (350)
+..+++|||+++|+|.+++... ..+++..+..++.|++.|+.||| ..+++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 9999999999999999998543 24678888999999999999999 4599999999999999
Q ss_pred cCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhh
Q 046877 196 NDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI 274 (350)
Q Consensus 196 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~ 274 (350)
++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~- 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF- 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 9999999999999976543322211122223467999999988889999999999999999999 88888644322211
Q ss_pred HHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 275 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.....+. ....+..++.++.+++.+||..+|++|||+.++++.|+++..
T Consensus 247 ------~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 247 ------KLLREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ------HHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111111 111123456789999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=305.29 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=195.0
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|....++ ..+|+|.+.... ......+..|..++..+ +||||+++++++.+.+..+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTD---ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 36999999999999876553 458999886432 23345567788888877 799999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++++|.+++.....+++..+..++.|++.||.||| +.+++|+||||+||++++++.+||+|||++........ .
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T 152 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence 999999999987788999999999999999999999 55999999999999999999999999999864322211 1
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....++..|+|||++.+..++.++||||+||++|+|++|+.||......... ..+..... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-------~~i~~~~~----------~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-------QSILEDEV----------RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-------HHHHcCCC----------CC
Confidence 12345889999999999999999999999999999999999999754432211 11111111 11
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTM-----RKVSQ 331 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~-----~~vl~ 331 (350)
+...+..+.+++.+||+.||++|||+ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 12356789999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=303.99 Aligned_cols=261 Identities=20% Similarity=0.260 Sum_probs=193.1
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+++.+.||+|+||.||+|....++ ..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....+++|
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNG---KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCC---CEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3556788999999999999976543 4689998864322 23346788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+.+ +|.+++.. ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 83 EYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred ECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 99965 77777654 356788899999999999999999 55999999999999999999999999999875432211
Q ss_pred cceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC---c-----
Q 046877 218 KTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---L----- 288 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~----- 288 (350)
......++..|+|||++.+ ..++.++||||+||++|+|++|..||....+..... . .......... +
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 159 --TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL-E-RIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred --cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-H-HHHHHhCCCChhhccchhh
Confidence 1133457889999999865 457889999999999999999999997543321110 0 0000000000 0
Q ss_pred -chhccccccCCC---------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 -DDLVEGDMEAMN---------DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 -~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
............ ....+..+.+++.+||+.||.+|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000 0113457889999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=290.56 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=210.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
...++.+.||+|.-|+||+++.+.+. ..+|+|.+++... +...+.+.|..+|+.++||.+.++++.++.....|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~---~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTN---CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCC---ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 33456678999999999999987764 6799999986543 34467888999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 136 LAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
++||||+||+|..+++++ ..++++.++.++..++.||+||| -.|||+|||||+||||.++|++-|+||.++....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999988654 67899999999999999999999 5699999999999999999999999999876442
Q ss_pred cC-------c------------------------c-c----------------------ceeeccccCCCccCcccccCC
Q 046877 214 LN-------Q------------------------R-K----------------------TIKTAIRGTKGYVAPEWFRKS 239 (350)
Q Consensus 214 ~~-------~------------------------~-~----------------------~~~~~~~~~~~y~aPE~~~~~ 239 (350)
.. . . . .....++||-.|+|||++.++
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 10 0 0 0 001134689999999999999
Q ss_pred CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCC
Q 046877 240 TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQED 319 (350)
Q Consensus 240 ~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 319 (350)
..+.++|.|+||+++|||+.|..||.+.+..+.. ..++.+....+...+.+..+.+||++.|.+|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 9999999999999999999999999887765543 3344455555555577889999999999999
Q ss_pred CCCCCC----HHHHH
Q 046877 320 PSLRPT----MRKVS 330 (350)
Q Consensus 320 p~~Rps----~~~vl 330 (350)
|++|.- +.||.
T Consensus 376 P~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIK 390 (459)
T ss_pred hhhhhccccchHHhh
Confidence 999998 77765
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=306.08 Aligned_cols=268 Identities=27% Similarity=0.391 Sum_probs=207.7
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCCC----cceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecce
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTT----TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGF 127 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 127 (350)
+++...++.+.+.||+|+||.||+|...... .....+++|...... .....++.+|+.+++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 4455566778899999999999999764322 223468899876432 22346788999999999 89999999999
Q ss_pred eecCCeeEEEEecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046877 128 CDEGQNRLLAYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQ 191 (350)
Q Consensus 128 ~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~ 191 (350)
+...+..++++||+++|+|.+++... ..+++..+..++.|++.|++||| +.+++|+||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence 99999999999999999999998642 23577888999999999999999 559999999999
Q ss_pred CeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccch
Q 046877 192 NILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGE 270 (350)
Q Consensus 192 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~ 270 (350)
||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999876543222211122234567999999998889999999999999999998 88888654322
Q ss_pred hhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 271 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
+.. ..+..+. ....+..++..+.+++.+||+.+|++|||+.++++.|+++....
T Consensus 244 ~~~-------~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 ELF-------KLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHH-------HHHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 211 1111111 11112245678999999999999999999999999999887443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=293.53 Aligned_cols=257 Identities=21% Similarity=0.346 Sum_probs=203.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+.+.+.||+|+||.||++....++ ..+++|.+.... .....++.+|+.+++.++||||+++++++.+.+..++
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDG---VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCC---ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 3556788999999999999875553 458888765422 2234578899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 137 AYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
+|||+++++|.+++.. ...+++..++.++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999999998752 355788999999999999999999 559999999999999999999999999998765
Q ss_pred ccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......... .......
T Consensus 157 ~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~------ 223 (267)
T cd08229 157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-----CKKIEQC------ 223 (267)
T ss_pred ccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH-----hhhhhcC------
Confidence 432211 123457889999999988889999999999999999999999996433221110 0111111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
..........+..+.+++.+||..||++|||+.++++.++++.
T Consensus 224 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 --DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111122346788999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.60 Aligned_cols=259 Identities=26% Similarity=0.421 Sum_probs=201.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+.+.+.||+|+||.||+|..+.++.. ..+++|.+.... ....+.+.+|+.++.++ +||||+++++++.+.+..++++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLK-MNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCc-ceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 45678899999999999987665432 235677665322 23345788999999999 7999999999999999999999
Q ss_pred ecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceE
Q 046877 139 EFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNAR 202 (350)
Q Consensus 139 e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~k 202 (350)
||+++++|.+++... ..+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 999999999998643 246788899999999999999994 5999999999999999999999
Q ss_pred EeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHH
Q 046877 203 ISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD 281 (350)
Q Consensus 203 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 281 (350)
|+|||++........ ......+..|+|||.+.+..++.++||||||+++|+|++ |..||......... .
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-------~ 229 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-------E 229 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------H
Confidence 999999864321111 111123457999999988889999999999999999997 99999654432211 1
Q ss_pred HhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCC
Q 046877 282 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~ 342 (350)
.... ......+..++..+.+++.+||+.+|.+|||++++++.|+++.....+
T Consensus 230 ~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 230 KLPQ---------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111 111112224567899999999999999999999999999988754443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.10 Aligned_cols=273 Identities=25% Similarity=0.382 Sum_probs=207.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCC-CcceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeec--CCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTT-TTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDE--GQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 135 (350)
.+.+.+.||+|+||.||++.+... ...+..+++|.+...... ....+.+|++.++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 345668899999999999987643 334567999988755433 46689999999999999999999999877 56789
Q ss_pred EEEecCCCCChhhhhcCCC-CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+++++|.+++.... .+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999996543 58999999999999999999994 5999999999999999999999999999987653
Q ss_pred Cccc-ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 215 NQRK-TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 215 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.... .......++..|+|||.+.+..++.++||||||+++|+|+||..|+.............. ........+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA-QGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc-cccccHHHHHHHHH
Confidence 3221 111223345679999999888899999999999999999999999864332211100000 00000000111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.......+..++.++.+++.+||+.+|++|||+.+++++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1222222334668899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.50 Aligned_cols=238 Identities=26% Similarity=0.298 Sum_probs=188.9
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHH-HHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVI-VIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|....++ ..+++|.+.... .....++..|.. +++.++||||+++++.+.+.+..+++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADG---KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 36899999999999976553 569999886432 122234445544 56788999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++|+|..++.....+++..+..++.|+++||.||| +.+++||||||+||+++.++.+||+|||++....... ..
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999999999988888999999999999999999999 4599999999999999999999999999987532221 11
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+. ...+..+. .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~--------~~--~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-------YDNILNKP--------LR--L 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-------HHHHHcCC--------CC--C
Confidence 2344689999999999988999999999999999999999999975432221 11111111 11 1
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMR 327 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~ 327 (350)
..+.+..+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112467899999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=321.16 Aligned_cols=250 Identities=24% Similarity=0.292 Sum_probs=198.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCC-----
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ----- 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 132 (350)
.|.+.+.||+|+||+||+|....++ ..+|+|.+.... ......+.+|+..+..++|+|++++...+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDG---EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCC---CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 5667788999999999999876553 569999886432 333456888999999999999999988764332
Q ss_pred ---eeEEEEecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEee
Q 046877 133 ---NRLLAYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISD 205 (350)
Q Consensus 133 ---~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D 205 (350)
..+++|||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 36799999999999998853 346788899999999999999999 55999999999999999999999999
Q ss_pred cccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 206 FGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 206 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
||++................||+.|+|||++.+..++.++||||||+++|+|++|+.||......+.. .....
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~-------~~~~~ 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM-------HKTLA 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHhc
Confidence 99998665432222234456899999999999889999999999999999999999999754332211 11111
Q ss_pred CCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+.. ...+..++.++.+++.+||+.||.+||++.+++.
T Consensus 260 ~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 260 GRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 111 1112245678999999999999999999999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.63 Aligned_cols=253 Identities=22% Similarity=0.262 Sum_probs=195.2
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+++.+.||+|+||.||++....++ ..+|+|.+.... ......+.+|+.++..++||||+++++.+.+....+++
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTG---HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCC---CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 455678999999999999876553 568999886532 22335678899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++|+|.+++.....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999999988888999999999999999999999 55999999999999999999999999999875432110
Q ss_pred c---------------------------------ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCC
Q 046877 218 K---------------------------------TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264 (350)
Q Consensus 218 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf 264 (350)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012346899999999999889999999999999999999999999
Q ss_pred CcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccC--CCCCCCCCHHHHHHH
Q 046877 265 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQ--EDPSLRPTMRKVSQM 332 (350)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~Rps~~~vl~~ 332 (350)
......+.. ..+..... ....+.....++++.+++.+++. .++..||+++++++-
T Consensus 237 ~~~~~~~~~-------~~i~~~~~------~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQETY-------KKVMNWKE------TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHH-------HHHHcCcC------cccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 754432211 11111100 00111111245677778877443 344456899999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.27 Aligned_cols=267 Identities=25% Similarity=0.369 Sum_probs=203.8
Q ss_pred HHhhhhhhccCCCccceEEEEEEcC-CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecC--Ce
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQT-TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--QN 133 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 133 (350)
+.++...+.||+|+||.||++.+.. ....+..+++|.+.... ......+.+|+.+++.++|||++++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4556777889999999999998643 23345679999886443 23346789999999999999999999998765 56
Q ss_pred eEEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
.+++|||+++++|.+++... ..+++..+..++.|++.|++|||+ .+++|+||||+||++++++.++|+|||++...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 88999999999999998654 457899999999999999999994 59999999999999999999999999999866
Q ss_pred ccCccc-ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhh--------hhHHHHHHHHh
Q 046877 213 TLNQRK-TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--------AILTDWAFDCY 283 (350)
Q Consensus 213 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~--------~~~~~~~~~~~ 283 (350)
...... .......++..|+|||.+.+..++.++||||||+++|+|+|++.|+........ ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 433221 111234466789999999888899999999999999999998776532211100 00000001111
Q ss_pred hcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
..+ .....+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 240 ~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111 11112234678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=293.65 Aligned_cols=255 Identities=24% Similarity=0.471 Sum_probs=195.3
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceee-cCCeeEEEEecCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCD-EGQNRLLAYEFLN 142 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 142 (350)
+.||+|+||.||+|...+.......+++|.+.... ....+.+.+|+.+++.++|||++++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999976655556779999875432 233567888999999999999999999765 4556789999999
Q ss_pred CCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc--
Q 046877 143 NGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT-- 219 (350)
Q Consensus 143 ~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 219 (350)
+++|.+++... ...++..+..++.|+++|+.|||+ .+++|+||||+||++++++.+||+|||++..........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999998653 345677788999999999999994 599999999999999999999999999987543221111
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhC-CCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
......++..|+|||.+.+..++.++||||||+++|||++| .+||....... .. .....+. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~----~~~~~~~---------~~ 221 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---IT----VYLLQGR---------RL 221 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHhcCC---------CC
Confidence 11123356789999999888899999999999999999995 45554332211 11 1111111 11
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
..+..++..+.+++.+||..+|++||++.++++.|+++..
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 1122345789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=306.87 Aligned_cols=265 Identities=26% Similarity=0.372 Sum_probs=201.6
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeec-
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDE- 130 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~- 130 (350)
.....+.+.+.||+|+||.||+|.... ....++.+|+|.+.... ......+.+|+.++..+ +||||+++++++..
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 344567788999999999999998543 22345679999986432 22345688999999999 78999999998754
Q ss_pred CCeeEEEEecCCCCChhhhhcCC---------------------------------------------------------
Q 046877 131 GQNRLLAYEFLNNGTLASFLFGN--------------------------------------------------------- 153 (350)
Q Consensus 131 ~~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------- 153 (350)
+...+++|||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45678999999999999988532
Q ss_pred ----------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeec
Q 046877 154 ----------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223 (350)
Q Consensus 154 ----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 223 (350)
..+++..+..++.|+++|++||| +.+++||||||+||+++.++.+||+|||++..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12567778889999999999999 55999999999999999999999999999976533222111122
Q ss_pred cccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcH
Q 046877 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 302 (350)
Q Consensus 224 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ......+... ..+.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~~~~---------~~~~ 305 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRM---------RAPD 305 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH------HHHHhccCCC---------CCCC
Confidence 335668999999988889999999999999999997 88998643322111 1111111111 1111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 303 KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 303 ~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
..+.++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 234678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=313.23 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=194.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+...+.||+|+||.||+|....++ ..+|+|.+.... ......+.+|+.+++.++||||+++++.+.+++..++|
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTK---ALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCC---CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 345678999999999999876553 568999886432 22345688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++|+|.+++.+...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999999987778899999999999999999999 55999999999999999999999999999753210000
Q ss_pred ---------------------------------------------cceeeccccCCCccCcccccCCCCCCCCcchhHHH
Q 046877 218 ---------------------------------------------KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGV 252 (350)
Q Consensus 218 ---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 252 (350)
........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011235899999999999889999999999999
Q ss_pred HHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCC---HHHH
Q 046877 253 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT---MRKV 329 (350)
Q Consensus 253 ~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~v 329 (350)
++|||++|..||......+... .. ... ......+.....++++.+++.+++ .+|.+|++ ++++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~------~i-~~~------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQM------KV-INW------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHH------HH-Hcc------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 9999999999997654322110 00 000 011111122234567888888876 49999997 7776
Q ss_pred HH
Q 046877 330 SQ 331 (350)
Q Consensus 330 l~ 331 (350)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 53
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=306.17 Aligned_cols=241 Identities=25% Similarity=0.282 Sum_probs=190.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHH-HHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEV-IVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|+...++ ..+++|.+.... ......+..|. .+++.++||||+++++++.+.+..+++|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEE---KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 36999999999999876553 468999886432 12223344444 456788999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++++|.+++.....+.+..+..++.|+++||.||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 999999999987788889999999999999999999 55999999999999999999999999999875432221 1
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....|++.|+|||++.+..++.++||||+||++|+|++|..||......+.. ..+.... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-------~~i~~~~--------~--~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-------DNILNKP--------L--QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH-------HHHHhCC--------c--CC
Confidence 23456899999999999989999999999999999999999999754432211 1111111 1 11
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
..+.+..+.+++.+||+.||.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 123467889999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=276.30 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=204.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.++.+.||+|-||.||.|+.+.+ .-.||+|.+.+.. .....++.+|+.+-+.|+||||++++++|.+...+|++
T Consensus 24 feigr~LgkgkFG~vYlarekks---~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKS---LFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred ccccccccCCccccEeEeeeccC---CcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 34678999999999999997655 4679999886532 34457899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhc--CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+||..+|+|...++ ...++++.....+..|++.|+.|+| .++|+||||||+|+|++..+.+|++|||-+...+..
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 99999999999998 6678999999999999999999999 669999999999999999999999999999755422
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
. .....||.-|.|||...+..++..+|+|++|++.||++.|.+||+.....+. +..+..-
T Consensus 178 -k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-------YkrI~k~--------- 237 (281)
T KOG0580|consen 178 -K---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-------YKRIRKV--------- 237 (281)
T ss_pred -C---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-------HHHHHHc---------
Confidence 2 2345689999999999999999999999999999999999999986553221 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+...+...+....++|.+|+..+|.+|.+..++++
T Consensus 238 -~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 -DLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -cccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 11112345678999999999999999999998864
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=299.62 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=201.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..+++.+.||+|+||.||+|..... +.....+++|.+.... ......+.+|+.+++.++|||++++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 4456678899999999999986531 2335678999876432 233466889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCC----------------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046877 136 LAYEFLNNGTLASFLFGN----------------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNI 193 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~----------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni 193 (350)
++|||+++++|.+++... ..+++..++.++.|++.|++|||+ .+++|+||+|+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhhe
Confidence 999999999999998532 235677889999999999999994 5999999999999
Q ss_pred EEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhh
Q 046877 194 LLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 272 (350)
Q Consensus 194 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~ 272 (350)
++++++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876543322211122234567999999988889999999999999999998 8888864433221
Q ss_pred hhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 273 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
...+..+... ..+..++.++.+++.+||+.+|++|||+.++++.|++
T Consensus 242 -------~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 242 -------IYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111222211 1122356789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=292.60 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=199.0
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
...+++.+.||+|+||.||+|..... ..+++|.+.... ...+.+.+|+.+++.++|+|++++++++. ....+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~----~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGN----TKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCC----ceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 34567788999999999999976533 348888876432 24567899999999999999999999875 4568999
Q ss_pred EecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||+++++|.+++... ..+++..+..++.|++.|++|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999998643 457889999999999999999995 48999999999999999999999999999765432
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ..+..+
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-------~~~~~~-------- 219 (260)
T cd05070 156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL-------EQVERG-------- 219 (260)
T ss_pred ccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcC--------
Confidence 211 1122234568999999988889999999999999999999 88899654332211 111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
.....+...+..+.+++.+||..+|++|||+.++.+.|++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 -YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=293.53 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=200.2
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
..+.+.+.||+|+||.||+|....+ ..+++|.+... ....+++.+|+.+++.++||||+++++++.+ ...+++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~----~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC----ceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 4567788999999999999986543 23889988643 2345678999999999999999999998754 5679999
Q ss_pred ecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+++++|.+++... ..+++..+..++.|+++|++||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999643 45788999999999999999999 4599999999999999999999999999997654332
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......++..|+|||...+..++.++||||||+++|+|+| |..||......... .....+
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-------~~~~~~--------- 219 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERG--------- 219 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-------HHHhcC---------
Confidence 21 1122345678999999988889999999999999999999 88888654322211 111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
........++..+.+++.+||+.||++|||+.++++.|++..
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 111122346778999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=294.73 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=195.4
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEecCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
+.||+|+||.||+|....++. ...+++|...... ......+.+|+.++.++ +||||+++++++...+..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCC-eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 358999999999999866543 2346777765432 33456788999999999 89999999999999999999999999
Q ss_pred CCChhhhhcCCC----------------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeec
Q 046877 143 NGTLASFLFGNL----------------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDF 206 (350)
Q Consensus 143 ~g~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 206 (350)
+++|.+++.... .+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 999999986432 36788899999999999999994 59999999999999999999999999
Q ss_pred ccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 207 GLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 207 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
|++....... .......+..|+|||++.+..++.++||||||+++|+|++ |..||......+.. .....
T Consensus 157 gl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-------~~~~~ 226 (270)
T cd05047 157 GLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------EKLPQ 226 (270)
T ss_pred CCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-------HHHhC
Confidence 9985322111 1111223567999999988889999999999999999997 99999643322110 11111
Q ss_pred CCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
+ .....+..++..+.+++.+||..||.+|||+.+++..|++++
T Consensus 227 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1 111112235578999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=303.66 Aligned_cols=244 Identities=23% Similarity=0.290 Sum_probs=192.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|....++ ..+|+|.+.... ....+.+.+|..++..+ +||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKND---QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 36999999999999876653 468999886532 22345578899988888 799999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++|+|..++.....+++..++.++.|++.|++||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T 152 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence 999999999887788999999999999999999999 55999999999999999999999999999875322111 1
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||....................... .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~--~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------IR--I 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------CC--C
Confidence 1345689999999999998999999999999999999999999975433222111111111111111 11 1
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
+...+..+.+++.+||..||.+|+++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 22345778999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=295.56 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=205.4
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
...+.+.+.||+|+||.||+|...........+++|...... ....+.+.+|+.+++.++|||++++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 344566788999999999999876553344568888876543 3345678999999999999999999998875 45789
Q ss_pred EEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 137 AYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+|||+++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999654 35789999999999999999999 459999999999999999999999999998765433
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.... .....++..|+|||.+....++.++||||||+++|++++ |..||......+.. ..+..+.
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-------~~~~~~~------- 225 (270)
T cd05056 161 SYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-------GRIENGE------- 225 (270)
T ss_pred ccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHcCC-------
Confidence 2111 122234568999999988889999999999999999996 99999755432211 1111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
....+..++..+.+++.+||..+|++|||+.++++.|+++...
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1112234567899999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=296.78 Aligned_cols=249 Identities=24% Similarity=0.284 Sum_probs=196.8
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
++..+.||+|+||.||++....+ +..+|+|.+..... .....+.+|+.+++.++||||+++++.+..++..+++
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCC---CceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 45567899999999999987654 35699998864321 2234577899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||+++|+|.+++... ..+++..+..++.|++.|+.||| +.+++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999999887543 45889999999999999999999 459999999999999999999999999998765322
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. .....++..|+|||++.+..++.++||||+|+++|+|++|..||........... ....+...
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~---~~~~~~~~--------- 220 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE---VERRVKED--------- 220 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH---HHHHhhhc---------
Confidence 21 1234578999999999888899999999999999999999999975433221100 00111100
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
....+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 -QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1111224567899999999999999999 8888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=293.01 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=190.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+.||+|+||.||+|....+ .....+++|.+..... .....+.+|+.+++.++||||+++++++.+....+++|||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCC-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 3599999999999987543 2345688888764432 2335788899999999999999999999999999999999999
Q ss_pred CChhhhhcCC-----CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 144 GTLASFLFGN-----LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 144 g~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+|.+++... ...++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999998642 23466777889999999999999 559999999999999999999999999998754433222
Q ss_pred ceeeccccCCCccCcccccCC-------CCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 219 TIKTAIRGTKGYVAPEWFRKS-------TISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
.......++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+.... .. .+....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~------~~-~~~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY------TV-REQQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH------Hh-hcccCC
Confidence 222234467789999998642 35789999999999999996 9999965433221110 00 011111
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
...+.. ....+..+.+++..|| .+|++|||+++++..|+
T Consensus 230 ~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 1123467888999999 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=303.96 Aligned_cols=244 Identities=23% Similarity=0.275 Sum_probs=192.1
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHH---hcCCCCceeeecceeecCCeeE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVI---GQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
.+.+.||+|+||.||+|....++ ..+++|.+.... ....+.+.+|.+++ +.++||||+++++++...+..+
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTG---ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 45678999999999999876553 568999886432 22334566666554 5668999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+||||+++++|..++. ...+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 79 lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999998885 457899999999999999999999 559999999999999999999999999998653322
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......... ..+..+..
T Consensus 155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~-------~~i~~~~~------- 218 (324)
T cd05589 155 GD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF-------DSIVNDEV------- 218 (324)
T ss_pred CC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCC-------
Confidence 11 123456899999999999889999999999999999999999999755432211 11111110
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
..+..++..+.+++.+||+.||.+|| ++.++++
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11123567889999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=292.19 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=201.6
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
+....+++.+.||+|+||.||+|...++ ..+++|.+.... ....++.+|+.+++.++|+|++++++++. .+..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGH----TKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCC----ceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 4456677889999999999999985432 458999876433 34567899999999999999999999874 45789
Q ss_pred EEEecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 136 LAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
++|||+.+++|.+++.. ...+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999999999998854 346788899999999999999999 5699999999999999999999999999997654
Q ss_pred cCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
..... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||......... .....
T Consensus 154 ~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~------- 218 (260)
T cd05067 154 DNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-------QNLER------- 218 (260)
T ss_pred CCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-------HHHHc-------
Confidence 32211 1122345678999999988889999999999999999999 99999754432211 01111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
......+...+.++.+++.+||..+|++|||++++++.|+.
T Consensus 219 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 219 --GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11111222356789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=291.55 Aligned_cols=251 Identities=19% Similarity=0.240 Sum_probs=199.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-----ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-----DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
+...+.||+|++|.||.+....++ ..+++|.+..... .....+.+|+.+++.++||||+++++++.++...+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~---~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTG---RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCC---cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 445678999999999999865543 4588887753321 12346888999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+++||+++++|.+++.....+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999999877788999999999999999999994 59999999999999999999999999998765432
Q ss_pred cccce-eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTI-KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......... .. ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~---------~~~ 222 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF------KI---------ATQ 222 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH------HH---------hcc
Confidence 21111 023346789999999998889999999999999999999999996433221110 00 000
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
......+..++..+.+++.+||..+|++|||+.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111223456789999999999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.81 Aligned_cols=252 Identities=22% Similarity=0.242 Sum_probs=196.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||++....++ ..+|+|.+.... ......+.+|+++++.++||||+++++++.+.+..+++
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTG---KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCC---CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 445688999999999999876554 568999875432 22345688899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++|+|.+++.....+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999999988788899999999999999999999 55999999999999999999999999999863321100
Q ss_pred c------------c---------------------------------eeeccccCCCccCcccccCCCCCCCCcchhHHH
Q 046877 218 K------------T---------------------------------IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGV 252 (350)
Q Consensus 218 ~------------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 252 (350)
. . ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001235899999999999889999999999999
Q ss_pred HHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCC---CCHHHH
Q 046877 253 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLR---PTMRKV 329 (350)
Q Consensus 253 ~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~v 329 (350)
++|||++|..||......+.. ..+... . .....+.....+.++.+++.+|+. +|.+| +|+.++
T Consensus 237 il~elltG~~Pf~~~~~~~~~-------~~i~~~--~----~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETY-------RKIINW--R----ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHH-------HHHHcc--C----CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999754432211 001110 0 001111112345788999999998 77765 588888
Q ss_pred HHH
Q 046877 330 SQM 332 (350)
Q Consensus 330 l~~ 332 (350)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=299.91 Aligned_cols=263 Identities=21% Similarity=0.311 Sum_probs=200.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+++.+.||+|+||.||++.+..++ ..+++|.+.... .....++.+|+++++.++||||+++++++.+++..+++||
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSG---LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCC---eEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 456678999999999999876553 457888775432 2234568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++++|.+++.....+++..+..++.|+++|+.|||+ ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 99999999999877888999999999999999999995 2489999999999999999999999999987543221
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC------------
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------------ 287 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------------ 287 (350)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+...................
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 1234578899999999888899999999999999999999999965432221110000000000000
Q ss_pred ---------cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 288 ---------LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 288 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
................++.++.+++.+||..||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000011111256789999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=303.53 Aligned_cols=241 Identities=24% Similarity=0.285 Sum_probs=192.6
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 136 (350)
+.+.+.||+|+||.||+|....++ ..+|+|.+.... ......+..|..++..+ +|++|+++++++.+.+..++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTD---ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 345678999999999999876553 468999886432 22234566677777777 68999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||||+++|+|.+++.....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999999987788999999999999999999999 5599999999999999999999999999987543221
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. ......|++.|+|||++.+..++.++|||||||++|+|+||+.||......... ..+.... .
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~-------~~i~~~~--------~ 218 (323)
T cd05616 156 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------QSIMEHN--------V 218 (323)
T ss_pred C--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC--------C
Confidence 1 113446899999999999999999999999999999999999999754432211 1111111 1
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
..+...+.++.+++.+||+.||++|++.
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1122356788999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=297.90 Aligned_cols=262 Identities=22% Similarity=0.282 Sum_probs=190.2
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcC---CCCceeeecceee-----c
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQT---HHKNLVRLLGFCD-----E 130 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~ 130 (350)
|++.+.||+|+||.||+|....++ +..+|+|.+.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCC--CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 556788999999999999864332 3568889876432 22234556677666654 6999999999874 3
Q ss_pred CCeeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 131 GQNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 131 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
....+++|||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999997 4898888543 45788999999999999999999 45999999999999999999999999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
+....... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||......+................+
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 97654321 123445889999999998888999999999999999999999999865543321110000000000000
Q ss_pred chh-------ccccccCC---CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDL-------VEGDMEAM---NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~-------~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
... ........ .....+..+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000 01134567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=290.25 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=196.2
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
.||+|+||.||+|.+.... .+..+++|....... ...+.+.+|+.+++.++||||+++++++. ....+++|||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCC-CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999765332 234588888765432 23456889999999999999999999875 45789999999999
Q ss_pred ChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce-ee
Q 046877 145 TLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI-KT 222 (350)
Q Consensus 145 ~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~ 222 (350)
+|.+++.. ...+++..+++++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++........... ..
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999864 4568999999999999999999994 5999999999999999999999999999975543322111 11
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
...++..|+|||.+.+..++.++||||||+++|++++ |..||......+.. .....+ .....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~---------~~~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQG---------KRLDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCC---------CCCCCC
Confidence 2223568999999988889999999999999999996 99999754332211 111111 111222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
..+++++.+++.+||..+|++||++.++.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34578999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=296.37 Aligned_cols=244 Identities=25% Similarity=0.308 Sum_probs=192.3
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
||+|+||+||++....++ ..+++|.+..... ...+.+..|+.+++.++|+||+++.+++..+...+++|||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATG---KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCC---cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 799999999999876553 4689998864322 2235677899999999999999999999999999999999999
Q ss_pred CChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 144 GTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 144 g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+|.+++. .+..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||++.........
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~- 153 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK- 153 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-
Confidence 99988773 3356889999999999999999999 559999999999999999999999999999765433221
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.....|+..|+|||.+.+..++.++||||+|+++|+|++|+.||.......... . .... .... ...
T Consensus 154 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~-~~~~--------~~~~--~~~ 219 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E-LKQR--------ILND--SVT 219 (280)
T ss_pred -ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--H-HHHh--------hccc--CCC
Confidence 233468899999999999999999999999999999999999997543221100 0 0000 0000 011
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
.+..++..+.+++.+||+.||++|| +++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1224567899999999999999999 6677774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=294.28 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=204.9
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcc-eeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTS-TTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~-~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
..+++.+.||+|+||.||+|..+.++.. ...+++|....... .....+.+|+..++.++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 3455678899999999999987655432 34688888764432 334678899999999999999999999887 78899
Q ss_pred EEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 137 AYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+|||+++|+|.+++... ..+++..+..++.|++.|++||| +.+++|+||+|+||++++++.+||+|||++......
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999998653 46889999999999999999999 459999999999999999999999999999876543
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..........++..|+|||.+....++.++|+||||+++|++++ |..||+.....+.. ..+..+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~-------- 227 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-------DLLEKG-------- 227 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHhCC--------
Confidence 32221122223568999999988889999999999999999998 99999754432211 111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.....+..++..+.+++.+||..||++|||+.++++.|+++..
T Consensus 228 -~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 -ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111122245678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=293.37 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=197.8
Q ss_pred ccCCCccceEEEEEEcCCC---cceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecC
Q 046877 66 EVGRGSFGIIYKGVIQTTT---TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~---~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
.||+|+||.||+|+..+.. .....+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 5899999999999876432 223568888775432 234567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCC-------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-----ceEEeecccc
Q 046877 142 NNGTLASFLFGN-------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-----NARISDFGLA 209 (350)
Q Consensus 142 ~~g~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-----~~kl~Dfg~~ 209 (350)
++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999998532 34678889999999999999999 45899999999999999877 8999999998
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
................++..|+|||.+.+..++.++||||||+++|+|+| |..||......+.. .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~-- 229 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL-------QHVTAG-- 229 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH-------HHHhcC--
Confidence 76543322222223345678999999998889999999999999999998 99999644332211 111111
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
.....+...+..+.+++.+||..+|++||++.++++.|++
T Consensus 230 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 -------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1112223457789999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=310.30 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=214.7
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
...|+||+|.||.|++|.+...+.+...||||.+...... ...+|.+|+..|.+|+|||+++++|+..+ ....||||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 3567899999999999999987777788999999765544 56789999999999999999999999988 688899999
Q ss_pred CCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 141 LNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 141 ~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
++.|+|.+.+++ ...+-....-.++.||+.||.||. ++.+|||||..+|+++-....|||||||+.+.++..+..
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999976 345667777889999999999999 669999999999999999999999999999988766544
Q ss_pred ceeec-cccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 219 TIKTA-IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 219 ~~~~~-~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
..... ..-...|+|||.+....++.+||||+|||++|||+| |..||-+..+-. +.+.++.+.
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAGE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhccccc
Confidence 44333 234669999999999999999999999999999997 777887554432 223445666
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
+...+..|++++++++..||..+|.+|||+..+.+.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 6777788999999999999999999999999997444
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=292.52 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=197.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+++.+.||+|+||.||++....++ ..+++|.+..........+.+|+.+++.++|||++++++++...+..++++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETG---VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCC---eEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3566788999999999999876553 4678888765544556678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|..++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++++|||++........
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 9999999888754 4568999999999999999999994 5999999999999999999999999999875532211
Q ss_pred ceeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 219 TIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
......++..|+|||.+. +..++.++|+||+||++|+|++|+.||......... ... .....
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~-~~~~~----- 225 (282)
T cd06643 159 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL------LKI-AKSEP----- 225 (282)
T ss_pred -ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH------HHH-hhcCC-----
Confidence 113345788999999984 345778999999999999999999999654322111 000 00100
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+..++.++.+++.+||+.||++|||+.++++
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 226 --PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011112235678999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=291.04 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=201.5
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
..+++.+.||+|+||.||+|... +..+++|.+..... ..+++.+|+.+++.++|+|++++++++.+.+..+++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-----~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-----GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-----CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 34566788999999999999754 24589999865533 4678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+++++|.+++.... .+++..+..++.|++.|+.||| ..+++|+||||+||+++.++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999986554 6899999999999999999999 4599999999999999999999999999998663221
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
. ....+..|+|||.+.+..++.++||||||+++|++++ |..||........ ......+
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~--------- 215 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPHVEKG--------- 215 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHhcC---------
Confidence 1 2234568999999988889999999999999999997 9999864432221 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.....+..++..+.+++.+||..+|++|||+.++++.|+++
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11111223567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.03 Aligned_cols=241 Identities=26% Similarity=0.276 Sum_probs=190.2
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHH-HHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVI-VIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|....++ ..+++|.+.... ......+..|.. +++.++||||+++++.+...+..+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDG---KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 36999999999999876553 568999886432 122334555554 56778999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++|+|..++.....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 152 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T 152 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence 999999999988888999999999999999999999 55999999999999999999999999999875322211 1
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...+..... .....+.. . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-------~~~~~~~~--------~--~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-------DNILHKPL--------V--L 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-------HHHHcCCc--------c--C
Confidence 23456899999999999989999999999999999999999999754332211 11111111 0 0
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
....+..+.+++.+|++.||.+||++.+.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 112456788999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=290.88 Aligned_cols=242 Identities=24% Similarity=0.366 Sum_probs=189.5
Q ss_pred hccCCCccceEEEEEEcCCC---------cceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 65 EEVGRGSFGIIYKGVIQTTT---------TSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~---------~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
+.||+|+||.||+|....+. .....+++|.+.....+....+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 36899999999999864322 123457888876554444557888999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-------eEEeecc
Q 046877 136 LAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN-------ARISDFG 207 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~-------~kl~Dfg 207 (350)
++|||+++++|..++.. ...+++..+++++.|+++|++||| +.+++||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999988864 356899999999999999999999 559999999999999987664 8999999
Q ss_pred cccccccCcccceeeccccCCCccCccccc-CCCCCCCCcchhHHHHHHHHH-hCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFR-KSTISAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
++...... ....++..|+|||++. +..++.++||||||+++|+|+ +|..||......+... +..
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~--------~~~ 223 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER--------FYE 223 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH--------HHh
Confidence 98654322 2234678899999886 457889999999999999998 5888876433222110 001
Q ss_pred CCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
+.. .. ....+.++.+++.+||+.||++||++.++++.|
T Consensus 224 ~~~--------~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQC--------ML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCc--------cC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 110 00 111346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=307.80 Aligned_cols=250 Identities=23% Similarity=0.256 Sum_probs=198.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||++....++ ..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATG---DIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 456788999999999999876554 468999886532 22345688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999999765 67899999999999999999999 5599999999999999999999999999998664332
Q ss_pred ccceeeccccCCCccCccccc------CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 217 RKTIKTAIRGTKGYVAPEWFR------KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
.. ......+++.|+|||++. ...++.++|||||||++|+|++|..||......... ..+....
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-------~~i~~~~--- 225 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY-------NNIMNFQ--- 225 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH-------HHHHcCC---
Confidence 22 223346899999999986 456788999999999999999999999754432211 1111110
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+.....+..+.+++.+||. +|.+|||++++++
T Consensus 226 ---~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 ---RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ---CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 001111122356788999999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=309.41 Aligned_cols=265 Identities=18% Similarity=0.196 Sum_probs=200.3
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
...+.+.+.||+|+||.||++..... .....+++|.+... ....+|+.+++.++||||+++++++......+++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~-~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCC-ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 34567778899999999999975433 33466888876532 3456799999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||++. ++|..++.....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99986 588888877788999999999999999999999 45999999999999999999999999999976654333
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc--------
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD-------- 289 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 289 (350)
........||..|+|||++.+..++.++|||||||++|+|++|+.||.........................
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 222234568999999999998899999999999999999999999997554322111111111111100000
Q ss_pred ------hhccccc---cC---CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 290 ------DLVEGDM---EA---MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 290 ------~~~~~~~---~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
....... .. ......+.++.+++.+||..||++|||+.+++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00 0011245678899999999999999999999753
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=288.98 Aligned_cols=257 Identities=22% Similarity=0.356 Sum_probs=203.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+.+.+.||+|+||.||+|....++ ..+++|.+... .......+.+|+++++.++|+|++++++++...+..++
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDG---RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCC---CEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3556788999999999999976443 45888877532 22335678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 137 AYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
+|||+++++|.+++.. ...+++..+..++.+++.|++||| +.+++|+||+|+||+++.++.++++|||++...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 9999999999998853 345788999999999999999999 559999999999999999999999999998755
Q ss_pred ccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......... ....+..+..
T Consensus 157 ~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~---- 225 (267)
T cd08224 157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIEKCDY---- 225 (267)
T ss_pred cCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH-----HHhhhhcCCC----
Confidence 432211 12345788999999998888999999999999999999999999643321111 0111111111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
........+..+.+++.+||..+|++|||+.++++.|+++.
T Consensus 226 ----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 ----PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11112256678999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=296.53 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=200.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+...+.||+|+||.||+|....+ +..+++|.+..........+.+|+.+++.++|||++++++.+..+...+++||
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~---~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVAT---GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCC---CcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 445567899999999999986544 34689998876555556778899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++++|.+++.. ..+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred ccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 9999999999853 46788999999999999999999 559999999999999999999999999998755432211
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ..... ......
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~------~~~~~--------~~~~~~ 237 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATN--------GTPELQ 237 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH------HHhcC--------CCCCCC
Confidence 123457889999999988888999999999999999999999997544322111 00000 001111
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+...+..+.+++.+||..+|++|||+.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 12345678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.31 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=199.6
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
..+.+.+.||+|+||.||+|....++ ..+++|.+..........+.+|+.+++.++||||+++++.+...+..+++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTG---ELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCC---cEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35667788999999999999876553 458888876554444556888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|.+++.....+++..++.++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 999999999999878889999999999999999999994 5999999999999999999999999999875543211
Q ss_pred ceeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 219 TIKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
......++..|+|||.+. ...++.++|+||+||++|+|++|..||........... ....... ..
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-------~~~~~~~---~~- 229 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MTKSNFQ---PP- 229 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-------hhccCCC---CC-
Confidence 113345888999999974 44678899999999999999999999864332111100 0000000 00
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......++..+.+++.+||+.+|++|||++++++
T Consensus 230 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 -KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00111134567899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.17 Aligned_cols=253 Identities=27% Similarity=0.342 Sum_probs=211.3
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc---cHHHHHHHHHHHhcCC-CCceeeecceeecC
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD---GEKEFKNEVIVIGQTH-HKNLVRLLGFCDEG 131 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 131 (350)
-....|++.+.||+|.||.||++..+.+ +..+|+|.+.+.... ....+.+|+++|+.+. ||||+.+.+.+++.
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~t---g~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKST---GKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCC---CceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 3444566778999999999999998776 456888888654432 3468999999999997 99999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC----CCceEEeecc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND----RYNARISDFG 207 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg 207 (350)
+..++|||++.||.|.+.+.+. .+++..+..++.|++.++.||| +.+++|||+||+|+|+.. ++.+|++|||
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999999766 4999999999999999999999 569999999999999953 3579999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
++..... ........||+.|+|||++....|+..+||||+|+++|.|++|..||.......... .+..++
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~ 254 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGD 254 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCC
Confidence 9998775 223356789999999999999999999999999999999999999998776544332 122222
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
. ........+.+..+.+++..|+..||..|+|+.++++
T Consensus 255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 2 2222333456789999999999999999999999987
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=289.49 Aligned_cols=247 Identities=25% Similarity=0.332 Sum_probs=199.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+.+.+.||+|++|.||++....++ ..+++|.+... .......+.+|+++++.++|||++++++++.+.+..+++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADK---RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCC---cEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 345678999999999999876554 45888887532 2334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+++++|.+++... ..+++..+..++.|++.|+.||| ..+++|+||+|+||++++++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999998653 56788899999999999999999 4599999999999999999999999999988665432
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. .....++..|+|||++.+..++.++|+||||+++|+|++|+.||......... .....+...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~------- 219 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI-------LKIIRGVFP------- 219 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCCC-------
Confidence 21 13345788999999999888999999999999999999999999755422110 111111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....++..+.+++.+||+.+|++||++.++++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 --PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 111245678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=294.63 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=190.6
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
||+|+||.||++..+.+ +..+++|.+.... ......+..|+.+++.++||||+++.+++.++...+++|||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNT---GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccC---CcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 79999999999987665 3568998875322 12234456799999999999999999999999999999999999
Q ss_pred CChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccccee
Q 046877 144 GTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK 221 (350)
Q Consensus 144 g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 221 (350)
++|.+++... ..+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||++........ .
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~ 151 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---I 151 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---e
Confidence 9999887543 35788888999999999999999 45999999999999999999999999999876543221 1
Q ss_pred eccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 222 TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 222 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
....++..|+|||++.+..++.++||||+||++|+|++|+.||.......... ... ....... .. ...
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~-~~~~~~~--------~~-~~~ 219 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELK-RRTLEDE--------VK-FEH 219 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHH-HHhhccc--------cc-ccc
Confidence 23457889999999988889999999999999999999999997543221110 000 0000111 00 011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..++.++.+++.+||+.||++||+++++++
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 135678999999999999999999976653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=312.18 Aligned_cols=252 Identities=19% Similarity=0.254 Sum_probs=196.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||+++...+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++.+.+++..+++
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDT---NALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCC---CCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 45678899999999999997665 4569999886432 22345688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++|+|.+++.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999999988888899999999999999999999 55999999999999999999999999999753210000
Q ss_pred -----------------------------------------cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHH
Q 046877 218 -----------------------------------------KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLE 256 (350)
Q Consensus 218 -----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 256 (350)
........||+.|+|||++.+..++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112468999999999998899999999999999999
Q ss_pred HHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCC---CHHHHHHH
Q 046877 257 IISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRP---TMRKVSQM 332 (350)
Q Consensus 257 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~vl~~ 332 (350)
|++|+.||......+.... +.... .....+...+.+.++.+++.+|+ .+|.+|+ |+.++++.
T Consensus 237 ll~G~~Pf~~~~~~~~~~~-------i~~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQLK-------VINWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHHH-------HhccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999976553322110 00000 00111111234567888888876 4999999 88888743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=301.71 Aligned_cols=241 Identities=24% Similarity=0.287 Sum_probs=192.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 136 (350)
+++.+.||+|+||.||+|....++ ..||+|.+.... ....+.+..|..++..+. |++|+++.+++.+.+..++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTD---ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 456688999999999999876553 569999886432 223455777888888874 6788889999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||||+++|+|.+++.....+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999999988788999999999999999999999 5599999999999999999999999999987543221
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. ......|+..|+|||++.+..++.++||||+||++|+|++|..||......... ..+.....
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-------~~i~~~~~-------- 218 (323)
T cd05615 156 V--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF-------QSIMEHNV-------- 218 (323)
T ss_pred c--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCC--------
Confidence 1 123345899999999999888999999999999999999999999754432211 11111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
..+...+.++.+++.+||+.+|.+|++.
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1112345688999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=287.65 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=196.6
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+.||+|+||.||++.... +..+++|........ ....+.+|+++++.++|+||+++++++.+....+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~----~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC----CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 369999999999998654 245899987654333 456789999999999999999999999999999999999999
Q ss_pred CChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceee
Q 046877 144 GTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT 222 (350)
Q Consensus 144 g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 222 (350)
++|.+++.. ...+++..+..++.+++.+++||| +.+++|+||+|+||+++.++.++|+|||++.............
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999999854 356788899999999999999999 4599999999999999999999999999997654222111111
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
....+..|+|||.+.+..++.++|+||||+++|+|+| |..||......... ..... ......+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-------~~~~~---------~~~~~~~ 217 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-------ERIES---------GYRMPAP 217 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-------HHHhc---------CCCCCCC
Confidence 2223567999999988889999999999999999999 88888654322211 11111 1111122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
...+..+.+++.+||..+|++|||++++++.|+.
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 3456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=290.29 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=197.3
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
..+.+.+.||+|++|.||++....+. .+++|.+... ....+.+.+|+++++.++|||++++++++. .+..+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~----~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT----KVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc----eEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 34567788999999999999865432 3788876543 234567889999999999999999998875 45688999
Q ss_pred ecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+.+++|.+++... ..+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999998643 347888999999999999999994 589999999999999999999999999997654322
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......++..|+|||...+..++.++||||||+++|+|+| |..||......+.. .....+
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~--------- 219 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-------EQVERG--------- 219 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC---------
Confidence 11 1122335678999999988889999999999999999999 89998754332211 111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
.....+...+..+.+++.+||..||++||+++++++.|++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111122456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=306.37 Aligned_cols=253 Identities=18% Similarity=0.254 Sum_probs=196.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..+++.+.||+|+||.||++....++ ..+|+|.+.... ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQ---KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34556678999999999999976654 458899876422 223445788999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999999999854 46788899999999999999999 559999999999999999999999999999865432
Q ss_pred cccceeeccccCCCccCcccccCC----CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKS----TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||......... ..+....
T Consensus 196 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~-------~~i~~~~---- 263 (370)
T cd05621 196 GMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY-------SKIMDHK---- 263 (370)
T ss_pred Cce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC----
Confidence 211 11345689999999998754 3788999999999999999999999755432211 1111100
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSL--RPTMRKVSQM 332 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~vl~~ 332 (350)
.....+.....+..+.+++.+|+..++.. |+|+.++++.
T Consensus 264 --~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 --NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 01111222345678899999999865543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.28 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=194.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+++.+.||+|+||.||+|....+ +..+++|.+... .......+.+|++++++++||||+++++++...+..+++||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLT---RRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCC---CcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 35667899999999999986554 356899987643 23334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++++|..+. .+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 80 FMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred cCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99999986653 5678888999999999999999 4599999999999999999999999999997554221
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...................... .....
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 220 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--------DPPVL 220 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--------CCCCC
Confidence 133468889999999998889999999999999999999999996533222111000000111111 11111
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
.....+.++.+++.+||+.+|++||+++++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 112245678999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=313.94 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=218.0
Q ss_pred hhhccCCCccceEEEEEEcCCCcc-eeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTS-TTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~-~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
-.+.||+|+||+||+|.+.-..+. ...|++|.+.... .....++.+|+.++.+++|||++++++++.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 346799999999999988755433 4568999886543 345678999999999999999999999998876 7889999
Q ss_pred CCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 141 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 141 ~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
+++|+|.+|++. +..+.....+.|..||++||.|||+ ..++||||..+||||.+-..+|+.|||+++...+.....
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999974 4667888899999999999999995 599999999999999999999999999999887665444
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
......-..-|+|-|.+....|+.++|||||||++||++| |..||++...++ +.++++.+.+.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~geRL 919 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKGERL 919 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhccccC
Confidence 3344445678999999999999999999999999999997 888987544333 45566777778
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
..+..|+.+++.++.+||..|++.||+++++...+.+.+.
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 8888999999999999999999999999999999987664
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=307.39 Aligned_cols=253 Identities=18% Similarity=0.252 Sum_probs=198.2
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
...+++.+.||+|+||.||+++...++ ..+|+|.+.... ......+.+|+.+++.++||||+++++++.+++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSK---QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 344566788999999999999976653 568999886432 22334578899999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
+++|||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999998854 45788889999999999999999 55999999999999999999999999999976543
Q ss_pred CcccceeeccccCCCccCcccccCC----CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKS----TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
... .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||......... ..+....
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-------~~i~~~~--- 263 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-------SKIMDHK--- 263 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH-------HHHHcCC---
Confidence 221 111345689999999998653 4788999999999999999999999765432211 1111110
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSL--RPTMRKVSQ 331 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~vl~ 331 (350)
.....+.....+.++.+++.+||+.+|++ |+|++++++
T Consensus 264 ---~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 264 ---NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred ---CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00111122235678999999999999987 999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=300.05 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=195.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+...+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++||||+++++++..++..+++||
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTE---NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCC---CeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 456678999999999999876553 458999876432 2234467889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++ +|.+++... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 9986 777777543 45788899999999999999999 45999999999999999999999999999875432221
Q ss_pred ceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH--------HHhhcC-Cc
Q 046877 219 TIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCYRNG-KL 288 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~~~~~-~~ 288 (350)
......++..|+|||.+.+ ..++.++||||+|+++|+|+||+.||...+..+......... ..+... ..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1123457889999998865 468889999999999999999999997655433221111000 000000 00
Q ss_pred chhcccccc----CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDLVEGDME----AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......... .......+.++.+++.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 0011235678899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=306.49 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=195.9
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCC-----ee
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ-----NR 134 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 134 (350)
+..+.||+|+||.||++....+ +..+|+|++.... .....++.+|+.+++.++||||+++++++...+ ..
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRD---GKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred cccceeeeCCCEEEEEEEECCC---CCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4567899999999999986554 3568999876432 223457889999999999999999999998776 78
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++++||+.+ +|.+++.....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 999999974 88888877788999999999999999999999 55999999999999999999999999999976543
Q ss_pred CcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc----
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD---- 289 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 289 (350)
.... ......++..|+|||.+.+. .++.++||||+||++|+|++|+.||............ ..........
T Consensus 156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~g~~~~~~~~~ 231 (372)
T cd07853 156 DESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLGTPSLEAMRS 231 (372)
T ss_pred Cccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHcCCCCHHHHHH
Confidence 3221 11334578899999998774 5789999999999999999999999765433221110 0000000000
Q ss_pred ------h-hccccccC-------CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 ------D-LVEGDMEA-------MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ------~-~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
. +....... ......++++.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0 00000000 011123578899999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=290.72 Aligned_cols=254 Identities=28% Similarity=0.468 Sum_probs=202.3
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
....+.+.+.||+|+||.||+|..+.+ ..+++|.+... .....++.+|+.+++.++|+|++++++++......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~----~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGT----TKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCC----ceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 344566778899999999999986433 34888887643 3345779999999999999999999999999899999
Q ss_pred EEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 137 AYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
+|||+++++|.+++... ..+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++++|||.+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999999654 367899999999999999999994 5999999999999999999999999999876543
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
... ........+..|+|||.+.+..++.++|+||+|+++|++++ |+.||......... .....+
T Consensus 156 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-------~~~~~~------- 220 (261)
T cd05034 156 DEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL-------EQVERG------- 220 (261)
T ss_pred hhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC-------
Confidence 211 11122234568999999998889999999999999999998 99999644322211 111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
.....+...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 221 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 --YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=301.97 Aligned_cols=238 Identities=23% Similarity=0.280 Sum_probs=188.4
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHH-HHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEV-IVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|+...++ ..+++|.+.... ......+..|. .+++.++||||+++++++.+.+..+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDG---SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCC---CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 36999999999999976553 568999886432 12233455554 467889999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++++|..++.....+++..+..++.|+++||.||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 999999999887788899999999999999999999 45999999999999999999999999999875322211 1
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.... ...+..+. . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~--------~--~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-------YDNILHKP--------L--QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-------HHHHhcCC--------C--CC
Confidence 2344689999999999988899999999999999999999999975432221 11111111 1 11
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMR 327 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~ 327 (350)
+...+..+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 123456889999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=286.96 Aligned_cols=246 Identities=25% Similarity=0.395 Sum_probs=194.3
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+.||+|+||.||+|...+ ...+++|.+..... .....+.+|+.+++.++||||+++++++...+..+++|||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~----~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD----KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecC----CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 368999999999998543 24588888765432 2234688999999999999999999999999999999999999
Q ss_pred CChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceee
Q 046877 144 GTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT 222 (350)
Q Consensus 144 g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 222 (350)
++|.+++... ..+++..+..++.|++.++.||| ..+++|+||+|+||+++.++.++++|||++......... ...
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSG 152 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCC
Confidence 9999988643 45789999999999999999999 559999999999999999999999999998754322111 111
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
...++..|+|||.+.+..++.++||||||+++|++++ |..||......... .....+. ....+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-------~~~~~~~---------~~~~~ 216 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-------EQVEKGY---------RMSCP 216 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcCC---------CCCCC
Confidence 2233567999999988889999999999999999998 99999654332211 1111111 11112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
..++..+.+++.+||..+|++|||+.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=288.53 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=195.7
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeeccee-ecCCeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFC-DEGQNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv 137 (350)
..+.+.+.||+|+||.||++.... ..+++|..... ...+.+.+|+.+++.++|+|++++++++ .+.+..+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRG-----NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcC-----CcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 345667889999999999997542 34788887543 3356788999999999999999999875 455678999
Q ss_pred EecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||+++++|.+++.... .+++..+..++.|++.|++||| ..+++|+||||+||++++++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999986543 4788999999999999999999 559999999999999999999999999998754322
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
. .....+..|+|||.+.+..++.++||||||+++|+|++ |+.||......... ..+..+
T Consensus 156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~-------~~~~~~-------- 215 (256)
T cd05082 156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKG-------- 215 (256)
T ss_pred C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcC--------
Confidence 1 12234567999999988889999999999999999998 99998643322211 111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
........++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 -YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11111224567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=290.54 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=189.3
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
.||+|+||.||+|..... .....+++|.+..... .....+.+|+..++.++||||+++++.+.+.+..+++|||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecC-CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 599999999999976443 3345688887654322 23456888999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC-----CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 145 TLASFLFGNL-----KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 145 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
+|.+++.... ..++.....++.|++.|++||| +.+++||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999986532 2356778899999999999999 4599999999999999999999999999986543322221
Q ss_pred eeeccccCCCccCcccccC-------CCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 220 IKTAIRGTKGYVAPEWFRK-------STISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
......++..|+|||++.. ..++.++||||+|+++|+|++ |..||......+.. ......+ ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL------KQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH------HHHhhcc-CccC
Confidence 1222345678999998742 356789999999999999999 77888644332211 1111111 1111
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
..+ .....++..+.+++..||. ||++|||++++++.|.
T Consensus 231 ~~~----~~~~~~~~~~~~~~~~~~~-dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKP----QLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLT 268 (269)
T ss_pred CCC----cccccCCHHHHHHHHHHhc-CcccccCHHHHHHHhc
Confidence 111 1122356778889999994 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=292.99 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=189.6
Q ss_pred hccCCCccceEEEEEEcCCCcc----eeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTS----TTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~----~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|.....+.. ...+++|..........+.+.+|..+++.++|||++++++++..++..+++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 4699999999999987654322 344777777654444456788999999999999999999999998999999999
Q ss_pred CCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--------eEEeecccccc
Q 046877 141 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN--------ARISDFGLAKL 211 (350)
Q Consensus 141 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~--------~kl~Dfg~~~~ 211 (350)
+++|+|..++..+ ..+++..+..++.|++.|++||| ..+++||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999654 45789999999999999999999 459999999999999987665 69999999865
Q ss_pred cccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCC-CCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
.... ....++..|+|||++.+. .++.++||||||+++|+|++|. .||.......... ....
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~---- 220 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED---- 220 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc----
Confidence 4322 223467889999999864 5788999999999999999985 5554322221110 0000
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
.. ..+.....++.+++.+||+.||++|||++++++.|+
T Consensus 221 -----~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -----RH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----cc--cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 011123367899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=306.69 Aligned_cols=262 Identities=28% Similarity=0.407 Sum_probs=219.3
Q ss_pred CHHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 52 SYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 52 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
.-+|++...-.....||-|-||.||.|.++.-. ..||||-++.. ....++|+.|..+++.++|||+|+++++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkys---lTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccc---eeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 445666555556678999999999999987653 45899988654 45578999999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCC--cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
..+||+.|||..|+|.+|++++.+ .+.-..+.|+.||..||.||. ..++|||||..+|+|+.++..+|++|||++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999999986644 455667899999999999999 569999999999999999999999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
+...... +........+.-|.|||.+.-+.++.|+|||+||++|||+.| |..||.+-+-. ++
T Consensus 413 RlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----------------qV 475 (1157)
T KOG4278|consen 413 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QV 475 (1157)
T ss_pred hhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----------------HH
Confidence 9876433 333334445778999999999999999999999999999997 88888643321 12
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
-.+++.+.+-..+..|++.+++||+.||+.+|.+||++.|+-+.++.+.
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 3445566666667789999999999999999999999999999987765
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=291.75 Aligned_cols=242 Identities=24% Similarity=0.351 Sum_probs=188.4
Q ss_pred ccCCCccceEEEEEEcCC---------------------CcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeee
Q 046877 66 EVGRGSFGIIYKGVIQTT---------------------TTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~---------------------~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 124 (350)
.||+|+||.||+|....+ ......+++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999975422 11234588888765444445568889999999999999999
Q ss_pred cceeecCCeeEEEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----
Q 046877 125 LGFCDEGQNRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY---- 199 (350)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---- 199 (350)
++++.+....++||||+++|+|..++.. ...+++..+..++.|+++||+||| ..+++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999864 466789999999999999999999 55999999999999997644
Q ss_pred ---ceEEeecccccccccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHH-hCCCCCCcccchhhhh
Q 046877 200 ---NARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAI 274 (350)
Q Consensus 200 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll-tg~~pf~~~~~~~~~~ 274 (350)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|..||......+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999988643221 12246778999998875 56889999999999999995 7899987543322111
Q ss_pred HHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 275 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
. .. .....+ ......+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 ~-------~~---------~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 F-------YE---------KKHRLP--EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H-------HH---------hccCCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 00 000000 112357899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=292.59 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=201.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+...+.||+|+||.||+|..+.+. ...+.+++|........ ....+.+|++++++++|+|++++++++.+.+..++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM 85 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence 3455678999999999999876543 23456888887654332 34678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC---------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecc
Q 046877 137 AYEFLNNGTLASFLFGNL---------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 207 (350)
+|||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++++|||
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999987554 6889999999999999999999 5599999999999999999999999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcC
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG 286 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 286 (350)
++......... ......++..|+|||.+.+...+.++||||||+++|++++ |..||........ ......+
T Consensus 163 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~-------~~~~~~~ 234 (275)
T cd05046 163 LSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-------LNRLQAG 234 (275)
T ss_pred cccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH-------HHHHHcC
Confidence 98654322211 1122345677999999988888999999999999999998 7888864332211 1111111
Q ss_pred CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
... ......++..+.+++.+||+.+|++|||+.++++.|.+
T Consensus 235 ~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111 11122456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.65 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=199.8
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
+....+.+.+.||+|+||.||++..... ..+++|.+... ....+.+.+|+.+++.++|+|++++++++.+ ...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~----~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKH----TKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCC----ccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 3445667788999999999999975433 23788876543 2335678899999999999999999999887 7789
Q ss_pred EEEecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 136 LAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
++|||+++++|.+++.. ...+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.+||+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 99999999999999865 3456888899999999999999994 599999999999999999999999999987654
Q ss_pred cCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.... .......++..|+|||.+....++.++|+||||+++|+++| |..||......... ..+..+
T Consensus 154 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~------ 219 (260)
T cd05073 154 DNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERG------ 219 (260)
T ss_pred CCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCC------
Confidence 3221 11122335667999999988889999999999999999999 89999754332211 111111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
.........+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 220 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 ---YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111122356789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=292.28 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=204.8
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
....+++.+.||+|+||+||++....++ ..+++|...... ......+.+|+++++.++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTG---TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCC---cEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 3455677889999999999999876553 458888765432 233567899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++|||+++++|.+++...+.+++..+..++.+++.++.|||+ ..+++|+||+|+||++++++.++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999999999877788999999999999999999995 247999999999999999999999999998644221
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhH-HHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL-TDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 294 (350)
. .....++..|+|||.+.+..++.++|+|||||++|+++||..||......+.... ....... .......
T Consensus 158 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 228 (284)
T cd06620 158 I----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----LQQIVQE 228 (284)
T ss_pred c----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH-----HHHHhhc
Confidence 1 1234578899999999888899999999999999999999999975543211000 0000000 0111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
.........++.++.+++.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111222366789999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.09 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=201.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+++.+.||+|+||.||+|.+..+ +..||+|++..... ...+++.+|+++++.++||||+++++++.+++..+++
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~t---g~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVC---SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCC---CcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 45668899999999999987655 35689998864322 2245788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-----------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeec
Q 046877 138 YEFLNNGTLASFLFGN-----------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDF 206 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 206 (350)
|||++|++|.+++... ...++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEec
Confidence 9999999999988531 23355677899999999999999 459999999999999999999999999
Q ss_pred ccccccccCcc----------------cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccch
Q 046877 207 GLAKLLTLNQR----------------KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGE 270 (350)
Q Consensus 207 g~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~ 270 (350)
|++........ ........||+.|+|||.+.+..++.++||||+||++|+|+||..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99976521110 00111245899999999999989999999999999999999999999753332
Q ss_pred hhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcccCCCC
Q 046877 271 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRP-TMRKVSQMLQEVVEVDV 341 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~vl~~L~~~~~~~~ 341 (350)
..... .............+.+..+.+++.+||+.||++|| +++++.+.|+..+...+
T Consensus 238 ki~~~--------------~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 238 KISYR--------------DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred hhhhh--------------hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 21100 00000001111124567889999999999999995 67778888887765544
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=303.29 Aligned_cols=255 Identities=18% Similarity=0.239 Sum_probs=196.2
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
....+.+.+.||+|+||.||++....++ ..+|+|.+.... ......+.+|..+++.++||||+++++.+.+.+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTR---KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCC---cEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3455667788999999999999977654 468899875422 2233457789999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.+++|||+++|+|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999999854 45788888999999999999999 5599999999999999999999999999998654
Q ss_pred cCcccceeeccccCCCccCcccccCC----CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRKS----TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..... ..+....
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~-- 263 (371)
T cd05622 194 KEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-------SKIMNHK-- 263 (371)
T ss_pred cCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCC--
Confidence 32211 11345689999999998754 3788999999999999999999999754432211 1111110
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSL--RPTMRKVSQM 332 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~vl~~ 332 (350)
.....+.....+..+.+++.+|+..++.+ |++++++++.
T Consensus 264 ----~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 264 ----NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ----CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00111122245678999999999844433 7788888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=292.24 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=198.2
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHH--HHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK--EFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
++.+.||+|+||+||++....++ ..+++|.+......... ....|+..++.++||||+++++++......+++||
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNG---QKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTT---EEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCC---eEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 46688999999999999977664 46899998765433322 23459999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++++|.+++.....+++..+..++.|+++||.+||+ .+++|+||||+||++++++.++|+|||.+..... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred cccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccc
Confidence 99999999999877888999999999999999999995 4999999999999999999999999999975411 112
Q ss_pred eeeccccCCCccCccccc-CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 220 IKTAIRGTKGYVAPEWFR-KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
......++..|+|||++. +..++.++||||+|+++|+|++|..||................ .........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~----- 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL----KRPLPSSSQ----- 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH----HTHHHHHTT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc----ccccccccc-----
Confidence 223456788999999998 7889999999999999999999999998652222111111000 000000000
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........+.+++.+||+.||++|||+.++++
T Consensus 225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001278999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=293.51 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=200.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.+.+.||.|++|.||+|....+ +..+++|.+........+.+.+|+..++.++|||++++++++......++++||
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVAT---GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCC---CcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 45567899999999999986554 356899988765555567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++++|..++.. ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 171 (296)
T cd06655 98 LAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-- 171 (296)
T ss_pred cCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--
Confidence 999999998854 46899999999999999999999 559999999999999999999999999998765433221
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....++..|+|||.+.+..++.++|+||||+++|++++|+.||...+........ .... ......
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~-------~~~~-------~~~~~~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNG-------TPELQN 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhcC-------CcccCC
Confidence 12345788999999998888999999999999999999999999765442221100 0000 001112
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
+..++..+.+++.+||..||++|||+.+++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 234567899999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=288.11 Aligned_cols=248 Identities=20% Similarity=0.269 Sum_probs=198.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+++.+.||+|+||.||++....++ ..+++|.+... .....+.+.+|+.+++.++|+|++++.+.+..++..+++||
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSD---QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCC---ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 456688999999999999876553 45888887532 23345678889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 140 FLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 140 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|+++++|.+++.. ...+++..+..++.|++.|+.||| ..+++|+||+|+||++++++.++++|||++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999998753 345788999999999999999999 55999999999999999999999999999876543221
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
......++..|+|||++.+..++.++|+||+|+++|+|++|..||...+..... .....+...
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~-------- 218 (255)
T cd08219 156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-------LKVCQGSYK-------- 218 (255)
T ss_pred --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH-------HHHhcCCCC--------
Confidence 123345788999999998888999999999999999999999999754322111 111111111
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
..+..++..+.+++.+||+.||++|||+.+++..
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122356688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=295.79 Aligned_cols=256 Identities=25% Similarity=0.443 Sum_probs=198.3
Q ss_pred hhhhccCCCccceEEEEEEcCCCcc-eeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTS-TTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~-~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+..+.||+|+||.||+|.+..++.. ...+++|.+..... .....+.+|+.+++.++||||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 4557799999999999987655432 23578887754322 2234688899999999999999999998754 4678999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++|+|.+++... ..+++..+..++.|++.|++||| +.+++|+||||+||++++++.+||+|||++.........
T Consensus 89 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 89 LMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred hcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 99999999998654 35788899999999999999999 559999999999999999999999999999865433222
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.......++..|+|||.+.+..++.++||||||+++|++++ |..||......... .....+. .
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~---------~ 229 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-------DLLEKGE---------R 229 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHCCC---------C
Confidence 11122335678999999988889999999999999999997 89998654322211 1111111 1
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
...+..++..+.+++..||..+|++||+++++++.|.++.
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111234568899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=286.72 Aligned_cols=251 Identities=29% Similarity=0.499 Sum_probs=201.3
Q ss_pred hhhccCCCccceEEEEEEcCCC-cceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTT-TSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~-~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.+.||.|+||.||++...... .....+++|.+...... ....+.+|+..++.++|+|++++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4578999999999999987643 22366899988654333 467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCC--cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 141 LNNGTLASFLFGNLK--PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
+++++|.+++..... +++..+..++.|++.|+++|| +.+++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999975544 899999999999999999999 559999999999999999999999999999876544222
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.. ....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......... .....+. .
T Consensus 160 ~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~-------~~~~~~~---------~ 222 (258)
T smart00219 160 KK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL-------EYLKKGY---------R 222 (258)
T ss_pred cc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcCC---------C
Confidence 21 12336789999999988889999999999999999998 78888653322211 1111111 1
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
.......+.++.+++.+||..||++|||+.++++.|
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111223577899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=286.04 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=187.5
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
.||+|+||.||++....+. ....+++|.+.... ....+.+.+|+..++.++||||+++++.+.+....+++|||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT-GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCC-CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999765433 23446677665432 234567899999999999999999999999999999999999999
Q ss_pred ChhhhhcCC----CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 145 TLASFLFGN----LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 145 ~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+|.+++.+. ...+...+..++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999998643 234566778999999999999994 5999999999999999999999999999864322221122
Q ss_pred eeccccCCCccCcccccC-------CCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 221 KTAIRGTKGYVAPEWFRK-------STISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.....++..|+|||++.. ..++.++||||||+++|+|++ |..||......+.. ..... +......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL------NHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHh-hcccccC
Confidence 233456789999998743 245789999999999999997 56677543322211 11111 1111111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
.+... ...++.+.+++..|| .+|++||+++++++.|.
T Consensus 231 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111 124567888999999 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=285.71 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=202.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+++.+.||+|+||.||+|....+. ..+++|.+..........+.+|+.+++.++|||++++++++..+...+++||
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATG---ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCC---CEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 3556788999999999999876553 4588888875545556789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|.+++... ..+++..+..++.|++.|+.||| ..+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 99999999998765 78899999999999999999999 45999999999999999999999999999876543221
Q ss_pred ceeeccccCCCccCcccccCC---CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKS---TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
......++..|+|||.+.+. .++.++|+||+|+++|+|+||..||............ ...... .
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~-------~~~~~~-----~ 223 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI-------SKSNFP-----P 223 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhccCC-----C
Confidence 11234578889999998766 7889999999999999999999999754432221110 001000 0
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.........+.++.+++.+||..+|.+|||+++++.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011122345678999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=289.79 Aligned_cols=256 Identities=22% Similarity=0.397 Sum_probs=197.7
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCC------e
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ------N 133 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 133 (350)
.+.+.||+|+||.||+|........+..+++|.+.... ....+++.+|+++++.++|||++++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35678999999999999877665566789999876432 233567889999999999999999999875432 2
Q ss_pred eEEEEecCCCCChhhhhcCC------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecc
Q 046877 134 RLLAYEFLNNGTLASFLFGN------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 207 (350)
.+++++|+.+|+|.+++... ..+++.....++.|++.|++||| +.+++|+||||+||++++++.+|++|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECccc
Confidence 36889999999998876421 24678889999999999999999 4599999999999999999999999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcC
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG 286 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 286 (350)
++................++..|++||.+.+..++.++||||||+++|+|++ |..||........ ...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~-------~~~~~~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI-------YNYLIKG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH-------HHHHHcC
Confidence 9886543322211122334568999999988888999999999999999999 8888864432211 1111111
Q ss_pred CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.. ...+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 232 ~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 011123567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=289.78 Aligned_cols=251 Identities=21% Similarity=0.293 Sum_probs=198.3
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
..+++.+.||+|+||.||+|....++ ..+++|............+.+|+.+++.++|||++++++.+..++..+++|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETG---ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCC---ceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 34667788999999999999876553 468899887655555677889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++++|..++.+ ...+++..+..++.|++.++.||| ..+++|+||+|+||+++.++.++|+|||++........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999999887753 456799999999999999999999 55999999999999999999999999999865432211
Q ss_pred cceeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 218 KTIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
......++..|+|||.+. ...++.++|+||||+++|+|++|..||......... . . .......
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~----~-~~~~~~~--- 233 (292)
T cd06644 166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--L----K-IAKSEPP--- 233 (292)
T ss_pred --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--H----H-HhcCCCc---
Confidence 112345788999999985 345678999999999999999999999654322110 0 0 0111100
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....+..++.++.+++.+||..||++||+++++++
T Consensus 234 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 ----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11112245668899999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=288.74 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=197.7
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc---------cHHHHHHHHHHHhcCCCCceeeecceeecCC
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD---------GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ 132 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 132 (350)
.+.+.||+|++|.||+|....+ +..+++|.+...... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASS---GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred cccceeecCCCeEEEEEEecCC---CcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 3557899999999999986554 345888877543222 1246888999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
..+++|||+++++|.+++.....+++..+..++.|++.|++|||+ .+++|+||+|+||++++++.++|+|||.+...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999999877888999999999999999999994 59999999999999999999999999998866
Q ss_pred ccCccc----ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 213 TLNQRK----TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 213 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~--- 226 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-------KIGE--- 226 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-------HHhc---
Confidence 422111 11122347889999999988888999999999999999999999997543221110 0001
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......+...+..+.+++.+||+.||++||++.++++
T Consensus 227 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111122245678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=311.32 Aligned_cols=263 Identities=22% Similarity=0.340 Sum_probs=189.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecC--------C
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--------Q 132 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~ 132 (350)
+.+.+.||+|+||.||+|....++ ..||+|++... .....+|+.+++.++||||+++.+++... .
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~---~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTS---EKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCC---CEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 456678999999999999876553 45899987532 22345799999999999999998876322 2
Q ss_pred eeEEEEecCCCCChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEeecc
Q 046877 133 NRLLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NARISDFG 207 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg 207 (350)
..+++|||+++ +|.+++. ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999986 6666553 4567889999999999999999999 55999999999999998654 69999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH-----H
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----D 281 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-----~ 281 (350)
++......... ....+++.|+|||++.+. .++.++||||+||++|+|++|.+||......+......... +
T Consensus 217 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99865432211 234578999999998764 68999999999999999999999997654433211100000 0
Q ss_pred Hhh--cC-----CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH--HHHhccc
Q 046877 282 CYR--NG-----KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS--QMLQEVV 337 (350)
Q Consensus 282 ~~~--~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl--~~L~~~~ 337 (350)
.+. .. .+............+...+.++.+++.+||+.||.+|||+.+++ ..++++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 000 00 00000001111111223457899999999999999999999998 4444443
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=292.63 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=201.3
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
..+.+.+.||+|+||.||++....++ ..+++|.+........+.+.+|+.+++.++|||++++++++...+..+++|
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATG---QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCC---CEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 45566788999999999999865443 468999887555555677889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|.+++.+ ..+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999999854 45788899999999999999999 459999999999999999999999999998765433221
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.....+++.|+|||.+.+..++.++|+||+|+++|++++|..||...+....... .........
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--------------~~~~~~~~~ 235 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------------IATNGTPEL 235 (297)
T ss_pred --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--------------eccCCCCCC
Confidence 1234578899999999888899999999999999999999999975443221100 000011111
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+...+..+.+++.+||..+|++|||++++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122345677899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=291.41 Aligned_cols=258 Identities=23% Similarity=0.274 Sum_probs=189.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcC---CCCceeeecceeec-----
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQT---HHKNLVRLLGFCDE----- 130 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~----- 130 (350)
|++.+.||+|+||.||+|....++ ..+++|.+..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSG---HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCC---cEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 456678999999999999976654 5688998764321 1223455677666654 79999999998754
Q ss_pred CCeeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 131 GQNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 131 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
....+++|||+.+ +|.+++... ..+++..++.++.|++.|+.||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCc
Confidence 3457899999985 888887643 34789999999999999999999 55999999999999999999999999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh---c
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---N 285 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~---~ 285 (350)
+........ .....++..|+|||++.+..++.++||||+||++|+|++|..||........... ...... .
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~---~~~~~~~~~~ 228 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK---IFDLIGLPPE 228 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH---HHHHhCCCCh
Confidence 976543221 1234578899999999888899999999999999999999999975543321110 000000 0
Q ss_pred CCcchh-------cccccc---CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 286 GKLDDL-------VEGDME---AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 286 ~~~~~~-------~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+... ...... .......+..+.+++.+||+.||++|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 000000 0011235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=295.35 Aligned_cols=197 Identities=21% Similarity=0.385 Sum_probs=157.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeec--CCeeEEEEecCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE--GQNRLLAYEFLN 142 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 142 (350)
+.||+|+||.||+|..... .....+++|.+... .....+.+|+.+++.++||||+++++++.. ....+++|||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~-~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDG-KDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred cccccCCCeEEEEEEEccC-CCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 5799999999999986543 23456899987543 224567889999999999999999998854 456789999986
Q ss_pred CCChhhhhcC---------CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCceEEeecccc
Q 046877 143 NGTLASFLFG---------NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL----NDRYNARISDFGLA 209 (350)
Q Consensus 143 ~g~L~~~l~~---------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~ 209 (350)
+ +|.+++.. ...+++..++.++.|++.||.||| +.+++||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 78777632 134788889999999999999999 5599999999999999 45678999999999
Q ss_pred cccccCccc-ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCccc
Q 046877 210 KLLTLNQRK-TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEM 268 (350)
Q Consensus 210 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~ 268 (350)
......... .......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 865432211 112345678999999998764 58899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=287.64 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=199.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+++.+.||.|++|.||+|....+ +..+++|.+.... ......+.+|+.+++.++|+|++++.+++.++...++++|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRT---NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCC---CeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 45667899999999999987654 3568999886443 3334578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++++|.+++... .+++..+..++.|++.|+.||| ..+++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 153 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-- 153 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--
Confidence 99999999998654 7899999999999999999999 55999999999999999999999999999987654321
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
......++..|+|||.+.+..++.++||||||+++|+|+||..||...+..... .....+.....
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-------~~~~~~~~~~~-------- 218 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-------FLIPKNNPPSL-------- 218 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-------HHhhhcCCCCC--------
Confidence 112345788899999999888999999999999999999999999754421110 01111111111
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....++..+.+++.+||..+|++|||++++++
T Consensus 219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11115678999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=300.15 Aligned_cols=261 Identities=23% Similarity=0.286 Sum_probs=192.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCC----
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ---- 132 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 132 (350)
..|.+.+.||+|+||.||++....+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVL---GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCC---CceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4566678899999999999986554 3568999885432 233456888999999999999999999885443
Q ss_pred --eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 133 --NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 133 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
..+++|||+++ +|...+. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 47999999976 5666553 34788889999999999999999 5599999999999999999999999999997
Q ss_pred ccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHH--------------
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-------------- 276 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~-------------- 276 (350)
...... ......+|..|+|||++.+..++.++||||+||++|+|++|+.||...+........
T Consensus 172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 172 TACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 543221 113346789999999999989999999999999999999999999755432211000
Q ss_pred --HHHHHHhhc-CCcc-----hhcccc---ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 277 --DWAFDCYRN-GKLD-----DLVEGD---MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 277 --~~~~~~~~~-~~~~-----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......... .... +..... .........+..+.+++.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 0000 000000 000011123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=304.25 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=194.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+++.+.||+|+||.||++....++ ..+|+|.+.... ......+.+|+.++..++||||+++++.+.+.+..+++
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTG---HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 345678999999999999976654 468999886432 23345688899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++|+|.+++.+...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999999988888999999999999999999999 55999999999999999999999999999865422110
Q ss_pred c---------------------------------ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCC
Q 046877 218 K---------------------------------TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264 (350)
Q Consensus 218 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf 264 (350)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011246899999999999999999999999999999999999999
Q ss_pred CcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 046877 265 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT---MRKVS 330 (350)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~vl 330 (350)
......... ..+.... .....+.....+.++.+++.+++. ||.+|++ +++++
T Consensus 237 ~~~~~~~~~-------~~i~~~~------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 237 CSETPQETY-------RKVMNWK------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCHHHHH-------HHHHcCC------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 755433211 1111100 000111111245678889988764 9999996 45544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=285.70 Aligned_cols=250 Identities=26% Similarity=0.449 Sum_probs=197.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.+.||+|+||.||++..... ..+++|.+... ......+.+|+++++.++|||++++++++......+++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~----~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEK----RKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCC----CeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 345668899999999999986532 34888887643 2335678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|.+++... ..+++..++.++.|++.+++|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999998653 457889999999999999999994 59999999999999999999999999998765432211
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
......++.+|+|||.+.+..++.++||||+|+++|+|++ |..||......... ..+..+ ..
T Consensus 157 -~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~---------~~ 219 (256)
T cd05112 157 -SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV-------ETINAG---------FR 219 (256)
T ss_pred -ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH-------HHHhCC---------CC
Confidence 1122234568999999988889999999999999999998 99999644322211 111111 01
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 0111123578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=287.40 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=198.6
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
..+...+.||+|+||.||+|....+ +..+++|.+.... ....+.+.+|+.+++.++||||+++++++..++..+++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRT---KEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCC---CeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 3455567899999999999986544 3568999876432 23345789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.+++. ...+++..+..++.|+++|+.||| ..+++|+||+|+||++++++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 81 MEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999999885 456789999999999999999999 55999999999999999999999999999876543221
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ....+ ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~---------~~ 218 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIPKN---------SP 218 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhhcC---------CC
Confidence 1123457889999999998889999999999999999999999986433222110 00111 11
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......++..+.+++.+||+.+|++|||+.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1112245678999999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=287.81 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=199.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+++.+.||.|+||.||++....+ +..+++|..........+.+.+|+.+++.++|||++++++.+..+...+++||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKET---GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCC---CcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 466778899999999999987654 35689998876555556778899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|.+++... ..+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999999998653 568999999999999999999994 5999999999999999999999999999875543221
Q ss_pred ceeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 219 TIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
......++..|+|||.+. ...++.++|+||+|+++|+|++|+.||......... .....+...
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~---- 226 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL-------LKILKSEPP---- 226 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH-------HHHhcCCCC----
Confidence 113345788999999875 334677999999999999999999999754322211 001111110
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....+..++.++.+++.+||+.+|++||++.++++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 227 ---TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ---CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 11112245678999999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=305.18 Aligned_cols=244 Identities=26% Similarity=0.347 Sum_probs=202.0
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGT 145 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 145 (350)
.||+|+||+||.|++..+ ....|+|.+.........-+.+|+.+.+.++|.|||+++|.+.+++.+-+.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~t---qvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDT---QVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccc---eeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 399999999999997665 45689998876655556668999999999999999999999999999999999999999
Q ss_pred hhhhhcCC-CCc--ChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEeecccccccccCccccee
Q 046877 146 LASFLFGN-LKP--NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLNQRKTIK 221 (350)
Q Consensus 146 L~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 221 (350)
|.++++.. +++ ++..+..+.+||++||.|||++ .|||||||-+|+|++ -.|.+||+|||-++++..-. .+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~T 733 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCT 733 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC--ccc
Confidence 99999643 566 7788889999999999999965 999999999999997 47889999999998765332 333
Q ss_pred eccccCCCccCcccccCC--CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 222 TAIRGTKGYVAPEWFRKS--TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 222 ~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
..+.||..|||||++..+ .|+.++|||||||++.||.||++||.....+... + .+.-......+
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-M-------------FkVGmyKvHP~ 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-M-------------FKVGMYKVHPP 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-h-------------hhhcceecCCC
Confidence 567799999999999765 5899999999999999999999999643332221 0 11111122344
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+...+.+...+|.+|+..||.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 56678899999999999999999999999984
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=284.78 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=200.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+...+.||.|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++||||+++++.+.+....+++|
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQ---QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCC---EEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 3445677999999999999876543 468898876432 334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|.+++.. ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999999999864 56788899999999999999999 55999999999999999999999999999976543221
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
......++..|+|||.+.+..++.++|+||||+++|+|+||..||.......... ........
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF----------------LIPKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----------------hhhcCCCC
Confidence 1123357788999999988889999999999999999999999997543222110 00111112
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
.....++..+.+++.+||+.+|++||+++++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2234577889999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=302.49 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=200.3
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeec-cccccHHHHHHHHHHHhcCCCCceeeecceeecCCe--eEEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR-VFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN--RLLAY 138 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~ 138 (350)
.|.+.||+|+|-+||+|.+..++....-..+|.-+. ..+...+++..|+.+|+.|+||||+++++++.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 456789999999999999765543322222222111 123344789999999999999999999999977655 77999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|.+..|+|..|+.+.+..+...++.|++||++||.|||.+ ..+|+|||||.+||||+ ..|.|||+|+|+|........
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 9999999999999999999999999999999999999987 78999999999999997 568999999999987754332
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
....|||.|||||... ..|++.+||||||++++||.|+.+||.-...... .++..-+|.....+..-.
T Consensus 202 ----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ------IYKKV~SGiKP~sl~kV~- 269 (632)
T KOG0584|consen 202 ----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ------IYKKVTSGIKPAALSKVK- 269 (632)
T ss_pred ----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH------HHHHHHcCCCHHHhhccC-
Confidence 3467999999999987 7899999999999999999999999975554443 233334444443333211
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+++++||.+|+.. ..+|||+.|+|.
T Consensus 270 -------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 -------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 25899999999999 999999999984
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=284.77 Aligned_cols=241 Identities=26% Similarity=0.433 Sum_probs=189.3
Q ss_pred hccCCCccceEEEEEEcCCCc-------ceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 65 EEVGRGSFGIIYKGVIQTTTT-------STTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~-------~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.||+|+||.||+|.+..+.. ....+++|........ ...+.+|+.+++.++||||+++++++.. ...+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 368999999999999876541 1234677766543222 6788999999999999999999999888 778999
Q ss_pred EecCCCCChhhhhcCCC-CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-------ceEEeecccc
Q 046877 138 YEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-------NARISDFGLA 209 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-------~~kl~Dfg~~ 209 (350)
|||+++|+|.+++.... .+++..+..++.|++.|++||| +.+++|+||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999997655 6889999999999999999999 55999999999999999887 7999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCC--CCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcC
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKS--TISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG 286 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 286 (350)
...... ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+... .....
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~~~ 222 (259)
T cd05037 156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQDQ 222 (259)
T ss_pred cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHhcC
Confidence 765431 223466789999999876 78899999999999999999 577775443221110 00000
Q ss_pred CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
.. ... .....+.+++.+||..+|++|||+.++++.|+
T Consensus 223 ~~-------~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HR-------LPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC-------CCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 000 01168899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=287.08 Aligned_cols=250 Identities=21% Similarity=0.353 Sum_probs=196.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+++.+.||+|+||.||++....+ +..+++|.+... .......+.+|+.+++.++||||+++++.+...+..+++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~---~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPT---GVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCC---CcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 356778899999999999987654 356888877543 2233467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC---CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 139 EFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 139 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
||+++++|..++... ..+++..+..++.|++.|+.|||+ ..+++|+||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999988653 368999999999999999999995 348999999999999999999999999998755322
Q ss_pred cccceeeccccCCCccCcccccCC------CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKS------TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
. .....++..|+|||.+.+. .++.++|+||+||++|+|++|+.||.......... .......+.
T Consensus 157 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~-- 226 (286)
T cd06622 157 L----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA----QLSAIVDGD-- 226 (286)
T ss_pred c----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH----HHHHHhhcC--
Confidence 1 1233477899999998543 35789999999999999999999996433211110 000011111
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....+.+++.++.+++.+||+.+|++||++++++.
T Consensus 227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 -------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11122346788999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=300.59 Aligned_cols=241 Identities=22% Similarity=0.270 Sum_probs=186.8
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcC---CCCceeeecceeecCCeeEEEEec
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQT---HHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
||+|+||.||+|+...++ ..+|+|.+..... ........|..++... +||||+++++.+.+.+..+++|||
T Consensus 1 lG~G~~g~Vy~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTR---RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCC---CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 799999999999876553 4689998864321 1223344555565544 799999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++|+|.+++.....+++..++.++.|+++|++||| +.+++||||||+||+++.++.++|+|||++........ .
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~ 152 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T 152 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence 999999999988888999999999999999999999 55999999999999999999999999999875432221 1
Q ss_pred eeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 221 KTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.....||..|+|||++.+. .++.++||||+||++|+|++|..||........ ...+..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~--------~~- 216 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-------YRNIAFGKV--------RF- 216 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-------HHHHHcCCC--------CC-
Confidence 2345689999999998764 578999999999999999999999975443221 111111111 11
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRPT----MRKVSQ 331 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rps----~~~vl~ 331 (350)
.....+.++.+++.+||..||++||+ +.++++
T Consensus 217 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11124578899999999999999984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=283.10 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=200.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.+.||+|+||.||+|....++ ..+++|.+..... .+++.+|+++++.++|||++++++++.+....++++|
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETG---QVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCC---cEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 4566788999999999999876543 4688888765422 6789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|.+++.. ...+++..+..++.|+++|+.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999999864 4567999999999999999999995 5999999999999999999999999999886654321
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||........... ... ......
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~-------~~~~~~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPN-------KPPPTL 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hcc-------CCCCCC
Confidence 11233478899999999888899999999999999999999999975433221100 000 000111
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..++..+.+++.+||+.||++|||++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 122345678999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=286.42 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=193.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecC------C
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG------Q 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~ 132 (350)
.++..+.||+|+||.||+|....++ ..+++|..... ......+..|+.+++.+ +|||++++.+++... .
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~---~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTG---QLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCC---cEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3455678999999999999876553 56889987654 34456788999999998 799999999998643 4
Q ss_pred eeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
..+++|||+.+++|.+++... ..+++..+..++.|++.|++|||+ .+++|+||+|+||++++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 578999999999999998753 467899999999999999999995 599999999999999999999999999987
Q ss_pred ccccCcccceeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
....... ......++..|+|||++. +..++.++|+||+||++|+|++|..||.......... . ...
T Consensus 160 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~-~~~ 230 (272)
T cd06637 160 QLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------L-IPR 230 (272)
T ss_pred ecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------H-Hhc
Confidence 5533221 123345788999999986 2357889999999999999999999996433221110 0 000
Q ss_pred CCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..........++..+.+++.+||..||.+|||+.++++
T Consensus 231 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 --------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 01111112235678999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=285.95 Aligned_cols=245 Identities=25% Similarity=0.336 Sum_probs=193.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
..||+|+||.||+|....+ +..+++|.+........+.+.+|+.+++.++|+||+++++++..++..++++||++++
T Consensus 14 ~~lg~g~~g~v~~~~~~~~---~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 14 VVLGKGTYGIVYAARDLST---QVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred EEEecCCceEEEEeEecCC---CcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 4699999999999986554 3568999877655555678999999999999999999999999999999999999999
Q ss_pred ChhhhhcCC-CCc--ChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEeecccccccccCcccce
Q 046877 145 TLASFLFGN-LKP--NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND-RYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 145 ~L~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+|.+++... ..+ ++..+..++.|++.|++||| +.+++|+||||+||+++. ++.++|+|||++........ .
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~ 165 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--C 165 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--c
Confidence 999998653 344 77888899999999999999 559999999999999976 67899999999876543221 1
Q ss_pred eeccccCCCccCcccccCC--CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 221 KTAIRGTKGYVAPEWFRKS--TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.......... +. .. . .....
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~-----~~----~--~~~~~ 231 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FK-----VG----M--FKIHP 231 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hh-----hh----h--hccCC
Confidence 1233578899999998654 37889999999999999999999996433211110 00 00 0 00111
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..+++++.+++.+||+.+|++|||+.++++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 122345678999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=292.78 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=195.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.+.+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++||||+++++++..++..+++|
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTD---NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCC---cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 3556678999999999999876543 468899876432 233456788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++ +|..++.. ...+++..+..++.|+++|+.||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99975 88887754 356788999999999999999999 55999999999999999999999999999875432221
Q ss_pred cceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc---
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE--- 293 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 293 (350)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+..+................+.....
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 11233468899999998654 578899999999999999999999976544322111000000000011111100
Q ss_pred ------ccccC----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 ------GDMEA----MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ------~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+.... ......+..+.+++.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 011235668899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=296.14 Aligned_cols=253 Identities=19% Similarity=0.223 Sum_probs=192.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+++.+.||+|+||.||++....++ +.+|+|.+.... ......+.+|..++..++|+||+++++++.+++..++|
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTG---QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCC---CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 456788999999999999976654 468999886421 22345588899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++|+|.+++.+ ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999965 457889999999999999999999 5599999999999999999999999999987554322
Q ss_pred ccceeeccccCCCccCcccccC-----CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRK-----STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
.. ......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||......+.. ...........+
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~~ 229 (331)
T cd05597 157 TV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEHFQF 229 (331)
T ss_pred Cc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCcccC
Confidence 11 1123458999999999863 45788999999999999999999999754332211 011111110000
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPS--LRPTMRKVSQM 332 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~--~Rps~~~vl~~ 332 (350)
.......+..+.+++.+|+..+++ .|++++++++.
T Consensus 230 ------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 ------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 011112567889999997765333 37888888754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=293.06 Aligned_cols=250 Identities=22% Similarity=0.251 Sum_probs=198.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc---cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD---GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
++..+.||+|+||.||+|....+ +..+++|.+...... ....+.+|+..++.++||||+++++.+......+++
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCC---CcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 34567899999999999987654 356899988654322 345688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||+.+++|.+++... ..+++..+..++.|+++|++||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999998643 56789999999999999999999 559999999999999999999999999998754322
Q ss_pred cccc---------------------------eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCccc
Q 046877 216 QRKT---------------------------IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEM 268 (350)
Q Consensus 216 ~~~~---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~ 268 (350)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1100 0112357888999999998889999999999999999999999997554
Q ss_pred chhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 046877 269 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT----MRKVSQ 331 (350)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~vl~ 331 (350)
...... ...............+..+.+++.+||..||++||| +++++.
T Consensus 237 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDETFS---------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHHHH---------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 322110 011111111222225789999999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=300.37 Aligned_cols=239 Identities=24% Similarity=0.318 Sum_probs=197.6
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
+.||.|+||.||-|.+..+. ..||||+..-. +.....++..|++.|++++|||++.+.++|-.+...|+|||||
T Consensus 32 rEIGHGSFGAVYfArd~~n~---evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC 108 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC 108 (948)
T ss_pred HHhcCCccceeEEeeccCcc---ceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH
Confidence 56999999999999876554 56999998532 2233456889999999999999999999999999999999999
Q ss_pred CCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 142 NNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 142 ~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
-| +-.|++. ..+++.+..+..|+.+.+.||+||| +.+.||||||..|||+++.|.|||+|||.+....+.
T Consensus 109 lG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 109 LG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred hc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 76 7777774 4577888899999999999999999 679999999999999999999999999999877654
Q ss_pred eeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 221 KTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
..++|||.|||||++. .+.|+.|+||||||++..||.-.++|+...+.-... -.+......
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL---------------YHIAQNesP 243 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------------YHIAQNESP 243 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH---------------HHHHhcCCC
Confidence 3567999999999984 568999999999999999999999998644332211 111122222
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......++.+++|+..||++-|++|||.++++.
T Consensus 244 tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3334578899999999999999999999998864
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=282.62 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=200.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|++.+.||.|+||.||.++...++ ..+++|.+... ......++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDD---SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCC---cEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 456688999999999999866543 45888887543 2344567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+++++|.+++... ..+++..+..++.|++.+++||| +.+++|+||+|+||++++++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999998654 45788999999999999999999 4599999999999999999999999999987654333
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......+.. ..+..+...
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~-------~~~~~~~~~------- 219 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV-------VKIVQGNYT------- 219 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHcCCCC-------
Confidence 1 123345789999999998888899999999999999999999999754332211 011111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
.....++.++.+++.+||..+|++|||+.++++.
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 --PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1113456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=298.44 Aligned_cols=261 Identities=23% Similarity=0.265 Sum_probs=192.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC-----
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG----- 131 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 131 (350)
..+.+.+.||+|+||.||++....++ ..+++|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCC---cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45667788999999999999866553 458999886432 23345678899999999999999999987543
Q ss_pred -CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 132 -QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 132 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
...+++|||+++ +|...+. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999976 6777664 34778889999999999999999 5599999999999999999999999999997
Q ss_pred ccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHH-------------
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD------------- 277 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~------------- 277 (350)
...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+......
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 654321 1234468899999999999899999999999999999999999997554322110000
Q ss_pred ---HHHHHhhcC-Cc-----chhcccc---ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 278 ---WAFDCYRNG-KL-----DDLVEGD---MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 278 ---~~~~~~~~~-~~-----~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......+. .. ....... ............+.+++.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000 00 0000000 000111123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.16 Aligned_cols=244 Identities=27% Similarity=0.402 Sum_probs=195.5
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
..||+|+||.||++....++ ..+++|.+........+.+.+|+..++.++|+|++++++.+...+..+++|||++++
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTG---KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hcccCCCCeEEEEEEECCCC---CEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 56999999999999865543 468999886554555667889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeecc
Q 046877 145 TLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224 (350)
Q Consensus 145 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 224 (350)
+|.+++. ...+++..+..++.|++.|++||| +.+++|+||+|+||++++++.++|+|||++......... ....
T Consensus 105 ~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 178 (292)
T cd06658 105 ALTDIVT-HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSL 178 (292)
T ss_pred cHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Ccee
Confidence 9999884 346889999999999999999999 459999999999999999999999999998754322211 1234
Q ss_pred ccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHH
Q 046877 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 304 (350)
Q Consensus 225 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......... ...... ..... ......
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-------~~~~~~-----~~~~~--~~~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-------RRIRDN-----LPPRV--KDSHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhc-----CCCcc--cccccc
Confidence 5788999999998888999999999999999999999999754332211 001100 00000 011134
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 305 VEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 305 ~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+..+.+++.+||..||.+|||++++++
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=287.06 Aligned_cols=248 Identities=25% Similarity=0.299 Sum_probs=195.2
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+..+.||+|+||.||++....++ +.+++|.+..... .....+.+|+.+++.++|+|++++.+.+.+.+..+++|
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCC---ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 44577999999999999876653 5689998764321 22345778999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+.+++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999988533 35788899999999999999999 5699999999999999999999999999987543222
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. ....|+..|+|||.+.+..++.++||||+|+++|+|++|+.||............. ..... .
T Consensus 157 ~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~-----~----- 220 (285)
T cd05630 157 TI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE-----V----- 220 (285)
T ss_pred cc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhh-----h-----
Confidence 11 23458899999999998889999999999999999999999997543321110000 00000 0
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPT-----MRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~vl~ 331 (350)
.......++..+.+++.+||+.||++||| ++++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00111234567899999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=289.45 Aligned_cols=262 Identities=24% Similarity=0.304 Sum_probs=193.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+.+.+.||+|++|.||+|....++ ..+++|.+.... ......+.+|+.+++.++|||++++++++.+++..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTG---QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCC---cEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 345678999999999999876553 468999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC---CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 139 EFLNNGTLASFLFG---NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 139 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
||++ ++|.+++.. ...+++..++.++.|+++||+||| ..+++|+||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9998 588887743 256789999999999999999999 559999999999999999999999999998755432
Q ss_pred cccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc------
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL------ 288 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------ 288 (350)
.. ......++..|+|||++.+. .++.++||||||+++|+|+||+.||.......................+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 155 VR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred cc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 21 11233468899999988654 5788999999999999999999999755432221100000000000000
Q ss_pred chh---ccc---cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDL---VEG---DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~---~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
... ... ..........+.++.+++.+||..||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 000 0000011125678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=292.59 Aligned_cols=256 Identities=16% Similarity=0.197 Sum_probs=192.0
Q ss_pred hhhccCCC--ccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 63 FKEEVGRG--SFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 63 ~~~~lg~G--~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+.+.||+| +|++||++..+.+ +..||+|.+.... ......+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPT---GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeeccc---CcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 45789999 6899999987655 3569999886432 233456888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+++|+|.+++.. ...+++..++.++.|++.||+||| +.+++||||||+||+++.++.++++||+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999999854 345789999999999999999999 4599999999999999999999999998654332111
Q ss_pred c-c----ceeeccccCCCccCcccccC--CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 217 R-K----TIKTAIRGTKGYVAPEWFRK--STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 217 ~-~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
. . .......++..|+|||++.+ ..++.++||||+||++|+|++|+.||......... ... ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~------~~~~~~ 228 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEK------LNGTVP 228 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-HHH------hcCCcc
Confidence 0 0 00112245678999999976 46889999999999999999999999743321110 000 000000
Q ss_pred hhc------------------------c------------ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 DLV------------------------E------------GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ~~~------------------------~------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
... . ..........++..+.+++.+||+.||++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 0 00001122345678999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=288.47 Aligned_cols=244 Identities=24% Similarity=0.356 Sum_probs=196.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
..||+|+||.||++....++ ..+++|.+........+.+.+|+.+++.++|||++++++++..++..++++||++++
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSG---RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhcCCCCceeEEEEEEcCCC---CEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 46999999999999865543 468999886544445667889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeecc
Q 046877 145 TLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224 (350)
Q Consensus 145 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 224 (350)
+|..++. ...+++..++.++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 104 ~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 177 (297)
T cd06659 104 ALTDIVS-QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL 177 (297)
T ss_pred CHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccce
Confidence 9998774 456889999999999999999999 55999999999999999999999999999875433221 11234
Q ss_pred ccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHH
Q 046877 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 304 (350)
Q Consensus 225 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
.++..|+|||.+.+..++.++||||+|+++|+|++|+.||......+... .+...... ........
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~-------~~~~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-------RLRDSPPP-------KLKNAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhccCCC-------CccccCCC
Confidence 57889999999988889999999999999999999999997544322111 11111100 01111234
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 305 VEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 305 ~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+..+.+++.+||+.+|++||+++++++
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 567899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=282.48 Aligned_cols=244 Identities=28% Similarity=0.472 Sum_probs=193.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.+.||+|+||.||++... +..+++|..... .....+.+|+.+++.++|||++++++++... ..+++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~-----~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYT-----GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HceeeeeeccCCCCceEecccC-----CCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 4566788999999999998642 234888887543 2346788999999999999999999998665 4799999
Q ss_pred cCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 140 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 140 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|+++++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999999998654 34688889999999999999999 4599999999999999999999999999987543211
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.. .....+ .
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~---------~ 214 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-------ECVEKG---------Y 214 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhCC---------C
Confidence 12234568999999988889999999999999999997 99998654332211 111111 1
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
.......++..+.+++.+||+.+|++||+++++++.|++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111122456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=283.56 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=192.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-----cccHHHHHHHHHHHhcCCCCceeeecceeec--CCe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-----QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE--GQN 133 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 133 (350)
+...+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++||||+++++++.+ ...
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTG---RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCC---cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 345678999999999999866553 468888775322 1223568889999999999999999998865 356
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.++++||+++++|.+++.....+++...+.++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 7899999999999999987777899999999999999999999 5599999999999999999999999999987553
Q ss_pred cCccc-ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 214 LNQRK-TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 214 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
..... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......... ... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~---------~ 222 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKI---------A 222 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHH---------h
Confidence 22111 1112334788999999999888999999999999999999999999743322111 000 0
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........+...+..+.+++ +||..+|++||+++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00011111223456677777 688889999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=287.32 Aligned_cols=263 Identities=23% Similarity=0.320 Sum_probs=198.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+++.+.||+|+||.||+|....+ +..+++|.+.... ....+.+.+|+.+++.++|||++++++++......+++|
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRET---GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCC---CcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 45667899999999999987654 3568888875432 223456789999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|..++.....+++..++.++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 999999998887777778999999999999999999994 59999999999999999999999999999866543211
Q ss_pred ceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH-H-------HhhcCCc-
Q 046877 219 TIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-D-------CYRNGKL- 288 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~-------~~~~~~~- 288 (350)
.....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......+......... . .+.....
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 157 --YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred --ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 123346788999999876 457889999999999999999999997655433221111000 0 0000000
Q ss_pred chhccccccCCC-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDLVEGDMEAMN-----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+...... ....+..+.+++.+||+.+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000000 1134678999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=285.00 Aligned_cols=248 Identities=24% Similarity=0.281 Sum_probs=194.9
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
...+.||+|+||+||++....++ +.+|+|.+.... ......+.+|+.+++.++|+|++.+.+.+..++..+++|
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATG---KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCC---cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 34567999999999999876653 468999876432 122345788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+++++|.+++.. ...+++..+..++.|++.|+.||| +.+++|+||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999988854 346899999999999999999999 5599999999999999999999999999987543221
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||........... .........
T Consensus 157 ~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~--------- 221 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETE--------- 221 (285)
T ss_pred c---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhccc---------
Confidence 1 1234588999999999888899999999999999999999999975433221111 001111110
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPT-----MRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~vl~ 331 (350)
.......+..+.+++..||+.||++||+ +.+++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0111234567899999999999999999 667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=301.91 Aligned_cols=258 Identities=20% Similarity=0.218 Sum_probs=190.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.+.+.||+|+||.||++.+..+. ..|++|... ...+.+|++++++++|+||+++++++..++..+++||+
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~---~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYP---QRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCC---CEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 455677999999999999876653 468888532 23457899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 141 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 141 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
+. ++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 96 5888877543 56899999999999999999999 5599999999999999999999999999997654332222
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCccc-chhhhhHHHHHHHHhhcCCc--chhc----
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKL--DDLV---- 292 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~---- 292 (350)
......||..|+|||++.+..++.++|||||||++|||++|..|+.... ..............+..... ..+.
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2234568999999999999899999999999999999999887653221 11100000001111111000 0000
Q ss_pred ---------------cccccC---CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 293 ---------------EGDMEA---MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 293 ---------------~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000000 000123457889999999999999999999986
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=283.19 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=195.7
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc------ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ------DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
...+.||+|+||.||+|.... +..+++|.+..... .....+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~----~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQ----GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred cccceEeccCCeEEEEEEEcC----CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence 456789999999999997532 34588888753321 12356889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+++||+++++|.+++.....+++..+..++.|++.|++||| ..+++|+||+|+||++++++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999999987778899999999999999999999 458999999999999999999999999998765321
Q ss_pred cc----cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 216 QR----KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 216 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
.. ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||............ ....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~--- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-----GAHRGLM--- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-----hhccCCC---
Confidence 11 11112345788999999999888999999999999999999999999643322111000 0000000
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+..++.++.+++.+||..+|++||++.++++
T Consensus 228 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112235678999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=288.26 Aligned_cols=268 Identities=22% Similarity=0.250 Sum_probs=200.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-----cHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-----GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
+.+.+.||+|+||.||+|....+ +..+++|.+...... ....+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKET---GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNIN 78 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCC---CcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEE
Confidence 34567899999999999987655 346899988654322 2345778999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCC-CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
+||||+ +++|.+++.... .+++..+..++.|+++||.||| ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999999 889999997665 7899999999999999999999 55999999999999999999999999999986654
Q ss_pred CcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC-------
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG------- 286 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~------- 286 (350)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||....+.+.... ........
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK---IFEALGTPTEENWPG 229 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH---HHHHcCCCchhhhhh
Confidence 3211 122345778999998865 4678899999999999999999888875544221110 01100000
Q ss_pred --CcchhccccccC-----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HhcccCCC
Q 046877 287 --KLDDLVEGDMEA-----MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM--LQEVVEVD 340 (350)
Q Consensus 287 --~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~--L~~~~~~~ 340 (350)
............ ......+..+.+++.+||+.||++|||+.++++. +++.....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 000000000000 0112346789999999999999999999999874 44443333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=298.86 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=192.3
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC-----
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG----- 131 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 131 (350)
..+...+.||+|+||.||++....+ +..+++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVL---DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCC---CceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3456678899999999999986544 3568999886432 22345678899999999999999999987543
Q ss_pred -CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 132 -QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 132 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
...+++|||+++ +|...+. ..+++..+..++.|+++||.||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357899999976 6666663 35788889999999999999999 5599999999999999999999999999997
Q ss_pred ccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHH-------------
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD------------- 277 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~------------- 277 (350)
...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 654322 1133468999999999998899999999999999999999999997544322110000
Q ss_pred ---HHHHHhhcC-Ccchh-----cccc-c--cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 278 ---WAFDCYRNG-KLDDL-----VEGD-M--EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 278 ---~~~~~~~~~-~~~~~-----~~~~-~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
......... ..... .... . ........+..+.+++.+||+.||++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00000 0000 0 000111235678999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=308.67 Aligned_cols=261 Identities=19% Similarity=0.255 Sum_probs=188.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC------CCceeeecceeecC-
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH------HKNLVRLLGFCDEG- 131 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~- 131 (350)
..|.+.+.||+|+||+||+|.+..+ +..||+|+++... ........|+.+++.++ |.+++++++++..+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKR---KEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCC---CeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 3456677899999999999987655 3569999986432 22334556666666654 45688888888654
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC------------
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY------------ 199 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~------------ 199 (350)
...+++||++ +++|.+++.+...+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 5788999987 66899988877889999999999999999999994 14899999999999998765
Q ss_pred ----ceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhH
Q 046877 200 ----NARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 275 (350)
Q Consensus 200 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~ 275 (350)
.+||+|||.+...... .....||..|+|||++.+..++.++|||||||++|||++|+.||+..+..+....
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4999999987643221 2345689999999999999999999999999999999999999986554332211
Q ss_pred HHHHHH-----------------Hhh-cCCcchhcccc-----c--cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 276 TDWAFD-----------------CYR-NGKLDDLVEGD-----M--EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 276 ~~~~~~-----------------~~~-~~~~~~~~~~~-----~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
...... .+. .+.......+. . ...........+.+|+.+||+.||++|||+++++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 110000 000 00000000000 0 0000011235688999999999999999999998
Q ss_pred H
Q 046877 331 Q 331 (350)
Q Consensus 331 ~ 331 (350)
+
T Consensus 437 ~ 437 (467)
T PTZ00284 437 T 437 (467)
T ss_pred c
Confidence 6
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=298.49 Aligned_cols=206 Identities=27% Similarity=0.393 Sum_probs=173.6
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CC-----ceeeecce
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HK-----NLVRLLGF 127 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~ 127 (350)
.|....+|++.+.||+|+||.|.+|.+..++ ..||||++++. ..-..+...|+++|..++ |. |+|+++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~---e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTG---EIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCC---cEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 3444446677899999999999999976664 56999999765 344567888999999986 33 89999999
Q ss_pred eecCCeeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--CCceEE
Q 046877 128 CDEGQNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND--RYNARI 203 (350)
Q Consensus 128 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~--~~~~kl 203 (350)
|...++.|||+|.+.. +|.+++..+ ..++...++.++.||+++|.+|| ..+|||+||||+||||.+ ...+|+
T Consensus 257 F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 257 FYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeE
Confidence 9999999999999865 999999765 45779999999999999999999 559999999999999964 346999
Q ss_pred eecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhh
Q 046877 204 SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 272 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~ 272 (350)
+|||.++....... .+..+..|+|||++.+.+|+.+.|||||||++.||++|.+.|.+++.-++
T Consensus 333 IDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred EecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 99999997654332 44567899999999999999999999999999999999998877665443
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=283.16 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=199.6
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+++.+.||+|++|.||++.+..++ ..+++|.+.... .....++.+|+.+++.++||||+++++.+......++++|
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTG---KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCC---cEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 456678999999999999876543 458888876543 2345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|.+++... ..+++..+..++.|+++|++|||+ ..+++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 99999999999765 778899999999999999999994 16999999999999999999999999999875532211
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
....++..|+|||.+.+..++.++||||+|+++|+|++|..||.......... .... . .........
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~-~--------~~~~~~~~~ 223 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FELL-Q--------YIVNEPPPR 223 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HHHH-H--------HHhcCCCCC
Confidence 11457889999999988899999999999999999999999996543211111 1100 0 011111111
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....++.++.+++.+||..||++|||+.+++.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111126778999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=280.68 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=196.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeec-CCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE-GQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 137 (350)
|++.+.||+|++|.||++....++ ..+++|.+.... ....+.+.+|+.+++.++|+|++++.+.+.. ....+++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDG---KQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCC---cEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 456788999999999999876553 458899876432 2334568899999999999999999988764 4467899
Q ss_pred EecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||+++++|.+++.. ...+++.++..++.|++.|+++|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999998864 345789999999999999999999 459999999999999999999999999998765432
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.... ... ...+..
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~-~~~~~~------- 219 (257)
T cd08223 156 CD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYR-IIEGKL------- 219 (257)
T ss_pred CC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHH-HHhcCC-------
Confidence 21 12334578899999999988899999999999999999999999974432211 111 111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+...+..+.+++.+||+.||++|||+.++++
T Consensus 220 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 --PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1112346678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=283.47 Aligned_cols=253 Identities=26% Similarity=0.356 Sum_probs=195.8
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc----------ccHHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ----------DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
...+.||+|+||.||+|....+ +..+++|.+..... ...+.+.+|+.+++.++|||++++++++...
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTT---GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred eecceecccCceEEEEEeecCC---CceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 3456799999999999986554 34688887753211 1124578899999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
+..+++|||+++++|.+++.....+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++++|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999999887888999999999999999999994 5999999999999999999999999999976
Q ss_pred cccCcccceeeccccCCCccCcccccCCC--CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKST--ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
..............++..|+|||.+.... ++.++|+||+|+++|++++|..||......... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~ 231 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM------FKLGNKRSAP 231 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH------HHhhccccCC
Confidence 54322222223345788999999987654 788999999999999999999999633221110 0100000000
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+ .......++..+.+++.+||..+|++|||+.++++
T Consensus 232 ~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PI-----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cC-----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 01 01111235688999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.85 Aligned_cols=264 Identities=25% Similarity=0.310 Sum_probs=200.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+++.+.||+|+||.||+|.+..++ ..+++|.+.... ....+.+.+|+++++.++|+||+++++++..++..+++|
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~---~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATG---EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCC---cEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 456788999999999999876653 468999876432 233467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||++++.+..+..+...+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 999998887777666778999999999999999999995 49999999999999999999999999998876543321
Q ss_pred ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh---------cCCc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---------NGKL 288 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~---------~~~~ 288 (350)
......++..|+|||++.+. .++.++||||+|+++|+|++|..||......+............. ....
T Consensus 157 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 157 -PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred -cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 11334578889999999887 789999999999999999999999975543322111110000000 0000
Q ss_pred ch--hccccc----cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DD--LVEGDM----EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~--~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. ...... ....+..++.++.+++.+||..+|++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 000000 00011124788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=294.10 Aligned_cols=253 Identities=20% Similarity=0.219 Sum_probs=193.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||++..+.++ ..+++|.+.+.. ......+.+|..++..++|+||+++++.+.+.+..++|
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNAD---KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCC---CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 456688999999999999976653 468899875421 22234578899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++|+|.+++.+ ...+++..++.++.|++.|+.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999976 467889999999999999999999 5599999999999999999999999999987543222
Q ss_pred ccceeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 217 RKTIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
. .......||+.|+|||++. ...++.++|||||||++|+|++|+.||......... ..+.......
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~-------~~i~~~~~~~- 227 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------GKIMNHKERF- 227 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCCCccc-
Confidence 1 1112346899999999986 345788999999999999999999999754322211 1111111000
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSL--RPTMRKVSQM 332 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~vl~~ 332 (350)
........++.++.+++.+|+..+++. |++++++++.
T Consensus 228 ----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000111235678899999988654444 6888888654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=281.20 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=207.1
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+..+.+.+.||+|+||.||+|.++.+ +..+|+|++.. .....++..|+.++.+++.|++|+++|.+.....+++
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~Es---G~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRES---GHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhcc---CcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 344556678899999999999987765 46799998754 3446788999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 137 AYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 137 v~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||||..|+..+.++ ++.++++..+..+++..++||+|||.. .-+|||||..|||++.+|.+||+|||.+..+...
T Consensus 106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 999999999999987 457889999999999999999999964 7799999999999999999999999999876543
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc--c
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV--E 293 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 293 (350)
... .....||+.|||||++..-.|+.++||||||++..||..|++||..-.+-- ...++ .
T Consensus 183 MAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------AIFMIPT~ 244 (502)
T KOG0574|consen 183 MAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------AIFMIPTK 244 (502)
T ss_pred HHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------eeEeccCC
Confidence 211 234579999999999998899999999999999999999999996322111 11111 1
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+..-...+...+.++-+++++||.+.|++|.|+-++++
T Consensus 245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 22223346678899999999999999999999888764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.27 Aligned_cols=258 Identities=22% Similarity=0.273 Sum_probs=189.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecC------
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG------ 131 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 131 (350)
.|...+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLR---QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCC---CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4566788999999999999866553 4689998864322 2345677899999999999999999987533
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
...+++++++ +++|.+++. ...+++..+..++.|+++||.||| +.+++||||||+||++++++.+||+|||++..
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 4568999987 668888774 457899999999999999999999 55999999999999999999999999999986
Q ss_pred cccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHH-HH-------HHHH
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-DW-------AFDC 282 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~-~~-------~~~~ 282 (350)
..... ....++..|+|||++.+ ..++.++||||+||++|+|++|+.||...+........ .. ....
T Consensus 168 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 168 ADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred cCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 23457899999999876 46889999999999999999999999754332211000 00 0000
Q ss_pred hhcCCcchhccccccCCC-------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 283 YRNGKLDDLVEGDMEAMN-------DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+........... ..... ....+..+.+++.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 243 ISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred cchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 00000 0112356789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=281.69 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=197.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc----------ccccHHHHHHHHHHHhc-CCCCceeeecceee
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV----------FQDGEKEFKNEVIVIGQ-THHKNLVRLLGFCD 129 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~ 129 (350)
+.+.+.||+|+||.||+|....++ ...+++|.+... ......++.+|+.++.+ ++|||++++++++.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~--~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNG--QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCC--CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 455678999999999999976532 356888876422 12223456778887765 69999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEee
Q 046877 130 EGQNRLLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISD 205 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D 205 (350)
+.+..+++|||+++++|.+++. ....+++..++.++.|++.++.|||+ ..+++|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988873 34567889999999999999999994 24799999999999999999999999
Q ss_pred cccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 206 FGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 206 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... .....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~-------~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA-------TKIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH-------HHHhh
Confidence 99998655432 223455788999999999888999999999999999999999999643322111 11111
Q ss_pred CCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
+... ......++..+.+++.+||+.||++||++.++.+++++
T Consensus 228 ~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1111 11111345789999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=293.70 Aligned_cols=252 Identities=18% Similarity=0.215 Sum_probs=192.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||+++...++ ..+|+|.+.... ......+.+|..++..++|+||+++++++.+.+..+++
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTE---RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 456688999999999999876553 468999876421 22334578899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999976 467889999999999999999999 5599999999999999999999999999997654332
Q ss_pred ccceeeccccCCCccCcccccC-----CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRK-----STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
.. ......|+..|+|||++.+ ..++.++||||+|+++|+|++|+.||......+.. ..+...... .
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-------~~i~~~~~~-~ 227 (331)
T cd05624 157 TV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------GKIMNHEER-F 227 (331)
T ss_pred ce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH-------HHHHcCCCc-c
Confidence 21 1123458999999999865 45788999999999999999999999754332211 111111000 0
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSL--RPTMRKVSQ 331 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~vl~ 331 (350)
.......+.+.++.+++.+|+..++++ |++++++++
T Consensus 228 ----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 ----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred ----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 000111234678999999999865544 457777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=281.88 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=198.0
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc------ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ------DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
+..+.||+|++|.||++....++ ..+++|.+..... ...+.+.+|+++++.++|+|++++++++.+.+..+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~---~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTG---TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred cccceecCcCceEEEEEEEcCCC---cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence 44577999999999999865543 4588888754321 12457889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~ 214 (350)
+++||+++++|.+++.....+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999999987778899999999999999999999 45999999999999998775 599999999876654
Q ss_pred Cccc--ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 215 NQRK--TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 215 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||........... .. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~---------~~~ 224 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IF---------KIA 224 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HH---------HHh
Confidence 3111 111234578899999999888899999999999999999999999964332211110 00 000
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........+...+.++.+++.+||..+|++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001111223346678999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=288.34 Aligned_cols=263 Identities=24% Similarity=0.308 Sum_probs=197.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+++.+.||+|+||.||+|....++ ..+++|.+..... ...+.+.+|+++++.++||||+++++++..++..++++
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETG---QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCC---CEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 456688999999999999876543 4588888754322 23456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|..+......+++..++.++.|+++|++|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 999999998887766678999999999999999999994 5999999999999999999999999999876543321
Q ss_pred ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh--------hcCCc-
Q 046877 219 TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY--------RNGKL- 288 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~- 288 (350)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+...-........ .....
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 11234578899999998753 57789999999999999999999997544322111000000000 00000
Q ss_pred chhcccccc-----CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDLVEGDME-----AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+... .....+.+..+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 0011235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=290.17 Aligned_cols=197 Identities=21% Similarity=0.388 Sum_probs=157.3
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceee--cCCeeEEEEecCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCD--EGQNRLLAYEFLN 142 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~ 142 (350)
..||+|+||.||+|...+. .....+++|.+... .....+.+|+.+++.++||||+++++++. .....+++|||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~-~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDG-KDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCC-CccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4699999999999986543 23466899987643 23446788999999999999999999884 4567889999987
Q ss_pred CCChhhhhcC---------CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCceEEeecccc
Q 046877 143 NGTLASFLFG---------NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL----NDRYNARISDFGLA 209 (350)
Q Consensus 143 ~g~L~~~l~~---------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~ 209 (350)
+ +|.+++.. ...+++..++.++.|++.||.||| +.+++||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 6 77776631 134678889999999999999999 5599999999999999 46678999999999
Q ss_pred cccccCccc-ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCccc
Q 046877 210 KLLTLNQRK-TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEM 268 (350)
Q Consensus 210 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~ 268 (350)
......... .......+|..|+|||.+.+. .++.++||||+||++|+|+||..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 865433211 112334578999999998764 57899999999999999999999997443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=280.41 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=198.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|.+.+.||+|+||.+|++....+ +..+++|.+... ......++.+|+.+++.++||||+++.+++...+..++++
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKED---GKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCC---CCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 45667899999999999987654 346899987643 2233457899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+++++|.+++... ..+++..++.++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999988643 35688899999999999999999 4599999999999999999999999999997654322
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......+.. ... ..+..
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~-~~~~~-------- 218 (256)
T cd08218 156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV------LKI-IRGSY-------- 218 (256)
T ss_pred hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH------HHH-hcCCC--------
Confidence 11 12334788899999998888999999999999999999999999744322211 011 11111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+..++.++.+++.+||+.+|++||++.++++
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 -PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1122345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=295.17 Aligned_cols=256 Identities=18% Similarity=0.249 Sum_probs=187.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.+.||+|+||.||+|....++ ..+++|..... ....|+.+++.++||||+++++++......+++||
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQP---DPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCC---ceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4667788999999999999876553 45888864322 23568999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
++.+ +|.+++.. ...+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 138 ~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 138 HYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred ccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 9965 77777753 466899999999999999999999 4599999999999999999999999999987432211
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCC-CcccchhhhhH---HHHHHHHhhc-C----Ccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAIL---TDWAFDCYRN-G----KLD 289 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf-~~~~~~~~~~~---~~~~~~~~~~-~----~~~ 289 (350)
......||..|+|||++.+..++.++|||||||++|+|+++..|+ ........... .......+.. + .+.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 112345899999999999889999999999999999999866554 32211100000 0001110000 0 000
Q ss_pred ---------hhccc---------cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 ---------DLVEG---------DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ---------~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+... ........+.+..+.++|.+||+.||.+|||+.++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00000 0000111234556778999999999999999999874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=274.22 Aligned_cols=274 Identities=22% Similarity=0.283 Sum_probs=212.3
Q ss_pred cccCHHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecce
Q 046877 49 RCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGF 127 (350)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 127 (350)
.+..+.|+.+.+.+ .||+|+++.|-.+....+ +..+|||++++.......++.+|+.++... .|+||+.++++
T Consensus 71 ~~g~F~d~YkLt~e---~LGeGAyasVqtcv~i~t---~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief 144 (463)
T KOG0607|consen 71 LSGKFEDMYKLTSE---LLGEGAYASVQTCVSIQT---GKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF 144 (463)
T ss_pred ccchHHHHHHhHHH---HhcCccceeeeeeeeecc---chhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH
Confidence 34556777666544 599999999999886655 456999999988777788999999999998 69999999999
Q ss_pred eecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEe
Q 046877 128 CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN---ARIS 204 (350)
Q Consensus 128 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~ 204 (350)
|+++..+|+|||.+.||+|..++.++..+++..+.++..+|+.||.+|| .++|.|||+||+|||-.+... +|||
T Consensus 145 FEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 145 FEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred hcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeee
Confidence 9999999999999999999999999999999999999999999999999 559999999999999865443 8999
Q ss_pred ecccccccccCcccc-----eeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhh
Q 046877 205 DFGLAKLLTLNQRKT-----IKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 274 (350)
Q Consensus 205 Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~ 274 (350)
||.+........... ......|...|||||+.. ...|+.+.|.||||+++|-|++|.+||.+.++.+-.+
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 999876443221111 113456788999999863 3368999999999999999999999998877654332
Q ss_pred HHHHHHHHhhcCCcchhccccccCC--CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 275 LTDWAFDCYRNGKLDDLVEGDMEAM--NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
-.+.+++.-.+.-+..+-+.....+ .....+.+..+++...+..|+.+|.++..++.
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 2221211111111111212222211 12356788999999999999999999988875
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=280.45 Aligned_cols=249 Identities=20% Similarity=0.257 Sum_probs=193.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-----cccHHHHHHHHHHHhcCCCCceeeecceeecC--Ce
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-----QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--QN 133 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 133 (350)
+.+.+.||+|+||.||.+....++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~---~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTG---RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCC---cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 345678999999999999876553 468888775321 12235688899999999999999999988663 56
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.+++|||+++++|.+++.....+++.....++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 7899999999999999977777888999999999999999999 4599999999999999999999999999987553
Q ss_pred cCccc-ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 214 LNQRK-TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 214 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... . ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~------~---------~~ 222 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF------K---------IA 222 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH------H---------Hh
Confidence 22111 11123357889999999988889999999999999999999999996432221110 0 00
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........+...+..+.+++.+||. +|++||+++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1111122334566788999999995 9999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=280.64 Aligned_cols=246 Identities=27% Similarity=0.379 Sum_probs=197.2
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-----cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-----QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
...+.||+|+||.||+|....++ ..+++|.+.... ....+.+.+|+.+++.++|+|++++++++.+....++
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDG---DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred cccceeeecCCceEEEEEEcCCC---cEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 34577999999999999876443 458888875432 2244678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
++||+++++|.+++.....+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999999987777899999999999999999999 5599999999999999999999999999987654332
Q ss_pred ccceeeccccCCCccCcccccCCC-CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKST-ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
......++..|+|||.+.... ++.++|+||||+++|+|++|..||......... ..........
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~------ 221 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSKELP------ 221 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHHHhcccCC------
Confidence 123445788999999987766 889999999999999999999999654321111 0000001111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..++..+.+++.+||+.+|++||++.+++.
T Consensus 222 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 ---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111235678899999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.59 Aligned_cols=256 Identities=22% Similarity=0.290 Sum_probs=196.4
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceeec-
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE- 130 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 130 (350)
.+.....|.+.+.||+|+||.||+|.+..+ ...+++|.+... .......+..|+.+++.++||||+++++++..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~t---g~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRT---QEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCC---CeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 444455677788999999999999997655 356788877532 22334678899999999999999999998744
Q ss_pred -CCeeEEEEecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCCeEEcC----
Q 046877 131 -GQNRLLAYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDC----SSQIIHCDIKPQNILLND---- 197 (350)
Q Consensus 131 -~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~----~~~i~H~dlkp~Nill~~---- 197 (350)
...+++||||+++++|.+++.. ...+++..++.|+.||+.||.|||+.. ..+|+|+||||+|||++.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4568999999999999998864 356899999999999999999999641 146999999999999964
Q ss_pred -------------CCceEEeecccccccccCcccceeeccccCCCccCcccccC--CCCCCCCcchhHHHHHHHHHhCCC
Q 046877 198 -------------RYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK--STISAKVDVYSFGVLLLEIISCRK 262 (350)
Q Consensus 198 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~ 262 (350)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|+||..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 23489999999976543221 133468999999999864 458899999999999999999999
Q ss_pred CCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 263 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 263 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
||......... ...+..+. .......+.++.+||..||+.+|.+|||+.+++.
T Consensus 242 PF~~~~~~~ql------i~~lk~~p----------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKANNFSQL------ISELKRGP----------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCCcHHHH------HHHHhcCC----------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99754332211 01111110 0011124578999999999999999999999983
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=284.55 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=200.5
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
..+.+.+.||+|+||.||++....++ ..+++|.+........+.+.+|+.+++.++|||++++++++...+..++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATG---QEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCC---CEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 45566788999999999999865443 458899876544455667899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|.+++.. ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999999854 45788899999999999999999 559999999999999999999999999988755433221
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.....++..|+|||.+.+..++.++|+||||+++|++++|..||............ ........
T Consensus 172 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~--------------~~~~~~~~ 235 (293)
T cd06647 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------ATNGTPEL 235 (293)
T ss_pred --cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--------------hcCCCCCC
Confidence 12335788899999998888899999999999999999999999754432211100 00001111
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
......+..+.+++.+||..+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1222356789999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=286.84 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=192.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+++.+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++|||++++++++.+....++++
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g---~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCC---cEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 455678999999999999976654 458888875432 222356788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++ +|.+++.. ...+++..++.++.|+++|+.||| ..+++|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 99975 77776643 567899999999999999999999 45999999999999999999999999999875543221
Q ss_pred cceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC------cch
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------LDD 290 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~ 290 (350)
......++..|+|||.+.+. .++.++||||+|+++|+|+||..|+....+..... ........... ...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL--KRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH--HHHHHHhCCCChHHhHHhhh
Confidence 11234568899999998765 47889999999999999999999875333221110 00000000000 000
Q ss_pred hccc----ccc-----CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 291 LVEG----DME-----AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 291 ~~~~----~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.... ... .......+.++.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 000 0111235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=279.25 Aligned_cols=252 Identities=27% Similarity=0.363 Sum_probs=199.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc--cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|...+.||+|+||.||+|....++ ..+++|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++++
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTG---ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCC---cEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 445678999999999999865543 45888887654332 5677999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|.+++.....+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999999987777899999999999999999999 559999999999999999999999999999876543322
Q ss_pred ce--eeccccCCCccCcccccCCC---CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 219 TI--KTAIRGTKGYVAPEWFRKST---ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 219 ~~--~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.. .....++..|+|||.+.+.. ++.++||||||+++|++++|..||......... ... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~~~-~~~~------- 222 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----MFH-VGAG------- 222 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----HHH-HhcC-------
Confidence 11 11245688999999998765 888999999999999999999999644321111 000 0001
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+.....+..+.+++.+||+.+|++|||+++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111122234678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=288.17 Aligned_cols=256 Identities=18% Similarity=0.246 Sum_probs=199.8
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+++.+.||+|+||.||++....+. ..+++|.+.... ......+.+|+.+++.++||||+++++.+..++..+++
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~---~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCC---cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 455678999999999999876653 458898876432 12345678899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.+++.....+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999987788899999999999999999999 45999999999999999999999999998864211100
Q ss_pred -------------cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 046877 218 -------------KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 218 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
........++..|+|||.+.+..++.++|+||||+++|++++|..||......+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~-------~~~~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-------GQVI 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHH
Confidence 00111234677899999998888999999999999999999999999744322111 1111
Q ss_pred cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.+.... ......++..+.+++.+||+.||++||++.++.+.|+.-
T Consensus 230 ~~~~~~-------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 230 SDDIEW-------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred hcccCC-------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 111000 001113567899999999999999999987777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=280.45 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=198.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceee--cCCeeEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCD--EGQNRLL 136 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~l 136 (350)
+++.+.||.|+||.||++....++ ..+++|.+... .....+++.+|+.+++.++|||++++++++. .+...++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDG---KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCC---CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 345678999999999999876553 45888877532 2333456889999999999999999999775 3456789
Q ss_pred EEecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 137 AYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDC--SSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
+|||+++++|.+++.. ...+++..++.++.|+++|+.|||..+ +.+++|+||+|+||++++++.+||+|||++.
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence 9999999999998854 467889999999999999999999433 4589999999999999999999999999998
Q ss_pred ccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.... ......+...
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~- 228 (265)
T cd08217 159 ILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL-------ASKIKEGKFR- 228 (265)
T ss_pred cccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH-------HHHHhcCCCC-
Confidence 76543321 1334578899999999888899999999999999999999999976542211 1111222211
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+...+..+.+++.+||+.+|++|||+.++++
T Consensus 229 --------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 229 --------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred --------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 122345678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=278.51 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=196.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|++.+.||+|+||.||++....+ ...+++|.+.... ......+.+|+.+++.++|||++++++.+..++..+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKAD---QKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCC---CcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 45667899999999999987654 3568888876432 334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEeecccccccccC
Q 046877 139 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR-YNARISDFGLAKLLTLN 215 (350)
Q Consensus 139 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 215 (350)
||+++++|.+++... ..+++..+..++.|++.++.||| +.+++|+||+|+||+++.+ +.++++|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999999653 45788999999999999999999 4599999999999999854 46899999999866533
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... ....++..|+|||.+.+..++.++||||+|+++|+|++|..||...+...... . ...+...
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~------~-~~~~~~~------ 219 (256)
T cd08220 156 SKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL------K-IMSGTFA------ 219 (256)
T ss_pred ccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH------H-HHhcCCC------
Confidence 211 23457889999999988888999999999999999999999997544322110 0 0111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..++..+.+++.+||+.+|++|||++++++
T Consensus 220 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 ---PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111235678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=287.89 Aligned_cols=264 Identities=17% Similarity=0.177 Sum_probs=187.5
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc--H---------HHHHHHHHHHhcCCCCceeee
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--E---------KEFKNEVIVIGQTHHKNLVRL 124 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~--~---------~~~~~e~~~l~~l~h~~iv~~ 124 (350)
+....+.+.+.||+|+||.||+|....+......+++|......... . .....+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 33345667789999999999999977663333445666533211110 0 112233445667789999999
Q ss_pred cceeecCC----eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 046877 125 LGFCDEGQ----NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN 200 (350)
Q Consensus 125 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~ 200 (350)
++...... ..+++++++.. ++.+.+......++..+..++.|+++|++||| +.+++||||||+||+++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence 98765443 34677887654 66666655555678889999999999999999 559999999999999999999
Q ss_pred eEEeecccccccccCccc-----ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhH
Q 046877 201 ARISDFGLAKLLTLNQRK-----TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 275 (350)
Q Consensus 201 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~ 275 (350)
++|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999765422111 111234689999999999999999999999999999999999999976533221100
Q ss_pred --HHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 276 --TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 276 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
.......+..+.. ...+++..+.+++..||..+|++||+++++++.|+
T Consensus 245 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFIKRLHEGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHHHHhhhhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000111111111 11134678999999999999999999999998874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=280.87 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=210.3
Q ss_pred hhccCCCccceEEEEEEcCC--CcceeEEEEEeeec-cccccHHHHHHHHHHHhcCCCCceeeecceee-cCCeeEEEEe
Q 046877 64 KEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDR-VFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCD-EGQNRLLAYE 139 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e 139 (350)
...+-+|+||.||.|.+.+. ....+.+-+|.++. .+.-+...+..|.-.+....|||+.+..+++. +....+.++.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 34588999999999976642 23334466665543 23334566888888999999999999999874 4566788899
Q ss_pred cCCCCChhhhhcCC--------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 140 FLNNGTLASFLFGN--------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 140 ~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
++..|+|..|+... ...+-.+...++.|++.|++||| +.+++|.||..+|++|++.-++||+|=.+++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhccc
Confidence 99999999999622 23455667889999999999999 66999999999999999999999999999999
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
+.+.++.....+...+..||+||.+.++.|+..+|+||||+++|||+| |+.||..-++.+ +..
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE----------------m~~ 509 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE----------------MEH 509 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH----------------HHH
Confidence 999888887777778899999999999999999999999999999997 888986444333 233
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.+..+.+...+.+||++|+.+|..||..+|++||++++++..|.+-
T Consensus 510 ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 510 YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 4556777778889999999999999999999999999999988753
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=286.31 Aligned_cols=245 Identities=22% Similarity=0.351 Sum_probs=206.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc--cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|.+.+.||+|-|..|-+|++.-+++ .||||++++.-.+ ...++.+|++.++.++|||||+++.+......+|+++
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGe---kVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGE---KVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccc---eeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 4456789999999999999887754 4999999765433 3457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE-cCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL-NDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|.=++|+|.+|+-+ ...+.++...+++.||+.|+.|+| ...+|||||||+|+.+ ..-|-|||.|||++..+.+..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999964 466899999999999999999999 4599999999999887 467889999999998776654
Q ss_pred ccceeeccccCCCccCcccccCCCCCC-CCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISA-KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ....|...|-|||++.+..|+. ++||||||++||.|++|+.||...++.+...... +
T Consensus 174 kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm---------------D-- 233 (864)
T KOG4717|consen 174 KL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM---------------D-- 233 (864)
T ss_pred hh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh---------------c--
Confidence 43 3456899999999999998864 6899999999999999999999877766543221 1
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+-..+.-.+.++.++|.+||..||.+|.|.+++..
T Consensus 234 CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 112223456789999999999999999999999864
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=281.30 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=196.4
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
.+.||+|++|.||++....++ ..+++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTG---RQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred ceEeccCCCeEEEEEEECCCC---CEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 357999999999999865543 45888887654444556788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeec
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 223 (350)
++|.+++.. ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 101 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 174 (285)
T cd06648 101 GALTDIVTH-TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKS 174 (285)
T ss_pred CCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cccc
Confidence 999999866 67889999999999999999999 55999999999999999999999999998865432211 1123
Q ss_pred cccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHH
Q 046877 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 303 (350)
Q Consensus 224 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (350)
..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..... .......... ......
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~-------~~~~~~~~~~-------~~~~~~ 240 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-------KRIRDNLPPK-------LKNLHK 240 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH-------HHHHhcCCCC-------Cccccc
Confidence 45788999999998888999999999999999999999999653322111 1111111000 011123
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 304 CVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 304 ~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+..+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 5678999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=280.32 Aligned_cols=247 Identities=24% Similarity=0.310 Sum_probs=200.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+++.+.||.|+||.||+|....++ ..+++|.+.... ....+.+.+|++.++.++||||+++++.+.++...+++
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTK---KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCC---cEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 456688999999999999876543 458999886432 23456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
+||+.+++|.+++.....+++..+..++.|+++|+.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 9999999999999777788999999999999999999995 5999999999999999999999999999986654321
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..||............. .... ..
T Consensus 156 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~----------~~ 218 (258)
T cd05578 156 ---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET----------AD 218 (258)
T ss_pred ---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc----------cc
Confidence 133457889999999988889999999999999999999999998655432111110 0000 11
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTM--RKVS 330 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~--~~vl 330 (350)
...+...+..+.+++.+||+.||.+||++ ++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11222356889999999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=282.43 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=192.3
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceee------cC
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCD------EG 131 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~------~~ 131 (350)
..+++.+.||+|+||.||+|.+..++ ..+++|..... .....++..|+.+++++ +|+|++++++++. ..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTG---QLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCC---cEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 34556688999999999999976553 46889887543 23345688899999988 7999999999884 34
Q ss_pred CeeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
...+++|||+.+|+|.+++... ..+++..+..++.|+++|+.||| +.+++|+||+|+||++++++.++|+|||++
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 6789999999999999988643 45778888999999999999999 559999999999999999999999999998
Q ss_pred cccccCcccceeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
........ ......++..|+|||.+. +..++.++|+||||+++|+|++|..||...........
T Consensus 169 ~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--------- 237 (282)
T cd06636 169 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--------- 237 (282)
T ss_pred hhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh---------
Confidence 75532211 112345788999999885 34578899999999999999999999964332211110
Q ss_pred cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.............++..+.+++.+||+.||.+|||+.++++
T Consensus 238 ------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00011111112246678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=282.31 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=191.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceee-----cCCe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCD-----EGQN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~ 133 (350)
++++.+.||+|+||.||++....++ ..+++|..... ......+.+|+.+++.+ +|||++++++++. .++.
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~---~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNG---SKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCC---ceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 4556688999999999999876553 45888876543 23346788899999999 7999999999873 4456
Q ss_pred eEEEEecCCCCChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 134 RLLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
.+++|||+++++|.+++. ....+++..+..++.|+++|+.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 899999999999998764 3356788889999999999999999 559999999999999999999999999998
Q ss_pred cccccCcccceeeccccCCCccCcccccC-----CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRK-----STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
........ ......++..|+|||.+.. ..++.++||||+||++|+|++|+.||.......... ...
T Consensus 172 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-------~~~ 242 (286)
T cd06638 172 AQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-------KIP 242 (286)
T ss_pred eecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-------hcc
Confidence 76543221 1133458899999998853 347889999999999999999999996443211100 000
Q ss_pred cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
.+... ....+..++..+.+++.+||+.||++|||+.++++.
T Consensus 243 ~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 RNPPP-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccCCC-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000 001111245679999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=278.10 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=203.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+++.+.||+|++|.||+|....++ ..+++|.+..... .....+.+|+..+..++|+|++++++++......+++||
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~---~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTG---KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCC---cEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 455688999999999999877643 5688998765433 345779999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++++|.+++.....+++..++.++.|+++|++|||+ ..+++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 99999999999877889999999999999999999994 1699999999999999999999999999998665433221
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
....++..|+|||.+.+..++.++|+||||+++|+|+||..||............ ..+... ....
T Consensus 158 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----~~~~~~---------~~~~ 222 (264)
T cd06623 158 --NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----QAICDG---------PPPS 222 (264)
T ss_pred --cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----HHHhcC---------CCCC
Confidence 2345788999999998888999999999999999999999999755421111111 111111 1111
Q ss_pred CcHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 300 NDIK-CVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 300 ~~~~-~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+.. ++..+.+++.+||..+|++|||+.++++
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1222 6789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.69 Aligned_cols=243 Identities=22% Similarity=0.304 Sum_probs=195.7
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
||.|++|.||++....+ +..+++|.+.... ....+.+.+|+++++.++||||+++++.+.++...++++||+++
T Consensus 1 lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSK---NRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCC---CcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 79999999999997654 3568899876432 23346789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeec
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 223 (350)
++|.+++.+...+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999999987777899999999999999999999 5599999999999999999999999999998665432 1123
Q ss_pred cccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHH
Q 046877 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 303 (350)
Q Consensus 224 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (350)
..++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....+...... ...........+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN-------------DILKGNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH-------------HHhccCCCCCCCcc
Confidence 35788999999998888999999999999999999999999765532211110 01100111112222
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046877 304 CVEKLLMISIWCIQEDPSLRPT-----MRKVSQ 331 (350)
Q Consensus 304 ~~~~l~~li~~cl~~dp~~Rps-----~~~vl~ 331 (350)
.+..+.+++.+||+.+|++||+ +.++++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 3678999999999999999999 677664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=283.29 Aligned_cols=242 Identities=24% Similarity=0.282 Sum_probs=197.2
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||++....++ ..+++|.+.... ......+.+|+++++.++||||+++++++.++...+++
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSG---KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 456688999999999999976653 568999875432 22345688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.+++.....+++..+..++.|+++|+.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999999888889999999999999999999994 59999999999999999999999999998765433
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.....+++.|+|||.+.+...+.++||||||+++|+|++|..||......... .....+..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~--------- 215 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY-------EKILEGKV--------- 215 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCc---------
Confidence 12335788999999998888899999999999999999999999754421110 11111110
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVS 330 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl 330 (350)
..+...+..+.+++.+||..||.+|+ ++++++
T Consensus 216 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 -RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11122367899999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=278.73 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=199.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+++.+.||.|+||.||+|....+ +..+++|.+.... ......+.+|+..++.++|+|++++++.+......++++|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPN---NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCC---CcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 45677899999999999986654 3458888875432 2345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC---CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 140 FLNNGTLASFLFGN---LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 140 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
++++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999998653 45789999999999999999999 5599999999999999999999999999987665433
Q ss_pred ccc--eeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 217 RKT--IKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 217 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
... ......++..|+|||.+... .++.++|+||||+++|+|++|+.||......... . +... ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~----~~~~-~~~----- 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--M----LTLQ-NDP----- 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--H----HHhc-CCC-----
Confidence 221 22334578899999998776 7889999999999999999999999754332211 0 0000 000
Q ss_pred ccccC-CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 GDMEA-MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..... .....++..+.+++.+||..||++|||++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00111 112356788999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=279.72 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=195.8
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-ccccHHHHHHHHHHHhcCC---CCceeeecceeecCCeeEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTH---HKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 136 (350)
++..+.||+|+||.||+|.+..++ ..+++|.+... ......++.+|+.+++.++ |||++++++++..+...++
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTG---RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCC---cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 455678999999999999975543 56899987643 2344567888999999886 9999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+++++|.+++.. ..+++..++.++.|++.|+.||| ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999999999855 47889999999999999999999 4599999999999999999999999999998765433
Q ss_pred ccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||......... .......
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~-------- 218 (277)
T cd06917 156 SK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKSK-------- 218 (277)
T ss_pred cc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccCC--------
Confidence 21 1334578899999998654 5788999999999999999999999754322111 0000000
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.........+.++.+++.+||+.||++||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 001111125678999999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=278.70 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=197.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+...+.||+|+||.||+|....+ +..+++|...... ......+.+|+..++.++||||+++++++.++...+++|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRT---QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCC---CcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 345667899999999999986554 3568898875332 233457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|..++. ...+++..+..++.|++.++.+|| ..+++|+||+|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 82 EYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred EeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999999885 456789999999999999999999 45999999999999999999999999999876543221
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......... .....+.. .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~---------~ 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL-------FLIPKNNP---------P 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH-------HHHhcCCC---------C
Confidence 112345788999999998888899999999999999999999999643321111 01111111 1
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....++..+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112235678999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=277.99 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=199.6
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC--CCCceeeecceeecC----CeeEE
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT--HHKNLVRLLGFCDEG----QNRLL 136 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~~~~l 136 (350)
+.+.||+|.||.||+|.+... .||||++.. ..+..+.+|.++.+.. +|+||+.+++.-... .++++
T Consensus 215 L~e~IGkGRyGEVwrG~wrGe-----~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWRGE-----DVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred EEEEecCccccceeeccccCC-----ceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 446799999999999998654 399999853 3466788888888874 999999999876443 35789
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHE-----DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~-----~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
|.+|.+.|||.||+.. ..++.+..++++..++.||++||. +++..|.|||||..||||..+|...|+|+|+|-.
T Consensus 287 vTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred eeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 9999999999999965 788889999999999999999994 3478899999999999999999999999999976
Q ss_pred cccCcc--cceeeccccCCCccCcccccCCC----CC--CCCcchhHHHHHHHHHhC----------CCCCCcccchhhh
Q 046877 212 LTLNQR--KTIKTAIRGTKGYVAPEWFRKST----IS--AKVDVYSFGVLLLEIISC----------RKSFDIEMGEEYA 273 (350)
Q Consensus 212 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~----~~--~~~DiwslG~~l~~lltg----------~~pf~~~~~~~~~ 273 (350)
...... .......+||.+|||||++...- +. ..+||||||.++||++.. +.||....+.++.
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 544321 11224567999999999997541 21 258999999999999862 3577655444433
Q ss_pred hHHHHHHHHhhcCCc-chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 274 ILTDWAFDCYRNGKL-DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.... ++-.- +++.......-...+....+.++|..||..||..|.|+-.+.+.|.++.+
T Consensus 446 ~eeM------rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 446 FEEM------RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHHH------hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2111 11000 11111111222344678889999999999999999999999999998875
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=279.41 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=199.6
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+++.+.||+|++|.||++.+..+ +..+++|.+..... ....+.+|+..++.++|+|++++++.+...+..++++||
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRAT---GKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccC---CcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 44557799999999999987644 34588888865433 466788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCC-CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 141 LNNGTLASFLFGNL-KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 141 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 171 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-- 171 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence 99999999998766 8899999999999999999999 56999999999999999999999999999875543221
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ....... ....
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~-------~~~~~~~-------~~~~ 237 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-------LITTKGI-------PPLK 237 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhcCC-------CCCc
Confidence 1122346788999999988889999999999999999999999996443322110 0001110 1111
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....++..+.+++.+||+.+|.+|||+.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12235678999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=309.66 Aligned_cols=265 Identities=25% Similarity=0.377 Sum_probs=212.8
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcCCCc----ceeEEEEEeeecccc-ccHHHHHHHHHHHhcC-CCCceeeeccee
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTT----STTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQT-HHKNLVRLLGFC 128 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 128 (350)
++....-.+.+.||+|.||.|++|....... ....||||.+..... ...+.+..|+++++.+ +|+||+.+++.+
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3333333566689999999999998664332 257799999875433 3456799999999999 699999999999
Q ss_pred ecCCeeEEEEecCCCCChhhhhcCCC----------------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046877 129 DEGQNRLLAYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQN 192 (350)
Q Consensus 129 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N 192 (350)
...+..++++||+..|+|.+++++.. .++....+.++.||+.|++||+ +.+++||||..+|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhh
Confidence 99999999999999999999997654 3677888999999999999999 5699999999999
Q ss_pred eEEcCCCceEEeecccccccccCcccceeecc-ccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccch
Q 046877 193 ILLNDRYNARISDFGLAKLLTLNQRKTIKTAI-RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGE 270 (350)
Q Consensus 193 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~ 270 (350)
||+.++..+||+|||+++...+.......... .-+..|||||.+....|+.||||||||++|||++| |..||.+....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999866554444322111 13557999999999999999999999999999997 77888642211
Q ss_pred hhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 271 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.. +-+.+..+.+...+..|+.+++++|..||+.+|++||++.++.+.|+..+
T Consensus 529 ~~---------------l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 EE---------------LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HH---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 11 11233444555556678899999999999999999999999999998843
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=278.52 Aligned_cols=242 Identities=24% Similarity=0.277 Sum_probs=187.6
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHH---HhcCCCCceeeecceeecCCeeEEEEe
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIV---IGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~---l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.||+|+||.||++....+ +..+++|.+..... .......+|..+ +...+|||++.+.+.+..++..+++||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCC---CcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 389999999999987654 35688998754321 112233444433 334479999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++++|.+++.....+++..+..++.|++.|+.||| +.+++|+||||+||++++++.++|+|||++........
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999999999987888999999999999999999999 55999999999999999999999999999875432211
Q ss_pred eeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 220 IKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
....++..|+|||.+.+ ..++.++||||+||++|+|++|..||............... .....
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------------~~~~~ 216 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--------------LTVNV 216 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh--------------hcCCc
Confidence 23458899999999864 56889999999999999999999999754432221111100 00111
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
..+...+.++.+++.+||..||.+|| |++++++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 12234668899999999999999999 5998887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=281.64 Aligned_cols=260 Identities=21% Similarity=0.278 Sum_probs=197.2
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+++.+.||+|+||.||+|....+ +..+++|.+.... ......+.+|+.+++.++|||++++++++..+...++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRET---GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCC---CceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 45667899999999999987655 3458888876543 233567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+ +++|.+++.. ...+++..++.++.|+++|++||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999 9999998853 456899999999999999999999 45999999999999999999999999999986654322
Q ss_pred cceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC----------
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---------- 286 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 286 (350)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||....+..... .........
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA---IVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH---HHHHHcCCCChHHHhhccC
Confidence 111334578899999998654 46889999999999999999988886544322111 011110000
Q ss_pred --CcchhccccccC----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 287 --KLDDLVEGDMEA----MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 287 --~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
............ ....+.+..+.+++.+||+.||++|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 001134588999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=278.38 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=194.6
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCC-----
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQ----- 132 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~----- 132 (350)
..+++.+.||+|++|.||+|....+ +..+++|.+.... ....++.+|+.+++.+ +|+||+++++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~---~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKT---GQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCC---CcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 3456678899999999999987654 3458888876443 3456789999999998 7999999999986544
Q ss_pred -eeEEEEecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecc
Q 046877 133 -NRLLAYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207 (350)
Q Consensus 133 -~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 207 (350)
..+++|||+++++|.+++.. ...+++..+..++.|+++|+.||| +.+++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 48999999999999998854 357889999999999999999999 5699999999999999999999999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccC-----CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK-----STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 282 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 282 (350)
++......... .....++..|+|||.+.. ..++.++||||||+++|+|++|..||........ .. .
T Consensus 159 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~- 229 (275)
T cd06608 159 VSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF----K- 229 (275)
T ss_pred cceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH----H-
Confidence 98765432211 133457889999998753 2467889999999999999999999964322111 10 0
Q ss_pred hhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+.. ........++.++.+++.+||..||++|||+.++++
T Consensus 230 ~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPP-------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCC-------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 011111 111122346678999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=281.21 Aligned_cols=245 Identities=24% Similarity=0.291 Sum_probs=192.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+...+.||+|+||.||+|....++ ..+++|.+.... .....++.+|+.+++.++|||++++.+++.+.+..++
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTN---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCC---cEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3556678999999999999876543 468888875332 2233568899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 137 AYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 137 v~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++||+.+ +|.+++. ....+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9999975 6666654 3456899999999999999999999 559999999999999999999999999998755432
Q ss_pred cccceeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
....++..|+|||++. ...++.++||||||+++|+|+||..||.......... . ....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~-~~~~------ 229 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------H-IAQN------ 229 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------H-HhcC------
Confidence 2235778999999874 3568889999999999999999999996543322110 0 0000
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
.........++..+.+++.+||..+|++||++.+++..
T Consensus 230 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 --DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01111123467789999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=287.95 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=195.5
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcC-CCCceeeecceeecCCe
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 133 (350)
....|+..++||+||.+.||++...+. ..+++|++... .......+.+|+.+|.++ +|.+|+++++|...++.
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~----~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDK----QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCC----cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 344567778999999999999974432 34777766432 234456799999999999 69999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCc-ChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
+||||||=+ .+|...+++.... ....++.++.|++.++.+.|+. +|||.||||.|+|+-.+ .+||+|||+|...
T Consensus 435 lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 435 LYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAI 509 (677)
T ss_pred EEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhccc
Confidence 999999754 4899999766443 3247889999999999999965 99999999999998764 8999999999998
Q ss_pred ccCcccceeeccccCCCccCcccccCC-----------CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKS-----------TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 281 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 281 (350)
.+...........||..||+||.+... ..+.++||||+||+||+|+.|+.||..-.. .|.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a-- 580 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA-- 580 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH--
Confidence 888777777889999999999998422 256789999999999999999999952111 111
Q ss_pred HhhcCCcchhccccccCCCc-HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 282 CYRNGKLDDLVEGDMEAMND-IKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
++..+.++.-....+ ..-..++.++|..||..||.+|||..++++
T Consensus 581 -----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 -----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 122222322211111 011234999999999999999999999975
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=278.14 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=197.4
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
||.|+||.||++....++ ..+++|.+..... .....+.+|+.+++.++|||++++++.+..+...++++||+++
T Consensus 1 lg~g~~~~vy~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTG---DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCC---CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 689999999999976543 4589998764332 3456788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc------
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR------ 217 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------ 217 (350)
++|.+++.....+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999999876788999999999999999999994 5999999999999999999999999999875533211
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
........++..|+|||.+.+...+.++|+||||+++|++++|..||......+.. .....+. ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~--------~~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF-------QNILNGK--------IE 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCC--------cC
Confidence 11123345678999999998888899999999999999999999999755432211 1111111 11
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~ 335 (350)
.+.....+..+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 11111236789999999999999999999666666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=303.12 Aligned_cols=267 Identities=19% Similarity=0.291 Sum_probs=184.8
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcce------------eE----EEEEeeeccccccHHHHHHHHHHHhcCCCCce
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTST------------TA----VAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~------------~~----vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~i 121 (350)
...|.+.+.||+|+||.||++..+...... .. ++.|... ........+.+|+.+++.++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 455677789999999999998764322110 00 0111111 112234568899999999999999
Q ss_pred eeecceeecCCeeEEEEecCCCCChhhhhcCC-----CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 046877 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196 (350)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~ 196 (350)
+++++++...+..+++++++.+ +|..++... .......++.++.|++.||.||| +.+|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 9999999999999999999865 677766432 22345667889999999999999 55999999999999999
Q ss_pred CCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCC-CcccchhhhhH
Q 046877 197 DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAIL 275 (350)
Q Consensus 197 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf-~~~~~~~~~~~ 275 (350)
.++.+||+|||++........ .......|+..|+|||++.+..++.++|||||||++|||++|..++ ..........+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999986643221 1123456899999999999989999999999999999999988644 32222211111
Q ss_pred HHHHHHHhh--cCCcc-------hhccc---------cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 276 TDWAFDCYR--NGKLD-------DLVEG---------DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 276 ~~~~~~~~~--~~~~~-------~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.... .... ...+. ..+.. ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 381 ~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1100 0000 00000 00000 0000001123456788899999999999999999985
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=281.25 Aligned_cols=250 Identities=23% Similarity=0.284 Sum_probs=194.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..+...+.||+|+||.||++....++ ..+++|.+.... ......+.+|+++++.++|||++++++++.+....+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTN---EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCC---cEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 33556678999999999999876543 468888876432 223456888999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+.+ +|.+.+. ....+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99999976 6766664 3566889999999999999999999 45999999999999999999999999999865432
Q ss_pred CcccceeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
. ....++..|+|||.+. +..++.++||||||+++|+|++|+.||.......... . +..+
T Consensus 178 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~-~~~~----- 239 (317)
T cd06635 178 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------H-IAQN----- 239 (317)
T ss_pred c------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH------H-HHhc-----
Confidence 2 2335788999999874 4568889999999999999999999986543222110 0 0011
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.........++..+.+++.+||+.+|++||++.++++..--.
T Consensus 240 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 240 ---ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ---cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 011111223567899999999999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=271.99 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=200.8
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecC
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
...+.||+|++|.||++....+ +..+++|............+.+|+..++.++|+|++++.+++......++++||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRT---GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred eeeeeeccCCceEEEEEEECCC---CcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4557899999999999987654 3468899887654445678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 142 NNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 142 ~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
++++|.+++... ..+++..+..++.|++.++.+|| ..+++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999998765 57899999999999999999999 56999999999999999999999999999987654432
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||........... ........ ...
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~-------~~~ 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-------IATNGPPG-------LRN 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-------HHhcCCCC-------cCc
Confidence 2334578899999999888889999999999999999999999975432221110 00011111 111
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...++..+.+++.+||+.||++|||+.++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1223678999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=279.05 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=191.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecC-----Cee
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG-----QNR 134 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~ 134 (350)
+.+.+.||+|+||.||++....++ +.+++|.+... ......+.+|+.++..+ +|||++++++++... +..
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~---~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDG---SLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCC---CEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 455678999999999999876553 45888887543 22346678899999998 899999999998643 358
Q ss_pred EEEEecCCCCChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 135 LLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
+++|||+++++|.+++. ....+++..++.++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++.
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 99999999999998875 34567899999999999999999994 599999999999999999999999999987
Q ss_pred ccccCcccceeeccccCCCccCcccccCC-----CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKS-----TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
........ .....++..|+|||.+... .++.++||||+|+++|+|++|+.||......... . . ...
T Consensus 177 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~--~----~-~~~ 247 (291)
T cd06639 177 QLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL--F----K-IPR 247 (291)
T ss_pred hccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--H----H-Hhc
Confidence 65432211 1233578899999998643 3678999999999999999999999644322111 0 0 111
Q ss_pred CCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+....+ ......+..+.+++.+||+.+|++||++.++++
T Consensus 248 ~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 248 NPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 112234567999999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=279.40 Aligned_cols=263 Identities=19% Similarity=0.216 Sum_probs=193.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecC--CeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--QNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 135 (350)
.+++.+.||+|+||.||+|....++ ..+++|.+..... .....+.+|+.+++.++||||+++.+++... ...+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTG---EIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCC---cEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 4566788999999999999876553 4588888764322 2234567899999999999999999998777 8899
Q ss_pred EEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+++ +|.+++... ..+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99999985 898888654 458999999999999999999994 5999999999999999999999999999886654
Q ss_pred CcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------HHHh--
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCY-- 283 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~~-- 283 (350)
.... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||............... +..+
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 3211 1233467889999998765 4688999999999999999999999755432221100000 0000
Q ss_pred ----hcCCcchhccccccCCCcHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 284 ----RNGKLDDLVEGDMEAMNDIK-CVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 284 ----~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.................... .+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000011111111 4678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=293.01 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=201.6
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
.++...||.|+||.||+|..+.++ ...|-|.+...+....+.+.-|+.+|..++||+|+++++.|..++.++++.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~---~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETK---LLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccch---hhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 456678999999999999876543 44677777777777778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 141 LNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 141 ~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|.||.....+- -...++++++.-+++|++.||.||| +.+|+|||||..|||++-+|.++|+|||.+...... ..
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ 185 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence 99999888764 3467899999999999999999999 669999999999999999999999999998754322 22
Q ss_pred eeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc-c
Q 046877 220 IKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV-E 293 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 293 (350)
....+.||+.|||||+.. ..+|+.++||||||++|.||..+.+|....+.---. .++. .
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl---------------lKiaKS 250 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---------------LKIAKS 250 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH---------------HHHhhc
Confidence 235678999999999863 457999999999999999999999997533221100 0111 1
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+-...+...+..+.+|+..||.+||..||++.++++
T Consensus 251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11122334467788999999999999999999999875
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=280.27 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=192.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
++..+.||.|++|.||+|....++ ..+++|.+.... ......+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTG---EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCC---CEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 345678999999999999876553 458888875432 223357889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+. ++|.+++.. ...+++..+..++.|++.|++||| ..+++|+||+|+||+++.++.+||+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 9996 588888754 356789999999999999999999 4599999999999999999999999999987654322
Q ss_pred ccceeeccccCCCccCcccccCCC-CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---------
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKST-ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG--------- 286 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 286 (350)
.. .....++..|+|||.+.+.. ++.++||||||+++|+|+||+.||.......... ... ......
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIF-RTLGTPDEVVWPGVT 229 (284)
T ss_pred cc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHH-HHhCCCChhhhhhhh
Confidence 11 12234678899999887654 5888999999999999999999997544322111 000 000000
Q ss_pred -------CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 287 -------KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 287 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
............ .....+.++.+++.+||+.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 01124567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=275.59 Aligned_cols=255 Identities=27% Similarity=0.334 Sum_probs=194.7
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeec--CCeeEEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDE--GQNRLLAY 138 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 138 (350)
+..+.||.|++|.||++.+..+ +..+++|.+..... ....++.+|+++++.++||||+++++++.+ .+..+++|
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNT---GMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred EEEEEeccCCceEEEEEEECCC---CeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3457799999999999997654 35689998764322 345678999999999999999999998854 34689999
Q ss_pred ecCCCCChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 139 EFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 139 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
||+++++|.+++. ....+++..+..++.|++.|+.||| ..+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999988764 2355788899999999999999999 45999999999999999999999999999875432
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ....++..|+|||.+.+..++.++||||+|+++|+|++|..||.....+...... ............+...
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 231 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE--LLSYIVNMPNPELKDE 231 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHH--HHHHHhcCCchhhccC
Confidence 211 2234678899999998888999999999999999999999999755321111000 0111111111111110
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......++.+.+++.+||..+|++|||+.++++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 ---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111235678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=278.14 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=187.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHH-HhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIV-IGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+++.+.||+|+||.||++....+ +..+|+|.+.... .....++..|... ++..+|||++++++++...+..+++|
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPT---GTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCC---CcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 45567899999999999987655 4569999886532 2233455556654 66679999999999999999999999
Q ss_pred ecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 139 EFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 139 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
||++ ++|.+++.. ...+++..++.++.|++.|++|||+ ..+++|+||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9997 477766642 3567899999999999999999994 23899999999999999999999999999876532
Q ss_pred CcccceeeccccCCCccCcccccC----CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRK----STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
.. ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||........ ... .
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~----~--------- 219 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLK----Q--------- 219 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHH----H---------
Confidence 21 1122457888999998864 3568899999999999999999999964222111 000 0
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.............++.++.+++.+||..+|++|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 220 VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000111111235678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=272.75 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=201.9
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecC--CeeEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--QNRLLA 137 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 137 (350)
...+.||+|++|.||+|....+ +..+++|....... ...+.+.+|+..+++++||||+++++.+... ...+++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDT---GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred eeeeEeeecCceEEEEEEECCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 3457799999999999987654 34688888765432 4467789999999999999999999999888 889999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
+||+++++|.+++.....+++..+..++.|++.+++|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999999877789999999999999999999995 5999999999999999999999999999987655432
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
........++..|+|||.+.+...+.++||||||+++|+|++|..||......... .... ......
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~---------~~~~~~ 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-----LYKI---------GSSGEP 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-----HHhc---------cccCCC
Confidence 11123445788999999998888999999999999999999999999755421111 0010 000111
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+...+..+.+++.+||..||++||++.+++.
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1122234689999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=279.79 Aligned_cols=262 Identities=19% Similarity=0.249 Sum_probs=190.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
|.+.+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++|+||+++.+++..+...+++||
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRING---QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCC---cEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 455678999999999999876554 458999876433 2223467889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+. ++|.+++.. ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 996 566666543 355678888999999999999999 459999999999999999999999999998754322111
Q ss_pred ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH-hhcC------Ccc-
Q 046877 219 TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC-YRNG------KLD- 289 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~------~~~- 289 (350)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|..||+...+........+..-. .... ...
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 --YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred --CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 1233468899999998754 5788999999999999999999999755432211111110000 0000 000
Q ss_pred ---hhccccccC-----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 ---DLVEGDMEA-----MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ---~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......... ......+..+.+++.+|+..||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 000112467889999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=277.48 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=195.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
..||+|+||.||++..+.+ +..+++|.+..........+.+|+.+++.++|+|++++++.+...+..+++|||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSS---GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEcCC---CeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 5699999999999987655 3568999876544445667899999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeecc
Q 046877 145 TLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224 (350)
Q Consensus 145 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 224 (350)
+|.+++. ...+++..+..++.|++.+++|||+ .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 103 ~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 103 ALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred cHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 9999874 4467899999999999999999994 5999999999999999999999999999875543221 11234
Q ss_pred ccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHH
Q 046877 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 304 (350)
Q Consensus 225 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
.++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......... ....+. . . ........
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-------~~~~~~-~----~--~~~~~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------MIRDNL-P----P--KLKNLHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhhC-C----c--ccCCcccC
Confidence 57889999999988888999999999999999999999997533222110 000000 0 0 01111234
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 305 VEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 305 ~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+..+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 567899999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=279.50 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=191.2
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+++.+.||+|++|.||+|....++ ..+++|.+..... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTG---QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCC---cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 456678999999999999865443 4689998764322 223457789999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+.+ +|.+++... ..+++..++.++.|+++|+.||| +.+++|+||+|+||+++.++.+||+|||++.........
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9985 898887643 46788999999999999999999 559999999999999999999999999998754322111
Q ss_pred ceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---Ccchh---
Q 046877 219 TIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDDL--- 291 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 291 (350)
.....++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.......... .......... .+...
T Consensus 160 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 160 --YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL--HKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH--HHHHHhcCCCChhhhhhhhhc
Confidence 122345788999999875 457889999999999999999999996544211110 0000100000 00000
Q ss_pred ---ccccccCC---------CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 292 ---VEGDMEAM---------NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 292 ---~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........ ........+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 00111267889999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=273.55 Aligned_cols=245 Identities=21% Similarity=0.251 Sum_probs=190.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc---cHHHHHHHHHH-HhcCCCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD---GEKEFKNEVIV-IGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+|+||.||+|....++ ..+++|.+...... ....+..|... ....+|+|++++++++...+..++++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTG---DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCC---CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 46999999999999875553 46899987643221 12234445444 4445899999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+++++|.+++.....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999999987778899999999999999999999 55999999999999999999999999999875432
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....++..|+|||.+.+..++.++||||+|+++|+|++|..||...+..... .....+... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-------DNILSRRIN------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhcccC------CCCcc
Confidence 12335788999999998888899999999999999999999999754432211 111111110 01111
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
...++..+.+++.+||+.||++||++.++.+.|+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1235678999999999999999998876666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=277.09 Aligned_cols=243 Identities=27% Similarity=0.335 Sum_probs=190.8
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
||+|+||+||++....++ ..+++|.+.... ......+.+|+.+++.++|||++++.+.+...+..+++|||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATG---KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCC---cEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 699999999999876553 458888875432 22344567899999999999999999999999999999999999
Q ss_pred CChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccccee
Q 046877 144 GTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK 221 (350)
Q Consensus 144 g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 221 (350)
++|.+++.... .+++..+..++.|++.|+.||| ..+++|+||+|+||++++++.++|+|||.+........ .
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~ 151 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---I 151 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---c
Confidence 99999987554 6889999999999999999999 45999999999999999999999999999875543111 1
Q ss_pred eccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 222 TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 222 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........... +...... .....+
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~------~~~~~~ 218 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-------LKRRTLE------MAVEYP 218 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-------HHhcccc------ccccCC
Confidence 234567899999999888899999999999999999999999965443111100 0000000 011112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
...++.+.+++.+||+.||++|| ++.+++.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 23467899999999999999999 6666753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=276.73 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=190.7
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 139 (350)
...+.||+|+||.||++....++ ..+++|.+.... ......+.+|+..+.++. ||||+++++++..+...+++||
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSG---TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCC---CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 34567999999999999876553 568999876432 234557889999999995 9999999999999999999999
Q ss_pred cCCCCChhhhh---c--CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 140 FLNNGTLASFL---F--GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 140 ~~~~g~L~~~l---~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
|+.. +|.++. . ....+++..+..++.|+++|++|||+ ..+++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9875 554432 1 34668899999999999999999995 34899999999999999999999999999875543
Q ss_pred CcccceeeccccCCCccCcccccCC---CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKS---TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
.... ....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ....... ..+...
T Consensus 161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~-~~~~~~-- 229 (288)
T cd06616 161 SIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLTQV-VKGDPP-- 229 (288)
T ss_pred CCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHHhhh-cCCCCC--
Confidence 2211 223478899999998765 6889999999999999999999999644310 0000010 011111
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.........++.++.+++.+||+.||++|||++++++
T Consensus 230 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 230 ---ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred ---cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111122346788999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=286.16 Aligned_cols=267 Identities=23% Similarity=0.316 Sum_probs=197.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC-----Ce
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-----QN 133 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 133 (350)
+...+.||+|+||+||++....+ +..+++|.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSET---NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCC---CCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45567899999999999987654 3568999876432 22345677899999999999999999987544 34
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.++++||+. ++|.+++.....+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 799999996 589999887788999999999999999999999 4599999999999999999999999999998654
Q ss_pred cCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH--------HHhh
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCYR 284 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~~~ 284 (350)
... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+............ ....
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 160 EKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 322 11233457889999998865 468899999999999999999999997554322111000000 0000
Q ss_pred cCCcchhccc---ccc---CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--Hhcc
Q 046877 285 NGKLDDLVEG---DME---AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM--LQEV 336 (350)
Q Consensus 285 ~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~--L~~~ 336 (350)
.......... ... .....+++.++.+++.+||+.+|++|||++++++- ++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0011100000 000 00112456789999999999999999999999865 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=278.51 Aligned_cols=259 Identities=24% Similarity=0.306 Sum_probs=193.4
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
++.+.||.|++|.||+|....++ ..+++|.+.... ......+.+|+..++.++|||++++++++.+++..+++||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTG---EIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCC---CEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 45678999999999999876543 458888876432 2233568889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 140 FLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|++ ++|.+++.... .+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 996 58999886554 68999999999999999999994 5999999999999999999999999999975532211
Q ss_pred cceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH--hhcC------Cc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC--YRNG------KL 288 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~--~~~~------~~ 288 (350)
. .....++..|+|||++.+. .++.++|+||+|+++|+|++|+.||........... ..... .... ..
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhCCCChHHhhhhhhc
Confidence 1 1223457889999988654 578899999999999999999999975543221110 00000 0000 00
Q ss_pred chhcc----cc--ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDLVE----GD--MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~~~----~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+... .. .........+..+.+++.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 00 000011234578999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=283.60 Aligned_cols=259 Identities=20% Similarity=0.226 Sum_probs=194.0
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc--------------HHHHHHHHHHHhcCCCCceeeeccee
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--------------EKEFKNEVIVIGQTHHKNLVRLLGFC 128 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~~~~~ 128 (350)
+.+.||+|+||.||+|....+ +..+++|.+....... ...+.+|+.+++.++|+||+++++++
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLT---GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY 89 (335)
T ss_pred hhhcccCCCceeEEEEEECCC---CCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence 346799999999999986544 3568888875432211 12577899999999999999999999
Q ss_pred ecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 129 DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 129 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
..++..+++|||+. ++|.+++.....+++.....++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 90 VEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred ecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999997 589999877778899999999999999999999 55999999999999999999999999999
Q ss_pred ccccccCcc------------cceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhH
Q 046877 209 AKLLTLNQR------------KTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 275 (350)
Q Consensus 209 ~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~ 275 (350)
+........ ........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...++.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~- 244 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG- 244 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence 976541110 0111223457789999998764 46889999999999999999999997665433211
Q ss_pred HHHHHHHhhcCC---cchhcc--------cccc---CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 276 TDWAFDCYRNGK---LDDLVE--------GDME---AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 276 ~~~~~~~~~~~~---~~~~~~--------~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......... +..... .... .......+.++.+++.+||+.+|++|||+++++.
T Consensus 245 --~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 245 --RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred --HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111100 000000 0000 0001234678999999999999999999999985
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=281.20 Aligned_cols=261 Identities=22% Similarity=0.281 Sum_probs=190.4
Q ss_pred hccCCC--ccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 65 EEVGRG--SFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G--~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.||+| +||+||++++..+ +..|++|...... ....+.+.+|+.+++.++||||+++++++..++..++++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPT---GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCC---CcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 457777 8999999987555 3568999876432 22346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 141 LNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 141 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
+.+++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 9999999988653 35788888999999999999999 559999999999999999999999999865432211110
Q ss_pred c-----eeeccccCCCccCcccccCC--CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHH--------------
Q 046877 219 T-----IKTAIRGTKGYVAPEWFRKS--TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD-------------- 277 (350)
Q Consensus 219 ~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~-------------- 277 (350)
. ......++..|+|||++.+. .++.++||||+||++|+|++|..||.............
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 00112245679999999764 47889999999999999999999997543221110000
Q ss_pred HHHHHh----------------hcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 278 WAFDCY----------------RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 278 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+ ..+.................++..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000 000000111112222334457789999999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=282.84 Aligned_cols=241 Identities=26% Similarity=0.310 Sum_probs=198.2
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
-+.||+||||.|+.++.+.++ +.+|.|++.+.. ...+....+|-++|.+++.+.||.+-..|++.+.+|+|+..
T Consensus 190 ~RvlGkGGFGEV~acqvraTG---KMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtl 266 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATG---KMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTL 266 (591)
T ss_pred eEEEecccccceeEEEEecch---hhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEe
Confidence 357999999999999987774 568888876432 33455678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 141 LNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 141 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+||+|.-+|.+.+ .+++..+..++.+|+.||++|| +..||+||+||+|||+|+.|+++|+|+|+|.........
T Consensus 267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999999998665 7899999999999999999999 569999999999999999999999999999877644322
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
+..+||.+|||||++.++.|+...|.||+||++|||+.|+.||.....-... .+++..+... .-
T Consensus 344 ---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~------------eEvdrr~~~~-~~ 407 (591)
T KOG0986|consen 344 ---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR------------EEVDRRTLED-PE 407 (591)
T ss_pred ---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH------------HHHHHHHhcc-hh
Confidence 4457999999999999999999999999999999999999999743322211 1111111111 11
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
..+..+++++.++....|.+||.+|.--
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1234678899999999999999999743
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=283.95 Aligned_cols=267 Identities=23% Similarity=0.341 Sum_probs=195.2
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcC-CCCceeeecceeecC--C
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG--Q 132 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~ 132 (350)
...+.+.+.||+|+||.||+|....+ +..+++|.+.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRT---KEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCC---CeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 34566778899999999999986544 3568888775321 22344577899999999 999999999988643 4
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
..+++|||+.+ +|..++... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 68999999975 999988655 7788899999999999999999 459999999999999999999999999999866
Q ss_pred ccCccc---ceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH--------
Q 046877 213 TLNQRK---TIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-------- 280 (350)
Q Consensus 213 ~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-------- 280 (350)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 433221 12233457889999998865 467889999999999999999999997544332211000000
Q ss_pred HHhhcCCcchhcc----cccc--CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 281 DCYRNGKLDDLVE----GDME--AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 281 ~~~~~~~~~~~~~----~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
..+.......+.. .... .....+++.++.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000100 0000 00111256789999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=277.08 Aligned_cols=262 Identities=22% Similarity=0.237 Sum_probs=195.8
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC--CeeEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--QNRLLA 137 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 137 (350)
++.+.||+|++|.||+|....++ ..+++|.+.... ......+.+|+.+++.++|+|++++++++... +..+++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTG---ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCC---eEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 45678999999999999876553 568999887543 23345688899999999999999999999888 889999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+||+++ +|.+++... ..+++..++.++.|+++|++|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 999985 888888654 578999999999999999999995 599999999999999999999999999998665433
Q ss_pred ccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc--
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-- 293 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 293 (350)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||.......................+.....
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 21 1123346778999998765 4578899999999999999999999976554332111110000000000000000
Q ss_pred ------------ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 ------------GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..........++..+.+++.+||..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000113678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=272.90 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=195.8
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+.+.+.||+|+||.||++....++ ..+++|.+.... ....+.+.+|+.+++.++|+|++++++.+...+..++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDS---EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCC---ceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 345678999999999999976654 458888876432 234457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEeecccccccccC
Q 046877 139 EFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NARISDFGLAKLLTLN 215 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 215 (350)
||+++++|.+++.... .+++..+..++.|+++|+.||| +.+++|+||+|+||++++++ .++++|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999986543 4689999999999999999999 55999999999999998875 4699999998766433
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... .....++..|+|||.+.+..++.++|+||+|+++|++++|..||...+.... .... ..+...
T Consensus 156 ~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~------ 220 (257)
T cd08225 156 MEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLKI-CQGYFA------ 220 (257)
T ss_pred ccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHH-hcccCC------
Confidence 211 1234578899999999888899999999999999999999999964432221 1111 111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......+..+.+++.+||..+|++|||+.++++
T Consensus 221 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 ---PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111234568999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=277.36 Aligned_cols=268 Identities=22% Similarity=0.246 Sum_probs=194.2
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCC-
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ- 132 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 132 (350)
.....+++.+.||+|+||.||+|..+.++ ..+++|.++... ......+.+|+.+++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTG---ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCC---cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 34455677789999999999999986653 458888876432 223356778999999999999999999886654
Q ss_pred ---------eeEEEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceE
Q 046877 133 ---------NRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNAR 202 (350)
Q Consensus 133 ---------~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~k 202 (350)
..++++||+++ ++..++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence 78999999987 66666643 3568999999999999999999995 5999999999999999999999
Q ss_pred EeecccccccccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 046877 203 ISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 281 (350)
Q Consensus 203 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 281 (350)
|+|||++.......... .....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.................
T Consensus 157 l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999997654332211 1222357789999988654 578899999999999999999999975443222111111000
Q ss_pred HhhcCCcchhccc--------cc-----cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 282 CYRNGKLDDLVEG--------DM-----EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 282 ~~~~~~~~~~~~~--------~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.........+... .. ........+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000000000 00 00001124678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=276.28 Aligned_cols=258 Identities=23% Similarity=0.323 Sum_probs=196.4
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc--cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
...+.||+|++|.||++....+ +..+++|.+...... ....+.+|+.+++.++|+|++++++++..++..++++|
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLT---GEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred ccceeeecCCCceEEEEEcCCC---CcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 3457899999999999986544 356888887644322 35678889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++ +|..++.. ...+++..+..++.|+++|+.|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 9986 77777755 3578999999999999999999994 5999999999999999999999999999976654331
Q ss_pred ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---Ccchhcc-
Q 046877 219 TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDDLVE- 293 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 293 (350)
......++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||...+..+..... .+..... .+..+..
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchHhcccchhh
Confidence 11234467889999998776 7889999999999999999999999755432221100 0000000 0000000
Q ss_pred --------cccc----CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 --------GDME----AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 --------~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.... .....+.+.++.+++.+||+.||++||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0112346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=282.61 Aligned_cols=265 Identities=21% Similarity=0.316 Sum_probs=196.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceee----cCCe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCD----EGQN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~ 133 (350)
.+++.+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++||||+++++++. ....
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSG---KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCC---CEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 4556678999999999999876554 468999876432 233456788999999999999999999875 3356
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.+++|||+. ++|.+++.....+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 899999996 5899999877789999999999999999999994 599999999999999999999999999997654
Q ss_pred cCccc--ceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------HHH
Q 046877 214 LNQRK--TIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDC 282 (350)
Q Consensus 214 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~ 282 (350)
..... .......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||............... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32211 11123467889999999865 46889999999999999999999999754432211100000 000
Q ss_pred hhcCCcchhcccc-ccCCC-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 283 YRNGKLDDLVEGD-MEAMN-----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 283 ~~~~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
............. ..... ....+.++.+++.+||+.+|++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000011111000 00000 1234688999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=280.39 Aligned_cols=266 Identities=20% Similarity=0.281 Sum_probs=192.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecC--CeeE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--QNRL 135 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 135 (350)
+.+.+.||+|+||.||+|....+ ..+..+++|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 45567899999999999997652 124569999887532 33346678899999999999999999999888 8899
Q ss_pred EEEecCCCCChhhhhcC-----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC----CCceEEeec
Q 046877 136 LAYEFLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND----RYNARISDF 206 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~----~~~~kl~Df 206 (350)
+||||+++ +|.+++.. ...+++..++.++.|++.|+.||| +.+++|+||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 66665532 136788999999999999999999 559999999999999999 999999999
Q ss_pred ccccccccCcc-cceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhh------HHHH
Q 046877 207 GLAKLLTLNQR-KTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI------LTDW 278 (350)
Q Consensus 207 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~------~~~~ 278 (350)
|++........ ........++..|+|||.+.+. .++.++||||||+++|+|++|..||.......... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 1111234568899999988764 57889999999999999999999997554432000 0000
Q ss_pred HHHHhhc------------CCcchhccccccCCCc-----------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 279 AFDCYRN------------GKLDDLVEGDMEAMND-----------IKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 279 ~~~~~~~------------~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....+.. ...............+ ...+.++.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 0000000000000000 023467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=284.07 Aligned_cols=261 Identities=23% Similarity=0.270 Sum_probs=193.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC-----
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG----- 131 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 131 (350)
..+...+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTG---QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCC---CEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 34556688999999999999876553 468999875432 23345677899999999999999999987543
Q ss_pred -CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 132 -QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 132 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
...+++|||+.+ +|.+.+... ++...+..++.|++.|++||| +.+++|+||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 357999999975 888877543 788899999999999999999 5599999999999999999999999999998
Q ss_pred ccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHH------------H-
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT------------D- 277 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~------------~- 277 (350)
....... .....++..|+|||.+.+..++.++||||+||++|+|++|+.||...+........ .
T Consensus 167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 167 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 6543221 12345788999999999989999999999999999999999999754321110000 0
Q ss_pred ---HHHHHhhcCC------cchhccccc----cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 278 ---WAFDCYRNGK------LDDLVEGDM----EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 278 ---~~~~~~~~~~------~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......... +.+...... ........+..+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000000 001100000 00112235678899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=271.12 Aligned_cols=245 Identities=25% Similarity=0.329 Sum_probs=198.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+++.+.||+|+||.||++....++ ..+++|.+.... ......+.+|+++++.++|+||+++.+++.+....++++
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDN---QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCC---CEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 345678999999999999876553 458888876432 233456788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 139 EFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 139 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
||+++++|.+++.+ ...+++..+..++.|++.|++||| +.+++|+||+|+||++++++.+|++|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999999998865 356788999999999999999999 55999999999999999999999999999987654
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.. .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..... .....+..
T Consensus 156 ~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~------ 218 (256)
T cd08530 156 NM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-------YKVQRGKY------ 218 (256)
T ss_pred CC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCC------
Confidence 31 12345788999999998888999999999999999999999999754432211 11111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......+.++.+++.+||..+|++|||+.++++
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 ---PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1122356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=262.19 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=192.5
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEec
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+...||.|+.|.|+++.++.++ ...|||....... ...+++.+.+.+..+. +.|.||+.+|+|..+...++.||.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~---~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTG---HIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hHHhhcCCCccceEEEEEcccc---eEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 4567999999999999987663 5689998875433 3345677777776665 599999999999999999999998
Q ss_pred CCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 141 LNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 141 ~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|.. .+..++. -..++++..+-++...++.||.||.+ +.+|+|||+||+|||+|+.|++|+||||++.++.....
T Consensus 173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 854 4444443 23567888888899999999999998 56999999999999999999999999999987654322
Q ss_pred eeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc-cc
Q 046877 220 IKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-GD 295 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 295 (350)
.+...|.+.|||||.+. ...|+.++||||||+.++||.||..||.+.+.+-... ..+.+ ..
T Consensus 248 -htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l--------------tkvln~eP 312 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL--------------TKVLNEEP 312 (391)
T ss_pred -cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH--------------HHHHhcCC
Confidence 23456889999999985 3478899999999999999999999998755432210 11111 11
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+....++..+.+++..||++|+.+||...++++
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 222223347889999999999999999999998875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=275.88 Aligned_cols=259 Identities=20% Similarity=0.232 Sum_probs=201.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 135 (350)
+.+.+.||+|++|.||++....+...+..+++|.+.... ......+.+|++++..+ +|||++++.+.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 345678999999999999876554455678999876421 12335678899999999 6999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++|||+++++|.+++.....+++..+..++.|++++|.||| ..+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999977778899999999999999999999 459999999999999999999999999998765433
Q ss_pred cccceeeccccCCCccCcccccCCC--CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKST--ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
... ......++..|+|||.+.+.. .+.++|+||+|+++|+|++|..||......... ........ .
T Consensus 159 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~---------~ 226 (288)
T cd05583 159 EEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRIL---------K 226 (288)
T ss_pred ccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHH---------c
Confidence 211 112345788999999987654 788999999999999999999999643221110 00000000 0
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
. ....+..++..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 227 ~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 S--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred c--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 0111223557889999999999999999999988887665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=284.98 Aligned_cols=267 Identities=22% Similarity=0.298 Sum_probs=194.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecC-----Ce
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-----QN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 133 (350)
.+.+.+.||+|+||.||+|....++ ..|++|.+.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTG---VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCC---CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4556788999999999999876553 568999875432 22345678899999999999999999986544 35
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.++++||+.+ +|.+++. ...+++..+..++.|+++||+||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 7999999975 8877774 457899999999999999999999 5599999999999999999999999999987654
Q ss_pred cCcccc-eeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc------
Q 046877 214 LNQRKT-IKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN------ 285 (350)
Q Consensus 214 ~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~------ 285 (350)
...... ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+....... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~---~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL---ILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCCHHHH
Confidence 322111 1123457889999998754 4688999999999999999999999965432211100 0000000
Q ss_pred -----CCcchhccc---cccCC---CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--Hhccc
Q 046877 286 -----GKLDDLVEG---DMEAM---NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM--LQEVV 337 (350)
Q Consensus 286 -----~~~~~~~~~---~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~--L~~~~ 337 (350)
......... ..... ...+.+.++.+++.+||+.||++|||+.++++. ++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000000 00000 011245789999999999999999999999875 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=274.79 Aligned_cols=259 Identities=20% Similarity=0.252 Sum_probs=189.3
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcC-CCCceeeecceeecC--CeeEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG--QNRLLA 137 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv 137 (350)
.+.+.||+|+||.||+|....++ ..+++|....... .......+|+..+..+ +|+|++++++++.+. +..+++
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~---~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTG---KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred ceEeeccccccceEEEEEEcCCC---cEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 45678999999999999876543 4688898765322 2223445688888888 599999999999877 889999
Q ss_pred EecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++ +|.+++.. ...+++..++.++.|++.|++|||+ .+++|+||+|+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 999975 77777754 3568999999999999999999995 59999999999999999 999999999997654322
Q ss_pred ccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHH--------HHHHhhcCC
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW--------AFDCYRNGK 287 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~--------~~~~~~~~~ 287 (350)
.. ....++..|+|||.+.. ..++.++||||+||++|+|++|..||...+..+....... .........
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 21 22346889999997654 4578899999999999999999999976544321100000 000000000
Q ss_pred cchhcccccc----CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 LDDLVEGDME----AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......+... .......+..+.+++.+||+.+|++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 0001245789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=272.12 Aligned_cols=242 Identities=24% Similarity=0.265 Sum_probs=187.4
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc---cHHHHHHHH---HHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD---GEKEFKNEV---IVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.||+|+||.||++....+ +..+++|.+...... ....+..|. +.++..+|||++++.+.+...+..+++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecC---CCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 389999999999986554 346999987643211 122233343 34455689999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+.+++|..++.....+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 99999999999877889999999999999999999994 5999999999999999999999999999875432211
Q ss_pred eeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 220 IKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||............ ..... ...
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~----------~~~ 216 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT----------MAV 216 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhhc----------cCC
Confidence 234588999999998754 6889999999999999999999999755332211100 00000 011
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
..+...+.++.+++.+||..+|.+|| ++.++++
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11123467899999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.78 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=200.6
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+.+.+.||+|++|.||++....++ ..+++|....... .....+.+|++++++++|||++++++++.+.+..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETG---DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCC---cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 445678999999999999876543 4588988865443 34567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|.+++.....+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999999987788999999999999999999999 559999999999999999999999999999876543321
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.....++..|+|||...+..++.++|+||+|+++|+|++|..||......... + . ..... ..
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~----~--~-~~~~~---------~~ 217 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL----F--R-IVQDD---------HP 217 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH----H--H-HhccC---------CC
Confidence 12345788999999998877889999999999999999999999744321110 0 0 00011 11
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+...+..+.+++.+||..+|++|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112234678999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.37 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=199.8
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+.+.+.||+|+||.||++....++ ..+++|.+..... .....+.+|++.++.++|||++++.+.+......++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDG---KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCC---cEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 345678999999999999976543 4588888865432 44567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC----CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 139 EFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 139 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
||+++++|.+++... ..+++..+..++.+++.|+.|||+ .+++|+||+|+||++++++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 999999999998653 678999999999999999999994 5999999999999999999999999999986654
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.. .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......... ..........
T Consensus 156 ~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~---- 222 (258)
T cd08215 156 TV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA-------LKILKGQYPP---- 222 (258)
T ss_pred Cc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH-------HHHhcCCCCC----
Confidence 32 1223345788999999998888999999999999999999999999654422110 0111111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+..++..+.+++.+||..+|++|||+.++++
T Consensus 223 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 -----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=276.51 Aligned_cols=249 Identities=23% Similarity=0.275 Sum_probs=193.4
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
...++...+.||+|+||.||+|....++ ..+++|.+... ......++.+|+++++.++|+|++++.+++.....
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 89 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCC---cEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence 3344555678999999999999976553 45888887532 22334567889999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 134 RLLAYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
.+++|||+.+ +|.+++. ....+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 90 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 90 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred eEEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 9999999974 7777664 3456788999999999999999999 459999999999999999999999999998765
Q ss_pred ccCcccceeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
... ....++..|+|||.+. ...++.++||||||+++|+|++|..||.......... ....+..
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~- 231 (308)
T cd06634 166 APA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNES- 231 (308)
T ss_pred cCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-------HHhhcCC-
Confidence 432 2234788999999874 3467889999999999999999999986433222111 0011111
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
.......++..+.+++.+||+.+|++||++++++..-
T Consensus 232 -------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 -------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1111224567899999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.31 Aligned_cols=249 Identities=20% Similarity=0.239 Sum_probs=194.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-----ccccHHHHHHHHHHHhcCCCCceeeecceeecC--Ce
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-----FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--QN 133 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 133 (350)
+.+.+.||+|+||.||+|....++ ..+++|.+... .......+.+|+.+++.++|+||+++++++.+. ..
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTG---RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCC---CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 456688999999999999876543 46888876421 122345788999999999999999999998654 45
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.++++||+++++|.+++.....+++.....++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 7899999999999999977677889999999999999999999 4599999999999999999999999999997653
Q ss_pred cCcc-cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 214 LNQR-KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 214 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~ 222 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---------------FKIA 222 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH---------------HHHH
Confidence 2111 11112345788999999998888899999999999999999999999643222110 0111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........+...++.+.+++.+||+ +|..||++.+++.
T Consensus 223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111122334566889999999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.49 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=194.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+++.+.||.|++|.||+|....+ +..+++|.+..... .....+.+|+.+++.++|||++++++++...+..+++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTT---GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCC---CeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 45567899999999999997655 35689998764432 234667889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC---CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 140 FLNNGTLASFLFGN---LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 140 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|+++ +|.+++... ..+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++++|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9986 888877543 457899999999999999999994 599999999999999999999999999987543221
Q ss_pred ccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------HHHhhcCC
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRNGK 287 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~~ 287 (350)
. ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+........ .+.+. .
T Consensus 155 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 230 (284)
T cd07836 155 N--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS--Q 230 (284)
T ss_pred c--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh--c
Confidence 1 11233467889999998664 5688999999999999999999999765543321100000 00000 0
Q ss_pred cchhcccccc------CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 LDDLVEGDME------AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......... .......+..+.+++.+||+.||.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 0001234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=270.23 Aligned_cols=239 Identities=20% Similarity=0.238 Sum_probs=184.8
Q ss_pred hhhhc--cCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEE
Q 046877 62 NFKEE--VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 62 ~~~~~--lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.+. ||+|+||.||++....++ ..+++|.......... |......+ +|||++++++.+...+..+++|
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQ---KLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCC---cEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 34444 599999999999876553 4588888754322111 22222222 7999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++++|.+++..+..+++..+..++.|+++|+.|||+ .+++|+||+|+||+++.++ .++|+|||++......
T Consensus 89 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 89 DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 999999999999877789999999999999999999994 5899999999999999888 9999999998765422
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
....++..|+|||++.+..++.++|+||+|+++|+|++|..||......... ...+... .. ..
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~----------~~--~~ 226 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-LESLLKR----------QQ--KK 226 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-HHHHHHh----------hc--cc
Confidence 2235788999999999888999999999999999999999999744332211 1111100 00 01
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCC-HHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPT-MRKVS 330 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~vl 330 (350)
.......+..+.+++.+||+.+|++||+ +++++
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred CCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 1112246778999999999999999996 58876
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=284.80 Aligned_cols=263 Identities=20% Similarity=0.225 Sum_probs=190.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecC--------
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-------- 131 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------- 131 (350)
++.+.+.||.|+||.||+|....++ ..+++|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~---~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCD---KRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCC---cEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 4556688999999999999876553 56899988765555567789999999999999999999876543
Q ss_pred ------CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEe
Q 046877 132 ------QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARIS 204 (350)
Q Consensus 132 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~ 204 (350)
...+++|||+++ +|.+++. ...+++..++.++.|+++|+.|||+ .+++|+||||+||+++ +++.++++
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 357899999974 8888875 3468899999999999999999994 5999999999999997 55678999
Q ss_pred ecccccccccCccc-ceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH--
Q 046877 205 DFGLAKLLTLNQRK-TIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-- 280 (350)
Q Consensus 205 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-- 280 (350)
|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||................
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999765432111 11122346889999998754 467889999999999999999999997554322211000000
Q ss_pred ------HHhhcCCcchhccccccCC-----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 281 ------DCYRNGKLDDLVEGDMEAM-----NDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 281 ------~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
................... .....+.++.+++.+||+.||++|||+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 0000000000000000000 0112457889999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=284.42 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=207.7
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccH--HHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
...-.+.+.+.||+|.|+.|.++.+..++ ..||+|.+++...+.. ..+.+|+++++.++||||++++.+......
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~---~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTG---TEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCC---ceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 33444566688999999999999988774 4599999987654332 457899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
+|+||||+.+|.+++++.++++..+..++.++.|+..|++||| +.+|+|||||++|++++.+.++||+|||++..+.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999999999999988999999999999999999 5699999999999999999999999999998776
Q ss_pred cCcccceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
... ....+.|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||++..-.+.. +..+
T Consensus 207 ~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl 268 (596)
T KOG0586|consen 207 YGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVL 268 (596)
T ss_pred ccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chhe
Confidence 332 2356779999999999998766 67899999999999999999999865432221 1111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....+.+. -.+.++.++++++|..+|.+|++.+++.+
T Consensus 269 ~gk~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 269 RGKYRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeecccc--eeechhHHHHHHhhccCccccCCHHHhhh
Confidence 22222222 23467888999999999999999999864
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=278.55 Aligned_cols=263 Identities=24% Similarity=0.254 Sum_probs=191.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecC--CeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--QNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 135 (350)
.+++.+.||+|+||.||+|....++ ..|++|.+..... .....+.+|+.+++.++|+|++++++++.+. +..+
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSG---EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCC---cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3556678999999999999876553 4588998764322 1233567899999999999999999998654 5689
Q ss_pred EEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+.+ +|.+++.. ...+++..++.++.|++.|++||| +.+++|+||+|+||++++++.+||+|||++.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99999975 78777754 366899999999999999999999 45999999999999999999999999999986653
Q ss_pred CcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc----
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD---- 289 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 289 (350)
.... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...+...................+.
T Consensus 161 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 161 PAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred ccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 3211 122335778999999865 467899999999999999999999997654433211111000000000000
Q ss_pred -----hhccccccCCC----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 -----DLVEGDMEAMN----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 -----~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........... ....+..+.+++.+||+.||++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000 0123677899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=276.13 Aligned_cols=259 Identities=20% Similarity=0.259 Sum_probs=189.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcC-CCCceeeecceeecCCe----
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQN---- 133 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~---- 133 (350)
++..+.||+|+||.||+|....++ ..+++|....... .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~---~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTG---KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCC---cEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 455678999999999999876553 4688988754322 2335688899999999 57999999999876655
Q ss_pred -eEEEEecCCCCChhhhhcC-----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEeec
Q 046877 134 -RLLAYEFLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND-RYNARISDF 206 (350)
Q Consensus 134 -~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Df 206 (350)
.+++|||+++ +|.+++.. ...+++..++.++.|+++||.||| +.+++|+||+|+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999986 78887743 235789999999999999999999 559999999999999998 889999999
Q ss_pred ccccccccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 207 GLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 207 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
|++.......... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........... .......
T Consensus 156 g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~~~ 230 (295)
T cd07837 156 GLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH---IFKLLGT 230 (295)
T ss_pred ccceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHhCC
Confidence 9987553321111 22346788999998865 4578999999999999999999999975443221100 0000000
Q ss_pred CC---cchh------cc-cccc----CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 286 GK---LDDL------VE-GDME----AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 286 ~~---~~~~------~~-~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. +... .. .... .......+.++.+++.+||..||.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 00 0000 0001235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=266.26 Aligned_cols=239 Identities=24% Similarity=0.258 Sum_probs=200.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
..|.+.||+|+||.|-+++-+.+ ++.+|+|++++..- +....-..|-++|+..+||.+..+...|+..+.+|+|
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat---~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKAT---GKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred hhHHHHhcCCccceEEEEeeccc---CceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 45788999999999999986555 56799999876432 2333456688999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||..||.|.-++++...+++...+.+-..|+.||.||| +++|+.||+|.+|.++|.+|++||+|||++...-. .
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--Y 321 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc--c
Confidence 999999999999999999999999999999999999999 66999999999999999999999999999975422 1
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
......+.||+.|+|||++....|+..+|.|.+|+++|||++|+.||...+.+....+.. ....+
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl---------------~ed~k 386 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL---------------MEDLK 386 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH---------------hhhcc
Confidence 223356789999999999999999999999999999999999999998665544432211 11111
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCC
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRP 324 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rp 324 (350)
.+...+++...++...|.+||.+|.
T Consensus 387 --FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 --FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --CCccCCHHHHHHHHHHhhcChHhhc
Confidence 2234567889999999999999996
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=282.70 Aligned_cols=270 Identities=23% Similarity=0.305 Sum_probs=202.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCC-----e
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ-----N 133 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~ 133 (350)
+.+.+.||+|++|.||+|....+ +..+++|.+.... ....+.+.+|+.+++.++||||+++.+++.... .
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRT---GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCC---CcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 45668899999999999986554 3458999886543 334567899999999999999999999987765 7
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.+++|||+.+ +|.+++.....+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 8999999985 89998877778999999999999999999999 5599999999999999999999999999998765
Q ss_pred cCccc-ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH--------h
Q 046877 214 LNQRK-TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC--------Y 283 (350)
Q Consensus 214 ~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~--------~ 283 (350)
..... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+........... .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 43210 111334578899999999877 7899999999999999999999999765543221110000000 0
Q ss_pred hcCCcchhcccccc-C-----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--Hhccc
Q 046877 284 RNGKLDDLVEGDME-A-----MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM--LQEVV 337 (350)
Q Consensus 284 ~~~~~~~~~~~~~~-~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~--L~~~~ 337 (350)
.............. . ....+.+..+.+++.+||+.+|++|||+++++.. +++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00001111110000 0 0012256789999999999999999999999863 55443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=277.18 Aligned_cols=265 Identities=20% Similarity=0.263 Sum_probs=189.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCC-----
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ----- 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 132 (350)
.++..+.||+|+||.||+|....+ +..+++|.+.... ......+.+|+++++.++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~---~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKT---KQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCC---CcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 355667899999999999987655 3568898875432 222345678999999999999999999876543
Q ss_pred ---eeEEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 133 ---NRLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 133 ---~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
..+++|||+.+ +|.+++... ..+++..++.++.|+++|+.|||+ .+++|+||+|+||+++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999975 777776543 368999999999999999999995 5999999999999999999999999999
Q ss_pred ccccccCccc--ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 209 AKLLTLNQRK--TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 209 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
+......... .......++..|+|||.+.+. .++.++||||+|+++|+|++|..||...+.................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9765432211 111233467889999988764 4788999999999999999999999765543322111111110000
Q ss_pred CCcchh-----ccc-cccC---------CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 286 GKLDDL-----VEG-DMEA---------MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 286 ~~~~~~-----~~~-~~~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...... ... .... ......+..+.+++.+||..||++|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000 000 0000 000012356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=272.50 Aligned_cols=254 Identities=21% Similarity=0.247 Sum_probs=195.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 135 (350)
+++.+.||+|+||.||.+........+..+++|.+.... ....+.+.+|+++++.+ +|+||+++.+.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 345678999999999999876544456679999886422 12245678899999999 6999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++|||+++++|.+++.....+++..+..++.|++.|+.||| ..+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999987778899999999999999999999 559999999999999999999999999998765432
Q ss_pred cccceeeccccCCCccCcccccCC--CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKS--TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||......... ......... .
T Consensus 159 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~-~------- 227 (290)
T cd05613 159 EVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK-S------- 227 (290)
T ss_pred ccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhc-c-------
Confidence 211 11234578899999998753 4678999999999999999999999643321111 000100000 0
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
....+..++..+.+++.+||+.||++|| +.++++.
T Consensus 228 ---~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ---EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0111223567889999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=274.50 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=190.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+++.+.||+|++|.||+|....++ ..+++|.+..... .....+.+|+++++.++|||++++++++.+....+++|
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTN---ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCC---cEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 455678999999999999876553 4589998754322 23456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEeecccccccccC
Q 046877 139 EFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND-RYNARISDFGLAKLLTLN 215 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 215 (350)
||+++ +|.+++.... ..++..++.++.|++.|++||| +.+++|+||+|+||+++. ++.+||+|||++......
T Consensus 81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99965 7877775433 3477888899999999999999 459999999999999985 567999999999765432
Q ss_pred cccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---Ccc--
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLD-- 289 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~-- 289 (350)
.. ......++..|+|||.+.+. .++.++||||+|+++|+|+||..||......+..... ....... .+.
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---FRILGTPNEETWPGV 231 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChhhcccc
Confidence 11 11233467899999998764 5788999999999999999999999754432221100 0000000 000
Q ss_pred ----hhcc--ccccCC----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 ----DLVE--GDMEAM----NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ----~~~~--~~~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.... ...... ...+.+.++.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000000 11234577899999999999999999999985
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=268.52 Aligned_cols=249 Identities=21% Similarity=0.298 Sum_probs=191.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|.+.+.||+|+||.||++....+.......++|..... ......++..|+.+++.++|||++++++++.+....++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 45668899999999999987655443333444443321 1223345778899999999999999999999999999999
Q ss_pred ecCCCCChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 139 EFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 139 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
||+++++|.+++. ....+++..++.++.|+++|+.||| +.+++|+||+|+||++++ +.++|+|||.+.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999998874 2456889999999999999999999 459999999999999975 5699999999876543
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||........ . .....+.
T Consensus 158 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--~-----~~~~~~~------- 221 (260)
T cd08222 158 SCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV--V-----LRIVEGP------- 221 (260)
T ss_pred Ccc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--H-----HHHHcCC-------
Confidence 221 11234578899999999888889999999999999999999999964322111 0 0111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....+..++.++.+++.+||..+|++||++.++++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11123356788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=272.38 Aligned_cols=241 Identities=24% Similarity=0.312 Sum_probs=188.5
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
..+.||+|+||.||+|....+ +..+++|.+..... .....+.+|+.+++.++|||++++++++.+....+++||
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~---~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHT---NEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred cceeeccCCCeEEEEEEECCC---CcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 345699999999999986554 35688888764322 233568889999999999999999999999999999999
Q ss_pred cCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+.+ +|.+++. ....+++..+..++.|++.++.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--- 174 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--- 174 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence 9975 6766664 3456789999999999999999999 459999999999999999999999999998643221
Q ss_pred ceeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 219 TIKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
....++..|+|||.+. +..++.++||||||+++|+|++|..||...+...... .. .....
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~-~~~~~------- 237 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HI-AQNDS------- 237 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HH-HhcCC-------
Confidence 2345788999999984 4568889999999999999999999986544322111 00 00111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........+..+.+++.+||+.+|++||++.+++.
T Consensus 238 -~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 -PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11112234567999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=272.51 Aligned_cols=257 Identities=17% Similarity=0.195 Sum_probs=187.5
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
+.+|.|+++.|+++ ..+ +..+|+|.+... .......+.+|+..++.++|+||+++++++.+.+..+++|||++
T Consensus 8 ~~~~~~~~v~~~~~--~~~---~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 8 KCFEDLMIVHLAKH--KPT---NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred HhhcCCceEEEEEe--cCC---CCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 34455555444444 333 456899988643 33445689999999999999999999999999999999999999
Q ss_pred CCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc--
Q 046877 143 NGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK-- 218 (350)
Q Consensus 143 ~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 218 (350)
+++|.+++... ..+++..+..++.|+++||.||| +.+++|+||||+||+++.++.+|++|||.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999998643 45788889999999999999999 459999999999999999999999999988755322111
Q ss_pred ---ceeeccccCCCccCcccccCC--CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh----h-----
Q 046877 219 ---TIKTAIRGTKGYVAPEWFRKS--TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY----R----- 284 (350)
Q Consensus 219 ---~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~----~----- 284 (350)
.......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||......... ........ .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchh
Confidence 111233467789999998753 5888999999999999999999999754322111 00000000 0
Q ss_pred --cCCcc--------hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 285 --NGKLD--------DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 285 --~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..... ...............+.++.+++.+||..||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 000011112223456678999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=270.06 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=192.3
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.||+|++|.||+|....++ ..+++|.+..... .......+|+..++.++ |||++++++++..++..+++||
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETG---ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred eeheeeccCCceEEEEEEECCCC---cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 45678999999999999976543 4589998764432 22334567889999998 9999999999999999999999
Q ss_pred cCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 140 FLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|+ +++|.+++.... .+++..+..++.|++.++.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99 779988886554 77999999999999999999994 5999999999999999999999999999976543221
Q ss_pred cceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHH----------HHHHHhhcC
Q 046877 218 KTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD----------WAFDCYRNG 286 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~----------~~~~~~~~~ 286 (350)
. ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+...... |........
T Consensus 155 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 Y---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred c---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1 23457889999998854 457889999999999999999999996554332211000 000000000
Q ss_pred CcchhccccccC---CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 287 KLDDLVEGDMEA---MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 287 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
............ ......+..+.+++.+||+.||++|||+++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000 000012467999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=311.31 Aligned_cols=246 Identities=26% Similarity=0.319 Sum_probs=198.0
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
.||.|.||.||.|.+.++++ ..|+|-+.-.. ......+.+|.+++..++|||+++++|+-.+.+..+|.||||++
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGe---llAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGE---LLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred ccCCcceeeeEEeecCCccc---hhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhcc
Confidence 59999999999998776654 46666654322 33446688999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc--cee
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK--TIK 221 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~ 221 (350)
|+|.+.+....-.++.....+..|++.|++|||+ .+||||||||.||+++.+|.+|++|||.|....+.... ...
T Consensus 1319 GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1319 GSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred CcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 9999999887778888888899999999999995 59999999999999999999999999999877554211 111
Q ss_pred eccccCCCccCcccccCC---CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 222 TAIRGTKGYVAPEWFRKS---TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 222 ~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
....||+.|||||++.+. ....+.||||+|||+.||+||+.||...+.+-. +...+..+...
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---------------IMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---------------IMYHVAAGHKP 1460 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---------------HHhHHhccCCC
Confidence 345799999999999764 356689999999999999999999964332111 11112222333
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
+.+...+.+-.+++.+||..||..|.++.++++.
T Consensus 1461 q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 3444578889999999999999999999887754
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=271.33 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=198.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 136 (350)
+.+.+.||+|+||.||++....+ +..+++|...... ......+.+|..+++.++ ||||+++++++...+..++
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKET---NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCC---CCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 45667899999999999987654 3568888875422 233456888999999998 9999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+||++++++|.+++.....+++..++.++.|++.|+.+||+ .+++|+||+|+||+++.++.++++|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999999888789999999999999999999994 599999999999999999999999999988664332
Q ss_pred cc------------------ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHH
Q 046877 217 RK------------------TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 278 (350)
Q Consensus 217 ~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 278 (350)
.. .......++..|+|||.+.+..++.++|+||||++++++++|..||.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----- 231 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF----- 231 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH-----
Confidence 11 1112345688999999998888899999999999999999999999754421110
Q ss_pred HHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 046877 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTM----RKVSQ 331 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~~vl~ 331 (350)
..... .....+...+..+.+++.+||+.+|++|||+ +++++
T Consensus 232 --~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 --QKILK----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHh----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000 0111112336789999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.71 Aligned_cols=257 Identities=25% Similarity=0.315 Sum_probs=189.8
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc--cHHHHHHHHHHHhcC---CCCceeeecceeecCCe---
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQT---HHKNLVRLLGFCDEGQN--- 133 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~--- 133 (350)
++.+.||+|+||.||+|..+.+ +..+++|.+...... ....+.+|+.+++.+ +|||++++++++...+.
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNT---GRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred eEEEEecccCceEEEEEEECCC---CCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 3457899999999999997654 346899988643221 223466677666555 69999999999987776
Q ss_pred --eEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 134 --RLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 134 --~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
.+++|||+.+ +|.+++... ..+++..++.++.|+++|+.|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 788887653 357899999999999999999994 59999999999999999999999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc-CC-
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-GK- 287 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~- 287 (350)
......... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||......+.. .... ..... ..
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIF-DVIGLPSEE 228 (287)
T ss_pred eeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHH-HHcCCCChH
Confidence 766433221 2234678899999999888999999999999999999999999765433221 1000 00000 00
Q ss_pred -cc-------hhcccccc---CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 -LD-------DLVEGDME---AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 -~~-------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+. ........ .......+..+.+++.+||+.||++||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 00000000 1111245678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=274.53 Aligned_cols=266 Identities=21% Similarity=0.224 Sum_probs=189.7
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc--cHHHHHHHHHHHhcCCCCceeeecceeecCC----
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ---- 132 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 132 (350)
..+.+.+.||+|+||.||+|..+.++ ..+++|.+...... ....+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTG---RVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCC---cEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 34556788999999999999976554 45888887543221 2345778999999999999999999874433
Q ss_pred ----eeEEEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecc
Q 046877 133 ----NRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207 (350)
Q Consensus 133 ----~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 207 (350)
..++++||+.+ +|...+.. ...+++..+..++.|+++|++||| +.+++|+||||+||++++++.++|+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 46899999976 56665543 457899999999999999999999 5599999999999999999999999999
Q ss_pred cccccccCcccc---------eeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHH
Q 046877 208 LAKLLTLNQRKT---------IKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 277 (350)
Q Consensus 208 ~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~ 277 (350)
++.......... ......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 997654322111 11223467889999988654 57899999999999999999999997655433221111
Q ss_pred HHHHHhhcCCcc------hh----ccccccCC---CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 278 WAFDCYRNGKLD------DL----VEGDMEAM---NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 278 ~~~~~~~~~~~~------~~----~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..........+. .. ........ ........+.+++.+||+.||++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000000000 00 00000000 00123367889999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=269.80 Aligned_cols=259 Identities=25% Similarity=0.315 Sum_probs=195.4
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.+.||+|++|.||+|....++ ..+++|...... ......+.+|+.+++.++|+|++++++++.+.+..++++||
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTG---EIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred eehcccccCcceEEEeeecCCC---cEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 4567999999999999876553 458888876542 33346678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 141 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 141 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
+++ +|.+++... ..+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 985 899999765 578999999999999999999995 4999999999999999999999999999876543321
Q ss_pred eeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH--------HHhh-----c
Q 046877 220 IKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCYR-----N 285 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~~~-----~ 285 (350)
......++..|+|||.+.+. .++.++|+||||+++|++++|..||......+......... .... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 11223456789999998766 78899999999999999999999997655332211000000 0000 0
Q ss_pred CCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........... .....+.+..+.+++.+||..||++||++++++.
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 0001123678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=257.91 Aligned_cols=242 Identities=23% Similarity=0.268 Sum_probs=192.3
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecC----CeeEEEEe
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG----QNRLLAYE 139 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e 139 (350)
+.||-|-.|.|..+.++.+++ .+|+|.+... ....+|+++.-.. .|||||.+++++++. .-+.+|||
T Consensus 68 qvLG~GinGkV~~C~~k~T~e---kfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQE---KFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhhccccCCceEEEEeccchh---hhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 579999999999999877754 3889887432 3456778776665 799999999988553 45679999
Q ss_pred cCCCCChhhhhcCCCC--cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCceEEeeccccccccc
Q 046877 140 FLNNGTLASFLFGNLK--PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN---DRYNARISDFGLAKLLTL 214 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~ 214 (350)
.++||.|+..+..++. +++.++..|+.||+.|+.||| +.+|.||||||+|+|.. .|..+||+|||+++....
T Consensus 140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 9999999999976654 899999999999999999999 66999999999999996 455699999999986653
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ......|+.|.|||++...+|+...|+||+|+++|-|++|.+||....+.... .|--..+...
T Consensus 217 ~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-----------pgMk~rI~~g 282 (400)
T KOG0604|consen 217 PGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKRRIRTG 282 (400)
T ss_pred Ccc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-----------hhHHhHhhcc
Confidence 222 23445799999999999999999999999999999999999999865542211 1111122222
Q ss_pred ccc--CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DME--AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
... .+...+.++...++|+.+|.-+|.+|.|+.++++
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 222 2223467889999999999999999999999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.82 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=188.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+.+.+.||+|+||.||+|..+.++ ..+++|.+.... ......+..|+..+... +||||+++++++.+....+++|
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTG---HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCC---eEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 456788999999999999976543 568999886432 22334566677666666 5999999999999999999999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+.+ +|.+++.. ...+++..+..++.|++.|++|||+ ..+++|+||+|+||++++++.+||+|||++........
T Consensus 94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 99865 67666643 4567889999999999999999995 24899999999999999999999999999876543221
Q ss_pred cceeeccccCCCccCcccccCCC----CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKST----ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
. ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||......... + ... ..+....
T Consensus 171 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~----~~~-~~~~~~~--- 238 (296)
T cd06618 171 K---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-L----TKI-LQEEPPS--- 238 (296)
T ss_pred c---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH-H----HHH-hcCCCCC---
Confidence 1 2234677899999987553 788999999999999999999999643221110 0 010 1111100
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
......++.++.+++.+||..||++||+++++++.
T Consensus 239 ----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ----LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111356789999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=262.27 Aligned_cols=237 Identities=26% Similarity=0.280 Sum_probs=192.0
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
||+|+||.||++....+ +..+++|.+..... .....+.+|+.+++.++|||++++++.+..+...+++|||+++
T Consensus 1 lg~G~~~~v~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCC---CcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 69999999999987654 34688888764322 2345788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeec
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 223 (350)
++|.+++.....+++..+..++.|+++|+.|||+ .+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT 152 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence 9999999877788999999999999999999994 5999999999999999999999999999976543321 1234
Q ss_pred cccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHH
Q 046877 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 303 (350)
Q Consensus 224 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (350)
..++..|+|||.+.+...+.++|+||||+++|++++|..||...+.... . ..... . ....+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~----~~~~~--------~--~~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---Y----EKILK--------D--PLRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHhc--------C--CCCCCCC
Confidence 4578899999999888889999999999999999999999965443111 0 00001 0 1111122
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHH
Q 046877 304 CVEKLLMISIWCIQEDPSLRPTMRK 328 (350)
Q Consensus 304 ~~~~l~~li~~cl~~dp~~Rps~~~ 328 (350)
.+..+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 3678899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=295.67 Aligned_cols=247 Identities=27% Similarity=0.369 Sum_probs=187.0
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeec------------
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE------------ 130 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------------ 130 (350)
.+.||+||||.||+++++-++ +.+|+|++.... ......+.+|+..+++++|||||+++..+.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDG---r~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~ 560 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDG---REYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVA 560 (1351)
T ss_pred HHHhcCCCCceEEEEeecccc---hhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccc
Confidence 356999999999999988774 569999997543 3334568899999999999999999854411
Q ss_pred --------------------------------------------------------------------------------
Q 046877 131 -------------------------------------------------------------------------------- 130 (350)
Q Consensus 131 -------------------------------------------------------------------------------- 130 (350)
T Consensus 561 ~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~ 640 (1351)
T KOG1035|consen 561 SDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSV 640 (1351)
T ss_pred cchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcc
Confidence
Q ss_pred -------------------C--------CeeEEEEecCCCCChhhhhcCCCCc-ChhHHHHHHHHHHHHHHHHHhcCCCC
Q 046877 131 -------------------G--------QNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLHEDCSSQ 182 (350)
Q Consensus 131 -------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~i~~~l~~Lh~~~~~~ 182 (350)
+ ..+||-||||+..+|.+++..+... .....++++++|++|++|+|+ .+
T Consensus 641 ~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~g 717 (1351)
T KOG1035|consen 641 ILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---QG 717 (1351)
T ss_pred ccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---Cc
Confidence 0 1247889999998888887655544 577889999999999999995 58
Q ss_pred eEecCCCCCCeEEcCCCceEEeecccccccc------c----------CcccceeeccccCCCccCcccccCC---CCCC
Q 046877 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLT------L----------NQRKTIKTAIRGTKGYVAPEWFRKS---TISA 243 (350)
Q Consensus 183 i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~------~----------~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~ 243 (350)
+|||||||.||++++++.|||+|||++.... . .......+...||.-|+|||++.+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998621 0 0111123567899999999999754 5999
Q ss_pred CCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCC
Q 046877 244 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLR 323 (350)
Q Consensus 244 ~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 323 (350)
|+|+||||++++||+. ||......... ...++.+.+... .....+....-..+|.++++.||.+|
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMERa~i------L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMERASI------LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHHHHH------HHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccC
Confidence 9999999999999996 57654433321 122333333332 01111233455779999999999999
Q ss_pred CCHHHHHH
Q 046877 324 PTMRKVSQ 331 (350)
Q Consensus 324 ps~~~vl~ 331 (350)
||+.+++.
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99999974
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=259.76 Aligned_cols=268 Identities=22% Similarity=0.265 Sum_probs=193.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCc-ceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeec-CCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTT-STTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE-GQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 135 (350)
.|+....||+|+||.||+|.-.+++. -.+.+|+|+++... +.-.....+|+.+++.++|||++.+..++-+ +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 35566789999999999996554432 23468999986432 2223467889999999999999999998866 77889
Q ss_pred EEEecCCCCChhhhhcC-----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC----CceEEeec
Q 046877 136 LAYEFLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR----YNARISDF 206 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~----~~~kl~Df 206 (350)
+++||.+. +|...++. ...++...+++++.||+.|+.||| ++=|+||||||.||++..+ |.|||+|+
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999988 88887742 245788899999999999999999 4589999999999999877 89999999
Q ss_pred ccccccccCcccc-eeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchh----h--hhHHHH
Q 046877 207 GLAKLLTLNQRKT-IKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEE----Y--AILTDW 278 (350)
Q Consensus 207 g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~----~--~~~~~~ 278 (350)
|+++.+...-..- .....+-|.+|+|||.+.+. .|+++.||||.||++.||+|..+.|......- . ....+.
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999876543322 22445679999999999875 68999999999999999999888885432110 0 111111
Q ss_pred HHHHhh---cCCcchhc---cc------cccCCC-c----------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 279 AFDCYR---NGKLDDLV---EG------DMEAMN-D----------IKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 279 ~~~~~~---~~~~~~~~---~~------~~~~~~-~----------~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+.+. ...+..+. +. ...... + ..-++..++++.++|..||-+|.|+++.++
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 111111 11111111 00 000000 0 002234788999999999999999998764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=276.71 Aligned_cols=271 Identities=21% Similarity=0.272 Sum_probs=193.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC------C
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG------Q 132 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 132 (350)
+...+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++||||+++++++... .
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTG---EKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCC---cEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 445578999999999999875543 468999875432 22235678899999999999999999988654 3
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
..++++||+.. +|..+. ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 46899999875 777765 346788999999999999999999 459999999999999999999999999998754
Q ss_pred ccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------HHHh
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCY 283 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~~ 283 (350)
.... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............... ....
T Consensus 168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 168 DAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 3211 23346788999999876 46888999999999999999999999754432211100000 0000
Q ss_pred hcCCcchhccccccCCC------cHHHHHHHHHHHHhccCCCCCCCCCHHHHH--HHHhcccCCCCCCCC
Q 046877 284 RNGKLDDLVEGDMEAMN------DIKCVEKLLMISIWCIQEDPSLRPTMRKVS--QMLQEVVEVDVPPNP 345 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~vl--~~L~~~~~~~~~~~~ 345 (350)
................. ....+..+.+++.+||+.||++||++++++ ..++......+.+.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~ 312 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQ 312 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCC
Confidence 00000000000000000 012456789999999999999999999999 447766554333333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=274.68 Aligned_cols=265 Identities=22% Similarity=0.263 Sum_probs=190.8
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcC-CCCceeeecceeec----CCe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDE----GQN 133 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 133 (350)
+.+.+.||+|+||.||++....+. .+..+++|.+..... .....+.+|+.+++.+ +||||+++++.+.. ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCC-cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 345678999999999999976542 135689998764322 2245678899999998 69999999987532 245
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.+++++|+. ++|.+++.....+++..+..++.|++.||.||| ..+++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788899886 589999887788999999999999999999999 4599999999999999999999999999998654
Q ss_pred cCccc--ceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHH--------HHHH
Q 046877 214 LNQRK--TIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW--------AFDC 282 (350)
Q Consensus 214 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~--------~~~~ 282 (350)
..... .......++..|+|||.+.+ ..++.++||||+|+++|++++|..||...+.......... ....
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 32211 11123457889999998765 4688999999999999999999999975443221100000 0000
Q ss_pred hhcCCcchhc---ccccc---CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 283 YRNGKLDDLV---EGDME---AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 283 ~~~~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
+......... ..... .......+..+.+++.+||+.||++|||+.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000 00000 000112356899999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=275.15 Aligned_cols=258 Identities=24% Similarity=0.270 Sum_probs=187.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC------C
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG------Q 132 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 132 (350)
+.+.+.||+|+||.||++....+ +..+++|++.... ....+.+.+|+.++++++||||+++.+++... .
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKT---GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCC---CeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 34557899999999999986554 3568999886432 22345678899999999999999999987533 3
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
..+++++++ +++|.+++.. ..+++..+..++.|+++|++||| +.+++|+||||+||++++++.+||+|||++...
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 467888876 6799887754 46899999999999999999999 459999999999999999999999999998754
Q ss_pred ccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHH-H-------HHHHHh
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-D-------WAFDCY 283 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~-~-------~~~~~~ 283 (350)
... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||............ . .....+
T Consensus 171 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 171 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 321 123457889999999866 46788999999999999999999999654332211000 0 000000
Q ss_pred hcCCcchhcc---ccccC---CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 284 RNGKLDDLVE---GDMEA---MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 284 ~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......... ..... ......+.++.+++.+||+.||++||++.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000000 00000 000123567899999999999999999999884
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=268.24 Aligned_cols=260 Identities=24% Similarity=0.313 Sum_probs=201.8
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeec--ccc-----ccHHHHHHHHHHHhcCCCCceeeeccee
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQ-----DGEKEFKNEVIVIGQTHHKNLVRLLGFC 128 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~--~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 128 (350)
+...+|-...+||+|||+.||+|.+... ...||+|+-.. .-. .-.+...+|.++.+.++||.||++++++
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~E---qRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTE---QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccch---hheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 4555666778899999999999985433 45688887532 111 1234577899999999999999999998
Q ss_pred e-cCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCceEEe
Q 046877 129 D-EGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN---DRYNARIS 204 (350)
Q Consensus 129 ~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~ 204 (350)
. +.+.+|-|+|||+|.+|.-|+..+..+++..++.|+.||+.||.||.+. +.+|+|-||||.|||+- ..|.+||.
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 4 5567889999999999999999999999999999999999999999988 88999999999999994 45789999
Q ss_pred ecccccccccCcccc-----eeeccccCCCccCcccccCC----CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhH
Q 046877 205 DFGLAKLLTLNQRKT-----IKTAIRGTKGYVAPEWFRKS----TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 275 (350)
Q Consensus 205 Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~ 275 (350)
|||++.......+.. ......||.+|+|||+|.-+ ..+.|+||||.|+++|+.+.|+.||...........
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 999999886554332 22345689999999998533 468899999999999999999999975543322111
Q ss_pred HHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 276 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
. ..+... .....+.....+.+..+||++||+...++|.+..++.
T Consensus 696 e---------NTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 E---------NTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h---------hchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 111111 1112233334667899999999999999998877764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=278.10 Aligned_cols=237 Identities=24% Similarity=0.321 Sum_probs=191.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+++...+|.|+|+.|-.+.+..+. +..++|++.+. ..+..+|+.++... +||||++..+.+.++.+.|+||
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~---~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTD---QEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred hhccccccCCCCccceeeeeccccc---cchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3456677999999999999876664 45788888654 22345566555554 8999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE-cCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL-NDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|.+.|+-|.+.+.....+. ..+..|+.+|+.|+.||| ..+++||||||+|||+ ++.++++|+|||.+....+.
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999988887666655 778889999999999999 5599999999999999 68999999999999877644
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.....-|..|.|||++....+++++|+||||++||+|++|+.||........ ....+..++..
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e------i~~~i~~~~~s-------- 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE------IHTRIQMPKFS-------- 532 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH------HHHhhcCCccc--------
Confidence 1233468899999999999999999999999999999999999974433211 11111122222
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
...++..++++.+||+.||.+||++.++.
T Consensus 533 ----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 533 ----ECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred ----cccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 45678999999999999999999999986
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=269.09 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=190.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeec-CCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE-GQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 136 (350)
.+.+.+.||.|+||.||++....++ ..+++|.+.... ......+.+|+.+++.++|||++++.+++.. ....++
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTG---QNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCC---CEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 3455688999999999999866553 458888775322 2334678889999999999999999998865 567889
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
++||+. ++|..++. ...+++.....++.|+++|+.||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 88 v~e~~~-~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 88 VTELLG-TDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred Eeehhc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 999984 58888875 345788888899999999999999 5599999999999999999999999999987543211
Q ss_pred ccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------HHHhhcCC
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRNGK 287 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~~ 287 (350)
....++..|+|||.+.+ ..++.++|+||+|+++|+|+||+.||............... ......+.
T Consensus 163 -----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 163 -----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred -----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 23346788999998865 56889999999999999999999999755432211100000 00000000
Q ss_pred cchhcccc-ccCCCc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 288 LDDLVEGD-MEAMND-----IKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 288 ~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
...+.... .....+ ..++..+.+++.+||+.+|++|||+++++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01110000 000001 1245789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=271.14 Aligned_cols=266 Identities=21% Similarity=0.263 Sum_probs=193.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCC-----
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ----- 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 132 (350)
++...+.||+|+||.||++....+ +..+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRT---GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCC---CcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 345567899999999999986554 3568999875422 222356889999999999999999999886543
Q ss_pred -eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 133 -NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 133 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
..+++|||+ +++|.+++. ...+++..++.++.|+++|++||| +.+++|+||||+||++++++.++++|||++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 458999998 668988875 457899999999999999999999 55999999999999999999999999999875
Q ss_pred cccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHH-H-------HHHHH
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-D-------WAFDC 282 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~-~-------~~~~~ 282 (350)
..... ....++..|+|||.+.+ ..++.++|+||+|+++|++++|..||............ . .....
T Consensus 168 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 168 TDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 53221 23356889999999876 45788999999999999999999999754432111000 0 00000
Q ss_pred hhcCCcchhcccccc------CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH--HHHhcccC
Q 046877 283 YRNGKLDDLVEGDME------AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS--QMLQEVVE 338 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl--~~L~~~~~ 338 (350)
+.............. .....+++..+.+++.+|++.||++|||+.+++ ..++....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 000100111000000 000123456789999999999999999999998 45554433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=258.54 Aligned_cols=221 Identities=19% Similarity=0.161 Sum_probs=176.3
Q ss_pred CccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCCChhhh
Q 046877 70 GSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASF 149 (350)
Q Consensus 70 G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 149 (350)
|.+|.||++.+..++ +.+++|.+.... ....|...+....|||++++++++.+.+..+++|||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~---~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQ---QTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCC---cEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999976654 468999886532 233445555556799999999999999999999999999999999
Q ss_pred hcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCC
Q 046877 150 LFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229 (350)
Q Consensus 150 l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 229 (350)
+.....+++..+..++.|+++|+.||| ..+++|+||||+||+++.++.++++|||.+....... ....++..
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 977777899999999999999999999 4599999999999999999999999999876544321 22335678
Q ss_pred ccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHH
Q 046877 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLL 309 (350)
Q Consensus 230 y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 309 (350)
|+|||.+.+..++.++|+||+|+++|+|++|..|+........ .......+...+..+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------------THTTLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------------cccccCCcccCCHHHH
Confidence 9999999888889999999999999999999988753211000 0000011123457899
Q ss_pred HHHHhccCCCCCCCCCHH
Q 046877 310 MISIWCIQEDPSLRPTMR 327 (350)
Q Consensus 310 ~li~~cl~~dp~~Rps~~ 327 (350)
+++.+||+.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=259.01 Aligned_cols=249 Identities=23% Similarity=0.310 Sum_probs=193.4
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhc-CCCCceeeecceeecCCeeEEEEecCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQ-THHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
.+||.|.||+|++-.++.. ++..|||+++.... ..+.++..|.....+ -+.||||+++|..-.++..|+.||.|+
T Consensus 70 g~iG~G~fG~V~KM~hk~s---g~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPS---GKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHhcCCcchhhhhhhcCcc---CcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 4699999999999987655 46799999975443 456678888875544 489999999999999999999999997
Q ss_pred CCChhhhh-----cCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 143 NGTLASFL-----FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 143 ~g~L~~~l-----~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
- ||..+. .++..++++..-.+....+.||.||.+ ...|+|||+||+|||++..|.+||||||++..+..+-.
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA 223 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA 223 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence 5 664433 245778888888999999999999997 56899999999999999999999999999976643322
Q ss_pred cceeeccccCCCccCcccccCC--CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKS--TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.+...|...|||||.+... .|+.+|||||||++|||+.||..||+..+..-.. + .....|....+...
T Consensus 224 ---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq-l-----~~Vv~gdpp~l~~~- 293 (361)
T KOG1006|consen 224 ---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ-L-----CQVVIGDPPILLFD- 293 (361)
T ss_pred ---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH-H-----HHHHcCCCCeecCc-
Confidence 2344578899999999643 5899999999999999999999999876652111 1 11112222222211
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
....+++..+..++--|+.+|...||...+++++
T Consensus 294 ---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 ---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1123467889999999999999999999998753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=275.43 Aligned_cols=258 Identities=23% Similarity=0.281 Sum_probs=190.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCe-----
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN----- 133 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 133 (350)
+.+.+.||+|++|.||+|....++ ..+++|.+.... ......+.+|+.+++.++|||++++.+++...+.
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTG---RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCC---cEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 445678999999999999876543 458999875432 2234567789999999999999999998765554
Q ss_pred -eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 134 -RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 134 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
.++++||+ +++|.+++.. ..+++..++.++.|+++|+.||| +.+++|+||+|+||++++++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999998 5699998854 57899999999999999999999 559999999999999999999999999999765
Q ss_pred ccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhH-HHH-------HHHHh
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL-TDW-------AFDCY 283 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~-~~~-------~~~~~ 283 (350)
... .....++..|+|||.+.+ ..++.++||||+|+++|++++|+.||........... ... ....+
T Consensus 169 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 432 123356888999999865 3678899999999999999999999975443221100 000 00000
Q ss_pred hcCCcchhccccccC--CC----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 284 RNGKLDDLVEGDMEA--MN----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~--~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......+....... .. ....+.++.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000000 00 0123678999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=291.96 Aligned_cols=251 Identities=19% Similarity=0.244 Sum_probs=204.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..+++.+.||+|+||.|..++.+.+. +.+|+|+++++. .....-|.+|-.+|..-+.+=|+.++..|+++.++|
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~---~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTE---KVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccc---cchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 44567889999999999999987764 679999998743 233456889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+||||++||+|..++.+..+++++-++.++..++.||.-+| +.|+|||||||+|||+|..|++||+|||.+-.....
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999999988888999999999999999999999 669999999999999999999999999999877643
Q ss_pred cccceeeccccCCCccCccccc----C-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFR----K-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
. .......+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||..+.-.+. -...+...+
T Consensus 229 G-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT------Y~KIm~hk~--- 298 (1317)
T KOG0612|consen 229 G-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET------YGKIMNHKE--- 298 (1317)
T ss_pred C-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH------HHHHhchhh---
Confidence 3 33335678999999999985 3 5789999999999999999999999974432221 111111111
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT---MRKVS 330 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~vl 330 (350)
.+..+.....+....+||.+.+. +|+.|.. ++++.
T Consensus 299 ----~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 299 ----SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred ----hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 11222233477899999999887 8888988 77665
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=277.62 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=195.2
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCC------eeEE
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ------NRLL 136 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~l 136 (350)
.+.||+|+||.||+++++.++ ..||+|.++... ....+....|++++++++|+|||+++++-++.. ...+
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG---~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETG---RLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred hhhhcCCccceeeeecccccc---cchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 467999999999999976664 569999987643 334567889999999999999999999876654 4579
Q ss_pred EEecCCCCChhhhhcC---CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCC--ceEEeecccc
Q 046877 137 AYEFLNNGTLASFLFG---NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN--DRY--NARISDFGLA 209 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~--~~~--~~kl~Dfg~~ 209 (350)
+||||.+|+|...+++ ...+++.+.+.++.+++.||.|||++ +|+||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999964 35679999999999999999999965 999999999999984 334 3799999999
Q ss_pred cccccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
+...... ......||..|.+||.+.. ..|+..+|.|||||++|+..||..||....++....-..|..-.-.....
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9876544 3366789999999999985 78899999999999999999999999866555322112221111111000
Q ss_pred -----chh---ccccccCCCc----HHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHhccc
Q 046877 289 -----DDL---VEGDMEAMND----IKCVEKLLMISIWCIQEDPSLRP--TMRKVSQMLQEVV 337 (350)
Q Consensus 289 -----~~~---~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rp--s~~~vl~~L~~~~ 337 (350)
.+. +......+.+ ...-..+-..+..+|..+|.+|. .+.+....++.++
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 000 0000011111 12233445566667888888888 6666666655554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=260.95 Aligned_cols=270 Identities=21% Similarity=0.317 Sum_probs=205.6
Q ss_pred cccCHHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC--CC----cee
Q 046877 49 RCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH--HK----NLV 122 (350)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~--h~----~iv 122 (350)
..+...|.....+.+.+.+|+|+||.|-.+.+..+ +..||+|+++... .-.+...-|++.+.++. .| -++
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~---~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRET---KEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCC---CceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 44566777788889999999999999999987666 4679999987653 23345666899999882 33 277
Q ss_pred eecceeecCCeeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---
Q 046877 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND--- 197 (350)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~--- 197 (350)
.+.++|.-.++.|+|+|.+ |-|+.+++..+ .+++..+++.|+.|+++++++|| ..+++|.||||+||++.+
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEY 230 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccce
Confidence 8888999999999999987 45999999765 56789999999999999999999 559999999999999832
Q ss_pred -----------------CCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhC
Q 046877 198 -----------------RYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISC 260 (350)
Q Consensus 198 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg 260 (350)
+..++++|||.+....... ...+.|..|+|||++.+-.++.++||||+||+|.|++||
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 2348999999998765443 345679999999999999999999999999999999999
Q ss_pred CCCCCcccchhhhhHHHHHH--------------HHhhcCCcc--hhcccc--------cc-----CCCcHHHHHHHHHH
Q 046877 261 RKSFDIEMGEEYAILTDWAF--------------DCYRNGKLD--DLVEGD--------ME-----AMNDIKCVEKLLMI 311 (350)
Q Consensus 261 ~~pf~~~~~~~~~~~~~~~~--------------~~~~~~~~~--~~~~~~--------~~-----~~~~~~~~~~l~~l 311 (350)
...|...++.+...+-+... +.+..+.++ +....+ .+ .........+|++|
T Consensus 306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 99998777655332222111 111112111 000000 00 01122455679999
Q ss_pred HHhccCCCCCCCCCHHHHHH
Q 046877 312 SIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 312 i~~cl~~dp~~Rps~~~vl~ 331 (350)
+.+||..||.+|+|+.|+++
T Consensus 386 l~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHccCccccccHHHHhc
Confidence 99999999999999999874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=272.03 Aligned_cols=242 Identities=25% Similarity=0.385 Sum_probs=196.5
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeec--cccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
+.||+|-||+||-|+++.++ +.||||.+++ .....++++.+|+.+|..++||.|+.+...|+..+..++|||.+.
T Consensus 570 evLGSGQFG~VYgg~hRktG---rdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTG---RDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred hhccCCcceeeecceecccC---ceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 67999999999999988775 4599999875 346677899999999999999999999999999999999999998
Q ss_pred CCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEeecccccccccCccc
Q 046877 143 NGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND---RYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 143 ~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|.-|.-.+. +.+++++..-..+..||+.||.|||.+ +|+|+||||+|||+.. -.++||||||+++..+...
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 866666664 457888888899999999999999955 9999999999999964 4579999999999887543
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
..+..+||+.|+|||++++..|+..-|+||.|+++|--++|..||..+.+-.. ..+ + .. +. ...
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQ-------N--Aa-FM---yPp 785 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQ-------N--AA-FM---YPP 785 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hhh-------c--cc-cc---cCC
Confidence 33567899999999999999999999999999999999999999964332111 110 0 00 11 111
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
....+.+....++|-..|+..-.+|.|....+
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 12234567788889899999999998877654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=231.39 Aligned_cols=259 Identities=21% Similarity=0.268 Sum_probs=197.4
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
-+.||+|+||+||+|++.++ ...||+|.++... ........+|+.+++.++|.||++++++...+...-+|+|||
T Consensus 7 mekigegtygtvfkarn~~t---~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRET---HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred HHhhcCCcceeeEecccCCc---cceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 35799999999999997665 4579999886433 334577899999999999999999999999999999999999
Q ss_pred CCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 142 NNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 142 ~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
.. +|..+.. -++.++.+.+++++.|+++|+.++| +.++.|||+||.|.+++.+|.+|++|||+++..+-.- ..
T Consensus 84 dq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--rc 157 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RC 157 (292)
T ss_pred hH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Ee
Confidence 76 7777664 4577899999999999999999999 6699999999999999999999999999998776443 22
Q ss_pred eeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhc---ccc
Q 046877 221 KTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV---EGD 295 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 295 (350)
....+-|.+|++|.++.+. -|+...|+||.||++.|+.. |.+.|.+.+-.++.--.-+......+..+..+. +..
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 3445679999999999876 58899999999999999995 666666555444332222223333333333322 111
Q ss_pred ccCCCc---------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMND---------IKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.-...+ .+....=++++...+.-+|.+|.++++.++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111 123334567888889999999999998764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=251.75 Aligned_cols=264 Identities=19% Similarity=0.264 Sum_probs=199.8
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeec--------
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE-------- 130 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 130 (350)
++-...||+|.||.||+|+.+++++ .|++|+.-... ..-.....+|+++|..++|+|++.++..|..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~k---kvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGK---KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccc---hhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3344579999999999999777654 37777653211 1123456789999999999999999988743
Q ss_pred CCeeEEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 131 GQNRLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 131 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
...+++||++|+. +|..++... .+++...+.+++.++..||.|+| +..|+|||+||.|+||+.+|.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 2458999999988 888888655 78899999999999999999999 569999999999999999999999999999
Q ss_pred cccccCcc--cceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 046877 210 KLLTLNQR--KTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 286 (350)
Q Consensus 210 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 286 (350)
+....... ....+..+.|.+|++||.+.+. .++++.|||..||++.||+|+.+.+.+........+....+..+...
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 75533221 1112455679999999999875 79999999999999999999999998877666554444444444433
Q ss_pred Ccchhccccc--------------c----CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 287 KLDDLVEGDM--------------E----AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 287 ~~~~~~~~~~--------------~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+.....-.+ + ...+..-.++..+++.+++..||.+|+++++++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 3333211100 0 0001112347789999999999999999999874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=258.78 Aligned_cols=243 Identities=26% Similarity=0.304 Sum_probs=199.0
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcC-CCCceeeecceeecCC
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQ 132 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 132 (350)
.....+|...||+|+||.|.++.-+.+. ..+|+|++++... +..+--..|-++|... +-|.+++++.+|+.-+
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtd---ELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTD---ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcc---hhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 3344578889999999999999855543 5688888865432 2223344577788877 5788999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
.+|+||||+.||+|..++++-+++.+..+..++..|+-||-+|| +.+|++||||.+||+++.+|.+||+|||++..-
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999999999999999999999999999999999 669999999999999999999999999999743
Q ss_pred ccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
-.. ........||+.|+|||++..++|+..+|.||+|++||||+.|++||++++.++..... .
T Consensus 501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI---------------~ 563 (683)
T KOG0696|consen 501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI---------------M 563 (683)
T ss_pred ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---------------H
Confidence 222 22336678999999999999999999999999999999999999999988876643211 1
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCC
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRP 324 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 324 (350)
+. .-..+...+.+...+....|.++|.+|.
T Consensus 564 eh--nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EH--NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred Hc--cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 1122334567888899999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=284.23 Aligned_cols=144 Identities=26% Similarity=0.369 Sum_probs=126.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ......+..|+.+++.++||||+++++.+......++|
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNS---KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCC---cEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 456688999999999999976543 568999886432 22236788899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
|||+.+++|.+++.....+++..++.++.|++.||.||| ..+|+||||||+|||++.++.+||+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999987778899999999999999999999 4599999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=268.72 Aligned_cols=238 Identities=21% Similarity=0.237 Sum_probs=198.0
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeee---ccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD---RVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
...||-||||.|=+++.+.... .+|+|+++ -..+.+++.+..|-.+|...+.|.|++++-.|.+....|++||-
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~---~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKA---TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhcccCccceEEEEEecccch---HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 3459999999999998765432 35666554 34566677889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
|-||.|+..++.++.++....+.++..+++|++||| +.+|++|||||+|.+++.+|-+||.|||++...+.....
T Consensus 502 ClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT-- 576 (732)
T KOG0614|consen 502 CLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT-- 576 (732)
T ss_pred hcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCce--
Confidence 999999999999999999999999999999999999 669999999999999999999999999999988765433
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
-.+.||+.|.|||++.+..++.++|.||||+++|||++|.+||.+.++-....+. .+.+.. ...
T Consensus 577 -wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I---LkGid~------------i~~ 640 (732)
T KOG0614|consen 577 -WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI---LKGIDK------------IEF 640 (732)
T ss_pred -eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH---Hhhhhh------------hhc
Confidence 4567999999999999999999999999999999999999999876654432111 111111 111
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCC
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPT 325 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps 325 (350)
+...+....++|++....+|.+|.-
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhc
Confidence 1234456778999999999999976
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=247.51 Aligned_cols=238 Identities=27% Similarity=0.335 Sum_probs=192.3
Q ss_pred ccceEEEEEEcCCCcceeEEEEEeeecccccc-HHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCCChhhh
Q 046877 71 SFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG-EKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASF 149 (350)
Q Consensus 71 ~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 149 (350)
+||.||+|....++ ..+++|.+....... .+.+.+|++.++.++|+|++++++++......++++||+.+++|.++
T Consensus 1 ~~g~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTG---KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCC---cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999876543 468999887654444 67899999999999999999999999999999999999999999999
Q ss_pred hcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCC
Q 046877 150 LFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229 (350)
Q Consensus 150 l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 229 (350)
+.....+++..+..++.+++.++.+||+ .+++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 8766668899999999999999999995 599999999999999999999999999998765432 1233457889
Q ss_pred ccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHH-HHHHH
Q 046877 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK-CVEKL 308 (350)
Q Consensus 230 y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l 308 (350)
|+|||.+.+..++.++||||+|+++|++++|..||......... . .....+... ...... ++.++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~--~----~~~~~~~~~--------~~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL--F----KKIGKPKPP--------FPPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--H----HHHhccCCC--------CccccccCCHHH
Confidence 99999998888899999999999999999999999753222111 0 111111110 000101 56789
Q ss_pred HHHHHhccCCCCCCCCCHHHHHH
Q 046877 309 LMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 309 ~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+++.+||..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=270.14 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=201.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceee-----cCCee
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCD-----EGQNR 134 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~ 134 (350)
.+|.+.||.|.+|.||+++...++ +..|+|+.... .+..+++..|+.+++.. +|||++.+++++. .++++
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~---~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTG---QLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecC---ceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 456788999999999999977664 34677776543 55677899999999988 7999999999883 45789
Q ss_pred EEEEecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 135 LLAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
|+|||||.+||..|+++. ..++.|..+..|++.++.|+.+|| ...++|||+|-.|||+++++.|||+|||.+..+
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 999999999999999864 467889999999999999999999 559999999999999999999999999999877
Q ss_pred ccCcccceeeccccCCCccCcccccCC-----CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKS-----TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
...... .....||+.|||||++... .|+..+|+||||++..||.-|.+|+....+--..
T Consensus 174 dsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-------------- 237 (953)
T KOG0587|consen 174 DSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------------- 237 (953)
T ss_pred eccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh--------------
Confidence 644332 2456799999999998532 4677899999999999999999998643321110
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+.-...+.+....+...+.++.++|..||.+|.++||++.++++
T Consensus 238 F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 01112233344556788999999999999999999999998864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=225.79 Aligned_cols=197 Identities=27% Similarity=0.390 Sum_probs=164.1
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEecC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
...||+|++|.|-+-++..+ ++..|+|.+.... ....++..+|+.+.... ..|.+++++|-...+...++.||.|
T Consensus 51 i~elGrGayG~vekmrh~~s---g~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQS---GTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhcCCccchhhheeeccC---CeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 45799999999998887665 4678999886443 34456788888775554 8999999999999999999999999
Q ss_pred CCCChhhhh----cCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 142 NNGTLASFL----FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 142 ~~g~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
+. ||..+- .+....++..+-+|+..+++||.|||+ ...++|||+||+|||++..|++|+||||.+..+.++-.
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 76 776654 456788999999999999999999998 57899999999999999999999999999987654322
Q ss_pred cceeeccccCCCccCcccccC----CCCCCCCcchhHHHHHHHHHhCCCCCCcccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRK----STISAKVDVYSFGVLLLEIISCRKSFDIEMG 269 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~ 269 (350)
. +...|...|+|||.+.. ..|+-||||||||+.+.||.+++.||+....
T Consensus 205 k---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 205 K---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred H---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 2 23447889999999852 3689999999999999999999999975544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=265.11 Aligned_cols=261 Identities=20% Similarity=0.205 Sum_probs=162.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCC-CcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecce------eecCC
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTT-TTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGF------CDEGQ 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~~~~ 132 (350)
.+.+.+.||+|+||.||+|.+..+ ...+..+++|++..... .+....+ .+....+.++..+... ..+..
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 455668899999999999998655 12235689998754221 1111111 1112222222222221 24566
Q ss_pred eeEEEEecCCCCChhhhhcCCCC--------------------cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLK--------------------PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQN 192 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N 192 (350)
..++++||+.+++|.+++..... .....+..++.|++.||.||| +.+|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHH
Confidence 78999999999999998854321 112345679999999999999 5599999999999
Q ss_pred eEEcC-CCceEEeecccccccccCcccceeeccccCCCccCcccccCC----------------------CCCCCCcchh
Q 046877 193 ILLND-RYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS----------------------TISAKVDVYS 249 (350)
Q Consensus 193 ill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Diws 249 (350)
||+++ ++.+||+|||++......... ......+++.|+|||.+... .++.++||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99985 678999999999755332211 12345678999999976322 2345679999
Q ss_pred HHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC------CCcHHHHHHHHHHHHhccCCCCCCC
Q 046877 250 FGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA------MNDIKCVEKLLMISIWCIQEDPSLR 323 (350)
Q Consensus 250 lG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~R 323 (350)
+||++|||+++..|++.....-...+.. .......+.......... ...........+|+.+||+.||++|
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKR---NDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHh---cCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 9999999999777654221100000000 000000000000000000 0000112345689999999999999
Q ss_pred CCHHHHHH
Q 046877 324 PTMRKVSQ 331 (350)
Q Consensus 324 ps~~~vl~ 331 (350)
||+.++++
T Consensus 442 ~ta~e~L~ 449 (566)
T PLN03225 442 ISAKAALA 449 (566)
T ss_pred CCHHHHhC
Confidence 99999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=238.13 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=194.1
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEE
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+.+.||+|+|..|.+++++.+. +.+|+|++++.. ....+..+.|-.+.... +||.++.+..+|+.++.+++|.
T Consensus 254 ll~vigrgsyakvl~~~~~~t~---qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTD---QIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred eeeeecCcchhhhhheehcccc---eeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 4467999999999999987764 568888876532 23345677788887776 8999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||++||+|.-++.++..++++.++.+...|+.||.||| ..+|+.||||.+|+|++.+|.+||.|||+++..-...
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g-- 405 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-- 405 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCC--
Confidence 99999999999999999999999999999999999999 5699999999999999999999999999998543222
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhh-hhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.....+.||+.|.|||++++..|...+|.|++|++++||+.|+.||+....... ..-.++.+.. +++.+.+
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------ilekqir 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------ILEKQIR 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hhhhccc
Confidence 223567899999999999999999999999999999999999999985332111 1111222221 2222222
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCC
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRP 324 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rp 324 (350)
.+. ..+.+...++..-|.+||.+|.
T Consensus 478 ipr--slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 IPR--SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccc--eeehhhHHHHHHhhcCCcHHhc
Confidence 222 2345566788888999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=253.87 Aligned_cols=263 Identities=19% Similarity=0.194 Sum_probs=173.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCC-------------CcceeEEEEEeeeccccccHHH--------------HHHHHHH
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTT-------------TTSTTAVAVKKLDRVFQDGEKE--------------FKNEVIV 112 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~-------------~~~~~~vavk~~~~~~~~~~~~--------------~~~e~~~ 112 (350)
.+.+.+.||+|+||.||+|..... ......|++|++........++ ...|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 455678899999999999975321 1233569999986432222222 2346666
Q ss_pred HhcCCCCce-----eeecceeec--------CCeeEEEEecCCCCChhhhhcCC------------------------CC
Q 046877 113 IGQTHHKNL-----VRLLGFCDE--------GQNRLLAYEFLNNGTLASFLFGN------------------------LK 155 (350)
Q Consensus 113 l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~------------------------~~ 155 (350)
+.+++|.++ ++++++|.. .+..++||||+++++|.+++... ..
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 667765544 566776643 35679999999999999988532 12
Q ss_pred cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCccc
Q 046877 156 PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235 (350)
Q Consensus 156 ~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 235 (350)
.++..++.++.|+++++.||| +.+++||||||+||+++.++.+||+|||++.......... .....+++.|+|||.
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEE 381 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhh
Confidence 356678889999999999999 4599999999999999999999999999997543321111 112234789999998
Q ss_pred ccCCCC----------------------CCCCcchhHHHHHHHHHhCCC-CCCcccchhhhh-HHHHHHHHhhcCCcchh
Q 046877 236 FRKSTI----------------------SAKVDVYSFGVLLLEIISCRK-SFDIEMGEEYAI-LTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 236 ~~~~~~----------------------~~~~DiwslG~~l~~lltg~~-pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 291 (350)
+..... ..+.||||+||++|+|+++.. ||.....-.... ........ +...
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~-----~r~~ 456 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR-----WRMY 456 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH-----HHhh
Confidence 754321 134799999999999999886 664221100000 00000000 1111
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDP---SLRPTMRKVSQ 331 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~~vl~ 331 (350)
.............++...+++.++|..+| .+|+|++++++
T Consensus 457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11111112223456789999999999876 68999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=250.34 Aligned_cols=277 Identities=21% Similarity=0.214 Sum_probs=213.7
Q ss_pred cccccccccCHHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-----
Q 046877 43 TIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH----- 117 (350)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~----- 117 (350)
.-..+++.+.+.|+....|.+....|+|-||+|..|.+...+ ..||||++.+.. ...+.=+.|+.+|++|+
T Consensus 416 dDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~---~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~E 491 (752)
T KOG0670|consen 416 DDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARG---QEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPE 491 (752)
T ss_pred ccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCC---CeeEEEEeecch-HHhhhhhHHHHHHHHhhccCch
Confidence 445567888899999999999999999999999999876654 379999997653 33455677999999985
Q ss_pred -CCceeeecceeecCCeeEEEEecCCCCChhhhhcCC---CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046877 118 -HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNI 193 (350)
Q Consensus 118 -h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni 193 (350)
--|+++++..|...+++|||+|-+.. +|.+.+.+. ..+....++.++.|+..||..|- ..+|+|.||||+||
T Consensus 492 dk~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNi 567 (752)
T KOG0670|consen 492 DKFHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNI 567 (752)
T ss_pred hhhHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccce
Confidence 34799999999999999999998765 899988643 45678899999999999999999 66999999999999
Q ss_pred EEcCC-CceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhh
Q 046877 194 LLNDR-YNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 272 (350)
Q Consensus 194 ll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~ 272 (350)
|++++ ..+||||||.|...+.... +.+.....|.|||++.|-+|+...|+||.||+||||.||+..|.+......
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred EeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 99865 5689999999987765433 334456689999999999999999999999999999999999977655443
Q ss_pred hhHHHH-----HHHHhhcCCcc-hhccccccC-------------------------------------CCcHHHHHHHH
Q 046877 273 AILTDW-----AFDCYRNGKLD-DLVEGDMEA-------------------------------------MNDIKCVEKLL 309 (350)
Q Consensus 273 ~~~~~~-----~~~~~~~~~~~-~~~~~~~~~-------------------------------------~~~~~~~~~l~ 309 (350)
.-+... ....++.|.+. +.++..+.. .........+.
T Consensus 644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~r 723 (752)
T KOG0670|consen 644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLR 723 (752)
T ss_pred HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHH
Confidence 322221 11222222211 111111100 00123556889
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 046877 310 MISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 310 ~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+|+..|+..||++|.|..++|.
T Consensus 724 dLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 724 DLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHhccChhhcCCHHHHhc
Confidence 9999999999999999998764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=238.33 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=195.7
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCC-----eeEE
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ-----NRLL 136 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 136 (350)
.+.||.|+||.||.+. ++.+++.|++|++.+... ..-+++-+|+++|..++|.|++..++..+... .+|+
T Consensus 58 DRPIGYGAFGVVWsVT---DPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVT---DPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCcccccceeEEEecc---CCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3569999999999887 455567899999865433 23467888999999999999999998875543 3567
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+.|.+.. +|...+.....++.+.++-+.+||+.|++||| +.+|.||||||.|.|++.|..+||||||+++.....+
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8888865 89888888888999999999999999999999 6699999999999999999999999999998765443
Q ss_pred ccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH--------HHhhcCC
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCYRNGK 287 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~~~~~~ 287 (350)
... .+..+-|..|+|||.+.+. .|+...||||.||++.|++..+..|....+.+...+..... +.--+|.
T Consensus 211 ~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 211 RLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 332 3445568899999999876 68999999999999999999999887655544322211110 0001111
Q ss_pred cchhccccccC---------CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 288 LDDLVEGDMEA---------MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 288 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
-..++....+. .....-..+...+...++.+||+.|.+..+.+.-+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111111111 11122334667788889999999999988876543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=251.37 Aligned_cols=202 Identities=23% Similarity=0.340 Sum_probs=172.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
+.||-|+||.|.+++-.++ ...+|.|.+.+.. .+.....+.|..+|..-+.+=||+++..|++++.+|+||||+
T Consensus 635 k~iGvGAFGeV~Lv~KvDT---~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYI 711 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDT---RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 711 (1034)
T ss_pred eeecccccceeEEEeecch---hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEecc
Confidence 4699999999999986665 3568888876543 344556888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc---ccCccc
Q 046877 142 NNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL---TLNQRK 218 (350)
Q Consensus 142 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~---~~~~~~ 218 (350)
+||++..++.+.+.+.++.++.++..+..|+++.| +.|+|||||||+|||||.+|.+||.|||++.-+ ++..++
T Consensus 712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999999999999999999999999999999999 669999999999999999999999999998633 111000
Q ss_pred c-------------------------------------eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCC
Q 046877 219 T-------------------------------------IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCR 261 (350)
Q Consensus 219 ~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~ 261 (350)
. ..-..+||+.|+|||++....++..+|.||.|++||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 0 001235899999999999999999999999999999999999
Q ss_pred CCCCcccchhh
Q 046877 262 KSFDIEMGEEY 272 (350)
Q Consensus 262 ~pf~~~~~~~~ 272 (350)
.||..+...+.
T Consensus 869 ~pf~~~tp~~t 879 (1034)
T KOG0608|consen 869 PPFLADTPGET 879 (1034)
T ss_pred CCccCCCCCcc
Confidence 99976665443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=237.66 Aligned_cols=266 Identities=23% Similarity=0.285 Sum_probs=189.9
Q ss_pred HHHHH-HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-----C---Cceeee
Q 046877 54 KELEE-ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-----H---KNLVRL 124 (350)
Q Consensus 54 ~~~~~-~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~ 124 (350)
.|+.. .+|.+.+.||.|-|++||++.+..+ .+.||+|+.+.. ..-.+....|+++|+.++ | .+||++
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~---~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQN---KRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccC---CeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 34444 5566778899999999999985444 477999998643 233456788999999873 2 369999
Q ss_pred cceee----cCCeeEEEEecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 046877 125 LGFCD----EGQNRLLAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR 198 (350)
Q Consensus 125 ~~~~~----~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~ 198 (350)
++.|. ++.+.|||+|++ |.+|..+|.. ...++...+++|++|++.||.|||.. .+|+|.||||+|||+..+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCST 224 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeecc
Confidence 99984 567899999998 4478777753 36688999999999999999999985 599999999999998422
Q ss_pred -----------C--------------------------------------------------------------------
Q 046877 199 -----------Y-------------------------------------------------------------------- 199 (350)
Q Consensus 199 -----------~-------------------------------------------------------------------- 199 (350)
+
T Consensus 225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n 304 (590)
T KOG1290|consen 225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN 304 (590)
T ss_pred ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 046877 200 -------------------------------------------------------------------------------- 199 (350)
Q Consensus 200 -------------------------------------------------------------------------------- 199 (350)
T Consensus 305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~ 384 (590)
T KOG1290|consen 305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI 384 (590)
T ss_pred cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence
Q ss_pred -------ceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhh
Q 046877 200 -------NARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 272 (350)
Q Consensus 200 -------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~ 272 (350)
.+||+|||.|+...... +.-..|..|+|||++.+..|++.+||||++|+++||+||...|+...++..
T Consensus 385 ~~~~~di~vKIaDlGNACW~~khF-----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y 459 (590)
T KOG1290|consen 385 PLPECDIRVKIADLGNACWVHKHF-----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY 459 (590)
T ss_pred CCCccceeEEEeeccchhhhhhhh-----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence 03344444443332211 112357899999999999999999999999999999999999986655432
Q ss_pred hh-----------HHHHHHHHhhcCC-cchhcccccc--------C-----------CCcHHHHHHHHHHHHhccCCCCC
Q 046877 273 AI-----------LTDWAFDCYRNGK-LDDLVEGDME--------A-----------MNDIKCVEKLLMISIWCIQEDPS 321 (350)
Q Consensus 273 ~~-----------~~~~~~~~~~~~~-~~~~~~~~~~--------~-----------~~~~~~~~~l~~li~~cl~~dp~ 321 (350)
.. +....+.....|+ ..+++...-. . ....+...++.+|+.-||+.+|+
T Consensus 460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe 539 (590)
T KOG1290|consen 460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE 539 (590)
T ss_pred CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence 21 1112222222332 1222221110 0 11245667899999999999999
Q ss_pred CCCCHHHHHH
Q 046877 322 LRPTMRKVSQ 331 (350)
Q Consensus 322 ~Rps~~~vl~ 331 (350)
+|||+.++++
T Consensus 540 KR~tA~~cl~ 549 (590)
T KOG1290|consen 540 KRPTAAQCLK 549 (590)
T ss_pred ccccHHHHhc
Confidence 9999999873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-33 Score=257.54 Aligned_cols=239 Identities=29% Similarity=0.407 Sum_probs=183.6
Q ss_pred hhccCCCccc-eEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEecC
Q 046877 64 KEEVGRGSFG-IIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 64 ~~~lg~G~~g-~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
.+.+|.|+-| .||+|.+..+ .||||.+- ........+|++.|..- +||||+++++...+....|+..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R-----~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGR-----EVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCc-----eehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 3568898875 5789987654 59999864 23455688999999998 6999999999999999999999999
Q ss_pred CCCChhhhhcCC-CCc---ChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---C--CceEEeeccccccc
Q 046877 142 NNGTLASFLFGN-LKP---NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND---R--YNARISDFGLAKLL 212 (350)
Q Consensus 142 ~~g~L~~~l~~~-~~~---~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~--~~~kl~Dfg~~~~~ 212 (350)
.. +|.+++... ... .....+..+.|+++|+++|| +.+|+||||||.||||+. + ..++|+|||+++..
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 76 999999753 111 11344778999999999999 679999999999999975 2 46899999999987
Q ss_pred ccCcc-cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhC-CCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 213 TLNQR-KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 213 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
..... ........||.+|+|||.+.+...+.++||||+||++|+.++| ..||...-..+...+. +...
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~---------~~~~- 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT---------GNYT- 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc---------Cccc-
Confidence 65422 2223456689999999999988888899999999999999986 8899754443322211 1100
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
-.......++ +..++|.+|+..+|+.||++.+|+
T Consensus 732 ----L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 732 ----LVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ----eeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0011111122 788999999999999999999986
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=214.27 Aligned_cols=255 Identities=18% Similarity=0.304 Sum_probs=190.2
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecC--Cee
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG--QNR 134 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~ 134 (350)
...+++.+.+|+|.++.||.|....+.+ .+++|.++. ...+.+.+|+++|..+ .||||+++++...+. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~e---K~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNE---KCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCc---eEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4556788899999999999998655543 377777753 3467899999999999 599999999998665 345
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEeecccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND-RYNARISDFGLAKLLT 213 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~ 213 (350)
.+++||.++.+...+. ..++...++.++.++++||.|+| |.||+|||+||.|+++|. .-.++|+|+|++.+++
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 7999999887655543 56778889999999999999999 779999999999999985 4569999999999998
Q ss_pred cCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccc-hhhh----------hHHHHHHH
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMG-EEYA----------ILTDWAFD 281 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~-~~~~----------~~~~~~~~ 281 (350)
+...... .+.+..|-.||.+.. ..|+-.-|+|||||++..|+..+.||....+ .++. .+..+...
T Consensus 185 p~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 7655443 235667889998864 4678888999999999999999999953322 2211 00011100
Q ss_pred H--------------hhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 282 C--------------YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 282 ~--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
. .....+..++...-+.. .+++..+++...|..|-++|+|+.|.+.
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl----~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHL----VSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCcccccc----CChHHHHHHHHHHhhccccccchHHHhc
Confidence 0 00112222222222222 3468889999999999999999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=217.52 Aligned_cols=210 Identities=33% Similarity=0.518 Sum_probs=179.9
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCCC
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGT 145 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 145 (350)
||+|.+|.||++....+ +..+++|........ ....+.+|++.++.++|++++++++++......++++|++++++
T Consensus 1 l~~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKT---GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCC---CcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 68999999999987653 345888887654322 34679999999999999999999999999999999999999999
Q ss_pred hhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEeecccccccccCcccceeec
Q 046877 146 LASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND-RYNARISDFGLAKLLTLNQRKTIKTA 223 (350)
Q Consensus 146 L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 223 (350)
|.+++... ...++..+..++.+++.++++||+ .+++|+||+|+||+++. ++.++|+|||.+........ ....
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99998655 468899999999999999999994 59999999999999999 89999999999986654321 1123
Q ss_pred cccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcH
Q 046877 224 IRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 302 (350)
Q Consensus 224 ~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
..+...|++||.+... ..+.++|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4467889999999876 788899999999999998
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 303 KCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 303 ~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
..+.+++.+|++.||++||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 467889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=226.04 Aligned_cols=254 Identities=24% Similarity=0.281 Sum_probs=184.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeec------CCeeEE
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE------GQNRLL 136 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~l 136 (350)
+.+|.|.- .|..+.+. -....|++|+..... ....++..+|..++..++|+||++++.++.- ....|+
T Consensus 23 ~p~~~g~~-~v~~a~D~---v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~ 98 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQ---VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYL 98 (369)
T ss_pred cccCCCCc-eEEecchh---hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHH
Confidence 45788877 56555433 334568888875432 2334678899999999999999999998843 345789
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||++.. +|...+. ..++-..+..+..|++.|++||| +.+|+||||||+||++..++.+|+.|||++...+..
T Consensus 99 v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 99 VMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 9999976 8888875 56677888999999999999999 669999999999999999999999999999865533
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHH-------------H---HHH
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-------------D---WAF 280 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~-------------~---~~~ 280 (350)
-..+.++.+..|.|||++.+..+.+.+||||+||++.||++|+..|.+.+.-++-... + ...
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 2345677889999999999888999999999999999999999998654332211100 0 000
Q ss_pred HHhhcC------Ccchhc-ccccc--CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 281 DCYRNG------KLDDLV-EGDME--AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 281 ~~~~~~------~~~~~~-~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
-..++. ...+.+ +.... ...+.--..-+.+++.+||..||++|.|+++++.
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 001100 000000 00000 0011123456788999999999999999999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=240.92 Aligned_cols=193 Identities=21% Similarity=0.310 Sum_probs=165.2
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--------ccHHHHHHHHHHHhcCC---CCceeeecceeecC
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--------DGEKEFKNEVIVIGQTH---HKNLVRLLGFCDEG 131 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~ 131 (350)
..+.+|.|+||.|++|.++.. ...|++|.+.+..- ...-.+..|+++|..++ |+||++++++|++.
T Consensus 565 tlq~lG~GAyGkV~lai~K~n---~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKEN---NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred eeeeccccccceEEEeeeccc---ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 346799999999999998765 46789998864311 11123567999999997 99999999999999
Q ss_pred CeeEEEEecCC-CCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 132 QNRLLAYEFLN-NGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 132 ~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
+.+|++||... +-+|++++.....+++..+.-|++|++.|+++|| +.+|+|||||-+|+.++.+|-+||+|||.+.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchh
Confidence 99999999764 5589999998999999999999999999999999 5599999999999999999999999999998
Q ss_pred ccccCcccceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCC
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFD 265 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~ 265 (350)
...... ...++||..|.|||++.+.+| +..-|||++|++||-++....||.
T Consensus 719 ~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 654332 256789999999999999887 456899999999999999888885
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=228.63 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=194.7
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEec
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
...+.||.|+|++||++...........|++|.+.. .....++.+|+.+|..+ .+.||+++.+++..+++..+|+||
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~--ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR--TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeeccc--ccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 345679999999999998776433456799999865 34567899999999999 799999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEeecccccccccCc---
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLNQ--- 216 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~--- 216 (350)
++.....++.. .++...++.+++.+..||+++| .+||+|||+||+|++.+ ..+.-.|.|||++.......
T Consensus 117 ~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 117 FEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred cCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 99988888874 4568889999999999999999 56999999999999998 45678999999998321000
Q ss_pred ---------------------------------------ccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHH
Q 046877 217 ---------------------------------------RKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLE 256 (350)
Q Consensus 217 ---------------------------------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ 256 (350)
.........||++|+|||++... ..++++||||.|++++.
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 00011234589999999998764 67999999999999999
Q ss_pred HHhCCCCCCcccchhhhhHHH---HHHHHhh-----cCC------------------cchh----cccc-----ccCCCc
Q 046877 257 IISCRKSFDIEMGEEYAILTD---WAFDCYR-----NGK------------------LDDL----VEGD-----MEAMND 301 (350)
Q Consensus 257 lltg~~pf~~~~~~~~~~~~~---~~~~~~~-----~~~------------------~~~~----~~~~-----~~~~~~ 301 (350)
++++..||....++....... +....++ .|. +..+ +.+. ......
T Consensus 271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~ 350 (418)
T KOG1167|consen 271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS 350 (418)
T ss_pred hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence 999999996544433221110 0000000 011 0000 0000 001111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+..+++++.+|+..||.+|.|+++.++
T Consensus 351 d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 351 DVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 234568999999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=214.80 Aligned_cols=243 Identities=19% Similarity=0.296 Sum_probs=184.1
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecce-eecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGF-CDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~l 136 (350)
..+.+.+.||+|.||.+-+++++.+. +.+++|-+... .....+|.+|...--.| .|.||+.-++. |+..+..++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~---t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSK---TRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCc---eEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 34567788999999999999987663 56888877654 34577899998776556 69999998875 677788889
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCCceEEeeccccccccc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN--DRYNARISDFGLAKLLTL 214 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~ 214 (350)
++||++.|+|.+-+.. ..+.+.....++.|+++|+.||| +.++||||||.+||||- +...+|+||||.+...+.
T Consensus 100 ~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999998743 55678888999999999999999 66999999999999993 445799999999986553
Q ss_pred CcccceeeccccCCCccCcccccC---C--CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRK---S--TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~---~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
-- .....+..|.+||.... + ...+.+|||+||+++|.++||+.||......+..+ |.+..+..+...
T Consensus 176 tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y---~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 176 TV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY---WEWEQWLKRKNP 247 (378)
T ss_pred ee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH---HHHHHHhcccCc
Confidence 21 11224567999997642 2 35778999999999999999999998544443332 334444444433
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCC
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLR 323 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 323 (350)
.....- ..+++.+..+..+-+..++++|
T Consensus 248 ~~P~~F------~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 248 ALPKKF------NPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cCchhh------cccCHHHHHHHHHhcCCccccc
Confidence 222211 1255778888889999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=242.49 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=203.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.++....+|+|++|.||+++++.+. ...|+|.++....+...-+++|+-+++..+||||+.+++.+-..+..++.||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~---elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSG---ELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred chhheeeecCCcccchhhhcccccC---chhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3445567999999999999966554 5578888877777778889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
||.+|+|++.-+..+.+++.++...++...+|++||| +.+=+|||||=.||++++.|.+|++|||.+..++-- ..
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~ 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA 167 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh--hh
Confidence 9999999999888899999999999999999999999 668899999999999999999999999999766532 11
Q ss_pred eeeccccCCCccCcccc---cCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 220 IKTAIRGTKGYVAPEWF---RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
....+.||+.|||||+- +...|..++|||++|+...|+---+.|-....+.....+ +.+......
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L------------mTkS~~qpp 235 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL------------MTKSGFQPP 235 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH------------hhccCCCCC
Confidence 22456799999999986 345789999999999999999887776532222111111 011111112
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.........+-+.+|++.|+.++|.+|||++.++.
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22233456778999999999999999999987654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=212.18 Aligned_cols=198 Identities=29% Similarity=0.462 Sum_probs=169.2
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
.+.+.||+|++|.||++....++ ..+++|........ ..+.+.+|+..++.++|+|++++++++......++++|+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTG---ELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCC---cEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 34578999999999999876543 45899988765443 567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCC-cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 141 LNNGTLASFLFGNLK-PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
+++++|.+++..... +++..+..++.+++.++.+||+ .+++|+|++|.||+++.++.++|+|||.+.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 999999999976666 8899999999999999999995 49999999999999999999999999999876543210
Q ss_pred eeeccccCCCccCcccc-cCCCCCCCCcchhHHHHHHHHHhCCCCCCc
Q 046877 220 IKTAIRGTKGYVAPEWF-RKSTISAKVDVYSFGVLLLEIISCRKSFDI 266 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~lltg~~pf~~ 266 (350)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11334567789999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=249.68 Aligned_cols=194 Identities=19% Similarity=0.228 Sum_probs=135.2
Q ss_pred CCC-Cceeeeccee-------ecCCeeEEEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 046877 116 THH-KNLVRLLGFC-------DEGQNRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHC 186 (350)
Q Consensus 116 l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~ 186 (350)
++| +||.++++++ .+...++.++|++ +++|.+++.. ...+++..++.++.||++||.||| +.+|+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 344 5777777776 2234567788887 5599999965 355899999999999999999999 5699999
Q ss_pred CCCCCCeEEcCCC-------------------ceEEeecccccccccCcc--------------cceeeccccCCCccCc
Q 046877 187 DIKPQNILLNDRY-------------------NARISDFGLAKLLTLNQR--------------KTIKTAIRGTKGYVAP 233 (350)
Q Consensus 187 dlkp~Nill~~~~-------------------~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aP 233 (350)
||||+||||+..+ .+|++|||+++....... ........+|+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 455556665543211000 0000123578889999
Q ss_pred ccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHH
Q 046877 234 EWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISI 313 (350)
Q Consensus 234 E~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 313 (350)
|++.+..++.++|||||||++|||++|..|+..... ...... ... .. ...........+++.
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~-----~~~----~~-----~~~~~~~~~~~~~~~ 246 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLR-----HRV----LP-----PQILLNWPKEASFCL 246 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHH-----Hhh----cC-----hhhhhcCHHHHHHHH
Confidence 999999999999999999999999998888652211 000000 000 00 000112334568889
Q ss_pred hccCCCCCCCCCHHHHHH
Q 046877 314 WCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 314 ~cl~~dp~~Rps~~~vl~ 331 (350)
+||+.||.+|||+.++++
T Consensus 247 ~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HhCCCChhhCcChHHHhh
Confidence 999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=198.03 Aligned_cols=166 Identities=21% Similarity=0.164 Sum_probs=125.6
Q ss_pred CChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceee
Q 046877 144 GTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT 222 (350)
Q Consensus 144 g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 222 (350)
|+|.+++.. ...+++..++.++.|++.||.|||+. + ||+||+++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999975 45689999999999999999999964 4 999999999999999 99987654322
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcH
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 302 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
..|++.|+|||++.+..++.++|||||||++|||+||..||......... ..... ..... .. ........
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~-~~~~~----~~---~~~~~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILL-NGMPA----DD---PRDRSNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHH-HHhcc----CC---ccccccHH
Confidence 24789999999999999999999999999999999999999654332211 11110 00000 00 00011122
Q ss_pred HHHH--HHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 303 KCVE--KLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 303 ~~~~--~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
..+. ++.+++.+||..||++|||+.++++.+..+
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 3333 699999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=197.15 Aligned_cols=262 Identities=20% Similarity=0.219 Sum_probs=194.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC----CCceeeeccee-ecCCee
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH----HKNLVRLLGFC-DEGQNR 134 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~ 134 (350)
.+.+.+.||+|+||.||.+....+. ...+|+|............+..|..++..+. .+++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 5567789999999999999876654 3457777765543333337888888888886 35888898888 577888
Q ss_pred EEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-----CceEEeecc
Q 046877 135 LLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR-----YNARISDFG 207 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Dfg 207 (350)
++||+.+ |.+|.++.... ..++......++.|++.+|.++| +.+++||||||.|+.+... ..+.+.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999976 66999987433 67899999999999999999999 5599999999999999754 469999999
Q ss_pred ccc--ccccCcc------cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhh-hHHHH
Q 046877 208 LAK--LLTLNQR------KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDW 278 (350)
Q Consensus 208 ~~~--~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~-~~~~~ 278 (350)
+++ ....... .......+||.+|.++.+..+...+.+.|+||++.++.++..|..||......... .....
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 3322211 11123466999999999999999999999999999999999999999654432211 11110
Q ss_pred HHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
.. ...... .....+..+.++...+-..+..++|....+...|+.+....
T Consensus 253 ~~----~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PR----KLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hh----hhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00 000000 11123456666666667789999999999999988776544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-26 Score=217.48 Aligned_cols=254 Identities=21% Similarity=0.272 Sum_probs=188.5
Q ss_pred hhhccCCCccceEEEEEEcCCCccee--EEEEEeeeccccccH----HHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTT--AVAVKKLDRVFQDGE----KEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~--~vavk~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
....+|.|.+|.|+........+... .+.++ .. ..... ..+..|+.+-..++|||++..+..+.+.....-
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~--~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK--PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcc-cC--CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 34569999999777766444333211 11222 10 11111 226678888888999999998888877776666
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
.||||+. +|..++.....++...+-.++.|++.|++|+| +.++.|||+||+|++++.+|.+||+|||.+....-..
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6999999 99999987778899999999999999999999 5699999999999999999999999999998654333
Q ss_pred cc--ceeeccccCCCccCcccccCCCCCCC-CcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 217 RK--TIKTAIRGTKGYVAPEWFRKSTISAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 217 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.. .......|...|+|||++.+..|++. .||||.|+++..|.+|+.||......+..... ..........
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~~~~~~~~- 547 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNYSDQRNIF- 547 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hccccccccc-
Confidence 32 34456778999999999999999774 89999999999999999999766554432100 0000000110
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..........+.+.+.+|.++|+.||.+|.|++++++
T Consensus 548 -~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 -EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1111112346778899999999999999999999974
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=193.70 Aligned_cols=174 Identities=19% Similarity=0.114 Sum_probs=127.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-----ccccHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-----FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
.|.+.+.||+|+||.||+|.+..+. +..+|+|+.... .......+.+|+++++.++|+|++..+.. .+..
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDP--GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCC--CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 4566788999999999999876532 234788876432 11234568999999999999999853322 2457
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeEEcCCCceEEeecccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDI-KPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
+++|||++|++|... ... . ...++.|+++++.||| +.+|+|||| ||+||+++.++.+||+|||++....
T Consensus 94 ~LVmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999999999632 111 1 2467899999999999 559999999 9999999999999999999998765
Q ss_pred cCcccce------eeccccCCCccCcccccCC------CCCCCCcch
Q 046877 214 LNQRKTI------KTAIRGTKGYVAPEWFRKS------TISAKVDVY 248 (350)
Q Consensus 214 ~~~~~~~------~~~~~~~~~y~aPE~~~~~------~~~~~~Diw 248 (350)
....... -+...++..|+|||.+... ..+..+|-|
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 4321110 1244578889999998532 233446666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-23 Score=183.95 Aligned_cols=258 Identities=27% Similarity=0.362 Sum_probs=193.5
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc---cHHHHHHHHHHHhcCCCC-ceeeecceeecCCeeEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD---GEKEFKNEVIVIGQTHHK-NLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv 137 (350)
.+.+.||.|+||.||++... ..+++|.+...... ....+.+|...++.+.|+ +++++.+.+......+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 76 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV 76 (384)
T ss_pred eeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence 44567999999999999876 34777877654332 366799999999999888 799999999888788999
Q ss_pred EecCCCCChhhhhcCCC---CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEeecccccccc
Q 046877 138 YEFLNNGTLASFLFGNL---KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NARISDFGLAKLLT 213 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 213 (350)
++++.++++.+++.... .........++.|++.++.|+|. .+++|||+||+||+++..+ .++++|||.+....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999997776554 78889999999999999999994 5899999999999999988 79999999998554
Q ss_pred cCcccc----eeeccccCCCccCcccccC---CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 046877 214 LNQRKT----IKTAIRGTKGYVAPEWFRK---STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 286 (350)
Q Consensus 214 ~~~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 286 (350)
...... ......++..|++||.+.+ ...+...|+||+|++++++++|..||........ .......+...
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~---~~~~~~~~~~~ 230 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA---TSQTLKIILEL 230 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc---HHHHHHHHHhc
Confidence 433221 2355678999999999987 5788899999999999999999999765543100 00011111111
Q ss_pred CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
..... ...............+.+++..|+..+|..|.+..+....
T Consensus 231 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTPSL-ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCccc-ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11100 0000000002234678899999999999999998887653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-25 Score=210.19 Aligned_cols=251 Identities=22% Similarity=0.244 Sum_probs=183.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-c---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-Q---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
...+.+.||++.|=+|.+|++.++ .|++|.+-+.. . ....+...|++ ...+++||.+.+.-+.......|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG-----~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG-----LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc-----eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHH
Confidence 456778899999999999986554 27777765432 2 22334444555 56679999999999888888889
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc---
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--- 212 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~--- 212 (350)
||-+|... +|.|.+.-+.-+..-+.+.|+.|++.|+..+| ..+|+|+|||.+||||+..+-+.|+||..-+..
T Consensus 98 lvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 98 LVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 99999987 99999987777788888999999999999999 559999999999999999999999999765432
Q ss_pred --ccCcccceeeccccCCCccCcccccC----------CC-CCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHH
Q 046877 213 --TLNQRKTIKTAIRGTKGYVAPEWFRK----------ST-ISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 278 (350)
Q Consensus 213 --~~~~~~~~~~~~~~~~~y~aPE~~~~----------~~-~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~ 278 (350)
++.+..-.....+...+|.|||.|.. .. .+++.||||+||++.||++ |.+||.... .
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---------L 244 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---------L 244 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---------H
Confidence 11222222334445668999998842 11 5678999999999999997 677885221 1
Q ss_pred HHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
. . .+.+. ....+..++...+ ..+++++..|++.||.+|.++++.++...++
T Consensus 245 ~-a-Yr~~~-~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 245 L-A-YRSGN-ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred H-h-HhccC-ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1 1 11221 1111111222211 2688899999999999999999999885444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=176.52 Aligned_cols=263 Identities=19% Similarity=0.241 Sum_probs=203.5
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeE
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 135 (350)
-...+.+.+.||+|.||.++.|++-.++ ..||||.-... ...-++..|++..+.| ..++|...+.+-.++.+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nn---e~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNN---EPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccC---ceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 3445677889999999999999876654 56999986543 2345788899999888 6899999999889999999
Q ss_pred EEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-----CceEEeecccc
Q 046877 136 LAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR-----YNARISDFGLA 209 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Dfg~~ 209 (350)
+|+|.+ |.||.|+..- ..+++...+..++.|++.-++|+|+ .++|.|||||+|+||... ..+.++|||++
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999987 6699888754 4678999999999999999999994 599999999999999643 34899999999
Q ss_pred cccccCccc-----ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 046877 210 KLLTLNQRK-----TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 210 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
..+...... .......||.+||+--...+.+.+.+.|.-|||=++.+.+-|..||.+.........-+...+..+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 987654321 222345689999999888899999999999999999999999999986554433322222222222
Q ss_pred cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
...+..+.+ ++|.++...+.-.-..+-++-|+.+-+...+..++
T Consensus 257 ~T~i~~Lc~---------g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 257 STPIEVLCE---------GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred cCCHHHHHh---------cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 333444433 36677777777777888888899888777776665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=176.96 Aligned_cols=246 Identities=19% Similarity=0.330 Sum_probs=187.0
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeee--ccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+...|.+.-.|..|+|+++.+. ++.|++. .......++|.+|.-.|+-+.||||+..++.|....+..++..
T Consensus 193 nl~tkl~e~hsgelwrgrwqgnd-----ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGND-----IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhccCCCcccccccccCcc-----hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 34556888899999999998664 4455543 2334445678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCC--cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEe--ecccccccccC
Q 046877 140 FLNNGTLASFLFGNLK--PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARIS--DFGLAKLLTLN 215 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~--Dfg~~~~~~~~ 215 (350)
|++.|+|.+.+.+... .+-.++.+++.+++.|++|||+- ..-|---.|....+++|++.+.+|+ |--++.+.
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe--- 343 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--- 343 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec---
Confidence 9999999999976644 46778899999999999999964 2334455688899999999887654 32222211
Q ss_pred cccceeeccccCCCccCcccccCCCCC---CCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTIS---AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
......+.|++||.++..+-+ ..+|+|||.+++||+.|...||....+-+.. .++.
T Consensus 344 ------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkia 402 (448)
T KOG0195|consen 344 ------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIA 402 (448)
T ss_pred ------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhh
Confidence 122357899999999865432 4689999999999999999999754433221 1122
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
-++++.-.+...+..+.++|.-|+..||.+||.+..++-.|+++.
T Consensus 403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 233443444566788889999999999999999999999998764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=169.19 Aligned_cols=256 Identities=19% Similarity=0.202 Sum_probs=189.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.+.+.||+|+||.+|.|.....+ ..||+|.-+. .....++.-|.++.+.++ -..|..+..+..+...-.+||
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~g---e~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSG---EEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCC---ceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4566788999999999999876554 5699998654 344567888999999884 668888888999999999999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCceEEeeccccccccc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN---DRYNARISDFGLAKLLTL 214 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~ 214 (350)
|.+ |.+|.++.+- ...++..+++-++-|++.-++|+| ..+.+||||||+|+|.. ....+.++|||++..+..
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 977 6799998863 367899999999999999999999 55999999999999986 345699999999987743
Q ss_pred Ccc-----cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 215 NQR-----KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 215 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
... ....+...||.+|.+--...+-..+.+.|+-|+|.+|.+.--|..||.+-.............+...+....
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 321 222345678999999877777778889999999999999999999998655433322111111111122222
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
.+.. .+|.++...+.-|-..--++-|+..-+.+.+
T Consensus 247 ~LC~---------G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 247 VLCK---------GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred HHhC---------CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 2222 2456666666677766667777665554443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-23 Score=169.88 Aligned_cols=176 Identities=12% Similarity=0.090 Sum_probs=130.7
Q ss_pred HHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHH---------HHHHHHHHhcCCCCceee
Q 046877 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---------FKNEVIVIGQTHHKNLVR 123 (350)
Q Consensus 53 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~---------~~~e~~~l~~l~h~~iv~ 123 (350)
..+.....+...+.+|.|+||.||++... ...+++|.+.......... +.+|++.+.++.|++|..
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~~-----~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDTD-----YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEecC-----CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 34455566677789999999999986542 2248999987544333332 678999999999999999
Q ss_pred ecceeecC--------CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 046877 124 LLGFCDEG--------QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL 195 (350)
Q Consensus 124 ~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill 195 (350)
+.+++... ...+++|||++|.+|.++.. .+. ....+++.++..+| ..+++|+|++|+|+++
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili 168 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIV 168 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEE
Confidence 98886532 35789999999999988742 222 34569999999999 5599999999999999
Q ss_pred cCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh
Q 046877 196 NDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259 (350)
Q Consensus 196 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt 259 (350)
+++| ++++|||........... ...+....+..++|+|+||+++.....
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred eCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 9988 999999988644211110 002334456678999999999886654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=180.62 Aligned_cols=218 Identities=25% Similarity=0.419 Sum_probs=163.1
Q ss_pred HhcCCCCceeeecceeecCCeeEEEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046877 113 IGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQ 191 (350)
Q Consensus 113 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~ 191 (350)
|+.+.|.|+.++++.+.++...+.+.+||..|+|.+.+.. ...+++.....+.++++.|++|||+. .--.|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 4568999999999999999999999999999999999975 56789999999999999999999963 33399999999
Q ss_pred CeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCC---C----CCCCCcchhHHHHHHHHHhCCCCC
Q 046877 192 NILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS---T----ISAKVDVYSFGVLLLEIISCRKSF 264 (350)
Q Consensus 192 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~----~~~~~DiwslG~~l~~lltg~~pf 264 (350)
|++++..+.+|++|||+.................-..-|.|||.+.+. . .+.+.||||+|++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998766421111111222235579999998753 1 366799999999999999999999
Q ss_pred Ccccchhh-hhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 265 DIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 265 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
+....... ..+...... .+. ....+... .....++++..++.+||..+|++||+++.+-..++.+...
T Consensus 159 ~~~~~~~~~~eii~~~~~---~~~--~~~rP~i~--~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK---GGS--NPFRPSIE--LLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHHHh---cCC--CCcCcchh--hhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 75433222 112211111 011 00011000 0114556899999999999999999999999988877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-22 Score=163.16 Aligned_cols=140 Identities=12% Similarity=0.125 Sum_probs=106.6
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc--c------------------------HHHHHHHHHHHhcCC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--G------------------------EKEFKNEVIVIGQTH 117 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~--~------------------------~~~~~~e~~~l~~l~ 117 (350)
.+.||+|+||.||+|... + +..||+|.++..... . ......|++.+..+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~---g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA-N---GEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC-C---CCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 357999999999999864 2 456999988643211 1 112345899999998
Q ss_pred CCceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 046877 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND 197 (350)
Q Consensus 118 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~ 197 (350)
++++.....+... ..+++|||++++++.........++......++.|++.++.++|+ +.+++||||||+||+++
T Consensus 78 ~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~- 152 (190)
T cd05147 78 TAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH- 152 (190)
T ss_pred HCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-
Confidence 8777544433222 238999999998776654445678889999999999999999932 45999999999999998
Q ss_pred CCceEEeeccccccc
Q 046877 198 RYNARISDFGLAKLL 212 (350)
Q Consensus 198 ~~~~kl~Dfg~~~~~ 212 (350)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-22 Score=170.91 Aligned_cols=227 Identities=21% Similarity=0.269 Sum_probs=143.4
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcCCC----------Cceeeeccee--
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQTHH----------KNLVRLLGFC-- 128 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l~h----------~~iv~~~~~~-- 128 (350)
.+.||.|+++.||.+.+..++ ..+++|..... .....+++++|......+.+ -.++-.++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~---~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETG---EEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTT---EEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred ccccccCCceEEEEEEEccCC---ceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 457999999999999987765 45788876432 23345667777655555322 1222222222
Q ss_pred -------ecC---C-----eeEEEEecCCCCChhhhhc---CC----CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 046877 129 -------DEG---Q-----NRLLAYEFLNNGTLASFLF---GN----LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHC 186 (350)
Q Consensus 129 -------~~~---~-----~~~lv~e~~~~g~L~~~l~---~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~ 186 (350)
... + ..+++|+-+.+ +|.+++. .. .......++.+..|+++.+++|| +.+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 111 1 23677887754 8877763 11 12234455677799999999999 5599999
Q ss_pred CCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccC--------CCCCCCCcchhHHHHHHHHH
Q 046877 187 DIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK--------STISAKVDVYSFGVLLLEII 258 (350)
Q Consensus 187 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~ll 258 (350)
||+|+|++++.+|.++|+||+.....+.... . ...+..|.|||.... -.++.+.|.|++|+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999988876553221 1 234678999997633 24688899999999999999
Q ss_pred hCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCC
Q 046877 259 SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLR 323 (350)
Q Consensus 259 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 323 (350)
++..||+.......... .. .... +.|+.+..+|.++|+.||++|
T Consensus 245 C~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999985543322110 11 1122 678999999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=184.34 Aligned_cols=235 Identities=23% Similarity=0.221 Sum_probs=187.1
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeecccccc--HHHHHHHHHHHhcCC-CCceeeecceeecCCeeEEEEecCCC
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--EKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+|+|.||.|+++.-......+..++.|...+..... ...-..|..++...+ ||.++++...++.+...++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 799999999988655555556677777765432111 114556778888886 99999999999999999999999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeec
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 223 (350)
|.|...+.+...+++.....+...++-+++++| ..+++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----- 153 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence 999999998888999999999999999999999 669999999999999999999999999999865432221
Q ss_pred cccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHH
Q 046877 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 303 (350)
Q Consensus 224 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (350)
.||.-|||||++. .....+|.||+|++.++|+||..||.. +.. ..+ ...+.+.+..
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~----------------~~I--l~~~~~~p~~ 209 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTM----------------KRI--LKAELEMPRE 209 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHH----------------HHH--hhhccCCchh
Confidence 6899999999998 467789999999999999999999975 000 001 1123444556
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH--HHHHHHH
Q 046877 304 CVEKLLMISIWCIQEDPSLRPTM--RKVSQML 333 (350)
Q Consensus 304 ~~~~l~~li~~cl~~dp~~Rps~--~~vl~~L 333 (350)
......+++..++..+|..|.-. ..+.+..
T Consensus 210 l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 210 LSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 77788889999999999999755 3444444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=157.69 Aligned_cols=142 Identities=14% Similarity=0.084 Sum_probs=108.9
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc---------------------c-----HHHHHHHHHHHhcCC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD---------------------G-----EKEFKNEVIVIGQTH 117 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~ 117 (350)
.+.||+|+||.||+|... + +..||+|..+..... . ...+..|...+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~---g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTG-D---GEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcC-C---CCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 357999999999999865 2 456999998753211 0 122457889999999
Q ss_pred CCceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 046877 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND 197 (350)
Q Consensus 118 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~ 197 (350)
|+++.....+.... .+++|||++++++.........++......++.|++.++.++|+ ..+++||||||+||+++
T Consensus 78 ~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 78 EAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred hCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 99876555444332 48999999988654433234567788899999999999999995 15999999999999999
Q ss_pred CCceEEeeccccccccc
Q 046877 198 RYNARISDFGLAKLLTL 214 (350)
Q Consensus 198 ~~~~kl~Dfg~~~~~~~ 214 (350)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=150.28 Aligned_cols=184 Identities=18% Similarity=0.081 Sum_probs=131.3
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc----cHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEE
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD----GEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
...|++|+||+|+.+... ...++.+.+.....- ....+.+|+++|+++ +|+++.+++++ +..+++|
T Consensus 7 ~~~l~~~~f~~v~~~~~~-----~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGG-----ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred ceeecCCCcceEEEeecC-----CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 457999999999976531 123555554432221 112578999999999 46889998886 4569999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDI-KPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+.|.+|...... ....++.|+++++.++| ..+|+|||| ||+||+++.++.++|+|||++....+...
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999988654321 12357889999999999 459999999 79999999999999999999986554331
Q ss_pred c----ce-------eeccccCCCccCcccccCC-CCC-CCCcchhHHHHHHHHHhCCCCCCc
Q 046877 218 K----TI-------KTAIRGTKGYVAPEWFRKS-TIS-AKVDVYSFGVLLLEIISCRKSFDI 266 (350)
Q Consensus 218 ~----~~-------~~~~~~~~~y~aPE~~~~~-~~~-~~~DiwslG~~l~~lltg~~pf~~ 266 (350)
. .. ..-...++.|++|+.-.-- ..+ ...+.++.|.-+|.++|+..|+-.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 00 0112257778888754321 222 456888999999999999988743
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8e-20 Score=151.66 Aligned_cols=133 Identities=20% Similarity=0.220 Sum_probs=102.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-----CCCceeeecceeecCC---eeE-
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-----HHKNLVRLLGFCDEGQ---NRL- 135 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~~~- 135 (350)
+.||+|+||.||. +..+.. .++|+.........+.+.+|+.+++.+ +||||++++++++++. ..+
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~----k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQ----RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred ceecCCCceEEEE--CCCCcC----eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 5699999999995 433321 368877654344567899999999999 5799999999998874 333
Q ss_pred EEEec--CCCCChhhhhcCCCCcChhHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCeEEcC----CCceEEeeccc
Q 046877 136 LAYEF--LNNGTLASFLFGNLKPNWNLRTNIAFQIARVL-LYLHEDCSSQIIHCDIKPQNILLND----RYNARISDFGL 208 (350)
Q Consensus 136 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l-~~Lh~~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg~ 208 (350)
+++|| +.+++|.+++.+. .+++. ..++.+++.++ +||| +.+|+||||||+||+++. ++.++|+||+.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5578999999653 45555 35677778777 9999 459999999999999973 34799999544
Q ss_pred c
Q 046877 209 A 209 (350)
Q Consensus 209 ~ 209 (350)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=154.71 Aligned_cols=197 Identities=21% Similarity=0.258 Sum_probs=137.9
Q ss_pred CCCceeeecceeec---------------------------CCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHH
Q 046877 117 HHKNLVRLLGFCDE---------------------------GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA 169 (350)
Q Consensus 117 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~ 169 (350)
+||||+++.+.|.+ +...|+||...+. +|..++..+.. +.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~-s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHR-SYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCC-chHHHHHHHHHHH
Confidence 59999999987633 3456899998766 99999865544 4445566889999
Q ss_pred HHHHHHHhcCCCCeEecCCCCCCeEE--cCCC--ceEEeecccccccccC----cccceeeccccCCCccCcccccCCC-
Q 046877 170 RVLLYLHEDCSSQIIHCDIKPQNILL--NDRY--NARISDFGLAKLLTLN----QRKTIKTAIRGTKGYVAPEWFRKST- 240 (350)
Q Consensus 170 ~~l~~Lh~~~~~~i~H~dlkp~Nill--~~~~--~~kl~Dfg~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~- 240 (350)
+|+.||| ..+|.|||+|.+|||+ ++++ .++++|||.+-..... .+..-.....|...-||||+....+
T Consensus 352 Eav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999 5599999999999998 3443 4789999987533221 1111112234677899999986432
Q ss_pred -----CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhc
Q 046877 241 -----ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWC 315 (350)
Q Consensus 241 -----~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 315 (350)
--.|+|.|+.|.+.||+++...||.....--... ....+.++. ..+..++..+.+++...
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------r~Yqe~qLP---------alp~~vpp~~rqlV~~l 493 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------RTYQESQLP---------ALPSRVPPVARQLVFDL 493 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheech------hhhhhhhCC---------CCcccCChHHHHHHHHH
Confidence 1248999999999999999999997522111000 001111111 22335778999999999
Q ss_pred cCCCCCCCCCHHHHHHHH
Q 046877 316 IQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 316 l~~dp~~Rps~~~vl~~L 333 (350)
|+.||.+|++..-....|
T Consensus 494 L~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hcCCccccCCccHHHhHH
Confidence 999999999987655554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-20 Score=168.05 Aligned_cols=170 Identities=25% Similarity=0.399 Sum_probs=130.2
Q ss_pred eeEEEEecCCCCChhhhhcCC---CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
..++.|++|+..+|.+++.++ ...++...+.++.|++.|+.| ++.+|+|+||.||+...+.++||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999654 345778889999999999999 28999999999999999999999999998
Q ss_pred cccccCc----ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhh
Q 046877 210 KLLTLNQ----RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 210 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
....... .....+...||..||+||.+.+..|+.|+||||||++++|+++ -...|+ .. -....++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~------~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RI------ATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HH------Hhhhhhh
Confidence 7665443 2334466789999999999999999999999999999999998 333322 11 1122233
Q ss_pred cCCcc-hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 046877 285 NGKLD-DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRK 328 (350)
Q Consensus 285 ~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 328 (350)
++.+. .+... . +.-+.|+.+++...|.+||++.+
T Consensus 474 ~g~ip~~~~~d---------~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGIIPPEFLQD---------Y-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCCChHHhhc---------C-cHHHHHHHHhcCCCcccCchHHH
Confidence 44444 11111 1 23457899999999999994433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=173.86 Aligned_cols=200 Identities=22% Similarity=0.222 Sum_probs=158.1
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC---CCceeeecceeec
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH---HKNLVRLLGFCDE 130 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 130 (350)
-++....+.+.++||+|+||+||+|...+ ++.||+|.-..... -+|.--.+++.+|+ -+.|..+...+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~----~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN----GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC----CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34555556677889999999999998655 46799998654322 12222233344443 3456666666677
Q ss_pred CCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-------CCCceEE
Q 046877 131 GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-------DRYNARI 203 (350)
Q Consensus 131 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-------~~~~~kl 203 (350)
.+..++++||.+-|+|.++++..+.+++..+..+..|++..++.||. .+|||+||||+|++|. ++..++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence 77889999999999999999988999999999999999999999994 5999999999999994 2345999
Q ss_pred eecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCC
Q 046877 204 SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS 263 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p 263 (350)
+|||-+.....-.........+.|-.+-.+|...|.+++-..|.|.+..+++-|+.|+.-
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999999866543333445667789999999999999999999999999999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=147.58 Aligned_cols=142 Identities=15% Similarity=0.167 Sum_probs=106.9
Q ss_pred hhhhhccCCCccceEEEEE-EcCCCcceeEEEEEeeeccccc------------------------cHHHHHHHHHHHhc
Q 046877 61 DNFKEEVGRGSFGIIYKGV-IQTTTTSTTAVAVKKLDRVFQD------------------------GEKEFKNEVIVIGQ 115 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~-~~~~~~~~~~vavk~~~~~~~~------------------------~~~~~~~e~~~l~~ 115 (350)
+.+.+.||+|+||.||+|. ...+ +..|++|........ ....+..|+.++..
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~---g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGS---GKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCC---CcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999997 3333 356999987643210 01235689999999
Q ss_pred CCCCc--eeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCC
Q 046877 116 THHKN--LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQ-IIHCDIKPQN 192 (350)
Q Consensus 116 l~h~~--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~-i~H~dlkp~N 192 (350)
+.+.+ +.+.++. ...++||||+++++|.................++.|++.++.+||+ .+ ++|+||||+|
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 97533 3333332 2358999999998887765444556666678999999999999994 48 9999999999
Q ss_pred eEEcCCCceEEeecccccccc
Q 046877 193 ILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 193 ill~~~~~~kl~Dfg~~~~~~ 213 (350)
|+++ ++.++++|||.+...+
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 7899999999987544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=143.82 Aligned_cols=134 Identities=20% Similarity=0.277 Sum_probs=109.0
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc--------cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--------GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
+.||+|++|.||+|..... .+++|........ ...++.+|+.++..++|+++.....++...+..++
T Consensus 2 ~~l~~G~~~~vy~~~~~~~-----~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGI-----KAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFII 76 (211)
T ss_pred cccccCceEEEEEEeeCCC-----ceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEE
Confidence 4699999999999986322 3777765432211 12357789999999999998888888777788899
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
+|||++|++|.+++..... ....++.+++.++.++| ..+++|+|++|+||+++ ++.++++|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999999854322 77889999999999999 55999999999999999 78899999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-19 Score=172.19 Aligned_cols=209 Identities=22% Similarity=0.250 Sum_probs=144.4
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecC
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
+-++.+..|++|.||.++++.+. +.+++|+-+.. -+.+. ++.....|.++
T Consensus 86 ~~IklisngAygavylvrh~~tr---qrfa~kiNkq~------lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETR---QRFAMKINKQN------LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccc---cchhhcccccc------hhhhc--cccccCCccee-------------------
Confidence 44578999999999999876553 45777442211 11111 33333444444
Q ss_pred CCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc----
Q 046877 142 NNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR---- 217 (350)
Q Consensus 142 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 217 (350)
|+-...+...+.++.. ++.+++||| +.+|+|||+||+|.+|+.-|.+|+.|||+++...-...
T Consensus 136 --gDc~tllk~~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred --chhhhhcccCCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 3444445444444433 278899999 77999999999999999999999999999875421100
Q ss_pred --------cc-eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 218 --------KT-IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 218 --------~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
.. ......||+.|.|||++....|+..+|.|++|+++|+.+.|+.||.++..++.....- . ..
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi--s------d~ 274 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI--S------DD 274 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh--h------hh
Confidence 00 1123468999999999999999999999999999999999999999887776542211 0 00
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHH
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMR 327 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 327 (350)
....+. +...+.+..+++.+.|+.+|.+|--..
T Consensus 275 i~wpE~------dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 275 IEWPEE------DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred cccccc------CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 111111 223457899999999999999996433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.8e-18 Score=161.42 Aligned_cols=133 Identities=16% Similarity=0.275 Sum_probs=106.3
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEee-eccc-------cccHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVF-------QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~-~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
..+.||+|+||.||++.+.... +++|+. .+.. ....+++.+|+++++.++|++++....++......
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-----~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-----AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-----ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3577999999999999865442 222221 1110 01235688999999999999999888877777788
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
+++|||+++++|.+++. ....++.++++++.+|| ..+++|||+||+||++ +++.++|+|||++...
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999999884 35778999999999999 4599999999999999 6778999999999743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.9e-18 Score=140.60 Aligned_cols=130 Identities=19% Similarity=0.317 Sum_probs=102.7
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cc-------cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QD-------GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.||+|+||.||+|.... ..+++|...... .. ...++.+|++++..++|+++.....++......+++
T Consensus 1 ~ig~G~~~~vy~~~~~~-----~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG-----LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeecCC-----ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEE
Confidence 38999999999998432 237777643221 11 125577899999999888776666666666777999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
|||++|++|.+++..... .++.+++.++.+|| ..+++|+|++|+||+++ ++.++++|||++..
T Consensus 76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999988743221 78999999999999 55999999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.4e-19 Score=168.18 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=191.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 136 (350)
.+.+.+.||+|+|+.|-......+. ...++.|.+.... .....+...|..+-+.+. |+|++++++...+.+..++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~--~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDP--ESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccchhhhhhhcCCC--cceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3455667999999999988754433 2346666665443 333455666888888886 9999999999999999999
Q ss_pred EEecCCCCChhhhh-cCCC-CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEeecccccccc
Q 046877 137 AYEFLNNGTLASFL-FGNL-KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NARISDFGLAKLLT 213 (350)
Q Consensus 137 v~e~~~~g~L~~~l-~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 213 (350)
..+|..++++.+-+ .... ..+......++.|+..++.|+|. ..++.|+|+||+|.+++.++ ..+++|||++..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999988 4443 56677788899999999999993 34899999999999999999 99999999999887
Q ss_pred c-Ccccceeecccc-CCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 214 L-NQRKTIKTAIRG-TKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 214 ~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
. ...........| ++.|.|||...+. ...+..|+||.|+++..+++|..|++........+ ..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--------------~~ 242 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--------------SS 242 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--------------ee
Confidence 6 333333345567 9999999999885 44677999999999999999999997655544221 11
Q ss_pred hccccc--cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 291 LVEGDM--EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 291 ~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
+..... .............+++.+++..+|..|.+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ecccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 111110 1111223456677888899999999999988874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.7e-17 Score=133.50 Aligned_cols=136 Identities=15% Similarity=0.132 Sum_probs=102.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc----------------------ccHHHHHHHHHHHhcCCC
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ----------------------DGEKEFKNEVIVIGQTHH 118 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~----------------------~~~~~~~~e~~~l~~l~h 118 (350)
+.+.+.||+|+||.||++... ++..+++|....... ........|+.++..+.|
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred hhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 455678999999999999764 235689997653210 011235678888888877
Q ss_pred Cc--eeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 046877 119 KN--LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196 (350)
Q Consensus 119 ~~--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~ 196 (350)
++ +...++ ....+++|||+++++|...... .....++.++++++.++|+ .+++|+||+|+||+++
T Consensus 93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVD 159 (198)
T ss_pred cCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEc
Confidence 74 333333 2345899999999998776421 3456788999999999995 5999999999999999
Q ss_pred CCCceEEeecccccccc
Q 046877 197 DRYNARISDFGLAKLLT 213 (350)
Q Consensus 197 ~~~~~kl~Dfg~~~~~~ 213 (350)
+++.++|+|||++....
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.2e-16 Score=122.67 Aligned_cols=135 Identities=20% Similarity=0.173 Sum_probs=111.2
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCC--CceeeecceeecCCeeEEEEecC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHH--KNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
.+.||+|.++.||++.... ..+++|....... ...+..|...++.+++ .++.+++.+....+..+++|||+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-----~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-----EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred ceecccccccceEEEEecC-----CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 3579999999999998643 3488888754322 5678899999999976 58889988888888899999999
Q ss_pred CCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 142 NNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 142 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
+++.+..+ +......++.+++++++++|.....+++|+|++|+||++++++.+++.|||.+...
T Consensus 76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 99877654 55667788999999999999643357999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=125.24 Aligned_cols=138 Identities=17% Similarity=0.175 Sum_probs=92.5
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc--HHH----------------------HHHHHHHHhcCCCC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--EKE----------------------FKNEVIVIGQTHHK 119 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~ 119 (350)
.+.||+|+||.||+|... + +..|++|......... ... ...|...+..+.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~---~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-D---GEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC-C---CCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 357999999999999864 2 3569999876432111 111 12445555555333
Q ss_pred c--eeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 046877 120 N--LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND 197 (350)
Q Consensus 120 ~--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~ 197 (350)
+ +.+.++. ...+++|||++++.+....-...... .....++.+++.++.++|. ..+++|+||||+||+++
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 2 2333322 24589999999954322111111111 5678899999999999994 16999999999999999
Q ss_pred CCceEEeecccccccc
Q 046877 198 RYNARISDFGLAKLLT 213 (350)
Q Consensus 198 ~~~~kl~Dfg~~~~~~ 213 (350)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.1e-15 Score=126.76 Aligned_cols=135 Identities=16% Similarity=0.131 Sum_probs=100.0
Q ss_pred hccC-CCccceEEEEEEcCCCcceeEEEEEeeecc------c-------cccHHHHHHHHHHHhcCCCCce--eeeccee
Q 046877 65 EEVG-RGSFGIIYKGVIQTTTTSTTAVAVKKLDRV------F-------QDGEKEFKNEVIVIGQTHHKNL--VRLLGFC 128 (350)
Q Consensus 65 ~~lg-~G~~g~V~~~~~~~~~~~~~~vavk~~~~~------~-------~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~ 128 (350)
..|| .||.|+||.+.... ..+++|..... . .....++.+|+.++..++|+++ +..+++.
T Consensus 37 ~~lg~~~g~gtv~~v~~~~-----~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPG-----VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEeCC-----ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 4587 88999999887642 24777766421 0 1223567889999999988875 6666654
Q ss_pred ecCCe----eEEEEecCCC-CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEE
Q 046877 129 DEGQN----RLLAYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI 203 (350)
Q Consensus 129 ~~~~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl 203 (350)
..... .+++||++++ .+|.+++.. ..++.. .+.+++.++.+||+ .+|+|+||||+|||++.++.++|
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 33222 3599999997 689888754 334433 36789999999995 59999999999999999889999
Q ss_pred eeccccccc
Q 046877 204 SDFGLAKLL 212 (350)
Q Consensus 204 ~Dfg~~~~~ 212 (350)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.2e-14 Score=121.67 Aligned_cols=197 Identities=21% Similarity=0.245 Sum_probs=135.1
Q ss_pred HHhcCCCCceeeecceeecC-----CeeEEEEecCCCCChhhhhcCC----CCcChhHHHHHHHHHHHHHHHHHhcCCCC
Q 046877 112 VIGQTHHKNLVRLLGFCDEG-----QNRLLAYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARVLLYLHEDCSSQ 182 (350)
Q Consensus 112 ~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~ 182 (350)
.+-.+-|.|+++++.++.+. ....++.||+..|+|..++++. ..+....-.+|+.||..||.|||.. ...
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 34445699999999998543 4568899999999999999643 4556667789999999999999976 889
Q ss_pred eEecCCCCCCeEEcCCCceEEeecccccccccCcccc---eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh
Q 046877 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT---IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259 (350)
Q Consensus 183 i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt 259 (350)
++|+++..+.|++..+|-+|++-- -.....+..... ......+-++|.+||.-...+.+.++|||+||+...+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999998887532 111111111110 1122346789999998777778889999999999999988
Q ss_pred CCCCC-CcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 260 CRKSF-DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 260 g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
+..-- ......+ .+.. . .......+.+ .-+.++..|++..|+.||+|++++
T Consensus 278 lEiq~tnseS~~~----~ee~---i--a~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 278 LEIQSTNSESKVE----VEEN---I--ANVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred heeccCCCcceee----hhhh---h--hhheeeccCc-----------cccCcCcccccCCCCCCcchhhhh
Confidence 76532 1111100 0000 0 0001111111 123466779999999999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.1e-14 Score=128.36 Aligned_cols=258 Identities=22% Similarity=0.248 Sum_probs=183.4
Q ss_pred CHHHHHHHhhhhhhccCC--CccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcC-CCCceeeecc
Q 046877 52 SYKELEEATDNFKEEVGR--GSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQT-HHKNLVRLLG 126 (350)
Q Consensus 52 ~~~~~~~~~~~~~~~lg~--G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~ 126 (350)
.+.+.........+.+|. |.+|.+|.+.... ..++..+++|+-..... ....+=.+|+...+++ .|+|.++...
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 344556666667778999 9999999987622 33345577777432222 2222334566666666 5999999999
Q ss_pred eeecCCeeEEEEecCCCCChhhhhcCCCC-cChhHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCeEEcCC-Cc
Q 046877 127 FCDEGQNRLLAYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIAR----VLLYLHEDCSSQIIHCDIKPQNILLNDR-YN 200 (350)
Q Consensus 127 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~----~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~ 200 (350)
.+++.+..++-.|++. .+|..+...... ++....+....+..+ |+.++| +.+++|.|+||.||+...+ ..
T Consensus 186 ~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 186 AWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred ccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccce
Confidence 9999999999999986 588888765444 677888888888888 999999 7799999999999999988 88
Q ss_pred eEEeecccccccccCcccce---eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHH
Q 046877 201 ARISDFGLAKLLTLNQRKTI---KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 277 (350)
Q Consensus 201 ~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~ 277 (350)
.+++|||+....+...-... .....+...|++||... .-++...|+|++|.+..+..++..++...-...
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------ 334 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------ 334 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------
Confidence 99999999988765542221 12225788999999875 456788999999999999999877654221111
Q ss_pred HHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 278 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+.++.............+.++...+.++++.+|-.|++.+.+..
T Consensus 335 ----------W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 ----------WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----------ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111111111111123456666899999999999999877653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.5e-13 Score=124.72 Aligned_cols=140 Identities=19% Similarity=0.225 Sum_probs=93.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccH----------------------------------------H
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE----------------------------------------K 104 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~----------------------------------------~ 104 (350)
+.||+|++|.||+|+..++ +.||||+......... -
T Consensus 123 ~plasaSigQVh~A~l~~G----~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El 198 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDG----KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL 198 (437)
T ss_pred cceeeeehhheEEEEecCC----CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence 3599999999999987643 4699998753211100 0
Q ss_pred HHHHHHHHHhcC-----CCCceeeecceeecCCeeEEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHH-HHHHHHh
Q 046877 105 EFKNEVIVIGQT-----HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIAR-VLLYLHE 177 (350)
Q Consensus 105 ~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~-~l~~Lh~ 177 (350)
++.+|.+.+..+ +++++.-..-+....+..+++|||++|++|.++.... ... ....++.+++. .+..+|
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~- 274 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL- 274 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH-
Confidence 133444444443 2344332222333345679999999999998876421 111 23456666655 366778
Q ss_pred cCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 178 ~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
..+++|+|++|.||++++++.++++|||++...++
T Consensus 275 --~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 --RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 45999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.8e-12 Score=118.89 Aligned_cols=161 Identities=17% Similarity=0.190 Sum_probs=118.9
Q ss_pred EEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHH
Q 046877 89 AVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI 168 (350)
Q Consensus 89 ~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i 168 (350)
.|.+...+...........+-++.++.++||||+++++.++.++..|+|+|.+. .|..++.+.. ....-.-++||
T Consensus 39 ~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl~qI 113 (690)
T KOG1243|consen 39 PVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLGLFQI 113 (690)
T ss_pred ceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHHHHHH
Confidence 455555544433334557788899999999999999999999999999999874 5666664332 45556678999
Q ss_pred HHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcch
Q 046877 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVY 248 (350)
Q Consensus 169 ~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 248 (350)
+.||.|||+ ..+++|+++.-+.|+++..|.+||++|.++........ ......--..|..|+.+.... -..|.|
T Consensus 114 l~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~ 187 (690)
T KOG1243|consen 114 LAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSW 187 (690)
T ss_pred HHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhh
Confidence 999999997 56999999999999999999999999988764322111 001111122466666554333 235999
Q ss_pred hHHHHHHHHHhC
Q 046877 249 SFGVLLLEIISC 260 (350)
Q Consensus 249 slG~~l~~lltg 260 (350)
-|||++++++.|
T Consensus 188 ~Lg~li~el~ng 199 (690)
T KOG1243|consen 188 GLGCLIEELFNG 199 (690)
T ss_pred hHHHHHHHHhCc
Confidence 999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.4e-13 Score=123.72 Aligned_cols=138 Identities=15% Similarity=0.107 Sum_probs=86.5
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc----------------------------------cHHH-----
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD----------------------------------GEKE----- 105 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~----------------------------------~~~~----- 105 (350)
+.||+|++|.||+|.++++ ++.||||........ -.+.
T Consensus 125 ~PlasaSiaQVh~A~l~~~---G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~El 201 (537)
T PRK04750 125 KPLASASIAQVHFARLKDN---GREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDEL 201 (537)
T ss_pred hhhcCCCccEEEEEEECCC---CCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhh
Confidence 4699999999999998764 345999988632110 0111
Q ss_pred -HHHHHHHHhcC----CCCceeeeccee-ecCCeeEEEEecCCCCChhhhh--cCCC----CcChhHHHHHHHHHHHHHH
Q 046877 106 -FKNEVIVIGQT----HHKNLVRLLGFC-DEGQNRLLAYEFLNNGTLASFL--FGNL----KPNWNLRTNIAFQIARVLL 173 (350)
Q Consensus 106 -~~~e~~~l~~l----~h~~iv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l--~~~~----~~~~~~~~~~~~~i~~~l~ 173 (350)
+.+|...+.++ .+.+.+.+=.++ .-.+..+++|||++|+.+.+.. ...+ .+....+..++.|+.
T Consensus 202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif---- 277 (537)
T PRK04750 202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF---- 277 (537)
T ss_pred CHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH----
Confidence 22333333333 122222222222 2245667999999999998743 2222 122223333444443
Q ss_pred HHHhcCCCCeEecCCCCCCeEEcCCC----ceEEeecccccccccC
Q 046877 174 YLHEDCSSQIIHCDIKPQNILLNDRY----NARISDFGLAKLLTLN 215 (350)
Q Consensus 174 ~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~ 215 (350)
..+++|+|+||+||+++.+| .++++|||++...+..
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 34999999999999999888 9999999999877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.4e-12 Score=104.24 Aligned_cols=129 Identities=19% Similarity=0.122 Sum_probs=91.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCcee-eecceeecCCeeEEEEecCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV-RLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+.|+.|.++.||++... +..+++|....... ....+..|+..++.+.+.+++ +++.+. .+..+++|||++|
T Consensus 4 ~~l~~G~~~~vy~~~~~-----~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-----NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEEC-----CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence 46899999999998753 23588888654321 233567888888888655543 344433 2345799999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC--SSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
.++.... ......+.+++++++.||... ...++|+|++|+||+++ ++.++++|||.+.
T Consensus 76 ~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred Ccccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 8876431 112345678999999999541 12369999999999999 6689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.6e-12 Score=125.59 Aligned_cols=245 Identities=19% Similarity=0.210 Sum_probs=172.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
+.+-+|.++.++.++-...+.....-..+...+......+....+-.++-..++|.+++....+......+++++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 45778888888876533332111222233322222333444555555555567888888877777788899999999999
Q ss_pred ChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC---------
Q 046877 145 TLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN--------- 215 (350)
Q Consensus 145 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--------- 215 (350)
+|...++.....+.+..+....-+.++.++|| +..+.|+|++|.|.+...++..++.|||.....+..
T Consensus 890 ~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~ 966 (1205)
T KOG0606|consen 890 DLPSKLHNSGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGP 966 (1205)
T ss_pred CchhhhhcCCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcCCcccc
Confidence 99999987777777777888888999999999 557899999999999999999999999843322100
Q ss_pred ------------ccc--------ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhH
Q 046877 216 ------------QRK--------TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 275 (350)
Q Consensus 216 ------------~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~ 275 (350)
... .......+|+.|.+||.+.+......+|.|+.|+++++.++|..||.........
T Consensus 967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f-- 1044 (1205)
T KOG0606|consen 967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF-- 1044 (1205)
T ss_pred cccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh--
Confidence 000 1112345799999999999999999999999999999999999999865544322
Q ss_pred HHHHHHHhhcCCcchhccccccCC-CcHHHHHHHHHHHHhccCCCCCCCCCHH
Q 046877 276 TDWAFDCYRNGKLDDLVEGDMEAM-NDIKCVEKLLMISIWCIQEDPSLRPTMR 327 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ 327 (350)
+.+.......+ -+...+++..+++...+..+|.+|..+.
T Consensus 1045 -------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1045 -------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred -------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 11111111111 1223456778888888999999998766
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.7e-11 Score=94.96 Aligned_cols=131 Identities=20% Similarity=0.331 Sum_probs=99.6
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEee-eccccc-------cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQD-------GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~-~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.+++|+-+.++.+.+.... +++|.= .+.... ..++-.+|.+++.++.--.|....-+..+.+...++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-----av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~ 77 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-----AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIV 77 (204)
T ss_pred hhhCCcceeEEeeeccCcc-----eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEE
Confidence 4788999999988654322 344432 111111 123467899999999877888888888888888999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
|||.+|..|.+.+... ...++..+-..+.-|| ..+|+|+||.++|+++.+++ +.++|||++...
T Consensus 78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999999888654 2456677777888899 55999999999999998875 999999999743
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-10 Score=94.50 Aligned_cols=141 Identities=14% Similarity=0.183 Sum_probs=95.2
Q ss_pred hccCCCccceEEEEEEcCCC---cceeEEEEEeeecccc---------------------cc-HHH----HHHHHHHHhc
Q 046877 65 EEVGRGSFGIIYKGVIQTTT---TSTTAVAVKKLDRVFQ---------------------DG-EKE----FKNEVIVIGQ 115 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~---~~~~~vavk~~~~~~~---------------------~~-~~~----~~~e~~~l~~ 115 (350)
..||.|--+.||.|...+.. ..+..+|+|+...... .. ... ..+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999743210 0234688888642100 00 112 3378888888
Q ss_pred CCC--CceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCC
Q 046877 116 THH--KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYL-HEDCSSQIIHCDIKPQN 192 (350)
Q Consensus 116 l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~~~~i~H~dlkp~N 192 (350)
+.. -++.+++++ ..-+++|||+.++.+..-.-+...++......+..+++.++..| | ..+++|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHH
Confidence 853 345555544 45689999998754422211223344556677889999999999 7 4599999999999
Q ss_pred eEEcCCCceEEeecccccccc
Q 046877 193 ILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 193 ill~~~~~~kl~Dfg~~~~~~ 213 (350)
|++++ +.+.++|||.+....
T Consensus 156 IL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC-CcEEEEECCCceeCC
Confidence 99974 679999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.8e-10 Score=97.41 Aligned_cols=143 Identities=16% Similarity=0.205 Sum_probs=105.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCC--ceeeecceeecCC---eeEEEE
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHK--NLVRLLGFCDEGQ---NRLLAY 138 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~---~~~lv~ 138 (350)
+.|+.|..+.+|++...+ +..+++|....... .....+..|.++++.+.+. ++.+++.+..... ..+++|
T Consensus 4 ~~l~~G~~n~~~~v~~~~----g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC----CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 468999999999998643 23488888654321 1345788999999998653 4566677665542 568999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC--------------------------------------- 179 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--------------------------------------- 179 (350)
||++|.++.+.+.. ..++......++.++++++..||+..
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999888776532 34666777788888888888888421
Q ss_pred --------------CCCeEecCCCCCCeEEcC--CCceEEeeccccccc
Q 046877 180 --------------SSQIIHCDIKPQNILLND--RYNARISDFGLAKLL 212 (350)
Q Consensus 180 --------------~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~ 212 (350)
...++|+|++|+||++++ ++.+.++||+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 667899999988643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.5e-11 Score=92.27 Aligned_cols=141 Identities=21% Similarity=0.284 Sum_probs=101.6
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEee-eccc-------cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVF-------QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~-~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
...+-+|+-+.|+++..... ...+|.- .+.. .-...+..+|.+.+.++.--.|.-..-++.+...-.
T Consensus 12 l~likQGAEArv~~~~~~Ge-----~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~ 86 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGE-----AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ 86 (229)
T ss_pred ceeeeccceeeEeeeccCCc-----eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe
Confidence 35688999999999876433 2344432 1111 111245788999999987667777777777777778
Q ss_pred EEEecCCC-CChhhhhcCC-CCcCh-hHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEeecccc
Q 046877 136 LAYEFLNN-GTLASFLFGN-LKPNW-NLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN---ARISDFGLA 209 (350)
Q Consensus 136 lv~e~~~~-g~L~~~l~~~-~~~~~-~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~ 209 (350)
++|||++| .++.+++... ..... .....++.++-+.+.-|| .++++|+||..+||++..++. +.++|||++
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecch
Confidence 99999987 4788888643 22222 333688999999999999 569999999999999965443 589999998
Q ss_pred ccc
Q 046877 210 KLL 212 (350)
Q Consensus 210 ~~~ 212 (350)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-11 Score=111.96 Aligned_cols=241 Identities=19% Similarity=0.207 Sum_probs=166.4
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHH--HHHHHHHHHhcC-CCCceeeecceeecCCeeEEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK--EFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~--~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
..+..||.|.|+.|+....+ ...+..+++|...+....... .-..|+.+...+ .|.++++.+..+....+.++--
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r--~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKR--PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred ceeEEccCCccccceeeeec--CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 34567999999999988743 223456788876543322221 123455555555 5889999888888888888999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR-YNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++...+.-...+++...+++..|++.++.++| +...+|+|++|+||++..+ +.-+++|||....+.....
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceecc
Confidence 99999998877754556778888999999999999999 6699999999999999876 7789999999864332211
Q ss_pred cceeeccccCCCcc--CcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 218 KTIKTAIRGTKGYV--APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 218 ~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
......++. +++......+..+.|++|||.-+.+..++...-.... .+..+...
T Consensus 423 -----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------------------~~~~i~~~- 478 (524)
T KOG0601|consen 423 -----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------------------QSLTIRSG- 478 (524)
T ss_pred -----cccccccccccchhhccccccccccccccccccccccccCcccCcccc------------------cceeeecc-
Confidence 111233444 4444455678889999999999999999775322100 01111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
..+...+..+.+..+...+...++..||.+.++...
T Consensus 479 -~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 479 -DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred -cccCCCchHHhhhhhhhhhcCCccccchhhhhhccc
Confidence 111112233667777778899999999988877543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.8e-09 Score=97.75 Aligned_cols=214 Identities=17% Similarity=0.186 Sum_probs=146.4
Q ss_pred cceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceee----cCCeeEEEEecCCC-CCh
Q 046877 72 FGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCD----EGQNRLLAYEFLNN-GTL 146 (350)
Q Consensus 72 ~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-g~L 146 (350)
-.+.|++....++ ..+++|++.............-++.++++.|+|+|++.+++. ....+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG---~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDG---NAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCC---ceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3678888866554 558899884433333334455678899999999999999885 34567899999886 467
Q ss_pred hhhhcC---------------CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 147 ASFLFG---------------NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 147 ~~~l~~---------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
.++-.. +...++..+|.++.|+..||.++| +.|+..+-|.|.+|+++.+..++|+.+|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceee
Confidence 665421 233467889999999999999999 55999999999999999999999999988766
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..+... |-+.+ ..+-|.=.||.++..|.||..--...+......
T Consensus 443 l~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~----------------- 486 (655)
T KOG3741|consen 443 LQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH----------------- 486 (655)
T ss_pred ecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHH-----------------
Confidence 543321 11111 124588889999999999864321111100000
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
.......++.++++++.-....++++ -++.+++.++
T Consensus 487 -----~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 -----LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred -----HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 00111245667777777777777776 5666666544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-08 Score=89.63 Aligned_cols=255 Identities=13% Similarity=0.112 Sum_probs=158.0
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecce-----e-ecC-CeeE
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGF-----C-DEG-QNRL 135 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-----~-~~~-~~~~ 135 (350)
.+.||+|+-+.+|..--..+ .+-|+..........+.. ..|... .||-+..=+.+ + -++ ..+-
T Consensus 16 gr~LgqGgea~ly~l~e~~d------~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD------QVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CccccCCccceeeecchhhc------hhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 45699999999995432111 344555544443333322 333333 56643321111 1 122 2367
Q ss_pred EEEecCCCC-Chhhhhc------CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 136 LAYEFLNNG-TLASFLF------GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 136 lv~e~~~~g-~L~~~l~------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
++|+.+.+. ....+.+ .....+|...++.++.++.+.+.||+. |.+-+|+.++|+|+++++.+.|.|=..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence 888888764 2333332 234568999999999999999999954 889999999999999999999998554
Q ss_pred ccccccCcccceeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhC-CCCCCcccc--hhhhhHHHHHH
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISC-RKSFDIEMG--EEYAILTDWAF 280 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg-~~pf~~~~~--~~~~~~~~~~~ 280 (350)
-.... ......-.+|...|.+||... +-.-+...|-|.||+++++++.| +.||.+-.. .......
T Consensus 164 fqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---- 236 (637)
T COG4248 164 FQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---- 236 (637)
T ss_pred eeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----
Confidence 43321 112223346788999999764 33456779999999999999976 889964321 1111000
Q ss_pred HHhhcCCcchhcccc------ccCCCcHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHHHhccc
Q 046877 281 DCYRNGKLDDLVEGD------MEAMNDIKCVEKLLMISIWCIQED--PSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~d--p~~Rps~~~vl~~L~~~~ 337 (350)
..+..|.+....+.+ .......-.+..+..+..+|+... +.-|||++.++..|.++.
T Consensus 237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 237 TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 011122222221111 111122235577888888888753 568999999999987765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3e-10 Score=106.04 Aligned_cols=150 Identities=19% Similarity=0.260 Sum_probs=105.8
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccccee-------eccccCCCccCcccccCC
Q 046877 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK-------TAIRGTKGYVAPEWFRKS 239 (350)
Q Consensus 167 ~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~ 239 (350)
+.+.|+.|+|. +.++||+.|.|++|.++.++.+||+.|+.+............ .-.....-|.|||.+.+.
T Consensus 107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44489999997 789999999999999999999999999988654432111110 112246689999999988
Q ss_pred CCCCCCcchhHHHHHHHHH-hCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCC
Q 046877 240 TISAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQE 318 (350)
Q Consensus 240 ~~~~~~DiwslG~~l~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 318 (350)
..+.++|+||+|+++|.+. .|+.-+.............. ..+...+ -...+.|.++.+=+.+++..
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~------~~~~~~~-------~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN------LLNAGAF-------GYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc------ccccccc-------cccccCcHHHHHHHHHHhcC
Confidence 8899999999999999999 56665554433332211110 0011111 11145778899999999999
Q ss_pred CCCCCCCHHHHHH
Q 046877 319 DPSLRPTMRKVSQ 331 (350)
Q Consensus 319 dp~~Rps~~~vl~ 331 (350)
++.-||++..+..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999997766543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.4e-08 Score=87.75 Aligned_cols=103 Identities=17% Similarity=0.181 Sum_probs=78.7
Q ss_pred HHHHHHHHHhcCCCCceee--ecceeec-----CCeeEEEEecCCCC-ChhhhhcC--CCCcChhHHHHHHHHHHHHHHH
Q 046877 105 EFKNEVIVIGQTHHKNLVR--LLGFCDE-----GQNRLLAYEFLNNG-TLASFLFG--NLKPNWNLRTNIAFQIARVLLY 174 (350)
Q Consensus 105 ~~~~e~~~l~~l~h~~iv~--~~~~~~~-----~~~~~lv~e~~~~g-~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~ 174 (350)
.+.+|...+..+...+|.. .+++.+. ....++|+|++++. +|.+++.. ....+......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 4778888888875444433 3445432 23478999999986 79888753 3445566778899999999999
Q ss_pred HHhcCCCCeEecCCCCCCeEEcC-------CCceEEeeccccc
Q 046877 175 LHEDCSSQIIHCDIKPQNILLND-------RYNARISDFGLAK 210 (350)
Q Consensus 175 Lh~~~~~~i~H~dlkp~Nill~~-------~~~~kl~Dfg~~~ 210 (350)
||+ .+++|+|++++|||++. ++.+.++||+.+.
T Consensus 154 LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHH---CcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 995 49999999999999975 4679999999885
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.9e-08 Score=82.10 Aligned_cols=107 Identities=19% Similarity=0.224 Sum_probs=82.6
Q ss_pred HHHHHHHHHHHhcCCCCc--eeeecceeecC----CeeEEEEecCCCC-ChhhhhcCCCCcChhHHHHHHHHHHHHHHHH
Q 046877 103 EKEFKNEVIVIGQTHHKN--LVRLLGFCDEG----QNRLLAYEFLNNG-TLASFLFGNLKPNWNLRTNIAFQIARVLLYL 175 (350)
Q Consensus 103 ~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~L 175 (350)
..+..+|...+..+...+ ..+.+++.+.. ...++++|++++. +|.+++......+......++.+++..++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 456778888777774333 34445554432 2457999999884 7999987644567777889999999999999
Q ss_pred HhcCCCCeEecCCCCCCeEEcCCC---ceEEeeccccccc
Q 046877 176 HEDCSSQIIHCDIKPQNILLNDRY---NARISDFGLAKLL 212 (350)
Q Consensus 176 h~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~ 212 (350)
|+ .+++|+|+++.|||++.++ .+.++||+-+...
T Consensus 135 H~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 95 4999999999999999887 7999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.2e-08 Score=91.18 Aligned_cols=146 Identities=16% Similarity=0.214 Sum_probs=94.4
Q ss_pred hhh-hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccH-------------------------------------
Q 046877 62 NFK-EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE------------------------------------- 103 (350)
Q Consensus 62 ~~~-~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~------------------------------------- 103 (350)
+|. +.|+.++-|.||+|++++ ++.||||+.........
T Consensus 127 eF~~~PiAsASIaQVH~A~L~s----G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKS----GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred HcCCCchhhhhHhhheeEEecC----CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 444 458899999999999876 35699999743111000
Q ss_pred ---HHHHHHHHHHhcC-----CCCceeeecceeecCCeeEEEEecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHH
Q 046877 104 ---KEFKNEVIVIGQT-----HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLY 174 (350)
Q Consensus 104 ---~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~ 174 (350)
-++..|...+.++ +.+++.-..-+++-.+...++|||++|-.+.+... +....+...+.....++.--.-+
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL 282 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1123344444333 35555444445555677899999999998888752 22334433333222222222223
Q ss_pred HHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 175 Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
-| +++|.|.+|.||+++.+|.+.+.|||+.....+..
T Consensus 283 ~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~ 319 (517)
T COG0661 283 RD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319 (517)
T ss_pred hc-----CccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence 23 99999999999999999999999999998776543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.5e-07 Score=79.29 Aligned_cols=133 Identities=15% Similarity=0.143 Sum_probs=91.6
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----------------------cccHHHHHHHHHHHhcCCCC
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----------------------QDGEKEFKNEVIVIGQTHHK 119 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~ 119 (350)
.+...||-|--|.||.|...+. ..+++|.-+.-. .-.....++|...|..+...
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g----~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKG----RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred hhccccccCccceEEEEECCCC----CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 4557899999999999986533 447887642100 01123467888899888655
Q ss_pred --ceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 046877 120 --NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND 197 (350)
Q Consensus 120 --~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~ 197 (350)
.+.+.+++ +.-.++||+++|-.|...-- +......++..|++-+.-+- ..|++|+|+++-||++++
T Consensus 170 G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 170 GVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEec
Confidence 66666665 34579999999966654421 23334445555555555444 349999999999999999
Q ss_pred CCceEEeeccccc
Q 046877 198 RYNARISDFGLAK 210 (350)
Q Consensus 198 ~~~~kl~Dfg~~~ 210 (350)
+|.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999996554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.6e-07 Score=75.90 Aligned_cols=137 Identities=14% Similarity=0.068 Sum_probs=98.9
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeeccc------cccHHHHHHHHHHHhcCCCCc--eeeecceeecC----Cee
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF------QDGEKEFKNEVIVIGQTHHKN--LVRLLGFCDEG----QNR 134 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~------~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~----~~~ 134 (350)
-|+||.|.|+....... .+-+|...+.. +.....|.+|+..+..+...+ +.+........ -..
T Consensus 26 ~~rgG~SgV~r~~~~g~-----~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA 100 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-----KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRA 100 (216)
T ss_pred cCCCCcceEEEEEeCCc-----EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEE
Confidence 56799999998775433 37777764211 335678999999988885333 44444221111 235
Q ss_pred EEEEecCCC-CChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--eEEeecccc
Q 046877 135 LLAYEFLNN-GTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN--ARISDFGLA 209 (350)
Q Consensus 135 ~lv~e~~~~-g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~ 209 (350)
+||+|-+.+ .+|.+++... .+.+......++.++++.++-||+ .++.|+|+.+.||+++.++. ++++||.-+
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 789997764 4888887543 345777788999999999999995 59999999999999986667 999999776
Q ss_pred cc
Q 046877 210 KL 211 (350)
Q Consensus 210 ~~ 211 (350)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 53
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.4e-07 Score=76.94 Aligned_cols=100 Identities=19% Similarity=0.227 Sum_probs=66.1
Q ss_pred HHHHHHHHHHhcCCCC--ceeeecceeecCCeeEEEEecCC--CCChhhhhcCCCCcChhHHHHHHHHHHHHHHH-HHhc
Q 046877 104 KEFKNEVIVIGQTHHK--NLVRLLGFCDEGQNRLLAYEFLN--NGTLASFLFGNLKPNWNLRTNIAFQIARVLLY-LHED 178 (350)
Q Consensus 104 ~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~-Lh~~ 178 (350)
....+|.+.|.++..- ++.+++++. ..++||||++ |..+..+... .++......++.+++..+.. +|
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~-- 124 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLH-- 124 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHH--
Confidence 3467899999999765 455555442 3479999998 6555544321 11244566677888885555 46
Q ss_pred CCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 179 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
..+++|+||.+.||+++++ .+.++|||.+....
T Consensus 125 -~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 125 -KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp -CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred -hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 5699999999999999988 99999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.9e-06 Score=71.74 Aligned_cols=137 Identities=15% Similarity=0.159 Sum_probs=82.2
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCc--eeeecceeecCCeeEEEEecCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN--LVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
..||+|..+.||+.. . ..+++|..... .......+|.+.++.+..-+ +.+.+++....+...++||+++
T Consensus 7 ~~i~~G~t~~~y~~~---~----~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---T----GKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEec---C----CCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 468999999999742 1 12567765432 23456788999998885433 4666777777777889999999
Q ss_pred CCC-hhhhh---------------------cCC--CCcChhHH-HHHHHH----------HHH-HHHHHHhc-CCCCeEe
Q 046877 143 NGT-LASFL---------------------FGN--LKPNWNLR-TNIAFQ----------IAR-VLLYLHED-CSSQIIH 185 (350)
Q Consensus 143 ~g~-L~~~l---------------------~~~--~~~~~~~~-~~~~~~----------i~~-~l~~Lh~~-~~~~i~H 185 (350)
|.+ +...+ +.- ...+.... ..+..+ +.+ ...+|... ....++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 21111 000 00010000 000000 001 11222211 1345789
Q ss_pred cCCCCCCeEEcCCCceEEeecccccc
Q 046877 186 CDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 186 ~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
+|+.|.||++++++ +.++||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999988 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.9e-06 Score=71.14 Aligned_cols=133 Identities=14% Similarity=0.089 Sum_probs=79.6
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHH---------HHHHHHHhcCCCCc---eeeeccee
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEF---------KNEVIVIGQTHHKN---LVRLLGFC 128 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~---------~~e~~~l~~l~h~~---iv~~~~~~ 128 (350)
+...+.+-......|.+...+. ..+++|.........++.+ .+.+....++...+ ...++...
T Consensus 33 ~~~~kv~k~~~r~~ValIei~~-----~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 33 YKIIKVFKNTKRNYVALIEIDG-----KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred ceEEEeecCCCccEEEEEEECC-----cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3444556666666666665433 2377887654332222222 22333333332222 22222222
Q ss_pred -----ecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEE
Q 046877 129 -----DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI 203 (350)
Q Consensus 129 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl 203 (350)
.-....+++|||++|..|.+... +++ .+...+.+++.-+| ..|+.|+|.+|+|+++++++ +++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEE
Confidence 22234568999999988876542 222 24456777889999 45999999999999999664 999
Q ss_pred eeccccc
Q 046877 204 SDFGLAK 210 (350)
Q Consensus 204 ~Dfg~~~ 210 (350)
+||+...
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9997664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1e-07 Score=88.66 Aligned_cols=182 Identities=18% Similarity=0.142 Sum_probs=128.2
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCc-eeeecceeecCCeeEEEEecCC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN-LVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
...+++|+++.+++.+--.+ +...++.+.. .....-++++|.+++||| .+..++-++.++..++.++++.
T Consensus 247 fh~fvK~altknpKkRptae----klL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAE----KLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHHhcCCCccCCChh----hheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 34588899999998753221 2233444322 245566789999999999 7777777888888999999998
Q ss_pred CC-Chhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 143 NG-TLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 143 ~g-~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
++ +-..... ....+...+...+.+.-.++++++|+ ..=+|+| ||+..+ +..+..||+....+.+.. .
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~ 386 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---K 386 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---c
Confidence 87 2222211 11222333445566667778999993 3457887 666655 589999999988776543 2
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFD 265 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~ 265 (350)
.+...+++.++|||+..++.+..+.|.|++|.--.++--|.+|-.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 245568999999999999999999999999987777777776653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.35 E-value=8e-06 Score=70.16 Aligned_cols=136 Identities=13% Similarity=0.061 Sum_probs=80.2
Q ss_pred cCCCcc-ceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEEEEecCCCC
Q 046877 67 VGRGSF-GIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 67 lg~G~~-g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
|..|.. ..||+..... ..+.+|...... ..++..|+++++.+. +--+.+++++....+..+++||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~~-----~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-----PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCCC-----CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 445555 7889886322 236777654322 345677888888873 444556777777666788999999998
Q ss_pred Chhhhhc------------------CCC-----CcCh--hHHHHHHH--------------------HHHHHHHHHHhc-
Q 046877 145 TLASFLF------------------GNL-----KPNW--NLRTNIAF--------------------QIARVLLYLHED- 178 (350)
Q Consensus 145 ~L~~~l~------------------~~~-----~~~~--~~~~~~~~--------------------~i~~~l~~Lh~~- 178 (350)
+|..... +.. .+.. ........ .+......|-..
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 7764320 000 0000 00000000 011112222111
Q ss_pred ---CCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 179 ---CSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 179 ---~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13458999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.5e-06 Score=69.79 Aligned_cols=103 Identities=25% Similarity=0.408 Sum_probs=83.2
Q ss_pred HHHHHHHhcCCC-CceeeecceeecCCeeEEEEecCCCCChhh---hhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCC
Q 046877 107 KNEVIVIGQTHH-KNLVRLLGFCDEGQNRLLAYEFLNNGTLAS---FLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQ 182 (350)
Q Consensus 107 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~---~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~ 182 (350)
.+|..++..+++ +++.+++|+|- .+++.||...+++.. .+.+-...+|..+.+++.++++.+.++++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347888888864 69999999983 367889998776642 1223346789999999999999999999865566
Q ss_pred eEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 183 i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
+.-.|++|+|+-++++|.+|+.|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8899999999999999999999998876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.5e-06 Score=77.57 Aligned_cols=143 Identities=17% Similarity=0.219 Sum_probs=86.8
Q ss_pred hhh-hccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc-------------------------------------H
Q 046877 62 NFK-EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG-------------------------------------E 103 (350)
Q Consensus 62 ~~~-~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~-------------------------------------~ 103 (350)
+|. +.||..+.|.||+|+.++ +..||||......... +
T Consensus 163 ~f~~~piaaASlaQVhrA~L~~----G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 163 EFDEEPIAAASLAQVHRARLKN----GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred hcCcchhhhcchhheEEEEecC----CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 444 459999999999999876 3458999864321111 0
Q ss_pred HHHHHHHHHHhc----CCCCc------eeeecceeecCCeeEEEEecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHH
Q 046877 104 KEFKNEVIVIGQ----THHKN------LVRLLGFCDEGQNRLLAYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVL 172 (350)
Q Consensus 104 ~~~~~e~~~l~~----l~h~~------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l 172 (350)
-+|..|.+...+ +.|-+ |.++ ++.-.....++|||++|..+.|.-. .....+...+..-+.+...-+
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~V--y~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKV--YWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ 316 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCee--hhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH
Confidence 113334433333 23434 2222 2233457799999999987766542 122333333333333322222
Q ss_pred HHHHhcCCCCeEecCCCCCCeEEcC----CCceEEeecccccccccC
Q 046877 173 LYLHEDCSSQIIHCDIKPQNILLND----RYNARISDFGLAKLLTLN 215 (350)
Q Consensus 173 ~~Lh~~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg~~~~~~~~ 215 (350)
-+-| |.+|+|-+|.||+++. ++.+.+.|||+.......
T Consensus 317 If~~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 317 IFKT-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHhc-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2333 8999999999999983 678999999999866544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.7e-05 Score=78.51 Aligned_cols=150 Identities=15% Similarity=0.234 Sum_probs=89.8
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-ccccHHHHHHHHHHHhcCC-CCce--eeecceeecC---CeeEE
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTH-HKNL--VRLLGFCDEG---QNRLL 136 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~l 136 (350)
.+.++.|.+..+|+......... ..+++|+.... .......+.+|.++++.+. |.++ .+.+.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~-~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSV-KRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcc-eeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 35688899999998875443221 23556654321 1223457889999999985 6665 6667776654 45789
Q ss_pred EEecCCCCChhhh-----------------------hcCC--C--------Cc-C--hhHHHHHHHH-------------
Q 046877 137 AYEFLNNGTLASF-----------------------LFGN--L--------KP-N--WNLRTNIAFQ------------- 167 (350)
Q Consensus 137 v~e~~~~g~L~~~-----------------------l~~~--~--------~~-~--~~~~~~~~~~------------- 167 (350)
||||++|..+.+- ++.- . .. . ..++..|..+
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 9999998654321 0000 0 00 0 0112222111
Q ss_pred --HHHHHHHHHhcC--------CCCeEecCCCCCCeEEcC-CCc-eEEeeccccccccc
Q 046877 168 --IARVLLYLHEDC--------SSQIIHCDIKPQNILLND-RYN-ARISDFGLAKLLTL 214 (350)
Q Consensus 168 --i~~~l~~Lh~~~--------~~~i~H~dlkp~Nill~~-~~~-~kl~Dfg~~~~~~~ 214 (350)
+...+.+|..+. ...++|+|++++|++++. ++. .-+.||.++...++
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 223456664421 135999999999999985 333 57999999876544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.6e-05 Score=67.57 Aligned_cols=139 Identities=19% Similarity=0.193 Sum_probs=78.9
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCC--ceeeeccee---ecCCeeEEEEe
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHK--NLVRLLGFC---DEGQNRLLAYE 139 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~---~~~~~~~lv~e 139 (350)
+.++.|..+.||+....+. .+++|..... .....+..|..+++.+... .+.+++... ......+++|+
T Consensus 3 ~~l~~G~~n~~~~v~~~~~-----~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDG-----RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEESSSSEEEEEEETTS-----EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECCc-----EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 4588899999999986542 4788876443 3456788888888877433 244555533 33345689999
Q ss_pred cCCCCChhh----------------hh---cCC----CCcChhH---------HHHH------------HHHHHH-HHHH
Q 046877 140 FLNNGTLAS----------------FL---FGN----LKPNWNL---------RTNI------------AFQIAR-VLLY 174 (350)
Q Consensus 140 ~~~~g~L~~----------------~l---~~~----~~~~~~~---------~~~~------------~~~i~~-~l~~ 174 (350)
+++|..+.. .+ +.. ....... .... ...+.+ .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999988777 00 000 0111000 0000 111222 2333
Q ss_pred HHh----cCCCCeEecCCCCCCeEEc-CCCceEEeeccccc
Q 046877 175 LHE----DCSSQIIHCDIKPQNILLN-DRYNARISDFGLAK 210 (350)
Q Consensus 175 Lh~----~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~ 210 (350)
+++ .....++|+|+.|+||+++ +++.+-++||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 332 1246799999999999999 55666799998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=4e-05 Score=63.07 Aligned_cols=131 Identities=18% Similarity=0.208 Sum_probs=87.4
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----------------cccHHHHHHHHHHHhcCC------CCcee
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----------------QDGEKEFKNEVIVIGQTH------HKNLV 122 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~iv 122 (350)
..||+|+.-.||.-- .++ ..+||+..... ....++..+|+.....+. +.+|.
T Consensus 7 ~~i~~G~~R~cy~HP--~dp----~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP--DDP----NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred cccccCCCceEEECC--CCC----CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 469999999999643 332 25777765433 123456666766555554 88999
Q ss_pred eecceeecCCeeEEEEecCCC------CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 046877 123 RLLGFCDEGQNRLLAYEFLNN------GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196 (350)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~ 196 (350)
+++|+.+++....+|+|...+ -+|.+++.+ ..++. ...+.+. +-..||- ..+|+.+|++|+||++.
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~---~f~~~l~---~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALD---EFKRYLL---DHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHH---HHHHHHH---HcCCeecCCCcccEEEE
Confidence 999999999999999998643 257777743 34444 3333333 3445666 34899999999999995
Q ss_pred CC--C--ceEEee-cccc
Q 046877 197 DR--Y--NARISD-FGLA 209 (350)
Q Consensus 197 ~~--~--~~kl~D-fg~~ 209 (350)
.+ + .+.|+| ||..
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 32 2 477777 4433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.2e-05 Score=64.03 Aligned_cols=136 Identities=18% Similarity=0.185 Sum_probs=86.8
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc-------------------H-----HHHHHHHHHHhcCC--CC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG-------------------E-----KEFKNEVIVIGQTH--HK 119 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~-------------------~-----~~~~~e~~~l~~l~--h~ 119 (350)
.|.+|--+.||+|... ....+|+|+.......- . .....|++.|+++. +-
T Consensus 55 ~istGKEA~Vy~a~~~----~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 55 CISTGKEANVYLAETG----DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eecCCcceEEEeeccC----CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 4778888999998742 23568999875322110 0 11345666666663 33
Q ss_pred ceeeecceeecCCeeEEEEecCCCCCh-hhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 046877 120 NLVRLLGFCDEGQNRLLAYEFLNNGTL-ASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR 198 (350)
Q Consensus 120 ~iv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~ 198 (350)
.+.+.+.+. .-.++|||+..... .=.+ +...........+..++++.+.-|-. ..++||+||+.-|||+. +
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-C
Confidence 334444443 33699999865311 1111 11222333567778888888888874 35999999999999999 7
Q ss_pred CceEEeecccccccc
Q 046877 199 YNARISDFGLAKLLT 213 (350)
Q Consensus 199 ~~~kl~Dfg~~~~~~ 213 (350)
+.+.++|||-+....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 799999999876443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.2e-05 Score=65.27 Aligned_cols=33 Identities=27% Similarity=0.424 Sum_probs=27.3
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 180 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
...++|+|+.++|+++++++..-++||+.+...
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 345899999999999997766679999987543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.05 E-value=8.9e-06 Score=81.01 Aligned_cols=197 Identities=19% Similarity=0.141 Sum_probs=137.2
Q ss_pred HHHHHHHHhcCCCCceeeecceeecCCeeE----EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCC
Q 046877 106 FKNEVIVIGQTHHKNLVRLLGFCDEGQNRL----LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181 (350)
Q Consensus 106 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~ 181 (350)
..-|...+.+..|+|+..++.+-.+..... +..+++..-++...+..-...+....+.+..++.+|++|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 344667788889999999998875543332 4457888888988888888899999999999999999999954
Q ss_pred CeEecCCCCC---CeEEcCCCceEEe--ecccccccccCcccceeeccccCCCccCcccccCCCCCC--CCcchhHHHHH
Q 046877 182 QIIHCDIKPQ---NILLNDRYNARIS--DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA--KVDVYSFGVLL 254 (350)
Q Consensus 182 ~i~H~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~DiwslG~~l 254 (350)
...|.-+..+ +.-.+.++.+.++ ||+.+...+..... .....+..+.+||....+.... ..|+|.+|...
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 4445444444 4445566677777 89888766543322 2223455678888776655444 47999999999
Q ss_pred HHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 255 LEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 255 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
..+..|..+-...-.. ..+.. ..+.....+...+|+..++++|+++.+++...-
T Consensus 383 ~~~~~~~~i~~~~~~~------------------~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVP------------------VSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhhhcCcccccccch------------------hhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 9999877653211100 00000 011125677888999999999999999986553
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=5.9e-05 Score=59.77 Aligned_cols=129 Identities=18% Similarity=0.308 Sum_probs=85.3
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCC
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
..+.|++|++|.||++.+... .+++|.-... +....+..|.++|..+.-.++-+=+..+.+ .++.|||..
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-----~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~ 95 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-----EVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYID 95 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-----eEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhc
Confidence 346799999999999987544 4788876543 335678999999999876665443332222 234599999
Q ss_pred CCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCCeEEcCCCceEEeecccccc
Q 046877 143 NGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIK-PQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 143 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlk-p~Nill~~~~~~kl~Dfg~~~~ 211 (350)
|-+|...-... +.. -...+++.-.-|. ..+|-|+.+. |...++.+++.+.|+||..+..
T Consensus 96 G~~L~~~~~~~---~rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG---DRK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc---cHH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 98887765322 222 2334555544455 4588898884 4444444444899999998863
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00046 Score=61.05 Aligned_cols=75 Identities=8% Similarity=0.014 Sum_probs=51.3
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCC---Cceeeecceeec---CCeeEEEE
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHH---KNLVRLLGFCDE---GQNRLLAY 138 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~ 138 (350)
+.||.|..+.||.....+. .+.+|..+. ......+..|...++.+.. -.+.+.++++.. .+..+++|
T Consensus 20 ~~i~~G~~~~vy~~~~~~~-----~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG-----NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eecCCccceeEEEEEcCCC-----CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 4699999999998753222 145555322 1123578889998888742 357777777644 36689999
Q ss_pred ecCCCCCh
Q 046877 139 EFLNNGTL 146 (350)
Q Consensus 139 e~~~~g~L 146 (350)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00031 Score=60.76 Aligned_cols=137 Identities=12% Similarity=0.084 Sum_probs=73.8
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCce-eeecceeecCCeeEEEEecCCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL-VRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g 144 (350)
.+..|-...+|+... + +..+++|........-.-...+|..+++.+...++ .+++.... -+++|||++|.
T Consensus 3 ~~~~G~tn~~y~~~~--~---~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--P---GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEEe--C---CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 356677888998762 2 12367776543211111235778888888854333 23333322 36899999987
Q ss_pred Chhhh-------h----------cCCC----CcChh-HHHHHHHHH---------HHHHHHHHhc-----CCCCeEecCC
Q 046877 145 TLASF-------L----------FGNL----KPNWN-LRTNIAFQI---------ARVLLYLHED-----CSSQIIHCDI 188 (350)
Q Consensus 145 ~L~~~-------l----------~~~~----~~~~~-~~~~~~~~i---------~~~l~~Lh~~-----~~~~i~H~dl 188 (350)
.+... . +... .++.. ....+..++ ...+..+... ....++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65431 0 1110 11111 111111111 1111112111 1235899999
Q ss_pred CCCCeEEcCCCceEEeeccccccc
Q 046877 189 KPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 189 kp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
.|.||++++++ +.++||..+...
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCcC
Confidence 99999999877 789999888643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00044 Score=61.21 Aligned_cols=139 Identities=15% Similarity=0.157 Sum_probs=80.9
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCc--eeeecce------eecCCeeEE
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN--LVRLLGF------CDEGQNRLL 136 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~l 136 (350)
+.+..|....+|+....+. .+++|.... ....++..|++++..+.+.+ +.+++.. ...++..++
T Consensus 20 ~~i~~G~~n~~y~v~~~~~-----~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 20 EGISAGIENTNYFVTTDSG-----RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred ecccCccccceEEEEeCCC-----cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 4577788889998864322 377777643 23456677777777774332 3444332 233456689
Q ss_pred EEecCCCCChhh----hh----------c---CC--C------CcChhHH----------HHHHHHHHHHHHHHHh----
Q 046877 137 AYEFLNNGTLAS----FL----------F---GN--L------KPNWNLR----------TNIAFQIARVLLYLHE---- 177 (350)
Q Consensus 137 v~e~~~~g~L~~----~l----------~---~~--~------~~~~~~~----------~~~~~~i~~~l~~Lh~---- 177 (350)
++++++|..+.. .. + .. . ...+... ......+..++.++.+
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999999876532 00 0 00 0 0011100 0011112233444442
Q ss_pred cCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 178 ~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
.....++|+|+.|.|+++++++.+.|.||+.+..
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 1135799999999999999987788999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00058 Score=58.18 Aligned_cols=30 Identities=23% Similarity=0.415 Sum_probs=26.6
Q ss_pred CCeEecCCCCCCeEEcC-CCceEEeeccccc
Q 046877 181 SQIIHCDIKPQNILLND-RYNARISDFGLAK 210 (350)
Q Consensus 181 ~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~ 210 (350)
..++|+|+.+.||++++ ++.+.++||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 46999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0039 Score=57.10 Aligned_cols=76 Identities=12% Similarity=0.157 Sum_probs=50.2
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecc-------ccccHHHHHHHHHHHhcCC---CCceeeecceeecCCee
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-------FQDGEKEFKNEVIVIGQTH---HKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-------~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~ 134 (350)
+.||.|.+..||++...++. +.+.+|.-... .+-..++...|...|+.+. -.++.+++.+ +.+..
T Consensus 32 ~elggGn~N~VyrV~~~~g~---~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~ 106 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGG---KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELA 106 (401)
T ss_pred eEcCCCceEEEEEEEeCCCC---eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCC
Confidence 56999999999999864321 34888874311 0223456777888777762 2345566665 44567
Q ss_pred EEEEecCCCCC
Q 046877 135 LLAYEFLNNGT 145 (350)
Q Consensus 135 ~lv~e~~~~g~ 145 (350)
+++||++++..
T Consensus 107 ~lVME~L~~~~ 117 (401)
T PRK09550 107 VTVMEDLSDHK 117 (401)
T ss_pred EEEEecCCCcc
Confidence 89999998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.004 Score=55.70 Aligned_cols=32 Identities=25% Similarity=0.328 Sum_probs=27.4
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 180 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
..+++|+|+.|+||+++++...-++||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 45799999999999999776668999998863
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0062 Score=54.20 Aligned_cols=140 Identities=14% Similarity=0.190 Sum_probs=77.9
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCc--eeeecce------eecCCeeEE
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN--LVRLLGF------CDEGQNRLL 136 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~l 136 (350)
+.++.|....+|+....+. .+++|..... .....+..|..++..+...+ +.+++.. ....+..++
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-----~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-----RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred cccCCccccceEEEEeCCC-----cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 4577777789998764222 2667765432 12344556666666653222 3333332 122456789
Q ss_pred EEecCCCCChhhh----h----------cC-CCC-----------cChhHHH------------HHHHHHHHHHHHHHh-
Q 046877 137 AYEFLNNGTLASF----L----------FG-NLK-----------PNWNLRT------------NIAFQIARVLLYLHE- 177 (350)
Q Consensus 137 v~e~~~~g~L~~~----l----------~~-~~~-----------~~~~~~~------------~~~~~i~~~l~~Lh~- 177 (350)
+++|++|..+... . +. ... ..|.... .....+.+.++++..
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 9999988654211 0 00 000 0111000 011122334444532
Q ss_pred ---cCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 178 ---DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 178 ---~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
....+++|+|+++.|+++++++...++||+.+..
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1246899999999999999888778999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0023 Score=56.84 Aligned_cols=141 Identities=21% Similarity=0.274 Sum_probs=78.4
Q ss_pred hccCCCccceEEEEEEcCC---CcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCce-eeecceeecCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTT---TTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL-VRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~---~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~ 140 (350)
+.+..|-...+|+...... ...+..+++|...... .......+|.++++.+...++ .++++++.. ..++||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 3456666778998875331 0112447778765432 233456778888877743333 334444432 357899
Q ss_pred CCCCChhhhh-----------------cCC-CCc------C----hhHHHH--------------------------HHH
Q 046877 141 LNNGTLASFL-----------------FGN-LKP------N----WNLRTN--------------------------IAF 166 (350)
Q Consensus 141 ~~~g~L~~~l-----------------~~~-~~~------~----~~~~~~--------------------------~~~ 166 (350)
++|.++.... +.. ... . +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9887764311 000 000 0 001101 111
Q ss_pred HHHHHHHHHHh------cCCCCeEecCCCCCCeEEcCC----CceEEeeccccc
Q 046877 167 QIARVLLYLHE------DCSSQIIHCDIKPQNILLNDR----YNARISDFGLAK 210 (350)
Q Consensus 167 ~i~~~l~~Lh~------~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~ 210 (350)
.+...+..+.. .....++|+|+.+.||+++++ +.+.++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22222333332 124578999999999999974 889999998885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0045 Score=50.80 Aligned_cols=136 Identities=24% Similarity=0.275 Sum_probs=86.6
Q ss_pred cccccccCHHHHHHHhhhhhhccCCCcc-ceEEEEEEcCCCcceeEEEEEeeeccc---c------------------cc
Q 046877 45 ETKSRCFSYKELEEATDNFKEEVGRGSF-GIIYKGVIQTTTTSTTAVAVKKLDRVF---Q------------------DG 102 (350)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~-g~V~~~~~~~~~~~~~~vavk~~~~~~---~------------------~~ 102 (350)
.++...++. .....++.+.||.|.- |.||++++... .+|+|...... . ..
T Consensus 26 gPKL~~F~~---h~~~I~flefLg~g~~~~~V~kv~I~g~-----~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y 97 (207)
T PF13095_consen 26 GPKLEPFTH---HGDDIEFLEFLGHGSHDGYVFKVEIDGR-----IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHY 97 (207)
T ss_pred CCCcCCcCC---CCCcEeeeeecCCCCceeEEEEEEECCe-----EEEEEEeeccccCCCccccccccccccccchhhhh
Confidence 344455555 2255677889999999 99999987543 59999832100 0 01
Q ss_pred HHHHHHHHHHHhcC---CCCce--eeecceeecC------------------CeeEEEEecCCCCChhhhhcCCCCcChh
Q 046877 103 EKEFKNEVIVIGQT---HHKNL--VRLLGFCDEG------------------QNRLLAYEFLNNGTLASFLFGNLKPNWN 159 (350)
Q Consensus 103 ~~~~~~e~~~l~~l---~h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 159 (350)
..-|.+|.+...++ ++.++ ++.+||..-. ....||.||.+... .++..
T Consensus 98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~ 168 (207)
T PF13095_consen 98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR 168 (207)
T ss_pred cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh
Confidence 12366777766655 45566 8888876211 11246667665532 22223
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 160 LRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 160 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
. +.++.+-+..+| ..+|+-+|+++.|.. .-||+|||.+
T Consensus 169 ~----~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 D----IPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred H----HHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 3 345666677788 669999999999986 4588999865
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0093 Score=53.95 Aligned_cols=141 Identities=18% Similarity=0.157 Sum_probs=78.1
Q ss_pred ccCCCccceEEEEEEcCCC-cceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCce-eeecceeecCCeeEEEEecCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTT-TSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL-VRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~-~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~ 143 (350)
.+..|-.-.+|++...... ..+..+++|........ .-...+|..+++.+...++ .++++.+..+ .+.+|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 4556778889988653321 12345778876543222 2223668888887754333 3445555332 47888887
Q ss_pred CChhhhh-----------------cCCC----C-c-ChhHHHHHHHHH-----------------HHHHHHHHh-----c
Q 046877 144 GTLASFL-----------------FGNL----K-P-NWNLRTNIAFQI-----------------ARVLLYLHE-----D 178 (350)
Q Consensus 144 g~L~~~l-----------------~~~~----~-~-~~~~~~~~~~~i-----------------~~~l~~Lh~-----~ 178 (350)
.+|...- +... . . .+..+.++..++ ...+..|.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 6664210 0000 0 1 122222332221 111222221 1
Q ss_pred CCCCeEecCCCCCCeEEcC-CCceEEeecccccc
Q 046877 179 CSSQIIHCDIKPQNILLND-RYNARISDFGLAKL 211 (350)
Q Consensus 179 ~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~ 211 (350)
....++|+|+++.||++++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1346899999999999986 47899999988753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.012 Score=52.81 Aligned_cols=143 Identities=18% Similarity=0.237 Sum_probs=77.3
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCce-eeecceeecCCeeEEEEecCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL-VRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+.|..|-...+|+............+++|....... ..-...+|..+++.+..-++ .++++++.. . ++.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGN--G--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCC--c--EeehhhcC
Confidence 446667778889886543322223577887654322 22234567888877754444 344555432 2 47888877
Q ss_pred CChhhh-------h----------cCCC-----Cc-ChhHHHHHHHHH----------------------HHHHHHHHh-
Q 046877 144 GTLASF-------L----------FGNL-----KP-NWNLRTNIAFQI----------------------ARVLLYLHE- 177 (350)
Q Consensus 144 g~L~~~-------l----------~~~~-----~~-~~~~~~~~~~~i----------------------~~~l~~Lh~- 177 (350)
..|..- + +... .+ -+..+.++..++ ..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 655321 1 1100 01 122222222221 111222211
Q ss_pred ----cCCCCeEecCCCCCCeEEcC-CCceEEeeccccccc
Q 046877 178 ----DCSSQIIHCDIKPQNILLND-RYNARISDFGLAKLL 212 (350)
Q Consensus 178 ----~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 212 (350)
....-.+|+|+.+.||++++ ++.++++||..+...
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 01123799999999999974 578999999888543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.019 Score=50.25 Aligned_cols=33 Identities=24% Similarity=0.479 Sum_probs=26.8
Q ss_pred CCeEecCCCCCCeEEcCCCc-eEEeecccccccc
Q 046877 181 SQIIHCDIKPQNILLNDRYN-ARISDFGLAKLLT 213 (350)
Q Consensus 181 ~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~~~ 213 (350)
..++|+|++|.||++++++. .-|.||+.+....
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 35899999999999997555 5699999886543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.027 Score=49.91 Aligned_cols=111 Identities=23% Similarity=0.303 Sum_probs=70.2
Q ss_pred cccHHHHHHHHHHHhcCCCC--ceeeecceeecCC--eeEEEEecCCCCChhhhhcCCCCcChhHHHHHH-HHHHHHHHH
Q 046877 100 QDGEKEFKNEVIVIGQTHHK--NLVRLLGFCDEGQ--NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLLY 174 (350)
Q Consensus 100 ~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~-~~i~~~l~~ 174 (350)
........+|+..++.+.-- -+...+++|.++. ..+.+|+|++|..+.+....... ..+++ ..+++.|+-
T Consensus 62 ~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~-----~~~~~~~~l~~~La~ 136 (321)
T COG3173 62 VESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESL-----GRQFALDALADFLAE 136 (321)
T ss_pred chhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccc-----hHHHHHHHHHHHHHH
Confidence 34455677788888877432 2344456665555 66899999998544333311100 01112 244444444
Q ss_pred HH--------------------------------------------------hc-----CCCCeEecCCCCCCeEEcCCC
Q 046877 175 LH--------------------------------------------------ED-----CSSQIIHCDIKPQNILLNDRY 199 (350)
Q Consensus 175 Lh--------------------------------------------------~~-----~~~~i~H~dlkp~Nill~~~~ 199 (350)
|| +. ....++|+|+++.|+++++++
T Consensus 137 LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~ 216 (321)
T COG3173 137 LHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR 216 (321)
T ss_pred HhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC
Confidence 44 22 135689999999999999988
Q ss_pred ceEEeecccccccccC
Q 046877 200 NARISDFGLAKLLTLN 215 (350)
Q Consensus 200 ~~kl~Dfg~~~~~~~~ 215 (350)
-+-+.||+++....+.
T Consensus 217 ~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 217 PTGVLDWELATLGDPL 232 (321)
T ss_pred eeEEEeccccccCCcH
Confidence 8999999999866554
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0036 Score=58.03 Aligned_cols=166 Identities=20% Similarity=0.263 Sum_probs=93.1
Q ss_pred cHHHHHHHHHHHhcCCCCceeeecceeecC-CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCC
Q 046877 102 GEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCS 180 (350)
Q Consensus 102 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 180 (350)
...++....++++.+.|+|....+++.+.. ....+|+|++.. ||.+.+..+. ...... . -|
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~s~------~------~~---- 86 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-LKDESL------L------AH---- 86 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-cchhhh------c------cc----
Confidence 345677788999999999999999987654 346788999865 8988875443 111110 0 22
Q ss_pred CCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhC
Q 046877 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISC 260 (350)
Q Consensus 181 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg 260 (350)
++.|-.+ .+.+| -++. + | | ....+|+||||+|.++.++.-|
T Consensus 87 -~~~~~~~------------~~~td-~~~t------~------------~--~-----~~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 87 -GVLHLNI------------IYITD-HFLT------K------------Y--P-----SPIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred -ccceehh------------hhccc-cccc------c------------C--C-----CCCCcchhhhhHHHHHHHHHHh
Confidence 3333221 22222 0000 0 0 0 0112499999999999999998
Q ss_pred CCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 046877 261 RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329 (350)
Q Consensus 261 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~v 329 (350)
...+......+..... ..-...++....... .......++....++...|+...|..||...++
T Consensus 128 ~~l~~~~~~s~~l~~i--~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 128 ISLEAELTESEYLEIL--LKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred hHHHHHHHHHHHHHHH--HHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 7665322221111000 000000111111111 112233567788999999999999998865544
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.00015 Score=74.61 Aligned_cols=158 Identities=11% Similarity=-0.005 Sum_probs=109.3
Q ss_pred HHHHHHHHhcCCCCceeeeccee--ecCCeeEEEEecCCCCChhhhhcCCC----CcChhHHHHHHHHHHHHHHHHHh--
Q 046877 106 FKNEVIVIGQTHHKNLVRLLGFC--DEGQNRLLAYEFLNNGTLASFLFGNL----KPNWNLRTNIAFQIARVLLYLHE-- 177 (350)
Q Consensus 106 ~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~Lh~-- 177 (350)
...|...+++..|+++.....-. .+....+..++|+.+|.+.+.+-++. .++...+.....+......-.|.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 33444556667888877655443 23345578899999999999885442 22333333233332344344332
Q ss_pred cCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHH
Q 046877 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEI 257 (350)
Q Consensus 178 ~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 257 (350)
+.+...+|+++|+-|.+|..+-.++++++|+.+...+.. .......+++.|+.|+....-.++.++|+|..|+-+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 224567899999999999999999999999998443321 122344577788999988877889899999999999999
Q ss_pred HhCCCCCC
Q 046877 258 ISCRKSFD 265 (350)
Q Consensus 258 ltg~~pf~ 265 (350)
..|..+|.
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 99888773
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.032 Score=50.16 Aligned_cols=80 Identities=16% Similarity=0.115 Sum_probs=47.5
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeecc-------ccccHHHHHHHHHHHhcCC--CCc-eeeecceeecCCeeE
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-------FQDGEKEFKNEVIVIGQTH--HKN-LVRLLGFCDEGQNRL 135 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-------~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~ 135 (350)
+||.|....||++....+ .+.++||.-... .+-..++..-|...|+..+ -|. +.+++. .+.+...
T Consensus 2 EigdGnlN~VfrV~~~~g---~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~ 76 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEG---DRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAV 76 (370)
T ss_pred cCCCCceEEEEEEEcCCC---CeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccce
Confidence 589999999999985322 245888875321 1223455566777776653 343 333333 3445566
Q ss_pred EEEecCCCC-Chhhhh
Q 046877 136 LAYEFLNNG-TLASFL 150 (350)
Q Consensus 136 lv~e~~~~g-~L~~~l 150 (350)
++||+++.. .|...+
T Consensus 77 ~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 77 TVMEDLSHHKIARKGL 92 (370)
T ss_pred ehHhhCccchHHHHHH
Confidence 899998543 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.034 Score=49.55 Aligned_cols=32 Identities=13% Similarity=0.306 Sum_probs=28.7
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 180 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
..+++|+|+.++|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 55799999999999999999999999988763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.013 Score=48.53 Aligned_cols=101 Identities=19% Similarity=0.225 Sum_probs=67.1
Q ss_pred EEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHH
Q 046877 90 VAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI 168 (350)
Q Consensus 90 vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i 168 (350)
..+|++...+-. ...-+.++.+++++++ .|+++.. .+.-...++.|+|..... ...-.+..+
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i------------~~~N~i~ag- 150 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI------------NFSNFITAG- 150 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc------------chhHHHHHh-
Confidence 456666544433 4456788888988875 5677662 133445688898865211 111112222
Q ss_pred HHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 169 ~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
+.+|.-.|+. +.+.+|+|..|+||+=|..|.+||.|=+.
T Consensus 151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 3556777855 77899999999999999999999999654
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.066 Score=49.13 Aligned_cols=80 Identities=16% Similarity=0.193 Sum_probs=49.3
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-------cccHHHHHHHHHHHhcCC---CCceeeecceeecCCe
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-------QDGEKEFKNEVIVIGQTH---HKNLVRLLGFCDEGQN 133 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~ 133 (350)
.+.||.|....||+..... ..++||+-.... +....+...|...|+.+. ..++.+++.++. +.
T Consensus 37 ~~eiggGn~N~VyrV~~~~-----~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSS-----GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TM 109 (418)
T ss_pred EEEcCCCceeeEEEEEcCC-----ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CC
Confidence 3568999999999987421 237888754111 113344444566666553 246777777776 45
Q ss_pred eEEEEecCCC--CChhhhh
Q 046877 134 RLLAYEFLNN--GTLASFL 150 (350)
Q Consensus 134 ~~lv~e~~~~--g~L~~~l 150 (350)
.+++||++++ ..+.+-+
T Consensus 110 ~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 110 ALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CEEEEeecCCcceehhhhh
Confidence 6788999977 2454444
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.034 Score=49.79 Aligned_cols=139 Identities=16% Similarity=0.180 Sum_probs=90.6
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---ccc-----------------------HHHHHHHHHHHhcCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDG-----------------------EKEFKNEVIVIGQTHH 118 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~-----------------------~~~~~~e~~~l~~l~h 118 (350)
..|..|--+.||.+.-.+ +..+|||+..... .+. .-....|++.|.+++.
T Consensus 150 GCiSTGKEANVYHat~~d----G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEED----GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred cccccCccceeEeeecCC----CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 457788889999985333 3458999874210 010 0124567778887765
Q ss_pred CceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 046877 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR 198 (350)
Q Consensus 119 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~ 198 (350)
..|.-.--..- ..-.|||+++.......=.-+...++...+..+-.|++.-|.-|.+. ..+||.||.--|+|+-++
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~LyhdG 301 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYHDG 301 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEECC
Confidence 55443322222 13468999986432221112344566777888889999999988874 589999999999998765
Q ss_pred CceEEeeccccccc
Q 046877 199 YNARISDFGLAKLL 212 (350)
Q Consensus 199 ~~~kl~Dfg~~~~~ 212 (350)
.+.++|.+-+...
T Consensus 302 -~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 -KLYIIDVSQSVEH 314 (520)
T ss_pred -EEEEEEccccccC
Confidence 7889998766543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.015 Score=52.62 Aligned_cols=60 Identities=18% Similarity=0.231 Sum_probs=40.2
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~ 196 (350)
..++=+|..|-++..++... ..++....+++.-.+.|+--+-- -.+.+|.|++|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence 35666788888888888543 34445555555555555443332 34899999999999994
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.037 Score=48.52 Aligned_cols=72 Identities=21% Similarity=0.287 Sum_probs=43.2
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC---CCceeeecceeecCCeeEEEEecC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH---HKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
+.++.|....+|+.. .+ ...+-+|... ......+..|..-|+.+. --.+.+.+++....+..+++|||+
T Consensus 23 ~~v~GG~i~~a~~~~--~~---~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD--TD---GGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEE--SSSSEEEEEE--TT---S-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred EecCCCChhheEEEE--CC---CccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 458888899999876 22 2347777754 233456788888777773 445778888887777789999998
Q ss_pred CCC
Q 046877 142 NNG 144 (350)
Q Consensus 142 ~~g 144 (350)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.034 Score=49.64 Aligned_cols=73 Identities=16% Similarity=0.193 Sum_probs=55.5
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
...|++|++- |+++... ....++++..++.+.+..+.-+.. ....=|||+...||+|+ +|++-|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3445666653 4344322 334678889999999888877775 56788999999999999 99999999999984
Q ss_pred c
Q 046877 212 L 212 (350)
Q Consensus 212 ~ 212 (350)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 3
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.076 Score=48.49 Aligned_cols=81 Identities=17% Similarity=0.234 Sum_probs=48.5
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecc------ccccHHHHHHHHHHHhcCC--CC-ceeeecceeecCCeeE
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV------FQDGEKEFKNEVIVIGQTH--HK-NLVRLLGFCDEGQNRL 135 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~------~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~ 135 (350)
+.||.|.-..||++...... ..++||+-... .+-..++..-|...|+... -| .+.+++.+ +.....
T Consensus 35 ~eigdGnlN~VfrV~~~~~~---~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~ 109 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKN---ISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNC 109 (409)
T ss_pred eEcCCCceEEEEEEeeCCCC---ceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhh
Confidence 56999999999999863212 34888875321 1233456667777777653 34 34444433 344556
Q ss_pred EEEecCCCC-Chhhhh
Q 046877 136 LAYEFLNNG-TLASFL 150 (350)
Q Consensus 136 lv~e~~~~g-~L~~~l 150 (350)
++||+++.. .|...+
T Consensus 110 ~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 110 CVMEDLSDHTILRTAL 125 (409)
T ss_pred HHHHhCcccHHHHHHH
Confidence 888888542 344443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.047 Score=48.07 Aligned_cols=133 Identities=13% Similarity=0.130 Sum_probs=84.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeec--cc--------------------cccHHHHHHHHHHHhcCCC
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VF--------------------QDGEKEFKNEVIVIGQTHH 118 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~--~~--------------------~~~~~~~~~e~~~l~~l~h 118 (350)
+.+..+||-|--+.+|.+-+.+. ...++|.-.. .+ .-+.-...+|...++.+..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G----~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEG----NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred hhhccccccccccceEEEecCCC----CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 45667899999999999975433 3355554210 00 0001124567777777742
Q ss_pred -C-ceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 046877 119 -K-NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196 (350)
Q Consensus 119 -~-~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~ 196 (350)
- -+.+.+++ +..++|||.+.+-.|...-. ..+.. .+...+..-+.-|. ..|+||+|..-=||+++
T Consensus 170 ~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~---v~d~~---~ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 170 RGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH---VEDPP---TLYDDLMGLIVRLA---NHGLIHGDFNEFNIMVK 236 (465)
T ss_pred cCCCCCCcccc----cceeeHHHhhcccceeeeee---cCChH---HHHHHHHHHHHHHH---HcCceecccchheeEEe
Confidence 2 23334443 45579999999877765432 12222 23444444555666 44999999999999999
Q ss_pred CCCceEEeeccccc
Q 046877 197 DRYNARISDFGLAK 210 (350)
Q Consensus 197 ~~~~~kl~Dfg~~~ 210 (350)
+++.++++||--..
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999996543
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.36 Score=42.54 Aligned_cols=75 Identities=13% Similarity=0.134 Sum_probs=43.7
Q ss_pred CCCccceEEEEEEcC-----CCcceeEEEEEeeecccc-----ccHHHHHHHHHHHhcCC---------C----Cceeee
Q 046877 68 GRGSFGIIYKGVIQT-----TTTSTTAVAVKKLDRVFQ-----DGEKEFKNEVIVIGQTH---------H----KNLVRL 124 (350)
Q Consensus 68 g~G~~g~V~~~~~~~-----~~~~~~~vavk~~~~~~~-----~~~~~~~~e~~~l~~l~---------h----~~iv~~ 124 (350)
|.|-.|.+|++.... .......+.+|....... .....+.+|+...+.+- . ....++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 678889999887744 233456688887642111 11244777776655431 1 123444
Q ss_pred cceeecCCeeEEEEecCC
Q 046877 125 LGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~ 142 (350)
+....+....+||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 444444556789998764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.35 Score=44.40 Aligned_cols=77 Identities=12% Similarity=0.208 Sum_probs=43.0
Q ss_pred ccCCCccceEEEEEEcCCCcc---eeEEEEEeeeccccccHHHHHHHHHHHhcCCCCce-eeecceeecCCeeEEEEecC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTS---TTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL-VRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~---~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 141 (350)
.|..|-...+|++........ .+.|.++..... ....-.-..|+++++.+...++ .++++.+.. +++.||+
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI 131 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV 131 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence 466688889998875433211 122444432211 1111223567888888855444 444555542 5889999
Q ss_pred CCCChh
Q 046877 142 NNGTLA 147 (350)
Q Consensus 142 ~~g~L~ 147 (350)
+|.+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 987664
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.03 Score=45.51 Aligned_cols=32 Identities=19% Similarity=0.195 Sum_probs=27.0
Q ss_pred CCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 181 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.-.+|+|+.|.|+++++++ ++++||+.+....
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gD 108 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGDGD 108 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccCCC
Confidence 3569999999999998877 9999999886443
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.046 Score=48.14 Aligned_cols=55 Identities=29% Similarity=0.520 Sum_probs=36.9
Q ss_pred hHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCeEEcCCCc------------------eEEeecccccccc
Q 046877 159 NLRTNIAFQIARVLLYL-HEDCSSQIIHCDIKPQNILLNDRYN------------------ARISDFGLAKLLT 213 (350)
Q Consensus 159 ~~~~~~~~~i~~~l~~L-h~~~~~~i~H~dlkp~Nill~~~~~------------------~kl~Dfg~~~~~~ 213 (350)
+-++.+..|++...-.. .-.+..+.+|.||||+|||+-++.. ++|.||.+++..+
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 352 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVAN 352 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHcc
Confidence 44566778887665344 3333668999999999999954331 4567777776543
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.61 Score=39.22 Aligned_cols=74 Identities=18% Similarity=0.196 Sum_probs=47.7
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC---CCCceeeecceeecCCeeEEEEecCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT---HHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
.+.-|..-..|...+ +. ..+-+|.-. ......|..|+.-|+.+ +.-++.+.+.+-...++.|+|+||++
T Consensus 23 ~v~gG~inea~~v~d---g~--~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 23 EVSGGDINEAWRLRD---GT--DPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred ccCCccccceeEeec---CC--cceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 344455555555442 22 235666532 22345678888777766 34567778888888999999999998
Q ss_pred CCChh
Q 046877 143 NGTLA 147 (350)
Q Consensus 143 ~g~L~ 147 (350)
.+.+.
T Consensus 95 ~~~~d 99 (286)
T COG3001 95 TGPLD 99 (286)
T ss_pred CCCCC
Confidence 87664
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.67 E-value=0.081 Score=46.89 Aligned_cols=55 Identities=29% Similarity=0.532 Sum_probs=35.4
Q ss_pred HHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEcCCC------------------ceEEeeccccccccc
Q 046877 160 LRTNIAFQIARVLLYLHED-CSSQIIHCDIKPQNILLNDRY------------------NARISDFGLAKLLTL 214 (350)
Q Consensus 160 ~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dlkp~Nill~~~~------------------~~kl~Dfg~~~~~~~ 214 (350)
-++.+..|++.-.--.-+. +..+.+|.||||+|||+-++. .++|.||.+++..+-
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~i 349 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVANI 349 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhccc
Confidence 3455666775543223222 356899999999999994432 257788888775543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.14 Score=44.49 Aligned_cols=31 Identities=32% Similarity=0.423 Sum_probs=27.9
Q ss_pred CeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 182 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
-++|+|+.|+|++.++.+.++|+||..|...
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN 184 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence 5899999999999999999999999887643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 350 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-50 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-37 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-18 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-18 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-18 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-18 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-18 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-18 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-18 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-18 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-18 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-18 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-18 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-18 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-18 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 352 bits (906), Expect = e-121
Identities = 116/295 (39%), Positives = 176/295 (59%), Gaps = 16/295 (5%)
Query: 49 RCFSYKELEEATDNFKEE--VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR-VFQDGEKE 105
+ FS +EL+ A+DNF + +GRG FG +YKG + T VAVK+L Q GE +
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL----VAVKRLKEERTQGGELQ 73
Query: 106 FKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP----NWNLR 161
F+ EV +I H+NL+RL GFC RLL Y ++ NG++AS L + +W R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 162 TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT-I 220
IA AR L YLH+ C +IIH D+K NILL++ + A + DFGLAKL ++ + T +
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDTHV 191
Query: 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDI--EMGEEYAILTDW 278
TA+RGT G++APE+ S K DV+ +GV+LLE+I+ +++FD+ ++ +L DW
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333
+ KL+ LV+ D++ + VE+L+ +++ C Q P RP M +V +ML
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 331 bits (852), Expect = e-113
Identities = 99/309 (32%), Positives = 162/309 (52%), Gaps = 13/309 (4%)
Query: 38 SPGDGTIETKSRCFSYKELEEATDNFKEE--VGRGSFGIIYKGVIQTTTTSTTAVAVKKL 95
+ +S +LEEAT+NF + +G G FG +YKGV++ VA+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRR 71
Query: 96 DRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLK 155
G +EF+ E+ + H +LV L+GFCDE +L Y+++ NG L L+G+
Sbjct: 72 TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 156 P----NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211
P +W R I AR L YLH IIH D+K NILL++ + +I+DFG++K
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
T + + T ++GT GY+ PE+F K ++ K DVYSFGV+L E++ R + + E
Sbjct: 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331
L +WA + + NG+L+ +V+ ++ + + K ++ C+ RP+M V
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 332 MLQEVVEVD 340
L+ + +
Sbjct: 309 KLEYALRLQ 317
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-109
Identities = 107/309 (34%), Positives = 164/309 (53%), Gaps = 28/309 (9%)
Query: 45 ETKSRCFSYKELEEATDNFKEE--------VGRGSFGIIYKGVIQTTTTSTTAVAVKKLD 96
+T+ FS+ EL+ T+NF E +G G FG++YKG + TT VAVKKL
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-----VAVKKLA 63
Query: 97 RVFQD----GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFG 152
+ +++F E+ V+ + H+NLV LLGF +G + L Y ++ NG+L L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 153 --NLKP-NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209
P +W++R IA A + +LHE+ IH DIK NILL++ + A+ISDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMG 269
+ + + + I GT Y+APE R I+ K D+YSFGV+LLEII+ + D
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 270 EEYAILTDWAFDCYRN-GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRK 328
+ L D + ++D ++ M D VE + ++ C+ E + RP ++K
Sbjct: 240 PQL--LLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 329 VSQMLQEVV 337
V Q+LQE+
Sbjct: 297 VQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 2e-71
Identities = 73/320 (22%), Positives = 123/320 (38%), Gaps = 33/320 (10%)
Query: 46 TKSRCFSYKELEEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG- 102
+ + L + + E RG FG ++K + VAVK QD
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-----VAVKIFPI--QDKQ 61
Query: 103 EKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN----RLLAYEFLNNGTLASFLFGNLKPNW 158
+ + EV + H+N+++ +G G + L F G+L+ FL N +W
Sbjct: 62 SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSW 120
Query: 159 NLRTNIAFQIARVLLYLHEDCSSQ-------IIHCDIKPQNILLNDRYNARISDFGLAKL 211
N +IA +AR L YLHED I H DIK +N+LL + A I+DFGLA
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 212 LTLNQRKTIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDI 266
+ GT+ Y+APE + ++D+Y+ G++L E+ S + D
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 267 EMGEEYAILTDWAFDCYRNGKLDDLVEGDM------EAMNDIKCVEKLLMISIWCIQEDP 320
+ E + + ++V + + L C D
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 321 SLRPTMRKVSQMLQEVVEVD 340
R + V + + ++ +
Sbjct: 301 EARLSAGCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-60
Identities = 71/302 (23%), Positives = 136/302 (45%), Gaps = 34/302 (11%)
Query: 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL--DRVFQDGEKEFKNEV 110
+ +L KE++G GSFG +++ + VAVK L + EF EV
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEWHGSD-----VAVKILMEQDFHAERVNEFLREV 85
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQ 167
++ + H N+V +G + N + E+L+ G+L L + + + R ++A+
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGT 227
+A+ + YLH + I+H ++K N+L++ +Y ++ DFGL++L + + GT
Sbjct: 146 VAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGT 202
Query: 228 KGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287
++APE R + K DVYSFGV+L E+ + ++ + + K
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-NLN-----PAQVVAAVGFKCK 256
Query: 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP-PNPS 346
++ + ++ C +P RP+ + +L+ +++ VP PN S
Sbjct: 257 RLEIPRNLNPQV-------AAIIEG--CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
Query: 347 PF 348
Sbjct: 308 DL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 8e-59
Identities = 79/302 (26%), Positives = 136/302 (45%), Gaps = 42/302 (13%)
Query: 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIV 112
YKE+E +E VGRG+FG++ K + VA+K+++ + K F E+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWRAKD-----VAIKQIES--ESERKAFIVELRQ 54
Query: 113 IGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP---NWNLRTNIAFQIA 169
+ + +H N+V+L G C L E+ G+L + L G + Q +
Sbjct: 55 LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYN-ARISDFGLAKLLTLNQRKTIKTAIRGTK 228
+ + YLH +IH D+KP N+LL +I DFG A + +T T +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSA 167
Query: 229 GYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288
++APE F S S K DV+S+G++L E+I+ RK FD G + I + + +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAVHNGTRP 223
Query: 289 DDLVEGDMEAMNDI--KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNPS 346
+ + + + C +DPS RP+M ++ +++ ++ P
Sbjct: 224 ------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR-YFPGADE 270
Query: 347 PF 348
P
Sbjct: 271 PL 272
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-57
Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 42/296 (14%)
Query: 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL----DRVFQDGEKEFKN 108
+ EL +E +G G FG +Y+ VAVK D + +
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFWIGDE-----VAVKAARHDPDEDISQTIENVRQ 55
Query: 109 EVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI 168
E + H N++ L G C + N L EF G L L G + ++ N A QI
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQI 114
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNAR--------ISDFGLAKLLTLNQRKTI 220
AR + YLH++ IIH D+K NIL+ + I+DFGLA+ +T
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTT 170
Query: 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 280
K + G ++APE R S S DV+S+GVLL E+++ F + + A+ A
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-GI-DGLAVAYGVAM 228
Query: 281 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336
+ + + C E + C DP RP+ + L +
Sbjct: 229 NKLA-----------LPIPST--CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-57
Identities = 72/311 (23%), Positives = 124/311 (39%), Gaps = 38/311 (12%)
Query: 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVI 113
+ + E +G+G FG K + T + +K+L R ++ ++ F EV V+
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGE---VMVMKELIRFDEETQRTFLKEVKVM 61
Query: 114 GQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVL 172
H N+++ +G + + E++ GTL + W+ R + A IA +
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR------------KTI 220
YLH S IIH D+ N L+ + N ++DFGLA+L+ + +
Sbjct: 122 AYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWA 279
+ + G ++APE + KVDV+SFG++L EII + D L
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 280 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV--- 336
F + C I++ C DP RP+ K+ L+ +
Sbjct: 239 F--LD-----------RYCPPN--CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
Query: 337 VEVDVPPNPSP 347
+ +P P
Sbjct: 284 LAGHLPLGPQL 294
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-57
Identities = 80/349 (22%), Positives = 126/349 (36%), Gaps = 75/349 (21%)
Query: 51 FSYKELEEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN 108
+ E DN K E +GRG +G +YKG + VAVK + F N
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-----VAVKVFS---FANRQNFIN 54
Query: 109 EVIV--IGQTHHKNLVRLLGFCDEG-----QNRLLAYEFLNNGTLASFLFGNLKPNWNLR 161
E + + H N+ R + + LL E+ NG+L +L + +W
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSS 113
Query: 162 TNIAFQIARVLLYLHEDCSS------QIIHCDIKPQNILLNDRYNARISDFGLAKLLT-- 213
+A + R L YLH + I H D+ +N+L+ + ISDFGL+ LT
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 214 ----LNQRKTIKTAIRGTKGYVAPEWFRKS-------TISAKVDVYSFGVLLLEIIS-CR 261
+ + GT Y+APE + + +VD+Y+ G++ EI C
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 262 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL----------- 308
F E EY + AF V E M + EK
Sbjct: 234 DLFPGESVPEYQM----AF--------QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN 281
Query: 309 ---------LMISIWCIQEDPSLRPTMRKVSQMLQEVV-EVDVPPNPSP 347
+ C +D R T + + + E++ + + SP
Sbjct: 282 SLAVRSLKETIED--CWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-54
Identities = 72/313 (23%), Positives = 132/313 (42%), Gaps = 46/313 (14%)
Query: 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL--DRVFQDGEKEFKNEV 110
+++LE E +G+G FG +Y G VA++ + +R +D K FK EV
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREV 80
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIA 169
+ QT H+N+V +G C + + TL S + + + N IA +I
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRG 226
+ + YLH + I+H D+K +N+ ++ I+DFGL + + Q R+ G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 227 TKGYVAPEWFRKSTI---------SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 277
++APE R+ + S DV++ G + E+ + F E I
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAII--- 252
Query: 278 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337
+ K + ++ I +++ I ++C + RPT K+ ML+++
Sbjct: 253 --WQMGTGMKPN---------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301
Query: 338 EVDV-PPNPSPFS 349
+ + +P F
Sbjct: 302 KRNRRLSHPGHFW 314
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-54
Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 27/279 (9%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL--DRVFQDGEKEFKNEVIVIGQTHHKN 120
+ +G GSFG +YKG VAVK L + FKNEV V+ +T H N
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
++ +G+ + ++ +L L K +IA Q AR + YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR-- 237
+ IIH D+K NI L++ +I DFGLA + + G+ ++APE R
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 238 -KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296
+ S + DVY+FG++L E+++ + + + I+ R DL +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII--EMVG--RGSLSPDLSKVRS 252
Query: 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
C +++ + C+++ RP+ ++ ++E
Sbjct: 253 N------CPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-53
Identities = 69/298 (23%), Positives = 127/298 (42%), Gaps = 44/298 (14%)
Query: 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE-------KE 105
E+E +++++G+G FG+++KG + + VA+K L +GE +E
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSV---VAIKSLILGDSEGETEMIEKFQE 69
Query: 106 FKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNI 164
F+ EV ++ +H N+V+L G + EF+ G L L P W+++ +
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILL-----NDRYNARISDFGLAKLLTLNQRKT 219
IA + Y+ + + I+H D++ NI L N A+++DFGL++
Sbjct: 128 MLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----H 181
Query: 220 IKTAIRGTKGYVAPEWF--RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 277
+ + G ++APE + + + K D YSF ++L I++ FD + +
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241
Query: 278 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
+ R +D C +L + C DP RP + + L E
Sbjct: 242 IREEGLRPTIPED-------------CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 4e-52
Identities = 55/292 (18%), Positives = 104/292 (35%), Gaps = 42/292 (14%)
Query: 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL--DRVFQDGEKEFKNEV 110
+K+L F ++ G ++KG Q + VK L ++F E
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRWQGND-----IVVKVLKVRDWSTRKSRDFNEEC 58
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAY--EFLNNGTLASFL--FGNLKPNWNLRTNIAF 166
+ H N++ +LG C ++ G+L + L N + + A
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG 226
+AR + +LH I + +++++++ ARIS +
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMY 170
Query: 227 TKGYVAPEWFRKS---TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 283
+VAPE +K T D++SF VLL E+++ F ++ I A +
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DL-SNMEIGMKVALEGL 228
Query: 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
R + + C+ EDP+ RP + +L++
Sbjct: 229 R-----------PTIPPG--ISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-47
Identities = 73/313 (23%), Positives = 120/313 (38%), Gaps = 65/313 (20%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNE--VIVIGQTHHKN 120
E VG+G +G +++G Q VAVK +D EK + E + H+N
Sbjct: 12 LLECVGKGRYGEVWRGSWQGEN-----VAVKIFSS--RD-EKSWFRETELYNTVMLRHEN 63
Query: 121 LVRLLGFCDEGQNRLLAY----EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
++ + ++ + G+L +L + I IA L +LH
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLH 122
Query: 177 EDCSSQ-----IIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKG 229
+ I H D+K +NIL+ I+D GLA + + NQ GTK
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 230 YVAPEWFRKSTISA------KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 283
Y+APE ++ +VD+++FG++L E+ S I E+Y F
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV--EDYKP----PF--- 233
Query: 284 RNGKLDDLVEGD--MEAMNDIKCVEKL-------------------LMISIWCIQEDPSL 322
D+V D E M + CV++ LM W ++PS
Sbjct: 234 -----YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW--YQNPSA 286
Query: 323 RPTMRKVSQMLQE 335
R T ++ + L +
Sbjct: 287 RLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-45
Identities = 58/306 (18%), Positives = 106/306 (34%), Gaps = 51/306 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNE--VIVIGQTHHKN 120
+E +G+G FG +++G + VAVK E+ + E + H+N
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEE-----VAVKIFS---SREERSWFREAEIYQTVMLRHEN 97
Query: 121 LVRLLGFCDEGQNRLLAY----EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
++ + ++ ++ +G+L +L +A A L +LH
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLH 156
Query: 177 EDCSSQ-----IIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKG 229
+ I H D+K +NIL+ I+D GLA + GTK
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 230 YVAPEWFRKSTISA------KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 283
Y+APE S + D+Y+ G++ EI I E+Y + Y
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH--EDYQL-------PY 267
Query: 284 RNGKLDDLVEGDM--------------EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ D +M + + + I C + + R T ++
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327
Query: 330 SQMLQE 335
+ L +
Sbjct: 328 KKTLSQ 333
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-45
Identities = 65/309 (21%), Positives = 116/309 (37%), Gaps = 51/309 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNE--VIVIGQTHHKN 120
+++G+G +G ++ G + VAVK + E + E + H+N
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEK-----VAVKVFFT--TE-EASWFRETEIYQTVLMRHEN 92
Query: 121 LVRLLGFCDEGQNRLLAY----EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
++ + +G ++ NG+L +L + + +A+ L +LH
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 177 EDCSSQ-----IIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKG 229
+ S I H D+K +NIL+ I+D GLA N+ GTK
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 230 YVAPE------WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 283
Y+ PE D+YSFG++L E+ S I EEY + Y
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI--VEEYQL-------PY 262
Query: 284 RNGKLDDLVEGDMEAM--------------NDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ D DM + + +C+ ++ + C +P+ R T +V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 330 SQMLQEVVE 338
+ L ++ E
Sbjct: 323 KKTLAKMSE 331
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 41/287 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNL 121
E++GRG+FG ++ G ++ T VAVK + + D + +F E ++ Q H N+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTL---VAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCS 180
VRL+G C + Q + E + G +FL + + A + YL S
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---S 231
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA----IRGTKGYVAPEWF 236
IH D+ +N L+ ++ +ISDFG+++ ++ T APE
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEAL 287
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD 295
S++ DV+SFG+LL E S G Y L+ N + + VE
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSL--------GASPYPNLS--------NQQTREFVEKG 331
Query: 296 --MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ C + + LM W +P RP+ + Q LQ + +
Sbjct: 332 GRLPCPEL--CPDAVFRLMEQCW--AYEPGQRPSFSTIYQELQSIRK 374
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-40
Identities = 77/297 (25%), Positives = 132/297 (44%), Gaps = 29/297 (9%)
Query: 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTST-TAVAVKKLDRVFQDGEKEFKNEVIV 112
EE + ++G+G+FG + +T VAVK+L D +++F+ E+ +
Sbjct: 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 113 IGQTHHKNLVRLLGFC--DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQI 168
+ H +V+ G Q+ L E+L +G L FL + + + + QI
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQI 136
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ-----RKTIKTA 223
+ + YL S + +H D+ +NIL+ + +I+DFGLAKLL L++ R+ ++
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 282
I APE + S + DV+SFGV+L E+ + C KS E+ + D
Sbjct: 194 IFWY----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC--SPSAEFLRMMGCERDV 247
Query: 283 YRNGKLDDLVEGD--MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQE 335
+L +L+E + A C ++ LM W P RP+ + L
Sbjct: 248 PALSRLLELLEEGQRLPAPPA--CPAEVHELMKLCW--APSPQDRPSFSALGPQLDM 300
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 39/285 (13%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
K ++G G +G +Y+GV + + + VAVK L + +EF E V+ + H NLV
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCS 180
+LLG C + EF+ G L +L + + +A QI+ + YL
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---K 336
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWFR 237
IH ++ +N L+ + + +++DFGL++L+T + K I+ T APE
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLA 392
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD-- 295
+ S K DV++FGVLL EI + S Y + ++ +L+E D
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMS-------PYPGID--------LSQVYELLEKDYR 437
Query: 296 MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
ME C EK+ LM + W Q +PS RP+ ++ Q + + +
Sbjct: 438 MERPEG--CPEKVYELMRACW--QWNPSDRPSFAEIHQAFETMFQ 478
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 71/318 (22%), Positives = 137/318 (43%), Gaps = 26/318 (8%)
Query: 35 IRNSPGDGTIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTST-TAVAVK 93
N G + + + EE F +++G+G+FG + +T VAVK
Sbjct: 17 TENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76
Query: 94 KLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFC--DEGQNRLLAYEFLNNGTLASFLF 151
KL ++ ++F+ E+ ++ H N+V+ G C +N L E+L G+L +L
Sbjct: 77 KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136
Query: 152 GNLKPNWNLRT--NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209
+ K + QI + + YL + + IH D+ +NIL+ + +I DFGL
Sbjct: 137 KH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 192
Query: 210 KLLTLNQRKTIKTA-----IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
K+L ++ I APE +S S DV+SFGV+L E+ + +
Sbjct: 193 KVLPQDKEYYKVKEPGESPIFWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKS 248
Query: 265 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--LMISIWCIQEDP 320
E ++ + L +L++ + + + C +++ +M W +
Sbjct: 249 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDG--CPDEIYMIMTECW--NNNV 304
Query: 321 SLRPTMRKVSQMLQEVVE 338
+ RP+ R ++ + ++ +
Sbjct: 305 NQRPSFRDLALRVDQIRD 322
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-39
Identities = 69/296 (23%), Positives = 134/296 (45%), Gaps = 22/296 (7%)
Query: 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTST-TAVAVKKLDRVFQDGEKEFKNEVIVI 113
+ EE F +++G+G+FG + +T VAVKKL ++ ++F+ E+ ++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 114 GQTHHKNLVRLLGFC--DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIA 169
H N+V+ G C +N L E+L G+L +L + K + QI
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQIC 124
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
+ + YL + + IH D+ +NIL+ + +I DFGL K+L + K +
Sbjct: 125 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEFFKVKEPGES 179
Query: 230 YV---APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 286
+ APE +S S DV+SFGV+L E+ + + E ++ +
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 287 KLDDLVEGD--MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
L +L++ + + + C +++ +M W + + RP+ R ++ + ++ +
Sbjct: 240 HLIELLKNNGRLPRPDG--CPDEIYMIMTECW--NNNVNQRPSFRDLALRVDQIRD 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVK--KLDRVFQDGEKEFKNEVIVIGQTHHKN 120
F E+GRGSF +YKG+ TT VA + ++ + + FK E ++ H N
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTV---EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 121 LVRLLGFC---DEGQNRLLAY-EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
+VR +G+ ++ E + +GTL ++L + + QI + L +LH
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 177 EDCSSQIIHCDIKPQNILLNDRY-NARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
+ IIH D+K NI + + +I D GLA L + K + GT ++APE
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEM 201
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSF-DIE-MGEEYAILTDWAFDCYRNGKLDDLVE 293
+ + VDVY+FG+ +LE+ + + + + + Y +T + D +
Sbjct: 202 Y-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV----KPASFDKVA- 255
Query: 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
E I+ CI+++ R + + +L
Sbjct: 256 -IPEVKEIIE----------GCIRQNKDERYS---IKDLLN 282
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-38
Identities = 73/322 (22%), Positives = 136/322 (42%), Gaps = 45/322 (13%)
Query: 42 GTIETKSRCFSYK---ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTST-TAVAVKKL-D 96
G I ++ + + E+ ++G G FG + +T VAVK L
Sbjct: 1 GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60
Query: 97 RVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFC--DEGQNRLLAYEFLNNGTLASFLFGNL 154
+ + K E+ ++ +H+N+V+ G C D G L EFL +G+L +L N
Sbjct: 61 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN- 119
Query: 155 KPNWNLRT--NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212
K NL+ A QI + + YL S Q +H D+ +N+L+ + +I DFGL K +
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176
Query: 213 TLNQ-----RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-------C 260
++ + + + APE +S DV+SFGV L E+++
Sbjct: 177 ETDKEYYTVKDDRDSPVFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232
Query: 261 RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--LMISIWCI 316
F +G + +T +L + ++ + + C +++ LM W
Sbjct: 233 MALFLKMIGPTHGQMT--------VTRLVNTLKEGKRLPCPPN--CPDEVYQLMRKCW-- 280
Query: 317 QEDPSLRPTMRKVSQMLQEVVE 338
+ PS R + + + + + +++
Sbjct: 281 EFQPSNRTSFQNLIEGFEALLK 302
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 77/289 (26%), Positives = 129/289 (44%), Gaps = 41/289 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+ ++G+G FG ++ G TT VA+K L + + F E V+ + H+ LV
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTR----VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCS 180
+L E + + E+++ G+L FL G L ++A QIA + Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 381
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWFR 237
+H D++ NIL+ + +++DFGLA+L+ N+ R+ K I+ T APE
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAAL 437
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD-- 295
+ K DV+SFG+LL E+ + + Y + N ++ D VE
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV--------NREVLDQVERGYR 482
Query: 296 MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342
M + C E L LM W +++P RPT + L++ P
Sbjct: 483 MPCPPE--CPESLHDLMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-38
Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 51/290 (17%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--EKEFKNEVIVIGQTHHKN 120
+ +G+G FG + G + VAVK + ++ + F E V+ Q H N
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK-----VAVKCI----KNDATAQAFLAEASVMTQLRHSN 247
Query: 121 LVRLLGFCDEGQNRLLAY---EFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYL 175
LV+LLG E + L Y E++ G+L +L + + + + YL
Sbjct: 248 LVQLLGVIVEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
+ +H D+ +N+L+++ A++SDFGL K + Q K ++ T APE
Sbjct: 306 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEA 357
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 294
R+ S K DV+SFG+LL EI S G Y + + VE
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSF--------GRVPYPRIP--------LKDVVPRVEK 401
Query: 295 D--MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340
M+A + C + +M + W D + RPT ++ + L+ + +
Sbjct: 402 GYKMDAPDG--CPPAVYDVMKNCW--HLDAATRPTFLQLREQLEHIRTHE 447
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 78/289 (26%), Positives = 128/289 (44%), Gaps = 41/289 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+ ++G+G FG ++ G TT VA+K L E F E V+ + H+ LV
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTR----VAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLV 242
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCS 180
+L E + + E+++ G+L FL G L ++A QIA + Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 298
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWFR 237
+H D++ NIL+ + +++DFGLA+L+ N+ R+ K I+ T APE
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAAL 354
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD-- 295
+ K DV+SFG+LL E+ + + Y + N ++ D VE
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV--------NREVLDQVERGYR 399
Query: 296 MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342
M + C E L LM W +++P RPT + L++ P
Sbjct: 400 MPCPPE--CPESLHDLMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 70/295 (23%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIV 112
+E+E + + ++ +G G G + G ++ VA+K L + + ++ +F +E +
Sbjct: 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 113 IGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIAR 170
+GQ H N++RL G G+ ++ E++ NG+L +FL + + + + +
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGA 162
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGY 230
+ YL +H D+ +N+L++ ++SDFGL+++L + T G K
Sbjct: 163 GMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT--TGGKIP 217
Query: 231 V---APE--WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYR 284
+ APE FR + DV+SFGV++ E+++ GE Y +T
Sbjct: 218 IRWTAPEAIAFRTFSS--ASDVWSFGVVMWEVLAY--------GERPYWNMT-------- 259
Query: 285 NGKLDDLVEGD--MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQE 335
N + VE + A C L LM+ W +D + RP ++ +L
Sbjct: 260 NRDVISSVEEGYRLPAPMG--CPHALHQLMLDCW--HKDRAQRPRFSQIVSVLDA 310
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 71/306 (23%), Positives = 120/306 (39%), Gaps = 28/306 (9%)
Query: 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTST-TAVAVKKLDRVFQDGE-KEFKNEVIV 112
+ ++G G FG + T T VAVK L +K E+ +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 113 IGQTHHKNLVRLLGFC--DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR 170
+ +H+++++ G C + L E++ G+L +L + A QI
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICE 145
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTA--IR 225
+ YLH + IH D+ +N+LL++ +I DFGLAK + R +
Sbjct: 146 GMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 284
APE ++ DV+SFGV L E+++ C S I
Sbjct: 203 WY----APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA--QGQMT 256
Query: 285 NGKLDDLVE--GDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340
+L +L+E + + C ++ LM + W + + S RPT + +L+ V E
Sbjct: 257 VLRLTELLERGERLPRPDK--CPAEVYHLMKNCW--ETEASFRPTFENLIPILKTVHEKY 312
Query: 341 VPPNPS 346
PS
Sbjct: 313 QGQAPS 318
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 66/299 (22%), Positives = 128/299 (42%), Gaps = 41/299 (13%)
Query: 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIV 112
+F E +GRG FG +Y G + AVK L+R+ GE +F E I+
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 113 IGQTHHKNLVRLLGFCDEGQN-RLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIA 169
+ H N++ LLG C + L+ ++ +G L +F+ N ++ Q+A
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVA 138
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL------TLNQRKTIKTA 223
+ + YL S + +H D+ +N +L++++ +++DFGLA+ + +++ + K
Sbjct: 139 KGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFD 281
++ A E + + K DV+SFGVLL E+++ G Y + +
Sbjct: 196 VKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFDITV 243
Query: 282 CYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
G+ + C + L +M+ W +RP+ ++ + +
Sbjct: 244 YLLQGRR-------LLQPEY--CPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 291
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-37
Identities = 74/295 (25%), Positives = 120/295 (40%), Gaps = 45/295 (15%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL---DRVFQDGEKEFKNEVIVIGQTHHK 119
E++G GSFG++ +G + T +VAVK L + +F EV + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHE 177
NL+RL G + E G+L L + + ++ L T A Q+A + YL
Sbjct: 82 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE- 138
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ-----RKTIKTAIRGTKGYVA 232
S + IH D+ +N+LL R +I DFGL + L N ++ K A
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----A 192
Query: 233 PEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDL 291
PE + T S D + FGV L E+ + G+E + L ++
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTY--------GQEPWIGLN--------GSQILHK 236
Query: 292 VEGD---MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDV 341
++ + + D C + + +M+ W P RPT + L E D+
Sbjct: 237 IDKEGERLPRPED--CPQDIYNVMVQCW--AHKPEDRPTFVALRDFLLEAQPTDM 287
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
++++G G FG ++ T VAVK + + + F E V+ H LV
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTK----VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCS 180
+L + + + EF+ G+L FL + L + + QIA + ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 302
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWFR 237
IH D++ NIL++ +I+DFGLA+++ N+ R+ K I+ T APE
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAIN 358
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 295
+ + K DV+SFG+LL+EI++ G Y ++ N ++ +E
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTY--------GRIPYPGMS--------NPEVIRALERGY 402
Query: 296 -MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQE 335
M + C E+L +M+ W + P RPT + +L +
Sbjct: 403 RMPRPEN--CPEELYNIMMRCW--KNRPEERPTFEYIQSVLDD 441
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 66/300 (22%), Positives = 126/300 (42%), Gaps = 41/300 (13%)
Query: 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVI 111
+F E +GRG FG +Y G + AVK L+R+ GE +F E I
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 112 VIGQTHHKNLVRLLGFCDEGQN-RLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQI 168
++ H N++ LLG C + L+ ++ +G L +F+ N ++ Q+
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQV 201
Query: 169 ARVLLYLHEDCSSQ-IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGT 227
A+ + +L +S+ +H D+ +N +L++++ +++DFGLA+ + K + T
Sbjct: 202 AKGMKFL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKT 254
Query: 228 KGYV-----APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AF 280
+ A E + + K DV+SFGVLL E+++ G Y + +
Sbjct: 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFDIT 306
Query: 281 DCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
G+ + C + L +M+ W +RP+ ++ + +
Sbjct: 307 VYLLQGRR-------LLQPEY--CPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 355
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-36
Identities = 66/288 (22%), Positives = 123/288 (42%), Gaps = 43/288 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+E+G G FG++ G + VAVK + E EF E + + H LV
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYD----VAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLV 66
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCS 180
+ G C + + E+++NG L ++L + + + + + +L S
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE---S 122
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWFR 237
Q IH D+ +N L++ ++SDFG+ + + +Q K ++ + APE F
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFH 178
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 295
S+K DV++FG+L+ E+ S +G+ Y + T N ++ V
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS--------LGKMPYDLYT--------NSEVVLKVSQGH 222
Query: 296 -MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340
+ + + + +M S W E P RPT +++ ++ + E D
Sbjct: 223 RLYRPHL--ASDTIYQIMYSCW--HELPEKRPTFQQLLSSIEPLREKD 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 74/296 (25%), Positives = 137/296 (46%), Gaps = 37/296 (12%)
Query: 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIV 112
KEL+ + + VG G FG + G ++ + +VA+K L + + ++ +F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 113 IGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIAR 170
+GQ H N++RL G + + ++ E++ NG+L SFL + + + + IA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIAS 158
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGY 230
+ YL +H D+ +NIL+N ++SDFGL ++L + T RG K
Sbjct: 159 GMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT--RGGKIP 213
Query: 231 V---APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNG 286
+ +PE ++ DV+S+G++L E++S GE Y ++ N
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPYWEMS--------NQ 257
Query: 287 KLDDLVEGD--MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ V+ + D C L LM+ W Q+D + RP ++ +L +++
Sbjct: 258 DVIKAVDEGYRLPPPMD--CPAALYQLMLDCW--QKDRNNRPKFEQIVSILDKLIR 309
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 43/286 (15%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
F +E+G G FG+++ G VA+K + R E++F E V+ + H LV
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDK----VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCS 180
+L G C E L EF+ +G L+ +L + + T + + + YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWFR 237
+ +IH D+ +N L+ + ++SDFG+ + + +Q K ++ +PE F
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFS 178
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 295
S S+K DV+SFGVL+ E+ S G+ Y + N ++ + +
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS--------EGKIPYENRS--------NSEVVEDISTGF 222
Query: 296 -MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ + +M W +E P RP ++ + L E+ E
Sbjct: 223 RLYKPRL--ASTHVYQIMNHCW--RERPEDRPAFSRLLRQLAEIAE 264
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 65/289 (22%), Positives = 120/289 (41%), Gaps = 42/289 (14%)
Query: 63 FKEEVGRGSFGIIYKGV-IQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKN 120
+ +G G+FG +YKG+ I VA+K+L + KE +E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHED 178
+ RLLG C L + + G L ++ + K N + N QIA+ + YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN----QRKTIKTAIRGTKGYVAPE 234
+++H D+ +N+L+ + +I+DFGLAKLL + K I+ A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189
Query: 235 WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE 293
+ + DV+S+GV + E+++ G + Y + ++ ++E
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT--------FGSKPYDGIP--------ASEISSILE 233
Query: 294 GD--MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ C + +M W D RP R++ ++
Sbjct: 234 KGERLPQPPI--CTIDVYMIMRKCW--MIDADSRPKFRELIIEFSKMAR 278
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-36
Identities = 70/288 (24%), Positives = 128/288 (44%), Gaps = 43/288 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
F +E+G G FG++ G + VA+K + + E EF E V+ H+ LV
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYD----VAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCS 180
+L G C + + + E++ NG L ++L + + + + + + YL S
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---S 138
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWFR 237
Q +H D+ +N L+ND+ ++SDFGL++ + ++ K +R + PE
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLM 194
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 295
S S+K D+++FGVL+ EI S G+ Y T N + + +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSL--------GKMPYERFT--------NSETAEHIAQGL 238
Query: 296 -MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340
+ + EK+ +M S W E RPT + + + +V++ +
Sbjct: 239 RLYRPHL--ASEKVYTIMYSCW--HEKADERPTFKILLSNILDVMDEE 282
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-36
Identities = 68/302 (22%), Positives = 128/302 (42%), Gaps = 52/302 (17%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN 120
K E+G G+FG ++ + VAVK L K+F+ E ++ H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 164
+V+ G C +G ++ +E++ +G L FL + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RKTIKT 222
A QIA ++YL S +H D+ +N L+ +I DFG+++ + R T
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 223 A--IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW- 278
IR PE + + DV+SFGV+L EI + G++ + L++
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTY--------GKQPWFQLSNTE 243
Query: 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEV 336
+C G++ +E C +++ +M+ W Q +P R ++++ ++L +
Sbjct: 244 VIECITQGRV-------LERPRV--CPKEVYDVMLGCW--QREPQQRLNIKEIYKILHAL 292
Query: 337 VE 338
+
Sbjct: 293 GK 294
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-36
Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 47/286 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--EKEFKNEVIVIGQTHHKN 120
+ +G+G FG + G + VAVK + ++ + F E V+ Q H N
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNK-----VAVKCI----KNDATAQAFLAEASVMTQLRHSN 75
Query: 121 LVRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHE 177
LV+LLG E + L + E++ G+L +L + + + + YL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 134
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
+ +H D+ +N+L+++ A++SDFGL K + Q K ++ T APE R
Sbjct: 135 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALR 187
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 295
+ S K DV+SFG+LL EI S G Y + + VE
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS--------FGRVPYPRIP--------LKDVVPRVEKGY 231
Query: 296 -MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
M+A + C + +M + W D ++RP+ ++ + L+ +
Sbjct: 232 KMDAPDG--CPPAVYEVMKNCW--HLDAAMRPSFLQLREQLEHIKT 273
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 76/301 (25%), Positives = 137/301 (45%), Gaps = 47/301 (15%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHK 119
E+G+GSFG++Y+GV + T VA+K ++ E+ EF NE V+ + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFL------FGNLKPNWNLR----TNIAFQIA 169
++VRLLG +GQ L+ E + G L S+L N +A +IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RKTIKTA--IR 225
+ YL+ +++ +H D+ +N ++ + + +I DFG+ + + RK K +R
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCY 283
+PE + + DV+SFGV+L EI + + E+ Y L++
Sbjct: 206 WM----SPESLKDGVFTTYSDVWSFGVVLWEIAT--------LAEQPYQGLSNEQVLRFV 253
Query: 284 RNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDV 341
G L ++ ++ C + L LM W Q +P +RP+ ++ ++E +E
Sbjct: 254 MEGGL-------LDKPDN--CPDMLFELMRMCW--QYNPKMRPSFLEIISSIKEEMEPGF 302
Query: 342 P 342
Sbjct: 303 R 303
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 81/286 (28%), Positives = 133/286 (46%), Gaps = 41/286 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
K ++G G +G +Y+GV + + + VAVK L + +EF E V+ + H NLV
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCS 180
+LLG C + EF+ G L +L + + +A QI+ + YL
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---K 129
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWFR 237
IH D+ +N L+ + + +++DFGL++L+T + K I+ T APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLA 185
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 295
+ S K DV++FGVLL EI + G Y + ++ +L+E D
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT--------YGMSPYPGID--------LSQVYELLEKDY 229
Query: 296 -MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
ME C EK+ LM + W Q +PS RP+ ++ Q + + +
Sbjct: 230 RMERPEG--CPEKVYELMRACW--QWNPSDRPSFAEIHQAFETMFQ 271
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 62/291 (21%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNL 121
+G+G FG++Y G + A+K L R+ + + F E +++ +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 122 VRLLGFCDEGQNRLLA-YEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHED 178
+ L+G + ++ +G L F+ + N ++ + Q+AR + YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA-- 141
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL------TLNQRKTIKTAIRGTKGYVA 232
+ +H D+ +N +L++ + +++DFGLA+ + ++ Q + + ++ T A
Sbjct: 142 -EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----A 196
Query: 233 PEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDL 291
E + + K DV+SFGVLL E+++ G Y + L
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT--------RGAPPYRHID--------PFDLTHF 240
Query: 292 VE--GDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ + C + L +M W + DP++RPT R + ++++V
Sbjct: 241 LAQGRRLPQPEY--CPDSLYQVMQQCW--EADPAVRPTFRVLVGEVEQIVS 287
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 76/312 (24%), Positives = 126/312 (40%), Gaps = 53/312 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHK 119
+G G+FG +Y+G + S VAVK L V + ++ +F E ++I + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT-------NIAFQIARVL 172
N+VR +G + R + E + G L SFL + ++A IA
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 173 LYLHEDCSSQIIHCDIKPQNILLN---DRYNARISDFGLAKLLTLNQ--RKTIKTA--IR 225
YL + IH DI +N LL A+I DFG+A+ + RK ++
Sbjct: 154 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCY 283
PE F + ++K D +SFGVLL EI S +G Y ++ +
Sbjct: 211 WM----PPEAFMEGIFTSKTDTWSFGVLLWEIFS--------LGYMPYPSKSNQEVLEFV 258
Query: 284 RNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQ------E 335
+G M+ + C + +M W Q P RP + + ++ +
Sbjct: 259 TSGGR-------MDPPKN--CPGPVYRIMTQCW--QHQPEDRPNFAIILERIEYCTQDPD 307
Query: 336 VVEVDVPPNPSP 347
V+ +P P
Sbjct: 308 VINTALPIEYGP 319
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 68/296 (22%), Positives = 128/296 (43%), Gaps = 38/296 (12%)
Query: 54 KELEEATDNFKEEVGRGSFGIIYKGV-IQTTTTSTTAVAVKKLDRVFQDGE-KEFKNEVI 111
+ +E + +G G FG ++KGV I + V +K ++ + + ++
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 112 VIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIA 169
IG H ++VRLLG C G + L ++L G+L + + + + N QIA
Sbjct: 68 AIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIA 125
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN----QRKTIKTAIR 225
+ + YL E ++H ++ +N+LL +++DFG+A LL + KT I+
Sbjct: 126 KGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYR 284
A E + + DV+S+GV + E+++ G E YA L
Sbjct: 183 WM----ALESIHFGKYTHQSDVWSYGVTVWELMTF--------GAEPYAGLR-------- 222
Query: 285 NGKLDDLVEGD--MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
++ DL+E + C + M+ + C D ++RPT ++++ +
Sbjct: 223 LAEVPDLLEKGERLAQPQI--CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 60/298 (20%), Positives = 117/298 (39%), Gaps = 48/298 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVK--KLDRVFQDGEKEFKNEVIVIGQTHHKN 120
+G+G FG + + ++ S VAVK K D + +EF E + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 121 LVRLLGFCDEGQNRLLAY------EFLNNGTLASFLFGNLKPNWNLR------TNIAFQI 168
+ +L+G + + F+ +G L +FL + I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RKTIKTA--I 224
A + YL S IH D+ +N +L + ++DFGL++ + R+ + +
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDC 282
+ A E + + DV++FGV + EI++ G+ YA + + ++
Sbjct: 204 KWL----ALESLADNLYTVHSDVWAFGVTMWEIMT--------RGQTPYAGIENAEIYNY 251
Query: 283 YRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
G ++ + C+E++ LM W DP RP+ + L+ ++
Sbjct: 252 LIGGNR-------LKQPPE--CMEEVYDLMYQCW--SADPKQRPSFTCLRMELENILG 298
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 81/283 (28%), Positives = 129/283 (45%), Gaps = 43/283 (15%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
E +G G FG ++ G T VAVK L + F E ++ Q H+ LV
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTK----VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCS 180
RL + + + E++ NG+L FL + ++A QIA + ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWFR 237
IH D++ NIL++D + +I+DFGLA+L+ N+ R+ K I+ T APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAIN 183
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 295
T + K DV+SFG+LL EI++ G Y +T N ++ +E
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT--------HGRIPYPGMT--------NPEVIQNLERGY 227
Query: 296 -MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQE 335
M ++ C E+L LM W +E P RPT + +L++
Sbjct: 228 RMVRPDN--CPEELYQLMRLCW--KERPEDRPTFDYLRSVLED 266
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-35
Identities = 71/294 (24%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTS-TTAVAVKKLDRVFQDGEK-EFKNEVI 111
E+ + ++ +G G FG +YKG+++T++ VA+K L + + ++ +F E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 98
Query: 112 VIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIA 169
++GQ H N++RL G + + ++ E++ NG L FL +++ + IA
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIA 157
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
+ YL + +H D+ +NIL+N ++SDFGL+++L + T T G K
Sbjct: 158 AGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT--SGGKI 212
Query: 230 YV---APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRN 285
+ APE ++ DV+SFG+++ E+++ GE Y L+ N
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT--------YGERPYWELS--------N 256
Query: 286 GKLDDLVEGD--MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQE 335
++ + + D C + LM+ W Q++ + RP + +L +
Sbjct: 257 HEVMKAINDGFRLPTPMD--CPSAIYQLMMQCW--QQERARRPKFADIVSILDK 306
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-35
Identities = 72/297 (24%), Positives = 128/297 (43%), Gaps = 47/297 (15%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVK--KLDRVFQDGEKEFKNEVIVIGQTHHKN 120
+ +G G FG + +G ++ ++ VAVK KLD Q +EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 121 LVRLLGFCDEGQNRLLAY-----EFLNNGTLASFL----FGNLKPNWNLRT--NIAFQIA 169
++RLLG C E ++ + F+ G L ++L + L+T IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RKTIKTA--IR 225
+ YL + +H D+ +N +L D ++DFGL+K + R+ ++
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCY 283
A E ++K DV++FGV + EI + G Y + + +D
Sbjct: 215 WI----AIESLADRVYTSKSDVWAFGVTMWEIAT--------RGMTPYPGVQNHEMYDYL 262
Query: 284 RNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+G ++ D C+++L +M S W + DP RPT + L++++E
Sbjct: 263 LHGHR-------LKQPED--CLDELYEIMYSCW--RTDPLDRPTFSVLRLQLEKLLE 308
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 40/289 (13%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNL 121
+G G FG +Y+GV VAVK D +++F +E +++ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDC 179
V+L+G +E + + E G L +L N K + + T + QI + + YL
Sbjct: 76 VKLIGIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE--- 130
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWF 236
S +H DI +NIL+ ++ DFGL++ + + I+ +PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE-- 293
+ DV+ F V + EI+S G++ + L N + ++E
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS--------FGKQPFFWLE--------NKDVIGVLEKG 230
Query: 294 GDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340
+ + C L LM W DPS RP ++ L +V +++
Sbjct: 231 DRLPKPDL--CPPVLYTLMTRCW--DYDPSDRPRFTELVCSLSDVYQME 275
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-35
Identities = 71/301 (23%), Positives = 126/301 (41%), Gaps = 51/301 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQ--TTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN 120
K E+G G+FG ++ VAVK L + ++F+ E ++ H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN---------------IA 165
+VR G C EG+ L+ +E++ +G L FL + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RKTIKTA 223
Q+A ++YL +H D+ +N L+ +I DFG+++ + R +T
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 224 --IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-A 279
IR PE + + DV+SFGV+L EI + G++ + L++ A
Sbjct: 222 LPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFT--------YGKQPWYQLSNTEA 269
Query: 280 FDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVV 337
DC G+ +E C ++ +M W Q +P R +++ V LQ +
Sbjct: 270 IDCITQGRE-------LERPRA--CPPEVYAIMRGCW--QREPQQRHSIKDVHARLQALA 318
Query: 338 E 338
+
Sbjct: 319 Q 319
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 40/287 (13%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNL 121
+G G FG +++G+ + AVA+K D + +F E + + Q H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDC 179
V+L+G E + E G L SFL K + +L + A+Q++ L YL
Sbjct: 79 VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--- 133
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ---RKTIKTAIRGTKGYVAPEWF 236
S + +H DI +N+L++ ++ DFGL++ + + K I+ APE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 189
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE-- 293
++ DV+ FGV + EI+ G + + + N + +E
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILM--------HGVKPFQGVK--------NNDVIGRIENG 233
Query: 294 GDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ + C L LM W DPS RP ++ L ++E
Sbjct: 234 ERLPMPPN--CPPTLYSLMTKCW--AYDPSRRPRFTELKAQLSTILE 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 59/302 (19%), Positives = 114/302 (37%), Gaps = 55/302 (18%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FKNEVIVIGQTH 117
+F+ + +GRG FG++++ A+K++ ++ +E EV + +
Sbjct: 5 TDFEPIQCLGRGGFGVVFEA---KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 118 HKNLVRLLG-FCDEGQNRLLAY-----------EFLNNGTLASFLF---GNLKPNWNLRT 162
H +VR + ++ L + L ++ + ++
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 163 NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL---------- 212
+I QIA + +LH S ++H D+KP NI ++ DFGL +
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 272
T T GTK Y++PE ++ S KVD++S G++L E++ F +M
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--- 232
Query: 273 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332
R L D+ + K + +M+ + P RP +
Sbjct: 233 -----------RVRTLTDVRNLKFPPLFTQKYPCEYVMVQ-DMLSPSPMERPE---AINI 277
Query: 333 LQ 334
++
Sbjct: 278 IE 279
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 76/312 (24%), Positives = 125/312 (40%), Gaps = 53/312 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHK 119
+G G+FG +Y+G + S VAVK L V + ++ +F E ++I + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT-------NIAFQIARVL 172
N+VR +G + R + E + G L SFL + ++A IA
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNAR---ISDFGLAKLLTLNQ--RKTIKTA--IR 225
YL + IH DI +N LL R I DFG+A+ + RK ++
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCY 283
PE F + ++K D +SFGVLL EI S +G Y ++ +
Sbjct: 252 WM----PPEAFMEGIFTSKTDTWSFGVLLWEIFS--------LGYMPYPSKSNQEVLEFV 299
Query: 284 RNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQ------E 335
+G M+ + C + +M W Q P RP + + ++ +
Sbjct: 300 TSGGR-------MDPPKN--CPGPVYRIMTQCW--QHQPEDRPNFAIILERIEYCTQDPD 348
Query: 336 VVEVDVPPNPSP 347
V+ +P P
Sbjct: 349 VINTALPIEYGP 360
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 66/287 (22%), Positives = 121/287 (42%), Gaps = 38/287 (13%)
Query: 63 FKEEVGRGSFGIIYKGV-IQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKN 120
+ +G G+FG +YKG+ I VA+K+L + KE +E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHED 178
+ RLLG C L + + G L ++ + K N + N QIA+ + YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN----QRKTIKTAIRGTKGYVAPE 234
+++H D+ +N+L+ + +I+DFGLAKLL + K I+ A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189
Query: 235 WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE 293
+ + DV+S+GV + E+++ G + Y + ++ ++E
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT--------FGSKPYDGIP--------ASEISSILE 233
Query: 294 GD--MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ C + MI + C D RP R++ ++
Sbjct: 234 KGERLPQPPI--CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 69/307 (22%), Positives = 124/307 (40%), Gaps = 58/307 (18%)
Query: 63 FKEEVGRGSFGIIYKGVIQTT----TTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHH 118
F E +G+G+F I+KGV + T V +K LD+ ++ + F ++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARVLLYL 175
K+LV G C G +L EF+ G+L ++L N + W L +A Q+A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFL 129
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNAR--------ISDFGLAKLLTLNQ--RKTIKTAIR 225
+ +IH ++ +NILL + + +SD G++ + ++ I
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP---- 182
Query: 226 GTKGYVAPE---WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFD 281
+V PE + + D +SFG L EI S G++ + L
Sbjct: 183 ----WVPPECIENPKNLNL--ATDKWSFGTTLWEICS--------GGDKPLSALD----- 223
Query: 282 CYRNGKLDDLVEGD--MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339
+ + E + A L+ + +P RP+ R + + L +
Sbjct: 224 ---SQRKLQFYEDRHQLPAPKA--AELANLINNCM--DYEPDHRPSFRAIIRDLNSLFTP 276
Query: 340 DVPPNPS 346
D+ P S
Sbjct: 277 DLVPRGS 283
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 77/280 (27%), Positives = 118/280 (42%), Gaps = 37/280 (13%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVK--KLDRVFQDGEKEFKNEVIVIGQTHHKNLVR 123
E+G G+FG + KG Q VAVK K + + E E V+ Q + +VR
Sbjct: 24 ELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
++G C E ++ +L E G L +L N + Q++ + YL E S
Sbjct: 83 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-E--ESNF 138
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV---APEWFRKST 240
+H D+ +N+LL ++ A+ISDFGL+K L ++ A K V APE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVKWYAPECINYYK 196
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD--ME 297
S+K DV+SFGVL+ E S G++ Y + ++ ++E M
Sbjct: 197 FSSKSDVWSFGVLMWEAFSY--------GQKPYRGMK--------GSEVTAMLEKGERMG 240
Query: 298 AMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQE 335
C ++ LM W D RP V L+
Sbjct: 241 CPAG--CPREMYDLMNLCW--TYDVENRPGFAAVELRLRN 276
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 39/281 (13%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV-IVIGQTHHKN 120
K+ +G G+ G I + VAVK++ EV ++ H N
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNR----DVAVKRILPEC---FSFADREVQLLRESDEHPN 79
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT-NIAFQIARVLLYLHEDC 179
++R + Q + +A E L TL ++ + L + Q L +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH--- 135
Query: 180 SSQIIHCDIKPQNILL-----NDRYNARISDFGLAKLLTLNQRKTIKTA-IRGTKGYVAP 233
S I+H D+KP NIL+ + + A ISDFGL K L + + + + + GT+G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 234 EWFRKSTI---SAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNGKL 288
E + + VD++S G + +IS + +L + DC L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-----L 250
Query: 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
D+ A I+ I DP RP+ + V
Sbjct: 251 HPEKHEDVIARELIE----------KMIAMDPQKRPSAKHV 281
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-34
Identities = 68/312 (21%), Positives = 124/312 (39%), Gaps = 56/312 (17%)
Query: 63 FKEEVGRGSFGIIYKG----VIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQ-T 116
+ +G G+FG + + + VAVK L + + + +E+ ++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN------------- 163
HKN++ LLG C + + E+ + G L +L P +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 164 ---IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RK 218
+Q+AR + YL S + IH D+ +N+L+ + +I+DFGLA+ + +K
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 219 TIKTA--IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAI 274
T ++ APE + + DV+SFGVL+ EI + +G I
Sbjct: 216 TTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGI 263
Query: 275 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQM 332
+ F + G M+ + C +L +M W PS RPT +++ +
Sbjct: 264 PVEELFKLLKEGHR-------MDKPAN--CTNELYMMMRDCW--HAVPSQRPTFKQLVED 312
Query: 333 LQEVVEVDVPPN 344
L ++ +
Sbjct: 313 LDRILTLTTNEE 324
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 58/283 (20%), Positives = 111/283 (39%), Gaps = 34/283 (12%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---FKNEVIVIGQ 115
NF+ +++GRG F +Y+ VA+KK+ K E+ ++ Q
Sbjct: 32 ANFRIEKKIGRGQFSEVYR-AACLLDGVP--VALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARV 171
+H N+++ E + E + G L+ + K + Q+
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKG 229
L ++H S +++H DIKP N+ + ++ D GL + ++ GT
Sbjct: 149 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPY 201
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289
Y++PE ++ + K D++S G LL E+ + + F + Y++
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK------------- 248
Query: 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332
+ + D + E+L + CI DP RP + V +
Sbjct: 249 KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-34
Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 59/303 (19%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHK 119
F EE+G FG +YKG + T AVA+K L D+ +EF++E ++ + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN---------------- 163
N+V LLG + Q + + + ++G L FL + T+
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 164 IAFQIARVLLYLHEDCSSQ-IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RKTI 220
+ QIA + YL SS ++H D+ +N+L+ D+ N +ISD GL + + +
Sbjct: 133 LVAQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 221 KTA--IRGTKGYVAPE--WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAIL 275
+ IR APE + K +I D++S+GV+L E+ S G + Y
Sbjct: 189 NSLLPIRWM----APEAIMYGKFSI--DSDIWSYGVVLWEVFS--------YGLQPYCGY 234
Query: 276 TDW-AFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQM 332
++ + RN ++ + +D C + LMI W E PS RP + +
Sbjct: 235 SNQDVVEMIRNRQV-------LPCPDD--CPAWVYALMIECW--NEFPSRRPRFKDIHSR 283
Query: 333 LQE 335
L+
Sbjct: 284 LRA 286
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-34
Identities = 68/306 (22%), Positives = 122/306 (39%), Gaps = 56/306 (18%)
Query: 63 FKEEVGRGSFGIIYKG----VIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQ-T 116
+ +G G FG + + + VAVK L + + + +E+ ++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN------------- 163
HKN++ LLG C + + E+ + G L +L P +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 164 ---IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RK 218
+Q+AR + YL S + IH D+ +N+L+ + +I+DFGLA+ + +K
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 219 TIKTA--IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAI 274
T ++ APE + + DV+SFGVL+ EI + +G I
Sbjct: 262 TTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGI 309
Query: 275 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQM 332
+ F + G M+ + C +L +M W PS RPT +++ +
Sbjct: 310 PVEELFKLLKEGHR-------MDKPAN--CTNELYMMMRDCW--HAVPSQRPTFKQLVED 358
Query: 333 LQEVVE 338
L ++
Sbjct: 359 LDRILT 364
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-34
Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 39/283 (13%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEVIVIGQTHHKNLV 122
E+G G+FG + +GV VA+K L + +E E ++ Q + +V
Sbjct: 15 DIELGCGNFGSVRQGVY-RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARVLLYLHEDCS 180
RL+G C + + +L E G L FL G + P N+ + Q++ + YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL---EE 128
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV---APEWFR 237
+H D+ +N+LL +R+ A+ISDFGL+K L + + TA K + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKWYAPECIN 186
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 295
S++ DV+S+GV + E +S G++ Y + ++ +E
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALS--------YGQKPYKKMK--------GPEVMAFIEQGK 230
Query: 296 -MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQE 335
ME + C +L LM W RP V Q ++
Sbjct: 231 RMECPPE--CPPELYALMSDCW--IYKWEDRPDFLTVEQRMRA 269
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 62/289 (21%), Positives = 115/289 (39%), Gaps = 57/289 (19%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E +G G FG ++K T +K++ ++ + EV + + H N+V
Sbjct: 17 ELIGSGGFGQVFK-AKHRIDGKT--YVIKRVKY----NNEKAEREVKALAKLDHVNIVHY 69
Query: 125 LG-FCDEGQNRLLAY---------------EFLNNGTLASFL---FGNLKPNWNLRTNIA 165
G + + + EF + GTL ++ G +
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL-ELF 128
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR 225
QI + + Y+H S ++I+ D+KP NI L D +I DFGL L + ++T
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--- 182
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285
GT Y++PE +VD+Y+ G++L E++ + E + + L R+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF-ETSKFFTDL--------RD 233
Query: 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
G + D+ D + ++ + + P RP S++L+
Sbjct: 234 GIISDIF--DKKEKTLLQ----------KLLSKKPEDRPN---TSEILR 267
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 68/287 (23%), Positives = 120/287 (41%), Gaps = 40/287 (13%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHKNL 121
+G G FG +++G+ + AVA+K D + +F E + + Q H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDC 179
V+L+G E + E G L SFL K + +L + A+Q++ L YL
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE--- 508
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN---QRKTIKTAIRGTKGYVAPEWF 236
S + +H DI +N+L++ ++ DFGL++ + + + K I+ APE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 564
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE-- 293
++ DV+ FGV + EI+ G + + + N + +E
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMH--------GVKPFQGVK--------NNDVIGRIENG 608
Query: 294 GDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ + C L LM W DPS RP ++ L ++E
Sbjct: 609 ERLPMPPN--CPPTLYSLMTKCW--AYDPSRRPRFTELKAQLSTILE 651
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 72/269 (26%), Positives = 113/269 (42%), Gaps = 36/269 (13%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLG 126
+G+G++GI+Y G + +A+K++ + E+ + HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQV---RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 127 FCDEGQNRLLAYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
E + E + G+L++ L +G LK N QI L YLH +QI
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQI 143
Query: 184 IHCDIKPQNILLNDRY-NARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI- 241
+H DIK N+L+N +ISDFG +K L T GT Y+APE K
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGPRG 201
Query: 242 -SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL--VEGDM-- 296
D++S G ++E+ + + F E+GE A + ++ G + M
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPF-YELGEPQAAM-------FKVGMFKVHPEIPESMSA 253
Query: 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPT 325
EA I C + DP R
Sbjct: 254 EAKAFILK----------CFEPDPDKRAC 272
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-33
Identities = 76/301 (25%), Positives = 115/301 (38%), Gaps = 58/301 (19%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV-IVIGQTHHKN 120
++ +G GS G + VAVK++ F D E+ ++ H N
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGR----PVAVKRMLIDFCD---IALMEIKLLTESDDHPN 70
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT-------NIAFQIARVLL 173
++R + +A E L N L + + NL+ ++ QIA +
Sbjct: 71 VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 174 YLHEDCSSQIIHCDIKPQNILL-------------NDRYNARISDFGLAKLLTLNQ---R 217
+LH S +IIH D+KPQNIL+ + ISDFGL K L Q R
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 218 KTIKTAIRGTKGYVAPEWFRKSTISA-------KVDVYSFGVLLLEIISCRKS-FDIEMG 269
+ GT G+ APE +S +D++S G + I+S K F +
Sbjct: 187 TNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 270 EEYAILT-DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRK 328
E I+ ++ D + L+ EA + I I DP RPT K
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIA---EATDLIS----------QMIDHDPLKRPTAMK 292
Query: 329 V 329
V
Sbjct: 293 V 293
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-33
Identities = 72/316 (22%), Positives = 130/316 (41%), Gaps = 56/316 (17%)
Query: 63 FKEEVGRGSFGIIYKG----VIQTTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQ-T 116
+ +G G+FG + + + T VAVK L + + + +E+ ++
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL------------FGNLKPNWNLR--- 161
HKN++ LLG C + + E+ + G L +L + P L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 162 -TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RK 218
+ A+Q+AR + YL S + IH D+ +N+L+ + +I+DFGLA+ + +K
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 219 TIKTA--IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAI 274
T ++ APE + + DV+SFGVLL EI + +G +
Sbjct: 250 TTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGSPYPGV 297
Query: 275 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQM 332
+ F + G M+ ++ C +L +M W PS RPT +++ +
Sbjct: 298 PVEELFKLLKEGHR-------MDKPSN--CTNELYMMMRDCW--HAVPSQRPTFKQLVED 346
Query: 333 LQEVVEVDVPPNPSPF 348
L +V + +
Sbjct: 347 LDRIVALTSNQEMGYY 362
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 69/313 (22%), Positives = 127/313 (40%), Gaps = 65/313 (20%)
Query: 63 FKEEVGRGSFGIIYKGVIQ--TTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHK 119
+ ++G G+FG +++ T VAVK L + +F+ E ++ + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN---------------- 163
N+V+LLG C G+ L +E++ G L FL ++
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 164 --------IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215
IA Q+A + YL + +H D+ +N L+ + +I+DFGL++ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 216 Q--RKTIKTA--IRGTKGYVAPE--WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMG 269
+ A IR PE ++ + T + DV+++GV+L EI S G
Sbjct: 228 DYYKADGNDAIPIRWM----PPESIFYNRYTT--ESDVWAYGVVLWEIFS--------YG 273
Query: 270 EE-YAILTDW-AFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPT 325
+ Y + R+G + + + C +L LM W + P+ RP+
Sbjct: 274 LQPYYGMAHEEVIYYVRDGNI-------LACPEN--CPLELYNLMRLCW--SKLPADRPS 322
Query: 326 MRKVSQMLQEVVE 338
+ ++LQ + E
Sbjct: 323 FCSIHRILQRMCE 335
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 66/306 (21%), Positives = 122/306 (39%), Gaps = 55/306 (17%)
Query: 63 FKEEVGRGSFGIIYKGVIQ--TTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQ-THH 118
F + +G G+FG + + + + VAVK L E+ +E+ V+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN--------------- 163
N+V LLG C G L+ E+ G L +FL +T+
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 164 ---IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RK 218
++Q+A+ + +L S IH D+ +NILL +I DFGLA+ + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 219 TIKTA--IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAI 274
++ APE + + DV+S+G+ L E+ S S + + +
Sbjct: 204 KGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 275 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQM 332
+ + G M + ++ +M + W DP RPT +++ Q+
Sbjct: 257 ----FYKMIKEGFR-------MLSPEH--APAEMYDIMKTCW--DADPLKRPTFKQIVQL 301
Query: 333 LQEVVE 338
+++ +
Sbjct: 302 IEKQIS 307
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 76/308 (24%), Positives = 124/308 (40%), Gaps = 59/308 (19%)
Query: 63 FKEEVGRGSFGIIYKGVIQ--TTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQ-THH 118
F + +G G+FG + + + VAVK L EK +E+ ++ H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL----------FGNLKPNWNLRTN----I 164
+N+V LLG C G L+ E+ G L +FL N T
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA- 223
+ Q+A+ + +L S IH D+ +N+LL + + A+I DFGLA R + +
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLA-------RDIMNDSN 219
Query: 224 -IRGTKGYV-----APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAIL 275
I + APE + + DV+S+G+LL EI S +G IL
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS--------LGLNPYPGIL 271
Query: 276 TDWAFDCYRNGKLDDLVEGD-MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQM 332
+ F + +G M + + +M + W +P+ RPT +++
Sbjct: 272 VNSKF-------YKLVKDGYQMAQPAF--APKNIYSIMQACW--ALEPTHRPTFQQICSF 320
Query: 333 LQEVVEVD 340
LQE + D
Sbjct: 321 LQEQAQED 328
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 54/305 (17%)
Query: 63 FKEEVGRGSFGIIYKGVIQ--TTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQ-THH 118
+ +GRG+FG + + T + VAVK L E +E+ ++ HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 119 KNLVRLLGFC-DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN-------------- 163
N+V LLG C G ++ EF G L+++L +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 164 --IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ--RKT 219
+FQ+A+ + +L S + IH D+ +NILL+++ +I DFGLA+ + + +
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 220 IKTA--IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAIL 275
++ APE + + DV+SFGVLL EI S S +++ EE
Sbjct: 208 GDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 259
Query: 276 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQML 333
+ G M A + ++ M+ W +PS RPT ++ + L
Sbjct: 260 ---FCRRLKEG-------TRMRAPDY--TTPEMYQTMLDCW--HGEPSQRPTFSELVEHL 305
Query: 334 QEVVE 338
+++
Sbjct: 306 GNLLQ 310
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 75/328 (22%), Positives = 130/328 (39%), Gaps = 52/328 (15%)
Query: 35 IRNSPGDGTIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKK 94
++ + Y L+ F++ +G G+FG + K I+ A+K+
Sbjct: 1 MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKR 59
Query: 95 LDRVFQDGEK-EFKNEVIVIGQ-THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFG 152
+ + +F E+ V+ + HH N++ LLG C+ LA E+ +G L FL
Sbjct: 60 MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 119
Query: 153 NLKPNWNLRTN----------------IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196
+ + A +AR + YL Q IH D+ +NIL+
Sbjct: 120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVG 176
Query: 197 DRYNARISDFGLAKLLTLNQRKTIKTA--IRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
+ Y A+I+DFGL++ K +R A E S + DV+S+GVLL
Sbjct: 177 ENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWM----AIESLNYSVYTTNSDVWSYGVLL 231
Query: 255 LEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LM 310
EI+S +G + ++ G +E + C +++ LM
Sbjct: 232 WEIVS--------LGGTPYCGMTCAELYEKLPQGYR-------LEKPLN--CDDEVYDLM 274
Query: 311 ISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
W +E P RP+ ++ L ++E
Sbjct: 275 RQCW--REKPYERPSFAQILVSLNRMLE 300
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-32
Identities = 71/297 (23%), Positives = 116/297 (39%), Gaps = 55/297 (18%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+G+G+FG + K + A+KK+ ++ +EV+++ +H+ +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRY---YAIKKIRHT-EEKLSTILSEVMLLASLNHQYVV 65
Query: 123 RLLGFCDEGQNRLLAY-------------EFLNNGTLASFL-FGNLKPNWNLRTNIAFQI 168
R E +N + E+ NGTL + NL + + QI
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIR--- 225
L Y+H S IIH D+KP NI +++ N +I DFGLAK + + +
Sbjct: 126 LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 226 ---------GTKGYVAPE-WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 275
GT YVA E + K+D+YS G++ E+I S +E L
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-YPFSTGMERVNILKKL 241
Query: 276 TDWAFDCYRNGKLD---DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
R+ ++ D + M+ I I I DP+ RP R +
Sbjct: 242 --------RSVSIEFPPDFDDNKMKVEKKI--------IR-LLIDHDPNKRPGARTL 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-32
Identities = 66/286 (23%), Positives = 118/286 (41%), Gaps = 36/286 (12%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQT 116
++++ +G GS+G K + + + + K+LD + +EV ++ +
Sbjct: 6 EDYEVLYTIGTGSYGRCQK-IRRKSDGKI--LVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 117 HHKNLVRLLG-FCDEGQNRLLAY-EFLNNGTLASFLFGNLKPNWNLR----TNIAFQIAR 170
H N+VR D L E+ G LAS + K L + Q+
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 171 VLLYLHE--DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK 228
L H D ++H D+KP N+ L+ + N ++ DFGLA++L + KT + GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFV-GTP 180
Query: 229 GYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288
Y++PE + + + K D++S G LL E+ + F L R GK
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKEL----AGKIREGKF 233
Query: 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
+ + +N+I I+ + RP+ V ++L+
Sbjct: 234 RRIPYRYSDELNEI--------IT-RMLNLKDYHRPS---VEEILE 267
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 39/295 (13%)
Query: 52 SYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL-DRVFQDGEKEFKNEV 110
+ E+G G+FG + +GV VA+K L + +E E
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVY-RMRKKQIDVAIKVLKQGTEKADTEEMMREA 387
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQI 168
++ Q + +VRL+G C + + +L E G L FL G + + + Q+
Sbjct: 388 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQV 445
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK 228
+ + YL +H ++ +N+LL +R+ A+ISDFGL+K L + + TA K
Sbjct: 446 SMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGK 500
Query: 229 GYV---APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYR 284
+ APE S++ DV+S+GV + E +S G++ Y +
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY--------GQKPYKKMK-------- 544
Query: 285 NGKLDDLVEGD--MEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQE 335
++ +E ME + C +L LM W RP V Q ++
Sbjct: 545 GPEVMAFIEQGKRMECPPE--CPPELYALMSDCW--IYKWEDRPDFLTVEQRMRA 595
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 35/230 (15%), Positives = 72/230 (31%), Gaps = 21/230 (9%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTA--VAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN 120
+G G+F +Y+ + +K + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNW-----NLRTNIAFQIARVLLYL 175
++ +L E + GTL + + L + A ++ ++ +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNA-----------RISDFGLAKLLTLNQRKTIKTAI 224
H +IIH DIKP N +L + + + D G + + L + TI TA
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 274
T G+ E + ++D + + ++ G E
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 72/312 (23%), Positives = 131/312 (41%), Gaps = 63/312 (20%)
Query: 63 FKEEVGRGSFGIIYKGVIQ--TTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQTHHK 119
+ +G G FG + K T VAVK L E + +E V+ Q +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR------------------ 161
++++L G C + LL E+ G+L FL + K
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 162 ------TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215
+ A+QI++ + YL +++H D+ +NIL+ + +ISDFGL++ +
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 216 Q--RKTIKTA--IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
K + ++ A E + + DV+SFGVLL EI++ +G
Sbjct: 204 DSYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVT--------LGGN 251
Query: 272 -YAILTDWAFDCYRNGKLDDLVE--GDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTM 326
Y + +L +L++ ME ++ C E++ LM+ W +++P RP
Sbjct: 252 PYPGIP--------PERLFNLLKTGHRMERPDN--CSEEMYRLMLQCW--KQEPDKRPVF 299
Query: 327 RKVSQMLQEVVE 338
+S+ L++++
Sbjct: 300 ADISKDLEKMMV 311
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 65/311 (20%), Positives = 116/311 (37%), Gaps = 60/311 (19%)
Query: 63 FKEEVGRGSFGIIYKGVIQ--TTTTSTTAVAVKKLDRVFQDGEK-EFKNEVIVIGQ-THH 118
F + +G G+FG + + T + VAVK L E+ +E+ ++ Q H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN--------------- 163
+N+V LLG C L +E+ G L ++L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 164 --------IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215
A+Q+A+ + +L +H D+ +N+L+ +I DFGLA+ + +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 216 Q--RKTIKTA--IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS--FDIEMG 269
++ APE + + K DV+S+G+LL EI S + I +
Sbjct: 226 SNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 270 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMR 327
+ +NG M+ E++ +M S W D RP+
Sbjct: 282 AN-------FYKLIQNGFK-------MDQPFY--ATEEIYIIMQSCW--AFDSRKRPSFP 323
Query: 328 KVSQMLQEVVE 338
++ L +
Sbjct: 324 NLTSFLGCQLA 334
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 58/285 (20%), Positives = 115/285 (40%), Gaps = 43/285 (15%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFK---NEVIVIGQ 115
+ + +++G GSFG V T +K+++ KE + EV V+
Sbjct: 24 EKYVRLQKIGEGSFGKAIL-VKSTEDGRQ--YVIKEINISRMS-SKEREESRREVAVLAN 79
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARV 171
H N+V+ +E + + ++ G L + N + + + QI
Sbjct: 80 MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLA 137
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231
L ++H +I+H DIK QNI L ++ DFG+A++L + I GT Y+
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACI-GTPYYL 192
Query: 232 APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291
+PE + K D+++ G +L E+ + + +F+ L + +
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNL------------VLKI 237
Query: 292 VEGDMEAMNDI--KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
+ G ++ + L+ + +P RP+ V+ +L+
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPS---VNSILE 276
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 66/278 (23%), Positives = 99/278 (35%), Gaps = 44/278 (15%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQ-THHKNL 121
+G GS+G ++K V AVK+ F+ EV + H
Sbjct: 63 SRLGHGSYGEVFK-VRSKEDGRL--YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
VRL +EG L E +L +G P + L +LH
Sbjct: 120 VRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLH--- 174
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLL-TLNQRKTIKTAIRGTKGYVAPEWFRK 238
S ++H D+KP NI L R ++ DFGL L T + + G Y+APE +
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----GDPRYMAPELLQG 230
Query: 239 STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM-- 296
S DV+S G+ +LE+ + GE + L R G L +
Sbjct: 231 S-YGTAADVFSLGLTILEVACNMELPH--GGEGWQQL--------RQGYLPPEFTAGLSS 279
Query: 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
E + + ++ DP LR T +L
Sbjct: 280 ELRSVLV----------MMLEPDPKLRAT---AEALLA 304
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-30
Identities = 55/297 (18%), Positives = 109/297 (36%), Gaps = 72/297 (24%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNL- 121
+++G G +++ + + A+K ++ D + ++NE+ + + +
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 122 -VRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHED 178
+RL + Q + E N L S+L ++ P R + + + +H
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLEAVHTIH-- 144
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE---- 234
I+H D+KP N L+ D ++ DFG+A + + +K + GT Y+ PE
Sbjct: 145 -QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 235 -------WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287
KS IS K DV+S G +L Y + GK
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCIL-----------------YYMTY---------GK 236
Query: 288 L--DDLVEGDMEAMNDIKCVEKLLMISIW-------------CIQEDPSLRPTMRKV 329
+ + ++ I ++ I C++ DP R ++ ++
Sbjct: 237 TPFQQI-INQISKLHAI--IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 54/282 (19%), Positives = 114/282 (40%), Gaps = 42/282 (14%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNL- 121
+++G G +++ + + A+K ++ D + ++NE+ + + +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 122 -VRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHED 178
+RL + Q + E N L S+L ++ P R + + + +H+
Sbjct: 118 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLEAVHTIHQ- 173
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE---- 234
I+H D+KP N L+ D ++ DFG+A + + +K + G Y+ PE
Sbjct: 174 --HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 235 -------WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287
KS IS K DV+S G +L + + F ++ + + L +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKL-------HAIID 282
Query: 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ +E D++ +L C++ DP R ++ ++
Sbjct: 283 PNHEIEFPDIPEKDLQ---DVLK---CCLKRDPKQRISIPEL 318
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 60/224 (26%), Positives = 91/224 (40%), Gaps = 21/224 (9%)
Query: 41 DGTIETKSRCFSYKELEEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV 98
+G + T+ E E VGRGSFG +++ + T AVKK+
Sbjct: 38 EGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ---CAVKKVR-- 92
Query: 99 FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKP 156
+ E E++ +V L G EG + E L G+L + G L
Sbjct: 93 LEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE 149
Query: 157 NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLN 215
+ Q L YLH + +I+H D+K N+LL+ D A + DFG A L +
Sbjct: 150 D--RALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 216 QRK---TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLE 256
I GT+ ++APE AKVD++S ++L
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 57/282 (20%), Positives = 116/282 (41%), Gaps = 42/282 (14%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIG--QTHHKN 120
+++G G +++ + + A+K ++ D + ++NE+ + Q H
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHED 178
++RL + Q + E N L S+L ++ P R + + + +H+
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLEAVHTIHQ- 126
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE---- 234
I+H D+KP N L+ D ++ DFG+A + + +K + GT Y+ PE
Sbjct: 127 --HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 235 -------WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287
KS IS K DV+S G +L + + F ++ + + L +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKL-------HAIID 235
Query: 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ +E D++ +L C++ DP R ++ ++
Sbjct: 236 PNHEIEFPDIPEKDLQ---DVLK---CCLKRDPKQRISIPEL 271
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 64/315 (20%), Positives = 116/315 (36%), Gaps = 57/315 (18%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ-THHKNLV 122
+ + G F +Y+ + A+K+L ++ + EV + + + H N+V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGRE---YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 123 RLLGFC-------DEGQNRLLAYEFLNNGTLASFLF-----GNLKPNWNLRTNIAFQIAR 170
+ D GQ L L G L FL G L + L+ I +Q R
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCR 147
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN--------QRKTIKT 222
+ ++H IIH D+K +N+LL+++ ++ DFG A ++ +R ++
Sbjct: 148 AVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 223 AI--RGTKGYVAPE---WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT- 276
I T Y PE + I K D+++ G +L + + F E G + I+
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKLRIVNG 264
Query: 277 --DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
+ L+ +Q +P R ++ +V LQ
Sbjct: 265 KYSIPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQ 304
Query: 335 EVVEVDVPPNPSPFS 349
E+ SP +
Sbjct: 305 EIAAARNVNPKSPIT 319
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 59/298 (19%), Positives = 103/298 (34%), Gaps = 50/298 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
F +++G G F + V A+K++ Q +E + E + +H N++
Sbjct: 33 FIQKLGEGGFSYVDL-VEGLHDGHF--YALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 123 RLLGFCDEGQNR----LLAYEFLNNGTLASFLFGNLKPNWNLRT----NIAFQIARVLLY 174
RL+ +C + L F GTL + + L + I R L
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI-------RGT 227
+H + H D+KP NILL D + D G ++ + + R T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 228 KGYVAPEWF---RKSTISAKVDVYSFGVLLLEIISCRKSFD--IEMGEEY--AILTDWAF 280
Y APE F I + DV+S G +L ++ +D + G+ A+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 281 --DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336
+ L L+ + DP RP + + L+ +
Sbjct: 267 PQSPRHSSALWQLLN--------------------SMMTVDPHQRPHIPLLLSQLEAL 304
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 55/297 (18%), Positives = 109/297 (36%), Gaps = 61/297 (20%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQ-THHKNL 121
E++G G FG ++K V + A+K+ + E+ EV H ++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGC---IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARVLLYLHE 177
VR E + L+ E+ N G+LA + N + + ++ Q+ R L Y+H
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH- 132
Query: 178 DCSSQIIHCDIKPQNILLN-------------------DRYNARISDFGLAKLLTLNQRK 218
S ++H DIKP NI ++ ++ +I D G ++ Q
Sbjct: 133 --SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-- 188
Query: 219 TIKTAIRGTKGYVAPE-WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 277
G ++A E T K D+++ + ++ G+++ +
Sbjct: 189 ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR--NGDQWHEI-- 240
Query: 278 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
R G+L + + + + ++ I DP RP+ +++
Sbjct: 241 ------RQGRLPRIPQVLSQEFTE--------LLK-VMIHPDPERRPS---AMALVK 279
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
++G GS GI+ + + VAVK +D Q + NEV+++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQ---VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFL-FGNLKPNWNLRTNIAF---QIARVLLYLHEDCS 180
G+ + EFL G L + L IA + + L YLH +
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-----IATVCEAVLQALAYLH---A 159
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKGYVAPEWFRK 238
+IH DIK +ILL ++SDFG + + +RK++ GT ++APE +
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWMAPEVISR 215
Query: 239 STISAKVDVYSFGVLLLEII 258
S + +VD++S G++++E++
Sbjct: 216 SLYATEVDIWSLGIMVIEMV 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE---KEFKNEVIVIGQTHHKNL 121
+++G G +Y T VA+K + ++ E K F+ EV Q H+N+
Sbjct: 17 DKLGGGGMSTVYLA---EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 122 VRLLGFCDEGQNRLLAY---EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHED 178
V ++ D + Y E++ TL+ ++ + + + N QI + + H+
Sbjct: 74 VSMI---DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD- 129
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
+I+H DIKPQNIL++ +I DFG+AK L+ T + GT Y +PE +
Sbjct: 130 --MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 239 STISAKVDVYSFGVLLLEIISCRKSFD 265
D+YS G++L E++ F+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 48/209 (22%), Positives = 81/209 (38%), Gaps = 37/209 (17%)
Query: 139 EFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL 195
+ L ++ + +I QIA + +LH S ++H D+KP NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197
Query: 196 NDRYNARISDFGLAKLL----------TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKV 245
++ DFGL + T T GTK Y++PE + S KV
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 246 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCV 305
D++S G++L E++ SF +M E I+TD RN K L + +
Sbjct: 258 DIFSLGLILFELLY---SFSTQM-ERVRIITD-----VRNLKFPLLFTQKYPQEHMM--- 305
Query: 306 EKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
+ + P+ RP + +++
Sbjct: 306 -----VQ-DMLSPSPTERPE---ATDIIE 325
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 21/200 (10%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E++G+G+ G +Y + T VA+++++ Q ++ NE++V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFL-FGNLKPNWNLRTNIAF---QIARVLLYLHEDCS 180
L G + E+L G+L + + IA + + L +LH S
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-----IAAVCRECLQALEFLH---S 134
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLT--LNQRKTIKTAIRGTKGYVAPEWFRK 238
+Q+IH DIK NILL + +++DFG +T ++R T+ GT ++APE +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTR 190
Query: 239 STISAKVDVYSFGVLLLEII 258
KVD++S G++ +E+I
Sbjct: 191 KAYGPKVDIWSLGIMAIEMI 210
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-28
Identities = 45/217 (20%), Positives = 93/217 (42%), Gaps = 29/217 (13%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FKNEVIVIGQTHHKN 120
+ +G+G+ +++G + T A+K + + + E V+ + +HKN
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDL---FAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 121 LVRLLGFCDEGQNRL--LAYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARVLLY 174
+V+L +E R L EF G+L + L + L + + + +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNH 127
Query: 175 LHEDCSSQIIHCDIKPQNILL----NDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGY 230
L + I+H +IKP NI+ + + +++DFG A+ L ++ + GT+ Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLY-GTEEY 181
Query: 231 VAPEWFRKSTI--------SAKVDVYSFGVLLLEIIS 259
+ P+ + ++ + A VD++S GV +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-28
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDG-EKEFKNEVIVIGQTHHKNLVRL 124
G+G FG +Y S +A+K L + + + G E + + EV + H N++RL
Sbjct: 18 GKGKFGNVYLA---REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARVLLYLHEDCS 180
G+ + L E+ GT+ + L+ ++A L Y H S
Sbjct: 75 YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCH---S 127
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
++IH DIKP+N+LL +I+DFG + ++R + GT Y+ PE
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRM 183
Query: 241 ISAKVDVYSFGVLLLEII 258
KVD++S GVL E +
Sbjct: 184 HDEKVDLWSLGVLCYEFL 201
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 28/234 (11%)
Query: 36 RNSPGDGTIETKSRCFSYKELEEATDNF--------KEEVGRGSFGIIYKGVIQTTTTST 87
R S I F ++ + E +G G FG ++K T
Sbjct: 58 RTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLK- 116
Query: 88 TAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLA 147
+A K + ++E KNE+ V+ Q H NL++L + + +L E+++ G
Sbjct: 117 --LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE-- 172
Query: 148 SFLFGN-LKPNWNLR----TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNAR 202
LF + ++NL QI + ++H I+H D+KP+NIL +R +
Sbjct: 173 --LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQ 227
Query: 203 I--SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
I DFGLA+ R+ +K GT ++APE +S D++S GV+
Sbjct: 228 IKIIDFGLARR--YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 45/199 (22%), Positives = 88/199 (44%), Gaps = 19/199 (9%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
E++GRG FGI+++ V ++ + K + D + K E+ ++ H+N+
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKT---YMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARVLLYLHE 177
+ L + + ++ +EF++ + + + L + Q+ L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH- 119
Query: 178 DCSSQIIHCDIKPQNILLNDRYNA--RISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
S I H DI+P+NI+ R ++ +I +FG A+ L + Y APE
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLF-TAPEYYAPEV 174
Query: 236 FRKSTISAKVDVYSFGVLL 254
+ +S D++S G L+
Sbjct: 175 HQHDVVSTATDMWSLGTLV 193
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
+ EE+G G+FG++++ V + T K ++ + + KNE+ ++ Q HH L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRV---FVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT-----NIAFQIARVLLYLH 176
+ L ++ +L EFL+ G LF + + N Q L ++H
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNAR--ISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE 234
I+H DIKP+NI+ + + I DFGLA LN + +K T + APE
Sbjct: 167 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPE 220
Query: 235 WFRKSTISAKVDVYSFGVLL 254
+ + D+++ GVL
Sbjct: 221 IVDREPVGFYTDMWAIGVLG 240
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 51/223 (22%), Positives = 97/223 (43%), Gaps = 16/223 (7%)
Query: 41 DGTIETKSRCFSYKELEEATDNF---KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR 97
++ + ++ +E + + +E+GRG F ++ + I +T A K R
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQ-CISKSTGQEYAAKFLKKRR 66
Query: 98 VFQDGEKEFKNEVIVIGQ-THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP 156
QD E +E+ V+ ++ L + +L E+ G + S L
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE 126
Query: 157 NWNLR--TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY---NARISDFGLAKL 211
+ + QI + YLH + I+H D+KPQNILL+ Y + +I DFG+++
Sbjct: 127 MVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183
Query: 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
+ ++ + GT Y+APE I+ D+++ G++
Sbjct: 184 I--GHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
+ EE+G G+FG++++ + T + A K + + ++ + E+ + H L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNN---FAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT-----NIAFQIARVLLYLH 176
V L ++ ++ YEF++ G LF + N + Q+ + L ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARI--SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE 234
+ +H D+KP+NI+ + + + DFGL L+ ++++K GT + APE
Sbjct: 273 ---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTT-GTAEFAAPE 326
Query: 235 WFRKSTISAKVDVYSFGVLL 254
+ D++S GVL
Sbjct: 327 VAEGKPVGYYTDMWSVGVLS 346
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 63/366 (17%), Positives = 139/366 (37%), Gaps = 62/366 (16%)
Query: 31 KKKWIRNSPGDGTIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAV 90
++ + T + K + E+ E+G G+ G+++K + + +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKI-----SELGAGNGGVVFKVSHKPSGL---VM 61
Query: 91 AVKKLDRVFQDGE-KEFKNEVIVIGQTHHKNLVRLLG-FCDEGQNRLLAYEFLNNGTLAS 148
A K + + + E+ V+ + + +V G F +G+ + E ++ G+L
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQ 120
Query: 149 FL-FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207
L P L ++ + + L YL E +I+H D+KP NIL+N R ++ DFG
Sbjct: 121 VLKKAGRIPEQILGK-VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEI---------I 258
++ L + + GT+ Y++PE + + S + D++S G+ L+E+
Sbjct: 178 VSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233
Query: 259 SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI-----KCVEK---LLM 310
++ + + + G+ + D I V + L
Sbjct: 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293
Query: 311 ISIW----------CIQEDPSLRPTMRK----------------VSQMLQEVVEVDVPPN 344
++ C+ ++P+ R +++ + L + ++ P
Sbjct: 294 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPST 353
Query: 345 PSPFSG 350
P+ +G
Sbjct: 354 PTHAAG 359
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-27
Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 21/196 (10%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDG-EKEFKNEVIVIGQTHHKNLVRL 124
G+G FG +Y + +A+K L + + ++G E + + E+ + H N++R+
Sbjct: 23 GKGKFGNVYLAR---EKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARVLLYLHEDCS 180
+ + + L EF G L + L+ + + ++A L Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCH---E 132
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
++IH DIKP+N+L+ + +I+DFG + +R+T+ GT Y+ PE T
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEGKT 188
Query: 241 ISAKVDVYSFGVLLLE 256
KVD++ GVL E
Sbjct: 189 HDEKVDLWCAGVLCYE 204
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-27
Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 16/202 (7%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAV---AVKKLDRVFQDGEKEFKNEVIVIGQTHHK 119
E +G+G F ++ + I T AV V K ++ K E + H
Sbjct: 28 LCEVIGKGPFSVVRR-CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARVLLYL 175
++V LL + +EF++ L + + ++ QI L Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNA---RISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
H + IIH D+KP +LL + N+ ++ FG+A L + + GT ++A
Sbjct: 147 H---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRV-GTPHFMA 201
Query: 233 PEWFRKSTISAKVDVYSFGVLL 254
PE ++ VDV+ GV+L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL 223
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FKNEVIVIGQTHHKN 120
+ +G+G+ +++G + T A+K + + + E V+ + +HKN
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDL---FAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 121 LVRLLGFCDEGQNRL--LAYEFLNNGTLASFLFGNLKPNWNLRT-----NIAFQIARVLL 173
+V+L +E R L EF G+L + L N + + +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 174 YLHEDCSSQIIHCDIKPQNILL----NDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
+L + I+H +IKP NI+ + + +++DFG A+ L ++ + GT+
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLY-GTEE 180
Query: 230 YVAPEWFRKSTI--------SAKVDVYSFGVLL 254
Y+ P+ + ++ + A VD++S GV
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAV---AVKKLDRVFQDGEKE-FKNEVIVIGQTH 117
+ EE+G G F I+ K + +T A ++ + +E + EV ++ Q
Sbjct: 15 DIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARVLL 173
H N++ L + + +L E ++ G L F L +L T+ QI +
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDR----YNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
YLH + +I H D+KP+NI+L D+ + ++ DFGLA + K GT
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GTPE 183
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLL 254
+VAPE + + D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-26
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVK-----KLDRVFQDGEKE-FKNEVIVIGQ 115
EE+G G F I+ K + T A K +L + +E + EV ++ +
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGK---EYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARV 171
H N++ L + + +L E ++ G L F L +L T QI
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDG 120
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNA----RISDFGLAKLLTLNQRKTIKTAIRGT 227
+ YLH S +I H D+KP+NI+L D+ ++ DFG+A + K GT
Sbjct: 121 VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF-GT 174
Query: 228 KGYVAPEWFRKSTISAKVDVYSFGVLL 254
+VAPE + + D++S GV+
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE---KEFKNEVIVIGQTHHKNL 121
E +G G ++ VAVK L F+ E +H +
Sbjct: 18 EILGFGGMSEVHLA---RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 122 VRLL--GFCDEGQNRLLAY---EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLY 174
V + G E L Y E+++ TL + G + P + + + L +
Sbjct: 75 VAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE--VIADACQALNF 131
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT-AIRGTKGYVAP 233
H+ + IIH D+KP NI+++ ++ DFG+A+ + + +T A+ GT Y++P
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 234 EWFRKSTISAKVDVYSFGVLLLEIISCRKSFD 265
E R ++ A+ DVYS G +L E+++ F
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FKNEVIVIGQTHHKNL 121
KE +G G FG + + + Q T VA+K+ + +E + E+ ++ + +H N+
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQ---VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 122 VRLLGFCDEGQN------RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARV 171
V D Q LLA E+ G L +L + L+ I+
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSA 133
Query: 172 LLYLHEDCSSQIIHCDIKPQNILL---NDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK 228
L YLHE ++IIH D+KP+NI+L R +I D G AK L + + GT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFV-GTL 187
Query: 229 GYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
Y+APE + + VD +SFG L E I+
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAV---AVKKLDRVFQDGEKE-FKNEVIVIGQTH 117
+ EE+G G F I+ K + +T A ++ + +E + EV ++ Q
Sbjct: 15 DIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARVLL 173
H N++ L + + +L E ++ G L F L +L T+ QI +
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDR----YNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
YLH + +I H D+KP+NI+L D+ + ++ DFGLA + K GT
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GTPE 183
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLL 254
+VAPE + + D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 33/305 (10%), Positives = 72/305 (23%), Gaps = 58/305 (19%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHK 119
E + G +++ A+K + + + +
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLED---FALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 120 NLV------RLLGFCDEGQ--------------------NRLLAYEFL--NNGTLASFLF 151
+ RLL D N LL + L S L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 152 GNLKPNWNL----RTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207
+ + Q+ R+ L S ++H P N+ + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWF--RKSTISAKVDVYSFGVLLLEIISCRKSFD 265
+ T A Y E+ +T + ++ + G+ + + F
Sbjct: 240 ALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 266 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDM-EAMNDIKCVEKLLMISIWCIQEDPSLRP 324
+ + L + + + + + + L D R
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTL--IGRFL-------NFDRRRRL 345
Query: 325 TMRKV 329
+
Sbjct: 346 LPLEA 350
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 42/212 (19%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVFQDGEKEFKNEVIVIGQTHHK 119
+ KEE+G+G+F ++ + V +TT A K ++ ++ ++ + E + + H
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTT---GLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIA 165
N+VRL E L ++ + G L AS
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-------------- 111
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA---RISDFGLAKLLTLNQRKTIKT 222
QI + Y H S+ I+H ++KP+N+LL + +++DFGLA + ++
Sbjct: 112 QQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHG 166
Query: 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
GT GY++PE +K S VD+++ GV+L
Sbjct: 167 FA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 22/196 (11%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDG-EKEFKNEVIVIGQTHHKNLVRL 124
G+GSF +Y+ + + VA+K +D+ +++ G + +NEV + Q H +++ L
Sbjct: 20 GKGSFAGVYRA---ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARVLLYLHEDCS 180
+ ++ L E +NG + +L +KP N A QI +LYLH S
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYLH---S 130
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL--NQRKTIKTAIRGTKGYVAPEWFRK 238
I+H D+ N+LL N +I+DFGLA L + + T+ GT Y++PE +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEIATR 186
Query: 239 STISAKVDVYSFGVLL 254
S + DV+S G +
Sbjct: 187 SAHGLESDVWSLGCMF 202
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 54/298 (18%), Positives = 97/298 (32%), Gaps = 54/298 (18%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL----DRVFQDGEKEFKNEVIVIGQTHHKN 120
+ G G IY + + V +K L D Q E + + H +
Sbjct: 86 GCIAHGGLGWIYLAL--DRNVNGRPVVLKGLVHSGDAEAQ---AMAMAERQFLAEVVHPS 140
Query: 121 LVRLL--GFCDEGQNRLLAY---EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYL 175
+V++ + + Y E++ +L L + +I L YL
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYL 198
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT-AIRGTKGYVAPE 234
H +++ D+KP+NI+L + ++ D G + + GT G+ APE
Sbjct: 199 HS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-------SFGYLYGTPGFQAPE 247
Query: 235 WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294
R + D+Y+ G L + + + G L + L+
Sbjct: 248 IVRTGP-TVATDIYTVGRTLAALTLDLPTRN---GRYVDGLPEDDPVLKTYDSYGRLLR- 302
Query: 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRP-TMRKVSQMLQEVV-EVDVPPNPSPFSG 350
+ ++ DP R T ++S L V+ EV P G
Sbjct: 303 --------RAIDP-----------DPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPG 341
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 41/210 (19%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
F E +G G+F ++ + T A+K + + + +NE+ V+ + H+N+
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGK---LFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQ 167
V L + + L + ++ G L AS + Q
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI--------------QQ 114
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA---RISDFGLAKLLTLNQRKTIKTAI 224
+ + YLH + I+H D+KP+N+L I+DFGL+K+ Q + TA
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTAC 168
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
GT GYVAPE + S VD +S GV+
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 20/200 (10%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD-RVFQDGEKEFKNEVIVIGQTHHKNLVR 123
E++G+GSFG ++KG+ T VA+K +D +D ++ + E+ V+ Q + +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKV---VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARVLLYLHEDCS 180
G + + E+L G+ L +P T IA +I + L YLH S
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---S 137
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKGYVAPEWFRK 238
+ IH DIK N+LL++ +++DFG+A L T +R T GT ++APE ++
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQ 193
Query: 239 STISAKVDVYSFGVLLLEII 258
S +K D++S G+ +E+
Sbjct: 194 SAYDSKADIWSLGITAIELA 213
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 53/222 (23%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR---------VFQDGEKEFKNEVIVI 113
KE +GRG ++ + + + T AVK +D Q+ + EV ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCK---EYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 114 GQ-THHKNLVRLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNW 158
+ + H N+++L + L ++ + G L +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM------- 130
Query: 159 NLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218
+ V+ LH I+H D+KP+NILL+D N +++DFG + L ++
Sbjct: 131 -------RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK- 179
Query: 219 TIKTAIRGTKGYVAPEWFRKSTISA------KVDVYSFGVLL 254
++ GT Y+APE S +VD++S GV++
Sbjct: 180 -LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD-RVFQDGEKEFKNEVIVIGQTHHKN 120
FK ++G G+FG ++ +++ +K ++ Q ++ + E+ V+ H N
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLE---RVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARVLLYLH 176
++++ ++ N + E G L + L + Q+ L Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 177 EDCSSQIIHCDIKPQNILLNDR---YNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAP 233
S ++H D+KP+NIL D +I DFGLA+L ++ A GT Y+AP
Sbjct: 142 ---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAA-GTALYMAP 195
Query: 234 EWFRKSTISAKVDVYSFGVLL 254
E F++ ++ K D++S GV++
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVM 215
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL------DRVFQDGEKEFKNEVIVIGQTHH 118
VGRG G +Y+ T VA+K + D VF+ + E G+
Sbjct: 40 RLVGRGGMGDVYEA---EDTVRERIVALKLMSETLSSDPVFR---TRMQREARTAGRLQE 93
Query: 119 KNLVRLLGFCDEGQNRLLAY---EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLL 173
++V + D G+ Y +N LA+ L G L P + I QI L
Sbjct: 94 PHVVPIH---DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQIGSALD 148
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAP 233
H H D+KP+NIL++ A + DFG+A T +++ T GT Y+AP
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAP 204
Query: 234 EWFRKSTISAKVDVYSFGVLLLEIISCRKSFD 265
E F +S + + D+Y+ +L E ++ +
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 43/211 (20%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
KE++G GS+ + + + + T AVK +D+ +D +E I++ H N+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKAT---NMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNI 78
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQ 167
+ L D+G+ + E + G L AS + F
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL--------------FT 124
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA----RISDFGLAKLLTLNQRKTIKTA 223
I + + YLH + ++H D+KP NIL D RI DFG AK L + T
Sbjct: 125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTP 180
Query: 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
T +VAPE + A D++S GVLL
Sbjct: 181 C-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 54/203 (26%), Positives = 101/203 (49%), Gaps = 27/203 (13%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E++G GS+G +YK + + T VA+K++ + +E E+ ++ Q ++V+
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQI---VAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARV-------LLYLHE 177
G + + + E+ G+++ + K L + +IA + L YLH
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTED---EIATILQSTLKGLEYLH- 142
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKGYVAPEW 235
+ IH DIK NILLN +A+++DFG+A L T+ +R T+ GT ++APE
Sbjct: 143 --FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI----GTPFWMAPEV 196
Query: 236 FRKSTISAKVDVYSFGVLLLEII 258
++ + D++S G+ +E+
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMA 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAV---AVKKLDRVFQDGEKE-FKNEVIVIGQTH 117
+ EE+G G F ++ K + +T A ++ + +E + EV ++ +
Sbjct: 14 DTGEELGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARVLL 173
H N++ L + + +L E + G L F L +L T QI +
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNA----RISDFGLAKLLTLNQRKTIKTAIRGTKG 229
YLH S QI H D+KP+NI+L DR +I DFGLA + + K GT
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF-GTPE 182
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLL 254
+VAPE + + D++S GV+
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 17/225 (7%)
Query: 37 NSPGDGTIETKSRCFSYKELEEATD--NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKK 94
N G ++ F + ++ +++G G++G + + T A+K
Sbjct: 13 NLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE---RAIKI 69
Query: 95 LD--RVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFG 152
+ V + EV V+ H N+++L F ++ +N L E G L +
Sbjct: 70 IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129
Query: 153 NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR---YNARISDFGLA 209
+K N I Q+ + YLH I+H D+KP+N+LL + +I DFGL+
Sbjct: 130 RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
+ ++ + GT Y+APE RK K DV+S GV+L
Sbjct: 187 AVFENQKKMKERL---GTAYYIAPEVLRKK-YDEKCDVWSIGVIL 227
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 6e-25
Identities = 36/242 (14%), Positives = 78/242 (32%), Gaps = 59/242 (24%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVK---KLDRVFQDGEKEFKNEVIVIGQ------ 115
+G+ + Q T S V +R + K+ K EV+ +
Sbjct: 79 TVLGQEDPYAYLEATDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 116 -------------------THHKNLVRLLGFCDEGQ--NRLLAYEFLNN------GTLAS 148
K ++R+ + +R Y + + L S
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 149 FLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208
+ + R + Q+ R+L LH ++H ++P +I+L+ R ++ F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWF-----------RKSTISAKVDVYSFGVLLLEI 257
R + ++G+ PE R++ ++ D ++ G+++ I
Sbjct: 253 LV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 258 IS 259
Sbjct: 307 WC 308
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-25
Identities = 46/210 (21%), Positives = 81/210 (38%), Gaps = 41/210 (19%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
+ +GRGS+G + V + T A KK+ + F + FK E+ ++ H N+
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIR---RAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQ 167
+RL ++ + L E G L A+ +
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM--------------KD 114
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDR---YNARISDFGLAKLLTLNQRKTIKTAI 224
+ + Y H + H D+KP+N L ++ DFGLA + ++T +
Sbjct: 115 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV 169
Query: 225 RGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
GT YV+P+ + D +S GV++
Sbjct: 170 -GTPYYVSPQVLEGL-YGPECDEWSAGVMM 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 47/221 (21%), Positives = 92/221 (41%), Gaps = 52/221 (23%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--------VFQDGEKEFKNEVIVIG 114
K+ +GRG ++ + V + T AVK ++ ++ + + E ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGH---EFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 115 Q-THHKNLVRLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWN 159
Q H +++ L+ + L ++ + G L +
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM-------- 206
Query: 160 LRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219
+ + +LH ++ I+H D+KP+NILL+D R+SDFG + L ++
Sbjct: 207 ------RSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-- 255
Query: 220 IKTAIRGTKGYVAPEWFRKSTISA------KVDVYSFGVLL 254
++ GT GY+APE + S +VD+++ GV+L
Sbjct: 256 LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E+G G+FG +YK + T A K ++ ++ +++ E+ ++ H +V+L
Sbjct: 25 GELGDGAFGKVYKAKNKETGAL---AAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR-TNIAF---QIARVLLYLHEDCS 180
LG + EF G + + + + L I Q+ L +LH S
Sbjct: 82 LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLH---S 135
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKGYVAPE---- 234
+IIH D+K N+L+ + R++DFG++ TL +R + GT ++APE
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----GTPYWMAPEVVMC 191
Query: 235 -WFRKSTISAKVDVYSFGVLLLEII 258
+ + K D++S G+ L+E+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMA 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 42/209 (20%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+ E+GRG+ I+Y+ + T A+K L + +K + E+ V+ + H N++
Sbjct: 57 VESELGRGATSIVYRCKQKGTQK---PYALKVLKK--TVDKKIVRTEIGVLLRLSHPNII 111
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQI 168
+L + L E + G L A+ QI
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK--------------QI 157
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA---RISDFGLAKLLTLNQRKTIKTAIR 225
+ YLH + I+H D+KP+N+L +I+DFGL+K++ +KT
Sbjct: 158 LEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVC- 211
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
GT GY APE R +VD++S G++
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR---VFQDGEKEFKNEVIVIGQTHH 118
+ +G+GSFG + + T AVK + + + ++ EV ++ Q H
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQE---CAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHED 178
N+++L F ++ L E G L + + + I Q+ + Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH-- 143
Query: 179 CSSQIIHCDIKPQNILLNDR---YNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
++I+H D+KP+N+LL + N RI DFGL+ +++ K GT Y+APE
Sbjct: 144 -KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEV 199
Query: 236 FRKSTISAKVDVYSFGVLL 254
+ K DV+S GV+L
Sbjct: 200 LHGT-YDEKCDVWSTGVIL 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 37/209 (17%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
EE+G+G+F ++ + ++ A + ++ ++ + E + H N+V
Sbjct: 15 LFEELGKGAFSVVRR-CVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQI 168
RL E + L ++ + G L AS QI
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI--------------QQI 119
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA---RISDFGLAKLLTLNQRKTIKTAIR 225
+L+ H ++H ++KP+N+LL + +++DFGLA + Q+ A
Sbjct: 120 LEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-- 174
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
GT GY++PE RK VD+++ GV+L
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 42/211 (19%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVFQDGEKEFKNEVIVIGQTHHKN 120
KEE+G+G+F ++ + V +TT A K ++ ++ ++ + E + + H N
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAF 166
+VRL E L ++ + G L AS
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI--------------Q 135
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA---RISDFGLAKLLTLNQRKTIKTA 223
QI + Y H S+ I+H ++KP+N+LL + +++DFGLA + ++
Sbjct: 136 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGF 190
Query: 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
GT GY++PE +K S VD+++ GV+L
Sbjct: 191 A-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 38/214 (17%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDR-----------------VFQDGEKEFKNEV 110
+G F I A+KK ++ + +FKNE+
Sbjct: 40 NQGKFNKIILC-----EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRT------ 162
+I ++ + G + YE++ N ++ F F L N+
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 163 NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT 222
I + Y+H I H D+KP NIL++ ++SDFG ++ + + K
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG--- 209
Query: 223 AIRGTKGYVAPEWF--RKSTISAKVDVYSFGVLL 254
RGT ++ PE+F S AKVD++S G+ L
Sbjct: 210 -SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 43/212 (20%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVFQDGEKEFKNEVIVIGQTHHK 119
N +G+GSFG + K + T AVK ++ EV ++ + H
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQ---EYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIA 165
N+++L ++ + + E G L A+ +
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII-------------- 127
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR---YNARISDFGLAKLLTLNQRKTIKT 222
Q+ + Y+H I+H D+KP+NILL + + +I DFGL+ N + +K
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKD 182
Query: 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
I GT Y+APE R + K DV+S GV+L
Sbjct: 183 RI-GTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 43/212 (20%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVFQDGEKEFKNEVIVIGQTHHK 119
N +G+GSFG + K + T AVK ++ EV ++ + H
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQE---YAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIA 165
N+++L ++ + + E G L A+ I
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------------RII 127
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR---YNARISDFGLAKLLTLNQRKTIKT 222
Q+ + Y+H I+H D+KP+NILL + + +I DFGL+ N + +K
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKD 182
Query: 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
I GT Y+APE R + K DV+S GV+L
Sbjct: 183 RI-GTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 43/212 (20%)
Query: 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ-THHK 119
D + +G GSF I K V + + A AVK + + E + E+ + H
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQ---AFAVKIISK---RMEANTQKEITALKLCEGHP 66
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIA 165
N+V+L + + L E LN G L AS I
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------------YIM 112
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NA--RISDFGLAKLLTLNQRKTIKT 222
++ + ++H ++H D+KP+N+L D N +I DFG A+L + + +KT
Sbjct: 113 RKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKT 168
Query: 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
T Y APE ++ D++S GV+L
Sbjct: 169 PC-FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 6e-24
Identities = 58/263 (22%), Positives = 91/263 (34%), Gaps = 61/263 (23%)
Query: 46 TKSRCFSYKELEEATDN--FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVK-----KLDRV 98
++ F L E K +G+GS+G++ + T A+K K+ ++
Sbjct: 11 RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRA---IRAIKIMNKNKIRQI 67
Query: 99 FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTL------------ 146
+ K EV ++ + HH N+ RL ++ Q L E + G L
Sbjct: 68 NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127
Query: 147 ------------------ASFLFGNLKPNWNLRTNIAF----------QIARVLLYLHED 178
+ + QI L YLH
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-- 185
Query: 179 CSSQIIHCDIKPQNILLNDRYNAR--ISDFGLAKLLTLN---QRKTIKTAIRGTKGYVAP 233
+ I H DIKP+N L + + + DFGL+K + + T GT +VAP
Sbjct: 186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAP 243
Query: 234 EWFRKST--ISAKVDVYSFGVLL 254
E + K D +S GVLL
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLL 266
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR-------------VFQDGEKEFKNE 109
++G G++G + + + A+K + + + +E NE
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSE---KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 110 VIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLR----TNIA 165
+ ++ H N+++L ++ + L EF G L F + NI
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAANIM 152
Query: 166 FQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR---YNARISDFGLAKLLTLNQRKTIKT 222
QI + YLH I+H DIKP+NILL ++ N +I DFGL+ + + + ++
Sbjct: 153 KQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--LRD 207
Query: 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
+ GT Y+APE +K + K DV+S GV++
Sbjct: 208 RL-GTAYYIAPEVLKKK-YNEKCDVWSCGVIM 237
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-24
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 21/195 (10%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDGEKE-FKNEVIVIGQTHHKNLVRL 124
G+G F ++ + + A K + + + + ++E E+ + H+++V
Sbjct: 50 GKGGFAKCFEI---SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARVLLYLHEDCS 180
GF ++ + E +L K L A QI YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---R 159
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLL-TLNQRKTIKTAIRGTKGYVAPEWFRKS 239
+++IH D+K N+ LN+ +I DFGLA + +RK K + GT Y+APE K
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KV-LCGTPNYIAPEVLSKK 216
Query: 240 TISAKVDVYSFGVLL 254
S +VDV+S G ++
Sbjct: 217 GHSFEVDVWSIGCIM 231
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-23
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 21/195 (10%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDGEKE-FKNEVIVIGQTHHKNLVRL 124
G+G F ++ + + A K + + + + ++E E+ + H+++V
Sbjct: 24 GKGGFAKCFEI---SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARVLLYLHEDCS 180
GF ++ + E +L K L A QI YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---R 133
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLL-TLNQRKTIKTAIRGTKGYVAPEWFRKS 239
+++IH D+K N+ LN+ +I DFGLA + +RK K + GT Y+APE K
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KV-LCGTPNYIAPEVLSKK 190
Query: 240 TISAKVDVYSFGVLL 254
S +VDV+S G ++
Sbjct: 191 GHSFEVDVWSIGCIM 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 48/248 (19%)
Query: 33 KWIRNSPGDGTIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAV 92
K G + + SY + + +G GSFG++Y+ + + VA+
Sbjct: 36 KVTTVVATPGQGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGEL---VAI 84
Query: 93 KKLDRVFQDGEKEFKN-EVIVIGQTHHKNLVRLLG-FCDEGQNRL-----LAYEFLNNGT 145
KK V QD K FKN E+ ++ + H N+VRL F G+ + L +++ T
Sbjct: 85 KK---VLQD--KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-T 138
Query: 146 LASFLFGNLKPNWNLRTN----IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYN 200
+ + L +Q+ R L Y+H S I H DIKPQN+LL+ D
Sbjct: 139 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAV 195
Query: 201 ARISDFGLAKLLTLNQRKTIKTAIRGTKGYV------APEW-FRKSTISAKVDVYSFGVL 253
++ DFG AK L + Y+ APE F + ++ +DV+S G +
Sbjct: 196 LKLCDFGSAKQLVRGEPNV---------SYICSRYYRAPELIFGATDYTSSIDVWSAGCV 246
Query: 254 LLEIISCR 261
L E++ +
Sbjct: 247 LAELLLGQ 254
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 37/215 (17%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVR 123
E VG G++G +YKG T A+K +D V D E+E K E+ ++ + HH+N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQL---AAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 124 LLG-----FCDEGQNRL-LAYEFLNNGTLA----SFLFGNLKPNWNLRTNIAF---QIAR 170
G ++L L EF G++ + LK W IA+ +I R
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILR 140
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTK 228
L +LH ++IH DIK QN+LL + ++ DFG++ L T+ +R T GT
Sbjct: 141 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI----GTP 193
Query: 229 GYVAPE-----WFRKSTISAKVDVYSFGVLLLEII 258
++APE +T K D++S G+ +E+
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 63/246 (25%), Positives = 104/246 (42%), Gaps = 43/246 (17%)
Query: 37 NSPGDGTIETKSRCFSYKELEEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKK 94
N D K K E+ + + +G GSFG++++ + + VA+KK
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE----VAIKK 71
Query: 95 LDRVFQDGEKEFKN-EVIVIGQTHHKNLVRLLGF-----CDEGQNRL-LAYEFLNNGTLA 147
V QD K FKN E+ ++ H N+V L F + + L L E++ T+
Sbjct: 72 ---VLQD--KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY 125
Query: 148 SFLFGNLKPNWNLRTN----IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNAR 202
K + +Q+ R L Y+H S I H DIKPQN+LL+ +
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLK 182
Query: 203 ISDFGLAKLLTLNQRKTIKTAIRGTKGYV------APEW-FRKSTISAKVDVYSFGVLLL 255
+ DFG AK+L + Y+ APE F + + +D++S G ++
Sbjct: 183 LIDFGSAKILIAGEPNV---------SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA 233
Query: 256 EIISCR 261
E++ +
Sbjct: 234 ELMQGQ 239
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 48/207 (23%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--------VFQDGEKEFKNEVIVI 113
+ +G G+ G + + T VA++ + + D + E+ ++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKK---VAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 114 GQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLL 173
+ +H ++++ F D ++ + E + G L + GN + +Q+ +
Sbjct: 195 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 174 YLHEDCSSQIIHCDIKPQNILL---NDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGY 230
YLH + IIH D+KP+N+LL + +I+DFG +K+L ++T GT Y
Sbjct: 254 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLC-GTPTY 307
Query: 231 VAPEWFRKSTI---SAKVDVYSFGVLL 254
+APE + VD +S GV+L
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 9e-23
Identities = 39/333 (11%), Positives = 90/333 (27%), Gaps = 82/333 (24%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVK---KLDRVFQDGEKEFKNEVIVIGQT----- 116
+G+ + Q T S V +R + K+ K EV+ +
Sbjct: 84 TVLGQEDPYAYLEATDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140
Query: 117 -----------------HHKNLVRLLGFCDEGQNRLLAYEFL-------NNGTLASFLFG 152
+++ + ++ + F N T L
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200
Query: 153 NLK----PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208
+ + R + Q+ R+L LH ++H ++P +I+L+ R ++ F
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKS 263
+ A + ++ D ++ G+ + I C
Sbjct: 258 LVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW-CADL 315
Query: 264 -F--DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM-EAMNDIKCVEKLLMISIWCIQED 319
D +G I ++ + + + +E L +
Sbjct: 316 PNTDDAALGGSEWIFRSCK---------------NIPQPVRAL--LEGFL-------RYP 351
Query: 320 PSLRPTMRKVS-----QMLQEVVEVDVPPNPSP 347
R + + L+ + +P +
Sbjct: 352 KEDRLLPLQAMETPEYEQLRTELSAALPLYQTD 384
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 28/205 (13%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE---KEFKNEVIVIGQTHHKNL 121
E+G GSFG +Y + VA+KK+ + ++ EV + + H N
Sbjct: 60 REIGHGSFGAVYFARDVRNSEV---VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 122 VRLLGFCDEGQNRLLAYEFLNNG--TLASFLFGNLKPNWNLRTNIAF---QIARVLLYLH 176
++ G L E+ L L+ IA + L YLH
Sbjct: 117 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGALQGLAYLH 171
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE-- 234
S +IH D+K NILL++ ++ DFG A + + GT ++APE
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANSFV----GTPYWMAPEVI 222
Query: 235 -WFRKSTISAKVDVYSFGVLLLEII 258
+ KVDV+S G+ +E+
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELA 247
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 48/219 (21%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ-THHKNLV 122
++ +G G+ + + T+ AVK +++ EV ++ Q H+N++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQ---EYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQI 168
L+ F +E L +E + G++ AS + +
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------------VVVQDV 120
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA---RISDFGLAKLLTLNQRKTIKTAIR 225
A L +LH + I H D+KP+NIL +I DF L + LN + +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 226 -----GTKGYVAPEWFRKSTISAK-----VDVYSFGVLL 254
G+ Y+APE + A D++S GV+L
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-22
Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE-KEFKNEV-IVIGQTHHKNLV 122
E+GRG++G + K V + + +AVK++ + E K+ ++ +V+ + +V
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQ---IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 123 RLLG-FCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTN------IAFQIARVLLY 174
+ G EG + E ++ + F + + I + L +
Sbjct: 85 QFYGALFREGD--CWICMELMS-TSFDKFY-KYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKGYVA 232
L E+ +IIH DIKP NILL+ N ++ DFG++ L ++ + + G + Y+A
Sbjct: 141 LKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-----GCRPYMA 193
Query: 233 PE----WFRKSTISAKVDVYSFGVLLLEI 257
PE + + DV+S G+ L E+
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 48/212 (22%), Positives = 83/212 (39%), Gaps = 37/212 (17%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE-KEFKNEV-IVIGQTHHKNLV 122
E+GRG++G++ K + +AVK++ E K ++ I + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQ---IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 123 RLLG-------------FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA 169
G D ++ T+ + G IA I
Sbjct: 70 TFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK----------IAVSIV 119
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
+ L +LH +IH D+KP N+L+N ++ DFG++ L + K G K
Sbjct: 120 KALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD--IDA-GCKP 174
Query: 230 YVAPE----WFRKSTISAKVDVYSFGVLLLEI 257
Y+APE + S K D++S G+ ++E+
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 59/248 (23%), Positives = 102/248 (41%), Gaps = 45/248 (18%)
Query: 40 GDGTIETKSRCFSYKELE-EATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD 96
G G++ + + + E + D F+ G+G+FG + G ++T S VA+KK
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMS---VAIKK-- 55
Query: 97 RVFQDGEKEFKN----EVIVIGQTHHKNLVRLL------GFCDEGQNRL-LAYEFLNNGT 145
V QD F+N + + HH N+V+L G D L + E++ + T
Sbjct: 56 -VIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-T 111
Query: 146 LASFLFGNLKPNWNLRTN----IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNA 201
L + FQ+ R + LH S + H DIKP N+L+N+
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170
Query: 202 -RISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR-------KSTISAKVDVYSFGVL 253
++ DFG AK L+ ++ Y+ ++R + VD++S G +
Sbjct: 171 LKLCDFGSAKKLSPSEPNV---------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 254 LLEIISCR 261
E++
Sbjct: 222 FAEMMLGE 229
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 48/221 (21%), Positives = 89/221 (40%), Gaps = 52/221 (23%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--------VFQDGEKEFKNEVIVI 113
+ +G G+ G + + T VA+K + + D + E+ ++
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCK---KVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 114 GQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTL--------------ASFLFGNLKPNWN 159
+ +H ++++ F D ++ + E + G L F
Sbjct: 70 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-------- 120
Query: 160 LRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL---NDRYNARISDFGLAKLLTLNQ 216
+Q+ + YLH + IIH D+KP+N+LL + +I+DFG +K+L
Sbjct: 121 ------YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 217 RKTIKTAIRGTKGYVAPE---WFRKSTISAKVDVYSFGVLL 254
++T GT Y+APE + + VD +S GV+L
Sbjct: 172 L--MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 48/201 (23%), Positives = 80/201 (39%), Gaps = 25/201 (12%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV-IVIGQTHHKNLV 122
K+ +G G G + + + T A+K L + + EV + ++V
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQ---KCALKLLYDS-----PKARQEVDHHWQASGGPHIV 85
Query: 123 RLLGFCDEGQNRLLAY----EFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARVLLYLH 176
+L + + E + G L S + + R I I + +LH
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 177 EDCSSQIIHCDIKPQNILLNDRY-NA--RISDFGLAKLLTLNQRKTIKTAIRGTKGYVAP 233
S I H D+KP+N+L + +A +++DFG AK T N +T T YVAP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYYVAP 198
Query: 234 EWFRKSTISAKVDVYSFGVLL 254
E D++S GV++
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-21
Identities = 33/208 (15%), Positives = 74/208 (35%), Gaps = 21/208 (10%)
Query: 65 EEVGRG--SFGIIYKGVIQTTTTSTTAVAVKK--LDRVFQDGEKEFKNEVIVIGQTHHKN 120
+G+G + + T V V++ L+ + + E+ V +H N
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEY---VTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 87
Query: 121 LVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARVLLYLHE 177
+V + F+ G+ L + IA+ + + L Y+H
Sbjct: 88 IVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIH- 145
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIR---GTKGYVA 232
+H +K +IL++ +S + +++ + + +++
Sbjct: 146 --HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 233 PEWFRKSTI--SAKVDVYSFGVLLLEII 258
PE +++ AK D+YS G+ E+
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELA 231
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD-RVFQDGEKEFKNEVIVIGQTHHKNLVR 123
E +G G+ ++ VA+K+++ Q E E+ + Q HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEK---VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARV-------LLYL 175
L + L+ G++ + + + + IA + L YL
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI----KTAIRGTKGYV 231
H + IH D+K NILL + + +I+DFG++ L T KT + GT ++
Sbjct: 138 H---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWM 193
Query: 232 APEWF-RKSTISAKVDVYSFGVLLLEII 258
APE + K D++SFG+ +E+
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELA 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 28/232 (12%)
Query: 37 NSPGDGTIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD 96
G TI + +LE E+G G+ G ++K + T +AVK++
Sbjct: 8 KQTGYLTIGGQRYQAEINDLEN-----LGEMGSGTCGQVWKMRFRKTGH---VIAVKQMR 59
Query: 97 RVFQDGE-KEFKNEV-IVIGQTHHKNLVRLLG-FCDEGQNRL-LAYEFLNNGTLASFLFG 152
R E K ++ +V+ +V+ G F + +A E +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD--VFIAMELMGTCAEKLKKRM 117
Query: 153 NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212
+ + I + L YL E +IH D+KP NILL++R ++ DFG++ L
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175
Query: 213 --TLNQRKTIKTAIRGTKGYVAPE-----WFRKSTISAKVDVYSFGVLLLEI 257
+ ++ G Y+APE K + DV+S G+ L+E+
Sbjct: 176 VDDKAKDRSA-----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-21
Identities = 51/216 (23%), Positives = 82/216 (37%), Gaps = 52/216 (24%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV-IVIGQTHHKNL 121
+ +G G G + + + T A+K L + + EV + + ++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQE---KFALKMLQDC-----PKARREVELHWRASQCPHI 117
Query: 122 VRLLG-FCDEGQNRLLAY---EFLNNGTL----------------ASFLFGNLKPNWNLR 161
VR++ + + R E L+ G L AS
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS------------- 164
Query: 162 TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL-NDRYNA--RISDFGLAKLLTLNQRK 218
I I + YLH S I H D+KP+N+L + R NA +++DFG AK T +
Sbjct: 165 -EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 219
Query: 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
+ T T YVAPE D++S GV++
Sbjct: 220 -LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 65/316 (20%), Positives = 114/316 (36%), Gaps = 76/316 (24%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR------VFQDGEKEFKNEV----IVIG 114
+G+G FG ++ G T VA+K + R EV V
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQ---VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 115 QTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIAR 170
H ++RLL + + + +L E LF + L + F Q+
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQD---LFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
+ + H S ++H DIK +NIL++ R A++ DFG LL + GT+
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFD-GTRV 203
Query: 230 YVAPEWFR-KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA-FDCYRNGK 287
Y PEW + V+S G+LL Y ++ F+ +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILL-----------------YDMVCGDIPFERDQ--- 243
Query: 288 LDDLVEGDM--------EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ---MLQEV 336
+++E ++ + I+ C+ PS RP++ ++ M
Sbjct: 244 --EILEAELHFPAHVSPDCCALIR----------RCLAPKPSSRPSLEEILLDPWMQTPA 291
Query: 337 VEVDVPP---NPSPFS 349
+V + P P+P +
Sbjct: 292 EDVPLNPSKGGPAPLA 307
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKEF-KNEVIVIGQTHHKNLV 122
+GRG FG + V +T + A KKL R+ + + E ++ + H + +V
Sbjct: 193 LGRGGFG---E-VFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIV 248
Query: 123 RLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLHE 177
L + E + L L +N G + ++ + N + A F A+++ +LH
Sbjct: 249 SLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH- 306
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
II+ D+KP+N+LL+D N RISD GLA L Q KT GT G++APE
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLL 362
Query: 238 KSTISAKVDVYSFGVLLLEII 258
VD ++ GV L E+I
Sbjct: 363 GEEYDFSVDYFALGVTLYEMI 383
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-19
Identities = 65/320 (20%), Positives = 116/320 (36%), Gaps = 87/320 (27%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR------VFQDGEKEFKNEVIVIGQTHH 118
+G G FG +Y G+ + VA+K +++ EV+++ +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 119 K--NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARVL 172
++RLL + + + +L E LF + L+ +A F Q+ +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAV 162
Query: 173 LYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231
+ H + ++H DIK +NIL++ +R ++ DFG LL + GT+ Y
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD-GTRVYS 215
Query: 232 APEWFR-KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL-- 288
PEW R V+S G+LL Y ++ G +
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILL-----------------YDMVC---------GDIPF 249
Query: 289 ---DDLVEGD--------MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV-------- 329
++++ G E + I+ WC+ PS RPT ++
Sbjct: 250 EHDEEIIRGQVFFRQRVSSECQHLIR----------WCLALRPSDRPTFEEIQNHPWMQD 299
Query: 330 ---SQMLQEVVEVDVPPNPS 346
Q E+ + P PS
Sbjct: 300 VLLPQETAEIHLHSLSPGPS 319
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-19
Identities = 65/194 (33%), Positives = 101/194 (52%), Gaps = 18/194 (9%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLG 126
G G++G + V + T + VAVK +D D + K E+ + +H+N+V+ G
Sbjct: 16 GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 127 FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARVLLYLHEDCSSQ 182
EG + L E+ + G L F ++P+ + A F Q+ ++YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI-KTAIRGTKGYVAPEWF-RKST 240
I H DIKP+N+LL++R N +ISDFGLA + N R+ + GT YVAPE R+
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184
Query: 241 ISAKVDVYSFGVLL 254
+ VDV+S G++L
Sbjct: 185 HAEPVDVWSCGIVL 198
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDGEKEFKN------EVIVIGQT 116
+G G+FG ++ V + V VK + + V +D E E+ ++ +
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKE---VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARVL 172
H N++++L + L E +G LF + + L +A F Q+ +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
YL IIH DIK +NI++ + + ++ DFG A L + K T GT Y A
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFC-GTIEYCA 197
Query: 233 PEWFR-KSTISAKVDVYSFGVLLLEIISCRKSFD 265
PE +++++S GV L ++ F
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 50/250 (20%), Positives = 92/250 (36%), Gaps = 70/250 (28%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN-EVIVIGQTHHKNLVR 123
+ +G GSFGI+ + + A+KK V QD +KN E+ ++ H N+++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKR---FALKK---VLQD--PRYKNRELDIMKVLDHVNIIK 64
Query: 124 LL--------------------GFCDEGQNRLLAYEFLNNGTLASFLFGNL--------- 154
L+ N + + + + N+
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 155 ----KPNWNLRTNI--------AFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNA 201
K +I +Q+ R + ++H S I H DIKPQN+L+N
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTL 181
Query: 202 RISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR-------KSTISAKVDVYSFGVLL 254
++ DFG AK L ++ Y+ ++R + + +D++S G +
Sbjct: 182 KLCDFGSAKKLIPSEPSV---------AYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 255 LEIISCRKSF 264
E+I + F
Sbjct: 233 GELILGKPLF 242
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLV 122
VG G++G + + + + VA+KKL R FQ K E++++ H+N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEK---VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 86
Query: 123 RLL------GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
LL + L F+ L + ++ + +Q+ + L Y+H
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE-KIQ-YLVYQMLKGLKYIH 143
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
S+ ++H D+KP N+ +N+ +I DFGLA+ + T GYV W+
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMT---------GYVVTRWY 189
Query: 237 RKSTI-------SAKVDVYSFGVLLLEIISCRKSF 264
R + + VD++S G ++ E+++ + F
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 34/288 (11%), Positives = 73/288 (25%), Gaps = 54/288 (18%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE---KEFKNEVIVIGQTHHKNL 121
G ++ + VA+ +D + +E + + + + +
Sbjct: 37 IFHGGVPPLQFWQALDTALDR---QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
R+L L+ E++ G+L + P +R +A H +
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHR---A 148
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI 241
+ P + +S G L +
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA------- 179
Query: 242 SAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEGDMEAM 299
+ + D+ G L ++ R D A +D + + A+
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239
Query: 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNPSP 347
+ + Q D +R ++ M Q D P
Sbjct: 240 -----AARSV-------QGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAV-AVKKLD--RVFQDGEKEF-KNEVIVIGQTH 117
F + +G GSF V+ +T+ A+K L+ + ++ + + E V+ +
Sbjct: 33 KFGKILGEGSFST----VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 118 HKNLVRLLG-FCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL- 173
H V+L F D+ +L + NG L ++ + F A ++
Sbjct: 89 HPFFVKLYFTFQDD--EKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 174 --YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231
YLH IIH D+KP+NILLN+ + +I+DFG AK+L+ ++ + GT YV
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 232 APEWFRKSTISAKVDVYSFGVLLLEIIS 259
+PE + + D+++ G ++ ++++
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 65/194 (33%), Positives = 101/194 (52%), Gaps = 18/194 (9%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLG 126
G G++G + V + T + VAVK +D D + K E+ + +H+N+V+ G
Sbjct: 16 GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 127 FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARVLLYLHEDCSSQ 182
EG + L E+ + G L F ++P+ + A F Q+ ++YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR-KTIKTAIRGTKGYVAPEWF-RKST 240
I H DIKP+N+LL++R N +ISDFGLA + N R + + GT YVAPE R+
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184
Query: 241 ISAKVDVYSFGVLL 254
+ VDV+S G++L
Sbjct: 185 HAEPVDVWSCGIVL 198
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKEF-KNEVIVIGQTHHKNLV 122
+G+G FG + V +T + A KKL R+ + + NE ++ + + + +V
Sbjct: 192 LGKGGFG---E-VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247
Query: 123 RLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARVLLYLHEDC 179
L + E ++ L L +N G L ++ + + + A +I L LH
Sbjct: 248 SL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--- 303
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
+I++ D+KP+NILL+D + RISD GLA + +TIK + GT GY+APE +
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRV-GTVGYMAPEVVKNE 360
Query: 240 TISAKVDVYSFGVLLLEII 258
+ D ++ G LL E+I
Sbjct: 361 RYTFSPDWWALGCLLYEMI 379
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 49/213 (23%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDR----VFQDGEKEFKNEVIVIGQTHHKNLVR 123
G GS+G + + + T AVK L + +GE K E+ ++ + HKN+++
Sbjct: 14 GEGSYGKVKEVLDSETLCR---RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 124 L---------------LGFCDEGQNRLLAYEFLNNGTL----ASFLFGNLKPNWNLRTNI 164
L + +C G +L + A F
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDS--VPEKRFPVCQAHGYFC------------ 116
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL-TLNQRKTIKTA 223
Q+ L YLH S I+H DIKP N+LL +IS G+A+ L T +T+
Sbjct: 117 --QLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 224 IRGTKGYVAPEWFR--KSTISAKVDVYSFGVLL 254
+G+ + PE + KVD++S GV L
Sbjct: 172 -QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 58 EATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV-IVIG 114
D+++ ++GRG + +++ + T V VK L V +K+ K E+ I+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEK---VVVKILKPVK---KKKIKREIKILEN 86
Query: 115 QTHHKNLVRLLG-FCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVL 172
N++ L D L +E +NN L+ L ++R + ++I + L
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDY-DIRFYM-YEILKAL 143
Query: 173 LYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231
Y H S I+H D+KP N++++ + R+ D+GLA+ Q V
Sbjct: 144 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---------VRV 191
Query: 232 APEWFRKSTI-------SAKVDVYSFGVLLLEIISCRKSF 264
A +F+ + +D++S G +L +I ++ F
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-18
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 32/212 (15%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLVRL 124
+G G+ GI+ + VA+KKL R FQ+ K E++++ +HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 125 L------GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHED 178
L +E Q+ + E ++ L + L + + +Q+ + +LH
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHE-RMSY-LLYQMLCGIKHLH-- 144
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR- 237
S+ IIH D+KP NI++ +I DFGLA+ + T YV ++R
Sbjct: 145 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVVTRYYRA 194
Query: 238 -----KSTISAKVDVYSFGVLLLEIISCRKSF 264
VD++S G ++ E+I F
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-18
Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 12/190 (6%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDR--VFQDGEKEFKNEVIVIGQTHHKNLVRLL 125
G+G+F + T VA+K +D+ + ++ EV ++ +H N+V+L
Sbjct: 24 GKGNFAKVKLARHILTGRE---VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 126 GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIH 185
+ + L E+ + G + +L + + + QI + Y H+ I+H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVH 137
Query: 186 CDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR-KSTISAK 244
D+K +N+LL+ N +I+DFG + T+ + G Y APE F+ K +
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFC-GAPPYAAPELFQGKKYDGPE 194
Query: 245 VDVYSFGVLL 254
VDV+S GV+L
Sbjct: 195 VDVWSLGVIL 204
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLV 122
+ +G G+ GI+ + VA+KKL R FQ+ K E++++ +HKN++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 123 RLL------GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
LL +E Q+ L E ++ L + L + + +Q+ + +LH
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHER--MSYLLYQMLCGIKHLH 181
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
S+ IIH D+KP NI++ +I DFGLA+ + T YV ++
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVVTRYY 229
Query: 237 R------KSTISAKVDVYSFGVLLLEIISCRKSF 264
R VD++S G ++ E++ + F
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 47/228 (20%), Positives = 82/228 (35%), Gaps = 49/228 (21%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE--FKN---------EVIVI 113
+ GS+G V + VA+K++ DG + E+ ++
Sbjct: 28 RFISSGSYGA----VCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 114 GQTHHKNLVRLL-----GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN----- 163
HH N++ L L E + + L + + +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQRIVISPQHIQY 138
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223
+ I L LH + ++H D+ P NILL D + I DF LA+ T + KT
Sbjct: 139 FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT---- 191
Query: 224 IRGTKGYVAPEWFRKSTI-------SAKVDVYSFGVLLLEIISCRKSF 264
YV W+R + + VD++S G ++ E+ + + F
Sbjct: 192 -----HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLV 122
VG G++G + T VAVKKL R FQ K E+ ++ H+N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 123 RLL------GFCDEGQNRLLAYEFLNNGT-LASFLFGNLKPNWNLRTNIAFQIARVLLYL 175
LL +E + L + G L + + + +++ + +QI R L Y+
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQ-FLIYQILRGLKYI 148
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
H S+ IIH D+KP N+ +N+ +I DFGLA+ T GYVA W
Sbjct: 149 H---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMT---------GYVATRW 194
Query: 236 FRKSTI-------SAKVDVYSFGVLLLEIISCRKSF 264
+R I + VD++S G ++ E+++ R F
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 21/205 (10%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGF 127
G G+FG+ + T VAVK ++R E + E+I H N+VR
Sbjct: 29 GSGNFGVARLMRDKLTKEL---VAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEV 84
Query: 128 CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARVLLYLHEDCSSQI 183
+ + E+ + G L + + + A F Q+ + Y H S QI
Sbjct: 85 ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQI 137
Query: 184 IHCDIKPQNILL--NDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF-RKST 240
H D+K +N LL + +I DFG +K L+ + K+ + GT Y+APE R+
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV-GTPAYIAPEVLLRQEY 194
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFD 265
DV+S GV L ++ F+
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 60/228 (26%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLV 122
+ VG G++G + V T VA+KKL R FQ K E+ ++ H+N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAK---VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 123 RLL------GFCDEGQNRLLAYEF-------------LNNGTLASFLFGNLKPNWNLRTN 163
LL D+ + L F L + ++
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY------------ 135
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223
Q+ + L Y+H ++ IIH D+KP N+ +N+ +I DFGLA+ + T
Sbjct: 136 ---QMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMT---- 183
Query: 224 IRGTKGYVAPEWFRKSTI-------SAKVDVYSFGVLLLEIISCRKSF 264
GYV W+R + + VD++S G ++ E+I+ + F
Sbjct: 184 -----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-16
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN-----EVIVI 113
+ ++ ++G GS+G+++K + T VA+KK + + E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQ---IVAIKK---FLESEDDPVIKKIALREIRML 56
Query: 114 GQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARV 171
Q H NLV LL + L +E+ ++ T+ L + P ++ +I +Q +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQA 114
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK-TIKTAIRGTKGY 230
+ + H IH D+KP+NIL+ ++ DFG A+LLT + A T+ Y
Sbjct: 115 VNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA---TRWY 168
Query: 231 VAPEWFRKSTI-SAKVDVYSFGVLLLEIISCR 261
+PE T VDV++ G + E++S
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 21/195 (10%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDR---VFQDGEKEFKNEVIVIGQTHHKNLVRL 124
G G+FG + G Q T VAVK L+R D + K E+ + H ++++L
Sbjct: 20 GVGTFGKVKIGEHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARVLLYLHEDCS 180
+ + E+++ G L F + + + A F QI + Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCH---R 129
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR-KS 239
++H D+KP+N+LL+ NA+I+DFGL+ +++ + ++T+ G+ Y APE +
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRL 186
Query: 240 TISAKVDVYSFGVLL 254
+VD++S GV+L
Sbjct: 187 YAGPEVDIWSCGVIL 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 8e-16
Identities = 49/211 (23%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN-----EVIVI 113
++ E++G G++G ++K T VA+K++ R+ D + E E+ ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKA-KNRETHEI--VALKRV-RL--DDDDEGVPSSALREICLL 55
Query: 114 GQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVL 172
+ HKN+VRL + L +EF + L + + + + FQ+ + L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
+ H S ++H D+KPQN+L+N ++++FGLA+ + R + T Y
Sbjct: 115 GFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRP 169
Query: 233 PEWFRKSTI-SAKVDVYSFGVLLLEIISCRK 262
P+ + + S +D++S G + E+ + +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 55/234 (23%), Positives = 106/234 (45%), Gaps = 53/234 (22%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE------------KEFKNEV 110
+++G+G++GI++K + + T VAVKK+ FQ+ E
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEV---VAVKKIFDAFQNSTDAQRTFREIMILTELSG-- 67
Query: 111 IVIGQTHHKNLVRLLG-FCDEGQNRL-LAYEFLNNGT-LASFLFGNLKPNWNLRTNIAFQ 167
H+N+V LL + + L ++++ T L + + N+ + + + +Q
Sbjct: 68 -------HENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQY-VVYQ 117
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGT 227
+ +V+ YLH S ++H D+KP NILLN + +++DFGL++ +R T +
Sbjct: 118 LIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 228 K-------------GYVAPEWFR-------KSTISAKVDVYSFGVLLLEIISCR 261
+ YVA W+R + + +D++S G +L EI+ +
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 59 ATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV------ 110
AT ++ E+G G++G +YK + + VA+K + RV +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHF-VALKSV-RV--PNGGGGGGGLPISTVR 60
Query: 111 -IVI----GQTHHKNLVRLL----GFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNL 160
+ + H N+VRL+ + + ++ L +E ++ L ++L P
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 161 RT--NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218
T ++ Q R L +LH ++ I+H D+KP+NIL+ +++DFGLA++ +
Sbjct: 120 ETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
T T Y APE +ST + VD++S G + E+
Sbjct: 177 TPVVV---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE-------------KE 105
++ E+G G++G ++K VA+K++ RV E +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRF--VALKRV-RVQTGEEGMPLSTIREVAVLRH 67
Query: 106 FKNEVIVIGQTHHKNLVRLL----GFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNL 160
+ H N+VRL + + +L L +E ++ L ++L +P
Sbjct: 68 LE-------TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 161 RT--NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218
T ++ FQ+ R L +LH S +++H D+KPQNIL+ +++DFGLA++ +
Sbjct: 120 ETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 176
Query: 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS 259
T T Y APE +S+ + VD++S G + E+
Sbjct: 177 TSVVV---TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 48/226 (21%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR-------------------------- 97
K+E+G+GS+G++ + T A+K L +
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTY---YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 98 VFQDGEKEFKNEVIVIGQTHHKNLVRLLG-FCDEGQNRL-LAYEFLNNGTLASFLFGNLK 155
+ ++ E+ ++ + H N+V+L+ D ++ L + +E +N G + LK
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--MEVPTLK 132
Query: 156 PNWNLRTNIA---F-QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211
P L + A F + + + YLH +IIH DIKP N+L+ + + +I+DFG++
Sbjct: 133 P---LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 212 LTLNQRKTIKTAIRGTKGYVAPE---WFRKSTISAKVDVYSFGVLL 254
+ T GT ++APE RK +DV++ GV L
Sbjct: 187 FKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FKN----EVIVIGQTHHK 119
VG GS+G++ K + T VA+KK + + + K E+ ++ Q H+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGR---IVAIKK---FLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLHE 177
NLV LL C + + L +EF+++ T+ L F N ++ FQI + + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ-KYLFQIINGIGFCH- 141
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK-TIKTAIRGTKGYVAPEWF 236
S IIH DIKP+NIL++ ++ DFG A+ L + A T+ Y APE
Sbjct: 142 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA---TRWYRAPELL 196
Query: 237 RKSTI-SAKVDVYSFGVLLLEIIS 259
VDV++ G L+ E+
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFM 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 49/238 (20%), Positives = 99/238 (41%), Gaps = 50/238 (21%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN---EVIVIGQTHHKN 120
+ +G GS+G + + + VA+KK+ RVF+D + K E+ ++ + +H +
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRV---VAIKKILRVFED-LIDCKRILREIAILNRLNHDH 113
Query: 121 LVRLLGFC----DEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARV 171
+V++L E + L + E + S + L + + +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIAD-----SDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK--- 228
+ Y+H S+ I+H D+KP N L+N + ++ DFGLA+ + + + I +
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 229 ----------------GYVAPEWFR-------KSTISAKVDVYSFGVLLLEIISCRKS 263
G+V W+R + + +DV+S G + E+++ K
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 33/184 (17%)
Query: 163 NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN----QRK 218
+FQ+A+ + +L S + IH D+ +NILL+++ +I DFGLA+ + + ++
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILT 276
+ ++ APE + + DV+SFGVLL EI S S +++ EE
Sbjct: 254 DARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FC 306
Query: 277 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMISIWCIQEDPSLRPTMRKVSQMLQ 334
+ R M A + ++ M+ W +PS RPT ++ + L
Sbjct: 307 RRLKEGTR-----------MRAPDY--TTPEMYQTMLDCW--HGEPSQRPTFSELVEHLG 351
Query: 335 EVVE 338
+++
Sbjct: 352 NLLQ 355
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 9e-08
Identities = 35/160 (21%), Positives = 62/160 (38%), Gaps = 12/160 (7%)
Query: 63 FKEEVGRGSFGIIYKGVIQ--TTTTSTTAVAVKKLDRVFQDGE-KEFKNEVIVIGQ-THH 118
+ +GRG+FG + + T + VAVK L E + +E+ ++ HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 119 KNLVRLLGFC-DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHE 177
N+V LLG C G ++ EF G L+++L + R + +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217
I D+K + + ++ S F K L+ +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 41/224 (18%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKEF-KNEVIVIGQTHHKNLV 122
+G+GSFG K V T + A+K + + + E E+ ++ H LV
Sbjct: 23 IGKGSFG---K-VCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 123 RLLG-FCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARV--------- 171
L F DE + + + L G L ++L+ N+ F+ V
Sbjct: 79 NLWYSFQDEE--DMFMVVDLLLGGDL----R------YHLQQNVHFKEETVKLFICELVM 126
Query: 172 -LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGY 230
L YL + +IIH D+KP NILL++ + I+DF +A +L + T + GTK Y
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPY 180
Query: 231 VAPEWFRKSTI---SAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
+APE F S VD +S GV E++ R+ + I
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 29/205 (14%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQ-DGEKEFKNEVIV---IGQTHHK 119
+GRG FG + V T + A+K L R+ GE NE I+ +
Sbjct: 197 IGRGGFG---E-VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 120 NLVRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---Y 174
+V + + ++L + +N G L +L + F A ++L +
Sbjct: 253 FIVCM-SYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE 234
+H + +++ D+KP NILL++ + RISD GLA + + GT GY+APE
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 360
Query: 235 WFRKSTISAK-VDVYSFGVLLLEII 258
+K D +S G +L +++
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 28/205 (13%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKE-FKNEVIVIGQTHHKNLV 122
+GRG+FG V + V A+K L + + E F+ E V+ K +
Sbjct: 82 IGRGAFG----EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 123 RLLG-FCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLH 176
L F D+ N L L ++ G L + L K L +A F +A +++ +H
Sbjct: 138 TLHYAFQDD--NNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
+H DIKP NIL++ + R++DFG L + A+ GT Y++PE
Sbjct: 193 ---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEIL 248
Query: 237 RKSTISAK-----VDVYSFGVLLLE 256
+ D +S GV + E
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 47/219 (21%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKN 120
K +G G++G++ + T VA+KK+ F E+ ++ H+N
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEI---VAIKKI-EPFDKPLFALRTLREIKILKHFKHEN 70
Query: 121 LVRLL-----GFCDEGQNRLLAYEFLNNGT-LASFLFGNLKPNWNLRTNIAFQIARVLLY 174
++ + + + E + T L + + + +++ +Q R +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQY-FIYQTLRAVKV 127
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK--GYVA 232
LH S +IH D+KP N+L+N + ++ DFGLA+++ + + + + +VA
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 233 PEWFR-------KSTISAKVDVYSFGVLLLEIISCRKSF 264
W+R + S +DV+S G +L E+ R F
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 51/232 (21%), Positives = 96/232 (41%), Gaps = 43/232 (18%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNL 121
K +GRGS+G +Y + T + VA+KK++R+F+D K E+ ++ + +
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKN---VAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 122 VRLLG-FCDEGQNRL----LAYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARVL 172
+RL + + + E + S L K L I + +
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIAD-----SDLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK---- 228
++H S IIH D+KP N LLN + ++ DFGLA+ + + I + +
Sbjct: 143 NFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 229 ----------GYVAPEWFR-------KSTISAKVDVYSFGVLLLEIISCRKS 263
+V W+R + + +D++S G + E+++ +S
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 28/206 (13%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKE-FKNEVIVIGQTHHKNLV 122
+GRG+F V T V A+K + + + GE F+ E V+ + +
Sbjct: 69 IGRGAFS----EVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 123 RLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLHE 177
+L F + +N L L E+ G L + L K + +A F +A +++ +H
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLL---SKFGERIPAEMARFYLAEIVMAIDSVH- 179
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
+H DIKP NILL+ + R++DFG L + A+ GT Y++PE +
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQ 236
Query: 238 KSTISAKVDVY-------SFGVLLLE 256
Y + GV E
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 53/195 (27%), Positives = 95/195 (48%), Gaps = 21/195 (10%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDR---VFQDGEKEFKNEVIVIGQTHHKNLVRL 124
G G+FG + G + T VAVK L+R D + + E+ + H ++++L
Sbjct: 25 GVGTFGKVKVGKHELTGHK---VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARVLLYLHEDCS 180
+ + E+++ G L F + N L + F QI + Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCH---R 134
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR-KS 239
++H D+KP+N+LL+ NA+I+DFGL+ +++ + ++T+ G+ Y APE +
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRL 191
Query: 240 TISAKVDVYSFGVLL 254
+VD++S GV+L
Sbjct: 192 YAGPEVDIWSSGVIL 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 6e-15
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 26/212 (12%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN-----EVIVI 113
+ ++ E+VG G++G++YK VA+K+ + D E E E+ ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRI----VALKR---IRLDAEDEGIPSTAIREISLL 73
Query: 114 GQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIAR 170
+ HH N+V L+ + L +EF+ L L L+ + ++ +Q+ R
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDS-QIKI-YLYQLLR 130
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGY 230
+ + H +I+H D+KPQN+L+N +++DFGLA+ + R + T Y
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWY 185
Query: 231 VAPEWFRKSTI-SAKVDVYSFGVLLLEIISCR 261
AP+ S S VD++S G + E+I+ +
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 72.5 bits (179), Expect = 9e-15
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN-----EVIVI 113
+ + E++G G++G++YK T A+KK + + E E E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKK---IRLEKEDEGIPSTTIREISIL 54
Query: 114 GQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARV 171
+ H N+V+L + +L +E L+ L L + T + Q+
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL-DVCEGGLESVTAKSFLLQLLNG 112
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231
+ Y H +++H D+KPQN+L+N +I+DFGLA+ + RK T T Y
Sbjct: 113 IAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYR 167
Query: 232 APEWFRKSTI-SAKVDVYSFGVLLLEIISCR 261
AP+ S S +D++S G + E+++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 44/216 (20%), Positives = 91/216 (42%), Gaps = 26/216 (12%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG-EKEFKNEVIVIGQTHHKNLV 122
+VGRG++G +YK + A+K+++ G E+ ++ + H N++
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKD-YALKQIEG---TGISMSACREIALLRELKHPNVI 81
Query: 123 RLLG-FCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTN---------IAFQIARV 171
L F ++ L +++ + L + + N + + +QI
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 172 LLYLHEDCSSQIIHCDIKPQNILLNDRYNAR----ISDFGLAKLLTLNQRK-TIKTAIRG 226
+ YLH ++ ++H D+KP NIL+ R I+D G A+L + +
Sbjct: 141 IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 227 TKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCR 261
T Y APE + + +D+++ G + E+++
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 27/203 (13%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKE-FKNEVIVIGQTHHKNLV 122
+GRG+FG V ST V A+K L + + + F E ++ + +V
Sbjct: 77 IGRGAFG----EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 123 RLLG-FCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLL---YLHE 177
+L F D+ L + E++ G L + + P R F A V+L +H
Sbjct: 133 QLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWAR----FYTAEVVLALDAIH- 185
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
S IH D+KP N+LL+ + +++DFG + TA+ GT Y++PE +
Sbjct: 186 --SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLK 242
Query: 238 KSTISAK----VDVYSFGVLLLE 256
D +S GV L E
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYE 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 68 GRGSFGIIYKGVIQTTTTSTTAVAVKKLDR---VFQDGEKEFKNEVIVIGQTHHKNLVRL 124
G GSFG + T VA+K + R D + E+ + H ++++L
Sbjct: 18 GEGSFGKVKLATHYKTQQK---VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASF--------LFGNLKPNWNLRTNIA---F-QIARVL 172
Y+ + T LF + + + F QI +
Sbjct: 75 -------------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
Y H +I+H D+KP+N+LL+D N +I+DFGL+ ++T +KT+ G+ Y A
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAA 175
Query: 233 PEWFR-KSTISAKVDVYSFGVLLLEIISCRKSFD 265
PE K +VDV+S G++L ++ R FD
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN-----EVIVI 113
D ++ ++G G++G +YK I T T T VA+K++ R+ + E+E EV ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKA-IDTVTNET--VAIKRI-RL--EHEEEGVPGTAIREVSLL 87
Query: 114 GQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLL 173
+ H+N++ L L +E+ N L ++ N + + + +Q+ +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNAR-----ISDFGLAKLLTLNQRKTIKTAIRGTK 228
+ H S + +H D+KPQN+LL+ + I DFGLA+ + R+ I T
Sbjct: 147 FCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TL 201
Query: 229 GYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCR 261
Y PE S S VD++S + E++
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKEF-KNEVIVIGQTHHKNLV 122
+G+G+FG K VI +T A+K L + + E E V+ + H L
Sbjct: 156 LGKGTFG---K-VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 123 RLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLHE 177
L + + +RL E+ N G L F +L + A F A ++ YLH
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
+ + +++ D+K +N++L+ + +I+DFGL K + GT Y+APE
Sbjct: 267 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAPEVLE 322
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFD 265
+ VD + GV++ E++ R F
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFY 350
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLV 122
+G G++G++ VA+KK+ F+ + E+ ++ + H+N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVR---VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENII 88
Query: 123 RLL-----GFCDEGQNRLLAYEFLNNGT-LASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
+ ++ ++ + + + T L L N ++ +QI R L Y+H
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 145
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK-TAIRGTKGYVAPEW 235
S+ ++H D+KP N+LLN + +I DFGLA++ + T T YVA W
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT------EYVATRW 196
Query: 236 FRKSTI-------SAKVDVYSFGVLLLEIISCRKSF 264
+R I + +D++S G +L E++S R F
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 44/216 (20%), Positives = 74/216 (34%), Gaps = 73/216 (33%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV-IVIGQTHHKNL 121
+ +G G G + + + T A+K L + + EV + + ++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQE---KFALKMLQDC-----PKARREVELHWRASQCPHI 73
Query: 122 VRLLG-FCDEGQNRLLAY---EFLNNGTL----------------ASFLFGNLKPNWNLR 161
VR++ + + R E L+ G L AS
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS------------- 120
Query: 162 TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NA--RISDFGLAKLLTLNQRK 218
I I + YLH S I H D+KP+N+L + NA +++DFG AK T
Sbjct: 121 -EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----- 171
Query: 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLL 254
+ Y D++S GV++
Sbjct: 172 --------GEKY-----------DKSCDMWSLGVIM 188
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 8e-14
Identities = 53/218 (24%), Positives = 103/218 (47%), Gaps = 38/218 (17%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG-------E----KEFK 107
+ + +++G G++ +YKG + T VA+K++ ++G E K+ K
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDN---LVALKEIRLEHEEGAPCTAIREVSLLKDLK 58
Query: 108 NEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL---FGNLKPNWNLRTNI 164
H N+V L ++ L +E+L+ L +L + + N++
Sbjct: 59 ----------HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH-NVKL-F 105
Query: 165 AFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAI 224
FQ+ R L Y H +++H D+KPQN+L+N+R +++DFGLA+ ++ + +
Sbjct: 106 LFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV 162
Query: 225 RGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCR 261
T Y P+ ST S ++D++ G + E+ + R
Sbjct: 163 --TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 49/224 (21%), Positives = 97/224 (43%), Gaps = 41/224 (18%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FKN----EVIVI 113
++ ++G+G+FG ++K + T VA+KK+ + + EKE F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQ---KVALKKV-LM--ENEKEGFPITALREIKIL 70
Query: 114 GQTHHKNLVRLLGFCDEGQNRL--------LAYEFLNN---GTLAS----FLFGNLKPNW 158
H+N+V L+ C + L ++F + G L++ F +K
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK--- 127
Query: 159 NLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218
+ + L Y+H ++I+H D+K N+L+ +++DFGLA+ +L +
Sbjct: 128 ----RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 219 TIK--TAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIIS 259
T T Y PE +D++ G ++ E+ +
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 20/162 (12%)
Query: 59 ATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN----EVIV 112
++ FK E++G G++ +YKG + TT VA+K++ ++ D E+ + E+ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKG-LNKTTGVY--VALKEV-KL--DSEEGTPSTAIREISL 56
Query: 113 IGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN---GTLASFLFGNLKPNWNLRT--NIAFQ 167
+ + H+N+VRL L +EF++N + S GN L +Q
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209
+ + L + H ++I+H D+KPQN+L+N R ++ DFGLA
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 25/163 (15%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKN--------EV 110
++ + +G G F +YK T VA+KK+ ++ E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKA-RDKNTNQI--VAIKKI-KL--GHRSEAKDGINRTALREI 63
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQ 167
++ + H N++ LL N L ++F+ L + L P+ +++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPS-HIKA-YMLM 120
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210
+ L YLH I+H D+KP N+LL++ +++DFGLAK
Sbjct: 121 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 45/225 (20%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLV 122
+ +G G G+++ V VA+KK+ V D + K E+ +I + H N+V
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKR---VAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 123 RLLGF----CDEGQNRLLAYEFLNNGTLASFLFG-NLKPNWNLRTN---------IAFQI 168
++ + + + + LN+ + +L L +Q+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDL--ANVLEQGPLLEEHARLFMYQL 129
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLL-TLNQRKTIKTAIRG 226
R L Y+H S+ ++H D+KP N+ +N + +I DFGLA+++ K +
Sbjct: 130 LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS---- 182
Query: 227 TKGYVAPEWFRKSTI-------SAKVDVYSFGVLLLEIISCRKSF 264
+ +W+R + + +D+++ G + E+++ + F
Sbjct: 183 --EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 24/198 (12%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKE-FKNEVIVIGQTHHKNLV 122
+G GSFG V+ + A+K L +V + + E NE ++ + LV
Sbjct: 49 LGTGSFG----RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLHED 178
+L + N + E++ G + F +L+ A F A+++L YLH
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 179 CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK 238
S +I+ D+KP+N+L++ + +++DFG AK + + +T T + GT +APE
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRT-WT-LCGTPEALAPEIILS 212
Query: 239 STISAKVDVYSFGVLLLE 256
+ VD ++ GVL+ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKEF-KNEVIVIGQTHHKNLV 122
+G+G+FG K VI +T A+K L + + E E V+ T H L
Sbjct: 13 LGKGTFG---K-VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 123 RLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLHE 177
L + + +RL E+ N G L F +L A F A ++ YLH
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVSALEYLH- 122
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
S +++ DIK +N++L+ + +I+DFGL K + KT GT Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KT-FCGTPEYLAPEVLE 178
Query: 238 KSTISAKVDVYSFGVLLLEIISCRKSFD 265
+ VD + GV++ E++ R F
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 4e-13
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 29/203 (14%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKL--DRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
+G+GSFG ++ + + + A+K L + K E ++ + +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 125 LGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARV----------LL 173
+ + + +L L +FL G L F L + F V L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL----F------TRLSKEVMFTEEDVKFYLAELALALD 140
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAP 233
+LH S II+ D+KP+NILL++ + +++DFGL+K +++K + GT Y+AP
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--YSFCGTVEYMAP 195
Query: 234 EWFRKSTISAKVDVYSFGVLLLE 256
E + + D +SFGVL+ E
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFE 218
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 9e-13
Identities = 50/223 (22%), Positives = 88/223 (39%), Gaps = 33/223 (14%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVK---KLDRVFQDGEKEFK-----NEVIVIGQT 116
++G G F ++ T VA+K + E E K N+ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNT---HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 117 H--HKNLVRLLG-FCDEGQNRL---LAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQI 168
++++LL F +G N + + +E L L + + L I+ Q+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLND------RYNARISDFGLAKLLTLNQRKTIKT 222
L Y+H C IIH DIKP+N+L+ +I+D G A + +I+
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ- 197
Query: 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFD 265
T+ Y +PE + D++S L+ E+I+ F+
Sbjct: 198 ----TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKEF-KNEVIVIGQ-THHKNL 121
+G+GSFG K V+ + T + AVK L D V QD + E E V+ L
Sbjct: 349 LGKGSFG---K-VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 122 VRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLH 176
+L C + +RL E++N G L +++ + A F A + + +L
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
S II+ D+K N++L+ + +I+DFG+ K + T KT GT Y+APE
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KT-FCGTPDYIAPEII 514
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 277
VD ++FGVLL E+++ + F+ E +E +I+
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKEF-KNEVIVIGQ-THHKNL 121
+G+GSFG K V+ T + AVK L D + QD + E E ++ +H L
Sbjct: 31 LGKGSFG---K-VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 122 VRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLH 176
+L C + +RL EF+N G L +++ + A F A ++ +LH
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
II+ D+K N+LL+ + +++DFG+ K N T GT Y+APE
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIAPEIL 196
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 277
++ VD ++ GVLL E++ F+ E ++ AIL D
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 2e-12
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 38/205 (18%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKE-FKNEVIVIGQTHHKNLV 122
+G GSFG + V + A+K L + V + + E +E +++ H ++
Sbjct: 14 LGTGSFG---R-VHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69
Query: 123 RLLG-FCDEGQNRL-LAYEFLNNGTLASFL-----FGNLKPNWNLRTNIA-FQIARVLL- 173
R+ G F D ++ + +++ G L S L F N +A F A V L
Sbjct: 70 RMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPN---------PVAKFYAAEVCLA 118
Query: 174 --YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231
YLH S II+ D+KP+NILL+ + +I+DFG AK + T + GT Y+
Sbjct: 119 LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYT-LCGTPDYI 170
Query: 232 APEWFRKSTISAKVDVYSFGVLLLE 256
APE + +D +SFG+L+ E
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYE 195
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 4e-12
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKEF-KNEVIVIGQ-THHKNL 121
+G+GSFG K V+ + T + AVK L D V QD + E E V+ L
Sbjct: 28 LGKGSFG---K-VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 122 VRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLH 176
+L C + +RL E++N G L +++ + A F A + + +L
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
S II+ D+K N++L+ + +I+DFG+ K + T KT GT Y+APE
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KT-FCGTPDYIAPEII 193
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 277
VD ++FGVLL E+++ + F+ E +E +I+
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKEF-KNEVIVIGQ-THHKNL 121
+G+GSFG K V+ + AVK L + + E++ +E V+ + H L
Sbjct: 46 IGKGSFG---K-VLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 122 VRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLH 176
V L F + ++L +++N G L F +L+ A F A + YLH
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
S I++ D+KP+NILL+ + + ++DFGL K + T + GT Y+APE
Sbjct: 157 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEYLAPEVL 211
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFD 265
K VD + G +L E++ F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKEF-KNEVIVIGQ-THHKNL 121
+GRGS+ K V+ T + A+K + + V D + ++ + E V Q ++H L
Sbjct: 17 IGRGSYA---K-VLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 122 VRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLH 176
V L C + ++RL E++N G L +++ L A F A + L YLH
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
II+ D+K N+LL+ + +++D+G+ K T + GT Y+APE
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEIL 182
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
R VD ++ GVL+ E+++ R FDI +
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKEF-KNEVIVIGQ-THHKNL 121
+GRGS+ K V+ T + A++ + + V D + ++ + E V Q ++H L
Sbjct: 60 IGRGSYA---K-VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 122 VRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLH 176
V L C + ++RL E++N G L +++ L A F A + L YLH
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
E II+ D+K N+LL+ + +++D+G+ K T + GT Y+APE
Sbjct: 171 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEIL 225
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271
R VD ++ GVL+ E+++ R FDI +
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 26/223 (11%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAV-AVKKL--DRVFQDGEKE-FKNEVIVIGQ-THHKNL 121
+G+GSFG K V T A+K L D V D + E E V+ H L
Sbjct: 25 LGKGSFG---K-VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 122 VRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL---YLH 176
+ + + L E+LN G L +++ + A F A ++L +LH
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
S I++ D+K NILL+ + +I+DFG+ K L KT GT Y+APE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEIL 190
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 277
+ VD +SFGVLL E++ + F + EE ++I D
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 5e-11
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 29/204 (14%)
Query: 67 VGRGSFGIIYKGVIQ---TTTTSTTAV-AVKKL--DRVFQDGEKEF---KNEVIVIGQTH 117
+G+G +G K V Q T +T + A+K L + ++ K+ K E ++ +
Sbjct: 25 LGKGGYG---K-VFQVRKVTGANTGKIFAMKVLKKAMIVRN-AKDTAHTKAERNILEEVK 79
Query: 118 HKNLVRLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARVLL-- 173
H +V L+ + + +L L E+L+ G L F L+ + A F +A + +
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMAL 134
Query: 174 -YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
+LH II+ D+KP+NI+LN + + +++DFGL K + T T GT Y+A
Sbjct: 135 GHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HT-FCGTIEYMA 189
Query: 233 PEWFRKSTISAKVDVYSFGVLLLE 256
PE +S + VD +S G L+ +
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYD 213
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 9e-11
Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 39/211 (18%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVK---KLDRVFQDGEKEFK--NEVIVIGQTHHK 119
+ +G+GSFG + K VA+K R + +E + + + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQH---VALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 120 NLVRLLGFCD---------E--GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI 168
N++ +L E N YE + F ++ A I
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGFSLPLVRK-------FAHSI 209
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLND--RYNARISDFGLAKLLTLNQRKTIKTAIRG 226
+ L LH ++IIHCD+KP+NILL R ++ DFG + + + + T I+
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQ- 261
Query: 227 TKGYVAPEWFRKSTISAKVDVYSFGVLLLEI 257
++ Y APE + +D++S G +L E+
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 35/158 (22%), Positives = 57/158 (36%), Gaps = 56/158 (35%)
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN--------------------------- 196
I Q+ + L YLH C +IIH DIKP+NILL+
Sbjct: 151 IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 197 ----------------------DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE 234
++ +I+D G A + + + I+ T+ Y + E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLE 263
Query: 235 WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 272
S + D++S + E+ + F+ GEEY
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 6/103 (5%)
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRG 226
+I L +LH II+ DIK +NILL+ + ++DFGL+K ++ + G
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCG 222
Query: 227 TKGYVAPE--WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIE 267
T Y+AP+ S VD +S GVL+ E+++ F ++
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 29/165 (17%), Positives = 66/165 (40%), Gaps = 26/165 (15%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTA-----VAVK------KLDRVFQDGEKEFKNEVIVIGQ 115
R + GI+Y+ +T T + ++K +L ++ K + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 116 THHKNLV----RLLGF-CDEGQNRLLAYEFLNNGT-LASFLFGNLKPNWNLRT--NIAFQ 167
+ + +GF + + R L L G L S L + K + R+ +A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI--SDFGLAK 210
+ L +LH ++ +H ++ +NI ++ +++ + +G A
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 36/161 (22%), Positives = 67/161 (41%), Gaps = 22/161 (13%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVK--KLDRVFQDGEKEFKNEVIVIGQT 116
++K +G GSFG+I++G T + VA+K E++ ++ G T
Sbjct: 10 VHYKVGRRIGEGSFGVIFEG---TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 66
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLY 174
+ + F EG + +L + L G L ++++T A Q+ +
Sbjct: 67 G---IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNAR-----ISDFGLAK 210
+H +++ DIKP N L+ + + DFG+ K
Sbjct: 122 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 37/155 (23%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVK--KLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+++G G+FG + G + VA+K + E++ + +
Sbjct: 15 KKIGCGNFGELRLG---KNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IP 68
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCS 180
++ F G+ + E L G LF ++L+T IA Q+ + Y+H S
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---S 123
Query: 181 SQIIHCDIKPQNILLNDRYNAR-----ISDFGLAK 210
+I+ D+KP+N L+ N I DF LAK
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 34/164 (20%), Positives = 62/164 (37%), Gaps = 27/164 (16%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLD-----------RVFQD-GEKEFKNEVIVIG 114
+G G FG+IY T A V K++ + +Q +K+ + I
Sbjct: 45 IGSGGFGLIYLA-FPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 115 QTHHKNLVRLLGF----CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQI 168
Q + + G R + E L G + + T + ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTVLQLGIRM 160
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI--SDFGLAK 210
VL Y+H ++ +H DIK N+LL + ++ +D+GL+
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILL--NDRYNARISDFGLAKLLTLNQRKTIK 221
A Q+ LL+L IIHCD+KP+NILL R +I DFG + + I
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIY 216
Query: 222 TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLE 256
I+ ++ Y +PE +D++S G +L+E
Sbjct: 217 QYIQ-SRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 41/152 (26%), Positives = 61/152 (40%), Gaps = 16/152 (10%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ-THHKNLVR 123
++G GSFG IY G T + VA+K + + E + +
Sbjct: 15 RKIGSGSFGDIYLG---TDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPT 69
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYLHEDCSS 181
+ EG ++ E L G LF ++L+T +A Q+ + Y+H S
Sbjct: 70 IRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 124
Query: 182 QIIHCDIKPQNILL---NDRYNARISDFGLAK 210
IH D+KP N L+ I DFGLAK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 29/114 (25%)
Query: 163 NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK- 221
++A+Q+ L +LHE +Q+ H D+KP+NIL + + + + + +I+
Sbjct: 127 HMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 222 -------------TAIRGTKGYVAPE------WFRKSTISAKVDVYSFGVLLLE 256
T I T+ Y PE W + DV+S G +L E
Sbjct: 184 ADFGSATFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFE 231
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 43/158 (27%), Positives = 66/158 (41%), Gaps = 18/158 (11%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHH 118
+ F+ ++G GSFG IY G T + VA+K + + + E +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLG---TNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQG 61
Query: 119 KNLV-RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARVLLYL 175
+ + F EG +L + L G LF +L+T +A Q+ + ++
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNAR---ISDFGLAK 210
H S +H DIKP N L+ A I DFGLAK
Sbjct: 120 H---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 1e-08
Identities = 29/205 (14%), Positives = 57/205 (27%), Gaps = 57/205 (27%)
Query: 59 ATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL--------DRVFQDGEKEFKN 108
T+ + E++G G FG +++ + T VA+K + + Q +E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTP-----VAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 109 EVIV---------IGQTHHKNLVRLLGFC------------------------------D 129
E+I+ + + L
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 130 EGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIK 189
+ + EF G + L + +I Q+ L + H D+
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKL-SSLATAKSILHQLTASLAVAEASL--RFEHRDLH 189
Query: 190 PQNILLNDRYNARISDFGLAKLLTL 214
N+LL ++ K T+
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTI 214
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 32/165 (19%), Positives = 68/165 (41%), Gaps = 26/165 (15%)
Query: 67 VGRGSFGIIYKGVIQTTTTSTTA--VAVKKL----------DRVFQD-GEKEFKNEVIVI 113
+G+G FG IY + ++ + + VK + +Q + E + I
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 114 GQTHHKNLVRLLGFCDEGQN----RLLAYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQ 167
+ + + + G +N R + + G+ ++ ++ +T ++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI--SDFGLAK 210
I +L Y+H + +H DIK N+LLN + ++ D+GLA
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 27/114 (23%), Positives = 46/114 (40%), Gaps = 29/114 (25%)
Query: 163 NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK- 221
+A+QI + + +LH +++ H D+KP+NIL + + + IK
Sbjct: 122 KMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 222 -------------TAIRGTKGYVAPE------WFRKSTISAKVDVYSFGVLLLE 256
+ + T+ Y APE W S DV+S G +L+E
Sbjct: 179 VDFGSATYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIE 226
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 30/120 (25%), Positives = 47/120 (39%), Gaps = 35/120 (29%)
Query: 163 NIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND--RYNARISDFGLAKLLTLNQRKTI 220
+I + L YL + + H D+KP+NILL+D + I+ + + +T
Sbjct: 141 LYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 221 KTAIR----G--------------TKGYVAPE------WFRKSTISAKVDVYSFGVLLLE 256
T I+ G T+ Y APE W D++SFG +L E
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAE 251
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 2e-06
Identities = 42/273 (15%), Positives = 84/273 (30%), Gaps = 82/273 (30%)
Query: 92 VKKLD-RVFQDGEKE-FKNEVI--VIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLA 147
V D + QD K E I +I + L + + + +F+
Sbjct: 30 VDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV--- 86
Query: 148 SFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC--SSQIIHCDIKPQNILLND-----RYN 200
L+ N+ F ++ + + S + I+ ++ L ND +YN
Sbjct: 87 ------LRINYK------FLMSP----IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYN 130
Query: 201 -ARISDF-GLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKV-------DVYSFG 251
+R+ + L + L L R I G G K+ ++ V F
Sbjct: 131 VSRLQPYLKLRQAL-LELRPAKNVLIDGVLG------SGKTWVALDVCLSYKVQCKMDFK 183
Query: 252 VLLLEIISCRKSFDI-EM------------------GEEYAILTDWAFD------CYRNG 286
+ L + +C + EM + +
Sbjct: 184 IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 287 K-----LDDLVEGDMEAMN--DIKCVEKLLMIS 312
+ L + V+ + +A N ++ C K+L+ +
Sbjct: 244 ENCLLVLLN-VQ-NAKAWNAFNLSC--KILLTT 272
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 5e-06
Identities = 52/343 (15%), Positives = 95/343 (27%), Gaps = 100/343 (29%)
Query: 28 FIYKKKWIRNSPGDGTIETK---SRCFSYKELEEATDNFKEE-----VGRGSFGIIYKGV 79
+I ++ + N D + K SR Y +L +A + G G K
Sbjct: 112 YIEQRDRLYN---DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K-- 163
Query: 80 IQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139
+ A+ V +V + + ++ + L C+ + L E
Sbjct: 164 ------TWVALDVCLSYKV----QCKMDFKIFWLN----------LKNCNSPETVL---E 200
Query: 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQI--------------------ARVLLYLHEDC 179
L L + PNW R++ + I LL L
Sbjct: 201 MLQK------LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ 254
Query: 180 SSQII-----HCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE 234
+++ C ILL R +++DF L+ I + + E
Sbjct: 255 NAKAWNAFNLSC-----KILLTTR-FKQVTDF-----LSAATTTHI-SLDHHSMTLTPDE 302
Query: 235 -------WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287
+ +V + L II+ + + + +
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS 362
Query: 288 LDDLVEGDMEAM--------NDIKCVEKLLMISIWC--IQEDP 320
L+ L + M LL + IW I+ D
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL-IWFDVIKSDV 404
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.14 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.81 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.71 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.36 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.35 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.34 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.24 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.94 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.87 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.7 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.65 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.62 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.33 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.22 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.78 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.8 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.19 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.48 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 91.94 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 85.58 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.95 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-61 Score=423.09 Aligned_cols=261 Identities=23% Similarity=0.447 Sum_probs=215.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.+.+.+.||+|+||.||+|++... ..++..||+|.++.......++|.+|++++++++||||+++++++.+++..++|
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 345678899999999999987642 234678999999876666677899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEe
Q 046877 138 YEFLNNGTLASFLFGN-------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARIS 204 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~ 204 (350)
||||++|+|.+++... ..+++..++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEEC
Confidence 9999999999999643 368999999999999999999995 599999999999999999999999
Q ss_pred ecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHh
Q 046877 205 DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 283 (350)
Q Consensus 205 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 283 (350)
|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. ..+
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~-------~~i 243 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-------ECI 243 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HHH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHH
Confidence 9999987655444333344568999999999999999999999999999999999 89999765433211 112
Q ss_pred hcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
..+. ....+..+++++.+++.+||+.||++|||++++.+.|+++.+.
T Consensus 244 ~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 TQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2222 1222335778999999999999999999999999999988653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-60 Score=423.78 Aligned_cols=259 Identities=25% Similarity=0.436 Sum_probs=207.6
Q ss_pred hhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.++||+|+||.||+|++.. ...++..||||.++.......++|.+|++++++++||||+++++++.+.+..++|||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 456789999999999999764 234467899999987666667789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC---------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEe
Q 046877 140 FLNNGTLASFLFGN---------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARIS 204 (350)
Q Consensus 140 ~~~~g~L~~~l~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~ 204 (350)
||++|+|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEc
Confidence 99999999998643 357899999999999999999995 599999999999999999999999
Q ss_pred ecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHh
Q 046877 205 DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 283 (350)
Q Consensus 205 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 283 (350)
|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. ..+
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~-------~~i 273 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-------DCI 273 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH-------HHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH-------HHH
Confidence 9999987655444444445678999999999999999999999999999999999 89999765433211 111
Q ss_pred hcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
..+ .+...+..+++++.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 274 ~~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 122 12223345778999999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-60 Score=421.55 Aligned_cols=266 Identities=26% Similarity=0.367 Sum_probs=216.5
Q ss_pred HHHHHHHhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceee
Q 046877 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCD 129 (350)
Q Consensus 53 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 129 (350)
..|+...+.+|.+.||+|+||.||+|.+.. ....++.||||.++... ....++|.+|+.++++++||||+++++++.
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 344444556788899999999999998753 23345789999986443 334578999999999999999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046877 130 EGQNRLLAYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNI 193 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni 193 (350)
+.+..++|||||++|+|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NI 176 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNV 176 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccce
Confidence 999999999999999999999542 347889999999999999999995 5999999999999
Q ss_pred EEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhh
Q 046877 194 LLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 272 (350)
Q Consensus 194 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~ 272 (350)
||++++.+||+|||+++.....+.........||++|+|||++.+..++.++|||||||++|||+| |..||......+.
T Consensus 177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987655444444455678999999999999999999999999999999998 8999976543321
Q ss_pred hhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 273 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
...+..+ ...+.+.+++..+.+++.+||+.||++|||+++|++.|+...
T Consensus 257 -------~~~i~~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 257 -------VEMIRNR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -------HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -------HHHHHcC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1112222 222334467889999999999999999999999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-59 Score=408.60 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=200.6
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
....+.+.||+|+||+||+|+++.+ ||||.++... ....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~~------vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHGD------VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSSE------EEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCc------EEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3445678899999999999986432 7888875432 3345679999999999999999999998865 56899
Q ss_pred EEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 137 AYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||||++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+|......
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999999964 4679999999999999999999995 59999999999999999999999999999876544
Q ss_pred cccceeeccccCCCccCcccccC---CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRK---STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
..........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.......... .....+...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~------~~~~~~~~~--- 256 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII------FMVGRGYAS--- 256 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHTTCCC---
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCCCC---
Confidence 33333345679999999999964 358999999999999999999999997654432211 111111110
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
+. ....+.+++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 257 -p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 257 -PD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp -CC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred -CC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 00 01122357789999999999999999999999999998664
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-58 Score=406.54 Aligned_cols=248 Identities=24% Similarity=0.341 Sum_probs=207.6
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
|++.+.||+|+||.||+|.++.++ +.||+|+++.......+.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSG---KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEeecCcCeEEEEEEECCCC---CEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 445577999999999999987664 56999999766556667789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
|++|+|.+++.+ ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.+|.+||+|||++........ .
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 226 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 226 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence 999999999864 578999999999999999999995 5999999999999999999999999999987654322 2
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....||+.|+|||++.+..|+.++||||+||++|||++|..||...+..+.. ..+..+.. .....
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------~~i~~~~~-------~~~~~ 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-------KMIRDNLP-------PRLKN 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSSC-------CCCSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------HHHHcCCC-------CCCCc
Confidence 24567999999999999999999999999999999999999999765433221 11111110 11122
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+++++.+|+.+||+.||++|||++|+++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2346788999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-58 Score=402.38 Aligned_cols=247 Identities=22% Similarity=0.290 Sum_probs=209.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.|++.+.||+|+||+||+|++..++ +.||+|.+.+. .....+.+.+|+++++.++||||+++++++++++..|+
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~---~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATS---REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccEEEEEEecccCeEEEEEEECCCC---CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3677899999999999999987664 56999998753 23446789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||||+||+|.+++.+.+.+++..++.++.|++.||+|||+ .+|+||||||+|||++.+|.+||+|||+|.......
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999999888899999999999999999999995 599999999999999999999999999999876544
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.........||+.|+|||++.+..|+.++||||+||++|+|+||..||...+..+.. ..+..+...
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------~~i~~~~~~------- 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF-------AKIIKLEYD------- 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCC-------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCCC-------
Confidence 433445668999999999999999999999999999999999999999765433221 111222211
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~v 329 (350)
.+...++++.+|+.+||+.||++|||++|+
T Consensus 253 ---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 253 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred ---CCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 112346789999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-58 Score=407.12 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=200.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.|++.+.||+|+||.||+|++..++ +.||+|.+.... ....+++.+|+++++.++||||+++++++.+++..|+|
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDG---RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTC---CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCC---CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4667789999999999999987664 569999986542 23356799999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
||||+||+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.+|.+||+|||+++.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999999643 456889999999999999999995 59999999999999999999999999999876432
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
. .......||+.|+|||++.+..|+.++|||||||++|||+||+.||...+..+.. ..+..+...
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~~~~~~------ 243 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV-------LKIISGSFP------ 243 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHTCCC------
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------HHHHcCCCC------
Confidence 2 1123457999999999999999999999999999999999999999865433221 111122211
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..++.++.+|+.+||+.||++|||++++++
T Consensus 244 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 ---PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112245678999999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=393.75 Aligned_cols=247 Identities=27% Similarity=0.410 Sum_probs=197.6
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeec----CCeeE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE----GQNRL 135 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~ 135 (350)
.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+++.+|+.+++.++||||+++++++.+ +...+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCC---eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 45677999999999999987654 569999886432 2334679999999999999999999999864 35589
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 214 (350)
+|||||++|+|.+++.+...+++..++.++.|++.||+|||++ +.+|+||||||+|||++ .+|.+||+|||+|.....
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999998888999999999999999999999954 22399999999999997 489999999999975432
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
. ......||+.|+|||++.+ .++.++|||||||++|||+||+.||........ ....+..+.....
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~------~~~~i~~~~~~~~--- 250 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPAS--- 250 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGG---
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH------HHHHHHcCCCCCC---
Confidence 2 2245679999999999875 699999999999999999999999975433221 1111222211111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+..+++++.+++.+||+.||++|||++++++
T Consensus 251 -----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11123467999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-57 Score=400.49 Aligned_cols=258 Identities=22% Similarity=0.231 Sum_probs=207.1
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecC
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
.+.+.||+|+||.||+|+++.++ ..||+|+++.... ..+|+.+++.++||||+++++++.+++..|+|||||
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g---~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTG---FQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTC---CEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EeCcEeccCCCeEEEEEEECCCC---CEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 44567999999999999987664 5699999875322 246999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEeecccccccccCccc--
Q 046877 142 NNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NARISDFGLAKLLTLNQRK-- 218 (350)
Q Consensus 142 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~-- 218 (350)
+||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||+|||++.+| .+||+|||++.........
T Consensus 133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 99999999988889999999999999999999999 56999999999999999887 5999999999876543221
Q ss_pred -ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 -TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.......||+.|+|||++.+..|+.++||||+||++|||+||+.||......+.... +..+... .
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-------i~~~~~~-------~ 275 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK-------IASEPPP-------I 275 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH-------HHHSCCG-------G
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH-------HHcCCCC-------c
Confidence 112335699999999999999999999999999999999999999976544332111 0111110 0
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc----CCCCCCC
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV----EVDVPPN 344 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~----~~~~~~~ 344 (350)
...+..+++.+.+++.+||+.||++|||+.|+++.|...+ ...+|+.
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~ 326 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK 326 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence 1122346789999999999999999999999998776543 4556643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-58 Score=411.02 Aligned_cols=266 Identities=25% Similarity=0.365 Sum_probs=215.4
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeecccc-ccHHHHHHHHHHHhcCC-CCceeeecceeec
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTH-HKNLVRLLGFCDE 130 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 130 (350)
|+....+++.+.||+|+||.||+|.+.... ...+.||+|.+..... ...+.+.+|++++.+++ ||||++++++|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 344455667789999999999999987543 3457899999875433 33467999999999995 5999999999865
Q ss_pred -CCeeEEEEecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046877 131 -GQNRLLAYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNI 193 (350)
Q Consensus 131 -~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni 193 (350)
++..++|||||++|+|.++++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence 46789999999999999999642 347899999999999999999994 5999999999999
Q ss_pred EEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhh
Q 046877 194 LLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 272 (350)
Q Consensus 194 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~ 272 (350)
|+++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||........
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987655444444445678999999999999999999999999999999998 8999976443221
Q ss_pred hhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 273 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
. ...+..+ .+...+..+++++.++|.+||+.||++|||++++++.|+++++
T Consensus 297 ~------~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 F------CRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp H------HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------HHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 1 1111222 2222333467899999999999999999999999999998764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=407.31 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=207.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
|++.+.||+|+||.||+|.++.++ +.||+|++........+.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSG---KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeeEeccCcCcEEEEEEECCCC---CEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 445678999999999999987664 56999999766556667799999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccce
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
|+||+|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.+|.+||+|||++........ .
T Consensus 230 ~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 303 (423)
T 4fie_A 230 LEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 303 (423)
T ss_dssp CTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred CCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence 99999999985 4568999999999999999999995 5999999999999999999999999999987654322 2
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....||+.|||||++.+..|+.++|||||||++|||++|..||......... ..+..+.. .....
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------~~i~~~~~-------~~~~~ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-------KMIRDNLP-------PRLKN 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSCC-------CCCSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------HHHHcCCC-------CCCcc
Confidence 24567999999999999999999999999999999999999999765433321 11111111 11112
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...++.++.+|+.+||+.||++|||++|+++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2245678999999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-57 Score=396.38 Aligned_cols=250 Identities=22% Similarity=0.257 Sum_probs=200.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.|++.+.||+|+||.||+|+...+...++.||+|.+++.. .....++.+|+.+++.++||||+++++++.+++..|+|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4677899999999999999876655566789999986532 22334688899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||||+||+|.+++.+...+++..++.++.|++.||+|||+ .+|+||||||+|||++.+|.+||+|||+|+.......
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 9999999999999888899999999999999999999995 5999999999999999999999999999986543222
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
......||+.|+|||++.+..++.++||||+||++|||+||+.||...+..+.. ..+..+..
T Consensus 182 --~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~~~~~--------- 243 (304)
T 3ubd_A 182 --KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM-------TMILKAKL--------- 243 (304)
T ss_dssp --CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC---------
T ss_pred --cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH-------HHHHcCCC---------
Confidence 223467999999999999999999999999999999999999999865443321 11111111
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTM-----RKVSQ 331 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~vl~ 331 (350)
..+..+++++.+++.+||+.||++|||+ +++++
T Consensus 244 -~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 -GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1122356789999999999999999984 56653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-56 Score=382.41 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=192.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.|++.+.||+|+||.||+|.+..+ ++.||+|.+++.. .....++.+|+++++.++||||+++++++.+++..|+
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTT---GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTT---CCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCC---CCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 567788999999999999997655 4569999986432 2345679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||||+ +|+|.+++.++..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+|.......
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99999 67999999888899999999999999999999995 599999999999999999999999999998654332
Q ss_pred ccceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
. .....||+.|+|||++.+..+ +.++||||+||++|+|+||+.||...+.... ...+..+...
T Consensus 167 ~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~-------~~~i~~~~~~------ 230 (275)
T 3hyh_A 167 F---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL-------FKNISNGVYT------ 230 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCC------
T ss_pred c---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCCC------
Confidence 2 234679999999999998876 5789999999999999999999975443221 1112222111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+..+++++.+++.+||+.||++|||++++++
T Consensus 231 ----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 ----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11235678999999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-55 Score=385.83 Aligned_cols=269 Identities=20% Similarity=0.247 Sum_probs=198.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCC----eeEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ----NRLL 136 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~l 136 (350)
+.+.+.||+|+||+||+|++. +..||||+++... ........|+..+..++||||+++++++.+.+ ..++
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~-----g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWR-----GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET-----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC-----CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 345678999999999999873 3569999986532 22233445667777889999999999987654 5799
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHED-----CSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
||||+++|+|.++++. ..++++.+.+++.|++.||+|||++ ...+|+||||||+|||++.++.+||+|||+++.
T Consensus 79 V~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999999964 4689999999999999999999953 134899999999999999999999999999987
Q ss_pred cccCcccc--eeeccccCCCccCcccccCC------CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhh--------H
Q 046877 212 LTLNQRKT--IKTAIRGTKGYVAPEWFRKS------TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--------L 275 (350)
Q Consensus 212 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~--------~ 275 (350)
........ ......||+.|+|||++.+. .++.++|||||||++|||+||..||.......... .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 65433221 12345799999999999754 36779999999999999999988875433211110 0
Q ss_pred HHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 276 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
..........+..... ........+++..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 238 ~~~~~~~~~~~~~rp~---~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPN---IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCC---CCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcccCCCC---CCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0011111111111000 001112335778899999999999999999999999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=374.97 Aligned_cols=248 Identities=22% Similarity=0.354 Sum_probs=186.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCC------
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ------ 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 132 (350)
.|++.+.||+|+||.||+|+++.++ ..||+|++..... ...+++.+|+++++.++||||+++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDD---CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTC---CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCC---CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 3567789999999999999977664 5699999865432 33467899999999999999999999986543
Q ss_pred ------eeEEEEecCCCCChhhhhcCCCCc---ChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEE
Q 046877 133 ------NRLLAYEFLNNGTLASFLFGNLKP---NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI 203 (350)
Q Consensus 133 ------~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl 203 (350)
..|++||||++|+|.+++...... ++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEE
Confidence 368999999999999999766544 445688999999999999995 59999999999999999999999
Q ss_pred eecccccccccCcccc----------eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhh
Q 046877 204 SDFGLAKLLTLNQRKT----------IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 273 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~ 273 (350)
+|||+|+......... ......||+.|+|||++.+..|+.++|||||||++|||++ ||........
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~- 235 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR- 235 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH-
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH-
Confidence 9999998765432211 1234569999999999999999999999999999999996 7753221110
Q ss_pred hHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 274 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
............. ..+.++.+.+++.+||+.||++|||+.++++
T Consensus 236 -----~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 -----TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -----HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111122222111 1234456788999999999999999999976
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=370.00 Aligned_cols=264 Identities=19% Similarity=0.267 Sum_probs=198.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.|++.+.||+|+||+||+|+.+.+...++.||+|.+... ....++.+|+++++.+ +||||+++++++.+.+..++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 356678899999999999987655555678999988653 3456788999999988 7999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR-YNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++|+|.+++. .+++..++.++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 100 E~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 100 PYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp ECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred eCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999999999983 58999999999999999999995 599999999999999876 7999999999976543211
Q ss_pred c--------------------------ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccch
Q 046877 218 K--------------------------TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGE 270 (350)
Q Consensus 218 ~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~ 270 (350)
. .......||+.|+|||++.+. .++.++||||+||++|+|+||+.||....++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 0 111234699999999999875 5899999999999999999999999654432
Q ss_pred hhhh-HHHHHH---------HHhhc----------CCcchhcc------------------ccccCCCcHHHHHHHHHHH
Q 046877 271 EYAI-LTDWAF---------DCYRN----------GKLDDLVE------------------GDMEAMNDIKCVEKLLMIS 312 (350)
Q Consensus 271 ~~~~-~~~~~~---------~~~~~----------~~~~~~~~------------------~~~~~~~~~~~~~~l~~li 312 (350)
.... ...... ..... ........ ...........++++.+|+
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 2110 000000 00000 00000000 0000011123457889999
Q ss_pred HhccCCCCCCCCCHHHHHH
Q 046877 313 IWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 313 ~~cl~~dp~~Rps~~~vl~ 331 (350)
.+||+.||.+|||++|+++
T Consensus 334 ~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHT
T ss_pred HHHCcCChhHCcCHHHHhc
Confidence 9999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=377.71 Aligned_cols=270 Identities=20% Similarity=0.304 Sum_probs=203.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeec------C
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDE------G 131 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~ 131 (350)
.|++.+.||+|+||.||+|.+..++ +.||+|++..... ...+++.+|+++|+.++||||+++++++.. .
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTG---QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CeEEEEEEecccCeEEEEEEECCCC---CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 3566788999999999999987664 5699999865432 234568899999999999999999998753 4
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
+..|+|||||+ |+|.+++.....+++..++.++.||+.||.|||+ .+|+||||||+|||++.+|.+||+|||++..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 67899999996 5899999888999999999999999999999994 5999999999999999999999999999986
Q ss_pred cccCc--ccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC--
Q 046877 212 LTLNQ--RKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-- 286 (350)
Q Consensus 212 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 286 (350)
..... .........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+...............
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 64321 12223456799999999998875 56899999999999999999999998765444321111100000000
Q ss_pred ------Ccchhccccc-cCCCc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcc
Q 046877 287 ------KLDDLVEGDM-EAMND-----IKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEV 336 (350)
Q Consensus 287 ------~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~ 336 (350)
.......... ....+ .+.+.++.+|+.+||..||++|||++++++ .+++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0000000000 00000 123578899999999999999999999875 44443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=355.26 Aligned_cols=273 Identities=33% Similarity=0.612 Sum_probs=231.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+.+.+.||+|+||.||+|.+.+ +..|++|..........+.+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 116 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRD----GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTT----CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred cCccceeecCCCeeEEEEEECC----CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence 3455779999999999998542 356999988766556677899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCC----CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 141 LNNGTLASFLFGNL----KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 141 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+++|+|.+++.... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999996543 47899999999999999999995 599999999999999999999999999998655433
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+......+.......+......++..
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence 33333445689999999999888999999999999999999999999987666555445555555556666666666666
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
......+++..+.+++.+||+.||++|||++++++.|+.++...
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 66667889999999999999999999999999999999887654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=383.42 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=207.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.|++.+.||+|+||.||+|.++.++ ..||+|.+........+.+.+|+.+|+.++||||+++++++.+.+..+++||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg---~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATG---NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEECCCC---CEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4567788999999999999987664 5699999876655556779999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC--CceEEeecccccccccCc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR--YNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~ 216 (350)
||+||+|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||++.......
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999999864 4679999999999999999999995 599999999999999854 899999999998775443
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. .....||+.|+|||++.+..|+.++||||+||++|+|++|..||...+..+.. ..+..+... .
T Consensus 312 ~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~-------~~i~~~~~~------~ 375 (573)
T 3uto_A 312 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-------RNVKSCDWN------M 375 (573)
T ss_dssp E---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHTTCCC------C
T ss_pred c---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------HHHHhCCCC------C
Confidence 2 23457999999999999999999999999999999999999999865543321 111111111 0
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......++.++.+||.+||+.||.+|||++++++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111235678999999999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=378.00 Aligned_cols=246 Identities=23% Similarity=0.250 Sum_probs=198.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHH---HHHHhcCCCCceeeecceeecCCee
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNE---VIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
+++.+.||+|+||.||+|+.+.++ ..||+|.+.+.. ........+| +.+++.++||||+++++++++.+.+
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg---~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred eEEEEEEecccCeEEEEEEECCCC---CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 455678999999999999987664 569999986432 2223334444 5677788999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
|+||||++||+|.+++.+...+++..++.++.||+.||+||| +.+|+||||||+|||++.+|.+||+|||+|.....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999988889999999999999999999999 66999999999999999999999999999987653
Q ss_pred CcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
... ....||+.|+|||++.+ ..|+.++|+||+||++|||++|..||..........+. .......
T Consensus 345 ~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~----~~i~~~~------ 410 (689)
T 3v5w_A 345 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTMA------ 410 (689)
T ss_dssp CCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH----HHHHHCC------
T ss_pred CCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhhcCCC------
Confidence 321 34579999999999964 57999999999999999999999999765443322111 1111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCC-----HHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT-----MRKVS 330 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~vl 330 (350)
...+..++.++.+|+.+||+.||.+|++ +++++
T Consensus 411 ----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 411 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 1112235678999999999999999998 57765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=349.12 Aligned_cols=263 Identities=26% Similarity=0.421 Sum_probs=200.5
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
..+.+.+.||+|+||.||+|+.. +..+|+|.+.... ....+++.+|+.++++++||||+++++++.+....++
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEWH-----GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-----TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred hHceeeeEeecCCCeEEEEEEEC-----CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34456688999999999999763 2458999886443 2334578899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCC---cChhHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 137 AYEFLNNGTLASFLFGNLK---PNWNLRTNIAFQIARVLLYLHEDCSSQ--IIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
+|||+++|+|.+++..... +++..++.++.|++.||+|||+ .+ ++||||||+||+++.++.+||+|||++..
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999976543 8899999999999999999994 47 99999999999999999999999999975
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~--------------- 251 (309)
T 3p86_A 189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV--------------- 251 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH---------------
T ss_pred ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------------
Confidence 44321 1123456899999999999999999999999999999999999999755433221110
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNPS 346 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~~~~~ 346 (350)
.........+..++..+.+++.+||+.||++|||++++++.|+.+++...||+++
T Consensus 252 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 252 GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 0011111222345678999999999999999999999999999999877776654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=346.15 Aligned_cols=284 Identities=40% Similarity=0.706 Sum_probs=231.5
Q ss_pred ccccCHHHHHHHhhhh--hhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeee
Q 046877 48 SRCFSYKELEEATDNF--KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRL 124 (350)
Q Consensus 48 ~~~~~~~~~~~~~~~~--~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~ 124 (350)
...++..++......| .+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD----GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS----SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecC----CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 4567777777766544 5789999999999997432 34599998865432 223468999999999999999999
Q ss_pred cceeecCCeeEEEEecCCCCChhhhhcCCC----CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 046877 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNL----KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN 200 (350)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~ 200 (350)
++++.+.+..+++|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+..+++|+||||+||+++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999997543 3889999999999999999999644449999999999999999999
Q ss_pred eEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccc--hhhhhHHHH
Q 046877 201 ARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMG--EEYAILTDW 278 (350)
Q Consensus 201 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~--~~~~~~~~~ 278 (350)
+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||+.... ........+
T Consensus 173 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 999999999876543322 22445689999999999888899999999999999999999999964321 122233444
Q ss_pred HHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
........................+.+..+.+++.+||+.||.+|||++++++.|++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 5555556666677777777777888999999999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=348.20 Aligned_cols=265 Identities=21% Similarity=0.385 Sum_probs=214.5
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
..+.+.+.||+|+||.||+|.+..++.....||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 34556678999999999999998777767789999987542 33456799999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999644 678999999999999999999995 499999999999999999999999999998765432
Q ss_pred ccc-eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 217 RKT-IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 217 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.......... ....
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~~~~--------- 269 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS-------SVEE--------- 269 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-------HHHT---------
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH-------HHHc---------
Confidence 221 1223345778999999998899999999999999999999 999997554333211 1111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCC
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~ 342 (350)
......+..++..+.+++.+||..||++|||++++++.|+.+......
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 112223335678999999999999999999999999999998765444
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=351.82 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=211.3
Q ss_pred hhhhhhccCCCccceEEEEEEcC----CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecCCe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQT----TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~----~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 133 (350)
.+.+.+.||+|+||.||+|.+.. ....+..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 44566789999999999998753 22446779999986543 23346789999999999 89999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCC----------------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 046877 134 RLLAYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND 197 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~ 197 (350)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||+++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECC
Confidence 999999999999999996542 46888999999999999999995 49999999999999999
Q ss_pred CCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHH
Q 046877 198 RYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT 276 (350)
Q Consensus 198 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~ 276 (350)
++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||+| |..||......+..
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~--- 315 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 315 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---
Confidence 99999999999986654433222234456788999999999999999999999999999999 99999754433221
Q ss_pred HHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 277 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.....+ .....+..++..+.+++.+||+.||++|||+.++++.|++++.
T Consensus 316 ----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 316 ----KLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ----HHHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111 1122233567889999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=347.01 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=209.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.+.||+|+||.||+|.+..++ ..+++|.+........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~---~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETG---EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTC---CEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HeeccceecCCCCEEEEEEEECCCC---cEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 3456688999999999999976654 5689998866656667789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999975 5678999999999999999999995 49999999999999999999999999999866433221
Q ss_pred c------------eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 046877 219 T------------IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 286 (350)
Q Consensus 219 ~------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 286 (350)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------- 234 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------- 234 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------
Confidence 1 011446899999999999999999999999999999999999998654332211000
Q ss_pred CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
..... .....+.+++..+.+++.+||+.||++|||++++++.|+++...
T Consensus 235 ~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 235 NVRGF----LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp CHHHH----HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhcc----ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00000 01111223556899999999999999999999999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=339.16 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=206.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+........+.+.+|+.+++.++||||+++++++..++..+++||
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVAT---GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTT---CCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceeeeeeeccCCCeEEEEEEECCC---CcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 345667899999999999986555 35699999876666667789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++++|.+++... .+++..++.++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 99999999998654 68999999999999999999995 49999999999999999999999999999866543322
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.....||+.|+|||++.+..++.++||||+|+++|+|++|..||........... ....+ .....
T Consensus 173 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~~~~--------~~~~~ 237 (297)
T 3fxz_A 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNG--------TPELQ 237 (297)
T ss_dssp -BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHHC--------SCCCS
T ss_pred -cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCC--------CCCCC
Confidence 2345689999999999999999999999999999999999999975543322111 00111 11112
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+..++..+.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 22345678999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=345.81 Aligned_cols=266 Identities=25% Similarity=0.341 Sum_probs=204.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCC----eeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ----NRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~ 135 (350)
.+++.+.||+|+||.||+|++. +..||+|.+... .........|+.+++.++||||+++++++.... ..+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-----NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-----TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hchhhheecccCceEEEEEEEC-----CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 4456788999999999999864 256999998643 233445677899999999999999999987754 369
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCC----------CeEecCCCCCCeEEcCCCceEEee
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSS----------QIIHCDIKPQNILLNDRYNARISD 205 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~----------~i~H~dlkp~Nill~~~~~~kl~D 205 (350)
++|||+++|+|.+++.. ..+++..++.++.|++.|++||| +. +++||||||+||+++.++.+||+|
T Consensus 99 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999999965 45899999999999999999999 56 999999999999999999999999
Q ss_pred cccccccccCcccceeeccccCCCccCcccccCC-----CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHH--
Q 046877 206 FGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-----TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW-- 278 (350)
Q Consensus 206 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~-- 278 (350)
||++................||+.|+|||++.+. .++.++|||||||++|+|+||+.||..............
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876544333333445689999999999763 456688999999999999999999976544322111100
Q ss_pred -------HHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 279 -------AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 279 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
............... .......++.++.+++.+||+.||++|||++++++.|+++.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLR---DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCC---GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCcc---ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000001111100000 011123567889999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=344.56 Aligned_cols=278 Identities=24% Similarity=0.379 Sum_probs=208.6
Q ss_pred HHhhhhhhccCCCccceEEEEEEcC-CCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeec--CCee
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQT-TTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE--GQNR 134 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 134 (350)
...+++.+.||+|+||.||+|++.. ....+..||+|.+........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 3456677899999999999998642 223457799999876655556789999999999999999999999854 3568
Q ss_pred EEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
+++|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999754 348999999999999999999995 599999999999999999999999999998765
Q ss_pred cCccc-ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 214 LNQRK-TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 214 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
..... .......++..|+|||.+.+..++.++||||||+++|+|+||..|+............................
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 43221 12233446778999999998999999999999999999999999986432211100000000000000011111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
........+..++.++.+++.+||+.||++|||++++++.|+++.+
T Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 2222333344577899999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=341.31 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=203.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.|.+.+.||+|+||.||+|.+..++ ..||+|++.... ....+++.+|+++++.++||||+++++++.+.+..++|
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTG---REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3556788999999999999976654 469999986542 23346788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.+++.....+++..++.++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 9999999999999887889999999999999999999995 5999999999999999999999999999976553322
Q ss_pred cceeeccccCCCccCcccccCCCCC-CCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTIS-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.....||+.|+|||++.+..+. .++||||+||++|+|++|..||...+..... ..+..+..
T Consensus 170 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~~-------- 231 (328)
T 3fe3_A 170 ---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR-------ERVLRGKY-------- 231 (328)
T ss_dssp ---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC--------
T ss_pred ---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCC--------
Confidence 2345689999999999888765 7899999999999999999999765433321 11111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+...+..+.+++.+||..||.+|||++++++
T Consensus 232 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 --RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111124578899999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=350.45 Aligned_cols=266 Identities=26% Similarity=0.378 Sum_probs=212.5
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcC-CCCceeeecceeec
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDE 130 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 130 (350)
++....+.+.+.||+|+||.||+|.+.. ....++.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.+
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 3444556677899999999999998654 344567899999875432 3345799999999999 89999999999877
Q ss_pred CCe-eEEEEecCCCCChhhhhcCCCC------------------------------------------------------
Q 046877 131 GQN-RLLAYEFLNNGTLASFLFGNLK------------------------------------------------------ 155 (350)
Q Consensus 131 ~~~-~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 155 (350)
.+. .+++|||+++|+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 554 8999999999999999965432
Q ss_pred ------------cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeec
Q 046877 156 ------------PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223 (350)
Q Consensus 156 ------------~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 223 (350)
+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..............
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence 7889999999999999999995 4999999999999999999999999999987654433333345
Q ss_pred cccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcH
Q 046877 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 302 (350)
Q Consensus 224 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
..+|+.|+|||++.+..++.++||||||+++|+|+| |..||.......... .....+. ....+.
T Consensus 255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~~~~~~~---------~~~~~~ 319 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLKEGT---------RMRAPD 319 (359)
T ss_dssp CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH------HHHHHTC---------CCCCCT
T ss_pred cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH------HHHHcCC---------CCCCCC
Confidence 567889999999998899999999999999999998 999997654332211 1111111 111222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 303 KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 303 ~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.++.++.+++.+||+.||.+|||++++++.|+++++
T Consensus 320 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 320 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 356789999999999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=342.32 Aligned_cols=264 Identities=21% Similarity=0.341 Sum_probs=195.5
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceeecCCee-
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR- 134 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~- 134 (350)
...+.+.+.||+|+||.||+|.+..++.....||+|.+... .....+.+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 34566778999999999999997766554457999988653 234457799999999999999999999999877665
Q ss_pred -----EEEEecCCCCChhhhhcCC------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEE
Q 046877 135 -----LLAYEFLNNGTLASFLFGN------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI 203 (350)
Q Consensus 135 -----~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl 203 (350)
+++|||+++++|.+++... ..+++..++.++.|++.|++|||+ .+++||||||+||++++++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEE
Confidence 9999999999999998532 258899999999999999999995 49999999999999999999999
Q ss_pred eecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHH
Q 046877 204 SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 282 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 282 (350)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......... .
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~ 251 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN-------Y 251 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------H
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH-------H
Confidence 99999987654443333344456788999999998899999999999999999999 999997654433211 1
Q ss_pred hhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
...+ .....+..++..+.+++.+||+.||++|||+.++++.|++++...
T Consensus 252 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 252 LIGG---------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HhcC---------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 111222345678999999999999999999999999999887543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=329.23 Aligned_cols=280 Identities=36% Similarity=0.630 Sum_probs=222.4
Q ss_pred cccccCHHHHHHHhhhhh--------hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----cccHHHHHHHHHHHh
Q 046877 47 KSRCFSYKELEEATDNFK--------EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----QDGEKEFKNEVIVIG 114 (350)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~--------~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~e~~~l~ 114 (350)
....+++.++...+..|. +.||+|+||.||+|... +..+++|.+.... ....+.+.+|+.+++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~ 85 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----NTTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-----SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-----CceEEEEEEecccCcchHHHHHHHHHHHHHHH
Confidence 346789999999998776 45999999999999853 2458999876432 233567899999999
Q ss_pred cCCCCceeeecceeecCCeeEEEEecCCCCChhhhhcC---CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046877 115 QTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFG---NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQ 191 (350)
Q Consensus 115 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~ 191 (350)
.++||||+++++++.+.+..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||||+
T Consensus 86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~ 162 (307)
T 2nru_A 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSA 162 (307)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGG
T ss_pred hcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHH
Confidence 99999999999999999999999999999999999863 3458899999999999999999995 49999999999
Q ss_pred CeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchh
Q 046877 192 NILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271 (350)
Q Consensus 192 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~ 271 (350)
||+++.++.+||+|||++................|++.|+|||.+.+ .++.++||||||+++|+|++|..||.......
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999999987654333333344568999999998865 57889999999999999999999997654433
Q ss_pred hhhHHHHHHHHhh-cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 272 YAILTDWAFDCYR-NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 272 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
... .+...... ...+...+.... ...+..++..+.+++.+||+.||.+|||++++++.|+++..
T Consensus 242 ~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 LLL--DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BTT--HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHH--HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 211 11111111 122233333222 33456788999999999999999999999999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=352.43 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=207.9
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
..+.+.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+++++.++||||+++++++...+..++|
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADN---TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTC---CEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCC---eEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34556788999999999999986543 5699998864322 2334688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999999654 458899999999999999999995 599999999999999999999999999998654332
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.........++..|+|||++.+..++.++||||||+++|||+| |..||......... ..... .
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------~~~~~---------~ 331 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------EFVEK---------G 331 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------HHHHT---------T
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHc---------C
Confidence 2211122235678999999998889999999999999999998 99999755433211 11111 1
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
...+.+..++..+.+++.+||+.||++|||++++++.|+++.+
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1222233467889999999999999999999999999988753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=339.12 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=203.1
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+++.+.||+|+||.||+|.+..++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hceeeeEEecCCCEEEEEEEECCCC---cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3556788999999999999876554 469999886432 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|.+++.....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999999888889999999999999999999995 59999999999999999999999999999866544333
Q ss_pred ceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||........... .+ .. ....
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~-----~~--------~~~~ 227 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DW-----KE--------KKTY 227 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH-HH-----HT--------TCTT
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HH-----hc--------cccc
Confidence 33345678999999999987765 7789999999999999999999976554332111 00 00 0111
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......++..+.+++.+||+.||++|||++++++
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1112235678899999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=342.97 Aligned_cols=262 Identities=25% Similarity=0.391 Sum_probs=212.2
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..+.+.+.||+|+||.||+|.+.... ..+..|++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 34556788999999999999986432 345779999987543 233567899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCC------------------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046877 136 LAYEFLNNGTLASFLFGN------------------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQ 191 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~ 191 (350)
++|||+++++|.+++... ..+++..++.++.|+++||.|||+ .+++|+||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcc
Confidence 999999999999998653 567889999999999999999995 49999999999
Q ss_pred CeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccch
Q 046877 192 NILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGE 270 (350)
Q Consensus 192 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~ 270 (350)
||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+| |..||......
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 283 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence 99999999999999999986654433333344567889999999998889999999999999999999 99999754432
Q ss_pred hhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 271 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
+.. ..+..+... ..+..++..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 284 ~~~-------~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 284 EVI-------YYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHH-------HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHH-------HHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 211 111222221 11224567899999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=347.29 Aligned_cols=268 Identities=26% Similarity=0.381 Sum_probs=216.7
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcCC----CcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeeccee
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTT----TTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFC 128 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 128 (350)
++....+.+.+.||+|+||.||+|.+... ......||+|++.... .....++.+|+++++.+ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 44445667778999999999999987542 2345679999986543 23346789999999999 999999999999
Q ss_pred ecCCeeEEEEecCCCCChhhhhcCCC----------------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046877 129 DEGQNRLLAYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQN 192 (350)
Q Consensus 129 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N 192 (350)
.+.+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcce
Confidence 99999999999999999999996543 48899999999999999999995 499999999999
Q ss_pred eEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchh
Q 046877 193 ILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 271 (350)
Q Consensus 193 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~ 271 (350)
|+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987655433333344557889999999999999999999999999999999 999997554332
Q ss_pred hhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCC
Q 046877 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDV 341 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~ 341 (350)
.. ..+..+. ....+..++.++.+++.+||+.||++|||++++++.|+++.....
T Consensus 302 ~~-------~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 302 LF-------KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HH-------HHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HH-------HHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11 1111111 111222456789999999999999999999999999998875443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=332.34 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=211.2
Q ss_pred cccccCHHHHHHHhhh------------hhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHh
Q 046877 47 KSRCFSYKELEEATDN------------FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIG 114 (350)
Q Consensus 47 ~~~~~~~~~~~~~~~~------------~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~ 114 (350)
..+.+++.++..++.. ..+.||+|+||.||+|....+ +..||+|.+........+.+.+|+.+++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~---g~~vavK~~~~~~~~~~~~~~~E~~~l~ 97 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS---GRQVAVKMMDLRKQQRRELLFNEVVIMR 97 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEETTTCCSHHHHHHHHHHHT
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCC---CcEEEEEEEeccchhHHHHHHHHHHHHH
Confidence 3456777777776643 335799999999999997654 3569999987666666778999999999
Q ss_pred cCCCCceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 046877 115 QTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNIL 194 (350)
Q Consensus 115 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil 194 (350)
.++||||+++++++...+..+++|||+++++|.+++. ...+++..+..++.|++.||.|||+ .+++||||||+||+
T Consensus 98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSIL 173 (321)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEE
T ss_pred hCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEE
Confidence 9999999999999999999999999999999999985 4578999999999999999999995 49999999999999
Q ss_pred EcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhh
Q 046877 195 LNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 274 (350)
Q Consensus 195 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~ 274 (350)
++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~- 250 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM- 250 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-
T ss_pred ECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence 999999999999999866543221 23456899999999999889999999999999999999999999754432211
Q ss_pred HHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 275 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+...... .......++..+.+++.+||+.||++|||++++++
T Consensus 251 ------~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 ------KRLRDSPPP-------KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ------HHHHHSSCC-------CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------HHHhcCCCC-------CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111 11112235678999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=341.51 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=203.6
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcc-eeEEEEEeeecc-ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTS-TTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~-~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
..+.+.+.||+|+||.||+|.+..++.. ...+++|.+... .....+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 3456678899999999999997655432 234688887533 2345678999999999999999999999998764 788
Q ss_pred EEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 137 AYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+++|+.+|+|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 9999999999999865 4678999999999999999999995 49999999999999999999999999999876554
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..........+|..|+|||.+.+..++.++||||||+++|+|+| |..||.......... .+..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----------------~~~~ 234 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----------------ILEK 234 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----------------HHHT
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH----------------HHHc
Confidence 43333344456789999999999999999999999999999999 999997654433211 1111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
......+..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 12222233456789999999999999999999999999987753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=336.20 Aligned_cols=247 Identities=22% Similarity=0.251 Sum_probs=204.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+++.+.||+|+||.||+|+.+.++ +.+|+|.+.+. .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATG---RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 3556788999999999999976553 56999998653 23456678899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+++|+|..++.....+++..++.++.|++.||+|||+ .+|+||||||+||+++.+|.+||+|||++.......
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999999887889999999999999999999995 499999999999999999999999999997543222
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. ......||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..... ..+..+..
T Consensus 160 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~~~~-------- 222 (337)
T 1o6l_A 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILMEEI-------- 222 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC--------
T ss_pred C--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCC--------
Confidence 1 123456899999999999999999999999999999999999999755432211 11111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
. .+..++.++.+++.+||+.||++|| +++++++
T Consensus 223 ~--~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 R--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C--CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1 1123567899999999999999999 8998874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=348.07 Aligned_cols=264 Identities=27% Similarity=0.383 Sum_probs=209.9
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeecc-ccccHHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
++....+.+.+.||+|+||.||+|..... ...+..||+|.+... ......++.+|+.+++.++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 33445566778899999999999996542 234567999998643 233455788999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCC-------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---ce
Q 046877 132 QNRLLAYEFLNNGTLASFLFGN-------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY---NA 201 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~ 201 (350)
...++||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999643 357889999999999999999995 5999999999999999555 49
Q ss_pred EEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHH
Q 046877 202 RISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF 280 (350)
Q Consensus 202 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 280 (350)
||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~------- 296 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL------- 296 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------
Confidence 9999999976543332223334557889999999998899999999999999999998 99999765433221
Q ss_pred HHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 281 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
..+..+. ....+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 297 ~~i~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 297 EFVTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111111 11222345678999999999999999999999999998775
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=330.46 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=209.1
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
...+.+.+.||+|+||.||+|.+..+ ..+++|.+.... ...+++.+|+.+++.++||||+++++++.+....+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQ----YDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT----EEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCc----eeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 34556778899999999999986542 458999986543 3457799999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++++|.+++... ..+++..++.++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999999754 458999999999999999999995 499999999999999999999999999998665433
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......++..|+|||.+.+..++.++||||+|+++|+|+| |..||........... ...+
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~~--------- 221 (268)
T 3sxs_A 159 YV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK-------VSQG--------- 221 (268)
T ss_dssp EE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------HHTT---------
T ss_pred hh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-------HHcC---------
Confidence 22 2233445678999999998889999999999999999999 9999975544332110 1111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
.....+...++.+.+++.+||+.||++|||+.++++.|+.+.+.+
T Consensus 222 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 222 HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 111112234578999999999999999999999999999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=347.45 Aligned_cols=260 Identities=23% Similarity=0.423 Sum_probs=199.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.+.+.||+|+||.||+|++......+..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 4455678999999999999877555556679999986542 334467999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999999765 468999999999999999999995 4999999999999999999999999999987654322
Q ss_pred cc-eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 218 KT-IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 218 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......++..|+|||++.+..++.++||||||+++|||++ |..||......... ..+ ...
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~-------~~i---------~~~ 266 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-------KAV---------DEG 266 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH-------HHH---------HTT
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHH---------HcC
Confidence 11 1122235678999999998899999999999999999998 99999754432211 111 111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.....+..++..+.+++.+||+.||++|||++++++.|+++..
T Consensus 267 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 2222333567889999999999999999999999999988753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=333.20 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=208.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.|.+.+.||+|+||.||+|.+..++ ..+++|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILN---IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTC---SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCC---CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4566788999999999999876553 4589998754322 234678899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+++++|.+++.....+++..++.++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999877889999999999999999999995 499999999999999999999999999998664332
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. ......||+.|+|||.+.+..++.++||||+|+++|+|+||..||......... ...... ......
T Consensus 166 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~-~~~~~~---- 233 (294)
T 4eqm_A 166 LT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQD-SVPNVT---- 233 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSS-CCCCHH----
T ss_pred cc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhc-cCCCcc----
Confidence 21 123456899999999999999999999999999999999999999765433221 111111 111110
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcccCCCCCC
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRP-TMRKVSQMLQEVVEVDVPP 343 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~vl~~L~~~~~~~~~~ 343 (350)
.....+++..+.+++.+||+.||.+|| +++++.+.|+.++......
T Consensus 234 -~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~ 280 (294)
T 4eqm_A 234 -TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280 (294)
T ss_dssp -HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred -hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence 011123567899999999999999998 9999999999887655443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=333.49 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=199.0
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
...+++.+.||+|+||.||+|.+..+......+++|...... ....+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 345667788999999999999987766666789999876533 233467899999999999999999999985 457899
Q ss_pred EEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 137 AYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999754 468999999999999999999995 49999999999999999999999999999866543
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+.. ..+..+.
T Consensus 170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~-------~~i~~~~------- 234 (281)
T 1mp8_A 170 TYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-------GRIENGE------- 234 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTC-------
T ss_pred cccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH-------HHHHcCC-------
Confidence 2211 123346778999999998889999999999999999996 99999765443321 1111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
....+.+++..+.+++.+||+.||++|||+.++++.|+++++
T Consensus 235 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 235 --RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 112223467889999999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=336.99 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=212.4
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
...+.+.+.||+|+||.||+|.+... ...+..|++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 34456678899999999999987532 2345779999986533 33446789999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCC------------------------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046877 135 LLAYEFLNNGTLASFLFGNL------------------------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKP 190 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~------------------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp 190 (350)
+++|||+++++|.+++.... .+++..++.++.|+++||.|||+ .+++|+||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 99999999999999997543 37888999999999999999995 4999999999
Q ss_pred CCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccc
Q 046877 191 QNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMG 269 (350)
Q Consensus 191 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~ 269 (350)
+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433333334456788999999998889999999999999999999 9999975544
Q ss_pred hhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 270 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.... .....+. ....+..++..+.+++.+||+.||++|||++++++.|++++.
T Consensus 259 ~~~~-------~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 ERLF-------NLLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGHH-------HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH-------HHhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3321 1111111 112223456889999999999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=338.73 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=204.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc------cHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD------GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
.|.+.+.||+|+||.||+|....++ ..+|+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTG---LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCC---CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3566788999999999999977654 56899988654321 34679999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----ceEEeecccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY----NARISDFGLA 209 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~ 209 (350)
.++||||+++|+|.+++.....+++..+..++.|++.|+.|||+ .+++||||||+||+++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999999888889999999999999999999995 5999999999999998776 7999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
........ .....||+.|+|||++.+..++.++||||+|+++|+|++|..||......+.. ..+..+...
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~-------~~i~~~~~~ 236 (361)
T 2yab_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------ANITAVSYD 236 (361)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHTTCCC
T ss_pred eEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhcCCC
Confidence 87654321 13456899999999999889999999999999999999999999765443321 111111110
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
. ........+..+.+++.+||..||.+|||+.++++
T Consensus 237 ~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 F------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00001124578999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=338.76 Aligned_cols=259 Identities=23% Similarity=0.390 Sum_probs=204.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcc-eeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTS-TTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~-~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.+.+.+.||+|+||.||+|.+..++.. ...+++|.+.... ......+.+|+.+++.++||||+++++++. .+..+++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 345667899999999999998765543 2347778765332 233356788999999999999999999886 4568999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+.+|+|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999764 578999999999999999999995 499999999999999999999999999998776554
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.........++..|+|||++.+..++.++||||||+++|+|+| |..||.......... .+..+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~--------- 233 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-------LLEKG--------- 233 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-------HHHTT---------
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-------HHHcC---------
Confidence 4433345567889999999998899999999999999999999 999997654333211 11111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.....+..++..+.+++.+||+.||++|||++++++.|+++..
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111222345678899999999999999999999999988763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=328.35 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=207.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.+.||+|+||.||+|.+.++ ..+++|.+... ....+++.+|+.++++++||||+++++++.+.+..+++||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTT----EEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hceeeheecCCCccEEEEEEecCC----CeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 456678899999999999987542 34899998754 3345779999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|.+++.. ...+++..++.++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 9999999999964 3568999999999999999999995 4999999999999999999999999999986543321
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.......++..|+|||.+.+..++.++||||+|+++|+|++ |..||......... .....+ ..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~-------~~~~~~---------~~ 225 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-------EDISTG---------FR 225 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTT---------CC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHhcC---------cc
Confidence 11233446778999999998899999999999999999999 99999754433221 111111 11
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
...+...+..+.+++.+||+.||++|||++++++.|+++.+.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 112223467899999999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=339.94 Aligned_cols=266 Identities=23% Similarity=0.361 Sum_probs=211.9
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecC
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG 131 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 131 (350)
+....+.+.+.||+|+||.||+|.+... ...+..|++|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3445566778899999999999997532 2345679999986432 33456799999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCC-----------------------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNL-----------------------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDI 188 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl 188 (350)
+..+++|||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+++|+||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 99999999999999999996543 26888999999999999999995 49999999
Q ss_pred CCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcc
Q 046877 189 KPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIE 267 (350)
Q Consensus 189 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~ 267 (350)
||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|+| |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987655443333344557889999999988899999999999999999998 99999765
Q ss_pred cchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 268 MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
...... ......+ .....+..++..+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus 279 ~~~~~~------~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 PVDANF------YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCSHHH------HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcHHHH------HHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 433221 1111111 11122234567899999999999999999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=332.81 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=205.2
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc------cHHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD------GEKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
...|.+.+.||+|+||.||+|....++ ..+|+|.+...... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTG---LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTC---CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCC---cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 345677889999999999999976554 56899988653321 357799999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----ceEEeecc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY----NARISDFG 207 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg 207 (350)
...+++|||+++++|.+++.....+++..++.++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999999888889999999999999999999995 5999999999999999887 79999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+... .+....
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~~~~~~ 233 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NVSAVN 233 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHHTC
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------HHHhcC
Confidence 9987653322 134568999999999998899999999999999999999999997654332211 111111
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. ........++..+.+++.+||+.||++|||++++++
T Consensus 234 ~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CC------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 000001124578899999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=335.75 Aligned_cols=264 Identities=23% Similarity=0.380 Sum_probs=213.9
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcC-CCCceeeecceeecCC
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQ 132 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 132 (350)
....+.+.+.||+|+||.||+|.+.. ....+..|++|.+..... ...+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 33456677889999999999998643 334467899999875432 3346789999999999 9999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCC------------------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 046877 133 NRLLAYEFLNNGTLASFLFGNL------------------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNIL 194 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil 194 (350)
..+++|||+++|+|.+++.... .+++..++.++.|++.||.|||+ .+++|+||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 9999999999999999986543 47899999999999999999995 49999999999999
Q ss_pred EcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhh
Q 046877 195 LNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 273 (350)
Q Consensus 195 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~ 273 (350)
++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|+| |..||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999987765544333344557789999999998899999999999999999999 99999755433221
Q ss_pred hHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 274 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
. ..... ......+..++..+.+++.+||+.||.+|||++++++.|+++++
T Consensus 258 ~------~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 258 Y------KMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp H------HHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------HHhcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1 11111 11112223456789999999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=344.03 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=204.9
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
...|.+.+.||+|+||.||+|....++ ..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~---~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAG---QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTT---EEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCC---cEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 455677889999999999999876654 568898886433 233456899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCceEEeeccccccc
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN---DRYNARISDFGLAKLL 212 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~ 212 (350)
++|||+++|+|.+++.....+++..+..++.|++.|+.|||+ .+|+||||||+||+++ +++.+||+|||++...
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999999999888889999999999999999999995 4999999999999998 5678999999999766
Q ss_pred ccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...... .....||+.|+|||++.+..++.++||||+||++|+|++|..||......... ..+..+....
T Consensus 164 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~~~-- 232 (444)
T 3soa_A 164 EGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY-------QQIKAGAYDF-- 232 (444)
T ss_dssp CTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHTCCCC--
T ss_pred cCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH-------HHHHhCCCCC--
Confidence 543221 23456899999999999989999999999999999999999999765433221 1112221111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+....+++++.+++.+||+.||++|||+.++++
T Consensus 233 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 ----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111235678999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=327.56 Aligned_cols=266 Identities=18% Similarity=0.204 Sum_probs=210.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.+.+.||+|+||.||+|....+ +..||+|.+... .....+.+|+..++.+ +|+|++++++++.+....+++|
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTT---TEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCC---CcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 456678899999999999987555 356999988643 2344688899999999 8999999999999999999999
Q ss_pred ecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-----eEEeeccccccc
Q 046877 139 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN-----ARISDFGLAKLL 212 (350)
Q Consensus 139 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~~~~~ 212 (350)
||+ +++|.+++... ..+++..++.++.|++.|++||| +.+++||||||+||+++.++. +||+|||++...
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 88999999754 45899999999999999999999 569999999999999987776 999999999876
Q ss_pred ccCccc-----ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 213 TLNQRK-----TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 213 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 543221 112445689999999999998999999999999999999999999986543322211111111111111
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCCC
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPP 343 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~~ 343 (350)
..... ..++..+.+++.+||+.||++|||++++++.|+++.+.....
T Consensus 242 ~~~~~---------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 242 LRELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHH---------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 11111 134678999999999999999999999999999987544433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=331.31 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=207.1
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
+....+.+.+.||+|+||.||++.+..+ ..|++|.+.... ...+++.+|+++++.++||||+++++++.+.+..+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTT----EEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCC----CeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 4445566778999999999999987532 458999987543 34577999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+++++|.+++.. ...+++..++.++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999976 4678999999999999999999995 4999999999999999999999999999986643
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
... .......+++.|+|||.+.+..++.++||||+|+++|+|+| |..||.......... .+..+
T Consensus 173 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~-------~~~~~------- 237 (283)
T 3gen_A 173 DEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-------HIAQG------- 237 (283)
T ss_dssp HHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------HHHTT-------
T ss_pred ccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH-------HHhcc-------
Confidence 321 11123346778999999998889999999999999999998 999997654332211 11111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.....+..+++.+.+++.+||+.||++|||++++++.|+++.+
T Consensus 238 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 238 --LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 1111222345789999999999999999999999999988764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=337.87 Aligned_cols=273 Identities=18% Similarity=0.193 Sum_probs=204.0
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-----------cHHHHHHHHHHHhcCCCCceeee
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-----------GEKEFKNEVIVIGQTHHKNLVRL 124 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~ 124 (350)
+....+.+.+.||+|+||.||+|.+..+......+++|........ ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 3445567778999999999999998775556677999988654221 12336678888999999999999
Q ss_pred cceeec----CCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-
Q 046877 125 LGFCDE----GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY- 199 (350)
Q Consensus 125 ~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~- 199 (350)
++++.. ....+++|||+ +++|.+++.....+++..++.++.|++.||+|||+ .+++||||||+||+++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence 999877 77899999999 89999999877789999999999999999999995 4999999999999998877
Q ss_pred -ceEEeecccccccccCccc-----ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhh
Q 046877 200 -NARISDFGLAKLLTLNQRK-----TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 273 (350)
Q Consensus 200 -~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~ 273 (350)
.+||+|||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876433211 1113446899999999999989999999999999999999999999653322221
Q ss_pred hHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 274 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
... ....... ........ ......++.++.+++.+||..||++|||++++++.|+++..
T Consensus 270 ~~~--~~~~~~~-~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQT--AKTNLLD-ELPQSVLK---WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHH--HHHHHHH-TTTHHHHH---HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHH--HHHhhcc-cccHHHHh---hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111 1111111 11111110 00111356789999999999999999999999999987643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=334.61 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=205.2
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCc----ceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTT----STTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
...+.+.+.||+|+||.||+|.+..+++ ....+++|.+........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3456677889999999999998776543 235699999877666667889999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCC-cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--------eEEe
Q 046877 134 RLLAYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN--------ARIS 204 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~--------~kl~ 204 (350)
.+++|||+++++|.+++..... +++..++.++.|++.||.|||+ .+++||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999976544 8999999999999999999995 49999999999999998877 9999
Q ss_pred ecccccccccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh
Q 046877 205 DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 283 (350)
Q Consensus 205 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 283 (350)
|||++...... ....++..|+|||++.+ ..++.++||||||+++|+|++|..|+.......... ...
T Consensus 164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~------~~~ 231 (289)
T 4fvq_A 164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL------QFY 231 (289)
T ss_dssp CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHH
T ss_pred cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH------HHh
Confidence 99998755322 22347889999999987 678999999999999999999655544332222110 000
Q ss_pred hcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCCC
Q 046877 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPP 343 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~~ 343 (350)
... . ..+...+.++.+++.+||+.||++|||++++++.|+++.....++
T Consensus 232 ~~~---------~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 232 EDR---------H--QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp HTT---------C--CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred hcc---------C--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 000 0 001112456889999999999999999999999999998755443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=329.33 Aligned_cols=260 Identities=23% Similarity=0.401 Sum_probs=207.4
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCee-EEEEecC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR-LLAYEFL 141 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~e~~ 141 (350)
.+.||+|+||.||+|.+..+......+++|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. +++|||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4779999999999999877777677899999865332 3346788999999999999999999999776665 9999999
Q ss_pred CCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc--
Q 046877 142 NNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK-- 218 (350)
Q Consensus 142 ~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 218 (350)
.+++|.+++.. ...+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 99999999976 4567899999999999999999995 49999999999999999999999999999865433211
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.......++..|+|||.+.+..++.++||||||+++|+|++|..|+......... . . ........
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~--~----~---------~~~~~~~~ 247 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--T----H---------FLAQGRRL 247 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH--H----H---------HHHTTCCC
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH--H----H---------HhhcCCCC
Confidence 1223445788999999999989999999999999999999966655432222111 0 0 11111112
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCC
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDV 341 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~ 341 (350)
..+..+++.+.+++.+||+.||.+|||++++++.|+++.+.-.
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 2233456789999999999999999999999999998865443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=331.85 Aligned_cols=262 Identities=24% Similarity=0.375 Sum_probs=200.4
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCe--
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN-- 133 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 133 (350)
...+.+.+.||+|+||.||+|........+..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 344556678999999999999887766667789999986432 2334678999999999999999999999877653
Q ss_pred ---eEEEEecCCCCChhhhhc------CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEe
Q 046877 134 ---RLLAYEFLNNGTLASFLF------GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARIS 204 (350)
Q Consensus 134 ---~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~ 204 (350)
.+++|||+++++|.+++. ....+++..++.++.|+++||.||| +.+++|+||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEe
Confidence 499999999999999983 3456899999999999999999999 5699999999999999999999999
Q ss_pred ecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHh
Q 046877 205 DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 283 (350)
Q Consensus 205 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 283 (350)
|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......... ..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-------~~ 262 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD-------YL 262 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-------HH
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH-------HH
Confidence 9999987654433233334456789999999998899999999999999999999 889997554433211 11
Q ss_pred hcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
..+. ....+..++..+.+++.+||..||.+|||++++++.|+++++
T Consensus 263 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 263 LHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 112223456789999999999999999999999999998864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=354.65 Aligned_cols=262 Identities=28% Similarity=0.429 Sum_probs=214.5
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
.++....+.+.+.||+|+||.||+|.+..+ +..||+|.+... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGG---TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCC---CeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 344555567778999999999999998654 356999998654 3346789999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 134 RLLAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
.++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++..
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeeccccee
Confidence 9999999999999999964 3558899999999999999999995 4999999999999999999999999999986
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
...... .......++..|+|||++.+..++.++||||||+++|||+| |..||......... .
T Consensus 368 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-------~--------- 430 (495)
T 1opk_A 368 MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------E--------- 430 (495)
T ss_dssp CTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------H---------
T ss_pred ccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------H---------
Confidence 643221 11223345678999999998889999999999999999999 99999765433211 1
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
.+....+...+..++..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus 431 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 431 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1111222233345678999999999999999999999999999988643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=327.59 Aligned_cols=244 Identities=24% Similarity=0.319 Sum_probs=203.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+++.+.||+|+||.||+|+...++ ..+|+|.+.... ....+.+.+|..+++.++||||+++++++.+....++
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNG---RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 3556788999999999999976553 569999986532 2345678899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+++|+|.+++.....+++..++.++.|++.||.||| +.+++||||||+||+++.+|.+||+|||++.......
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence 9999999999999988888999999999999999999999 5699999999999999999999999999998654321
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
....||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..... ..+..+..
T Consensus 161 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~~-------- 220 (318)
T 1fot_A 161 -----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-------EKILNAEL-------- 220 (318)
T ss_dssp -----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHCCC--------
T ss_pred -----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCC--------
Confidence 2346899999999999999999999999999999999999999754432211 11111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
. .+...+.++.+++.+||..||.+|| +++++++
T Consensus 221 ~--~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 R--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp C--CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1 1123457899999999999999999 8888873
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=331.88 Aligned_cols=249 Identities=20% Similarity=0.278 Sum_probs=202.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.|.+.+.||+|+||.||+|....++ ..+++|.+... ......+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~---~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSK---KTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCC---cEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3556788999999999999976553 56899987643 3345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--CCceEEeecccccccccCc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND--RYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~ 216 (350)
|+++++|.+++... ..+++..++.++.|++.|+.|||+ .+++||||||+||+++. ++.+||+|||++.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999765 468999999999999999999995 49999999999999987 7899999999998765432
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. .....+|+.|+|||++.+..++.++||||+|+++|+|++|..||......... ..+..+.....
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~~~----- 223 (321)
T 1tki_A 159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII-------ENIMNAEYTFD----- 223 (321)
T ss_dssp E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHTCCCCC-----
T ss_pred c---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH-------HHHHcCCCCCC-----
Confidence 2 23456899999999999888899999999999999999999999765433221 11111111100
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+++.++.+++.+||..||.+|||+.++++
T Consensus 224 -~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 -EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000134678999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=331.64 Aligned_cols=259 Identities=18% Similarity=0.184 Sum_probs=205.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.+.+.||+|+||.||+|....+ +..||+|.+.... ....+.+|+.+++.+ +||||+++++++.+.+..+++|
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYT---NEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTT---TEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEeeccCCceEEEEEECCC---CcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 345678899999999999997655 3569999886432 234688999999999 9999999999999999999999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-----eEEeeccccccc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN-----ARISDFGLAKLL 212 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~~~~~ 212 (350)
||+ +++|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++. +||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999 8899999875 4678999999999999999999995 49999999999999998887 999999999876
Q ss_pred ccCcccc-----eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 213 TLNQRKT-----IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 213 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 4432211 12345689999999999999999999999999999999999999986544332211111111100011
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
..... ..++ ++.+++..||+.||.+||+++++.+.|+++.
T Consensus 241 ~~~~~---------~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 241 IEVLC---------ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHHT---------TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHh---------ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 10000 0134 8999999999999999999999999998775
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=349.02 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=210.1
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
++....+.+.+.||+|+||.||+|.++.+ ..||+|.+.... ...+.+.+|+.+++.++||||+++++++. .+..
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKH----TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTT----EEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCc----cEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 33444556778899999999999987542 458999987543 45778999999999999999999999986 5678
Q ss_pred EEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 9999999999999999754 367888999999999999999995 49999999999999999999999999999865
Q ss_pred ccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..... .......++..|+|||++....++.++||||||+++|||+| |..||......+.. ..+..+
T Consensus 335 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~----- 401 (454)
T 1qcf_A 335 EDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERG----- 401 (454)
T ss_dssp CCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------HHHHHT-----
T ss_pred CCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC-----
Confidence 43221 11123345778999999998899999999999999999999 99999755433221 111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
...+.+.++++.+.+++.+||+.||++|||++++++.|+++....
T Consensus 402 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 402 ----YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred ----CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 122223356789999999999999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.03 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=205.7
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
....|.+.+.||+|+||.||+|.+..++ ..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 3456777889999999999999976554 569999986532 23346788999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---ceEEeecccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY---NARISDFGLAKL 211 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~ 211 (350)
+++|||+++|+|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||++..
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999999999888889999999999999999999995 4999999999999998654 599999999986
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..... ..+..+....
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------~~i~~~~~~~- 249 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-------AQIKAGAYDY- 249 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCC-
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhCCCCC-
Confidence 653322 13456899999999999889999999999999999999999999755432211 1111221110
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......++.++.+++.+||+.||++|||+.++++
T Consensus 250 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 01111235678999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=336.68 Aligned_cols=267 Identities=24% Similarity=0.389 Sum_probs=213.3
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcCC----CcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeeccee
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTT----TTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFC 128 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 128 (350)
++....+.+.+.||+|+||.||+|.+... ...+..||+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34445666778999999999999987532 2345679999986543 23346788999999999 899999999999
Q ss_pred ecCCeeEEEEecCCCCChhhhhcCCC----------------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046877 129 DEGQNRLLAYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQN 192 (350)
Q Consensus 129 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N 192 (350)
.+.+..+++|||+++++|.+++.... .+++..++.++.|+++||.|||+ .+++|+||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccce
Confidence 99999999999999999999997543 37888999999999999999995 499999999999
Q ss_pred eEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchh
Q 046877 193 ILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 271 (350)
Q Consensus 193 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~ 271 (350)
|+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999999999999987654433333334456788999999988889999999999999999999 999997544322
Q ss_pred hhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
.. ..+..+. ....+..++..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 268 ~~-------~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 268 LF-------KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HH-------HHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH-------HHHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11 1111111 11122345678999999999999999999999999999887543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=332.99 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=201.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQ---QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3556788999999999999976654 469999886432 2334678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+ +|+|.+++.....+++..++.++.|++.|+.|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 679999988778899999999999999999999955 99999999999999999999999999998665432
Q ss_pred ccceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ....||+.|+|||++.+..+ +.++||||+|+++|+|++|..||......... ......
T Consensus 163 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~- 223 (336)
T 3h4j_B 163 FL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSC- 223 (336)
T ss_dssp TT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSS-
T ss_pred cc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcC-
Confidence 22 34468999999999988776 68999999999999999999999754332211 011110
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....+...+..+.+++.+||+.||.+|||++++++
T Consensus 224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11112235678999999999999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=338.70 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=200.6
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcC-CCCceeeecceeecC
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG 131 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 131 (350)
+....+++.+.||+|+||.||+|+++.++ ..+|+|.+.+. .......+..|..+++.+ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETG---DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCC---CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 33445677789999999999999987654 56999998653 233456688899999988 799999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
+..++||||+++|+|..++.....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 9999999999999999999888889999999999999999999995 4999999999999999999999999999975
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.. ..+..+..
T Consensus 174 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~~~--- 241 (353)
T 3txo_A 174 GICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF-------EAILNDEV--- 241 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC---
T ss_pred cccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCC---
Confidence 432221 223456899999999999888999999999999999999999999865543321 11111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTM------RKVSQ 331 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~------~~vl~ 331 (350)
..+...+..+.+++.+||+.||.+||++ +++++
T Consensus 242 -------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1112245789999999999999999998 66653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=336.89 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=204.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.+.||+|+||.||+|....++ ..+++|.+..........+.+|+.+++.++||||+++++++.+....+++||
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATG---RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCEEEEEEEECCCC---CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 4566788999999999999976654 5689998876554456679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--CCceEEeecccccccccCc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND--RYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~ 216 (350)
|+++|+|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||++.......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999998755 468999999999999999999995 49999999999999974 5779999999998765432
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+...... .
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-------~~i~~~~~~------~ 269 (387)
T 1kob_A 206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-------QNVKRCDWE------F 269 (387)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHHCCCC------C
T ss_pred c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC------C
Confidence 2 23346899999999999989999999999999999999999999765432221 111111110 1
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......++.++.+++.+||+.||++|||+.++++
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11112245678999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=340.15 Aligned_cols=258 Identities=23% Similarity=0.463 Sum_probs=197.7
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceee-cCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCD-EGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e 139 (350)
.+.+.||+|+||.||+|....+......+++|.+.... ....+++.+|+.+++.++||||+++++++. .++..+++||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 44578999999999999987666556779999886432 334567999999999999999999999864 4567899999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++|+|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999754 457889999999999999999995 49999999999999999999999999999865433221
Q ss_pred c--eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 219 T--IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 219 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
. ......++..|+|||++.+..++.++||||||+++|+|+| |..||......+... ....+
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-------~~~~~--------- 312 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------YLLQG--------- 312 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-------HHHTT---------
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-------HHHcC---------
Confidence 1 1133456778999999998999999999999999999999 677776544332211 01111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.....+..++..+.+++.+||+.||++|||++++++.|+++..
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1112223456789999999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=322.42 Aligned_cols=252 Identities=25% Similarity=0.463 Sum_probs=200.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc-------HHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG-------EKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
..+.+.+.||+|+||.||+|.+..++ ..||+|.+....... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDK---SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTC---CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred ccceehhccccCCceeEEEEEEcCCc---eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 44566788999999999999976553 569999885433221 16789999999999999999999998766
Q ss_pred CeeEEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeEEcCCCc-----eEE
Q 046877 132 QNRLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQ--IIHCDIKPQNILLNDRYN-----ARI 203 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~~~~~-----~kl 203 (350)
. +++|||+++++|.+++... ..+++..++.++.|++.|++|||+ .+ ++|+||||+||+++.++. +||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 5 6999999999998887544 568999999999999999999994 47 999999999999988776 999
Q ss_pred eecccccccccCcccceeeccccCCCccCccccc--CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 046877 204 SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR--KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 281 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 281 (350)
+|||++...... .....+++.|+|||++. ...++.++||||+|+++|+|++|..||..............
T Consensus 171 ~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--- 242 (287)
T 4f0f_A 171 ADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI--- 242 (287)
T ss_dssp CCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH---
T ss_pred CCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH---
Confidence 999999754332 23456899999999984 45678899999999999999999999976544332211110
Q ss_pred HhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 282 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
.........+..++..+.+++.+||+.||++|||++++++.|+++
T Consensus 243 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 ----------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111112222334568899999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=333.25 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=202.4
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcce-eEEEEEeeecc-ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTST-TAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~-~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
..+.+.+.||+|+||.||+|.+..++... ..+++|.+... .......+.+|+.+++.++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 34566788999999999999987655432 34677777533 3445678999999999999999999999998765 788
Q ss_pred EEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 137 AYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+++|+.+|+|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 9999999999999865 4568999999999999999999995 49999999999999999999999999999876544
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..........+|..|+|||.+.+..++.++||||||+++|+|++ |..||.......... .+..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----------------~~~~ 234 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----------------ILEK 234 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----------------HHHT
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----------------HHHc
Confidence 33333344456778999999999999999999999999999999 999997654433211 1111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
......+..++..+.+++.+||+.||.+|||++++++.|+++..
T Consensus 235 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 12222233456789999999999999999999999999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=347.21 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=203.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCC-eeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ-NRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 138 (350)
.+.+.+.||+|+||.||+|.+. +..||+|.+... ...+.+.+|+.++++++||||+++++++.+.. ..+++|
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-----TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred HeEEEeeecCcCCeeEEEEEec-----CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 3455678999999999999864 236999998653 34678999999999999999999999986654 789999
Q ss_pred ecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 9999999999997543 36889999999999999999995 499999999999999999999999999997543221
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
....++..|+|||++.+..++.++||||||+++|||+| |..||......+.. ..+.. .
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~---------~ 402 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEK---------G 402 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-------HHHHT---------T
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHc---------C
Confidence 22346889999999999999999999999999999998 99999754433211 11111 1
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
.+...+..++..+.++|.+||+.||++|||+.++++.|+++...+
T Consensus 403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 222233457789999999999999999999999999999886543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=328.35 Aligned_cols=260 Identities=23% Similarity=0.452 Sum_probs=202.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeeccee-ecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFC-DEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 138 (350)
+.+.+.||+|+||.||+|.+..+......+++|.+.... ....+.+.+|+.++++++||||+++++++ ..++..+++|
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 445678999999999999987666666778999886533 23346789999999999999999999985 5566889999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++++|.+++.. ...+++..++.++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 99999999999965 4557899999999999999999995 4999999999999999999999999999986654322
Q ss_pred c--ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 218 K--TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 218 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
. .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||......+.... ...
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-------~~~--------- 247 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------LLQ--------- 247 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH-------HHT---------
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-------Hhc---------
Confidence 1 12234456788999999998899999999999999999999 5556654333221110 011
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
......+..++..+.+++.+||+.||++|||++++++.|+++...
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 248 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111122223567899999999999999999999999999988754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=329.03 Aligned_cols=262 Identities=29% Similarity=0.424 Sum_probs=214.2
Q ss_pred CHHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 52 SYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 52 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
...++....+.+.+.||+|+||.||+|.+..+ +..+++|.+... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGG---TEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCC---CEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 33445555667778999999999999997654 356999988653 34467899999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
+..+++|||+++++|.+++.. ...+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence 999999999999999999975 34588999999999999999999955 9999999999999999999999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-------------- 223 (288)
T 3kfa_A 159 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------------- 223 (288)
T ss_dssp GTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH--------------
T ss_pred eeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------------
Confidence 87654332 22234456788999999998899999999999999999999 999997544332211
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
..........+..++..+.+++.+||..||.+|||++++++.|+++.
T Consensus 224 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 224 --LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp --HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 11111222223345688999999999999999999999999998765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=324.48 Aligned_cols=261 Identities=20% Similarity=0.257 Sum_probs=198.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|++.+.||+|+||+||+|.+..++ ..+|+|.+..... .....+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeeeEecCCCCeEEEEEEECCCC---ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 456788999999999999976653 5699998864332 23467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||++++.+..+......+++..++.++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 999875555555556789999999999999999999995 4999999999999999999999999999986643322
Q ss_pred ceeeccccCCCccCcccccCCC-CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh---cCCcchhcc-
Q 046877 219 TIKTAIRGTKGYVAPEWFRKST-ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---NGKLDDLVE- 293 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~- 293 (350)
......+|+.|+|||++.+.. ++.++||||+|+++|+|++|..||.......... ........ ...+.....
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL--KRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH--HHHHHHHCCCCTTTCTTGGGS
T ss_pred -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHH--HHHHHHhCCCChhhhhhhccc
Confidence 123456799999999998765 7999999999999999999988864433322111 11111111 111111100
Q ss_pred -----------ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 -----------GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 -----------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...........+..+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00001111245678999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=323.53 Aligned_cols=268 Identities=18% Similarity=0.231 Sum_probs=207.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCC--eeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ--NRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 137 (350)
|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+ ..+++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTG---DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred EEEEEEecCCCCeEEEEEEECCCC---cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 456788999999999999987653 469999987543 334567889999999999999999999987665 77999
Q ss_pred EecCCCCChhhhhcCCCC---cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCceEEeeccccc
Q 046877 138 YEFLNNGTLASFLFGNLK---PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL----NDRYNARISDFGLAK 210 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~~ 210 (350)
|||+++++|.+++..... +++..++.++.|++.||+|||+ .+++|+||||+||++ +.++.+||+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999975433 8999999999999999999995 499999999999999 788889999999998
Q ss_pred ccccCcccceeeccccCCCccCccccc--------CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhh-hHHHHHHH
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFR--------KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDWAFD 281 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~-~~~~~~~~ 281 (350)
........ ....||+.|+|||++. +..++.++|||||||++|+|+||..||......... ........
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 76543322 2345899999999986 567899999999999999999999999754432221 11111111
Q ss_pred HhhcCCcchhc-----------cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 282 CYRNGKLDDLV-----------EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 282 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
......+.... ............+..+.+++.+||+.||++|||++++++-.++-.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11111111000 001112334678899999999999999999999999998876543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=326.20 Aligned_cols=259 Identities=23% Similarity=0.367 Sum_probs=206.6
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
..+.+.+.||+|+||.||+|.+.........|++|.+.... ....+.+.+|+.+++.++||||+++++++.++ ..+++
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence 34556788999999999999987766667789999987542 33456789999999999999999999998754 56899
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++++|.+++... ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999999999654 458999999999999999999995 599999999999999999999999999998665432
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... .....++..|+|||++.+..++.++||||||+++|+|+| |+.||.......... ....+.
T Consensus 168 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-------~~~~~~-------- 231 (281)
T 3cc6_A 168 YYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-------VLEKGD-------- 231 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-------HHHHTC--------
T ss_pred ccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-------HHhcCC--------
Confidence 211 133446778999999988889999999999999999998 999997544333211 111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
....+..+++.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 -RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 111222356789999999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=335.41 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=193.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.|.+.+.||+|+||.||++....++ ..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTK---ELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTC---CEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCC---cEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4567789999999999999976554 569999986543 334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--eEEeecccccccccCcc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN--ARISDFGLAKLLTLNQR 217 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~ 217 (350)
|+++|+|.+++.....+++..++.++.|++.||+|||+ .+++||||||+||+++.++. +||+|||++........
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 99999999999877889999999999999999999995 59999999999999987765 99999999874332211
Q ss_pred cceeeccccCCCccCcccccCCCCCCC-CcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........... .. . .......
T Consensus 174 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--~~-~--------~~~~~~~ 239 (361)
T 3uc3_A 174 ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK--TI-Q--------RILSVKY 239 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH--HH-H--------HHHTTCC
T ss_pred ---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH--HH-H--------HHhcCCC
Confidence 134468999999999988877665 8999999999999999999976443222110 00 0 0111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+....++..+.+++.+||+.||++|||++++++
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 11222234578999999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=325.20 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=193.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--------------------------ccHHHHHHHHHHH
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--------------------------DGEKEFKNEVIVI 113 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--------------------------~~~~~~~~e~~~l 113 (350)
.|.+.+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|+.++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDN---TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTT---EEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred ceEEEeEEeecCCEEEEEEEECCCC---cEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4566788999999999999876553 5699998864321 1134688999999
Q ss_pred hcCCCCceeeecceeec--CCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046877 114 GQTHHKNLVRLLGFCDE--GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQ 191 (350)
Q Consensus 114 ~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~ 191 (350)
+.++||||+++++++.+ ....+++|||+++++|.+++ ....+++..++.++.|++.||+|||+ .+++|+||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 99999999999999976 56889999999999999876 44578999999999999999999995 49999999999
Q ss_pred CeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCC---CCCCCcchhHHHHHHHHHhCCCCCCccc
Q 046877 192 NILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST---ISAKVDVYSFGVLLLEIISCRKSFDIEM 268 (350)
Q Consensus 192 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~lltg~~pf~~~~ 268 (350)
||+++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999987654322 123456899999999997654 3678999999999999999999997543
Q ss_pred chhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 269 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..... ..+.... ...+....++..+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~-------~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 IMCLH-------SKIKSQA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHH-------HHHHHCC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHH-------HHHhccc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 32211 1111111 111112235678999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=333.26 Aligned_cols=279 Identities=23% Similarity=0.346 Sum_probs=209.8
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcC-CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecC--
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQT-TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-- 131 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 131 (350)
+....+++.+.||+|+||.||+|.+.. ....+..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 334446677889999999999998542 23345779999986432 33457899999999999999999999999776
Q ss_pred CeeEEEEecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 132 QNRLLAYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
...+++|||+++++|.+++. ....+++..++.++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 66899999999999999994 44678999999999999999999995 499999999999999999999999999998
Q ss_pred ccccCccc-ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 211 LLTLNQRK-TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 211 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
........ .......+|..|+|||.+.+..++.++||||+|+++|+|+||..|+............. ...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 253 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP-THGQMTVTRLV 253 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS-CCGGGHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCC-cccccCHHHHH
Confidence 76543322 22234557888999999998889999999999999999999999874322110000000 00000000011
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
...........+..+++.+.+++.+||+.||.+|||++++++.|+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 1111222222334567899999999999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=346.11 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=206.3
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
+....+.+.+.||+|+||.||+|.+..+ ..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT----EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCC----ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 3344456678899999999999987643 349999987543 346789999999999999999999999876 6789
Q ss_pred EEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 136 LAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++....
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 999999999999999642 458899999999999999999995 599999999999999999999999999998664
Q ss_pred cCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.... .......++..|+|||++.+..++.++||||||+++|+|+| |..||......+.. ..+..+
T Consensus 332 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~------ 397 (452)
T 1fmk_A 332 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERG------ 397 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTT------
T ss_pred CCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC------
Confidence 3221 11233446778999999998899999999999999999999 99999755433211 111111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCC
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~ 342 (350)
.+...+..++..+.+++.+||+.||++|||++++++.|+++.....|
T Consensus 398 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 398 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 12222335678999999999999999999999999999998765544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=335.97 Aligned_cols=276 Identities=24% Similarity=0.346 Sum_probs=213.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcC-CCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceee--cCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQT-TTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCD--EGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 135 (350)
..+.+.+.||+|+||.||+|.+.. +...+..|++|.+........+.+.+|+++++.++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 345677889999999999998643 23345779999987765566677999999999999999999999886 556789
Q ss_pred EEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999999999965 3568999999999999999999995 5999999999999999999999999999987654
Q ss_pred Cccc-ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 215 NQRK-TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 215 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.... .......++..|+|||++.+..++.++||||||+++|+|++|..||............. ...............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC-ERDVPALSRLLELLE 258 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc-ccccccHHHHHHHhh
Confidence 3322 12233457788999999998889999999999999999999999986443321110000 000000001111222
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.......+..++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 222333344567899999999999999999999999999998864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=334.36 Aligned_cols=247 Identities=25% Similarity=0.322 Sum_probs=202.5
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcC-CCCceeeecceeecCCee
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 134 (350)
..+.+.+.||+|+||.||+|+++.++ +.+|+|.+.... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTN---QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34566788999999999999987653 569999987532 34456788899998876 999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++||||+++|+|.+++.....+++..++.++.|++.||+|||+ .+++||||||+||+++.+|.+||+|||++.....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 9999999999999999877889999999999999999999995 5999999999999999999999999999975432
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..... ..+..+..
T Consensus 171 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~~~~------ 235 (345)
T 1xjd_A 171 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIRMDNP------ 235 (345)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------
T ss_pred CCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHhCCC------
Confidence 221 123456899999999999999999999999999999999999999765433221 11111110
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMR-KVS 330 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-~vl 330 (350)
..+..++.++.+++.+||..||++||++. +++
T Consensus 236 ----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11123467899999999999999999997 554
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=333.03 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=204.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..+.+.+.||+|+||.||+|....++ ..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~---~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTK---KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34566788999999999999976654 569999886432 334567889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+||||+.+|+|.+++.....+++..++.++.|++.||.|||+ .+|+||||||+||+++.+|.+||+|||++......
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999999888889999999999999999999995 59999999999999999999999999999876533
Q ss_pred cccceeeccccCCCccCcccccC---CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRK---STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............. +....
T Consensus 169 ~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~~~~~----- 236 (384)
T 4fr4_A 169 TQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT----FETTV----- 236 (384)
T ss_dssp CC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH----HHHCC-----
T ss_pred Cc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhhcc-----
Confidence 22 244568999999999964 4589999999999999999999999975544332221111 11111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT-MRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~vl~ 331 (350)
...+..++..+.+++.+||+.||.+||+ ++++++
T Consensus 237 -----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1112235678999999999999999998 666653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=318.71 Aligned_cols=254 Identities=28% Similarity=0.387 Sum_probs=205.9
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
...+.+.+.||+|+||.||+|....++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCC---cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 345677789999999999999876553 468999886433 3345778999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+++++|.+++.....+++..++.++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999999888889999999999999999999995 499999999999999999999999999998664433
Q ss_pred ccceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.........+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.......... . .+....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~-----~~~~~~-------- 225 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-S-----DWKEKK-------- 225 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH-H-----HHHTTC--------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH-H-----Hhhhcc--------
Confidence 2222344568999999999987665 678999999999999999999997655432211 1 111110
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.........+..+.+++.+||+.||++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011112235678999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=334.91 Aligned_cols=279 Identities=23% Similarity=0.343 Sum_probs=211.6
Q ss_pred hhhhccCCCccceEEEEEEcC-CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeec--CCeeEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQT-TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE--GQNRLLA 137 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~-~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 137 (350)
.+.+.||+|+||.||++.+.. ....+..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ....+++
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 567889999999999997653 33456789999987543 2335678999999999999999999999977 4678999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.+++... .+++..++.++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999654 48999999999999999999995 4999999999999999999999999999987654332
Q ss_pred c-ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 218 K-TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 218 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. .......++..|+|||.+.+..++.++||||||+++|+|+||..||........... .+..................
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI-GIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH-CSCCHHHHHHHHHHHHHTTC
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh-cccccchhHHHHHHHHhccc
Confidence 1 122344577889999999988899999999999999999999999864332111000 00000000011122222233
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNP 345 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~~~~ 345 (350)
....+..++..+.+++.+||+.||++|||++++++.|+++.+.-..+.|
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 3333445678999999999999999999999999999988765544444
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=329.72 Aligned_cols=251 Identities=22% Similarity=0.266 Sum_probs=195.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----cccHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
..+++.+.||+|+||.||+++.......++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 45667788999999999999876544556779999986532 22345678899999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
+++|||+++++|.+++.....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 9999999999999999877889999999999999999999995 4999999999999999999999999999875432
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..+....
T Consensus 174 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-------~~i~~~~------- 237 (327)
T 3a62_A 174 DGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI-------DKILKCK------- 237 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHTC-------
T ss_pred CCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhCC-------
Confidence 221 123456899999999999888999999999999999999999999765433211 1111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
. ..+...+.++.+++.+||+.||.+|| ++.++++
T Consensus 238 -~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 -L--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -C--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -C--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 11123467899999999999999999 6777764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=331.34 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=210.4
Q ss_pred HHhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcC-CCCceeeecceeecCC-
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQ- 132 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~- 132 (350)
...+.+.+.||+|+||.||+|.+.. ....+..|++|.+..... .....+.+|+.+++.+ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 3455677889999999999998654 334567899999875432 2345789999999999 7999999999987654
Q ss_pred eeEEEEecCCCCChhhhhcCCCC----------------cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLK----------------PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~ 196 (350)
..+++|||+++++|.+++..... +++..++.++.|+++|+.|||+ .+++|+||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEEC
Confidence 58999999999999999976543 7889999999999999999995 4999999999999999
Q ss_pred CCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhH
Q 046877 197 DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 275 (350)
Q Consensus 197 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~ 275 (350)
.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|+| |..||.........
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-- 260 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 260 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH--
Confidence 999999999999987654433333344567889999999998899999999999999999998 99999755433211
Q ss_pred HHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 276 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
......+.. ...+..++..+.+++.+||+.||.+|||+.++++.|+++++
T Consensus 261 ----~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 261 ----CRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp ----HHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111111111 11122346789999999999999999999999999998763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=330.01 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=198.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 135 (350)
.+.+.+.||+|+||.||+|+.+.++ ..+|+|.+..... .....+.+|..+++.+ +||||+++++++.+.+..+
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTD---RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCC---CEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 3556788999999999999986653 5699999875432 2345688899999887 8999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+||||+++|+|.+++.....+++..++.++.|++.||.|||+ .+|+||||||+||+++.+|.+||+|||++......
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999999877889999999999999999999995 59999999999999999999999999999754322
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhh--hHHHHHHHHhhcCCcchhcc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--ILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 293 (350)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .........+..+..
T Consensus 164 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 236 (345)
T 3a8x_A 164 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 236 (345)
T ss_dssp TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-----
T ss_pred CC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-----
Confidence 21 123456899999999999999999999999999999999999999753221110 011111111111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
. .+...+.++.+++.+||+.||.+||++
T Consensus 237 ---~--~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ---R--IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---C--CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---C--CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1 122356789999999999999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=332.67 Aligned_cols=269 Identities=20% Similarity=0.279 Sum_probs=202.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCe---
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN--- 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 133 (350)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRD---HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCC---CceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 456678899999999999997655 35699999865432 223568899999999999999999999866543
Q ss_pred -eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 134 -RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 134 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
.++||||+++++|.+++.....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 39999999999999999877889999999999999999999995 49999999999999999999999999999866
Q ss_pred ccCccc-ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 213 TLNQRK-TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 213 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ...........
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~~~ 240 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPIPPS 240 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCCCHH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCCCCCcc
Confidence 443221 12234568999999999999999999999999999999999999997654433211 11111111100
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHH-HHHHHhcccCCCCCCCCCC
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRK-VSQMLQEVVEVDVPPNPSP 347 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~-vl~~L~~~~~~~~~~~~~~ 347 (350)
.....++.++.+++.+||+.||++||++.+ +...+.++....+|+.|..
T Consensus 241 -------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~ 290 (311)
T 3ork_A 241 -------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290 (311)
T ss_dssp -------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCC
T ss_pred -------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 001125678999999999999999996554 5577777766666655543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=326.53 Aligned_cols=262 Identities=22% Similarity=0.276 Sum_probs=196.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.|++.+.||+|+||.||+|.+.+ +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+++..+++
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQ----GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETT----SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hhHhhhhccCCCCeEEEEEEECC----CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 35567889999999999998743 35699998864322 2246788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++ +|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 999986 777776544 558999999999999999999995 499999999999999999999999999998764332
Q ss_pred ccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc--
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-- 293 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 293 (350)
.. .....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+................+....+
T Consensus 174 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 174 RS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred cc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 21 234467999999999876 5689999999999999999999999986655443211111000000011110000
Q ss_pred ----cccc-------CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 ----GDME-------AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ----~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.... ......++.++.+++.+||+.||++|||++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 0001124568899999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=327.64 Aligned_cols=264 Identities=26% Similarity=0.425 Sum_probs=196.1
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
.|+....+.+.+.||+|+||.||+|.+.. .+++|.+.... ....+.+.+|+.+++.++||||++++++. ..
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 34555566777899999999999998543 28888876432 33346789999999999999999999965 45
Q ss_pred CeeEEEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
...+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecc
Confidence 678999999999999999854 4568999999999999999999995 499999999999999999999999999998
Q ss_pred ccccCcccceeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
...............||+.|+|||.+. +..++.++||||||+++|+|++|+.||......... ......+.
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~ 242 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGS 242 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH------HHHHHHTS
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH------HHHhcccc
Confidence 655433333334456899999999986 556888999999999999999999999765443321 11111221
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
...... ....+++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 243 ~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 LSPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCcchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111110 1122456889999999999999999999999999998864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=330.47 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=180.9
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEEEEecCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+.||+|+||.||+|.+..++ ..+|+|.+... ....+.+|+.+++.+. ||||+++++++.+....++||||+++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSN---QAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEETTTC---CEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEECCCC---CEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 67999999999999976553 56999998643 4567889999999996 99999999999999999999999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---ceEEeecccccccccCcccce
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY---NARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
|+|.+++.....+++..++.++.|++.|++|||+ .+++||||||+||+++.++ .+||+|||++.........
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 165 (325)
T 3kn6_A 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-- 165 (325)
T ss_dssp CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence 9999999888889999999999999999999995 4999999999999997665 7999999999865433221
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....+|+.|+|||++.+..++.++||||+|+++|+|++|..||..................+..+.... ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Cccc
Confidence 2344579999999999999999999999999999999999999976543221111111122222222110 0001
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
..+++.++.+++.+||+.||++|||+++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 123567899999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=334.45 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=201.7
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-----cccHHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-----QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
....|++.+.||+|+||.||+|....++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETG---QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCC---CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3456778889999999999999876654 569999886321 12457799999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEe
Q 046877 132 QNRLLAYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN---ARIS 204 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~ 204 (350)
+..++||||+++++|.+++.. ...+++..++.++.|+++||.|||+ .+++||||||+||+++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEe
Confidence 999999999999999887753 2357899999999999999999995 49999999999999986655 9999
Q ss_pred ecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 046877 205 DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 205 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+.
T Consensus 176 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~i~ 245 (351)
T 3c0i_A 176 GFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL--------FEGII 245 (351)
T ss_dssp CCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH--------HHHHH
T ss_pred cCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH--------HHHHH
Confidence 9999987654322 1234568999999999999899999999999999999999999997532111 11111
Q ss_pred cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+....... ....++.++.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 246 KGKYKMNPR------QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HTCCCCCHH------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCCCCcc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111110000 00124578999999999999999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=319.37 Aligned_cols=251 Identities=21% Similarity=0.297 Sum_probs=205.5
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
...+.+.+.||+|+||.||+|....+. ..+++|++........+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTR---IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCC---cEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 345667788999999999999976653 45899998776666678899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEeeccccccccc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL---NDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~ 214 (350)
|||+++++|.+++.....+++..++.++.|++.|++|||+ .+++|+||||+||++ +.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999999877889999999999999999999995 499999999999999 7888999999999986654
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... .....+|+.|+|||.+.+. ++.++||||||+++|+|++|..||......+.. ..+..+.......
T Consensus 162 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~- 229 (277)
T 3f3z_A 162 GKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM-------LKIREGTFTFPEK- 229 (277)
T ss_dssp TSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCCCCHH-
T ss_pred ccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhCCCCCCch-
Confidence 322 2344689999999998654 899999999999999999999999765433221 1111111110000
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+++..+.+++.+||+.||++|||+.++++
T Consensus 230 -----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 -----DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00124678999999999999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=338.43 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=204.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.|.+.+.||+|+||.||+|.+..++ ..||+|.+.... .+....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTG---HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTC---CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3456688999999999999977554 469999986432 2335678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+++|+|.+++.....+++..++.++.|++.|++||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999999988888999999999999999999999 5699999999999999999999999999998765432
Q ss_pred ccceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
. .....||+.|+|||++.+..+ +.++||||+||++|+|++|..||......... ..+..+..
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~~------- 233 (476)
T 2y94_A 171 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF-------KKICDGIF------- 233 (476)
T ss_dssp C---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH-------HHHHTTCC-------
T ss_pred c---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH-------HHHhcCCc-------
Confidence 2 234568999999999988765 67899999999999999999999765433211 11112211
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..++.++.+++.+||+.||++|||++++++
T Consensus 234 ---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111224568999999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=325.80 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=189.1
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+++.+.||+|+||.||+|....+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTT---GVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp -------------CEEEEEECSSS---CCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ceeEeeEECCCCCEEEEEEEECCC---CcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 456678899999999999986654 3569999886443 233467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 139 EFLNNGTLASFLFGN------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 139 e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
||+++ +|.+++... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 99985 898888532 357889999999999999999995 49999999999999999999999999999866
Q ss_pred ccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||......+................+...
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 159 GIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp TSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred CCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 43221 12344689999999999764 6899999999999999999999999866543322111100000000000000
Q ss_pred cc-----cc------------ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 292 VE-----GD------------MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 292 ~~-----~~------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. .. .........+.++.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 00 000011134578999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=325.06 Aligned_cols=251 Identities=29% Similarity=0.482 Sum_probs=195.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+++.+.||+|+||.||+|... +..+++|.+.. ....+.+.+|+.++++++||||+++++++.+ ..+++||
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-----AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-----TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred HeeeeeEeecCCCceEEEEEEC-----CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 3456688999999999999864 24589999854 3345678999999999999999999998874 4789999
Q ss_pred cCCCCChhhhhcCCCC---cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-eEEeecccccccccC
Q 046877 140 FLNNGTLASFLFGNLK---PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN-ARISDFGLAKLLTLN 215 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~ 215 (350)
|+++++|.+++..... +++..++.++.|+++|++|||+.+..+++||||||+||+++.++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999999976543 578889999999999999999632268999999999999998876 799999999755422
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
. ....|++.|+|||++.+..++.++||||||+++|+|++|+.||........... .....+.
T Consensus 160 ~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~~~~-------- 221 (307)
T 2eva_A 160 M-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-----WAVHNGT-------- 221 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH-----HHHHTTC--------
T ss_pred c-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH-----HHHhcCC--------
Confidence 1 234589999999999998999999999999999999999999975433222111 0011111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
......+++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 222 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 222 -RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp -CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred -CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111222456789999999999999999999999999988764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=322.76 Aligned_cols=252 Identities=29% Similarity=0.412 Sum_probs=193.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc----ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ----DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
.+.+.+.||+|+||.||+|.+. +..+++|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred heeeeeeeccCCCeEEEEEEEc-----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 3456688999999999999864 24589998764322 23467899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--------CCceEEeecc
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND--------RYNARISDFG 207 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~--------~~~~kl~Dfg 207 (350)
++|||+++++|.+++. ...+++..++.++.|++.|++|||+....+++|+||||+||+++. ++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999999985 557899999999999999999999652123999999999999986 7789999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
++........ ....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||...........
T Consensus 162 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------------ 225 (271)
T 3dtc_A 162 LAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG------------ 225 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH------------
T ss_pred cccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh------------
Confidence 9976543322 234689999999999988899999999999999999999999975543322110
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
..........+..+++.+.+++.+||+.||++|||++++++.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 226 ---VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0011111222234567899999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=335.04 Aligned_cols=264 Identities=25% Similarity=0.390 Sum_probs=211.2
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCc--ceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecC
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTT--STTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG 131 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 131 (350)
+....+.+.+.||+|+||.||+|.+..++. ....+++|.+.... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 334455667889999999999999865432 23568999886543 23456789999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcC--------------CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 046877 132 QNRLLAYEFLNNGTLASFLFG--------------NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND 197 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~--------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~ 197 (350)
+..+++|||+++|+|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECC
Confidence 999999999999999999853 2357889999999999999999995 49999999999999999
Q ss_pred CCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHH
Q 046877 198 RYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT 276 (350)
Q Consensus 198 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~ 276 (350)
++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|+| |..||..........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-- 277 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY-- 277 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH--
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH--
Confidence 99999999999987654433333344556789999999998889999999999999999998 999997544332211
Q ss_pred HHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 277 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.....+ .....+..++..+.+++.+||+.||.+|||++++++.|+++.
T Consensus 278 ----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 278 ----KLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp ----HHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 111111 111122234678999999999999999999999999998765
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=330.70 Aligned_cols=248 Identities=23% Similarity=0.284 Sum_probs=202.7
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcC-CCCceeeecceeecCCee
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 134 (350)
..+++.+.||+|+||.||+|+.+.+ +..+|+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTE---EEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCC---CCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 3456678899999999999987544 5679999987532 34456788999999988 899999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++||||+++|+|.+++.....+++..++.++.|++.||.|||+ .+|+||||||+||+++.+|.+||+|||++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999999877889999999999999999999995 5999999999999999999999999999975432
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..+.. ..+..+..
T Consensus 174 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~~~------ 238 (353)
T 2i0e_A 174 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------QSIMEHNV------ 238 (353)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------
T ss_pred CCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH-------HHHHhCCC------
Confidence 211 123456899999999999999999999999999999999999999765433211 11111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPT-----MRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~vl~ 331 (350)
. .+...+.++.+++.+||..||.+||+ ++++++
T Consensus 239 --~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 --A--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --C--CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --C--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 11235678999999999999999995 466653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=335.12 Aligned_cols=249 Identities=23% Similarity=0.309 Sum_probs=198.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 135 (350)
.+++.+.||+|+||.||+|+.+.++ ..+|+|.+.+... .....+..|..++..+ +||||+++++++.+.+..+
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~---~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTD---RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4566788999999999999987654 5689999875432 2234578899998877 8999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+||||+++|+|..++.....+++..++.++.|++.||+|||+ .+|+||||||+|||++.+|.+||+|||++......
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999999999888889999999999999999999995 59999999999999999999999999999753322
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhh--hHHHHHHHHhhcCCcchhcc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--ILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 293 (350)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.. .........+..+..
T Consensus 207 ~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 279 (396)
T 4dc2_A 207 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 279 (396)
T ss_dssp TC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----
T ss_pred CC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----
Confidence 21 124457899999999999999999999999999999999999999754322111 111111111111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
..+..++.++.+++.+||+.||.+||++
T Consensus 280 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1122356789999999999999999996
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=330.14 Aligned_cols=257 Identities=24% Similarity=0.446 Sum_probs=200.3
Q ss_pred hhhhccCCCccceEEEEEEcCCC-cceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTT-TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~-~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.||+|+||.||+|.+..+. .....|++|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 34567999999999999877543 335669999986543 2334568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 127 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 99999999999654 678999999999999999999995 49999999999999999999999999999876543221
Q ss_pred c-eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 219 T-IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 219 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+.. ..+..+ .
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~---------~ 267 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-------KAINDG---------F 267 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTT---------C
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHHCC---------C
Confidence 1 1122345778999999998899999999999999999999 99999754432211 111111 1
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
....+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11222346678999999999999999999999999998765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=330.27 Aligned_cols=264 Identities=25% Similarity=0.443 Sum_probs=211.3
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCC
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ 132 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 132 (350)
+....+.+.+.||+|+||.||+|.+.. ....+..|++|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 334456677899999999999998763 223457799999865432 33456889999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCC----------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceE
Q 046877 133 NRLLAYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNAR 202 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~k 202 (350)
..+++|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEE
Confidence 999999999999999998642 346889999999999999999995 4999999999999999999999
Q ss_pred EeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHH
Q 046877 203 ISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD 281 (350)
Q Consensus 203 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 281 (350)
|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......... .
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~ 251 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-------R 251 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-------H
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH-------H
Confidence 999999986654333222233456788999999998889999999999999999999 88999754432211 1
Q ss_pred HhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 282 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
....+.. ...+..++..+.+++.+||+.||++|||+.++++.|++..+
T Consensus 252 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 FVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111111 11122456789999999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=333.16 Aligned_cols=273 Identities=16% Similarity=0.190 Sum_probs=204.8
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCc--ceeEEEEEeeecccccc-----------HHHHHHHHHHHhcCCCCceee
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTT--STTAVAVKKLDRVFQDG-----------EKEFKNEVIVIGQTHHKNLVR 123 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~vavk~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~ 123 (350)
....+.+.+.||+|+||.||+|.+..+.. .++.||+|.+....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 33456777899999999999998865431 23568999876432111 112334556677888999999
Q ss_pred ecceeecC----CeeEEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--
Q 046877 124 LLGFCDEG----QNRLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-- 196 (350)
Q Consensus 124 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-- 196 (350)
+++++... ...+++|||+ +++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 99998664 4579999999 99999999765 678999999999999999999995 4999999999999999
Q ss_pred CCCceEEeecccccccccCcccc-----eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchh
Q 046877 197 DRYNARISDFGLAKLLTLNQRKT-----IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271 (350)
Q Consensus 197 ~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~ 271 (350)
.++.+||+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|+||+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 88999999999998765432211 1123458999999999999899999999999999999999999998543322
Q ss_pred hhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
... ....... ......+.+.... ..+++.++.+++..||+.||++|||++++++.|+++++.
T Consensus 269 ~~~--~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 269 KYV--RDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHH--HHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH--HHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 211 1111111 1122222222111 113467899999999999999999999999999988643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=324.29 Aligned_cols=256 Identities=29% Similarity=0.406 Sum_probs=204.4
Q ss_pred hhhhh-ccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKE-EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~-~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+ .||+|+||.||+|.+... ..+..+++|.+..... ...+++.+|+.+++.++||||+++++++ +.+..+++
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECS-SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhccCccccccCeeeEeeeecCC-CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 34445 899999999999975433 3356799999865432 2356799999999999999999999999 55678999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.+++.....+++..++.++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 9999999999999888889999999999999999999995 4999999999999999999999999999987654332
Q ss_pred cc-eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 218 KT-IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 218 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......... .....+.
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~-------- 237 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGE-------- 237 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTC--------
T ss_pred cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCC--------
Confidence 21 1123345688999999988888999999999999999999 99999765443211 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
....+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 238 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 238 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11122346788999999999999999999999999999876
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=329.52 Aligned_cols=261 Identities=23% Similarity=0.289 Sum_probs=197.2
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEecCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+.||+|+||.||+|....+ +..||+|.+..........+.+|+.++.++ +||||+++++++.+.+..+++|||+++
T Consensus 19 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLIT---SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95 (316)
T ss_dssp CCCCCCSSEEEEEEECSSS---CCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ceecCCceEEEEEEEEcCC---CcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCC
Confidence 6799999999999986554 356999998766566677899999999885 799999999999999999999999999
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEeecccccccccCccc--
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN---ARISDFGLAKLLTLNQRK-- 218 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~-- 218 (350)
++|.+++.....+++..++.++.|++.||+|||+ .+++||||||+||+++.++. +||+|||++.........
T Consensus 96 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 96 GSILSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred CcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 9999999877889999999999999999999995 49999999999999998776 999999998765422111
Q ss_pred ---ceeeccccCCCccCcccccC-----CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhH--------HHHHHHH
Q 046877 219 ---TIKTAIRGTKGYVAPEWFRK-----STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL--------TDWAFDC 282 (350)
Q Consensus 219 ---~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~--------~~~~~~~ 282 (350)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+.... .......
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence 11123458999999999875 4578999999999999999999999976543221100 0111111
Q ss_pred hhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhccc
Q 046877 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVV 337 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~ 337 (350)
+..+.... ... ....++..+.+++.+||+.||++|||++++++ .+++..
T Consensus 253 i~~~~~~~-~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 253 IQEGKYEF-PDK-----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHCCCCC-CHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HhccCccc-Cch-----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 22221110 000 00124578999999999999999999999986 444443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=329.12 Aligned_cols=244 Identities=22% Similarity=0.241 Sum_probs=203.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+.+.+.||+|+||.||+|+...++ ..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESG---NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCC---CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3455678999999999999976654 569999986432 2345678899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||||+++|+|.+++.....+++..++.++.|++.||.|||+ .+|+||||||+||+++.+|.+||+|||++.......
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 99999999999999877889999999999999999999995 599999999999999999999999999998664322
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...+..+..
T Consensus 196 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~-------- 255 (350)
T 1rdq_E 196 -----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-------YEKIVSGKV-------- 255 (350)
T ss_dssp -----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC--------
T ss_pred -----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-------HHHHHcCCC--------
Confidence 234689999999999999999999999999999999999999976543221 111112211
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPT-----MRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~vl~ 331 (350)
..+..++..+.+++.+||+.||.+||+ ++++++
T Consensus 256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111235678999999999999999998 788764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=330.96 Aligned_cols=246 Identities=24% Similarity=0.282 Sum_probs=195.9
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
.+.||+|+||.||+|....++ ..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g---~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATG---LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTC---CEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCC---cEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 356999999999999876553 56999998765555667899999999999999999999999999999999999999
Q ss_pred CChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE--cCCCceEEeecccccccccCcccce
Q 046877 144 GTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL--NDRYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 144 g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++.........
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-- 245 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-- 245 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--
Confidence 9999888544 468999999999999999999995 499999999999999 56789999999999876543322
Q ss_pred eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
....||+.|+|||++.+..++.++|||||||++|+|++|..||......+... .+...... .....
T Consensus 246 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-------~i~~~~~~------~~~~~ 311 (373)
T 2x4f_A 246 -KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN-------NILACRWD------LEDEE 311 (373)
T ss_dssp -CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHTCCC------SCSGG
T ss_pred -ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhccCC------CChhh
Confidence 23458999999999998889999999999999999999999997655433211 11111110 00011
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...++.++.+++.+||+.||.+|||++++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1234678999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=325.36 Aligned_cols=265 Identities=21% Similarity=0.253 Sum_probs=205.0
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceee----cCCe
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCD----EGQN 133 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~ 133 (350)
...+.+.+.||+|+||.||++....+ +..||+|.+........+.+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHD---GHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTT---CCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCC---CcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34566778999999999999997655 3569999886655556678999999999999999999999986 3457
Q ss_pred eEEEEecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 134 RLLAYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
.+++|||+++++|.+++.. ...+++..++.++.|+++||.|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8899999999999998864 4678999999999999999999995 49999999999999999999999999998
Q ss_pred cccccCcccc-------eeeccccCCCccCcccccCCC---CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH
Q 046877 210 KLLTLNQRKT-------IKTAIRGTKGYVAPEWFRKST---ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 279 (350)
Q Consensus 210 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 279 (350)
.......... ......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||..........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----- 256 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV----- 256 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-----
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-----
Confidence 7553211100 012234689999999987553 6889999999999999999999996322111110
Q ss_pred HHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCC
Q 046877 280 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~ 342 (350)
..........+....++..+.+++.+||+.||++|||++++++.|+.+....++
T Consensus 257 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 257 ---------ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp ---------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred ---------hHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 000111111222234567899999999999999999999999999987654443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=323.46 Aligned_cols=255 Identities=30% Similarity=0.468 Sum_probs=205.9
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
...+.+.+.||+|+||.||+|.... ...+++|.+... ....+.+.+|+.+++.++||||+++++++.. +..+++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNG----HTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----TEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcC----CcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 3456677899999999999998643 245899988654 3346789999999999999999999999864 468999
Q ss_pred EecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999996543 68899999999999999999995 59999999999999999999999999999876543
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ..+..+
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~-------- 226 (279)
T 1qpc_A 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-------QNLERG-------- 226 (279)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTT--------
T ss_pred cc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH-------HHHhcc--------
Confidence 22 11233446778999999988889999999999999999999 99999754432211 111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.....+..++..+.+++.+||+.||++|||++++++.|+++..
T Consensus 227 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 1112223456789999999999999999999999999998863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=330.26 Aligned_cols=249 Identities=25% Similarity=0.332 Sum_probs=188.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.+.||+|+||.||+|....++ ..||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQ---KPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCC---cEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3556788999999999999976553 56999998653 234668899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEeecccccccccCc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND---RYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 216 (350)
|+++++|.+++.....+++..++.++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||++.......
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 99999999999888889999999999999999999995 49999999999999975 8899999999998654322
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...+...... .
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~i~~~~~~------~ 270 (349)
T 2w4o_A 206 ---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM------FRRILNCEYY------F 270 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH------HHHHHTTCCC------C
T ss_pred ---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH------HHHHHhCCCc------c
Confidence 123456899999999999989999999999999999999999999755443211 1111111111 0
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......+.+.++.+++.+||+.||++|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111235678999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=319.46 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=201.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC--CeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG--QNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 135 (350)
.+.+.+.||+|+||.||+|.+. +..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ-----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET-----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred HhHHHHHhcCCCcceEEEEEEC-----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 4556788999999999999874 2458899886432 33346799999999999999999999999877 7889
Q ss_pred EEEecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 136 LAYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQ--IIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
++|||+++|+|.+++.... .+++..++.++.|++.|++|||+ .+ ++|+||||+||+++.++.++++|||++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 9999999999999997665 47999999999999999999994 47 99999999999999999999999988764
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCC---CCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISA---KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
... ....+|+.|+|||.+.+..++. ++||||||+++|+|++|..||.......... ..
T Consensus 163 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~------ 223 (271)
T 3kmu_A 163 FQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KV------ 223 (271)
T ss_dssp TSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------HH------
T ss_pred ecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------HH------
Confidence 322 2235789999999998765554 7999999999999999999997544332211 11
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.........+..++..+.+++.+||+.||++|||++++++.|+++.+
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 224 ---ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11111122233456789999999999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=333.10 Aligned_cols=276 Identities=24% Similarity=0.374 Sum_probs=209.1
Q ss_pred HhhhhhhccCCCccceEEEEEEcC-CCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCC--eeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQT-TTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ--NRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 135 (350)
..+.+.+.||+|+||.||+|.+.. ....+..|++|.+........+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 345667889999999999998542 23346779999987665556678999999999999999999999886654 789
Q ss_pred EEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+++++|.+++... ..+++..++.++.|+++||.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999999754 468999999999999999999995 4999999999999999999999999999987654
Q ss_pred Cccc-ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 215 NQRK-TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 215 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.... .......++..|+|||.+.+..++.++||||||+++|+|+||..||.......................+.+.+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 3321 112234467789999999888899999999999999999999999863311100000000000000000111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.......+..++.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12222233456789999999999999999999999999998875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=325.68 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=196.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhc--CCCCceeeecceeec----CCe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ--THHKNLVRLLGFCDE----GQN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~~ 133 (350)
.+.+.+.||+|+||.||+|.+. +..||+|.+... ....+..|.+++.. ++||||+++++++.. ...
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSWQ-----GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEET-----TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cEEEEEeeccCCCcEEEEEEEC-----CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 4566788999999999999862 356999998643 34455566666655 799999999998643 356
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHED-----CSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
.+++|||+++|+|.+++. ...+++..++.++.|++.|++|||.. ++.+++||||||+||+++.++.+||+|||+
T Consensus 81 ~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 889999999999999994 45789999999999999999999921 134999999999999999999999999999
Q ss_pred ccccccCcccc--eeeccccCCCccCcccccCC------CCCCCCcchhHHHHHHHHHhC----------CCCCCcccch
Q 046877 209 AKLLTLNQRKT--IKTAIRGTKGYVAPEWFRKS------TISAKVDVYSFGVLLLEIISC----------RKSFDIEMGE 270 (350)
Q Consensus 209 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~~lltg----------~~pf~~~~~~ 270 (350)
+.......... ......||+.|+|||++.+. .++.++||||||+++|+|+|| ..||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 97654432221 11234689999999999876 445789999999999999999 7787644332
Q ss_pred hhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 271 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
...... ............... .......++..+.+++.+||+.||++|||++++++.|+++
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFED-MRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHH-HHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccchhh-hhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 221110 000000011111110 1111235788999999999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=319.84 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=207.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+.+.+.||+|+||.||+|.+.++ ..+++|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~----~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTT----EEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred heeeeeEecCCCceeEEEEEecCC----CeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 455678899999999999987532 458999987543 345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|.+++... ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 99999999999754 568999999999999999999995 4999999999999999999999999999986543211
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.......++..|+|||++.+..++.++||||+|+++|+|++ |..||......... ..+..+ ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~i~~~---------~~ 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-------EDISTG---------FR 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTT---------CC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH-------HHHhcC---------Cc
Confidence 11123446778999999998889999999999999999999 89999754432211 111111 11
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
...+..++..+.+++.+||+.||++|||++++++.|+++.+.
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111223467899999999999999999999999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=323.44 Aligned_cols=263 Identities=19% Similarity=0.214 Sum_probs=200.3
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc---cHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD---GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..|.+.+.||+|+||.||+|.+..+ ++.|++|.+...... ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVR---ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTT---TEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCC---CeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 3456678899999999999987655 356999998654322 2367889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++|||+++++|.+++.....+++..++.++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 999999999999999877789999999999999999999995 49999999999999999999999999999765433
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ........ ..
T Consensus 188 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~-~~----- 253 (309)
T 2h34_A 188 KLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-------GAHINQAI-PR----- 253 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-------HHHHHSCC-CC-----
T ss_pred ccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-------HHHhccCC-CC-----
Confidence 221 12344688999999999988999999999999999999999999975443211 11111110 00
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcccCCCCC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRP-TMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~vl~~L~~~~~~~~~ 342 (350)
......+++..+.+++.+||+.||++|| |++++++.|++.+....+
T Consensus 254 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 254 -PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp -GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred -ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0111223567899999999999999999 999999999988766544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=323.68 Aligned_cols=252 Identities=25% Similarity=0.313 Sum_probs=205.1
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc------cHHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD------GEKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
...|.+.+.||+|+||.||+|....++ ..+++|.+...... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTG---LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCC---eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 445677889999999999999976553 56899988653321 356799999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----ceEEeecc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY----NARISDFG 207 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg 207 (350)
+..+++|||+++++|.+++.....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999999888889999999999999999999995 4999999999999999887 79999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+.. ..+....
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------ANITSVS 234 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHTTC
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhcc
Confidence 9986654322 13445899999999999889999999999999999999999999765433221 1111111
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. . ........+..+.+++.+||+.||++|||++++++
T Consensus 235 ~~-~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 YD-F-----DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC-C-----CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc-c-----ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0 00000124568999999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=332.71 Aligned_cols=266 Identities=15% Similarity=0.190 Sum_probs=199.6
Q ss_pred hhhhhhccCCC--ccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 60 TDNFKEEVGRG--SFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G--~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
.|++.+.||+| +||.||+|.+..++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTG---EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCC---CEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45667889999 99999999987653 569999987543 233467888999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 136 LAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999654 678999999999999999999995 599999999999999999999999999986543
Q ss_pred cCcc-----cceeeccccCCCccCcccccC--CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHH-HHHHHH-hh
Q 046877 214 LNQR-----KTIKTAIRGTKGYVAPEWFRK--STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-DWAFDC-YR 284 (350)
Q Consensus 214 ~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~-~~~~~~-~~ 284 (350)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ...... ..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 2211 111123467889999999987 57899999999999999999999999764433321100 000000 00
Q ss_pred -----c-------------CCcchhc---------cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 285 -----N-------------GKLDDLV---------EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 285 -----~-------------~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
. ....... ...........++..+.+++.+||+.||++|||++++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 0000000 000011122345678999999999999999999999984
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=327.25 Aligned_cols=261 Identities=28% Similarity=0.435 Sum_probs=206.6
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 136 (350)
..+.+.+.||+|+||.||+|.+..++. ...+++|.+.... ......+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTE-EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCc-ccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 445677899999999999999776543 2235888876432 33455789999999999 99999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC----------------CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 046877 137 AYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN 200 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~ 200 (350)
+|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 999999999999997553 68999999999999999999995 59999999999999999999
Q ss_pred eEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHH
Q 046877 201 ARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 279 (350)
Q Consensus 201 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 279 (350)
+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|+| |..||.........
T Consensus 181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~------ 251 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------ 251 (327)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------
T ss_pred EEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH------
Confidence 9999999987433221 1123346789999999988889999999999999999998 99999755432211
Q ss_pred HHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCC
Q 046877 280 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~ 342 (350)
..+..+ .....+..++..+.+++.+||..||++|||++++++.|+++.+....
T Consensus 252 -~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 252 -EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp -HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -HHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 111111 11122234567899999999999999999999999999988765444
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.67 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=196.9
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-----ccHHHHHHHHHHHhcC---CCCceeeecc
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-----DGEKEFKNEVIVIGQT---HHKNLVRLLG 126 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-----~~~~~~~~e~~~l~~l---~h~~iv~~~~ 126 (350)
++....|++.+.||+|+||.||+|.+..+ ++.||+|.+..... .....+.+|+.+++.+ +||||+++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHS---GHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTT---CCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCC---CcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 44556677889999999999999986554 45699998864321 1234566777777666 5999999999
Q ss_pred eeecCC-----eeEEEEecCCCCChhhhhcCCCC--cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 046877 127 FCDEGQ-----NRLLAYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY 199 (350)
Q Consensus 127 ~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~ 199 (350)
++.... ..+++|||+.+ +|.+++..... +++..++.++.|++.||+|||+ .+++||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGG 157 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTS
T ss_pred eeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCC
Confidence 987655 47899999975 99999876544 8999999999999999999995 4899999999999999999
Q ss_pred ceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH
Q 046877 200 NARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 279 (350)
Q Consensus 200 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 279 (350)
.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus 158 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp CEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred CEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999986543322 23456899999999999999999999999999999999999999765543322111100
Q ss_pred HHHhhcCCcchhcc---ccc--cCC-----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 280 FDCYRNGKLDDLVE---GDM--EAM-----NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 280 ~~~~~~~~~~~~~~---~~~--~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........+..... ... ... ...+++..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000111110000 000 000 01135578999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=353.99 Aligned_cols=252 Identities=29% Similarity=0.408 Sum_probs=202.6
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
+.||+|+||.||+|.+... ..++.||+|.+..... ...+++.+|+++++.++||||+++++++.. +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCC-CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 3699999999999976543 3356799999875432 335789999999999999999999999975 45889999999
Q ss_pred CCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc-ccee
Q 046877 143 NGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR-KTIK 221 (350)
Q Consensus 143 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 221 (350)
+|+|.+++.....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........ ....
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999999888889999999999999999999995 4999999999999999999999999999987654322 1222
Q ss_pred eccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 222 TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 222 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
....+|..|+|||++.+..++.++||||||+++|||++ |..||......+.. ..+..+ .....
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~---------~~~~~ 593 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKG---------ERMGC 593 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTT---------CCCCC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC---------CCCCC
Confidence 33446788999999998899999999999999999998 99999765543321 111111 12222
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
+..++.++.++|.+||+.||++|||++++++.|+++.
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 3356789999999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=332.33 Aligned_cols=266 Identities=27% Similarity=0.392 Sum_probs=205.5
Q ss_pred HHHHHHHhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceee
Q 046877 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCD 129 (350)
Q Consensus 53 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 129 (350)
+.++....+.+.+.||+|+||.||+|.+.. ....+..|++|.+.... .....++.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 344555667788999999999999998543 22345679999986432 334567889999999999999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhhcCC-------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CC
Q 046877 130 EGQNRLLAYEFLNNGTLASFLFGN-------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND---RY 199 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~ 199 (350)
+....+++|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++. +.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcc
Confidence 999999999999999999999654 347888999999999999999995 49999999999999984 44
Q ss_pred ceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHH
Q 046877 200 NARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 278 (350)
Q Consensus 200 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~ 278 (350)
.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+| |..||.........
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----- 255 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL----- 255 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-----
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH-----
Confidence 699999999976543333222334557889999999988889999999999999999998 99999754432211
Q ss_pred HHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.....+. ....+..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 256 --~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 256 --EFVTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp --HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHhcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 1111111 11122345678999999999999999999999999998775
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=323.97 Aligned_cols=263 Identities=23% Similarity=0.291 Sum_probs=198.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|.+.+.||+|+||.||+|.+..++ ..+|+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTG---QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceEeeEEeecCCeEEEEEEeCCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 456788999999999999976653 5699998754332 22456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|.+++.....+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999999999998888889999999999999999999995 49999999999999999999999999999866533221
Q ss_pred ceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH--------HHhhcCCcc
Q 046877 219 TIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCYRNGKLD 289 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~~~~~~~~ 289 (350)
.....++..|+|||++.+ ..++.++||||+|+++|+|++|..||......+......... ..+......
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 159 --YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred --cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 234468899999999976 568999999999999999999999998665544322111100 000000000
Q ss_pred -hhccccccCCC-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 -DLVEGDMEAMN-----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 -~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....+...... ..+++..+.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000000 0235678999999999999999999999984
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=316.10 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=209.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+.+.+.||+|+||.||+|....+ +..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQN---KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hceeeheecCCCCeEEEEEEEcCC---CcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 456678899999999999987654 3568999886432 2335678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+++++|.+++.....+++..++.++.|++.|+.||| +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999999987778999999999999999999999 5699999999999999999999999999987554322
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||......+.. ..+.....
T Consensus 169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~-------- 229 (284)
T 2vgo_A 169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-------RRIVNVDL-------- 229 (284)
T ss_dssp ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTCC--------
T ss_pred ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-------HHHhcccc--------
Confidence 13346899999999999989999999999999999999999999765433221 11111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcccCCCCCCC
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVVEVDVPPN 344 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~~~~~~~~ 344 (350)
..+...+..+.+++.+||+.||++|||++++++ .+........||.
T Consensus 230 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~ 277 (284)
T 2vgo_A 230 --KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277 (284)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCC
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCc
Confidence 111234578999999999999999999999985 5555544444443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=319.82 Aligned_cols=258 Identities=22% Similarity=0.289 Sum_probs=194.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|.+.+.||+|+||.||+|... + +..+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~-~---~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNN-Y---GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET-T---SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred chhhhhcccCCCEEEEEEEcC-C---CCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 456788999999999999863 2 3468999885432 223467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
||+++ +|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 99986 888888653 678999999999999999999995 4999999999999999999999999999976543221
Q ss_pred cceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc---CCcchhcc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLDDLVE 293 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 293 (350)
......+|+.|+|||++.+. .++.++||||+|+++|+|++|..||......+.... ....... ..+.....
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHHCCCChhhchhhhc
Confidence 11334579999999999764 589999999999999999999999976544332111 1111111 01110000
Q ss_pred -----ccc-------cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 -----GDM-------EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 -----~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
... ........+.++.+++.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00011235678999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=324.03 Aligned_cols=264 Identities=20% Similarity=0.324 Sum_probs=198.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+.+.+.||+|+||.||+|....++ ..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDG---VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTC---CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCC---ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4667788999999999999876553 569999886422 2344678899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 137 AYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
+|||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999998853 4668899999999999999999995 49999999999999999999999999998765
Q ss_pred ccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ...........
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~-- 257 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-----CKKIEQCDYPP-- 257 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH-----HHHHHTTCSCC--
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH-----HHHhhcccCCC--
Confidence 43321 1133458999999999998899999999999999999999999997543222111 11111111111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCCCC
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPN 344 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~~~ 344 (350)
.....++.++.+++.+||..||++|||++++++.|+++.....+|.
T Consensus 258 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 258 ------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 1112356789999999999999999999999999999976655543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=342.05 Aligned_cols=248 Identities=21% Similarity=0.235 Sum_probs=194.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+++.+.||+|+||.||+|....++ ..||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATG---RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCC---CEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3556688999999999999976653 56999998643 22334567889999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||||+++|+|.+++.....+++..++.++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||++.......
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 99999999999999888889999999999999999999995 1489999999999999999999999999997543222
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+.... .
T Consensus 304 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-------~i~~~~--------~ 366 (446)
T 4ejn_A 304 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------LILMEE--------I 366 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCC--------C
T ss_pred c--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH-------HHHhCC--------C
Confidence 1 1234678999999999999999999999999999999999999997654433211 111111 1
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
. .+...+.++.+++.+||+.||.+|| |++++++
T Consensus 367 ~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 R--FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp C--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C--CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1 1123467899999999999999999 9999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=326.97 Aligned_cols=243 Identities=22% Similarity=0.311 Sum_probs=200.8
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--------ccHHHHHHHHHHHhcCCCCceeeecceee
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--------DGEKEFKNEVIVIGQTHHKNLVRLLGFCD 129 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 129 (350)
...|.+.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKN---KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTT---EEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCC---cEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345667788999999999999876653 5699998865421 12345778999999999999999999999
Q ss_pred cCCeeEEEEecCCCC-ChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 130 EGQNRLLAYEFLNNG-TLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
+.+..+++|||+.+| +|.+++.....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999999777 999999888889999999999999999999995 4999999999999999999999999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
+......... ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......
T Consensus 177 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------- 237 (335)
T 3dls_A 177 AAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------- 237 (335)
T ss_dssp CEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------------
T ss_pred ceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------------
Confidence 9876543222 33568999999999988776 788999999999999999999996422110
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQM 332 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~ 332 (350)
.... ..+..++.++.+++.+||+.||++|||++++++-
T Consensus 238 -----~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 -----EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 1111245789999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=349.53 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=201.7
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
.||+|+||.||+|.+..+. .+..||+|.+.... ....+++.+|+++++.++||||+++++++.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSS-CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCC-CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 6999999999999876543 34679999987543 3356789999999999999999999999976 5689999999999
Q ss_pred ChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc-ceee
Q 046877 145 TLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK-TIKT 222 (350)
Q Consensus 145 ~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 222 (350)
+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......... ....
T Consensus 421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 999998644 558999999999999999999995 49999999999999999999999999999876433221 1112
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
...++..|+|||++.+..++.++||||||+++|||+| |..||......+.. ..+..+ .+...+
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~---------~~~~~p 561 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQG---------KRMECP 561 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-------HHHHTT---------CCCCCC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcC---------CCCCCC
Confidence 2345678999999998899999999999999999998 99999865543321 111122 122233
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
..++.++.++|.+||+.||++|||+.++++.|+.+.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 357789999999999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=320.12 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=202.6
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
.||+|+||.||+|.+..+. .+..|++|.+.... ....+.+.+|+.+++.++||||+++++++. .+..+++|||++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGG 94 (287)
T ss_dssp EEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTE
T ss_pred cccccCceeEEEeEeccCC-CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEEeCCCC
Confidence 7999999999999865432 24669999987543 334567899999999999999999999994 55689999999999
Q ss_pred ChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc-ceee
Q 046877 145 TLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK-TIKT 222 (350)
Q Consensus 145 ~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 222 (350)
+|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++......... ....
T Consensus 95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 999998643 568999999999999999999995 49999999999999999999999999999876543222 1122
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
...+++.|+|||++.+..++.++||||||+++|+|+| |..||......+.. ..+..+. ....+
T Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~i~~~~---------~~~~~ 235 (287)
T 1u59_A 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGK---------RMECP 235 (287)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTTC---------CCCCC
T ss_pred cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHhcCC---------cCCCC
Confidence 3346788999999988889999999999999999998 99999765443221 1111111 11222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 346789999999999999999999999999999885
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=328.51 Aligned_cols=249 Identities=20% Similarity=0.306 Sum_probs=191.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCC--CceeeecceeecCCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHH--KNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~ 135 (350)
.|.+.+.||+|+||.||++.... +..||+|.+.... ....+.+.+|+.+++.++| |||+++++++.+....+
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTT----SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred EEEEEEEEecCCCeEEEEEEeCC----CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 35567889999999999998632 3569999886432 2334678999999999976 99999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++|| +.+++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||+++ ++.+||+|||++......
T Consensus 86 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999 5677999999888889999999999999999999995 4999999999999997 578999999999876544
Q ss_pred cccceeeccccCCCccCcccccC-----------CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRK-----------STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---------- 230 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---------- 230 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH----------
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH----------
Confidence 43333345679999999999864 568889999999999999999999997533321110
Q ss_pred cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
............+...+..+.+++.+||+.||.+|||+.++++
T Consensus 231 ----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 231 ----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp ----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 0111111111112223467899999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=338.89 Aligned_cols=252 Identities=19% Similarity=0.227 Sum_probs=200.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+++.+.||+|+||.||+|+++.++ +.+|+|.+.+.. ......+.+|..++..++||||+++++++.+.+..++|
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNAD---KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCC---cEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 345578999999999999987653 569999986532 12223488899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999999999976 5789999999999999999999995 599999999999999999999999999997654332
Q ss_pred ccceeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 217 RKTIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+..... ......-....
T Consensus 230 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~~~~~~~p~- 304 (437)
T 4aw2_A 230 T-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---MNHKERFQFPT- 304 (437)
T ss_dssp C-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTHHHHCCCCS-
T ss_pred C-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh---hhccccccCCc-
Confidence 2 1223457999999999986 457899999999999999999999999865543321110 00000000000
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSL--RPTMRKVSQ 331 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~vl~ 331 (350)
....++.++.+++.+||..+|++ ||+++++++
T Consensus 305 --------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 305 --------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp --------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred --------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 01124678999999999988888 999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=322.67 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=193.3
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCC-----
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ----- 132 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 132 (350)
..+++.+.||+|+||.||+|++..++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDD---CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTC---CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCC---cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 34567788999999999999977554 469999986433 334567999999999999999999999885543
Q ss_pred ----------------------------------------------------eeEEEEecCCCCChhhhhcCCCC---cC
Q 046877 133 ----------------------------------------------------NRLLAYEFLNNGTLASFLFGNLK---PN 157 (350)
Q Consensus 133 ----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~---~~ 157 (350)
..+++|||+++++|.+++..... .+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 37999999999999999976544 34
Q ss_pred hhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc----------ceeeccccC
Q 046877 158 WNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK----------TIKTAIRGT 227 (350)
Q Consensus 158 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~ 227 (350)
+..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 55688999999999999995 49999999999999999999999999999876543211 112345689
Q ss_pred CCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHH
Q 046877 228 KGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEK 307 (350)
Q Consensus 228 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (350)
+.|+|||.+.+..++.++||||||+++|+|++|..|+.... ............. .....+..
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---------~~~~~~~~~~~~~---------~~~~~~~~ 301 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------RIITDVRNLKFPL---------LFTQKYPQ 301 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---------HHHHHHHTTCCCH---------HHHHHCHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---------HHHHHhhccCCCc---------ccccCChh
Confidence 99999999999999999999999999999999877642110 0011111111111 12245577
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 046877 308 LLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 308 l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+.+++.+||+.||++|||++++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 899999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=325.75 Aligned_cols=255 Identities=26% Similarity=0.302 Sum_probs=197.0
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-----ccccHHHHHHHHHHHhcCCCCceeeecceeecCC
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-----FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ 132 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 132 (350)
...+.+.+.||+|+||.||+|....+ +..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQT---RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTT---CCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhheeecceeeecCCeEEEEEEECCC---CceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34567778999999999999987655 356899988643 2344577999999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcC----------------------------------------CCCcChhHHHHHHHHHHHHH
Q 046877 133 NRLLAYEFLNNGTLASFLFG----------------------------------------NLKPNWNLRTNIAFQIARVL 172 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~----------------------------------------~~~~~~~~~~~~~~~i~~~l 172 (350)
..++||||+++|+|.+++.. ...+++..++.++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999998842 11235677889999999999
Q ss_pred HHHHhcCCCCeEecCCCCCCeEEcCCC--ceEEeecccccccccCccc--ceeeccccCCCccCcccccC--CCCCCCCc
Q 046877 173 LYLHEDCSSQIIHCDIKPQNILLNDRY--NARISDFGLAKLLTLNQRK--TIKTAIRGTKGYVAPEWFRK--STISAKVD 246 (350)
Q Consensus 173 ~~Lh~~~~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 246 (350)
+|||+ .+++|+||||+||+++.++ .+||+|||++......... .......||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 99995 4999999999999998776 8999999999865432211 11234568999999999975 57889999
Q ss_pred chhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 247 VYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 247 iwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
|||||+++|+|++|+.||......+... ... .+... ...+....++..+.+++.+||+.||.+|||+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~------~~~-~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTIS------QVL-NKKLC------FENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-HCCCC------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHH------HHH-hcccc------cCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 9999999999999999997655433211 111 11100 0111112346789999999999999999999
Q ss_pred HHHHH
Q 046877 327 RKVSQ 331 (350)
Q Consensus 327 ~~vl~ 331 (350)
.++++
T Consensus 326 ~~~l~ 330 (345)
T 3hko_A 326 MRALQ 330 (345)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=329.82 Aligned_cols=268 Identities=16% Similarity=0.167 Sum_probs=204.1
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCc-----ceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceee----------
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTT-----STTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVR---------- 123 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---------- 123 (350)
..+.+.+.||+|+||.||+|.+..+.. .+..+|+|.+... ..+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 345667889999999999999876422 3466999998643 46788999999999999988
Q ss_pred -----ecceeec-CCeeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 046877 124 -----LLGFCDE-GQNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL 195 (350)
Q Consensus 124 -----~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill 195 (350)
+++++.. ....+++|||+ +++|.+++... ..+++..++.++.|++.||.|||+ .+++||||||+||++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 4556554 67889999999 99999999765 778999999999999999999995 499999999999999
Q ss_pred cCCC--ceEEeecccccccccCcccc-----eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCccc
Q 046877 196 NDRY--NARISDFGLAKLLTLNQRKT-----IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEM 268 (350)
Q Consensus 196 ~~~~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~ 268 (350)
+.++ .+||+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 89999999998665432211 1133468999999999999899999999999999999999999998654
Q ss_pred chhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCC
Q 046877 269 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDV 341 (350)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~ 341 (350)
........ .... +.. ....+.... .....++..+.+++.+||+.||++|||++++++.|+++.+..-
T Consensus 273 ~~~~~~~~-~~~~-~~~-~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 273 PNTEDIMK-QKQK-FVD-KPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TCHHHHHH-HHHH-HHH-SCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCHHHHHH-HHHh-ccC-Chhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 22221111 1111 111 111111110 0011235789999999999999999999999999998874433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=315.85 Aligned_cols=245 Identities=26% Similarity=0.359 Sum_probs=199.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+.+.+.||+|+||.||+|.+..++ ..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSK---FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEEecCCCeEEEEEEEccCC---cEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3456788999999999999976653 468999885432 2335678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+++++|.+++.....+++..++.++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999987788999999999999999999999 5699999999999999999999999999986543322
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......... .+....
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~--------- 223 (279)
T 3fdn_A 164 ----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-------RISRVE--------- 223 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHTC---------
T ss_pred ----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH-------HHHhCC---------
Confidence 134468999999999998899999999999999999999999997544332211 111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+...+..+.+++.+||+.||++|||++++++
T Consensus 224 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 224 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111234578899999999999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=321.67 Aligned_cols=262 Identities=25% Similarity=0.350 Sum_probs=201.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..+++.+.||+|+||.||+|.+.........|++|.+.... ....+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 34567788999999999999977655555678999886432 234567899999999999999999999998765 88
Q ss_pred EEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+++++|.+++... ..+++..+..++.|+++|+.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999998653 568899999999999999999995 4999999999999999999999999999987654
Q ss_pred Ccccc-eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 215 NQRKT-IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 215 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
..... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......... .....
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~------- 239 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-------HKIDK------- 239 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHT-------
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH-------HHHHc-------
Confidence 33221 1223456778999999988888999999999999999999 99999765433211 11111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
.......+..++..+.+++.+||..||++|||+.++++.|+++...
T Consensus 240 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 240 -EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1111122234668899999999999999999999999999887643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=316.91 Aligned_cols=266 Identities=18% Similarity=0.195 Sum_probs=204.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeeccee-ecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFC-DEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 138 (350)
.+.+.+.||+|+||.||+|.+..+ +..||+|.+.... ...++.+|+.+++.++|++++..+..+ .+....+++|
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAA---GEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTT---TEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEEccCCCeEEEEEEEcCC---CcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 345678899999999999997655 3569999876532 334688999999999888766666554 6677889999
Q ss_pred ecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEeeccccccccc
Q 046877 139 EFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL---NDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 139 e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~ 214 (350)
||+ +++|.+++. ....+++..++.++.|++.||+|||+ .+++|+||||+||++ +.++.+||+|||++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 889999986 45678999999999999999999995 499999999999999 4888999999999987654
Q ss_pred Ccccc-----eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 215 NQRKT-----IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 215 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 32211 1234568999999999999899999999999999999999999998644322211111111110011111
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCCC
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPP 343 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~~ 343 (350)
.. ...++.++.+++.+||+.||++|||++++++.|+++....-.+
T Consensus 241 ~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 241 VL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HH---------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 11 0124578999999999999999999999999999887544443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=325.30 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=199.6
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 136 (350)
...|++.+.||+|+||.||+|.++.++ ..+|+|.+...... ..+|+.++.++ +||||+++++++.+....++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATN---MEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 345667789999999999999976653 56999998754332 34577788777 89999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC----CceEEeeccccccc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR----YNARISDFGLAKLL 212 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~~~ 212 (350)
||||+++|+|.+++.....+++..+..++.|++.||.|||+ .+++||||||+||++.++ +.+||+|||++...
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999999888889999999999999999999995 499999999999998533 35999999999866
Q ss_pred ccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||..........+ ...+..+....
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~----~~~i~~~~~~~-- 242 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI----LARIGSGKFSL-- 242 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH----HHHHHHCCCCC--
T ss_pred cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH----HHHHccCCccc--
Confidence 543221 2345689999999999887889999999999999999999999975432222111 11222222111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......++.++.+++.+||..||++|||+.++++
T Consensus 243 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 ----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111235678999999999999999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=315.35 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=202.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.+.+.+.||+|+||.||+|.+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCC---ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3556788999999999999876654 458999886433 23346788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEeeccccccccc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN---ARISDFGLAKLLTL 214 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~ 214 (350)
|||+++++|.+++.....+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999999998877889999999999999999999995 49999999999999986655 99999999976654
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.... ....+++.|+|||++.+..++.++||||+|+++|+|++|..||......... .....+....
T Consensus 161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~---- 226 (284)
T 3kk8_A 161 SEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-------AQIKAGAYDY---- 226 (284)
T ss_dssp SCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCC----
T ss_pred Cccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH-------HHHHhccccC----
Confidence 3221 3356899999999999999999999999999999999999999754433221 1111111110
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......++.++.+++.+||+.||++|||++++++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 --PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11111235678999999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=331.29 Aligned_cols=248 Identities=19% Similarity=0.295 Sum_probs=192.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCC--CCceeeecceeecCCeeEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTH--HKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~l 136 (350)
|.+.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.+++.++ ||||+++++++...+..++
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTT----CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcCC----CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 5667889999999999998543 4569999886432 234467899999999996 5999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|| +.+++|.+++.....+++..++.++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||++.......
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999 567899999988888899999999999999999999 56999999999999995 5789999999998765443
Q ss_pred ccceeeccccCCCccCcccccC-----------CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRK-----------STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ...
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-----~~~---- 279 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHA---- 279 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-----HHH----
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-----HHH----
Confidence 3323345579999999999865 36888999999999999999999999754322111 011
Q ss_pred CCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..........+...+..+.+++.+||+.||++|||+.++++
T Consensus 280 -----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 280 -----IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp -----HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 11111111111122468899999999999999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=347.50 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=210.5
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
+....+.+.+.||+|+||.||+|.+..+ ..||+|.+.... ...+.+.+|+++++.++||||+++++++.+ ...+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTT----EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECCC----ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 3344456678899999999999987643 349999987543 345789999999999999999999999876 6789
Q ss_pred EEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 136 LAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 999999999999999643 458899999999999999999995 499999999999999999999999999998664
Q ss_pred cCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.... .......++..|+|||++.+..++.++||||||+++|||++ |..||......+.. ..+..+
T Consensus 415 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~-------~~i~~~------ 480 (535)
T 2h8h_A 415 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERG------ 480 (535)
T ss_dssp CHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH-------HHHHTT------
T ss_pred CCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC------
Confidence 3211 11123346778999999998899999999999999999999 99999755433211 111111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCC
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~ 342 (350)
.+...+..++..+.++|.+||+.||++|||++++++.|+++.....|
T Consensus 481 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 481 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 12222335678899999999999999999999999999998765444
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=326.22 Aligned_cols=245 Identities=23% Similarity=0.294 Sum_probs=196.7
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..+...+.||+|+||.||+|....+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccC---CeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 3455667899999999999987655 3569999986432 223356889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
+||||+. |+|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9999998 47777764 45678999999999999999999995 4999999999999999999999999999976543
Q ss_pred CcccceeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
. ....||+.|+|||++. +..++.++||||||+++|+|++|..||......... .... .+.
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~-~~~---- 269 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIA-QNE---- 269 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHH-HSC----
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHH-hcC----
Confidence 2 2346899999999984 567899999999999999999999999754432211 1111 111
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........++..+.+++.+||+.||++|||++++++
T Consensus 270 ----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 270 ----SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111112235678999999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=315.28 Aligned_cols=246 Identities=27% Similarity=0.400 Sum_probs=195.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeec----CCee
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE----GQNR 134 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 134 (350)
+.+.+.||+|+||.||+|.+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~---~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCc---eEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345567999999999999876553 568888876432 3345678999999999999999999998754 4568
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeEEc-CCCceEEeecccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQ--IIHCDIKPQNILLN-DRYNARISDFGLAKL 211 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~ 211 (350)
+++|||+++++|.+++.....+++..++.++.|++.||.|||+ .+ ++|+||||+||+++ .++.+||+|||++..
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999999877889999999999999999999995 46 99999999999997 789999999999975
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..... .....+++.|+|||++.+ .++.++||||+|+++|+|++|..||......... ......+.....
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPAS 250 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCCCGG
T ss_pred ccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH------HHHHhccCCccc
Confidence 44322 234568999999998874 5899999999999999999999999754433221 111111111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+...++++.+++.+||+.||++|||++++++
T Consensus 251 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 --------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11123467999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=318.75 Aligned_cols=256 Identities=24% Similarity=0.331 Sum_probs=204.8
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
...+.+.+.||+|+||.||++....++ ..+++|.+..........+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTG---KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCC---CEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 345677789999999999999976553 56999998765444556789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEeeccccccccc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL---NDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~ 214 (350)
|||+++++|.+++.....+++..+..++.|++.|+.|||+ .+++|+||||+||++ ++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999999877889999999999999999999995 499999999999999 7888999999999875432
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.. .....+++.|+|||++.+..++.++||||+|+++|+|++|..||........ ...+..+...
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~~~----- 225 (304)
T 2jam_A 162 GI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-------FEKIKEGYYE----- 225 (304)
T ss_dssp BT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHCCCC-----
T ss_pred Cc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCCC-----
Confidence 21 1234589999999999998999999999999999999999999975443221 1111121111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcc
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEV 336 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~ 336 (350)
........++..+.+++.+||..||++|||++++++ .+++.
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 111112245678999999999999999999999985 44443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=326.80 Aligned_cols=260 Identities=21% Similarity=0.275 Sum_probs=188.6
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CCceeeeccee--------
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HKNLVRLLGFC-------- 128 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~-------- 128 (350)
...+.+.+.||+|+||.||+|.+..++ ..||+|.+..........+.+|+.+++++. ||||+++++++
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSG---REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTC---CEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCC---cEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 345667789999999999999976553 569999886655555677899999999995 99999999988
Q ss_pred ecCCeeEEEEecCCCCChhhhhcC---CCCcChhHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeEEcCCCceEE
Q 046877 129 DEGQNRLLAYEFLNNGTLASFLFG---NLKPNWNLRTNIAFQIARVLLYLHEDCSSQ--IIHCDIKPQNILLNDRYNARI 203 (350)
Q Consensus 129 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~~~~~~kl 203 (350)
......+++|||+. |+|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEE
Confidence 33445789999996 588888753 5678999999999999999999994 47 999999999999999999999
Q ss_pred eecccccccccCcccc----------eeeccccCCCccCcccc---cCCCCCCCCcchhHHHHHHHHHhCCCCCCcccch
Q 046877 204 SDFGLAKLLTLNQRKT----------IKTAIRGTKGYVAPEWF---RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGE 270 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~ 270 (350)
+|||++.......... ......+|+.|+|||++ .+..++.++||||||+++|+|++|..||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998765432211 11134588999999998 4567888999999999999999999999643221
Q ss_pred hhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCCC
Q 046877 271 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPP 343 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~~ 343 (350)
.. .............+..+.+++.+||+.||++|||++++++.|+.+......+
T Consensus 260 ~~-------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 260 RI-------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred Hh-------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 10 0111111111223456889999999999999999999999999887544433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=317.42 Aligned_cols=262 Identities=19% Similarity=0.207 Sum_probs=201.4
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeeccee-ecCCeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFC-DEGQNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv 137 (350)
..+.+.+.||+|+||.||+|.+..++ ..||+|...... ....+.+|+.+++.++|++++..+..+ .+.+..+++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAG---EEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCC---ceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 45667789999999999999976553 569999865432 234578899999999888776666554 777888999
Q ss_pred EecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEeecccccccc
Q 046877 138 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL---NDRYNARISDFGLAKLLT 213 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 213 (350)
|||+ +++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 8899999863 5678999999999999999999995 499999999999999 788999999999998765
Q ss_pred cCccc-----ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 214 LNQRK-----TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 214 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 43221 1123456899999999999989999999999999999999999999765443322111111111001111
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.... ..++.++.+++.+||+.||++|||++++++.|+++..
T Consensus 240 ~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 240 EVLC---------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHT---------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhh---------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 1000 1235789999999999999999999999999998864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=325.03 Aligned_cols=263 Identities=20% Similarity=0.264 Sum_probs=193.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+++.++||||+++++++.+++..++|
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVT---NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTT---TEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEECCC---CceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 456678899999999999987655 35699999864332 2245678999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-----CCCceEEeeccccccc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-----DRYNARISDFGLAKLL 212 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-----~~~~~kl~Dfg~~~~~ 212 (350)
|||+++ +|.+++.....+++..++.++.|++.||+|||+ .+|+||||||+||+++ .++.+||+|||++...
T Consensus 112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999985 999999888889999999999999999999995 4999999999999994 4556999999999866
Q ss_pred ccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+................+...
T Consensus 188 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 188 GIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp C-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred CCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 43221 12344579999999999875 5899999999999999999999999765543322111100000000011000
Q ss_pred cc--------ccccCC-----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 292 VE--------GDMEAM-----NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 292 ~~--------~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. +..... ....++.++.+++.+||+.||++|||++++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 000000 01114578899999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=320.77 Aligned_cols=273 Identities=21% Similarity=0.309 Sum_probs=200.4
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC--CCCceeeecceeecC
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT--HHKNLVRLLGFCDEG 131 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~ 131 (350)
.+.....+.+.+.||+|+||.||+|++. +..||+|.+... .......|..++... +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-----GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-----CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3444566778899999999999999864 356999988543 234445555555554 999999999998777
Q ss_pred ----CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeEEcCCCceE
Q 046877 132 ----QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC-----SSQIIHCDIKPQNILLNDRYNAR 202 (350)
Q Consensus 132 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-----~~~i~H~dlkp~Nill~~~~~~k 202 (350)
...+++|||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. ..+++||||||+||+++.++.+|
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 788999999999999999954 46899999999999999999999320 12999999999999999999999
Q ss_pred EeecccccccccCcccc--eeeccccCCCccCcccccCCCCCCC------CcchhHHHHHHHHHhC----------CCCC
Q 046877 203 ISDFGLAKLLTLNQRKT--IKTAIRGTKGYVAPEWFRKSTISAK------VDVYSFGVLLLEIISC----------RKSF 264 (350)
Q Consensus 203 l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------~DiwslG~~l~~lltg----------~~pf 264 (350)
|+|||++.......... ......||+.|+|||++.+...+.+ +|||||||++|+|+|| ..||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997654332211 1124468999999999987766665 9999999999999999 5565
Q ss_pred CcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 265 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
............ ............ .........+++.++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 263 ~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 263 HDLVPSDPSYED--MREIVCIKKLRP---SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTSCSSCCHHH--HHHHHTTSCCCC---CCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhhcCCCCchhh--hHHHHhhhccCc---cccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 433222211100 011111111000 00111112378899999999999999999999999999999886543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=329.38 Aligned_cols=246 Identities=25% Similarity=0.275 Sum_probs=192.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHH-HhcCCCCceeeecceeecCCee
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIV-IGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
..+++.+.||+|+||.||+|+.+.++ ..+|+|.+.+... .....+..|..+ ++.++||||+++++++.+.+..
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~---~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEE---VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTC---CEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCC---CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34667789999999999999976653 5689999875432 233456666666 5678999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++||||+++|+|.+++.....+++..++.++.|++.||+|||+ .+|+||||||+||+++.+|.+||+|||++.....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999999887889999999999999999999995 5999999999999999999999999999975432
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ......||+.|+|||++.+..++.++|+|||||++|||++|..||...+..+.. ..+..+.
T Consensus 192 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~~------- 255 (373)
T 2r5t_A 192 HNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-------DNILNKP------- 255 (373)
T ss_dssp CCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-------HHHHHSC-------
T ss_pred CCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHhcc-------
Confidence 221 224457899999999999999999999999999999999999999765433221 1111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~v 329 (350)
.. .+..++..+.+++.+||+.||.+||++.+.
T Consensus 256 -~~--~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 256 -LQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp -CC--CCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred -cC--CCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 11 112345789999999999999999998543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=314.87 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=195.6
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
...+.+.+.||+|+||.||++....++ ..+++|.+.... ....+.+.+|+++++.++||||+++++++.+....++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSG---LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCC---ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 346777899999999999999876553 458899886543 3345789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEeecccc
Q 046877 137 AYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL---NDRYNARISDFGLA 209 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~ 209 (350)
+|||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||++ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999998843 3678999999999999999999995 499999999999999 45678999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
........ .....+++.|+|||.+. ..++.++||||||+++|+|++|+.||............ ......
T Consensus 175 ~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~-------~~~~~~ 243 (285)
T 3is5_A 175 ELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-------TYKEPN 243 (285)
T ss_dssp CC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCCC
T ss_pred eecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh-------ccCCcc
Confidence 76543221 23456899999999986 46888999999999999999999999765433321110 000000
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. ......++.+.+++.+||+.||++|||++++++
T Consensus 244 ~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YA-------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC-------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc-------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000113568899999999999999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=329.02 Aligned_cols=269 Identities=18% Similarity=0.235 Sum_probs=208.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCC--eeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ--NRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 136 (350)
.|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+ ..++
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTG---DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCC---cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3456788999999999999987653 569999987543 334567889999999999999999999987765 7799
Q ss_pred EEecCCCCChhhhhcCCCC---cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCceEEeecccc
Q 046877 137 AYEFLNNGTLASFLFGNLK---PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL----NDRYNARISDFGLA 209 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~ 209 (350)
+|||+++|+|.+++..... +++..++.++.|++.||+|||+ .+++||||||+||++ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999975433 8999999999999999999995 499999999999999 77888999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccC--------CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRK--------STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 281 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 281 (350)
......... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .....
T Consensus 164 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~ 238 (396)
T 4eut_A 164 RELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYK 238 (396)
T ss_dssp EECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHH
T ss_pred eEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHH
Confidence 876543221 33568999999999864 457789999999999999999999997544322211 11111
Q ss_pred HhhcCC---cchhc-----------cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 282 CYRNGK---LDDLV-----------EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 282 ~~~~~~---~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
...... +.... ............+..+.+++.+||+.||++|||+.++++.+++++..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111111 00000 00111223467889999999999999999999999999999888754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=324.81 Aligned_cols=264 Identities=24% Similarity=0.344 Sum_probs=199.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc--cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.|.+.+.||+|+||.||+|.+..++ ..|++|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTG---RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTC---CEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEECCCC---ceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3556678999999999999976653 56999987544322 245578999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++++|.++......+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999999999988777889999999999999999999995 4999999999999999999999999999976543222
Q ss_pred cceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------HHHhhcC-C
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRNG-K 287 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~-~ 287 (350)
......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+........ ...+... .
T Consensus 180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 12344689999999999875 7899999999999999999999999766543322111100 0000000 0
Q ss_pred cchhccccccCC-----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 LDDLVEGDMEAM-----NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......+..... ....+++.+.+++.+||+.||++|||++++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000011100 01135678999999999999999999998874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=313.73 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=180.2
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||+|....++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTG---LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeeeecCCCceEEEEEEEccCC---ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 456688999999999999875543 569999986432 22346789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++++|.+++... ..+++..++.++.|+++|+.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999765 668999999999999999999995 499999999999999999999999999998664332
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......... ........
T Consensus 167 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~ 229 (278)
T 3cok_A 167 EK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLADY 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC
T ss_pred Cc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhccc
Confidence 21 12345899999999999888999999999999999999999999754432211 00111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..++.++.+++.+||+.||++|||++++++
T Consensus 230 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 --EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 112235678999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=329.13 Aligned_cols=263 Identities=20% Similarity=0.306 Sum_probs=202.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.+.+.||+|+||.||+|.+..++ ..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceeeeeecCCCCeEEEEEEECCCC---cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 4456678999999999999976553 568999886542 333567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++++|.+++.....+++..+..++.|++.|+.|||+. .+++|+||||+||+++.++.+||+|||++.......
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 186 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 186 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc--
Confidence 9999999999998778899999999999999999999951 379999999999999999999999999987553221
Q ss_pred ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH------------------
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF------------------ 280 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~------------------ 280 (350)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 187 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 187 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp ------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred --ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 134468999999999999999999999999999999999999997654433211100000
Q ss_pred -----HHhhcCCc----chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 281 -----DCYRNGKL----DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 281 -----~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........ ...............++.++.+++.+||+.||++|||++++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000 0001111111122235678999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=337.12 Aligned_cols=253 Identities=25% Similarity=0.311 Sum_probs=204.7
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
.....|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQ---QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTC---CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCC---CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 34566788899999999999999976553 569999986432 3346789999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCceEEeeccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN---DRYNARISDFGLAK 210 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~ 210 (350)
.+++|||+.+++|.+++.....+++..++.++.|++.||.|||+ .+|+||||||+||+++ .++.+||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999999999877889999999999999999999995 4999999999999995 45679999999998
Q ss_pred ccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
....... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||......+.. ..+..+....
T Consensus 173 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~~ 241 (486)
T 3mwu_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-------KRVETGKYAF 241 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCS
T ss_pred ECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCCC
Confidence 6543322 234568999999999976 5899999999999999999999999765443221 1111221111
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+....+++.+.+++.+||+.||.+|||+.++++
T Consensus 242 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 ------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp ------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111235678999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=332.09 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=191.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC------
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG------ 131 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 131 (350)
.|++.+.||+|+||.||+|.+..++ ..||+|++.... .....++.+|+.+++.++||||+++++++...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLD---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTT---EEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CeEEEEEeecCCCeEEEEEEECCCC---CEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3556678999999999999876653 569999987542 33356788999999999999999999998654
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
...++||||+++ +|.+.+. ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 457999999987 4666664 348899999999999999999995 4999999999999999999999999999986
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH------------
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA------------ 279 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~------------ 279 (350)
..... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+........
T Consensus 214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 214 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ---CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred cCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 65332 224467899999999999999999999999999999999999999865543321110000
Q ss_pred ----HHHhhcC------Ccchhcccccc---CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 280 ----FDCYRNG------KLDDLVEGDME---AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 280 ----~~~~~~~------~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....... .+......... .......+.++.+|+.+||+.||++|||++++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00000000000 0001123678999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=330.71 Aligned_cols=263 Identities=23% Similarity=0.385 Sum_probs=188.5
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCC-CCceeeecceeecCC--e
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQ--N 133 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~ 133 (350)
..|.+.+.||+|+||.||+|.+..++ ..||+|++.... .....++.+|+.+++.+. ||||+++++++...+ .
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTG---EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTC---CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCC---CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45667789999999999999876654 569999885432 233456788999999996 999999999997544 6
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.++||||+++ +|..++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 86 ~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 8999999984 89888864 578899999999999999999995 599999999999999999999999999997653
Q ss_pred cCc-------------------ccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhh
Q 046877 214 LNQ-------------------RKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 273 (350)
Q Consensus 214 ~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~ 273 (350)
... .........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 211 1111234578999999999986 57899999999999999999999999765543322
Q ss_pred hHHHHHHHHhhcCCcch-----------hcc----------ccc------------cCCCcHHHHHHHHHHHHhccCCCC
Q 046877 274 ILTDWAFDCYRNGKLDD-----------LVE----------GDM------------EAMNDIKCVEKLLMISIWCIQEDP 320 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~-----------~~~----------~~~------------~~~~~~~~~~~l~~li~~cl~~dp 320 (350)
... ........... ... ... ......++++++.+++.+||+.||
T Consensus 241 ~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 241 ERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 111 01000000000 000 000 000011345789999999999999
Q ss_pred CCCCCHHHHHHH
Q 046877 321 SLRPTMRKVSQM 332 (350)
Q Consensus 321 ~~Rps~~~vl~~ 332 (350)
++|||++++++-
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=314.63 Aligned_cols=257 Identities=25% Similarity=0.324 Sum_probs=203.9
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc------ccHHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ------DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
...+.+.+.||+|+||.||+|....++ ..+++|.+..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTG---KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCC---CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 345677889999999999999976553 4688888764321 1357899999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----ceEEeecc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY----NARISDFG 207 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg 207 (350)
+..+++|||+++++|.+++.....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999999999877789999999999999999999995 4999999999999998877 79999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
++........ .....+++.|+|||++.+..++.++||||||+++|+|++|..||......+.. ..+....
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-------TNISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTC
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH-------HHhHhcc
Confidence 9986643322 13345899999999999889999999999999999999999999765433211 1111111
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcc
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEV 336 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~ 336 (350)
... ........+..+.+++.+||..||++|||+.++++ .++.+
T Consensus 228 ~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 228 YDF------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCC------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred cCC------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 000 00001124568999999999999999999999986 44444
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=318.94 Aligned_cols=260 Identities=23% Similarity=0.303 Sum_probs=204.2
Q ss_pred ccCHHHHHHHhhhhh-hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcC-CCCceeeec
Q 046877 50 CFSYKELEEATDNFK-EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQT-HHKNLVRLL 125 (350)
Q Consensus 50 ~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~ 125 (350)
.+...+.....+.+. +.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.+ +||||++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTG---QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCC---CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 344445555555555 78999999999999976654 568999886533 23457889999999999 579999999
Q ss_pred ceeecCCeeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCc
Q 046877 126 GFCDEGQNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND---RYN 200 (350)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~ 200 (350)
+++.+.+..+++|||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||+++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999998543 678999999999999999999995 49999999999999987 789
Q ss_pred eEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH
Q 046877 201 ARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 280 (350)
Q Consensus 201 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 280 (350)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+....
T Consensus 173 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----- 244 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----- 244 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----
T ss_pred EEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-----
Confidence 99999999987653322 1334689999999999999999999999999999999999999976554332111
Q ss_pred HHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 281 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+.... ..........++..+.+++.+||+.||++|||++++++
T Consensus 245 --i~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 245 --ISQVN------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp --HHHTC------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --HHhcc------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 01110 01111112245678999999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=320.39 Aligned_cols=250 Identities=23% Similarity=0.250 Sum_probs=192.7
Q ss_pred HHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcC-CCCceeeecceee
Q 046877 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQT-HHKNLVRLLGFCD 129 (350)
Q Consensus 53 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 129 (350)
..+.....++..+.||+|+||+||+|.+..++ ..||+|++..... ........|+..+..+ +||||+++++++.
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDG---RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTS---CEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCC---eEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 44566677888889999999999999976553 5699998754322 2223444555555554 9999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 130 EGQNRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
+++..+++|||+ +++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEcccee
Confidence 999999999999 5588887754 4568999999999999999999995 4999999999999999999999999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
+........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..|+...... ..+..+..
T Consensus 204 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~ 269 (311)
T 3p1a_A 204 LVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----------QQLRQGYL 269 (311)
T ss_dssp CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----------HHHTTTCC
T ss_pred eeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------HHHhccCC
Confidence 876643322 234458999999999876 7899999999999999999997776532211 11111111
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
... ....++.++.+++.+||+.||++|||++++++
T Consensus 270 ~~~--------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 PPE--------FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CHH--------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Ccc--------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 01134678999999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=329.99 Aligned_cols=251 Identities=19% Similarity=0.208 Sum_probs=197.8
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+++.+.||+|+||.||+++.+.++ +.+|+|.+.+.. ......+.+|..++..++||||+++++++.+.+..++|
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~---~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTG---QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 445578999999999999986553 569999986532 22234588899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++|+|.+++.+. ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999999754 478999999999999999999995 599999999999999999999999999998765432
Q ss_pred ccceeeccccCCCccCccccc-------CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFR-------KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
.. ......||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+..... ..........
T Consensus 217 ~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i---~~~~~~~~~p 292 (412)
T 2vd5_A 217 TV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI---VHYKEHLSLP 292 (412)
T ss_dssp CE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTHHHHCCCC
T ss_pred cc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH---HhcccCcCCC
Confidence 21 123457899999999987 356899999999999999999999999765543321100 0000000000
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLR---PTMRKVSQ 331 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~vl~ 331 (350)
.....++.++.+++.+||. +|.+| |+++++++
T Consensus 293 ---------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 293 ---------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ---------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0112356789999999999 99998 58888874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=329.17 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=199.9
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-----CCceeeecceee
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-----HKNLVRLLGFCD 129 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~ 129 (350)
++....|.+.+.||+|+||.||+|.+..++ ..||+|.+... ......+..|+.+++.++ ||||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNK---KYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCC---eEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 344456677789999999999999976553 56999998643 334556788999999886 999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC----------
Q 046877 130 EGQNRLLAYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND---------- 197 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---------- 197 (350)
..+..+++|||+ +++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccch
Confidence 999999999999 889999986543 58899999999999999999995 59999999999999975
Q ss_pred ---------------CCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCC
Q 046877 198 ---------------RYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRK 262 (350)
Q Consensus 198 ---------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~ 262 (350)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 7889999999998654322 34468999999999999999999999999999999999999
Q ss_pred CCCcccchhhhhHHHHH---------HHHhhcCCcchhccc-cc-----cCCCc---------------HHHHHHHHHHH
Q 046877 263 SFDIEMGEEYAILTDWA---------FDCYRNGKLDDLVEG-DM-----EAMND---------------IKCVEKLLMIS 312 (350)
Q Consensus 263 pf~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~-~~-----~~~~~---------------~~~~~~l~~li 312 (350)
||......+........ ..... ......... .. ..... ...++.+.+++
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATK-TNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTT-SGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhh-ccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 99765543322111100 00000 000000000 00 00000 01126788999
Q ss_pred HhccCCCCCCCCCHHHHHH
Q 046877 313 IWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 313 ~~cl~~dp~~Rps~~~vl~ 331 (350)
.+||+.||++|||++++++
T Consensus 337 ~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCChhhCCCHHHHhc
Confidence 9999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=336.24 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=200.1
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCee
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 134 (350)
....|.+.+.||+|+||.||+|....++ ..+|+|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTH---VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTC---CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCC---cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 4456777889999999999999976553 458999886542 33456789999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CceEEeecccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR---YNARISDFGLAKL 211 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~ 211 (350)
++||||+++|+|.+++.....+++..++.++.|++.||.|||+ .+|+||||||+||+++.+ +.+||+|||++..
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999999999888889999999999999999999995 499999999999999764 4599999999987
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
...... .....||+.|+|||++. ..++.++||||+||++|+|++|..||......+.. ..+..+....
T Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~~- 256 (494)
T 3lij_A 189 FENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL-------RKVEKGKYTF- 256 (494)
T ss_dssp CBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCC-
T ss_pred CCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCCC-
Confidence 654322 23456899999999986 46899999999999999999999999765543321 1111121110
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+....++..+.+++.+||+.||.+|||+.++++
T Consensus 257 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 -----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00111234678999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=325.57 Aligned_cols=254 Identities=17% Similarity=0.200 Sum_probs=202.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC---CCceeeecceeecCCe
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH---HKNLVRLLGFCDEGQN 133 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~ 133 (350)
..+.+.+.||+|+||.||+|.... ....++.||+|.+... ...++..|.++++.++ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 445566789999999999995432 1233466999998643 3556777888877776 9999999999999999
Q ss_pred eEEEEecCCCCChhhhhc-----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----------
Q 046877 134 RLLAYEFLNNGTLASFLF-----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND----------- 197 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~----------- 197 (350)
.++||||+++|+|.+++. ....+++..++.++.|++.||+||| +.+|+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccc
Confidence 999999999999999996 3567899999999999999999999 569999999999999998
Q ss_pred CCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHH
Q 046877 198 RYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 277 (350)
Q Consensus 198 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~ 277 (350)
++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+||+.||.........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---- 294 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---- 294 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----
Confidence 8999999999997654333333445567999999999999999999999999999999999999999643321110
Q ss_pred HHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHhcccCC
Q 046877 278 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLR-PTMRKVSQMLQEVVEV 339 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-ps~~~vl~~L~~~~~~ 339 (350)
........ ..++.+.+++..|+..+|.+| |+++++.+.|++.+..
T Consensus 295 --------------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 295 --------------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 01111111 125678889999999999999 6788888888876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=330.49 Aligned_cols=250 Identities=18% Similarity=0.242 Sum_probs=199.6
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||+|++..++ ..+|+|.+.+.. ......+.+|..+++.++||||+++++++.+....++|
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~---~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTR---KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEEEEcCCCEEEEEEEECCCC---cEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 345578999999999999987654 569999886421 22334588899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.+|.+||+|||++........
T Consensus 148 ~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp ECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 999999999999864 468999999999999999999995 5999999999999999999999999999986654322
Q ss_pred cceeeccccCCCccCcccccCCC----CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKST----ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+....... +..+.
T Consensus 224 -~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-------i~~~~------ 289 (410)
T 3v8s_A 224 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK-------IMNHK------ 289 (410)
T ss_dssp -EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------HHTHH------
T ss_pred -ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHH-------HHhcc------
Confidence 1223557999999999997654 78899999999999999999999986554332110 00000
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSL--RPTMRKVSQ 331 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~vl~ 331 (350)
.....+....++.++.+++.+||..+|.+ ||+++++++
T Consensus 290 ~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 290 NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 00111111134678999999999999988 999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=322.19 Aligned_cols=248 Identities=21% Similarity=0.305 Sum_probs=203.7
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..|.+.+.||+|+||.||++.+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTK---EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34556788999999999999976653 468999886432 233467889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++|||+++++|.+++.....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999999999877889999999999999999999995 49999999999999999999999999999866432
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... .....++..|+|||++.+..++.++||||||+++|+|++|..||......+... ....+..
T Consensus 195 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~~------- 258 (335)
T 2owb_A 195 GER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-------RIKKNEY------- 258 (335)
T ss_dssp TCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHTCC-------
T ss_pred ccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------HHhcCCC-------
Confidence 211 234568999999999998889999999999999999999999997654332111 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..++..+.+++.+||+.||++|||++++++
T Consensus 259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111134568899999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=316.85 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=196.2
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecC-CeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-QNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 137 (350)
..+.+.+.||+|+||.||++... +..+++|.+... ...+.+.+|+.+++.++||||+++++++.+. +..+++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-----TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhceEEeEEecCCCceEEEEEEc-----CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 34566788999999999999863 346899988643 3457799999999999999999999986544 578999
Q ss_pred EecCCCCChhhhhcCCCC--cChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||+++++|.+++..... +++..++.++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999999965433 7888999999999999999995 49999999999999999999999999998755432
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
. ....++..|+|||.+.+..++.++||||||+++|+|+| |..||......... .....+
T Consensus 171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-------~~~~~~-------- 230 (278)
T 1byg_A 171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKG-------- 230 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-------HHHTTT--------
T ss_pred c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcC--------
Confidence 2 22346889999999998889999999999999999998 99999754432211 111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
.....+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 231 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 231 -YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11222334568899999999999999999999999999987643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=327.71 Aligned_cols=244 Identities=23% Similarity=0.280 Sum_probs=187.0
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHh-cCCCCceeeecceeec----CCeeEEEEe
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIG-QTHHKNLVRLLGFCDE----GQNRLLAYE 139 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----~~~~~lv~e 139 (350)
+.||+|+||.||+|.+..++ ..||+|.+.. ...+.+|+.++. ..+||||+++++++.. ....++|||
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~---~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQ---EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp EEEEEETTEEEEEEEETTTC---CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ceeeeccCeEEEEEEECCCC---CEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 57999999999999976654 5699999853 245677888764 4589999999998865 567899999
Q ss_pred cCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEeeccccccccc
Q 046877 140 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND---RYNARISDFGLAKLLTL 214 (350)
Q Consensus 140 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~ 214 (350)
|+++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||++.....
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999999999764 358999999999999999999995 59999999999999987 78899999999986543
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ ...+..+...
T Consensus 217 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~~~~~~----- 285 (400)
T 1nxk_A 217 HNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQYE----- 285 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHHHTCCC-----
T ss_pred CCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHHcCccc-----
Confidence 221 23456899999999999899999999999999999999999999765433211000 0111111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
........++.++.+++.+||+.||++|||+.++++
T Consensus 286 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 286 -FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011111235678999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=324.03 Aligned_cols=265 Identities=23% Similarity=0.276 Sum_probs=194.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCC-----
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ----- 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 132 (350)
.|.+.+.||+|+||.||+|.+..++ ..||+|++..... ...+++.+|+.+++.++||||+++++++....
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTG---AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTC---CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCC---CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3556688999999999999976553 5699999854322 23457889999999999999999999987653
Q ss_pred -eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 133 -NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 133 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
..+++|||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 7799999865 568999999999999999999995 5999999999999999999999999999986
Q ss_pred cccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH--------HH
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DC 282 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~ 282 (350)
.... .....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+......... ..
T Consensus 178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 5432 134568999999999877 679999999999999999999999998655433211100000 00
Q ss_pred hhcCCcchhc-------cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcccC
Q 046877 283 YRNGKLDDLV-------EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVVE 338 (350)
Q Consensus 283 ~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~~ 338 (350)
+......... .... .....+.+..+.+++.+||+.||++|||++++++ .+++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 0000000000 0000 0011234678999999999999999999999987 4555543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=326.19 Aligned_cols=257 Identities=20% Similarity=0.239 Sum_probs=202.9
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----cccHHHHHHHHHHHhcC-CCCceeeecceeecCCe
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 133 (350)
..+.+.+.||+|+||.||+++.......+..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 35667788999999999999986544456789999886432 22345677899999999 79999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.++||||+++++|.+++.....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999999877889999999999999999999995 499999999999999999999999999998654
Q ss_pred cCcccceeeccccCCCccCcccccCC--CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRKS--TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......... ....... ..
T Consensus 211 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~-~~----- 281 (355)
T 1vzo_A 211 ADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRIL-KS----- 281 (355)
T ss_dssp GGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHH-HC-----
T ss_pred cCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHh-cc-----
Confidence 32221 12345689999999999863 47889999999999999999999997544322111 1111110 00
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQM 332 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~~ 332 (350)
....+..++..+.+++.+||..||++|| |++++++.
T Consensus 282 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 -----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1112223567899999999999999999 99999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=336.91 Aligned_cols=252 Identities=25% Similarity=0.309 Sum_probs=206.3
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
....|.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITG---QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCC---CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4456777889999999999999976554 569999986432 3346789999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEeeccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL---NDRYNARISDFGLAK 210 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~ 210 (350)
.+++|||+.+++|.+++.....+++..++.++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999999999888899999999999999999999995 499999999999999 567899999999998
Q ss_pred ccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
....... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||......+.. ..+..+....
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~~ 246 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL-------KKVEKGKYTF 246 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCCC
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHcCCCCC
Confidence 6654322 134468999999999876 6899999999999999999999999765443321 1112221111
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+....++..+.+++.+||+.||.+|||+.++++
T Consensus 247 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 11111235678999999999999999999999984
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=313.87 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=198.7
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
.....+.+.+.||+|+||.||+|.+..++ ..|++|.+... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETG---QIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTC---CEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCC---CEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34455667788999999999999876553 56999988653 34567899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+++++|.+++. ....+++..++.++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999999986 45678999999999999999999995 5999999999999999999999999999976643
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......... .......
T Consensus 178 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~------ 242 (314)
T 3com_A 178 TMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-------MIPTNPP------ 242 (314)
T ss_dssp TBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSCC------
T ss_pred hcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHhcCCC------
Confidence 322 1234468899999999998899999999999999999999999997544322111 0011110
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+..++..+.+++.+||..||.+|||+.++++
T Consensus 243 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 243 -PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011112234678999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=312.46 Aligned_cols=254 Identities=24% Similarity=0.299 Sum_probs=198.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----cccHHHHHHHHHHHhcCCCCceeeeccee--ecCCe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----QDGEKEFKNEVIVIGQTHHKNLVRLLGFC--DEGQN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~ 133 (350)
.|.+.+.||+|+||.||++....+ +..+++|.+.... ......+.+|+.+++.++||||+++++++ .+...
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSET---LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTT---CCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred ceeEeeEEecCCCeEEEEEEECCC---CcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 356678899999999999986554 3568999886432 23456799999999999999999999998 45568
Q ss_pred eEEEEecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 134 RLLAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
.+++|||++++ |.+++.. ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999986 6666643 4568999999999999999999995 4999999999999999999999999999987
Q ss_pred cccCcccceeeccccCCCccCcccccCCC--CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKST--ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
..............++..|+|||++.+.. ++.++||||||+++|+|++|..||......... ..+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF-------ENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-------HHHhcCCC-
Confidence 65433333334556899999999997643 377899999999999999999999754432211 11111111
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhccc
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVV 337 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~ 337 (350)
..+.+++..+.+++.+||+.||++|||++++++ .+.+..
T Consensus 231 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 231 ---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred ---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 111235678999999999999999999999995 455443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=314.22 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=203.1
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.|.+.+.||+|+||.||++.+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTK---EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCC---ceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3456688999999999999976553 468899876542 2334678899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+++++|.+++.....+++..++.++.|+++|++|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999999877889999999999999999999995 499999999999999999999999999998654322
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. .....+++.|+|||.+.+..++.++||||+|+++|+|++|..||......+.. .....+..
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-------- 232 (294)
T 2rku_A 170 ER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-------LRIKKNEY-------- 232 (294)
T ss_dssp CC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTCC--------
T ss_pred cc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhhccC--------
Confidence 21 23456899999999999888999999999999999999999999765433211 11111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+...+..+.+++.+||+.||++|||++++++
T Consensus 233 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 --SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111234578999999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=328.86 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=192.5
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--------ccHHHHHHHHHHHhcCCCCceeeecce
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--------DGEKEFKNEVIVIGQTHHKNLVRLLGF 127 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~ 127 (350)
.....|.+.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.++++++||||++++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTC---KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCC---cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34455677788999999999999977654 5699998864321 112347899999999999999999999
Q ss_pred eecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---ceEEe
Q 046877 128 CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY---NARIS 204 (350)
Q Consensus 128 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~ 204 (350)
+.. +..+++|||+++|+|.+++.....+++..++.++.|++.||+|||+ .+++||||||+||+++.++ .+||+
T Consensus 209 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 209 FDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp EES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred Eec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEe
Confidence 865 4579999999999999999888899999999999999999999995 4999999999999997544 59999
Q ss_pred ecccccccccCcccceeeccccCCCccCcccccC---CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 046877 205 DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK---STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 281 (350)
Q Consensus 205 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 281 (350)
|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......... .
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~------~ 355 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK------D 355 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH------H
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH------H
Confidence 999998765332 1234568999999999853 567889999999999999999999997543322110 1
Q ss_pred HhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 282 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+..+....... ....++..+.+++.+||+.||++|||++++++
T Consensus 356 ~i~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 QITSGKYNFIPE------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHTTCCCCCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCCCch------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111111111000 00124678999999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=335.55 Aligned_cols=249 Identities=24% Similarity=0.274 Sum_probs=201.5
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+.+.+.||+|+||.||+|....++ ..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 344577999999999999987654 569999986532 33456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 138 YEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
|||+++|+|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+||+++.+|.+||+|||++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999987654 38999999999999999999995 49999999999999999999999999999876533
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||........... ....+....
T Consensus 340 ~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~~i~~~~-------- 405 (576)
T 2acx_A 340 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEVP-------- 405 (576)
T ss_dssp CC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHHHHHHCC--------
T ss_pred cc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHHHhhccc--------
Confidence 22 2345799999999999998999999999999999999999999986543221100 111111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
...+..++.++.+++.+||+.||.+|| +++++++
T Consensus 406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 111123567899999999999999999 7788874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=319.96 Aligned_cols=266 Identities=19% Similarity=0.226 Sum_probs=197.4
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeec------
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE------ 130 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 130 (350)
..|.+.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTG---QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTC---CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cceeEEEEEecCCCcEEEEEEECCCC---CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 34667788999999999999976554 469999875432 2234578899999999999999999999876
Q ss_pred --CCeeEEEEecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecc
Q 046877 131 --GQNRLLAYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207 (350)
Q Consensus 131 --~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 207 (350)
.+..++||||+++ +|.+.+. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4568999999986 6666554 34678999999999999999999995 499999999999999999999999999
Q ss_pred cccccccCcc--cceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 046877 208 LAKLLTLNQR--KTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 208 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
++........ ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....................
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9986643221 112234567999999999876 4589999999999999999999999987654443222211111111
Q ss_pred cCCcchhcccc--------cc-CCCc------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 285 NGKLDDLVEGD--------ME-AMND------IKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 285 ~~~~~~~~~~~--------~~-~~~~------~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+....... .. .... ...+..+.+++.+||+.||++|||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11111110000 00 0000 012456899999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=348.59 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=206.1
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
..+.+.+.||+|+||.||+|.+..+......+++|...... ....+.+.+|+.+++.++||||+++++++.+ +..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence 34456678999999999999987766666789999886533 2334678999999999999999999999854 568999
Q ss_pred EecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999999999744 468899999999999999999995 499999999999999999999999999998764432
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+.. ..+..+.
T Consensus 546 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~-------~~i~~~~-------- 609 (656)
T 2j0j_A 546 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-------GRIENGE-------- 609 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHHTC--------
T ss_pred cee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHcCC--------
Confidence 211 123346778999999998899999999999999999997 99999755433211 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
....+.+++..+.+++.+||..||++|||+.++++.|+++++
T Consensus 610 -~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 -RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111223467889999999999999999999999999988753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=315.36 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=203.4
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeec---
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE--- 130 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 130 (350)
.+.....+...+.||+|+||.||+|.+..++ ..+++|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDG---KTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTC---CEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCC---eEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 3445566777889999999999999976543 568999886432 356789999999999999999998754
Q ss_pred -------------CCeeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 046877 131 -------------GQNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL 195 (350)
Q Consensus 131 -------------~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill 195 (350)
....+++|||+++++|.+++... ..+++..++.++.|++.|+.|||+ .+++|+||||+||++
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFL 155 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEE
Confidence 44578999999999999999643 578899999999999999999995 499999999999999
Q ss_pred cCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhH
Q 046877 196 NDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 275 (350)
Q Consensus 196 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~ 275 (350)
+.++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++|..|+.....
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------ 226 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------ 226 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH------
T ss_pred cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH------
Confidence 9999999999999987654322 1334589999999999988899999999999999999999988742110
Q ss_pred HHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCC
Q 046877 276 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDV 341 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~ 341 (350)
.......+... ..++..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 227 ---~~~~~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 227 ---FFTDLRDGIIS------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ---HHHHHHTTCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ---HHHHhhccccc------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11111111111 1245678999999999999999999999999988765433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=344.10 Aligned_cols=246 Identities=24% Similarity=0.280 Sum_probs=203.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 135 (350)
.+++.+.||+|+||.||+|....++ ..||+|.+.+. .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~---~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTD---ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSC---CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCC---cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3456678999999999999987654 56999998643 234456788899999988 7999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+||||+++|+|.+++.....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 999999999999999887889999999999999999999995 59999999999999999999999999999854322
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..||...+..+.. ..+..+.
T Consensus 496 ~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~-------~~i~~~~-------- 558 (674)
T 3pfq_A 496 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------QSIMEHN-------- 558 (674)
T ss_dssp TC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHSSC--------
T ss_pred Cc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH-------HHHHhCC--------
Confidence 21 124567999999999999999999999999999999999999999865443321 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCH-----HHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTM-----RKVS 330 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~vl 330 (350)
. ..+...+.++.+++.+||+.||++||++ ++++
T Consensus 559 ~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 559 V--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp C--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred C--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 1 1122356789999999999999999997 6665
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=332.76 Aligned_cols=237 Identities=14% Similarity=0.141 Sum_probs=183.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHH---HHHhcCCCCceeeec-------ce
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEV---IVIGQTHHKNLVRLL-------GF 127 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~ 127 (350)
+.+.+.||+|+||.||+|.+..+ +..||+|.+... .....+.+.+|+ +.++.++||||++++ ++
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CC---CCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred EEEcceeecCCCEEEEEEEECCC---CcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 34457899999999999997554 356999998632 233457789999 555566899999998 55
Q ss_pred eecCC-----------------eeEEEEecCCCCChhhhhcCCCCcCh-------hHHHHHHHHHHHHHHHHHhcCCCCe
Q 046877 128 CDEGQ-----------------NRLLAYEFLNNGTLASFLFGNLKPNW-------NLRTNIAFQIARVLLYLHEDCSSQI 183 (350)
Q Consensus 128 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~i~~~l~~Lh~~~~~~i 183 (350)
+.+.+ ..+++|||+ +|+|.+++.....+++ ..++.++.|++.||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 278999999 5799999975444444 7888899999999999995 499
Q ss_pred EecCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCC-----------CCCCCCcchhHHH
Q 046877 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-----------TISAKVDVYSFGV 252 (350)
Q Consensus 184 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~ 252 (350)
+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985432 1234456 999999999877 7999999999999
Q ss_pred HHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 253 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 253 ~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
++|+|++|+.||......... ..... . ...++.++.+++.+||+.||++|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~---------------~~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS---------------EWIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS---------------GGGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch---------------hhhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999644322211 11111 0 0134578999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=321.09 Aligned_cols=264 Identities=25% Similarity=0.333 Sum_probs=191.1
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHH--HHhcCCCCceeeeccee-----ecCC
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVI--VIGQTHHKNLVRLLGFC-----DEGQ 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~--~l~~l~h~~iv~~~~~~-----~~~~ 132 (350)
.+.+.+.||+|+||.||+|+.. +..||+|.+.... ...+..|.. .+..++||||+++++.+ ....
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSLD-----ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEET-----TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred HhheeeecccCCCeEEEEEEEC-----CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3456788999999999999752 3569999986432 333444444 45558999999999754 2334
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCC---------CeEecCCCCCCeEEcCCCceEE
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSS---------QIIHCDIKPQNILLNDRYNARI 203 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~---------~i~H~dlkp~Nill~~~~~~kl 203 (350)
..+++|||+++|+|.+++... ..++..+..++.|+++||+||| +. +++||||||+||+++.++.+||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred eEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEE
Confidence 678999999999999999644 4488889999999999999999 56 9999999999999999999999
Q ss_pred eecccccccccCcc------cceeeccccCCCccCcccccC-------CCCCCCCcchhHHHHHHHHHhCCCCCCcccch
Q 046877 204 SDFGLAKLLTLNQR------KTIKTAIRGTKGYVAPEWFRK-------STISAKVDVYSFGVLLLEIISCRKSFDIEMGE 270 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~ 270 (350)
+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999986643221 111224468999999999976 35667899999999999999998776433221
Q ss_pred hh-hhHHH----------HHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 271 EY-AILTD----------WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 271 ~~-~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.. ..... ............... .........++..+.+++.+||+.||++|||++++++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF--PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCC--CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCC--CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 11 00000 000000000000000 0111223457889999999999999999999999999999886
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=313.93 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=201.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+...+.||+|+||.||+|....+ +..|++|.+.... ....+.+.+|+.+++.++||||+++++++.+....+++||
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRT---QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTT---CCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHhhhhcccCCeEEEEEEECCC---CcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45667899999999999987654 3568999886543 3445789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++++|.+++. ...+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 175 (303)
T 3a7i_A 101 YLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 175 (303)
T ss_dssp CCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred eCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence 999999999985 4678999999999999999999995 49999999999999999999999999999866543221
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......... ....+.. ..
T Consensus 176 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~---------~~ 238 (303)
T 3a7i_A 176 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-------LIPKNNP---------PT 238 (303)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSCC---------CC
T ss_pred -cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH-------HhhcCCC---------CC
Confidence 234568999999999999899999999999999999999999997544322111 1111111 11
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....++..+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11234578999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=323.68 Aligned_cols=269 Identities=21% Similarity=0.287 Sum_probs=195.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
|.+.+.||+|+||.||+|....++ ..||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTD---NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred eEEEEEEcCCCCEEEEEEEECCCC---cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 456688999999999999976554 56999988643221 11235579999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++ +|.+++... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 9985 888887654 458899999999999999999995 4999999999999999999999999999976543221
Q ss_pred ceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc---
Q 046877 219 TIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG--- 294 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 294 (350)
......+|+.|+|||++.+ ..++.++||||+|+++|+|++|..||......+................+......
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 1234467999999999876 56899999999999999999999999876544432211111111111111111110
Q ss_pred ------cccC----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcccC
Q 046877 295 ------DMEA----MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVVE 338 (350)
Q Consensus 295 ------~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~~ 338 (350)
.... .....++.++.+++.+||+.||++|||++++++ .+.++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0000 001134578899999999999999999999986 4555543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=329.75 Aligned_cols=194 Identities=22% Similarity=0.383 Sum_probs=152.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceee-----cCC
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCD-----EGQ 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 132 (350)
.|.+.+.||+|+||.||+|.+..+ +..||+|++..... ...+++.+|+.+++.++||||+++++++. ...
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLE---KRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp TEEECCC-------CEEEEEECC-----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CeEEeeEeeecCCeEEEEEEECCC---CcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 456778899999999999987655 35699998865322 23467889999999999999999999984 335
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
..|+||||+. ++|.+++.....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 7899999985 6999999888889999999999999999999995 59999999999999999999999999999876
Q ss_pred ccCccc-------------------------ceeeccccCCCccCcccc-cCCCCCCCCcchhHHHHHHHHHhC
Q 046877 213 TLNQRK-------------------------TIKTAIRGTKGYVAPEWF-RKSTISAKVDVYSFGVLLLEIISC 260 (350)
Q Consensus 213 ~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~lltg 260 (350)
...... .......||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 432111 122345689999999986 456799999999999999999993
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=315.84 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=197.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeeccee--ecCCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFC--DEGQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~ 135 (350)
.+++.+.||+|+||.||++....++ +.+++|.+.... ....+.+.+|+.+++.++||||+++++++ ......+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDG---KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCC---cEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 3456788999999999999976553 568999886432 23456789999999999999999999987 4467889
Q ss_pred EEEecCCCCChhhhhcCC----CCcChhHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 136 LAYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARVLLYLHEDC--SSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
++|||+++++|.+++... ..+++..++.++.|++.|++|||+.. ..+++|+||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999998643 34899999999999999999999651 012999999999999999999999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...+..+...
T Consensus 164 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~~~~ 234 (279)
T 2w5a_A 164 RILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKIREGKFR 234 (279)
T ss_dssp HHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCC
T ss_pred eeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH-------HHHHhhcccc
Confidence 866433211 1234589999999999988899999999999999999999999976543221 1112222221
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQML 333 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L 333 (350)
. .+..++.++.+++.+||+.||++|||++++++.+
T Consensus 235 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 235 R---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp C---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred c---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 1 1223567899999999999999999999998755
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=316.15 Aligned_cols=275 Identities=20% Similarity=0.292 Sum_probs=208.1
Q ss_pred cCHHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhc--CCCCceeeeccee
Q 046877 51 FSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ--THHKNLVRLLGFC 128 (350)
Q Consensus 51 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~ 128 (350)
+...+.....+.+.+.||+|+||.||+|... +..||+|.+... ....+.+|.+++.. ++||||+++++++
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-----GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-----CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 3344555667788899999999999999863 356999998542 35567788888877 7999999999999
Q ss_pred ecCC----eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCeEEcCCC
Q 046877 129 DEGQ----NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHED-----CSSQIIHCDIKPQNILLNDRY 199 (350)
Q Consensus 129 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-----~~~~i~H~dlkp~Nill~~~~ 199 (350)
.... ..+++|||+++|+|.+++.. ..+++..++.++.|++.|+.|||.. ++.+++|+||||+||+++.++
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 8776 78999999999999999964 4689999999999999999999921 024899999999999999999
Q ss_pred ceEEeecccccccccCcccc--eeeccccCCCccCcccccCCC------CCCCCcchhHHHHHHHHHhC----------C
Q 046877 200 NARISDFGLAKLLTLNQRKT--IKTAIRGTKGYVAPEWFRKST------ISAKVDVYSFGVLLLEIISC----------R 261 (350)
Q Consensus 200 ~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~~lltg----------~ 261 (350)
.+||+|||++.......... ......+|+.|+|||++.+.. ++.++||||||+++|+|+|| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999997665433211 123446899999999997652 33689999999999999999 6
Q ss_pred CCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 262 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 262 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
.||.......... .. ............... ......+++..+.+++.+||+.||++|||++++++.|+++.+.
T Consensus 265 ~p~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 265 LPYYDLVPSDPSV-EE-MRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CTTTTTSCSSCCH-HH-HHHHHTTSCCCCCCC---GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCccccCcCcccH-HH-HHHHHHHHHhCCCCc---ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 7886543322111 00 111111111110000 0112236788999999999999999999999999999988654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=315.02 Aligned_cols=250 Identities=20% Similarity=0.308 Sum_probs=196.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.+++.+.||+|+||.||+|.+..++ ..+++|.+........+.+.+|+.+++.++||||+++++++...+..+++||
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETG---ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTC---CEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ceeecceeccCCCeEEEEEEEcCCC---cEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4566788999999999999976553 5689998876666667889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++++|.+++.. ...+++..++.++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 9999999998864 4668999999999999999999995 499999999999999999999999999875432111
Q ss_pred ceeeccccCCCccCcccc-----cCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 219 TIKTAIRGTKGYVAPEWF-----RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.......+++.|+|||++ .+..++.++||||||+++|+|++|..||......... .. ...+..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~----- 239 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LK-IAKSDP----- 239 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HH-HHHSCC-----
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HH-HhccCC-----
Confidence 111334589999999998 3567889999999999999999999999754432211 01 111111
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+..++..+.+++.+||+.||++|||++++++
T Consensus 240 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 --PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111122345678999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=329.03 Aligned_cols=260 Identities=18% Similarity=0.217 Sum_probs=203.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCC-CceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHH-KNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.+.+.||+|+||.||+|.+..++ ..||+|.+.... ...++..|+.+++.++| +++..+..++.+.+..+++|
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTC---CEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCC---cEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 3566788999999999999976553 469999876432 23457889999999976 56666666778888899999
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEeeccccccccc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL---NDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~ 214 (350)
||+ +++|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 8899999964 5678999999999999999999995 499999999999999 5889999999999987654
Q ss_pred Cccc-----ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 215 NQRK-----TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 215 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
.... .......||..|+|||.+.+..++.++|||||||++|+|++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 3221 11235568999999999999999999999999999999999999998655433222211111111111111
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.+.. .++.++.+++.+||+.||++||+++++++.|+++.
T Consensus 239 ~l~~---------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 239 ALCR---------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHT---------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHhc---------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1111 24678999999999999999999999999998874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=310.60 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=194.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
..||+|+||.||+|.+..+ +..|++|.+........+.+.+|+.+++.++||||+++++++.+.+..+++|||++++
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSN---QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp CEEEECSSSEEEEEEETTT---CCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEeecCcEEEEEEEECCC---CeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 3799999999999997655 3569999987665555678999999999999999999999999999999999999999
Q ss_pred ChhhhhcCC---CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEeecccccccccCcccce
Q 046877 145 TLASFLFGN---LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND-RYNARISDFGLAKLLTLNQRKTI 220 (350)
Q Consensus 145 ~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~ 220 (350)
+|.+++... ...++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.+||+|||++........ .
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~ 179 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--C 179 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--c
Confidence 999998644 345688889999999999999995 49999999999999987 89999999999986643221 1
Q ss_pred eeccccCCCccCcccccCCC--CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 221 KTAIRGTKGYVAPEWFRKST--ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 221 ~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.....++..|+|||++.+.. ++.++||||||+++|+|++|..||............. .. . ....
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~--~---------~~~~ 245 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV---GM--F---------KVHP 245 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH---HH--H---------CCCC
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh---cc--c---------cccc
Confidence 23446899999999997643 7889999999999999999999997543322211100 00 0 0111
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..++.++.+++.+||+.||++|||++++++
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122245678999999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=308.46 Aligned_cols=246 Identities=25% Similarity=0.382 Sum_probs=194.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+.+.+.||+|+||.||+|.+..++ ..+++|.+.... ....+.+.+|+..++.++||||+++++++.+.+..++
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTG---HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCC---ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3456688999999999999976543 469999886432 2345678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+++++|.+++.....+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999999998777899999999999999999999955 99999999999999999999999999998664332
Q ss_pred ccceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
. .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||........ ...+..+..
T Consensus 166 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~------- 228 (276)
T 2h6d_A 166 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL-------FKKIRGGVF------- 228 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC-------
T ss_pred c---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-------HHHhhcCcc-------
Confidence 1 133458899999999987765 5789999999999999999999975433221 111111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..++..+.+++.+||+.||++|||++++++
T Consensus 229 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 ---YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011224578999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=334.67 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=199.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-------------ccHHHHHHHHHHHhcCCCCceeeec
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-------------DGEKEFKNEVIVIGQTHHKNLVRLL 125 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~ 125 (350)
..|.+.+.||+|+||.||+|....++ ..+|+|.+..... ...+.+.+|+.+++.++||||++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGH---SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTC---CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCC---cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45667789999999999999976654 4689998864321 2346789999999999999999999
Q ss_pred ceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---ceE
Q 046877 126 GFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY---NAR 202 (350)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~k 202 (350)
+++.+....++||||+++|+|.+++.....+++..++.++.|++.||+|||+ .+++||||||+||+++.++ .+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence 9999999999999999999999999877889999999999999999999995 4999999999999998776 699
Q ss_pred EeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH
Q 046877 203 ISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 282 (350)
Q Consensus 203 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 282 (350)
|+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++|..||......+.. ..
T Consensus 190 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~ 258 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII-------KK 258 (504)
T ss_dssp ECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HH
T ss_pred EEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HH
Confidence 999999987654322 23456899999999987 46899999999999999999999999865543321 11
Q ss_pred hhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+..+....... ....++.++.+++.+||+.||.+|||++++++
T Consensus 259 i~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGKYYFDFN------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCCCCCCHH------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCCCCCcc------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 12221110000 00124578999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=327.63 Aligned_cols=198 Identities=25% Similarity=0.411 Sum_probs=163.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecC-----C
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-----Q 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 132 (350)
.|.+.+.||+|+||.||+|.+..++ ..||+|++..... ...+++.+|+.+++.++||||+++++++... .
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTE---KNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTT---EEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CEEEEEEEeecCCEEEEEEEECCCC---cEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4566788999999999999976653 5699999865322 2346789999999999999999999998766 5
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
..++||||+.+ +|.+++.....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 78999999874 999999888889999999999999999999995 59999999999999999999999999999876
Q ss_pred ccCccc--------------------ceeeccccCCCccCcccc-cCCCCCCCCcchhHHHHHHHHHhCCCCC
Q 046877 213 TLNQRK--------------------TIKTAIRGTKGYVAPEWF-RKSTISAKVDVYSFGVLLLEIISCRKSF 264 (350)
Q Consensus 213 ~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~lltg~~pf 264 (350)
...... .......||+.|+|||++ .+..++.++||||+||++|||++|..||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 543211 112456789999999986 4567999999999999999999865555
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=319.69 Aligned_cols=264 Identities=22% Similarity=0.237 Sum_probs=195.9
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-----cHHHHHHHHHHHhcCCCCceeeecceeecCCe
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-----GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
..|.+.+.||+|+||.||+|.+..+ +..||+|.+...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNT---NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSC---CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred cccEEEeEEeecCCEEEEEEEECCC---CcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 4466678899999999999987654 356999988643221 12467899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
.+++|||+++ +|.+++... ..+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999987 888887654 468899999999999999999995 49999999999999999999999999999866
Q ss_pred ccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+................+...
T Consensus 163 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 163 GSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred cCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 43322 12345689999999999764 5788999999999999999999999765543321111000000001111111
Q ss_pred cc------ccccCCC-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 292 VE------GDMEAMN-----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 292 ~~------~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. ....... ....+.++.+++.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 0000000 0234578999999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=311.74 Aligned_cols=243 Identities=22% Similarity=0.315 Sum_probs=195.2
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcC-CCCceeeecceeecCCee
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 134 (350)
...+.+.+.||+|+||.||+|....++ ..|++|.+.... .....++.+|+..+..+ +||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDG---CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCC---ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 455667789999999999999976553 569999886532 33456788899999998 999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCC----CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC------------
Q 046877 135 LLAYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR------------ 198 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~------------ 198 (350)
+++|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999999999654 568999999999999999999995 499999999999999844
Q ss_pred -------CceEEeecccccccccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccch
Q 046877 199 -------YNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGE 270 (350)
Q Consensus 199 -------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~ 270 (350)
..+||+|||.+....... ...+++.|+|||++.+. .++.++||||||+++|+|++|..|+.....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 236 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence 479999999998665332 23489999999999766 566899999999999999999987643221
Q ss_pred hhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 271 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+..+.... .+..++..+.+++.+||+.||++|||+.++++
T Consensus 237 ---------~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ---------WHEIRQGRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---------HHHHHTTCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------HHHHHcCCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11111222211 11235678999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=316.25 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=183.1
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
..+.+.+.||+|+||.||+|....+ +..|++|.+.... ....+++.+|+.+++.++||||+++++++...+..+++
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPK---KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC-------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhheeccccceEEEEEEECCC---CcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3456678899999999999986544 3569999876432 23356788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcC--------CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 138 YEFLNNGTLASFLFG--------NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
|||+++++|.+++.. ...+++..++.++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999852 4568999999999999999999995 49999999999999999999999999998
Q ss_pred cccccCcc---cceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 210 KLLTLNQR---KTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 210 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
........ ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... ... .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~-~ 241 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTL-Q 241 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHH-T
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------HHh-c
Confidence 76543221 111234468999999999875 468999999999999999999999997654332211 001 1
Q ss_pred CCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 286 GKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+.................++..+.+++.+||+.||.+|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111111100111111234578999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=318.36 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=199.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--------ccHHHHHHHHHHHhcC-CCCceeeecceeec
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--------DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDE 130 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 130 (350)
.+.+.+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATG---HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hcccceEEecCCCEEEEEEEECCCC---cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 3455578999999999999976553 5699998864321 1134678899999999 89999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 131 GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 131 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
.+..+++|||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 99999999999999999999877789999999999999999999995 499999999999999999999999999998
Q ss_pred ccccCcccceeeccccCCCccCcccccC------CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRK------STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
........ ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||......... ..+.
T Consensus 249 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-------~~i~ 318 (365)
T 2y7j_A 249 HLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML-------RMIM 318 (365)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHH
T ss_pred ccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH-------HHHH
Confidence 76543221 34568999999999863 35788999999999999999999999754332211 1111
Q ss_pred cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+...... + .....+..+.+++.+||+.||++|||++++++
T Consensus 319 ~~~~~~~~-~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQFSS-P-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCCCCH-H-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCCCC-c-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111000 0 00123567999999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=318.96 Aligned_cols=259 Identities=24% Similarity=0.283 Sum_probs=180.1
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC------
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG------ 131 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 131 (350)
.|.+.+.||+|+||.||+|.+..+ +..||+|++.... .....++.+|+.+++.++||||+++++++...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKT---GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTT---TEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred ceEEeeEEeecCCeEEEEEEECCC---CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 455678899999999999987655 3569999986432 23346788999999999999999999998654
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
...++++|++ +++|.+++.. ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 5679999998 6799998854 678999999999999999999995 5999999999999999999999999999976
Q ss_pred cccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH--------H
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD--------C 282 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~--------~ 282 (350)
.... .....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+............. .
T Consensus 182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 5432 234568999999999877 6789999999999999999999999976554332211100000 0
Q ss_pred hhcCCcchhcccccc--CCC----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 283 YRNGKLDDLVEGDME--AMN----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~--~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+.............. ... ..+.+..+.+|+.+||+.||++|||++++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000000000000000 000 0123578899999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=317.21 Aligned_cols=256 Identities=20% Similarity=0.324 Sum_probs=201.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc-----------------HHHHHHHHHHHhcCCCCce
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG-----------------EKEFKNEVIVIGQTHHKNL 121 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i 121 (350)
..+.+.+.||+|+||.||+|.. + +..|++|.+....... .+.+.+|+.+++.++||||
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--D---NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--T---TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred CceEEEEEEcCCCCeEEEEEEc--C---CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3456678899999999999987 2 4679999986432211 1789999999999999999
Q ss_pred eeecceeecCCeeEEEEecCCCCChhhh------hcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046877 122 VRLLGFCDEGQNRLLAYEFLNNGTLASF------LFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNI 193 (350)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni 193 (350)
+++++++.+.+..+++|||+++++|.++ +.. ...+++..++.++.|++.|+.|||+ ..+++|+||||+||
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNI 183 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhE
Confidence 9999999999999999999999999998 655 5778999999999999999999995 15999999999999
Q ss_pred EEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCC-CCCC-CCcchhHHHHHHHHHhCCCCCCcccchh
Q 046877 194 LLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-TISA-KVDVYSFGVLLLEIISCRKSFDIEMGEE 271 (350)
Q Consensus 194 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~~l~~lltg~~pf~~~~~~~ 271 (350)
+++.++.+||+|||++...... ......++..|+|||++.+. .++. ++||||||+++|+|++|..||.......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 9999999999999999865433 22445689999999999877 6666 8999999999999999999998655421
Q ss_pred hhhHHHHHHHHhhcCCcchhcc---------ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 272 YAILTDWAFDCYRNGKLDDLVE---------GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. ...+..+....... ..........++..+.+++.+||+.||++|||++++++
T Consensus 260 ~~------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 EL------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HH------HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH------HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 11112221110000 00000011345678999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=322.97 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=191.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeec---------
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE--------- 130 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------- 130 (350)
.|.+.+.||+|+||.||+|.+..++ ..||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESG---KRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTC---CEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCC---CEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 4566788999999999999976654 5699998864322 23469999999999999999999843
Q ss_pred -----------------------------CCeeEEEEecCCCCChhhhh----cCCCCcChhHHHHHHHHHHHHHHHHHh
Q 046877 131 -----------------------------GQNRLLAYEFLNNGTLASFL----FGNLKPNWNLRTNIAFQIARVLLYLHE 177 (350)
Q Consensus 131 -----------------------------~~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 177 (350)
....++||||+++ +|.+.+ .....+++..++.++.|++.||+|||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH- 158 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH- 158 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 3347899999985 666555 35678899999999999999999999
Q ss_pred cCCCCeEecCCCCCCeEEc-CCCceEEeecccccccccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHH
Q 046877 178 DCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLL 255 (350)
Q Consensus 178 ~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~ 255 (350)
+.+++||||||+||+++ .++.+||+|||++......... ....+|+.|+|||++.+. .++.++||||+||++|
T Consensus 159 --~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 --SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp --TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred --HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 56999999999999997 6889999999999866443222 344679999999998775 5899999999999999
Q ss_pred HHHhCCCCCCcccchhhhhHHHHHHHHhhcC---------------CcchhccccccCCCcHHHHHHHHHHHHhccCCCC
Q 046877 256 EIISCRKSFDIEMGEEYAILTDWAFDCYRNG---------------KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDP 320 (350)
Q Consensus 256 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 320 (350)
+|++|+.||......+...... ...... ..............+...+..+.+++.+||+.||
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~---~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRII---QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHH---HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHhCCCCCCCCChHHHHHHHH---HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999998665443221110 000000 0001111111111122356789999999999999
Q ss_pred CCCCCHHHHHH
Q 046877 321 SLRPTMRKVSQ 331 (350)
Q Consensus 321 ~~Rps~~~vl~ 331 (350)
++|||+.++++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999983
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=319.06 Aligned_cols=260 Identities=26% Similarity=0.358 Sum_probs=197.0
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
...+.+.+.||+|+||.||+|.+... +++|.+.... ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~~------~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESSS------EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcCe------EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 34456778899999999999987542 7888875432 223456788999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCC-CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+++++|.+++.... .+++..++.++.|++.|++|||+ .+++|+||||+||+++ ++.+||+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999997654 68999999999999999999995 4999999999999998 67999999999875532
Q ss_pred Ccc---cceeeccccCCCccCcccccC---------CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH
Q 046877 215 NQR---KTIKTAIRGTKGYVAPEWFRK---------STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 282 (350)
Q Consensus 215 ~~~---~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 282 (350)
... ........|+..|+|||++.+ ..++.++||||||+++|+|++|..||......... ..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~ 254 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-------WQ 254 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-------HH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HH
Confidence 211 111233458899999999864 34788999999999999999999999755433221 11
Q ss_pred hhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCC
Q 046877 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~ 342 (350)
...+..... ....++.++.+++.+||..||++|||++++++.|+++.+....
T Consensus 255 ~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 255 MGTGMKPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHTTCCCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred hccCCCCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111111111 1112456789999999999999999999999999999765443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=324.46 Aligned_cols=250 Identities=10% Similarity=0.033 Sum_probs=178.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHH---HHHhcCCCCceeeec-------ce
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEV---IVIGQTHHKNLVRLL-------GF 127 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~ 127 (350)
+.+.+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|+ +.++. +||||++++ ++
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERL---EDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCC---ceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 456678999999999999976553 5699999876432 2345677774 45555 799988754 33
Q ss_pred eecC-----------------CeeEEEEecCCCCChhhhhcCC-CCcChhHH------HHHHHHHHHHHHHHHhcCCCCe
Q 046877 128 CDEG-----------------QNRLLAYEFLNNGTLASFLFGN-LKPNWNLR------TNIAFQIARVLLYLHEDCSSQI 183 (350)
Q Consensus 128 ~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~------~~~~~~i~~~l~~Lh~~~~~~i 183 (350)
+... ...++||||++ ++|.+++... ..+.+..+ ..++.|++.||+|||+ .+|
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~i 215 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGL 215 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCC
Confidence 3322 34799999999 7999999753 33455555 6788999999999995 599
Q ss_pred EecCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccC--CCCCCCCcchhHHHHHHHHHhCC
Q 046877 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK--STISAKVDVYSFGVLLLEIISCR 261 (350)
Q Consensus 184 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~ 261 (350)
+||||||+|||++.++.+||+|||++...+... ....+|+.|+|||++.+ ..++.++|||||||++|+|+||+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998654321 13456799999999987 67899999999999999999999
Q ss_pred CCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 262 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 262 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.||........... ....................++..+.+++.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99986543321100 000001111111122222346789999999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=330.33 Aligned_cols=246 Identities=26% Similarity=0.309 Sum_probs=198.1
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
.+.||+|+||.||+|+.+.++ +.+|+|.+.... ......+.+|..+++.++||||+++++++.+.+..++||||
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg---~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATG---KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEECCCC---cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 356999999999999976553 569999986432 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCC----CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 141 LNNGTLASFLFGN----LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 141 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
++||+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.+|.+||+|||++.......
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 9999999998653 468999999999999999999995 599999999999999999999999999998765432
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||......... .. ....+....
T Consensus 344 ~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~-~~~~i~~~~--------- 409 (543)
T 3c4z_A 344 TK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KE-LKQRVLEQA--------- 409 (543)
T ss_dssp CC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HH-HHHHHHHCC---------
T ss_pred cc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HH-HHHHHhhcc---------
Confidence 21 23457999999999999999999999999999999999999999765332111 00 011111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCH-----HHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTM-----RKVS 330 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~vl 330 (350)
...+..++..+.+++.+||+.||++||++ ++++
T Consensus 410 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 410 -VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred -cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 11122456789999999999999999975 5565
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=309.96 Aligned_cols=258 Identities=19% Similarity=0.289 Sum_probs=197.0
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CCceeeecceeec--CCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDE--GQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~ 135 (350)
..+.+.+.||+|+||.||+|.+..++ ..||+|.+.. ...+.+.+|+.+++.++ ||||+++++++.+ ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNN---EKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCC---cEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 34556788999999999999876553 5699999863 34577899999999996 9999999999987 67789
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~ 214 (350)
++|||+++++|.+++. .+++..++.++.|++.||+|||+ .+++||||||+||+++.++ .+||+|||++.....
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999999884 48889999999999999999995 4999999999999999766 899999999986654
Q ss_pred CcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHH--H-----HHHHHhhcC
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT--D-----WAFDCYRNG 286 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~--~-----~~~~~~~~~ 286 (350)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||............ . .....+...
T Consensus 184 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 3322 33468889999999977 67899999999999999999999999644332211100 0 000000000
Q ss_pred Cc------ch--------hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 287 KL------DD--------LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 287 ~~------~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. .. .............++.++.+++.+||+.||++|||++++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 00 00001111122235688999999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=312.53 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=197.4
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--------cccHHHHHHHHHHHhcCCCCceeeecce
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--------QDGEKEFKNEVIVIGQTHHKNLVRLLGF 127 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 127 (350)
.....|.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTC---KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCC---cEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeE
Confidence 34456778899999999999999976553 569999885432 1123458899999999999999999999
Q ss_pred eecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEe
Q 046877 128 CDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN---ARIS 204 (350)
Q Consensus 128 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~ 204 (350)
+..+. .+++|||+++++|.+++.....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++. +||+
T Consensus 84 ~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 84 FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred EcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 87765 89999999999999999888889999999999999999999995 49999999999999987664 9999
Q ss_pred ecccccccccCcccceeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 046877 205 DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 281 (350)
Q Consensus 205 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 281 (350)
|||++........ .....|++.|+|||++. +..++.++||||||+++|+|++|..||......... . .
T Consensus 160 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~----~ 230 (322)
T 2ycf_A 160 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--K----D 230 (322)
T ss_dssp CCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--H----H
T ss_pred cCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--H----H
Confidence 9999986643221 12345899999999974 457889999999999999999999999754432211 0 1
Q ss_pred HhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 282 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+..+....... ....++..+.+++.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QITSGKYNFIPE------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHTCCCCCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCccccCch------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111111110000 00124578999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=308.61 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=200.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---------cccHHHHHHHHHHHhcCC-CCceeeecceee
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---------QDGEKEFKNEVIVIGQTH-HKNLVRLLGFCD 129 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 129 (350)
.+.+.+.||+|+||.||+|.+..++ ..|++|.+.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTC---KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred ccceeeeecCCCceEEEEEEEcCcC---ceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4456678999999999999976553 569999986432 112356789999999995 999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 130 EGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
.....+++|||+++++|.+++.....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 999999999999999999999877889999999999999999999995 49999999999999999999999999999
Q ss_pred cccccCcccceeeccccCCCccCccccc------CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFR------KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 283 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 283 (350)
........ .....+++.|+|||++. ...++.++||||||+++|+|++|..||......... ..+
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~ 241 (298)
T 1phk_A 172 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RMI 241 (298)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHH
T ss_pred hhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH-------HHH
Confidence 86654322 13345889999999985 456788999999999999999999999754432211 111
Q ss_pred hcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+... ...+....++..+.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111 011112245678999999999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=310.50 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=183.5
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
..+++.+.||+|+||.||+|....++ ..+|+|.+..... .....+.++...++.++||||+++++++.+++..++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSG---QIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCC---eEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34566788999999999999976553 5699998864322 222334555566888899999999999999999999
Q ss_pred EEecCCCCChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 137 AYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 137 v~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
+|||+++ +|.+++. ....+++..++.++.|++.|++|||+. .+++|+||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9999985 8777664 456789999999999999999999941 28999999999999999999999999999766
Q ss_pred ccCcccceeeccccCCCccCcccc----cCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWF----RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
...... ....+++.|+|||++ .+..++.++||||+|+++|+|++|..||.......... .....
T Consensus 161 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~---- 228 (290)
T 3fme_A 161 VDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL-----KQVVE---- 228 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH-----HHHHH----
T ss_pred cccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH-----HHHhc----
Confidence 443221 234589999999996 45578889999999999999999999997533322111 01111
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..........++.++.+++.+||+.||++|||++++++
T Consensus 229 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 229 -----EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111112235678999999999999999999999976
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=315.57 Aligned_cols=260 Identities=22% Similarity=0.261 Sum_probs=189.1
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCC-----
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ----- 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 132 (350)
.|.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred heeEeeeeEecCCEEEEEEEECCCC---ceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4566788999999999999876553 569999986532 233456889999999999999999999987654
Q ss_pred -eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 133 -NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 133 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
..++||||+++ +|.+++. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999986 7888775 458899999999999999999995 4999999999999999999999999999986
Q ss_pred cccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHH--------------
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD-------------- 277 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~-------------- 277 (350)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.........
T Consensus 177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 54322 1234568999999999999899999999999999999999999997654432210000
Q ss_pred --HHHHHhhcC-C-----cchhcccccc---CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 278 --WAFDCYRNG-K-----LDDLVEGDME---AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 278 --~~~~~~~~~-~-----~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......... . +......... .......+..+.+++.+||+.||++|||++++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000000 0 0000000000 0011234778999999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.96 Aligned_cols=265 Identities=20% Similarity=0.250 Sum_probs=200.0
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC--------CCceeeec
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH--------HKNLVRLL 125 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~ 125 (350)
.++....|.+.+.||+|+||.||+|....+ +..||+|.+... ....+.+.+|+.+++.++ |+||++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQG---KKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCC---CeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 344445677788999999999999987655 356999998643 334567889999998885 78899999
Q ss_pred ceee----cCCeeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCeEEcCC
Q 046877 126 GFCD----EGQNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSS-QIIHCDIKPQNILLNDR 198 (350)
Q Consensus 126 ~~~~----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~-~i~H~dlkp~Nill~~~ 198 (350)
+++. +....++||||+.+ +|.+++... ..+++..++.++.|++.||+||| +. +|+||||||+|||++.+
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp EEEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCC
T ss_pred cceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEecc
Confidence 9987 56788999999955 555555433 56899999999999999999999 44 89999999999999977
Q ss_pred C-------------------------------------------------ceEEeecccccccccCcccceeeccccCCC
Q 046877 199 Y-------------------------------------------------NARISDFGLAKLLTLNQRKTIKTAIRGTKG 229 (350)
Q Consensus 199 ~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 229 (350)
+ .+||+|||++....... ....||+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~ 258 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQ 258 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGG
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCc
Confidence 5 79999999998665332 33468999
Q ss_pred ccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHH---HHHHHHhh--------cCCcc-hhcccc--
Q 046877 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT---DWAFDCYR--------NGKLD-DLVEGD-- 295 (350)
Q Consensus 230 y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~---~~~~~~~~--------~~~~~-~~~~~~-- 295 (350)
|+|||++.+..++.++|||||||++|+|+||..||............ ........ .+... .+....
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 99999999989999999999999999999999999765543221110 00111100 01100 000000
Q ss_pred -----------------ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 -----------------MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 -----------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+...+..+.+|+.+||+.||++|||++++++
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 011234677889999999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=312.67 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=190.9
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeec------CCe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDE------GQN 133 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~ 133 (350)
+.+.+.||+|+||.||+|.+..++ ..|++|.+... ......+.+|+.+++.+ +||||+++++++.. .+.
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTG---QLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred EEEEEEeccCCCEEEEEEEECCCC---CeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 456688999999999999976553 56899988644 33457889999999998 89999999999876 467
Q ss_pred eEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
.+++|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 89999999999999999654 568899999999999999999995 4999999999999999999999999999976
Q ss_pred cccCcccceeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 286 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 286 (350)
...... ......+++.|+|||++. +..++.++||||||+++|+|++|..||.......... .....
T Consensus 179 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~ 249 (326)
T 2x7f_A 179 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------LIPRN 249 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHS
T ss_pred cCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-------HhhcC
Confidence 543221 123346899999999986 4568899999999999999999999997544322111 01111
Q ss_pred CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
... ......++..+.+++.+||..||++|||++++++
T Consensus 250 ~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PAP--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCC--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccc--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 1111234678999999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=319.84 Aligned_cols=200 Identities=23% Similarity=0.333 Sum_probs=168.2
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC------CCCceeeecceeecCC
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT------HHKNLVRLLGFCDEGQ 132 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~ 132 (350)
..|++.+.||+|+||.||+|.+..+ +..||+|.+... .....++.+|+.+++.+ +|+||+++++++....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~---~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKV---HQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTT---TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCC---CcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 3466778899999999999987665 356999998653 23345677788777766 5779999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--eEEeeccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN--ARISDFGL 208 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~ 208 (350)
..+++|||+. ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999997 5898888654 3489999999999999999999954 9999999999999999887 99999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchh
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~ 271 (350)
+....... ....+|+.|+|||++.+..++.++|||||||++|+|+||..||...+..+
T Consensus 249 a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 249 SCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp CEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 97554322 23468999999999999899999999999999999999999998665433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=303.83 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=203.8
Q ss_pred HHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecC
Q 046877 54 KELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG 131 (350)
Q Consensus 54 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 131 (350)
.+.....+.+.+.||+|+||.||+|....++ ..|++|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQ---QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCC---cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 3444566778899999999999999976543 468999886433 23467899999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CceEEeeccc
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR---YNARISDFGL 208 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~ 208 (350)
+..+++|||+++++|.+++.....+++..++.++.|++.|+.|||+ .+++|+||||+||+++.+ +.+||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 9999999999999999998777789999999999999999999995 499999999999999754 4699999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
+......... ....+++.|+|||.+.+. ++.++||||||+++|+|++|..||........ ...+..+..
T Consensus 171 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~ 239 (287)
T 2wei_A 171 STCFQQNTKM---KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-------LKRVETGKY 239 (287)
T ss_dssp GGTBCCCSSC---SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC
T ss_pred ceeecCCCcc---ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 9865433221 233478899999998754 88999999999999999999999976543221 111112211
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. ..+....++.++.+++.+||+.||++|||+.++++
T Consensus 240 ~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 240 AF------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CC------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 10 01111234678999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=311.49 Aligned_cols=262 Identities=21% Similarity=0.310 Sum_probs=199.4
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCc------eeeecceeecC
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN------LVRLLGFCDEG 131 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~ 131 (350)
...|.+.+.||+|+||.||+|..... .+..||+|.+... ....+.+.+|+.+++.++|++ ++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKA--GGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCC--CCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 34566778999999999999986332 2467999998643 233567888999988886654 99999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC------------
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND------------ 197 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~------------ 197 (350)
+..+++|||+ +++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999 789999987554 67899999999999999999995 49999999999999987
Q ss_pred -------CCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccch
Q 046877 198 -------RYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGE 270 (350)
Q Consensus 198 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~ 270 (350)
++.+||+|||++....... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 6689999999997654322 2346899999999999889999999999999999999999999865544
Q ss_pred hhhhHHHHHHH-----HhhcCCcchhc---------------------cc-cccCCCcHHHHHHHHHHHHhccCCCCCCC
Q 046877 271 EYAILTDWAFD-----CYRNGKLDDLV---------------------EG-DMEAMNDIKCVEKLLMISIWCIQEDPSLR 323 (350)
Q Consensus 271 ~~~~~~~~~~~-----~~~~~~~~~~~---------------------~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~R 323 (350)
+.......... ........... .. ..........++++.+++.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 32211111000 00000000000 00 00011233567899999999999999999
Q ss_pred CCHHHHHH
Q 046877 324 PTMRKVSQ 331 (350)
Q Consensus 324 ps~~~vl~ 331 (350)
||++++++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=310.13 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=190.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCC--CCceeeecceeecCCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTH--HKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~ 135 (350)
.|.+.+.||+|+||.||++.... +..+|+|.+.... ....+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eEEEEEEecCCCCEEEEEEEcCC----CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 35567889999999999998643 4568999886432 234567899999999996 599999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++|| +.+++|.+++.....+++..++.++.|+++||.|||+ .+++|+||||+||++++ +.+||+|||++......
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 9999 5678999999888889999999999999999999995 49999999999999965 79999999999876544
Q ss_pred cccceeeccccCCCccCcccccC-----------CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRK-----------STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
..........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......... ...
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~--- 251 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHA--- 251 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHH---
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-----HHH---
Confidence 33322334568999999999865 46788999999999999999999999754332211 001
Q ss_pred cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..........+...+..+.+++.+||+.||++|||++++++
T Consensus 252 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 252 ------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp ------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11111111111123568999999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=312.30 Aligned_cols=263 Identities=20% Similarity=0.236 Sum_probs=190.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeeccee-----------
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFC----------- 128 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~----------- 128 (350)
.|...+.||+|+||.||+|....++ ..|++|.+........+++.+|+.+++.++||||+++++++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCD---KRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTT---EEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred ceeEEEEeccCCCeEEEEEEECCCC---eEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3456678999999999999976553 56999988765555667899999999999999999999887
Q ss_pred ---ecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEe
Q 046877 129 ---DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARIS 204 (350)
Q Consensus 129 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~ 204 (350)
.+....+++|||++ |+|.+++. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++ +++.+||+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 34467899999998 59999985 4578899999999999999999995 4999999999999997 56799999
Q ss_pred ecccccccccCcc-cceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH---
Q 046877 205 DFGLAKLLTLNQR-KTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--- 279 (350)
Q Consensus 205 Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--- 279 (350)
|||++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+........
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999986643211 111233457889999998865 67899999999999999999999999865543221110000
Q ss_pred -----HHHhhcCCcchhcccccc-CC-----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 280 -----FDCYRNGKLDDLVEGDME-AM-----NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 280 -----~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..... ............ .. ....++.++.+++.+||+.||++|||++++++
T Consensus 244 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 244 VHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred Cchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000 000000000000 00 01135678999999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=317.12 Aligned_cols=261 Identities=20% Similarity=0.258 Sum_probs=197.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecC-----Ce
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-----QN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 133 (350)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+++++.++||||+++++++... ..
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cEEEEEEeecCCCeEEEEEEECCC---CeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 456678899999999999987655 35699999864332 2336788999999999999999999998654 46
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.+++|||+.+ +|.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 8999999985 89998854 468999999999999999999995 499999999999999999999999999998765
Q ss_pred cCcccc-eeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc--
Q 046877 214 LNQRKT-IKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD-- 289 (350)
Q Consensus 214 ~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 289 (350)
...... ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......+...... .........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDL 256 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCCHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCCHHHH
Confidence 432211 1234568999999998754 458999999999999999999999997665443321110 000000000
Q ss_pred ---------hhccccc-cCCC-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 ---------DLVEGDM-EAMN-----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ---------~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....... .... ..+.+.++.+++.+||+.||++|||++++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 0000 0124578999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=319.62 Aligned_cols=264 Identities=21% Similarity=0.266 Sum_probs=191.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCC------e
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ------N 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 133 (350)
.|.+.+.||+|+||.||+|++..+. .+++|++..... ...+|+++++.++||||+++++++.... .
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~----~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESD----EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTE----EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCC----eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 4566788999999999999876542 278887754322 2236999999999999999999985433 3
Q ss_pred eEEEEecCCCCChhhhh---cCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEeecccc
Q 046877 134 RLLAYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLA 209 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~ 209 (350)
.+++|||++++.+.... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++ .++.+||+|||++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 78999999885443322 235678999999999999999999995 5999999999999999 7999999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH--------
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-------- 280 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-------- 280 (350)
......... ....+|+.|+|||++.+. .++.++||||+||++|+|++|+.||......+.........
T Consensus 190 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 190 KILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp EECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 866433221 345679999999998765 58999999999999999999999998765433221110000
Q ss_pred HHh----hcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhccc
Q 046877 281 DCY----RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVV 337 (350)
Q Consensus 281 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~ 337 (350)
... .....................+.++.+++.+||+.||.+|||+.++++ .++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 000 000000000000000011235678999999999999999999999985 355543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=319.89 Aligned_cols=261 Identities=20% Similarity=0.319 Sum_probs=178.5
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeeccee--ecCCeeEEEEecC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFC--DEGQNRLLAYEFL 141 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~ 141 (350)
.+.||+|+||.||+|.++++ ..+..||+|.+... .....+.+|+.+++.++||||+++++++ ......+++|||+
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~ 102 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDG-KDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102 (405)
T ss_dssp SCCCC-----EEEEEEESSS-SCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred CcEeeecCCeEEEEEEEccC-CCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence 35799999999999987643 23456999998643 2345788999999999999999999999 4577899999999
Q ss_pred CCCChhhhhcC---------CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCceEEeeccc
Q 046877 142 NNGTLASFLFG---------NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL----NDRYNARISDFGL 208 (350)
Q Consensus 142 ~~g~L~~~l~~---------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~ 208 (350)
.+ +|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+
T Consensus 103 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp SE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred CC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 75 77777642 1248899999999999999999995 499999999999999 6778999999999
Q ss_pred ccccccCccc-ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhh------hhHHHHHH
Q 046877 209 AKLLTLNQRK-TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY------AILTDWAF 280 (350)
Q Consensus 209 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~------~~~~~~~~ 280 (350)
+......... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ........
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~ 258 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence 9876532211 122345689999999999874 589999999999999999999999975443210 00000011
Q ss_pred HHhh---cCCcchhcc-------------ccccCCCc--------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 281 DCYR---NGKLDDLVE-------------GDMEAMND--------IKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 281 ~~~~---~~~~~~~~~-------------~~~~~~~~--------~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+. ...+..+.. ........ ...+..+.+|+.+||+.||.+|||++++++
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 000111000 00000000 011467899999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=320.59 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=192.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecC------Ce
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG------QN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 133 (350)
.|...+.||+|+||.||+|.+..++ ..||+|++.... ....+|+++++.++||||+++++++... ..
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSG---ELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCC---cEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 3556678999999999999986653 569999886432 2234699999999999999999987431 23
Q ss_pred eEEEEecCCCCChhhhhc----CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEeeccc
Q 046877 134 RLLAYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR-YNARISDFGL 208 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~ 208 (350)
.+++|||+++ +|.+.+. ....+++..++.++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 6799999986 5555443 4567899999999999999999999 5699999999999999954 6789999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHH-----HH
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----DC 282 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-----~~ 282 (350)
+........ .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+......... +.
T Consensus 204 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 986543322 1345689999999998765 78999999999999999999999998655433211110000 00
Q ss_pred hh--cCCcchhccccccC-----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhccc
Q 046877 283 YR--NGKLDDLVEGDMEA-----MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVV 337 (350)
Q Consensus 283 ~~--~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~ 337 (350)
+. .........+.... ......+.++.+|+.+||+.||.+|||+.++++ .++++.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 00 00111111111000 011234678999999999999999999999984 455543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=314.90 Aligned_cols=271 Identities=21% Similarity=0.220 Sum_probs=187.2
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCe-----
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN----- 133 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 133 (350)
..+.+.+.||+|+||.||+|.+..++ ..||+|++.... .......++++.++.++||||+++++++.....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTG---MSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp TTEEEC----------CEEEEETTTC---CEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 44566788999999999999976653 469999885432 233456778888899999999999999855333
Q ss_pred --eEEEEecCCCCCh---hhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEeecc
Q 046877 134 --RLLAYEFLNNGTL---ASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND-RYNARISDFG 207 (350)
Q Consensus 134 --~~lv~e~~~~g~L---~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg 207 (350)
.+++|||++++.+ ..+......+++..++.++.|++.|+.|||.. +.+++||||||+||+++. ++.+||+|||
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 7899999997532 23334567788999999999999999999933 459999999999999996 8999999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH-------
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA------- 279 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~------- 279 (350)
++......... ....+|+.|+|||++.+. .++.++||||||+++|+|++|..||...............
T Consensus 178 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 178 SAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp TCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 99876543322 344679999999998765 4899999999999999999999999865543322111000
Q ss_pred -HHHhhcCC-cchhcc-cc-----ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhccc
Q 046877 280 -FDCYRNGK-LDDLVE-GD-----MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVV 337 (350)
Q Consensus 280 -~~~~~~~~-~~~~~~-~~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~ 337 (350)
........ ...... .. .........+.++.+++.+||+.||.+|||+.++++ .++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 00000000 000000 00 000111225678999999999999999999999985 355544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=315.71 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=192.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCee---
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR--- 134 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--- 134 (350)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+++.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRS---GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cEEEEeEEecCCCeEEEEEEECCC---CCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 455667899999999999987665 35699999865322 2346788999999999999999999999877665
Q ss_pred ---EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 135 ---LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 135 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
+++|||+. ++|.+++. ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999998 58888874 458999999999999999999995 4999999999999999999999999999976
Q ss_pred cccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH-----Hhh-
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-----CYR- 284 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~-----~~~- 284 (350)
.... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+.......... ...
T Consensus 194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 5432 134568999999999987 6789999999999999999999999986554332111000000 000
Q ss_pred --cCCcchhccccccC--C----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 285 --NGKLDDLVEGDMEA--M----NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 285 --~~~~~~~~~~~~~~--~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.............. . ....++..+.+++.+||+.||++|||++++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000000000000 0 01124678999999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=311.86 Aligned_cols=267 Identities=21% Similarity=0.281 Sum_probs=197.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecC-----Ce
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-----QN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 133 (350)
.+.+.+.||+|+||.||+|.+..++ ..||+|.+.... .....++.+|+.+++.++||||+++++++... ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTG---EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCC---cEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3456688999999999999976553 569999986432 22345688999999999999999999987654 67
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.+++|||+. ++|.+++.. ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 899999997 489998864 568999999999999999999995 499999999999999999999999999998765
Q ss_pred cCcccc--------eeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 046877 214 LNQRKT--------IKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 214 ~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||............ .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI---FGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHHhC
Confidence 322111 1123467999999998765 67899999999999999999999999865543321111 01000
Q ss_pred cCC----c--------chhcccccc--CC----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhccc
Q 046877 285 NGK----L--------DDLVEGDME--AM----NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVV 337 (350)
Q Consensus 285 ~~~----~--------~~~~~~~~~--~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~ 337 (350)
... . .+....... .. ....++.++.+++.+||+.||++|||++++++ .++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 000 0 000000000 00 01135678999999999999999999999986 455443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=311.82 Aligned_cols=272 Identities=20% Similarity=0.274 Sum_probs=200.9
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-----------CCceeeecc
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-----------HKNLVRLLG 126 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~ 126 (350)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+|+.+++.++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVN---NTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCC---CcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 34567788999999999999987655 356999998643 234566888999888875 899999999
Q ss_pred eeecCC----eeEEEEecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCeEEc---
Q 046877 127 FCDEGQ----NRLLAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSS-QIIHCDIKPQNILLN--- 196 (350)
Q Consensus 127 ~~~~~~----~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~-~i~H~dlkp~Nill~--- 196 (350)
++...+ ..+++|||+ +++|.+++.. ...+++..++.++.|++.||+||| +. +++||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccC
Confidence 987654 789999999 8899999864 345899999999999999999999 44 899999999999994
Q ss_pred ---CCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhh
Q 046877 197 ---DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 273 (350)
Q Consensus 197 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~ 273 (350)
..+.+||+|||++....... ....+|+.|+|||++.+..++.++||||||+++|+|+||..||.........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 44579999999998664322 2346899999999999999999999999999999999999999865432211
Q ss_pred hHHHH---HHHHhh--------cCCcc-----------hhcc---------ccccCCCcHHHHHHHHHHHHhccCCCCCC
Q 046877 274 ILTDW---AFDCYR--------NGKLD-----------DLVE---------GDMEAMNDIKCVEKLLMISIWCIQEDPSL 322 (350)
Q Consensus 274 ~~~~~---~~~~~~--------~~~~~-----------~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 322 (350)
..... ...... .+... .... .......+...+.++.+++.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 00000 000000 00000 0000 00012234678899999999999999999
Q ss_pred CCCHHHHHH--HHhcccCCCCC
Q 046877 323 RPTMRKVSQ--MLQEVVEVDVP 342 (350)
Q Consensus 323 Rps~~~vl~--~L~~~~~~~~~ 342 (350)
|||++++++ .+.+.......
T Consensus 325 Rpt~~ell~hp~f~~~~~~~~~ 346 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDTLGMEEI 346 (373)
T ss_dssp CBCHHHHHTCGGGTTCTTCTTC
T ss_pred cCCHHHHhhChhhhcccCcccc
Confidence 999999986 56665544443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=302.59 Aligned_cols=251 Identities=27% Similarity=0.377 Sum_probs=188.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeec--------
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE-------- 130 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 130 (350)
..+++.+.||+|+||.||+|....++ ..+++|.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDS---RYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCC---eEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 34567788999999999999976553 56899988643 3445678999999999999999999998754
Q ss_pred -----CCeeEEEEecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEe
Q 046877 131 -----GQNRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARIS 204 (350)
Q Consensus 131 -----~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~ 204 (350)
.+..+++|||+++++|.+++.. ...+++..++.++.|+++|++|||+ .+++|+||||+||+++.++.+||+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 4567899999999999999974 3467888999999999999999995 499999999999999999999999
Q ss_pred ecccccccccCcc------------cceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchh
Q 046877 205 DFGLAKLLTLNQR------------KTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEE 271 (350)
Q Consensus 205 Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~ 271 (350)
|||++........ ........+++.|+|||++.+. .++.++||||||+++|+|++ ||.......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 9999986543210 1112344588999999999865 68999999999999999998 554221111
Q ss_pred hhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
. ....+.... ...........+..+.+++.+||+.||++|||++++++
T Consensus 236 ~------~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 N------ILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp H------HHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H------HHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0 011111111 01111222345678899999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=309.92 Aligned_cols=254 Identities=21% Similarity=0.274 Sum_probs=192.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecCCe-----
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN----- 133 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 133 (350)
|.+.+.||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRS---GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT---TEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred EEEeeeEecCCCeEEEEEEECCC---CCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 45567899999999999987655 35699999865322 234678899999999999999999999987654
Q ss_pred -eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 134 -RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 134 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
.+++|||+. ++|.+++. ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999998 58988874 358999999999999999999995 49999999999999999999999999999765
Q ss_pred ccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC----
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---- 287 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 287 (350)
... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+..... ........
T Consensus 177 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~ 248 (353)
T 3coi_A 177 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI---LKVTGVPGTEFV 248 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH---HHHHCBCCHHHH
T ss_pred CCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHHH
Confidence 432 133467999999999877 67899999999999999999999999865543221110 00000000
Q ss_pred -------cchhcc---ccc---cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 -------LDDLVE---GDM---EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 -------~~~~~~---~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...... ... ........+..+.+++.+||..||++|||++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 000 00112245688999999999999999999999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=308.33 Aligned_cols=201 Identities=26% Similarity=0.342 Sum_probs=167.7
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CC-----ceeeecceeecCC
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HK-----NLVRLLGFCDEGQ 132 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~ 132 (350)
..+.+.+.||+|+||.||+|....+ +..||+|.+... .....++..|+.+++.++ |+ +++++.+++...+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVE---QEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTT---TEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCC---CcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4566678899999999999987655 356999998643 233456778888888774 44 4999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCCceEEeeccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN--DRYNARISDFGL 208 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~ 208 (350)
..++||||+.+ +|.+++... ..+++..++.++.|++.||.|||.. ..+|+||||||+||+++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999999975 999988654 4589999999999999999999943 45899999999999995 577899999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccch
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGE 270 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~ 270 (350)
+....... ....+|+.|+|||++.+..++.++|||||||++|+|+||+.||......
T Consensus 208 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 208 SCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp CEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 98764322 3346899999999999999999999999999999999999999865543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=314.63 Aligned_cols=257 Identities=22% Similarity=0.270 Sum_probs=185.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-----------cHHHHHHHHHHHhcCCCCceeeecceee
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-----------GEKEFKNEVIVIGQTHHKNLVRLLGFCD 129 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 129 (350)
|.+.+.||+|+||.||+|.... +..||+|++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDSE----GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECTT----SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred eEEeEEeccCCCEEEEEEECCC----CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4556889999999999998543 456999988543221 1267899999999999999999999983
Q ss_pred -----cCCeeEEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEE
Q 046877 130 -----EGQNRLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARI 203 (350)
Q Consensus 130 -----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl 203 (350)
.....+++|||+.+ +|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp ECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred eccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEE
Confidence 33468999999985 777776543 468999999999999999999995 49999999999999999999999
Q ss_pred eecccccccccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH
Q 046877 204 SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 282 (350)
Q Consensus 204 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 282 (350)
+|||++........ .....+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||......+.... ....
T Consensus 176 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~~~ 249 (362)
T 3pg1_A 176 CDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK---IVEV 249 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHH
T ss_pred EecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHH
Confidence 99999975443222 234467889999999877 6789999999999999999999999976543322111 0010
Q ss_pred hhcCCcc-----------hhcccccc---C----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 283 YRNGKLD-----------DLVEGDME---A----MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 283 ~~~~~~~-----------~~~~~~~~---~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
....... ........ . ......+..+.+++.+||+.||++|||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0000000 00000000 0 001123567999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=305.01 Aligned_cols=269 Identities=22% Similarity=0.333 Sum_probs=180.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc-c-HHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD-G-EKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~-~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.+.+.+.||+|+||.||+|.+..++ ..|++|.+...... . .+.+.++..+++.++||||+++++++.+.+..+++
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTG---HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTC---CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cccccceeeecCCeeEEEEEEecCC---eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 4556678999999999999976553 46999998654322 1 23344555678888999999999999999999999
Q ss_pred EecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+ ++.+..+... ...+++..++.++.|++.|+.|||+. .+++|+||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9999 4455555432 56789999999999999999999951 289999999999999999999999999997654322
Q ss_pred ccceeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 217 RKTIKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
. .....+++.|+|||++. +..++.++||||||+++|+|++|..||......... .. .. ..+...
T Consensus 180 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~----~~-~~~~~~-- 248 (318)
T 2dyl_A 180 A---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LT----KV-LQEEPP-- 248 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HH----HH-HHSCCC--
T ss_pred c---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-HH----HH-hccCCC--
Confidence 1 13345899999999984 456888999999999999999999999753322211 00 11 111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH----------------HHhcccCCCCCCCCCCCCC
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ----------------MLQEVVEVDVPPNPSPFSG 350 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~----------------~L~~~~~~~~~~~~~~~~~ 350 (350)
..+....++.++.+++.+||+.||.+|||++++++ .+..+.....+|.+.|-||
T Consensus 249 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (318)
T 2dyl_A 249 -----LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRSGPSSG 318 (318)
T ss_dssp -----CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCCCHHHHHHHHHHTTC---------
T ss_pred -----CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccchhHHHhhcccCCCCCCCCCCCCC
Confidence 11111235678999999999999999999999875 2444445555555555554
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=310.76 Aligned_cols=241 Identities=24% Similarity=0.424 Sum_probs=196.6
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc------cHHHHHHHHHHHhcCC--CCceeeecceee
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD------GEKEFKNEVIVIGQTH--HKNLVRLLGFCD 129 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~------~~~~~~~e~~~l~~l~--h~~iv~~~~~~~ 129 (350)
...+.+.+.||+|+||.||+|....++ ..||+|.+...... ....+.+|+.+++.++ ||||+++++++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTT---EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCC---cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344667788999999999999876553 56999998654321 2245677899999985 699999999999
Q ss_pred cCCeeEEEEecCCC-CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEeecc
Q 046877 130 EGQNRLLAYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFG 207 (350)
Q Consensus 130 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg 207 (350)
+.+..+++||++.+ ++|.+++.....+++..++.++.|++.||+|||+ .+++||||||+||+++ +++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999986 8999999877889999999999999999999995 5999999999999999 78999999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 286 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 286 (350)
++........ ....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....... .+
T Consensus 196 ~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-------------~~ 258 (320)
T 3a99_A 196 SGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RG 258 (320)
T ss_dssp TCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH-------------HC
T ss_pred cccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh-------------cc
Confidence 9986653321 33458999999999987665 678999999999999999999996432100 01
Q ss_pred CcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. .....++.++.+++.+||+.||++|||++++++
T Consensus 259 ~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 259 QV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 011124578999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=307.94 Aligned_cols=262 Identities=22% Similarity=0.311 Sum_probs=197.8
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCc------eeeecceeecC
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN------LVRLLGFCDEG 131 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~ 131 (350)
...|.+.+.||+|+||.||+|....++ ...||+|.+... ....+.+.+|+.+++.++|++ ++.+.+++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARG--KSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT--TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCC--ceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 445677889999999999999876553 256999998643 334567888999999887665 89999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE--------------
Q 046877 132 QNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL-------------- 195 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill-------------- 195 (350)
+..+++|||+. ++|.+++... ..+++..++.++.|++.||+||| +.+++||||||+||++
T Consensus 95 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccc
Confidence 99999999994 5666666443 46899999999999999999999 5699999999999999
Q ss_pred -----cCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccch
Q 046877 196 -----NDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGE 270 (350)
Q Consensus 196 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~ 270 (350)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 567889999999997654322 3346899999999999989999999999999999999999999865543
Q ss_pred hhhhHHHHHHH-----HhhcCCcchh-ccc---------------------cccCCCcHHHHHHHHHHHHhccCCCCCCC
Q 046877 271 EYAILTDWAFD-----CYRNGKLDDL-VEG---------------------DMEAMNDIKCVEKLLMISIWCIQEDPSLR 323 (350)
Q Consensus 271 ~~~~~~~~~~~-----~~~~~~~~~~-~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~R 323 (350)
+.......... .......... ... ..........+..+.+++.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 32211111000 0000000000 000 00112223457789999999999999999
Q ss_pred CCHHHHHH
Q 046877 324 PTMRKVSQ 331 (350)
Q Consensus 324 ps~~~vl~ 331 (350)
||+.++++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999973
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=307.27 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=174.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHH-HHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVI-VIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.+.+.+.||+|+||.||+|....+ +..||+|.+..... ....++..|.. +++.++||||+++++++.+.+..+++
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPS---GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTT---TEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhehheeccCCCEEEEEEEEcCC---CCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 345567899999999999997655 35699999865422 23344555555 77788999999999999999999999
Q ss_pred EecCCCCChhhhhcC-----CCCcChhHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 138 YEFLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARVLLYLHEDCSS-QIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
|||+++ +|.+++.. ...+++..+..++.|++.|+.||| +. +++|+||||+||+++.++.+||+|||++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999986 77777642 567899999999999999999999 45 899999999999999999999999999976
Q ss_pred cccCcccceeeccccCCCccCcccc----cCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWF----RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
...... .....|++.|+|||++ .+..++.++||||||+++|+|++|..||.......... .....+.
T Consensus 176 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~~ 246 (327)
T 3aln_A 176 LVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL------TQVVKGD 246 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSC
T ss_pred cccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH------HHHhcCC
Confidence 543321 1233589999999998 45578999999999999999999999997533211100 0000010
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. .........++..+.+++.+||+.||++|||+.++++
T Consensus 247 ~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00 1111111235678999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=304.77 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=194.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcC---CCCceeeecceee-----
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQT---HHKNLVRLLGFCD----- 129 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~----- 129 (350)
.|.+.+.||+|+||.||+|.+... .+..|++|.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred ceeeeeeecccccEEEEEEEecCC--CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 355678899999999999987422 235689998864322 1223456677666655 8999999999986
Q ss_pred cCCeeEEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecc
Q 046877 130 EGQNRLLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 207 (350)
.....+++|||+. |+|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCc
Confidence 5677899999998 5999998654 348999999999999999999995 499999999999999999999999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC-
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG- 286 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 286 (350)
++....... ......++..|+|||++.+..++.++||||||+++|+|++|..||........... ........
T Consensus 166 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~ 239 (326)
T 1blx_A 166 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPG 239 (326)
T ss_dssp SCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCC
T ss_pred ccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCC
Confidence 998654322 12345689999999999988999999999999999999999999986554332111 11111100
Q ss_pred --Ccchhc--------c--ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 287 --KLDDLV--------E--GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 287 --~~~~~~--------~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+.... . ..........++..+.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0 00000111235678999999999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=306.57 Aligned_cols=254 Identities=21% Similarity=0.232 Sum_probs=171.5
Q ss_pred hhh-hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeec----CCeeE
Q 046877 61 DNF-KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE----GQNRL 135 (350)
Q Consensus 61 ~~~-~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~ 135 (350)
|.+ .+.||+|+||.||+|.+..++ ..||+|.+... .....+....++.++||||+++++++.. ....+
T Consensus 30 y~i~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 30 YQLSKQVLGLGVNGKVLECFHRRTG---QKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred eEecceeeeeCCCeEEEEEEECCCC---CEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 444 346999999999999987553 56999998542 2222333344666799999999999865 45589
Q ss_pred EEEecCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEeeccccc
Q 046877 136 LAYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND---RYNARISDFGLAK 210 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~ 210 (350)
++|||+++|+|.+++.... .+++..++.++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999997653 68999999999999999999995 49999999999999976 4559999999997
Q ss_pred ccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcch
Q 046877 211 LLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 290 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
...... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||............ ......+
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~---- 248 (336)
T 3fhr_A 180 ETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLG---- 248 (336)
T ss_dssp EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcc----
Confidence 654322 13345799999999998888999999999999999999999999754432211000 0000000
Q ss_pred hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhccc
Q 046877 291 LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVV 337 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~ 337 (350)
...........++.++.+++.+||+.||++|||++++++ .+.+..
T Consensus 249 --~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 249 --QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred --ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 001111112245678999999999999999999999996 555443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=307.96 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=190.1
Q ss_pred HHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc------cHHHHHHHHHHHhcC----CCCcee
Q 046877 53 YKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD------GEKEFKNEVIVIGQT----HHKNLV 122 (350)
Q Consensus 53 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~------~~~~~~~e~~~l~~l----~h~~iv 122 (350)
..+.....|.+.+.||+|+||.||+|.+..+ +..|++|.+...... ....+.+|+.++.++ +||||+
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~ 101 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTD---RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTT---CCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccC---CeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence 3445556677889999999999999986554 356999998643221 223356788888888 899999
Q ss_pred eecceeecCCeeEEEEec-CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCc
Q 046877 123 RLLGFCDEGQNRLLAYEF-LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYN 200 (350)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~ 200 (350)
++++++.+.+..+++||+ +.+++|.+++.....+++..++.++.|++.||.|||+. +++|+||||+||+++ .++.
T Consensus 102 ~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp CEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred eEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 999999999999999999 78999999998777899999999999999999999955 999999999999999 8899
Q ss_pred eEEeecccccccccCcccceeeccccCCCccCcccccCCCCC-CCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH
Q 046877 201 ARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTIS-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 279 (350)
Q Consensus 201 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 279 (350)
+||+|||++........ ....++..|+|||++.+..+. .++||||||+++|+|++|+.||.......
T Consensus 179 ~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------- 246 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL-------- 246 (312)
T ss_dssp EEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------
T ss_pred EEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh--------
Confidence 99999999987654321 344589999999999776654 48999999999999999999996422100
Q ss_pred HHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 280 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
... . ..+..++..+.+++.+||+.||++|||++++++
T Consensus 247 -----~~~--------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 -----EAE--------L--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -----HTC--------C--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----hhc--------c--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 111234678999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=312.51 Aligned_cols=245 Identities=27% Similarity=0.319 Sum_probs=182.8
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEecCC
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
.+.||+|+||+||.+... + +..||+|.+... ..+.+.+|+.+++.+ +||||+++++++.+.+..+++|||+.
T Consensus 20 ~~~LG~G~~g~V~~~~~~-~---g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSF-Q---GRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEECSTTCEEEEEES-S---SSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred cCeEeeCCCeEEEEEEEE-C---CeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 467999999999865432 2 356999988643 345678899999876 89999999999999999999999996
Q ss_pred CCChhhhhcCCCCc-------ChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-------------CceE
Q 046877 143 NGTLASFLFGNLKP-------NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR-------------YNAR 202 (350)
Q Consensus 143 ~g~L~~~l~~~~~~-------~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-------------~~~k 202 (350)
|+|.+++...... ++..++.++.|++.||+|||+ .+|+||||||+||+++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 5999999755332 233457899999999999995 599999999999999754 4799
Q ss_pred EeecccccccccCcccc--eeeccccCCCccCcccccC-------CCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhh
Q 046877 203 ISDFGLAKLLTLNQRKT--IKTAIRGTKGYVAPEWFRK-------STISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 272 (350)
Q Consensus 203 l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~ 272 (350)
|+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|+| |..||........
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 99999998765432211 1234568999999999965 568899999999999999999 9999965433221
Q ss_pred hhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 273 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
... .+.. ............++.++.+++.+||+.||.+|||+.++++
T Consensus 249 ~i~---------~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NII---------RGIF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH---------HTCC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHh---------cCCC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 110 1110 0111122334578899999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=323.60 Aligned_cols=273 Identities=25% Similarity=0.286 Sum_probs=200.7
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-ccccHHHHHHHHHHHhcCCCCceeeecceeec------C
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE------G 131 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~ 131 (350)
..|.+.+.||+|+||.||+|.+..++ ..||+|.+... .....+.+.+|+.+++.++||||+++++++.. +
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg---~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTG---EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTT---CCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCC---cEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 45778899999999999999865543 45999988653 23345678999999999999999999998755 6
Q ss_pred CeeEEEEecCCCCChhhhhcCCC---CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEee
Q 046877 132 QNRLLAYEFLNNGTLASFLFGNL---KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN---ARISD 205 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~D 205 (350)
+..+++|||+++|+|.+++.... .+++..++.++.|++.|++|||+ .+++|+||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 77899999999999999997543 58899999999999999999995 59999999999999997765 99999
Q ss_pred cccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhh--HHHHHHHH-
Q 046877 206 FGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--LTDWAFDC- 282 (350)
Q Consensus 206 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~--~~~~~~~~- 282 (350)
||++........ .....+++.|+|||.+.+..++.++||||+|+++|+|++|..||.......... ........
T Consensus 168 FG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 168 LGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred cccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 999987654322 234568999999999999999999999999999999999999997543221100 00000000
Q ss_pred hhcCCcchhc--cc--cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHH-----HHHHHhcccCCC
Q 046877 283 YRNGKLDDLV--EG--DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRK-----VSQMLQEVVEVD 340 (350)
Q Consensus 283 ~~~~~~~~~~--~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~-----vl~~L~~~~~~~ 340 (350)
.......... .. ..........+..+.+++.+||..||++|||+++ +.+.++.+++..
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000000000 00 0111223457889999999999999999999977 556666555433
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=304.66 Aligned_cols=245 Identities=26% Similarity=0.306 Sum_probs=180.0
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+...+.||+|+||+|+..... + ++.||+|++..... ..+.+|+++++.+ +||||+++++++.+....+++||
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~-~---~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMF-D---NRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEES-S---SSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EecCCeeecCcCEEEEEEEEe-C---CeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 445578999999996643322 2 34599999864322 2356799999999 89999999999999999999999
Q ss_pred cCCCCChhhhhcCCC-CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----CCceEEeecccccccc
Q 046877 140 FLNNGTLASFLFGNL-KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND-----RYNARISDFGLAKLLT 213 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~ 213 (350)
|+.+ +|.+++.... ...+..+..++.|++.||.|||+ .+|+||||||+||+++. ...+||+|||++....
T Consensus 99 ~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 9974 9999986543 45556778999999999999995 49999999999999953 2358899999998765
Q ss_pred cCcc-cceeeccccCCCccCccccc---CCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 214 LNQR-KTIKTAIRGTKGYVAPEWFR---KSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 214 ~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
.... ........||+.|+|||++. ...++.++|||||||++|+|+| |..||.......... .......
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~~~~~~ 247 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLGACSL 247 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HTTCCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------HhccCCc
Confidence 3321 12223456899999999997 3567889999999999999999 999996433222111 0001010
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
. ........+..+.+++.+||+.||.+|||+++++
T Consensus 248 ~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 248 D-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp T-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred c-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 0 1111234567789999999999999999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=288.68 Aligned_cols=240 Identities=11% Similarity=0.053 Sum_probs=185.6
Q ss_pred cCHHH-HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc---cHHHHHHHHHHHhcCCCCceeeecc
Q 046877 51 FSYKE-LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD---GEKEFKNEVIVIGQTHHKNLVRLLG 126 (350)
Q Consensus 51 ~~~~~-~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~ 126 (350)
+...+ +....|.+.+.||+|+||.||+|.+..++ +.||+|.+...... ..+.+.+|+..++.++||||+++++
T Consensus 22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~ 98 (286)
T 3uqc_A 22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALD---RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98 (286)
T ss_dssp CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTT---EEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCC---ceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeE
Confidence 33343 44455777889999999999999976543 56999998754332 2367899999999999999999999
Q ss_pred eeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeec
Q 046877 127 FCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDF 206 (350)
Q Consensus 127 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 206 (350)
++.+.+..++||||+++++|.+++... .....+.+++.|++.||+|||+ .+++||||||+||+++.+|.+||+++
T Consensus 99 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 99 VVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp EEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSC
T ss_pred EEEECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEec
Confidence 999999999999999999999999543 3556788899999999999995 49999999999999999999999844
Q ss_pred ccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 046877 207 GLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 286 (350)
Q Consensus 207 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 286 (350)
+ |++| ++.++||||||+++|+|+||+.||...........
T Consensus 174 ~----------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----------- 213 (286)
T 3uqc_A 174 A----------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----------- 213 (286)
T ss_dssp C----------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------
T ss_pred c----------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------
Confidence 3 3332 67889999999999999999999986543221100
Q ss_pred Ccchhcccccc--CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCC
Q 046877 287 KLDDLVEGDME--AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVD 340 (350)
Q Consensus 287 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~ 340 (350)
.......... .....+++.++.+++.+||+.||++| |+.++++.|+++....
T Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 214 -AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0000000000 00112356789999999999999999 9999999999876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=321.95 Aligned_cols=244 Identities=20% Similarity=0.276 Sum_probs=191.7
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCe-
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQN- 133 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 133 (350)
+....|.+.+.||+|+||.||+|.+... .+..|++|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNV--NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGG--TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCC--CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 3345677788999999999999987642 13569999875432 2334578899999999999999999999977655
Q ss_pred ----eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 134 ----RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 134 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
.|+||||+++++|.+++.. .+++..++.++.|++.||.|||+ .+|+||||||+||+++.+ .+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999998754 78999999999999999999995 499999999999999986 8999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
...... ....||+.|+|||++.+.. +.++||||||+++|+|++|..||........
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------- 284 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------- 284 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------
T ss_pred hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------------
Confidence 866432 3345899999999987654 8899999999999999999988763221110
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHhccc
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT-MRKVSQMLQEVV 337 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~vl~~L~~~~ 337 (350)
.........+..+.+++.+||+.||++||+ ++++.+.|.+++
T Consensus 285 ------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 ------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 011111234578999999999999999994 666666666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=285.65 Aligned_cols=231 Identities=22% Similarity=0.300 Sum_probs=176.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHH-hcCCCCceeeecceeec----CCeeEEEEe
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVI-GQTHHKNLVRLLGFCDE----GQNRLLAYE 139 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~lv~e 139 (350)
+.||+|+||.||+|.+..++ ..||+|.+.. ...+.+|+.++ +..+||||+++++++.. ....+++||
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQ---EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp EEEEEETTEEEEEEEETTTC---CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cccccCCCeEEEEEEEcCCC---cEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 67999999999999976553 5699999853 34567788887 55699999999999876 677899999
Q ss_pred cCCCCChhhhhcCCC--CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEeeccccccccc
Q 046877 140 FLNNGTLASFLFGNL--KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND---RYNARISDFGLAKLLTL 214 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~ 214 (350)
|+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 999999999997543 68999999999999999999995 59999999999999997 7889999999986432
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
+..++.++||||+|+++|+|++|..||......... ..........
T Consensus 172 -----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~~~~~ 217 (299)
T 3m2w_A 172 -----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTRIRMG 217 (299)
T ss_dssp -----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTT
T ss_pred -----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHHHhhc
Confidence 234677899999999999999999999754332210 0000111111
Q ss_pred cccCCC--cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcccCCCC
Q 046877 295 DMEAMN--DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVVEVDV 341 (350)
Q Consensus 295 ~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~~~~~ 341 (350)
....+. ...++.++.+++.+||+.||++|||++++++ .+.+......
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~ 268 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCC
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCC
Confidence 111110 0235678999999999999999999999986 4555544333
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=297.16 Aligned_cols=234 Identities=15% Similarity=0.123 Sum_probs=173.0
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCC-Cceeeec-------------
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHH-KNLVRLL------------- 125 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h-~~iv~~~------------- 125 (350)
..+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|+.+++.++| +|.....
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g---~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETG---ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTC---CEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred EecccccCCCEEEEEEEecCCC---CceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 3467999999999999977654 4699998863222 235678999999999976 3221111
Q ss_pred --------ceeec-----CCeeEEEEecCCCCChhhhhc-------CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 046877 126 --------GFCDE-----GQNRLLAYEFLNNGTLASFLF-------GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIH 185 (350)
Q Consensus 126 --------~~~~~-----~~~~~lv~e~~~~g~L~~~l~-------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H 185 (350)
.++.. ....+++|+++ +++|.+++. ....+++..++.++.|+++||+|||+ .+|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence 11111 22456777765 569998883 13446788889999999999999995 59999
Q ss_pred cCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccc----------cCCCCCCCCcchhHHHHHH
Q 046877 186 CDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF----------RKSTISAKVDVYSFGVLLL 255 (350)
Q Consensus 186 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DiwslG~~l~ 255 (350)
|||||+|||++.++.+||+|||++...+.. .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999998765432 233456 999999999 5556888999999999999
Q ss_pred HHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 256 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 256 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
+|+||+.||......... ....... .+++..+.+++.+||+.||++|||+.+++
T Consensus 309 elltg~~Pf~~~~~~~~~---------------~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGS---------------EWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSCS---------------GGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhhH---------------HHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999754432211 1111111 12357899999999999999999966653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=288.81 Aligned_cols=243 Identities=14% Similarity=0.109 Sum_probs=180.8
Q ss_pred HHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--------cccHHHHHHHHHHHhcCC-----------
Q 046877 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--------QDGEKEFKNEVIVIGQTH----------- 117 (350)
Q Consensus 57 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--------~~~~~~~~~e~~~l~~l~----------- 117 (350)
....+.+.+.||+|+||.||+|++ + +..||+|.+.... ....+.+.+|+.+++.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ 92 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--D---HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--T---TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred ccccchheeeecccCceEEEEEEe--C---CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence 345677889999999999999986 2 3679999987542 223377889999888876
Q ss_pred ---------------CCceeeecceeec-------------CCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHH
Q 046877 118 ---------------HKNLVRLLGFCDE-------------GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA 169 (350)
Q Consensus 118 ---------------h~~iv~~~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~ 169 (350)
||||+++++++.+ .+..++||||+++|++.+.+.+ ..+++..++.++.|++
T Consensus 93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLT 171 (336)
T ss_dssp CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHH
T ss_pred chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHH
Confidence 4555555555543 7889999999999977776643 6689999999999999
Q ss_pred HHHHHHH-hcCCCCeEecCCCCCCeEEcCCC--------------------ceEEeecccccccccCcccceeeccccCC
Q 046877 170 RVLLYLH-EDCSSQIIHCDIKPQNILLNDRY--------------------NARISDFGLAKLLTLNQRKTIKTAIRGTK 228 (350)
Q Consensus 170 ~~l~~Lh-~~~~~~i~H~dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 228 (350)
.||+||| +. +|+||||||+|||++.++ .+||+|||++...... ...||+
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 9999999 66 899999999999999887 8999999999865432 235899
Q ss_pred CccCcccccCCCCCCCCcchhHHHH-HHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHH
Q 046877 229 GYVAPEWFRKSTISAKVDVYSFGVL-LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEK 307 (350)
Q Consensus 229 ~y~aPE~~~~~~~~~~~DiwslG~~-l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (350)
.|+|||++.+.. +.++||||+|++ .+++++|..||..... ............... ..........++++
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-----LHYLTDKMLKQMTFK----TKCNTPAMKQIKRK 311 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-----HHHHHHHHHHTCCCS----SCCCSHHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh-----hhHHHHhhhhhhccC----cccchhhhhhcCHH
Confidence 999999998766 889999998777 7778899999842110 000000000000000 01111123468899
Q ss_pred HHHHHHhccCCCCCCCCCHHHHH
Q 046877 308 LLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 308 l~~li~~cl~~dp~~Rps~~~vl 330 (350)
+.+|+.+||+.| |+++++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=261.38 Aligned_cols=186 Identities=18% Similarity=0.104 Sum_probs=127.9
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----------cccHHHHHHHHHHHhcC-CCCceeeecceeecCCee
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----------QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNR 134 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 134 (350)
..+.|++|.+..+.....+ ..+++|.+.... ....+++.+|+++|+++ +|+||++++++++++...
T Consensus 241 ~~~~~~~~~h~~~rr~~fg---~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFG---EDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp C-C--------CCEEEEEC---SSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred ccccCCccccccccccccc---ceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 3566666655554433332 237888875431 12235699999999999 799999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
||||||++|++|.+++.....++.. +++.||+.||+|+|+ .+|+||||||+|||++++|.+||+|||+++....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999999888877754 588999999999995 5999999999999999999999999999986643
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCC
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS 263 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p 263 (350)
... ......||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 322 2234579999999999975 456789999999999888765544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=231.45 Aligned_cols=184 Identities=18% Similarity=0.248 Sum_probs=142.2
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--------ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--------DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
.+.||+|+||.||+|.... ..+++|+...... ...+++.+|++++++++||||+++..++...+..+
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLD-----FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp -------CCEEEEEEECSS-----CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred CCEEeeCCCEEEEEEEECC-----CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 4679999999999995432 2366766432211 11345899999999999999997777777777889
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++|||+++++|.+++.. +..++.|+++||.|||+ .+|+||||||+|||++. .+||+|||++......
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999999965 56899999999999995 59999999999999999 9999999999877543
Q ss_pred cccc-----eeeccccCCCccCcccccC--CCCCCCCcchhHHHHHHHHHhCCCCCC
Q 046877 216 QRKT-----IKTAIRGTKGYVAPEWFRK--STISAKVDVYSFGVLLLEIISCRKSFD 265 (350)
Q Consensus 216 ~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~ 265 (350)
.... ......||+.|+|||++.. ..|+..+|+|+..+-..+-..++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2221 1235578999999999976 568888999999998888887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-24 Score=187.33 Aligned_cols=141 Identities=13% Similarity=0.081 Sum_probs=111.5
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc------------------ccHHHHHHHHHHHhcCCCCceeee
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ------------------DGEKEFKNEVIVIGQTHHKNLVRL 124 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~ 124 (350)
+.+.||+|+||.||+|.+ .+ +..+|+|.+..... .....+.+|+.+++.++ | +++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~---g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EK---FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TT---TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred ecCEeccCCCceEEEEEe-CC---CCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 347899999999999987 33 35699999853221 12456889999999998 5 666
Q ss_pred cceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEe
Q 046877 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARIS 204 (350)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~ 204 (350)
.+++.. +..+++|||+++++|.+ +.. .....++.|++.|+.|||+ .+++||||||+||+++ ++.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEE
Confidence 665544 45699999999999988 421 2355799999999999994 5999999999999999 9999999
Q ss_pred ecccccccccCcccceeeccccCCCccCccccc
Q 046877 205 DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237 (350)
Q Consensus 205 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 237 (350)
|||++.. +..+.|||.+.
T Consensus 235 DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE---------------TTSTTHHHHHH
T ss_pred ECCCCeE---------------CCCCCHHHHHH
Confidence 9999862 34578898874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.5e-20 Score=158.31 Aligned_cols=137 Identities=16% Similarity=0.099 Sum_probs=101.0
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeE--EEEEeeeccccc------------------------cHHHHHHHHHHHhcC
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTA--VAVKKLDRVFQD------------------------GEKEFKNEVIVIGQT 116 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~--vavk~~~~~~~~------------------------~~~~~~~e~~~l~~l 116 (350)
+.+.||+|+||.||+|....+ +.. ||+|........ ....+.+|+.++..+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~---g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFD---GKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEET---TEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hCCEEeecceEEEEEEEEcCC---CcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 457799999999999987433 245 899986432111 113678899999999
Q ss_pred CCCceeeecceeecCCeeEEEEecCCC-C----ChhhhhcCCCCcChhHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCC
Q 046877 117 HHKNLVRLLGFCDEGQNRLLAYEFLNN-G----TLASFLFGNLKPNWNLRTNIAFQIARVLLYLH-EDCSSQIIHCDIKP 190 (350)
Q Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~~~~i~H~dlkp 190 (350)
+|+++.....+.. ...++||||+.+ | +|.++... .++.....++.|++.++.||| +. +++||||||
T Consensus 128 ~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCST
T ss_pred HhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCH
Confidence 8876432222222 356899999942 3 66665422 235577899999999999999 54 999999999
Q ss_pred CCeEEcCCCceEEeeccccccc
Q 046877 191 QNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 191 ~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
+|||+++ .++|+|||++...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=6.4e-17 Score=144.91 Aligned_cols=137 Identities=11% Similarity=0.054 Sum_probs=93.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--------------ccHHH--------HHHHHHHHhcCCC
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--------------DGEKE--------FKNEVIVIGQTHH 118 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--------------~~~~~--------~~~e~~~l~~l~h 118 (350)
|.+.+.||+|+||.||+|...+ +..||+|+.+.... ..... ...|...+.++.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~----G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEK----GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTT----CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECCC----CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999998532 45699998642110 00111 2345555555544
Q ss_pred CceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 046877 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDR 198 (350)
Q Consensus 119 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~ 198 (350)
.++....-+... ..++||||++|++|..+.. ......++.|++.++.+||+ .+++||||||.|||++++
T Consensus 173 ~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 173 EGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREE 241 (397)
T ss_dssp TTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEE
T ss_pred cCCCCCeeeecc--CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCC
Confidence 443222111111 2379999999988876642 12346788999999999995 499999999999999877
Q ss_pred Cc----------eEEeeccccccc
Q 046877 199 YN----------ARISDFGLAKLL 212 (350)
Q Consensus 199 ~~----------~kl~Dfg~~~~~ 212 (350)
+. +.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 63 899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.6e-12 Score=110.49 Aligned_cols=140 Identities=14% Similarity=0.050 Sum_probs=106.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+.+...++.|+.+.||++... +..+++|............+.+|..+++.+ ++..+.+++++..+.+..+++||
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-----~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-----NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-----SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ceeEeeccCCCCCeEEEEECC-----CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 334566888888999998632 235888887643223344688899999988 46778889999988889999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC---------------------------------------- 179 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~---------------------------------------- 179 (350)
+++|.+|.+... +......++.+++++++.||+..
T Consensus 91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999999887631 22334578899999999999710
Q ss_pred ----------------CCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 180 ----------------SSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 180 ----------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
...++|+|++|+||++++++.+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876667799998875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=8.8e-11 Score=100.59 Aligned_cols=130 Identities=15% Similarity=0.045 Sum_probs=93.2
Q ss_pred ccC-CCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCc--eeeecceeecCCeeEEEEecCC
Q 046877 66 EVG-RGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN--LVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 66 ~lg-~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
.++ .|..+.||++...+ +..+++|..... ....+..|..+++.+.+.+ +.+++++....+..+++|||++
T Consensus 26 ~~~~gg~~~~v~~~~~~~----g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQG----RPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp ECSCTTSSCEEEEEECTT----SCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred ecccCCCCceEEEEecCC----CCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 354 55569999986422 234788876432 2345778888888885434 5568888888788999999999
Q ss_pred CCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 046877 143 NGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC------------------------------------------- 179 (350)
Q Consensus 143 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------------------------------------------- 179 (350)
|.+|. ... . ....++.++++.++.||...
T Consensus 99 G~~l~--~~~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 99 GQDLL--SSH---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp SEETT--TSC---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred CcccC--cCc---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 98884 211 1 12356778888888888531
Q ss_pred ------------CCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 180 ------------SSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 180 ------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
...++|+|++|+||++++++.+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.9e-10 Score=103.43 Aligned_cols=142 Identities=16% Similarity=0.199 Sum_probs=103.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeee--ccc-cccHHHHHHHHHHHhcCC--CCceeeecceeecC---CeeEE
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVF-QDGEKEFKNEVIVIGQTH--HKNLVRLLGFCDEG---QNRLL 136 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~l 136 (350)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|..+++.+. +..+.+++.++.+. +..++
T Consensus 44 ~~l~~G~sn~~y~v~~~~-----~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-----QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EECCC-CCSCEEEEECSS-----CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEcCCcccceEEEEEECC-----ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 468999999999987432 246777654 211 122456888999999886 44577888887766 45799
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC------------------------------------- 179 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------------------------------------- 179 (350)
+|||++|..+.+.. ...++......++.++++.|+.||...
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998875532 134567788889999999999999621
Q ss_pred ------------------CCCeEecCCCCCCeEEcCCCc--eEEeecccccccc
Q 046877 180 ------------------SSQIIHCDIKPQNILLNDRYN--ARISDFGLAKLLT 213 (350)
Q Consensus 180 ------------------~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~ 213 (350)
...++|+|++|+||+++.++. +.++||+.+....
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 246999999999999997653 6899999987544
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=9.9e-10 Score=96.42 Aligned_cols=182 Identities=18% Similarity=0.156 Sum_probs=117.6
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCc--eeeecceeecCC---eeEEEE
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKN--LVRLLGFCDEGQ---NRLLAY 138 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~ 138 (350)
+.++.|....||+.. . .+++|.... ......+.+|...++.+ .+.. +.+.+......+ ..|++|
T Consensus 26 ~~~~~G~~n~v~~v~---~-----~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---R-----DFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST---T-----SEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC---C-----EEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 357889999999753 1 277777542 23456788999999877 3333 333443333332 347899
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC--------------------------------------- 179 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--------------------------------------- 179 (350)
++++|.+|..... ..++..+...++.+++..++.||...
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999988875432 34566677778888888888888510
Q ss_pred ----------------CCCeEecCCCCCCeEEcC--CCceEEeecccccccccCcccceeeccccCCCc---cCccccc-
Q 046877 180 ----------------SSQIIHCDIKPQNILLND--RYNARISDFGLAKLLTLNQRKTIKTAIRGTKGY---VAPEWFR- 237 (350)
Q Consensus 180 ----------------~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y---~aPE~~~- 237 (350)
...++|+|++|+||++++ ++.+.++||+.+....+...... ...+ ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~------~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS------LMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT------TCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH------HHhhccccCHHHHHH
Confidence 135899999999999998 56688999999876543211100 0011 2222211
Q ss_pred ---C-CCC---------CCCCcchhHHHHHHHHHhCCCCC
Q 046877 238 ---K-STI---------SAKVDVYSFGVLLLEIISCRKSF 264 (350)
Q Consensus 238 ---~-~~~---------~~~~DiwslG~~l~~lltg~~pf 264 (350)
. ... ....+.|++|.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 000 11258999999999999998876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=8.9e-07 Score=75.97 Aligned_cols=135 Identities=17% Similarity=0.138 Sum_probs=93.1
Q ss_pred cCCCccc-eEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEEEEecCCCC
Q 046877 67 VGRGSFG-IIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 67 lg~G~~g-~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
+..|..+ .||+.....+ +..+.+|.... .....+..|...++.+. +--+.+.+.++.+.+..+++||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~---~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPN---APELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTT---CCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCC---CeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 3344444 6887764332 23477776532 23556888999888773 334677788888889999999999998
Q ss_pred ChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 046877 145 TLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC--------------------------------------------- 179 (350)
Q Consensus 145 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--------------------------------------------- 179 (350)
++.+.... .......+..+++..++.||...
T Consensus 106 ~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 87765421 22334456666777777777310
Q ss_pred ----------CCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 180 ----------SSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 180 ----------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
...++|+|+.+.||++++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.8e-06 Score=74.33 Aligned_cols=137 Identities=19% Similarity=0.214 Sum_probs=90.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCC---ceeeecceee-cCCeeEEEEec
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHK---NLVRLLGFCD-EGQNRLLAYEF 140 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~ 140 (350)
+.++.|....||+. .. .+++|.... ......+..|..+++.+.+. .+.+.+.+.. ..+..+++||+
T Consensus 25 ~~l~~G~~n~v~~v---g~-----~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NG-----DWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE---TT-----TEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE---CC-----EEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 34777888889877 11 267777422 23356789999999998642 2455555553 44567899999
Q ss_pred CCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 046877 141 LNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHED------------------------------------------ 178 (350)
Q Consensus 141 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~------------------------------------------ 178 (350)
++|.+|..... ..++......++.++.+.++.||..
T Consensus 95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99988876321 1223444445555555555555532
Q ss_pred ---------------CCCCeEecCCCCCCeEEcC---CCc-eEEeecccccccc
Q 046877 179 ---------------CSSQIIHCDIKPQNILLND---RYN-ARISDFGLAKLLT 213 (350)
Q Consensus 179 ---------------~~~~i~H~dlkp~Nill~~---~~~-~kl~Dfg~~~~~~ 213 (350)
....++|+|++|.||+++. ++. +.|+||+.+....
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 1335799999999999987 455 5899999886443
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.9e-06 Score=77.14 Aligned_cols=84 Identities=7% Similarity=-0.037 Sum_probs=52.0
Q ss_pred hcc-CCCccceEEEEEEcC--CCc-ceeEEEEEeeeccc---cccHHHHHHHHHHHhcCC-C--CceeeecceeecC---
Q 046877 65 EEV-GRGSFGIIYKGVIQT--TTT-STTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTH-H--KNLVRLLGFCDEG--- 131 (350)
Q Consensus 65 ~~l-g~G~~g~V~~~~~~~--~~~-~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~--- 131 (350)
+.| +.|....+|+..... ++. .+..+++|...... ......+..|..+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 446 788889999876430 110 13457777654321 001245777888888773 2 3466677776554
Q ss_pred CeeEEEEecCCCCChhh
Q 046877 132 QNRLLAYEFLNNGTLAS 148 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~ 148 (350)
+..+++||+++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=4.9e-05 Score=68.93 Aligned_cols=75 Identities=13% Similarity=0.109 Sum_probs=45.8
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-------ccHHHHHHHHHHHhcCCC--Cc-eeeecceeecCCee
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-------DGEKEFKNEVIVIGQTHH--KN-LVRLLGFCDEGQNR 134 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~-iv~~~~~~~~~~~~ 134 (350)
+.||.|..+.||++....+ +..+++|....... ...+++..|..+++.+.. +. +.+++.+ +.+..
T Consensus 36 ~~lg~G~~n~vyrv~~~~~---~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEH---DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EECCCCceEEEEEEEECCC---CcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 4699999999999964432 23488887542211 123456778888877632 33 3344443 34456
Q ss_pred EEEEecCCCC
Q 046877 135 LLAYEFLNNG 144 (350)
Q Consensus 135 ~lv~e~~~~g 144 (350)
+++||++++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=0.0001 Score=65.10 Aligned_cols=31 Identities=23% Similarity=0.301 Sum_probs=28.2
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 180 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
...++|+|++++||+++.++.+.++||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5689999999999999888899999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00016 Score=63.10 Aligned_cols=74 Identities=20% Similarity=0.178 Sum_probs=55.3
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC---CCceeeecceeecCCeeEEEEecC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH---HKNLVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~ 141 (350)
+.|+.|....+|+.... ...+++|.... .....+..|...|+.+. ...+.+.+.+....+..+++||++
T Consensus 42 ~~l~gG~~n~~y~v~~~-----~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-----VQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEECCSSSSEEEEEESS-----SCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred EEeCCccceeeeEEEEC-----CCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 35889999999998632 23477777543 23567888988888873 356778888888778899999999
Q ss_pred CCCCh
Q 046877 142 NNGTL 146 (350)
Q Consensus 142 ~~g~L 146 (350)
++..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00016 Score=66.02 Aligned_cols=80 Identities=9% Similarity=0.020 Sum_probs=47.8
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCC---CCCCCcchhHHHHHHH
Q 046877 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST---ISAKVDVYSFGVLLLE 256 (350)
Q Consensus 180 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~ 256 (350)
...++|+|++|+||+++.++ ++++||+.+....+.......- ..-...|.+|+...... -....++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 56899999999999999876 9999999987654321111000 00112355555443111 1112445577778887
Q ss_pred HHhCC
Q 046877 257 IISCR 261 (350)
Q Consensus 257 lltg~ 261 (350)
.+++.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0017 Score=52.81 Aligned_cols=101 Identities=14% Similarity=0.040 Sum_probs=65.0
Q ss_pred Chhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccceeec
Q 046877 145 TLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223 (350)
Q Consensus 145 ~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 223 (350)
+|.+.+. .+.+++++++|.++.|.+.+|.-+-.. ..+ ..+=..|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-------------
Confidence 6778775 457899999999999999998776321 111 1223356899999999987764 1110
Q ss_pred cccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCC
Q 046877 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS 263 (350)
Q Consensus 224 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p 263 (350)
.....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1233577888763 3446678899999999999975554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0011 Score=57.20 Aligned_cols=74 Identities=19% Similarity=0.236 Sum_probs=48.7
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CCc--eeeecceeecCCeeEEEEecC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HKN--LVRLLGFCDEGQNRLLAYEFL 141 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~~~~lv~e~~ 141 (350)
+.+|.|..+.||+....+. ..+.+|............+..|...|+.+. ... +.+.+++ + ..+++||++
T Consensus 21 ~~~g~G~~~~vyrv~l~DG----~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l 92 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADG----TPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWV 92 (288)
T ss_dssp EEEEEETTEEEEEEEETTS----CEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECC
T ss_pred EecCCCCCeEEEEEEECCC----CEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEee
Confidence 4589999999999986543 358888765433333456788998888774 212 3333333 2 347899998
Q ss_pred CCCCh
Q 046877 142 NNGTL 146 (350)
Q Consensus 142 ~~g~L 146 (350)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00052 Score=59.60 Aligned_cols=32 Identities=22% Similarity=0.288 Sum_probs=26.3
Q ss_pred CCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 181 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
..++|+|+.++||+ .+++.+.++||..+....
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 45899999999999 566678999999886443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0012 Score=59.29 Aligned_cols=142 Identities=17% Similarity=0.209 Sum_probs=80.2
Q ss_pred hccCCCccceEEEEEEcCC----CcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEEEEe
Q 046877 65 EEVGRGSFGIIYKGVIQTT----TTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~----~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 139 (350)
+.|..|-...+|++..... ......+++|+.... ......+.+|.++++.+. +.-..++++.+.+ .++||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 3477777888999875421 112345778775332 234556678998888774 2223455555543 28999
Q ss_pred cCCCCChhhh-h----------------cC-----CCCcC--hhHHHHHHHHHHH-------------------HHHHHH
Q 046877 140 FLNNGTLASF-L----------------FG-----NLKPN--WNLRTNIAFQIAR-------------------VLLYLH 176 (350)
Q Consensus 140 ~~~~g~L~~~-l----------------~~-----~~~~~--~~~~~~~~~~i~~-------------------~l~~Lh 176 (350)
|++|.+|..- + +. ..... +.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 0 00 01111 3444555544322 223332
Q ss_pred ----hc-CCCCeEecCCCCCCeEEcCC----CceEEeecccccc
Q 046877 177 ----ED-CSSQIIHCDIKPQNILLNDR----YNARISDFGLAKL 211 (350)
Q Consensus 177 ----~~-~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~~ 211 (350)
.. ....++|+|+.++||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 11 13468999999999999876 7899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0042 Score=54.19 Aligned_cols=139 Identities=12% Similarity=0.099 Sum_probs=74.2
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCc--eeeecce------eecCCeeEEE
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN--LVRLLGF------CDEGQNRLLA 137 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv 137 (350)
.|+.|....+|+....+. .+++|..... .....+..|..+++.+...+ +.+++.. ....+..+++
T Consensus 29 ~i~~G~~n~~~~v~~~~g-----~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-----PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EECC---EEEEEEEESSC-----CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred ccCCCcccceEEEEeCCc-----cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 466787788998875332 2778876542 12234556776666653212 2333321 1223567899
Q ss_pred EecCCCCChhhh--------------hc---CC---CC---c---ChhHHHH------------HHHHHHHHHHHHHhc-
Q 046877 138 YEFLNNGTLASF--------------LF---GN---LK---P---NWNLRTN------------IAFQIARVLLYLHED- 178 (350)
Q Consensus 138 ~e~~~~g~L~~~--------------l~---~~---~~---~---~~~~~~~------------~~~~i~~~l~~Lh~~- 178 (350)
+++++|..+... ++ .. .. . .|..... +...+...++.+++.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 999998654210 00 00 00 0 1111000 001133445555432
Q ss_pred ---CCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 179 ---CSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 179 ---~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
....++|+|++++||++++++.+.++||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 134799999999999999876668999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0018 Score=59.19 Aligned_cols=76 Identities=12% Similarity=0.198 Sum_probs=46.4
Q ss_pred hccCCCccceEEEEEEcCCC----cceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCce-eeecceeecCCeeEEEEe
Q 046877 65 EEVGRGSFGIIYKGVIQTTT----TSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL-VRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~----~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 139 (350)
+.|+.|....+|++...... ..+..+++|+.... .....+..|..+++.+...++ .++++.+.+ .+++|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 35788888999998764311 11245778776331 122455678888888743333 455555442 28899
Q ss_pred cCCCCCh
Q 046877 140 FLNNGTL 146 (350)
Q Consensus 140 ~~~~g~L 146 (350)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0061 Score=53.51 Aligned_cols=34 Identities=29% Similarity=0.310 Sum_probs=28.8
Q ss_pred CCCeEecCCCCCCeEEcCC----CceEEeecccccccc
Q 046877 180 SSQIIHCDIKPQNILLNDR----YNARISDFGLAKLLT 213 (350)
Q Consensus 180 ~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~~~~ 213 (350)
...++|+|+.++||+++.+ +.+.++||+.+....
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 4579999999999999874 679999999887544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.015 Score=50.85 Aligned_cols=137 Identities=10% Similarity=0.046 Sum_probs=74.3
Q ss_pred cCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCc--eeeecce-----eecCCeeEEEEe
Q 046877 67 VGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN--LVRLLGF-----CDEGQNRLLAYE 139 (350)
Q Consensus 67 lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~-----~~~~~~~~lv~e 139 (350)
++ |....||+....+ +..+++|..... ......+..|..+++.+.... +.+++.. ....+..+++|+
T Consensus 34 l~-g~~n~~y~v~~~~----g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 34 LN-SYENRVYQFQDED----RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EC-CSSSEEEEECCTT----CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ec-CcccceEEEEcCC----CCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 55 7778899875322 224788887522 123456777877777663212 3333332 222456678999
Q ss_pred cCCCCChhh----hh----------c---CC------CCcChhHH----HHH---------------HHHHHHHHHHHHh
Q 046877 140 FLNNGTLAS----FL----------F---GN------LKPNWNLR----TNI---------------AFQIARVLLYLHE 177 (350)
Q Consensus 140 ~~~~g~L~~----~l----------~---~~------~~~~~~~~----~~~---------------~~~i~~~l~~Lh~ 177 (350)
+++|..+.. .. + .. ...+.... ..+ ...+-..++.+.+
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998855421 00 0 00 01111100 001 1111112233322
Q ss_pred c----CCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 178 D----CSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 178 ~----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
. ....++|+|++++||+++ + .+.++||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 245689999999999999 4 899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.01 Score=54.65 Aligned_cols=73 Identities=15% Similarity=0.083 Sum_probs=42.6
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCce-eeecceeecCCeeEEEEecCCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL-VRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g 144 (350)
.|+.|-...+|++...+. +..+++|...... ...-....|..+++.+...++ .++++.+. + ..++||++|.
T Consensus 115 ~lsgG~tN~~y~v~~~~~---~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSK---QAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EECC--CEEEEEEEETTT---TEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EcCCCeEeEEEEEEECCC---CceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 477787889999875431 2347777654321 111122578888888854444 45566553 2 2599999875
Q ss_pred Ch
Q 046877 145 TL 146 (350)
Q Consensus 145 ~L 146 (350)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 55
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0056 Score=54.66 Aligned_cols=32 Identities=22% Similarity=0.401 Sum_probs=25.9
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 180 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
...++|+|+.+.||++++++ +.++||..+...
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g 242 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGFN 242 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCEEE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCCCC
Confidence 34689999999999998665 899999887643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.041 Score=48.43 Aligned_cols=34 Identities=24% Similarity=0.335 Sum_probs=29.0
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 180 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
...++|+|+.+.||++++++.+.++||+.+....
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 3579999999999999988889999998876443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.56 E-value=0.024 Score=32.97 Aligned_cols=9 Identities=22% Similarity=0.080 Sum_probs=3.6
Q ss_pred ccchhhHHH
Q 046877 4 GSVLLGSSV 12 (350)
Q Consensus 4 ~~~~~~~~~ 12 (350)
++|..|++.
T Consensus 11 ~~IA~gVVg 19 (44)
T 2ks1_B 11 PSIATGMVG 19 (44)
T ss_dssp SSSTHHHHH
T ss_pred ceEEeehhH
Confidence 344344333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.22 E-value=0.092 Score=47.64 Aligned_cols=31 Identities=23% Similarity=0.424 Sum_probs=26.9
Q ss_pred CCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 181 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
..++|+|+.++|++ ++++.+.++||..+...
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 45899999999999 88889999999988643
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.78 E-value=0.036 Score=32.12 Aligned_cols=24 Identities=21% Similarity=0.394 Sum_probs=9.5
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHhh
Q 046877 9 GSSVFVNFALVCAVGLGFFFIYKK 32 (350)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~ 32 (350)
+..++.++++++++++.++++.|+
T Consensus 13 A~gVVgGv~~v~ii~~~~~~~~RR 36 (44)
T 2l2t_A 13 AAGVIGGLFILVIVGLTFAVYVRR 36 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeehHHHHHHHHHHHHHHHHhhh
Confidence 333333344433444443333333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.80 E-value=0.068 Score=30.90 Aligned_cols=11 Identities=18% Similarity=0.365 Sum_probs=4.0
Q ss_pred HHHHHHHHHHh
Q 046877 21 AVGLGFFFIYK 31 (350)
Q Consensus 21 ~~~~~~~~~~~ 31 (350)
++++++|+.+|
T Consensus 28 ~l~~~~~~RRR 38 (44)
T 2jwa_A 28 GVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHhheehh
Confidence 33333333333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.19 E-value=0.24 Score=40.28 Aligned_cols=115 Identities=10% Similarity=0.070 Sum_probs=76.8
Q ss_pred CCCceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCCeEE
Q 046877 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLL-YLHEDCSSQIIHCDIKPQNILL 195 (350)
Q Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~-~Lh~~~~~~i~H~dlkp~Nill 195 (350)
.||++ -..+..+++...+.++.-+++.=+..+ ...+...+++++.+++.... +++ .-+|--++|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEE
Confidence 57777 455557777777777765443222233 46678888999999888666 555 67788999999999
Q ss_pred cCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCC
Q 046877 196 NDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFD 265 (350)
Q Consensus 196 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~ 265 (350)
+.++.+++.-.|+-..+.|.. +.+|-+ .-++=|++..++.++..|+
T Consensus 118 ~~~~~p~i~hRGi~~~lpP~e--------------~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 NRALEPFFLHVGVKESLPPDE--------------WDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CTTCCEEESCCEETTTBSSCS--------------CCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred eCCCcEEEEEcCCcccCCCCC--------------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 999999998877654332211 111111 1245677788888888775
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.48 E-value=0.29 Score=39.62 Aligned_cols=116 Identities=12% Similarity=0.124 Sum_probs=77.6
Q ss_pred CCCceeeecceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 046877 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196 (350)
Q Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~ 196 (350)
.||+.+.. .+..+++...+.++.-+ +...+- .-...+...+++++.+++....+++ .=+|--++|+|++++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~-~ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD-NIKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG-GGGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH-HHHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEEc
Confidence 57877766 46666666666665443 222222 1245678889999999988876665 567889999999999
Q ss_pred CCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCC
Q 046877 197 DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFD 265 (350)
Q Consensus 197 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~ 265 (350)
.++.+++.-.|+...+. |..+ ++..=.-.+=|++..+++++..|+
T Consensus 114 ~~~~p~i~~RGik~~l~-------------------P~~~-----~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 114 RDGLPIAKTRGLQNVVD-------------------PLPV-----SEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TTSCEEESCCEETTTBS-------------------CCCC-----CHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCCEEEEEccCccCCC-------------------CCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999998777654322 2111 111112255678888999988885
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=91.94 E-value=0.15 Score=28.62 Aligned_cols=14 Identities=7% Similarity=0.088 Sum_probs=6.5
Q ss_pred ccchhhHHHHHHHH
Q 046877 4 GSVLLGSSVFVNFA 17 (350)
Q Consensus 4 ~~~~~~~~~~~~~~ 17 (350)
.+.+.|+++.+++.
T Consensus 10 ~GaIAGiVvG~v~g 23 (38)
T 2k1k_A 10 GGEIVAVIFGLLLG 23 (38)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred CCceeeeehHHHHH
Confidence 44445555544433
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.58 E-value=0.5 Score=26.92 Aligned_cols=24 Identities=25% Similarity=0.229 Sum_probs=10.4
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHhh
Q 046877 9 GSSVFVNFALVCAVGLGFFFIYKK 32 (350)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~ 32 (350)
..++++++++++++++.+++++|+
T Consensus 16 ~~~vv~Gv~ll~~iv~~~~~~~rR 39 (41)
T 2k9y_A 16 IGGVAVGVVLLLVLAGVGFFIHRR 39 (41)
T ss_dssp HHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred EeehhHHHHHHHHHHHHheeEeee
Confidence 334444444444234444444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.95 E-value=0.42 Score=42.96 Aligned_cols=30 Identities=27% Similarity=0.402 Sum_probs=25.1
Q ss_pred eEecCCCCCCeEE------cCCCceEEeeccccccc
Q 046877 183 IIHCDIKPQNILL------NDRYNARISDFGLAKLL 212 (350)
Q Consensus 183 i~H~dlkp~Nill------~~~~~~kl~Dfg~~~~~ 212 (350)
++|+|+.+.||++ +++..+.++||..+...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 5799999999999 44667999999988643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 350 | ||||
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-67 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-18 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (541), Expect = 1e-67
Identities = 68/304 (22%), Positives = 131/304 (43%), Gaps = 34/304 (11%)
Query: 51 FSYKELEEATDNFKEEV-----------GRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF 99
F++++ EA F +E+ G G FG + G ++ VA+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 100 -QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-N 157
+ ++F +E ++GQ H N++ L G + ++ EF+ NG+L SFL N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 158 WNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217
+ IA + YL + +H D+ +NIL+N ++SDFGL++ L +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 218 K---TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 274
T + + APE + ++ DV+S+G+++ E++S +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233
Query: 275 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
+ N + + +E D + C L + + C Q+D + RP ++ L
Sbjct: 234 -----YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 335 EVVE 338
+++
Sbjct: 289 KMIR 292
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 5e-66
Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 23/280 (8%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+ +G GSFG +YKG AV + + + FKNEV V+ +T H N++
Sbjct: 12 VGQRIGSGSFGTVYKG----KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
+G+ Q + ++ +L L K +IA Q A+ + YLH
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR---K 238
IIH D+K NI L++ +I DFGLA + + + G+ ++APE R K
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 239 STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298
+ S + DVY+FG++L E+++ + + + + Y + L +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLSKVRSN---- 237
Query: 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
C + + + C+++ RP ++ ++ +
Sbjct: 238 -----CPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-62
Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 27/275 (9%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
E +G G FG ++ G T VAVK L + F E ++ Q H+ LV
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTK----VAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARVLLYLHEDCS 180
RL + + E++ NG+L FL +K N ++A QIA + ++ E
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
IH D++ NIL++D + +I+DFGLA+L+ N+ + + + APE T
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGT 186
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300
+ K DV+SFG+LL EI++ + + N ++ +E +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP---------------YPGMTNPEVIQNLERGYRMVR 231
Query: 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
C E+L + C +E P RPT + +L++
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 7e-62
Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 28/289 (9%)
Query: 54 KELEEATDNFK---EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE-KEFKNE 109
K+L DN E+G G+FG + +GV + VA+K L + + + +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ-IDVAIKVLKQGTEKADTEEMMRE 59
Query: 110 VIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQI 168
++ Q + +VRL+G C + + +L E G L FL G + + + Q+
Sbjct: 60 AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ-RKTIKTAIRGT 227
+ + YL E +H D+ +N+LL +R+ A+ISDFGL+K L + T ++A +
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 228 KGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKS-FDIEMGEEYAILTDWAFDCYRNG 286
+ APE S++ DV+S+GV + E +S + + G E G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG 228
Query: 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
K + C +L + C RP V Q ++
Sbjct: 229 KRMECPPE---------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-61
Identities = 63/293 (21%), Positives = 125/293 (42%), Gaps = 23/293 (7%)
Query: 57 EEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE-KEFKNEVIVIGQ 115
+F E +GRG FG +Y G + AVK L+R+ GE +F E I++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 116 THHKNLVRLLGFCDEGQNR-LLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLL 173
H N++ LLG C + L+ ++ +G L +F+ P Q+A+
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK--- 141
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI--KTAIRGTKGYV 231
+ S + +H D+ +N +L++++ +++DFGLA+ + + ++ KT + ++
Sbjct: 142 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 232 APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291
A E + + K DV+SFGVLL E+++ ++ D + +L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRRLLQ- 255
Query: 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPN 344
C + L + + C +RP+ ++ + + + +
Sbjct: 256 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-61
Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 25/276 (9%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
F +E+G G FG++ G + VA+K + E EF E V+ H+ L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYD----VAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKL 61
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLHEDCS 180
V+L G C + + + E++ NG L ++L + + + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+H D+ +N L+ND+ ++SDFGL++ + + T + + PE S
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300
S+K D+++FGVL+ EI S K ++ + N + + + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYR 222
Query: 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336
EK+ I C E RPT + + + +V
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-60
Identities = 68/278 (24%), Positives = 119/278 (42%), Gaps = 25/278 (8%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL 121
F +E+G G FG+++ G VA+K + E++F E V+ + H L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDK----VAIKTIREGAMS-EEDFIEEAEVMMKLSHPKL 62
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLHEDCS 180
V+L G C E L +EF+ +G L+ +L + + + YL E C
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+IH D+ +N L+ + ++SDFG+ + + + + T T + + +PE F S
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300
S+K DV+SFGVL+ E+ S K ++ N ++ + +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIP---------------YENRSNSEVVEDISTGFRLYK 223
Query: 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ I C +E P RP ++ + L E+ E
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 7e-60
Identities = 68/316 (21%), Positives = 123/316 (38%), Gaps = 47/316 (14%)
Query: 52 SYKELEEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTT--AVAVKKLDR-VFQDGEKEF 106
LE +N + ++G G+FG +++ VAVK L D + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 107 KNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP---------- 156
+ E ++ + + N+V+LLG C G+ L +E++ G L FL
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 157 --------------NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNAR 202
+ + IA Q+A + YL E +H D+ +N L+ + +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180
Query: 203 ISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRK 262
I+DFGL++ + ++ PE + + + DV+++GV+L EI S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 263 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSL 322
M E R+G + E C +L + C + P+
Sbjct: 241 QPYYGMAHE------EVIYYVRDGNILACPEN---------CPLELYNLMRLCWSKLPAD 285
Query: 323 RPTMRKVSQMLQEVVE 338
RP+ + ++LQ + E
Sbjct: 286 RPSFCSIHRILQRMCE 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 8e-59
Identities = 68/283 (24%), Positives = 121/283 (42%), Gaps = 27/283 (9%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+ ++G+G FG ++ G TT VA+K L + F E V+ + H+ LV
Sbjct: 21 LEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 75
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQIARVLLYLHEDCS 180
+L + + E+++ G+L FL G ++A QIA + Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+H D++ NIL+ + +++DFGLA+L+ N+ T + + + APE
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGR 190
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300
+ K DV+SFG+LL E+ + + + N ++ D VE
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNREVLDQVERGYRMPC 235
Query: 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPP 343
+C E L + C +++P RPT + L++ P
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (479), Expect = 2e-58
Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 27/291 (9%)
Query: 52 SYKELEEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNE 109
+Y + E + ++G G +G +Y+GV + + VAVK L + E EF E
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL---TVAVKTLKEDTMEVE-EFLKE 63
Query: 110 VIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQ 167
V+ + H NLV+LLG C + EF+ G L +L + + + +A Q
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGT 227
I+ + YL IH D+ +N L+ + + +++DFGL++L+T T +
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 179
Query: 228 KGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287
+ APE + S K DV++FGVLL EI + S + +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQ 224
Query: 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ +L+E D C EK+ + C Q +PS RP+ ++ Q + + +
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-58
Identities = 57/304 (18%), Positives = 121/304 (39%), Gaps = 39/304 (12%)
Query: 56 LEEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG-EKEFKNEVIV 112
+E D+F+ E+G G+ G+++K + + +A K + + + E+ V
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGL---VMARKLIHLEIKPAIRNQIIRELQV 57
Query: 113 IGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVL 172
+ + + +V G + E ++ G+L L + + ++ + + L
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
YL E I+H D+KP NIL+N R ++ DFG++ L + + GT+ Y++
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMS 171
Query: 233 PEWFRKSTISAKVDVYSFGVLLLEIISCRKSFD------IEMGEEYAILTDWAFDCYRNG 286
PE + + S + D++S G+ L+E+ R +E+ + D A R
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 287 KLDDLVEGDMEAMNDIKCVEKLLMISI---------------------WCIQEDPSLRPT 325
+ + +LL + C+ ++P+ R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 326 MRKV 329
++++
Sbjct: 292 LKQL 295
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-58
Identities = 72/273 (26%), Positives = 115/273 (42%), Gaps = 23/273 (8%)
Query: 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLVR 123
E+G G+FG + KG Q T VAVK L D E E V+ Q + +VR
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKT-VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 124 LLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQI 183
++G C E ++ +L E G L +L N + Q++ + YL E S
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 128
Query: 184 IHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ-RKTIKTAIRGTKGYVAPEWFRKSTIS 242
+H D+ +N+LL ++ A+ISDFGL+K L ++ +T + + APE S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 243 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 302
+K DV+SFGVL+ E S + + + ++ ++E
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMGCPA 233
Query: 303 KCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
C ++ + C D RP V L+
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 6e-58
Identities = 67/298 (22%), Positives = 120/298 (40%), Gaps = 39/298 (13%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTA--VAVKKLDR-VFQDGEKEFKNEVIVIGQ-THH 118
F + +G G+FG + + S A VAVK L + +E+ V+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP------------------NWNL 160
N+V LLG C G L+ E+ G L +FL +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 161 RTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220
+ ++Q+A+ + +L S IH D+ +NILL +I DFGLA+ + + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 280
K R ++APE + + DV+S+G+ L E+ S S
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYP 249
Query: 281 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ K +++ ++ ++ I C DP RPT +++ Q++++ +
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-57
Identities = 54/298 (18%), Positives = 111/298 (37%), Gaps = 29/298 (9%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+E +G+G FG +++G + VAVK ++ + E+ H+N++
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEE-----VAVKIFSSR-EERSWFREAEIYQTVMLRHENIL 60
Query: 123 RLLGFCDEGQNRL----LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHED 178
+ ++ L ++ +G+L +L +A A L +LH +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHME 119
Query: 179 C-----SSQIIHCDIKPQNILLNDRYNARISDFGLAKLL--TLNQRKTIKTAIRGTKGYV 231
I H D+K +NIL+ I+D GLA + GTK Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 232 APEWF------RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY----AILTDWAFD 281
APE + + D+Y+ G++ EI I + + +D + +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 282 CYRNGKLDDLVEGDM-EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
R + + ++ + + + I C + + R T ++ + L ++ +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-57
Identities = 63/299 (21%), Positives = 116/299 (38%), Gaps = 44/299 (14%)
Query: 63 FKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVFQDGEKE-FKNEVIVIGQ-THH 118
F + +G G+FG + T + VAVK L E+E +E+ ++ Q H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP---------------------- 156
+N+V LLG C L +E+ G L ++L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 157 -NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215
+ A+Q+A+ + +L +H D+ +N+L+ +I DFGLA+ + +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 275
++ R ++APE + + K DV+S+G+LL EI S + + +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 276 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334
L++ + E++ +I C D RP+ ++ L
Sbjct: 278 --------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-57
Identities = 64/277 (23%), Positives = 116/277 (41%), Gaps = 33/277 (11%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
+ +G+G FG + G + VAVK + + F E V+ Q H NLV
Sbjct: 11 LLQTIGKGEFGDVMLGDYRGNK-----VAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 123 RLLGFCDEGQNRL-LAYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQIARVLLYLHEDC 179
+LLG E + L + E++ G+L +L + + + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
+ +H D+ +N+L+++ A++SDFGL K + + + + + APE R+
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREK 175
Query: 240 TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299
S K DV+SFG+LL EI S + + + G D +G
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMDAPDG----- 224
Query: 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336
C + + C D ++RP+ ++ + L+ +
Sbjct: 225 ----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 8e-57
Identities = 63/311 (20%), Positives = 132/311 (42%), Gaps = 34/311 (10%)
Query: 43 TIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTST-TAVAVKKLDRVF-Q 100
T E C + +++ +G G FG +YKG+++T++ VA+K L + +
Sbjct: 1 TTEIHPSCVTRQKV----------IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE 50
Query: 101 DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWN 159
+F E ++GQ H N++RL G + + ++ E++ NG L FL +
Sbjct: 51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL 110
Query: 160 LRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219
+ IA + + +H D+ +NIL+N ++SDFGL+++L + T
Sbjct: 111 QLVGMLRGIAA---GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167
Query: 220 IKT-AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 278
T + + APE ++ DV+SFG+++ E+++ +
Sbjct: 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------------- 213
Query: 279 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ N ++ + + C + + + C Q++ + RP + +L +++
Sbjct: 214 -YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
Query: 339 VDVPPNPSPFS 349
P + +
Sbjct: 273 --APDSLKTLA 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-55
Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 25/283 (8%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQ 115
+ + E++G GSFG++ +G + T +VAVK L + +F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLY 174
H+NL+RL G +++ E G+L L + + A Q+A + Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK-TIKTAIRGTKGYVAP 233
L IH D+ +N+LL R +I DFGL + L N ++ + + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 234 EWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293
E + T S D + FGV L E+ + + I + IL + R + +D
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPED--- 239
Query: 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336
C + + + + C P RPT + L E
Sbjct: 240 ----------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-55
Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 30/274 (10%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD--RVFQDGEKEFKNEVIVIGQTHHKN 120
F E+GRGSF +YKG+ TT VA +L ++ + + FK E ++ H N
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTV---EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 121 LVRLLGFC----DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
+VR + +L E + +GTL ++L + + QI + L +LH
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 177 EDCSSQIIHCDIKPQNILLNDR-YNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
IIH D+K NI + + +I D GLA L + K + GT ++APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEM 184
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295
+ + VDVY+FG+ +LE+ + + + G
Sbjct: 185 YEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--------------YRRVTSGV 229
Query: 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
A D + ++ I CI+++ R +++ +
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-55
Identities = 60/276 (21%), Positives = 110/276 (39%), Gaps = 20/276 (7%)
Query: 62 NFKEEVGRGSFGIIYKGV-IQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHK 119
+ +G G+FG +YKG+ I VA+K+L KE +E V+ +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
++ RLLG C +L+ L N QIA+ + YL
Sbjct: 72 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---E 128
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
+++H D+ +N+L+ + +I+DFGLAKLL +++ + ++A E
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 240 TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299
+ + DV+S+GV + E+++ +D ++ ++E
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKGERLP 233
Query: 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQE 335
C + MI + C D RP R++ +
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-55
Identities = 71/295 (24%), Positives = 127/295 (43%), Gaps = 40/295 (13%)
Query: 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQ-THHK 119
F++ +G G+FG + K I+ A+K++ +D ++F E+ V+ + HH
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP----------------NWNLRTN 163
N++ LLG C+ LA E+ +G L FL + + +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 164 IAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTA 223
A +AR + YL Q IH D+ +NIL+ + Y A+I+DFGL++ + KT
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 185
Query: 224 IRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 283
R ++A E S + DV+S+GVLL EI+S + +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---------------YCGM 230
Query: 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+L + + + C +++ + C +E P RP+ ++ L ++E
Sbjct: 231 TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 7e-55
Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 22/278 (7%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-FKNEVIVIGQTHHKNL 121
+G G FG +++G+ + AVA+K D +E F E + + Q H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLHEDCS 180
V+L+G E + E G L SFL + A+Q++ L YL
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 181 SQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKST 240
+H DI +N+L++ ++ DFGL++ + + + + ++APE
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 185
Query: 241 ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300
++ DV+ FGV + EI+ + NG+ +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERLPMPPN------ 233
Query: 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
C L + C DPS RP ++ L ++E
Sbjct: 234 ---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-54
Identities = 70/273 (25%), Positives = 126/273 (46%), Gaps = 24/273 (8%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD-RVFQDGEKEFKNEVIVIGQTH 117
+++ + +G G++G + V + T AVAVK +D + D + K E+ + +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEE---AVAVKIVDMKRAVDCPENIKKEICINKMLN 61
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHE 177
H+N+V+ G EG + L E+ + G L + ++ Q+ ++YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 120
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR 237
I H DIKP+N+LL++R N +ISDFGLA + N R+ + + GT YVAPE +
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 238 KSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296
+ + VDV+S G++L +++ +D + + +DW + D
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWKEKKTYLNPWKKI---DS 234
Query: 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ + + E+PS R T+ +
Sbjct: 235 APLALLH----------KILVENPSARITIPDI 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-54
Identities = 62/281 (22%), Positives = 115/281 (40%), Gaps = 33/281 (11%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQT 116
++++ +G GS+G K ++ + K+LD + +EV ++ +
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGK---ILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 117 HHKNLVRLLGFCDEGQNRLL--AYEFLNNGTLASFLFGNLKP----NWNLRTNIAFQIAR 170
H N+VR + N L E+ G LAS + K + + Q+
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 171 VLLYLHE--DCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK 228
L H D ++H D+KP N+ L+ + N ++ DFGLA++L + A GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTP 178
Query: 229 GYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288
Y++PE + + + K D++S G LL E+ + F +E R GK
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKF 231
Query: 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ + +N+I I+ + RP++ ++
Sbjct: 232 RRIPYRYSDELNEI--------IT-RMLNLKDYHRPSVEEI 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-53
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 38/277 (13%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQ 115
++F+ +G+G FG +Y + + +A+K L + E + + EV +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKF---ILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYL 175
H N++RL G+ + L E+ GT+ L K + ++A L Y
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
H S ++IH DIKP+N+LL +I+DFG + ++R T+ GT Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEM 175
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNGKLDDLV 292
KVD++S GVL E + + F+ +E I ++ F + DL+
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 235
Query: 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
++ +PS RP +R+V
Sbjct: 236 S--------------------RLLKHNPSQRPMLREV 252
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (444), Expect = 5e-53
Identities = 57/273 (20%), Positives = 97/273 (35%), Gaps = 33/273 (12%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE---KEFKNEVIVIGQTHHKNL 121
E+G GSFG +Y + VA+KK+ + ++ EV + + H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSE---VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
++ G L E+ + + L YLH S
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 182 QIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFR---K 238
+IH D+K NILL++ ++ DFG A ++ GT ++APE +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMDE 188
Query: 239 STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298
KVDV+S G+ +E+ + F+ L + + + A
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPL---------------FNMNAMSALYHIAQNESPA 233
Query: 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331
+ E C+Q+ P RPT + +
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 6e-52
Identities = 60/267 (22%), Positives = 118/267 (44%), Gaps = 27/267 (10%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRL 124
E++G+G+ G +Y + T VA+++++ Q ++ NE++V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQ---EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQII 184
L G + E+L G+L + + + + + L +LH S+Q+I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 185 HCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAK 244
H DIK NILL + +++DFG +T Q K + + GT ++APE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196
Query: 245 VDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 302
VD++S G++ +E+I + + + Y I T+ + KL + +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA------IFRDFL 250
Query: 303 KCVEKLLMISIWCIQEDPSLRPTMRKV 329
C+ D R + +++
Sbjct: 251 N----------RCLDMDVEKRGSAKEL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-51
Identities = 67/289 (23%), Positives = 125/289 (43%), Gaps = 31/289 (10%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTT--AVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHK 119
E+G+GSFG++Y+GV + VA+K ++ EF NE V+ + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIA 169
++VRLLG +GQ L+ E + G L S+L P+ + +A +IA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
+ YL +++ +H D+ +N ++ + + +I DFG+ + +
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289
+++PE + + DV+SFGV+L EI + + + E G L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVMEGGLL 254
Query: 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
D + C + L + C Q +P +RP+ ++ ++E +E
Sbjct: 255 DKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 5e-51
Identities = 56/278 (20%), Positives = 109/278 (39%), Gaps = 30/278 (10%)
Query: 60 TDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH 117
D ++ E+G G+FG +YK + T+ A K +D ++ +++ E+ ++
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSV---LAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLH 176
H N+V+LL N + EF G + + + +P + + Q L YLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
++IIH D+K NIL + +++DFG++ T ++ + GT ++APE
Sbjct: 128 ---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVV 182
Query: 237 -----RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291
+ K DV+S G+ L+E+ + L
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTL 235
Query: 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ + C++++ R T ++
Sbjct: 236 AQPS-------RWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 6e-50
Identities = 72/299 (24%), Positives = 120/299 (40%), Gaps = 40/299 (13%)
Query: 63 FKEEVGRGSFGIIYKGVIQTT----TTSTTAVAVKKLDR-VFQDGEKEFKNEVIVIGQ-T 116
+ +G G+FG + T VAVK L + + +E+ ++
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP----------------NWNL 160
HKN++ LLG C + + E+ + G L +L P +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 161 RTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTI 220
+ A+Q+AR + YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 221 KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 280
T R ++APE + + DV+SFGVLL EI + S + E F
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ELF 247
Query: 281 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339
+ G D C +L M+ C PS RPT +++ + L +V +
Sbjct: 248 KLLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 4e-49
Identities = 69/297 (23%), Positives = 121/297 (40%), Gaps = 38/297 (12%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTA--VAVKKLDR-VFQDGEKEFKNEVIVIGQT-HH 118
+ +GRG+FG + + + T VAVK L + +E+ ++ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 119 KNLVRLLGFC-DEGQNRLLAYEFLNNGTLASFLFGNLKP----------------NWNLR 161
N+V LLG C G ++ EF G L+++L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 162 TNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIK 221
+FQ+A+ + +L S + IH D+ +NILL+++ +I DFGLA+ + + K
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 222 TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 281
R ++APE + + DV+SFGVLL EI S S + + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCR 248
Query: 282 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
+ G + ++ + C +PS RPT ++ + L +++
Sbjct: 249 RLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-47
Identities = 53/274 (19%), Positives = 109/274 (39%), Gaps = 28/274 (10%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR---VFQDGEKEFKNEVIVIGQ 115
++FK + +G GSF + T+ A+K L++ + ++ E V+ +
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSRE---YAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYL 175
H V+L + + + NG L ++ + F A ++ L
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSAL 121
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
IIH D+KP+NILLN+ + +I+DFG AK+L+ ++ + GT YV+PE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295
+ + D+++ G ++ ++++ F F + D +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEYDFPEKFF 234
Query: 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+A + ++ + D + R ++
Sbjct: 235 PKARDLVE----------KLLVLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 159 bits (404), Expect = 1e-46
Identities = 57/273 (20%), Positives = 111/273 (40%), Gaps = 31/273 (11%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
EE+G G+FG++++ + T + A K + + ++ + E+ + H LV
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNN---FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLHEDCSS 181
L ++ ++ YEF++ G L + + + Q+ + L ++HE+
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 182 QIIHCDIKPQNILLNDRYNARI--SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKS 239
+H D+KP+NI+ + + + DFGL L K GT + APE
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 240 TISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNGKLDDLVEGDM 296
+ D++S GVL ++S F E +E + + DW D + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE------ 254
Query: 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ + I+ + DP+ R T+ +
Sbjct: 255 DGKDFIR----------KLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (390), Expect = 2e-44
Identities = 60/274 (21%), Positives = 110/274 (40%), Gaps = 27/274 (9%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHH 118
D + EE+G G+FG++++ V + T K ++ + + KNE+ ++ Q HH
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRV---FVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 119 KNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYLHE 177
L+ L ++ +L EFL+ G L + + N Q L ++H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH- 144
Query: 178 DCSSQIIHCDIKPQNILLNDRYNARI--SDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
I+H DIKP+NI+ + + + DFGLA L ++ + T T + APE
Sbjct: 145 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEI 199
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295
+ + D+++ GVL ++S F E E + + +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEFDEDAF 252
Query: 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ K + +Q++P R T+
Sbjct: 253 SSVSPEAK---DFIK---NLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 6e-44
Identities = 62/283 (21%), Positives = 113/283 (39%), Gaps = 28/283 (9%)
Query: 53 YKELEEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR-VFQDGEKEFKNE 109
+K+ E+ D + + +G G+F + + T VA+K + + + E +NE
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQK---LVAIKCIAKKALEGKEGSMENE 57
Query: 110 VIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA 169
+ V+ + H N+V L + G + L + ++ G L + + + FQ+
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 117
Query: 170 RVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKG 229
+ YLH+ L++ ISDFGL+K+ ++ + GT G
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPG 174
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNG 286
YVAPE + S VD +S GV+ ++ F E + IL ++ FD
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234
Query: 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ D A + I+ +++DP R T +
Sbjct: 235 DISD------SAKDFIR----------HLMEKDPEKRFTCEQA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-42
Identities = 67/273 (24%), Positives = 108/273 (39%), Gaps = 31/273 (11%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDR---VFQDGEKEFKNEVIVIGQ 115
++F + +G+GSFG ++ + T A+K L + + D + E V+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQ---FFAIKALKKDVVLMDDDVECTMVEKRVLSL 58
Query: 116 T-HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLY 174
H L + +N E+LN G L + K + + T A +I L +
Sbjct: 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE 234
L S I++ D+K NILL+ + +I+DFG+ K L K GT Y+APE
Sbjct: 119 L---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPE 173
Query: 235 WFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294
+ VD +SFGVLL E++ + F + EE F R
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPFYPRWL 226
Query: 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMR 327
+ EA + + +P R +R
Sbjct: 227 EKEAKDLLV----------KLFVREPEKRLGVR 249
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 1e-41
Identities = 54/278 (19%), Positives = 112/278 (40%), Gaps = 28/278 (10%)
Query: 57 EEATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIG 114
+E + + E++GRG FGI+++ V ++ + K + D + K E+ ++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKT---YMAKFVKVKGTD-QVLVKKEISILN 56
Query: 115 QTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLL 173
H+N++ L + + ++ +EF++ + + + N + Q+ L
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNAR--ISDFGLAKLLTLNQRKTIKTAIRGTKGYV 231
+LH S I H DI+P+NI+ R ++ I +FG A+ L + + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYY 170
Query: 232 APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291
APE + +S D++S G L+ ++S F E ++ + N +
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYTFD 223
Query: 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
E E + + + ++ R T +
Sbjct: 224 EEAFKEISIEAM---DFVD---RLLVKERKSRMTASEA 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 146 bits (369), Expect = 2e-41
Identities = 59/279 (21%), Positives = 103/279 (36%), Gaps = 33/279 (11%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVI-- 113
++F +GRG FG +Y T A+K LD+ + GE NE I++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKM---YAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 114 -GQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVL 172
+V + + +N G L L + + A +I L
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 173 LYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
++H +++ D+KP NILL++ + RISD GLA + K A GT GY+A
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 233 PEWFRKST-ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291
PE +K + D +S G +L +++ F ++ + ++
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVELP 229
Query: 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330
E + ++ +Q D + R
Sbjct: 230 DSFSPELRSLLE----------GLLQRDVNRRLGCLGRG 258
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 6e-41
Identities = 62/278 (22%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQ 115
+F+ +G GSFG ++ + A+K L + + +E +++
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRY---YAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYL 175
H ++R+ G + Q + +++ G L S L + + + A ++ L YL
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
H II+ D+KP+NILL+ + +I+DFG AK + + + GT Y+APE
Sbjct: 121 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 172
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILT-DWAFDCYRNGKLDDLV 292
+ +D +SFG+L+ E+++ F M IL + F + N + DL+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232
Query: 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330
I D S R +
Sbjct: 233 SR--------------------LITRDLSQRLGNLQNG 250
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (357), Expect = 1e-40
Identities = 54/287 (18%), Positives = 110/287 (38%), Gaps = 40/287 (13%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLD---------RVFQDGEKEFKNE 109
+N++ E +GRG ++ + + + T AVK +D Q+ + E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSAEEVQELREATLKE 59
Query: 110 VIVIGQTH-HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI 168
V ++ + H N+++L + L ++ + G L +L + + I +
Sbjct: 60 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK 228
V+ LH I+H D+KP+NILL+D N +++DFG + L ++ + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 229 GYVAPEWFR------KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 282
Y+APE +VD++S GV++ +++ F + ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW---HRKQMLMLRMIMSG 230
Query: 283 YRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ + + + + P R T +
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVS----------RFLVVQPQKRYTAEEA 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 2e-40
Identities = 53/295 (17%), Positives = 93/295 (31%), Gaps = 26/295 (8%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
++G GSFG IY G VA+K + + E + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEE---VAIKLECV--KTKHPQLHIESKIYKMMQGGVGI 65
Query: 123 RLLGFC-DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
+ +C EG ++ E L F F + K + +A Q+ + Y+H S
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 122
Query: 182 QIIHCDIKPQNILLNDR---YNARISDFGLAKLLTLNQRKTI-----KTAIRGTKGYVAP 233
IH D+KP N L+ I DFGLAK + + GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 234 EWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293
S + D+ S G +L+ + + + + ++ L +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVPPNPSPF 348
G + +C +P + Q+ + + F
Sbjct: 243 G---------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 140 bits (353), Expect = 5e-40
Identities = 56/293 (19%), Positives = 111/293 (37%), Gaps = 37/293 (12%)
Query: 60 TDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIG 114
+D ++ E +G G ++ VAVK L F+ E
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRD---VAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 115 QTHHKNLVRLLGFC----DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR 170
+H +V + G + E+++ TL + + +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122
Query: 171 VLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKT-AIRGTKG 229
L + + IIH D+KP NI+++ ++ DFG+A+ + + +T A+ GT
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 230 YVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA---ILTDWAFDCYRNG 286
Y++PE R ++ A+ DVYS G +L E+++ F + A + D R+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 287 KLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339
L ++ +++ + ++P R ++M ++V V
Sbjct: 240 GLSAD-------------LDAVVL---KALAKNPENRYQT--AAEMRADLVRV 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-38
Identities = 57/285 (20%), Positives = 99/285 (34%), Gaps = 25/285 (8%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE-----FKNEVIVIGQTHHK 119
+ +G G F +YK + T VA+KK+ + K+ E+ ++ + H
Sbjct: 4 DFLGEGQFATVYKARDKNTNQ---IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 120 NLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC 179
N++ LL N L ++F+ +L + L L
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT---LQGLEYLH 117
Query: 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE-WFRK 238
I+H D+KP N+LL++ +++DFGLAK + T T+ Y APE F
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 239 STISAKVDVYSFGVLLLEIISCRKSFD----------IEMGEEYAILTDWAFDCYRNGKL 288
VD+++ G +L E++ I W C +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 289 DDLVEGDMEAMNDIKCVEKLLMISI-WCIQEDPSLRPTMRKVSQM 332
+ + L+ I +P R T + +M
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-38
Identities = 59/278 (21%), Positives = 105/278 (37%), Gaps = 44/278 (15%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL------DRVFQDGEKEFKNEVIVIGQ- 115
+G G FG +Y G+ + VA+K + D EV+++ +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNL---PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 116 -THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLL 173
+ ++RLL + + + +L E L + +Q+ +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 174 YLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
+ H ++H DIK +NIL++ +R ++ DFG LL + T+ T GT+ Y
Sbjct: 125 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSP 177
Query: 233 PEWFR-KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291
PEW R V+S G+LL +++ F+ +E I F + + L
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---HDEEIIRGQVFFRQRVSSECQHL 234
Query: 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ WC+ PS RPT ++
Sbjct: 235 IR--------------------WCLALRPSDRPTFEEI 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (342), Expect = 2e-38
Identities = 53/285 (18%), Positives = 106/285 (37%), Gaps = 24/285 (8%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQT 116
+ + E++G G++G++YK T A+KK+ +D E+ ++ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
H N+V+L + +L +E L+ + Q+ + Y H
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
+ ++H D+KPQN+L+N +I+DFGLA+ + RK I
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLM 173
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNGKLDDL 291
S +D++S G + E+++ F + + IL + N
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 292 VEGDMEAMNDIKCVEKLLMISI-------WCIQEDPSLRPTMRKV 329
+ + + L + ++ DP+ R T ++
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 135 bits (341), Expect = 4e-38
Identities = 46/287 (16%), Positives = 92/287 (32%), Gaps = 28/287 (9%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ-THHKNL 121
+G GSFG+I++G VA+K R + + ++E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQ---VAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 122 VRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSS 181
+ F EG + +L + L K + A Q+ + +H
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EK 120
Query: 182 QIIHCDIKPQNILLNDRYN-----ARISDFGLAKLLTLNQRKTI-----KTAIRGTKGYV 231
+++ DIKP N L+ + + DFG+ K K K + GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 232 APEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291
+ S + D+ + G + + + + + + ++ L +L
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338
G E+ + P + + +V+E
Sbjct: 241 CAG---------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-37
Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 36/279 (12%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE------KEFKNEVIVIGQT 116
EE+G G F ++ K ++T A K + + ++ + EV ++ +
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQ---YAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
H N++ L + + +L E + G L FL T QI L ++
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI---LNGVY 127
Query: 177 EDCSSQIIHCDIKPQNILLNDR----YNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVA 232
S QI H D+KP+NI+L DR +I DFGLA + I GT +VA
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 184
Query: 233 PEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292
PE + + D++S GV+ ++S F + +E L ++
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---------------TLANVS 229
Query: 293 EGDMEAMNDI--KCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ E ++ + +DP R T++
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-37
Identities = 59/313 (18%), Positives = 118/313 (37%), Gaps = 25/313 (7%)
Query: 58 EATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIG 114
+ + +G G++G++ VA+KK+ Q + E+ ++
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKV---RVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 115 QTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLY 174
+ H+N++ + + +L + + L+ LK +I + + ++L
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ-RKTIKTAIRGTKGYVAP 233
L S+ ++H D+KP N+LLN + +I DFGLA++ + T T+ Y AP
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 234 EWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNGK 287
E S + +D++S G +L E++S R F + + IL + +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 288 LDDLVEGDMEAMNDIKCVEKLLMISI---------WCIQEDPSLRPTMRKVSQ---MLQE 335
+ + K L + + +P R + + + Q
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 336 VVEVDVPPNPSPF 348
D P +PF
Sbjct: 302 YDPSDEPIAEAPF 314
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 5e-37
Identities = 61/292 (20%), Positives = 110/292 (37%), Gaps = 27/292 (9%)
Query: 59 ATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIV---I 113
A ++ E+G G++G ++K A+ ++ + EV V +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 114 GQTHHKNLVRLLGFC-----DEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQ 167
H N+VRL C D L +E ++ ++ FQ
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 168 IARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGT 227
+ R L +LH ++H D+KPQNIL+ +++DFGLA++ + + T++ T
Sbjct: 125 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVT 178
Query: 228 KGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTDWAFD 281
Y APE +S+ + VD++S G + E+ + F + I D
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 282 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMISI----WCIQEDPSLRPTMRKV 329
R+ L A K V + + C+ +P+ R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-36
Identities = 57/276 (20%), Positives = 106/276 (38%), Gaps = 33/276 (11%)
Query: 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEV-IVIGQTHHKNLV 122
+ +G G G + + + T A+K L + + EV + + ++V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEK---FALKMLQDC-----PKARREVELHWRASQCPHIV 68
Query: 123 RLLGFCD----EGQNRLLAYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARVLLYLH 176
R++ + + L+ E L+ G L S + G+ + I I + YLH
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 177 EDCSSQIIHCDIKPQNILLNDRYN---ARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAP 233
S I H D+KP+N+L + +++DFG AK T + T T YVAP
Sbjct: 129 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAP 182
Query: 234 EWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293
E D++S GV++ ++ F ++ R G+ +
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKV 329
E ++K L+ ++ +P+ R T+ +
Sbjct: 240 EWSEVSEEVK---MLIR---NLLKTEPTQRMTITEF 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-36
Identities = 66/287 (22%), Positives = 119/287 (41%), Gaps = 26/287 (9%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKL--DRVFQDGEKEFKNEVIVIGQT 116
+NF+ E++G G++G++YK + T VA+KK+ D + E+ ++ +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 117 HHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARVLLYL 175
+H N+V+LL L +EFL+ L L + FQ+ + L +
Sbjct: 59 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
H ++H D+KPQN+L+N +++DFGLA+ + R T T Y APE
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEI 173
Query: 236 FRKS-TISAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAIL--------TDWAFDCYR 284
S VD++S G + E+++ R F D E+ + + I W
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 285 NGKLDDLVEGDMEAMNDI--KCVEKLLMISIWCIQEDPSLRPTMRKV 329
+ + + + E + + DP+ R + +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-34
Identities = 50/280 (17%), Positives = 106/280 (37%), Gaps = 22/280 (7%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD--GEKEFKNEVIVIGQTHHKNLV 122
E++G G++G ++K + T VA+K++ D E+ ++ + HKN+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 123 RLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQ 182
RL + L +EF + F N + + + FQ+ L L S
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL---LKGLGFCHSRN 121
Query: 183 IIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTIS 242
++H D+KPQN+L+N ++++FGLA+ + R + F S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYS 180
Query: 243 AKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTDWAFDCYRNGKLDDLVEGDM 296
+D++S G + E+ + + + + +L + + + +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 297 EAMNDIKCVEKLLMISI-------WCIQEDPSLRPTMRKV 329
V + ++ ++ +P R + +
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-34
Identities = 51/293 (17%), Positives = 107/293 (36%), Gaps = 34/293 (11%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG--EKEFKNEVIVIGQTHHKNLV 122
++G+G+FG ++K + T VA+KK+ + E+ ++ H+N+V
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQK---VALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 123 RLLGFCDEGQNR--------LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLY 174
L+ C + L ++F + +K + + + L
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML---LNG 129
Query: 175 LHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL--NQRKTIKTAIRGTKGYVA 232
L+ ++I+H D+K N+L+ +++DFGLA+ +L N + T T Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 233 PEWFRKST-ISAKVDVYSFGVLLLEIISCRKSFDIE--------MGEEYAILTDWAFDCY 283
PE +D++ G ++ E+ + + + +T +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIW-------CIQEDPSLRPTMRKV 329
N +L + +E +K K + + + DP+ R
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 5e-34
Identities = 55/281 (19%), Positives = 101/281 (35%), Gaps = 32/281 (11%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQ 115
++F + +G+G+FG + + T A+K L + +D E V+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRY---YAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYL 175
T H L L E+ N G L L +I + L
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI---VSAL 118
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
S +++ DIK +N++L+ + +I+DFGL K + GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295
+ VD + GV++ E++ R F + E F+ ++
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIRFPRTLS 229
Query: 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRK--VSQMLQ 334
EA + + +++DP R ++++
Sbjct: 230 PEAKSLLA----------GLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 6e-34
Identities = 65/344 (18%), Positives = 128/344 (37%), Gaps = 51/344 (14%)
Query: 35 IRNSPGDGTIETKSRCFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKK 94
+ +PG G + + SY + + +G GSFG++Y+ + + VA+KK
Sbjct: 6 VVATPGQGP--DRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGE---LVAIKK 52
Query: 95 LDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNR------LLAYEFLNNGTLAS 148
+ + ++ E+ ++ + H N+VRL F + L +++
Sbjct: 53 VLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 149 FLFGNLKP---NWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARIS 204
+ +Q+ R L Y+H S I H DIKPQN+LL+ D ++
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLC 165
Query: 205 DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSF 264
DFG AK L + + + I F + ++ +DV+S G +L E++ + F
Sbjct: 166 DFGSAKQL--VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223
Query: 265 DIE------------MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMIS 312
+ +G Y K + + + + + +
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 283
Query: 313 IWCIQEDPSLRPTMRKVSQM--LQEVVEVDV-----PPNPSPFS 349
++ P+ R T + E+ + +V P+ F+
Sbjct: 284 SRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFN 327
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (309), Expect = 7e-33
Identities = 59/275 (21%), Positives = 110/275 (40%), Gaps = 33/275 (12%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKE---FKNEVIVIGQ 115
D F + +G GSFG + + + A+K LD+ K+ NE ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGN---HYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 116 THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYL 175
+ LV+L + N + E++ G + S L + + A QI YL
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 176 HEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEW 235
H S +I+ D+KP+N+L++ + +++DFG AK + K + GT +APE
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 236 FRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295
+ VD ++ GVL+ E+ + F + + ++ +GK+
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVRFPSHFS 262
Query: 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330
+ + ++ +Q D + R K
Sbjct: 263 SDLKDLLR----------NLLQVDLTKRFGNLKNG 287
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-32
Identities = 56/277 (20%), Positives = 101/277 (36%), Gaps = 26/277 (9%)
Query: 61 DNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----QDGEKEFKNEVIVIG 114
+NF+ + +G G++G ++ + + A+K L + + + E V+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 115 Q-THHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLL 173
LV L L +++N G L + L + + +I +L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI---VL 140
Query: 174 YLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAP 233
L II+ DIK +NILL+ + ++DFGL+K GT Y+AP
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAP 199
Query: 234 EWFR--KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291
+ R S VD +S GVL+ E+++ F ++ + +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPPYP 256
Query: 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRK 328
E A + I+ + +DP R
Sbjct: 257 QEMSALAKDLIQ----------RLLMKDPKKRLGCGP 283
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-31
Identities = 68/327 (20%), Positives = 120/327 (36%), Gaps = 40/327 (12%)
Query: 51 FSYKELEEATDNFK------EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE- 103
F +E+ + + + VG G++G + V T VA+KKL R FQ
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGA---KVAIKKLYRPFQSELF 60
Query: 104 -KEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNL----KPNW 158
K E+ ++ H+N++ LL + +F G L K
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 120
Query: 159 NLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218
+ + +Q+ + L Y+H IIH D+KP N+ +N+ +I DFGLA+ Q
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QAD 172
Query: 219 TIKTAIRGTKGYVAPEWFRKST-ISAKVDVYSFGVLLLEIISCRKSFDIE---------- 267
+ T T+ Y APE + VD++S G ++ E+I+ + F
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232
Query: 268 --MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISI--WCIQEDPSLR 323
G A + L E + + I L +++ + D R
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292
Query: 324 PTMRKVSQM--LQEVVEVDVPPNPSPF 348
T + + + + + P +
Sbjct: 293 VTAGEALAHPYFESLHDTEDEPQVQKY 319
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (285), Expect = 1e-29
Identities = 58/331 (17%), Positives = 123/331 (37%), Gaps = 58/331 (17%)
Query: 42 GTIETKSRCF---------SYKELEEAT------DNFK--EEVGRGSFGIIYKGVIQTTT 84
G + +++R + Y + E D+++ ++GRG + +++ + T
Sbjct: 1 GPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN 60
Query: 85 TSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ-THHKNLVRLLGFCDEGQNRLLA--YEFL 141
V VK L V +K+ K E+ ++ N++ L + +R A +E +
Sbjct: 61 EK---VVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114
Query: 142 NNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILL-NDRYN 200
NN ++I + L Y H I+H D+KP N+++ ++
Sbjct: 115 NNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRK 168
Query: 201 ARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPE-WFRKSTISAKVDVYSFGVLLLEIIS 259
R+ D+GLA+ Q ++ ++ + PE +D++S G +L +I
Sbjct: 169 LRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 260 CRKSFDIEMGEEYAIL-------TDWAFDCYRNGKLD-DLVEGDMEAMNDIKCVEKLLMI 311
++ F ++ T+ +D ++ D D+ + K E+ +
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 285
Query: 312 SIW-------------CIQEDPSLRPTMRKV 329
++ D R T R+
Sbjct: 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 5e-29
Identities = 69/329 (20%), Positives = 120/329 (36%), Gaps = 42/329 (12%)
Query: 51 FSYKELE----EATDNFK--EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE- 103
F +EL E + ++ VG G++G + T VAVKKL R FQ
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL---RVAVKKLSRPFQSIIH 60
Query: 104 -KEFKNEVIVIGQTHHKNLVRLLGFCDEGQ-----NRLLAYEFLNNGTLASFLFGNLKPN 157
K E+ ++ H+N++ LL + N + L L + + K
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLT 119
Query: 158 WNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217
+ + +QI R L Y+H IIH D+KP N+ +N+ +I DFGLA
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA-----RHT 171
Query: 218 KTIKTAIRGTKGYVAPEWFRKST-ISAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAIL 275
T T+ Y APE + VD++S G ++ E+++ R F ++ ++
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231
Query: 276 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIW-------------CIQEDPSL 322
E + + + K+ +++ + D
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291
Query: 323 RPTMRKVSQM--LQEVVEVDVPPNPSPFS 349
R T + + + D P P+
Sbjct: 292 RITAAQALAHAYFAQYHDPDDEPVADPYD 320
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-28
Identities = 62/322 (19%), Positives = 118/322 (36%), Gaps = 53/322 (16%)
Query: 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGE--KEFKNEVIVIGQTHHKNLV 122
+ +G G+ GI+ + VA+KKL R FQ+ K E++++ +HKN++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 123 RLLGFC------DEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH 176
LL +E Q+ L E ++ + + + + +Q+ + +LH
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH 136
Query: 177 EDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWF 236
IIH D+KP NI++ +I DFGLA+ + T T+ Y APE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRAPEVI 190
Query: 237 RKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296
VD++S G ++ E++ + F G +Y + + + + +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILF---PGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 297 EAMNDIKCVEKLLMISI----------------------------WCIQEDPSLRPTMRK 328
N ++ K ++ + DP+ R ++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 329 VSQM--LQEVVEVDVPPNPSPF 348
Q + + P P
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQ 329
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.7 bits (247), Expect = 3e-24
Identities = 53/333 (15%), Positives = 107/333 (32%), Gaps = 56/333 (16%)
Query: 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLV 122
++G G F ++ T VA+K + + + ++E+ ++ + + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTH---VAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNT 72
Query: 123 RLLGFCDEGQNRLLAY----------------EFLNNGTLASFLFGNLKPNWNLRTNIAF 166
+ +LL + N + + I+
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 167 QIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTLNQRKTIKTAIR 225
Q+ L Y+H C IIH DIKP+N+L+ + +A L T
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 226 GTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-----------AI 274
T+ Y +PE + D++S L+ E+I+ F+ + G Y +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 275 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISI--------------------W 314
L + RNGK + +I ++ + +
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 315 CIQEDPSLRPTMRKVSQM--LQEVVEVDVPPNP 345
+Q DP R + L++ + ++ P
Sbjct: 311 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVP 343
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.3 bits (192), Expect = 9e-18
Identities = 29/208 (13%), Positives = 61/208 (29%), Gaps = 30/208 (14%)
Query: 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVK----------KLDRVFQDGEKEFKNEV 110
D + +G G ++ + VK K+ G+ F
Sbjct: 2 DAIGKLMGEGKESAVFNC----YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA 57
Query: 111 IVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTN--IAFQI 168
I + + L +L G Y + N L + + + I
Sbjct: 58 IRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMI 112
Query: 169 ARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTK 228
+ + I+H D+ N+L+++ I DF + + + I
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILE----RD 164
Query: 229 GYVAPEWFRKSTISAKVDVYSFGVLLLE 256
+F ++ + D+ S +L+
Sbjct: 165 VRNIITYFSRTY-RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.11 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.89 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.7 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.83 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-57 Score=399.48 Aligned_cols=270 Identities=24% Similarity=0.435 Sum_probs=208.2
Q ss_pred ccCHHHHHHHhhhh-----------hhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCC
Q 046877 50 CFSYKELEEATDNF-----------KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTH 117 (350)
Q Consensus 50 ~~~~~~~~~~~~~~-----------~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~ 117 (350)
.++++++.+++.+| .+.||+|+||+||+|.++.+++....||+|.+.... ....+++.+|++++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 34566666665544 356999999999999988776666779999886533 334467999999999999
Q ss_pred CCceeeecceeecCCeeEEEEecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 046877 118 HKNLVRLLGFCDEGQNRLLAYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196 (350)
Q Consensus 118 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~ 196 (350)
||||+++++++.+++..+++|||+++|+|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+|||++
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVN 162 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEEC
Confidence 999999999999999999999999999999988764 568999999999999999999995 5999999999999999
Q ss_pred CCCceEEeecccccccccCcccce---eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhh
Q 046877 197 DRYNARISDFGLAKLLTLNQRKTI---KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 272 (350)
Q Consensus 197 ~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~ 272 (350)
.++.+||+|||+++.......... .....+|+.|+|||.+.+..++.++|||||||++|||+| |..||......+.
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~ 242 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999987654322211 123457889999999999999999999999999999998 8999975543321
Q ss_pred hhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 273 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
. ..+ ....+.+.+.+++..+.+++.+||+.||++|||++++++.|+++++
T Consensus 243 ~-------~~i---------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 243 I-------NAI---------EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp H-------HHH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred H-------HHH---------HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 111 1122233344577899999999999999999999999999998765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-57 Score=391.15 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=205.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.|++.+.||+|+||+||+|.++.++ +.||+|.++... .+..+++.+|+.++++++||||+++++++.+++..++||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 3567789999999999999987664 569999986543 233456899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+++|+|.+++..+..+++..++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||++.........
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999999888899999999999999999999995 59999999999999999999999999999877554444
Q ss_pred ceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 TIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.......||+.|+|||++.+..+ +.++||||+||++|+|+||+.||............ ... ....
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~------~~~--------~~~~ 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------WKE--------KKTY 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH------HHT--------TCTT
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH------Hhc--------CCCC
Confidence 44456679999999999988776 57899999999999999999999765543322110 001 1111
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+.++++.+++.+||+.||++|||++++++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112235678899999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-57 Score=394.60 Aligned_cols=266 Identities=28% Similarity=0.430 Sum_probs=216.3
Q ss_pred ccCHHHHHHHhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceee
Q 046877 50 CFSYKELEEATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCD 129 (350)
Q Consensus 50 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 129 (350)
.+.-+|+....+++.+.||+|+||.||+|.++.++ ..||+|++... ....+++.+|++++++++||||+++++++.
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGT---EEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCC---eEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 33334455556677889999999999999987653 56999998654 345678999999999999999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecc
Q 046877 130 EGQNRLLAYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 207 (350)
+++..+++|||+++|+|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEcccc
Confidence 99999999999999999999854 3677999999999999999999995 499999999999999999999999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
++........ .......|++.|+|||++.+..++.++|||||||++|||++|..||....+.... ...+
T Consensus 161 ~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~------~~~i---- 229 (287)
T d1opja_ 161 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELL---- 229 (287)
T ss_dssp CTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH------HHHH----
T ss_pred ceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH------HHHH----
Confidence 9987654322 2223445788999999999999999999999999999999987776543332211 1111
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
........+..+++++.+++.+||+.||++|||++++++.|+.+.+
T Consensus 230 -----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 230 -----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -----hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122223334567899999999999999999999999999988764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-56 Score=387.03 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=207.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.|++.+.||+|+||+||+|.+..++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~---~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATG---QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTC---CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCC---CEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 3566788999999999999976554 5699999876655667789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 140 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 140 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
|+++|+|.+++.+ ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.+|.+||+|||++.........
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~- 172 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc-
Confidence 9999999998754 568999999999999999999995 59999999999999999999999999999876543222
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 299 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.....||+.|+|||++.+..++.++||||+||++|+|+||..||...+...... .....+ .....
T Consensus 173 -~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~--------~~~~~ 237 (293)
T d1yhwa1 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNG--------TPELQ 237 (293)
T ss_dssp -BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHC--------SCCCS
T ss_pred -ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCC--------CCCCC
Confidence 244569999999999999999999999999999999999999997554332211 111111 11112
Q ss_pred CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 300 NDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 300 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+..++.++.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23346788999999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-57 Score=391.54 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=200.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.+.+.+.||+|+||.||+|+++. .||+|.++.. .....+.+.+|+.++++++||||+++++++.+ ...+++
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~~------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESSS------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cEEEEEEEeeCCCcEEEEEEECC------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 34567889999999999998543 2899988643 23445789999999999999999999998754 568999
Q ss_pred EecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999999964 4668999999999999999999995 599999999999999999999999999998765544
Q ss_pred ccceeeccccCCCccCcccccCC---CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKS---TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 293 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.........||+.|+|||++.+. .++.++|||||||++|||+||+.||.......... .....+.....
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------~~~~~~~~~p~-- 230 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------FMVGRGYLSPD-- 230 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHHTSCCCC--
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCCCCCc--
Confidence 43334556789999999998643 57889999999999999999999997654433211 11111111100
Q ss_pred ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 294 GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 294 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
....+.++++++.+++.+||+.||++|||++++++.|+.+.+
T Consensus 231 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 ---LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ---GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011223467899999999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=385.05 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=197.2
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+++.+.||+|+||.||+|.+.++ ..||+|+++.. ....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~----~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTT----EEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cEEEEEEeeCCCeEEEEEEECCC----CEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 45678899999999999987543 45999998754 34467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 141 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 141 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
+++|+|.+++... ..+++..++.++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 9999999988644 667899999999999999999995 49999999999999999999999999999876543322
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhC-CCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
......||..|+|||++.+..++.++|||||||++|||+|+ .+||......+.. ..+..+ .+.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~-------~~i~~~---------~~~ 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-------EDISTG---------FRL 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH-------HHHHHT---------CCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHhc---------CCC
Confidence 22345689999999999999999999999999999999995 4455433222111 111111 112
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
..+..++.++.+++.+||+.||++|||++++++.|+++++
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 2223456789999999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=388.60 Aligned_cols=248 Identities=21% Similarity=0.278 Sum_probs=204.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.|++.+.||+|+||.||+|++..++ +.||+|.+... .....+.+.+|++++++++||||+++++++.+++..|+
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATS---REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 3677889999999999999987654 56999998643 23445679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||||+++|+|.+++...+.+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999999888899999999999999999999995 599999999999999999999999999998775444
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.........||+.|+|||++.+..++.++||||+||++|+|+||..||...+..... ..+..+..
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------~~i~~~~~-------- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-------QKIIKLEY-------- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHTTCC--------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-------HHHHcCCC--------
Confidence 333334567999999999999999999999999999999999999999865432211 11112211
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVS 330 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl 330 (350)
..+..+++++.+++.+||+.||++|||++|++
T Consensus 228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11123567899999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=379.97 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=206.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.|++.+.||+|+||.||+|.++.++ ..||+|.+.+.. ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSK---FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCC---cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 3667789999999999999987654 569999886432 3345678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||||+++|+|.+++.....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 99999999999999888889999999999999999999995 599999999999999999999999999997654322
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.. ..+..+..
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~-------- 221 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------KRISRVEF-------- 221 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTCC--------
T ss_pred ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCC--------
Confidence 23456999999999999999999999999999999999999999765433221 11111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..+++++.+++.+||+.||++|||++++++
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 112235678999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=383.14 Aligned_cols=251 Identities=29% Similarity=0.406 Sum_probs=204.0
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCC
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLN 142 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 142 (350)
++||+|+||.||+|.++.+ ...+.||+|.+.... ....+++.+|++++++++||||+++++++.++ ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccC-CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 4699999999999987644 345779999986432 22346799999999999999999999998654 5789999999
Q ss_pred CCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc-cee
Q 046877 143 NGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK-TIK 221 (350)
Q Consensus 143 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 221 (350)
+|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999999888899999999999999999999995 49999999999999999999999999999876543322 222
Q ss_pred eccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCC
Q 046877 222 TAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 300 (350)
Q Consensus 222 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
....||+.|+|||++.+..++.++|||||||++|||+| |..||......+.. ..+..+ .+...
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-------~~i~~~---------~~~~~ 231 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKG---------ERMGC 231 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTT---------CCCCC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-------HHHHcC---------CCCCC
Confidence 34568999999999999999999999999999999998 89999754433211 112222 22223
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 301 DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 301 ~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
+..+++++.+++.+||+.||++|||++++++.|++.
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 345678999999999999999999999999988754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-56 Score=394.03 Aligned_cols=261 Identities=23% Similarity=0.374 Sum_probs=211.0
Q ss_pred HHHHhhhhhhccCCCccceEEEEEEcCCCc--ceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecC
Q 046877 56 LEEATDNFKEEVGRGSFGIIYKGVIQTTTT--STTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEG 131 (350)
Q Consensus 56 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 131 (350)
+....+++.+.||+|+||+||+|.+....+ ....||+|.+.... ......+.+|+.++.++ +||||+++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 333456677899999999999999875443 34568999875432 33446788999999998 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCC-----------------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 046877 132 QNRLLAYEFLNNGTLASFLFGN-----------------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDI 188 (350)
Q Consensus 132 ~~~~lv~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl 188 (350)
+..++||||+++|+|.+++... ..+++..++.++.|+++||+|||+ .+|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccC
Confidence 9999999999999999999643 246888999999999999999995 59999999
Q ss_pred CCCCeEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcc
Q 046877 189 KPQNILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIE 267 (350)
Q Consensus 189 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~ 267 (350)
||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987665554444445668999999999999999999999999999999998 89999754
Q ss_pred cchhhhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 046877 268 MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQ 334 (350)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~ 334 (350)
...... .. .+....+...+..+++++.++|.+||+.||++|||+++|++.|.
T Consensus 271 ~~~~~~------~~---------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDANF------YK---------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHHH------HH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHH------HH---------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 433221 11 11122223334456789999999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=382.90 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=205.2
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
|++.+.||+|+||.||+|++..++ ..||+|.+........+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETS---VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEeEEEeeCCCcEEEEEEECCCC---eEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 566788999999999999977664 56999999876666677899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 141 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 141 ~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
+++|+|.+++.+ ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc--
Confidence 999999998754 4668999999999999999999995 4999999999999999999999999999976543211
Q ss_pred eeeccccCCCccCccccc-----CCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 220 IKTAIRGTKGYVAPEWFR-----KSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
......||+.|+|||++. +..++.++||||+||++|+|+||+.||......+... .+..+..
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~-------~i~~~~~------ 232 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-------KIAKSEP------ 232 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-------HHHHSCC------
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH-------HHHcCCC------
Confidence 123456899999999984 4467899999999999999999999997654433211 1111111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+..++.++.+++.+||+.||++|||++++++
T Consensus 233 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 -PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223356789999999999999999999999865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-55 Score=376.92 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=197.2
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeec----CCeeE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE----GQNRL 135 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~ 135 (350)
++.+.||+|+||+||+|.+..++ ..||+|.+.... ....+.+.+|+++++.++||||+++++++.+ +...+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~---~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCC---eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 45678999999999999976654 468999886542 2334578999999999999999999999854 45679
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEeeccccccccc
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN-DRYNARISDFGLAKLLTL 214 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 214 (350)
++|||+++|+|.+++.+...+++..++.++.|+++||+|||++ +.+|+||||||+|||++ +++.+||+|||++.....
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999998888899999999999999999999954 22399999999999996 578999999999975433
Q ss_pred CcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.. .....||+.|+|||++.+ .++.++||||+||++|||++|+.||......... ...+..+.....
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~------~~~i~~~~~~~~--- 233 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPAS--- 233 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCCCGG---
T ss_pred Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH------HHHHHcCCCCcc---
Confidence 21 234579999999999875 5999999999999999999999999754433221 111122211111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.+...++++.+++.+||+.||++|||++|+++
T Consensus 234 -----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11124567899999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-56 Score=393.42 Aligned_cols=264 Identities=19% Similarity=0.285 Sum_probs=205.5
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
..|++.+.||+|+||+||+|.+..+ +..||+|.++... .....++.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTT---TEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCC---CcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4566778999999999999997655 4679999986543 33356789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||+++|+|.+++.+...+++..++.++.|++.||.|||+. ++|+||||||+|||++++|.+||+|||+|.......
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 99999999999998888899999999999999999999952 379999999999999999999999999998654322
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHH-HHHHhh------------
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW-AFDCYR------------ 284 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~-~~~~~~------------ 284 (350)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......... ......
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2345799999999999999999999999999999999999999976543322111000 000000
Q ss_pred ----------cCCcch----hccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 285 ----------NGKLDD----LVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 285 ----------~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+ ..............+.++.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000 00000011111224578999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-55 Score=374.32 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=209.2
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
+++.+.||+|+||+||+|++++ +..||+|.++.. ....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~----~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETT----TEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred CEEeEEEecCCCeEEEEEEECC----CCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 4577899999999999999753 356899998764 33467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcccc
Q 046877 141 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRKT 219 (350)
Q Consensus 141 ~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 219 (350)
+++|+|..++.. ...+++..+.+++.|+++||+|||+ .+|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 999999998654 4668899999999999999999995 49999999999999999999999999999866544332
Q ss_pred eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccC
Q 046877 220 IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 298 (350)
Q Consensus 220 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
......+|..|+|||.+.+..++.++||||||+++|||+| |+.||......+.. ..+..+ .+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~-------~~i~~~---------~~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-------EHIAQG---------LRL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-------HHHHTT---------CCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH-------HHHHhC---------CCC
Confidence 2244568999999999999999999999999999999998 89999866544321 111111 222
Q ss_pred CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 299 MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 299 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
..+..++.++.+++.+||+.||++|||++++++.|.++
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 22334667899999999999999999999999998653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=381.78 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=204.5
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
..+++.+.||+|+||.||+|.++.+ ..||||+++.. ....+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~----~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTT----EEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEECCC----CEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 4556778899999999999987532 45999998754 3446789999999999999999999998755 5679999
Q ss_pred ecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+++|+|.+++... ..+++..++.++.|+++||.|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999999987544 358999999999999999999995 599999999999999999999999999998765432
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. .......+|+.|+|||++.+..++.++|||||||++|||+||..|+......... ...+.. ..
T Consensus 164 ~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~------~~~i~~---------~~ 227 (272)
T d1qpca_ 164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLER---------GY 227 (272)
T ss_dssp E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHHT---------TC
T ss_pred c-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH------HHHHHh---------cC
Confidence 2 2224456889999999999889999999999999999999976655433222111 111111 12
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
+...+..+++++.+++.+||+.||++|||++++++.|++..
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 22233456788999999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-55 Score=378.95 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=204.1
Q ss_pred ccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEecCCCC
Q 046877 66 EVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEFLNNG 144 (350)
Q Consensus 66 ~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 144 (350)
+||+|+||.||+|.++.+.. ...||||.++... ....+++.+|++++++++||||+++++++.+ +..++||||+++|
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g 93 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKK-QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 93 (285)
T ss_dssp EEECCTTEEEEEEEEC---C-CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EEecccCeEEEEEEEecCCC-cEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCC
Confidence 49999999999998765432 4579999986543 3345679999999999999999999999875 4689999999999
Q ss_pred ChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc-ceee
Q 046877 145 TLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK-TIKT 222 (350)
Q Consensus 145 ~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 222 (350)
+|.+++.. +..+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++......... ....
T Consensus 94 ~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (285)
T d1u59a_ 94 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170 (285)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccccccccc
Confidence 99998754 4678999999999999999999995 59999999999999999999999999999877544322 2223
Q ss_pred ccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccccCCCc
Q 046877 223 AIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 301 (350)
Q Consensus 223 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
...||+.|+|||++.+..++.++|||||||++|||+| |..||......+.. ..+..+. +...+
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-------~~i~~~~---------~~~~p 234 (285)
T d1u59a_ 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGK---------RMECP 234 (285)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTTC---------CCCCC
T ss_pred ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC---------CCCCC
Confidence 4457899999999998999999999999999999998 89999765443221 1122222 22233
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 302 IKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 302 ~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.++++++.+++.+||+.||++|||+.++++.|+...
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 457789999999999999999999999999987653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=378.74 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=192.4
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeec--CCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE--GQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 135 (350)
.|++.+.||+|+||.||+|+++.++ +.||+|.+.... ....+.+.+|+++++.++||||+++++++.+ .+..+
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDG---KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCC---CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 3567789999999999999987664 569999986543 2334568899999999999999999998854 45689
Q ss_pred EEEecCCCCChhhhhcC----CCCcChhHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 136 LAYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARVLLYLHEDC--SSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
+||||+++|+|.+++.+ ...+++..++.++.|+++||+|||+.. ..+|+||||||+|||++.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998853 467899999999999999999999752 235999999999999999999999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
........ ......||+.|+|||++.+..++.++|||||||++|||+||..||...+..+. ...+..+...
T Consensus 162 ~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-------~~~i~~~~~~ 232 (269)
T d2java1 162 RILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKIREGKFR 232 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCCC
T ss_pred eecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCC
Confidence 87654322 22446789999999999999999999999999999999999999975543321 1122222222
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
. .+..+++++.+++.+||+.||++|||++++++
T Consensus 233 ~---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 R---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 12245678999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=381.59 Aligned_cols=259 Identities=23% Similarity=0.427 Sum_probs=201.9
Q ss_pred hhhhccCCCccceEEEEEEcCCC-cceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTT-TSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~-~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
...+.||+|+||.||+|.++.++ .....||+|.+..... ....++.+|+.++++++||||+++++++.+.+..+++||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 45678999999999999987654 3345799999865432 334568999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+.++++.+++.. ...+++..+..++.|++.|++|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 9999999987764 4678999999999999999999995 59999999999999999999999999999876443222
Q ss_pred -ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 219 -TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 219 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.......||+.|+|||++.+..++.++|||||||++|||++|..|+........ ....+. ...+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~------~~~~i~---------~~~~ 231 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAIN---------DGFR 231 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHH---------TTCC
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH------HHHHHh---------ccCC
Confidence 122345688999999999999999999999999999999997666643332221 111111 1222
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.+.+.+++.++.+++.+||+.||++|||++++++.|+++.+
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 33344567899999999999999999999999999998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-54 Score=380.43 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=191.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.|++.+.||+|+||+||+|+++.++ ..||+|.+.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQ---KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTC---CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEeeccCeEEEEEEECCCC---CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3677889999999999999977654 569999987543 233456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCceEEeecccccccccC
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN---DRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~ 215 (350)
||++||+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||++. +++.+||+|||++......
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999999999888899999999999999999999995 5999999999999994 5789999999999866433
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. .....||+.|+|||++.+..++.++||||+||++|+|++|..||......... ..+..+.. .
T Consensus 164 ~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------~~i~~~~~------~ 227 (307)
T d1a06a_ 164 SV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-------EQILKAEY------E 227 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHTTCC------C
T ss_pred Ce---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHhccCC------C
Confidence 22 23456999999999999999999999999999999999999999754433211 11111111 1
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...+...++++++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111222346678999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=377.15 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=200.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
..+++.+.||+|+||.||+|.+..++.....||+|.+..... ...+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 356677899999999999999887766677899999865433 334679999999999999999999999864 678999
Q ss_pred EecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++|+|.+++.. ...+++..++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999998654 4578999999999999999999995 599999999999999999999999999998665332
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||......+.. ..+..+.
T Consensus 163 ~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~-------~~i~~~~-------- 226 (273)
T d1mp8a_ 163 YY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-------GRIENGE-------- 226 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTC--------
T ss_pred ce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCC--------
Confidence 22 2234567899999999999999999999999999999998 88999765543321 1112221
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
..+.+.++++++.+++.+||+.||++|||++++++.|+++++
T Consensus 227 -~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 227 -RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122333567899999999999999999999999999988753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-54 Score=379.61 Aligned_cols=246 Identities=22% Similarity=0.266 Sum_probs=202.7
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..|+..+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|++++++++||||+++++++.+++..+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCC---cEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 44666788999999999999976653 5699999865432 23356889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++||||.+|+|..++..+..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999999998888778889999999999999999999995 59999999999999999999999999999865432
Q ss_pred cccceeeccccCCCccCcccccC---CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRK---STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
....||+.|+|||++.+ ..++.++|||||||++|||++|..||......+... .. ..+.
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~------~i-~~~~----- 230 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HI-AQNE----- 230 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HH-HHSC-----
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HH-HhCC-----
Confidence 23569999999999864 458999999999999999999999997544322111 11 1111
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....+..+++.+.+++.+||+.||++|||++++++
T Consensus 231 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111122345678999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-53 Score=381.69 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=207.1
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.|++.+.||+|+||.||+|.+..++ ..||+|++........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATG---NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTT---EEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4677889999999999999976653 5699999876655556779999999999999999999999999999999999
Q ss_pred cCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCCceEEeecccccccccCc
Q 046877 140 FLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN--DRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 140 ~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|+++|+|.+++. ....+++..++.++.||+.||+|||+ .+++||||||+|||++ .++.+||+|||++.......
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999999985 45679999999999999999999995 5999999999999996 46789999999998765433
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. .....||+.|+|||++.+..++.++||||+||++|+|+||+.||...+..+.. ..+..+... .
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~~------~ 244 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-------RNVKSCDWN------M 244 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCC------S
T ss_pred c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC------C
Confidence 2 24456899999999999999999999999999999999999999765443321 111111111 0
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......+++++.+++.+||+.||++|||++++++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111235678999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-54 Score=380.63 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=211.2
Q ss_pred hhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeeccccc-cHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVFQD-GEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+++.+.||+|+||+||+|+.+. ...++..||+|+++..... ..+++.+|+.+++.++||||+++++++...+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 45667899999999999999764 2345678999998754333 34679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCC------------------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046877 137 AYEFLNNGTLASFLFGN------------------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQN 192 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N 192 (350)
+|||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccc
Confidence 99999999999998532 236888999999999999999994 599999999999
Q ss_pred eEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCC-CCCCcccchh
Q 046877 193 ILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCR-KSFDIEMGEE 271 (350)
Q Consensus 193 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~-~pf~~~~~~~ 271 (350)
||++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++|. .||......+
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 999999999999999998765544444444566889999999999999999999999999999999986 5666544333
Q ss_pred hhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.. ..+..+... ..+..++.++.+++.+||+.||++||||.+|+++|+++.+
T Consensus 251 ~~-------~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 251 VI-------YYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HH-------HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HH-------HHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 21 112223221 1223456789999999999999999999999999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=374.34 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=203.8
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
..+++.+.||+|+||.||+|.++++ ..||+|.+... ....+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~----~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT----EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC----CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 3567788999999999999987654 34899998654 3446789999999999999999999999855 5689999
Q ss_pred ecCCCCChhhhhcC--CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 139 EFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 139 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||+++|+|..++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999988854 3568999999999999999999995 499999999999999999999999999998664332
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. .......+|+.|+|||++.+..++.++||||||+++|||+||..||......... ...+.. ..
T Consensus 168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~------~~~i~~---------~~ 231 (285)
T d1fmka3 168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVER---------GY 231 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHHT---------TC
T ss_pred c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH------HHHHHh---------cC
Confidence 2 2224456899999999999999999999999999999999977666433322211 111111 11
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCC
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~ 342 (350)
..+.+..++.++.+++.+||+.||++|||+++|++.|++......|
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 2223335678999999999999999999999999999998766555
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.9e-53 Score=379.35 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=207.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 139 (350)
.|++.+.||+|+||.||+|.+..++ ..||+|.+..........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATG---RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCC---CEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4677789999999999999976653 5699999876655556678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCCceEEeecccccccccCc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN--DRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||++.......
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999999887654 468999999999999999999995 5999999999999997 67899999999998776443
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. .....||+.|+|||++.+..++.++||||+||++|+|+||..||......... ..+..+... .
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-------~~i~~~~~~------~ 247 (352)
T d1koba_ 184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-------QNVKRCDWE------F 247 (352)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHHCCCC------C
T ss_pred c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC------C
Confidence 2 24456899999999999999999999999999999999999999765443321 111111111 1
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.......++.++.+|+.+||+.||.+|||++++++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122245678999999999999999999999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-53 Score=373.67 Aligned_cols=247 Identities=22% Similarity=0.247 Sum_probs=207.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc---ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV---FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.+++.+.||+|+||.||+|+.+.++ ..||+|++.+. .....+++.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~---~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATG---RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 3567789999999999999977654 56999998753 23446778999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
||||+++|+|.+++.....+++..++.++.|++.||+|||+ .+|+||||||+|||++.+|.+||+|||++.......
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999999988899999999999999999999994 599999999999999999999999999998654332
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+.. ..+..+..
T Consensus 160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-------~~i~~~~~-------- 222 (337)
T d1o6la_ 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILMEEI-------- 222 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC--------
T ss_pred c--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH-------HHHhcCCC--------
Confidence 2 223457999999999999999999999999999999999999999866543321 11111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPT-----MRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~vl~ 331 (350)
..+..++.++.+|+.+||+.||.+||+ ++++++
T Consensus 223 --~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112235678999999999999999995 777765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-54 Score=370.41 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=201.2
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
+++.+.||+|+||.||+|++....+....||+|++.... ....+++.+|+.++++++||||+++++++.+ ...+++
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 566788999999999999987766666779999986432 2334679999999999999999999999976 467899
Q ss_pred EecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 999999999987754 4568999999999999999999995 599999999999999999999999999999775543
Q ss_pred ccce-eeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccc
Q 046877 217 RKTI-KTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 294 (350)
Q Consensus 217 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.... .....++..|+|||++.+..++.++||||||+++|||+| |..||...+..+... .+...
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~---------------~i~~~ 230 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---------------KIDKE 230 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---------------HHHTS
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH---------------HHHhC
Confidence 3222 234457889999999999999999999999999999998 899997554433211 11111
Q ss_pred cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q 046877 295 DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEV 336 (350)
Q Consensus 295 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~ 336 (350)
..+.+.+.+++..+.+++.+||+.||++|||++++.+.|+++
T Consensus 231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 222233345678899999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=371.35 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=205.6
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc------ccHHHHHHHHHHHhcCCCCceeeecceeecCC
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ------DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ 132 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 132 (350)
..|++.+.||+|+||+||+|.++.++ ..||+|.+.+... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~---~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTG---LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCC---CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34677789999999999999986654 5699998864321 23577999999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----ceEEeeccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY----NARISDFGL 208 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~ 208 (350)
..++||||+++|+|.+++.....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++ .+|++|||+
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999999888889999999999999999999995 5999999999999998776 499999999
Q ss_pred ccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 209 AKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
+......... ....+|+.|+|||++.+..++.++||||+||++|+|+||+.||...+..+.. ..+..+..
T Consensus 164 a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------~~i~~~~~ 233 (293)
T d1jksa_ 164 AHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------ANVSAVNY 233 (293)
T ss_dssp CEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHTTCC
T ss_pred hhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH-------HHHHhcCC
Confidence 9876543222 3456899999999999999999999999999999999999999865433321 11111111
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.. ......+++..+.+++.+||+.||++|||++++++
T Consensus 234 ~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 EF------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 00011134678999999999999999999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-54 Score=376.29 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=200.6
Q ss_pred HHhhhhhhccCCCccceEEEEEEcCCC--cceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeec-CC
Q 046877 58 EATDNFKEEVGRGSFGIIYKGVIQTTT--TSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDE-GQ 132 (350)
Q Consensus 58 ~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~ 132 (350)
...+++.+.||+|+||.||+|.+.... ..++.||+|++.... ....+.+.+|...+.++ +|+||+.+++++.+ +.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 345677789999999999999987543 345789999986433 23345677787777776 79999999998765 45
Q ss_pred eeEEEEecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 046877 133 NRLLAYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~ 196 (350)
..+++|||+++|+|.+++... ..+++..++.++.|+++||+|||+ .+|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 689999999999999998533 347889999999999999999995 5999999999999999
Q ss_pred CCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCC-CCCCcccchhhhhH
Q 046877 197 DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAIL 275 (350)
Q Consensus 197 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~-~pf~~~~~~~~~~~ 275 (350)
+++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||. .||.........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~-- 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 99999999999998765544443334567899999999999999999999999999999999875 577644332211
Q ss_pred HHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 276 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
...+..+. ....+..+++++.+++.+||+.||++|||++++++.|+++++
T Consensus 247 ----~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 ----CRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ----HHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111221 122223456789999999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=371.72 Aligned_cols=259 Identities=24% Similarity=0.450 Sum_probs=204.9
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc-ccccHHHHHHHHHHHhcCCCCceeeecceeec-CCeeEEEEe
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE-GQNRLLAYE 139 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 139 (350)
+|.+.||+|+||+||+|.+..++.....||+|.++.. .....+++.+|++++++++||||+++++++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 3456799999999999998776655567999998643 33445779999999999999999999999764 568899999
Q ss_pred cCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 140 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 140 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
|+++|+|.+++... ...++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||++.........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999988644 456788899999999999999994 59999999999999999999999999999876543222
Q ss_pred c--eeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 219 T--IKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 219 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. ......||..|+|||.+.+..++.++||||||+++|||+||+.||........ .. ..+..+ .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~----~~i~~g---------~ 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--IT----VYLLQG---------R 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH----HHHHTT---------C
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcC---------C
Confidence 1 22345688999999999999999999999999999999998888764332211 11 111111 1
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
+...+..+++++.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 222233466789999999999999999999999999998864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-52 Score=366.57 Aligned_cols=243 Identities=24% Similarity=0.317 Sum_probs=205.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
|++.+.||+|+||+||+|+++.++ +.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNG---RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCcCcEEEEEEECCCC---CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 567789999999999999976654 569999986432 33457799999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|||++||+|..++.....+++..++.++.|++.|++||| +.+|+||||||+|||++.+|.+||+|||++.......
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 999999999999998889999999999999999999999 5699999999999999999999999999998765332
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
....||+.|+|||++.+..++.++||||+||++|+|+||+.||...+..+.. ..+..+..
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~i~~~~~--------- 218 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-------EKILNAEL--------- 218 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHCCC---------
T ss_pred ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH-------HHHHcCCC---------
Confidence 3456999999999999999999999999999999999999999765433221 11111111
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
..+...+.++.+++.+||..||.+|+ |++++++
T Consensus 219 -~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11123467899999999999999996 8999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-54 Score=368.44 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=196.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeec-CCeeEEEEe
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE-GQNRLLAYE 139 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 139 (350)
+++.+.||+|+||.||+|.++. ..||+|+++.. ...+++.+|++++++++||||+++++++.+ .+..++|||
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~-----~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYRG-----NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-----EEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred eEEeEEEecCCCeEEEEEEECC-----eEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 4567889999999999998742 35999998653 345779999999999999999999998854 566899999
Q ss_pred cCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 140 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 140 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|+++|+|.+++... ..+++..+++++.|++.||.|||+ .+++||||||+||+++.++.+|++|||++.......
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 99999999999644 347999999999999999999995 599999999999999999999999999998654322
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
....++..|+|||++.+..+++++||||||+++|||+| |+.||......+.. ..+. ...
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~-------~~i~---------~~~ 217 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVE---------KGY 217 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-------HHHT---------TTC
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHH---------cCC
Confidence 23457889999999999999999999999999999998 67787654433221 1111 122
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCC
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEV 339 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~ 339 (350)
+.+.+..++.++.+++.+||+.||++|||+.++++.|+++...
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 2333445678999999999999999999999999999987643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=368.44 Aligned_cols=261 Identities=26% Similarity=0.385 Sum_probs=208.3
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCC----cceeEEEEEeeecccc-ccHHHHHHHHHHHhcC-CCCceeeecceeecCC
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTT----TSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQ 132 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~----~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 132 (350)
..+++.+.||+|+||.||+|+...+. .....||+|++..... ....++.+|...+.++ +||||+++++++.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 35567789999999999999876543 2346799999875443 3346788888888888 8999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 046877 133 NRLLAYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLN 196 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~ 196 (350)
..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 999999999999999999644 347899999999999999999995 5999999999999999
Q ss_pred CCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhH
Q 046877 197 DRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 275 (350)
Q Consensus 197 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~ 275 (350)
.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---- 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH----
Confidence 999999999999987765544444455668899999999999999999999999999999998 688886444322
Q ss_pred HHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 276 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
....+..+ .....+..++.++.+++.+||+.||++|||+.++++.|++++.
T Consensus 246 ---~~~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 ---LFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11222222 2222233466789999999999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=371.58 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=203.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcc-eeEEEEEeeecc-ccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTS-TTAVAVKKLDRV-FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~-~~~vavk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+++.+.||+|+||+||+|.+..+++. ...||+|.+... .....+++.+|+.++++++||||+++++++.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 56678999999999999998765432 345889987643 334567899999999999999999999999875 567888
Q ss_pred ecCCCCChhhhhcC-CCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCcc
Q 046877 139 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 139 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 217 (350)
+|+.+|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 99999999887754 4678999999999999999999995 5999999999999999999999999999987765544
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
........||+.|+|||++.+..++.++|||||||++|||+| |..||......+... .+.. +.
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-------~i~~---------~~ 230 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEK---------GE 230 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-------HHHH---------TC
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHc---------CC
Confidence 444445568999999999999999999999999999999998 788887554333211 1111 22
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
+.+.+..++.++.+++.+||+.||++|||+.++++.|+.+.
T Consensus 231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 22333456789999999999999999999999999887653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=364.86 Aligned_cols=265 Identities=21% Similarity=0.252 Sum_probs=200.2
Q ss_pred hhccCCCccceEEEEEEcCCCcceeEEEEEeeecccccc-----HHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 64 KEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDG-----EKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 64 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.+.||+|+||+||+|.+..+ ++.||+|++....... .+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNT---NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp EEEEEEETTEEEEEEECSSC---CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred ceEeccCcCeEEEEEEECCC---CcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehh
Confidence 36799999999999997655 3569999986432221 246889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+.++++..+......+++..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++.........
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 999999888888777889999999999999999999995 59999999999999999999999999999866543222
Q ss_pred ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc----
Q 046877 219 TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE---- 293 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 293 (350)
.....||+.|+|||++.+. .++.++||||+||++|||+||..||......+................+.....
T Consensus 157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred --ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 2345689999999998754 679999999999999999999999976654432211110000000000000000
Q ss_pred ---ccccCCC----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcc
Q 046877 294 ---GDMEAMN----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEV 336 (350)
Q Consensus 294 ---~~~~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~ 336 (350)
....... ....++++.+|+.+||+.||++|||++|+++ .|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000000 0134578999999999999999999999986 45443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=370.66 Aligned_cols=265 Identities=24% Similarity=0.397 Sum_probs=215.1
Q ss_pred HHHHHhhhhhhccCCCccceEEEEEEcC--CCcceeEEEEEeeecccc-ccHHHHHHHHHHHhcC-CCCceeeecceeec
Q 046877 55 ELEEATDNFKEEVGRGSFGIIYKGVIQT--TTTSTTAVAVKKLDRVFQ-DGEKEFKNEVIVIGQT-HHKNLVRLLGFCDE 130 (350)
Q Consensus 55 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 130 (350)
|+....+++.+.||+|+||.||+|++.. +....+.||+|++..... .....+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 3444566778899999999999998753 335567899999875433 3345688999999999 79999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhcCC------------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046877 131 GQNRLLAYEFLNNGTLASFLFGN------------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQN 192 (350)
Q Consensus 131 ~~~~~lv~e~~~~g~L~~~l~~~------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N 192 (350)
....+++|||+++|+|.+++... ..+++..+..++.|+++|++|||+ .+++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccc
Confidence 99999999999999999998643 257889999999999999999995 599999999999
Q ss_pred eEEcCCCceEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhC-CCCCCcccchh
Q 046877 193 ILLNDRYNARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISC-RKSFDIEMGEE 271 (350)
Q Consensus 193 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~pf~~~~~~~ 271 (350)
|+++.++.+|++|||++................||+.|+|||.+.+..++.++||||||+++|||+|+ .+||......+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999977655554555567789999999999999999999999999999999995 55554433322
Q ss_pred hhhHHHHHHHHhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 272 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.. ..++..+.+...+..++.++.+|+.+||+.||++|||++++++.|++.+
T Consensus 256 ~~---------------~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 256 KF---------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HH---------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---------------HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 11 1111122222333345688999999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=367.71 Aligned_cols=259 Identities=28% Similarity=0.454 Sum_probs=206.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcC-CCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
+++.+.||+|+||.||+|.++.++. ...||+|++.... .+..+.+.+|+++++++ +||||+++++++.+++..++||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTE-EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCe-EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 3467889999999999999876643 3457888876433 33455799999999998 7999999999999999999999
Q ss_pred ecCCCCChhhhhcCC----------------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceE
Q 046877 139 EFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNAR 202 (350)
Q Consensus 139 e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~k 202 (350)
||+++|+|.+++... ..+++..+..++.|++.|+.|||+ .+++||||||+|||++.++.+|
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceE
Confidence 999999999998643 567899999999999999999995 4999999999999999999999
Q ss_pred EeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCC-CCCcccchhhhhHHHHHHH
Q 046877 203 ISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRK-SFDIEMGEEYAILTDWAFD 281 (350)
Q Consensus 203 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~-pf~~~~~~~~~~~~~~~~~ 281 (350)
|+|||++......... ....+|..|+|||.+.+..++.++||||||+++|||++|.. ||...+..+. ..
T Consensus 168 l~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~-------~~ 237 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------YE 237 (309)
T ss_dssp ECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HH
T ss_pred Eccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH-------HH
Confidence 9999999755432221 23458999999999999999999999999999999999765 5654332221 11
Q ss_pred HhhcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccCCCCC
Q 046877 282 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVEVDVP 342 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~~~~~ 342 (350)
.+..+ .+...+.++++++.+++.+||+.||++|||++++++.|+++.+...+
T Consensus 238 ~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 238 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred HHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 11111 22223345678999999999999999999999999999998765443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-51 Score=357.37 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=204.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc---------cHHHHHHHHHHHhcCC-CCceeeecceee
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD---------GEKEFKNEVIVIGQTH-HKNLVRLLGFCD 129 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~---------~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 129 (350)
.|++.+.||+|+||+||+|++..+ ++.+|+|++...... ..+.+.+|+.++++++ ||||+++++++.
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~---~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cCEEceEEecCcCeEEEEEEECCC---CCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 356678899999999999997655 467999998654321 1245889999999996 999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccc
Q 046877 130 EGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLA 209 (350)
Q Consensus 130 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 209 (350)
+++..|+||||+++|+|.+++..+..+++..++.++.||++||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999998888999999999999999999999954 9999999999999999999999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccC------CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRK------STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 283 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 283 (350)
........ .....||+.|+|||.+.+ ..++.++||||+||++|+|+||+.||......... ..+
T Consensus 158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-------~~i 227 (277)
T d1phka_ 158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RMI 227 (277)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHH
T ss_pred eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-------HHH
Confidence 87754322 244568999999999852 35688999999999999999999999865433321 111
Q ss_pred hcCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 284 RNGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+... .......++++++.+++.+||+.||++|||++++++
T Consensus 228 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112111 122223356789999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4e-52 Score=361.58 Aligned_cols=259 Identities=21% Similarity=0.286 Sum_probs=202.1
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc---ccHHHHHHHHHHHhcCCCCceeeecceeecCC----
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ---DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ---- 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 132 (350)
.|++.+.||+|+||.||+|.+..++ +.||+|.+..... ....++.+|+++++.++||||+++++++...+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLH---RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCC---CEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3567789999999999999976653 5699999865432 23456899999999999999999999986543
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
..|+||||++|++|..++.....+++..++.++.|+++|++|||+ .+++||||||+||+++.++..+++|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence 378999999999999999888899999999999999999999995 59999999999999999999999999998765
Q ss_pred ccCcc-cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchh
Q 046877 213 TLNQR-KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 291 (350)
Q Consensus 213 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..... ........||+.|+|||++.+..++.++||||+||++|+|+||+.||......+.. ......+...
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~~-- 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIP-- 233 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCC--
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCCCC--
Confidence 43322 22234557899999999999999999999999999999999999999765433321 1111221111
Q ss_pred ccccccCCCcHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhccc
Q 046877 292 VEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRP-TMRKVSQMLQEVV 337 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~vl~~L~~~~ 337 (350)
......++++++.+++.+||+.||++|| |++++++.|.++.
T Consensus 234 -----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111123567899999999999999999 8999999887764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-51 Score=367.75 Aligned_cols=244 Identities=22% Similarity=0.232 Sum_probs=204.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 136 (350)
.|++.+.||+|+||.||+|+++.++ ..||+|.+.+.. ....+.+.+|+++++.++||||+++++++.+....++
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g---~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESG---NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCC---CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 4566788999999999999987664 469999986432 3345678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
+|||+.+|+|..++.....+++..++.++.||+.||.|||+ .+|+||||||+|||++.+|.+||+|||++.......
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 99999999999999888889999999999999999999995 599999999999999999999999999998765332
Q ss_pred ccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhccccc
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 296 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
....||+.|+|||++.+..++.++|||||||++|+|+||..||...+..... ..+..+..
T Consensus 196 -----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~i~~~~~-------- 255 (350)
T d1rdqe_ 196 -----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-------EKIVSGKV-------- 255 (350)
T ss_dssp -----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC--------
T ss_pred -----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH-------HHHhcCCC--------
Confidence 3456899999999999999999999999999999999999999755432211 11111111
Q ss_pred cCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046877 297 EAMNDIKCVEKLLMISIWCIQEDPSLRP-----TMRKVSQ 331 (350)
Q Consensus 297 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~vl~ 331 (350)
..+..++.++.+++.+||+.||.+|+ |++++++
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11223567899999999999999994 8999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-51 Score=368.20 Aligned_cols=248 Identities=23% Similarity=0.253 Sum_probs=199.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHH---HHHHHhcCCCCceeeecceeecCCe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKN---EVIVIGQTHHKNLVRLLGFCDEGQN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~ 133 (350)
.|++.+.||+|+||.||+|++..++ ..||+|.+.... ......+.+ ++++++.++||||+++++++.+.+.
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~---~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCC---CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 3566789999999999999977664 569999986432 122233444 4677888899999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccc
Q 046877 134 RLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLT 213 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 213 (350)
.|+||||+++|+|.+++.....+++..++.++.||+.||.|||+ .+++||||||+|||++.+|.+||+|||++....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999999888889999999999999999999995 599999999999999999999999999998665
Q ss_pred cCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 214 LNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.... ....||+.|+|||++.+ ..++.++|||||||++|+|+||+.||..........+. ....
T Consensus 159 ~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~-------- 222 (364)
T d1omwa3 159 KKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL-------- 222 (364)
T ss_dssp SSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSS--------
T ss_pred CCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hhcc--------
Confidence 4321 34569999999999975 56899999999999999999999999865443322111 0000
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT-----MRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~vl~ 331 (350)
......+..+++++.++|.+||+.||++||| ++++++
T Consensus 223 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 223 --TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0111112235678999999999999999999 688864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=363.36 Aligned_cols=248 Identities=20% Similarity=0.275 Sum_probs=202.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEEec
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAYEF 140 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 140 (350)
|.+.+.||+|+||+||+|.+..++ ..||+|.+.... .....+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~---~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSK---KTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEEEEEEecCCCeEEEEEEECCCC---cEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 566789999999999999977664 569999987543 3345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCC-CcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--CCceEEeecccccccccCcc
Q 046877 141 LNNGTLASFLFGNL-KPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND--RYNARISDFGLAKLLTLNQR 217 (350)
Q Consensus 141 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~ 217 (350)
|+||+|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+|||++. .+.+||+|||++........
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999997654 78999999999999999999995 59999999999999985 45799999999987654322
Q ss_pred cceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccccc
Q 046877 218 KTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 297 (350)
Q Consensus 218 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.....+++.|+|||.+.+..++.++||||+||++|+|++|..||...+..+.. ..+..+.... ..
T Consensus 160 ---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~-------~~i~~~~~~~-~~---- 224 (321)
T d1tkia_ 160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII-------ENIMNAEYTF-DE---- 224 (321)
T ss_dssp ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHTCCCC-CH----
T ss_pred ---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCCC-Ch----
Confidence 23446899999999999999999999999999999999999999765543221 1111111100 00
Q ss_pred CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 298 AMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 298 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
.....++.++.+++.+||..||++|||++++++
T Consensus 225 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 -EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000124578999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=364.95 Aligned_cols=246 Identities=25% Similarity=0.320 Sum_probs=202.3
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc---cccHHHHHHHHHHHh-cCCCCceeeecceeecCCeeE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF---QDGEKEFKNEVIVIG-QTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~ 135 (350)
.|++.+.||+|+||+||+|++..++ +.||+|.+.+.. ....+.+..|..++. .++||||+++++++.+++..|
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~---~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTN---QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCC---CEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 3567789999999999999987664 579999986432 233455666666655 689999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
+||||+++|+|.+++.....+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||++......
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999999888889999999999999999999995 49999999999999999999999999999865543
Q ss_pred cccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcccc
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......||+.|+|||++.+..++.++||||+||++|+|+||+.||.+.+..... ..+..+..
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~~~~~------- 220 (320)
T d1xjda_ 157 DA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIRMDNP------- 220 (320)
T ss_dssp TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC-------
T ss_pred cc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCC-------
Confidence 22 224457899999999999999999999999999999999999999865543321 11111111
Q ss_pred ccCCCcHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 046877 296 MEAMNDIKCVEKLLMISIWCIQEDPSLRPTMR-KVS 330 (350)
Q Consensus 296 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-~vl 330 (350)
..+..++.++.+++.+||+.||++|||+. +++
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 11123567899999999999999999995 665
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=363.84 Aligned_cols=261 Identities=25% Similarity=0.431 Sum_probs=211.1
Q ss_pred HhhhhhhccCCCccceEEEEEEcCC--CcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeE
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTT--TTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRL 135 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 135 (350)
..+++.+.||+|+||.||+|.+... ......||||+++... ......+.+|+.++++++||||+++++++..+...+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 4456678899999999999987532 2345679999987543 233356899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCC----------CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEee
Q 046877 136 LAYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISD 205 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D 205 (350)
+||||+++|+|.+++... ..+++..+..++.|+++||.|||+ .+|+||||||+|||+++++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 999999999999988532 346888999999999999999995 4999999999999999999999999
Q ss_pred cccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCC-CCCCcccchhhhhHHHHHHHHhh
Q 046877 206 FGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYR 284 (350)
Q Consensus 206 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~ 284 (350)
||++................+|+.|+|||.+.+..++.++||||||+++|||+||. .||......+.. ..+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~-------~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-------RFVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-------HHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHH
Confidence 99998765544433334456899999999999999999999999999999999985 666544332211 1112
Q ss_pred cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 285 NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
++. ....+..++..+.+++.+||+.||++|||++++++.|++.++
T Consensus 250 ~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222 122233467889999999999999999999999999988765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-51 Score=361.08 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=194.6
Q ss_pred hhhh-hccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhc-CCCCceeeecceeec----CCee
Q 046877 61 DNFK-EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQ-THHKNLVRLLGFCDE----GQNR 134 (350)
Q Consensus 61 ~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~ 134 (350)
|.+. +.||+|+||.||+|.+..++ +.||+|+++. ...+.+|+.++.+ .+||||+++++++++ ....
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~---~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQ---EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCC---CEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4444 45999999999999976654 5699999853 3457789988655 589999999999865 4668
Q ss_pred EEEEecCCCCChhhhhcCC--CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEeecccc
Q 046877 135 LLAYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND---RYNARISDFGLA 209 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~ 209 (350)
|+|||||+||+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++ ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 9999999999999999754 468999999999999999999995 59999999999999985 567999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
......... ....||+.|+|||++.+..++.++||||+||++|+|+||+.||........... . ..
T Consensus 162 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~--------~~ 227 (335)
T d2ozaa1 162 KETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---M--------KT 227 (335)
T ss_dssp EECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred eeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---H--------HH
Confidence 876543322 345699999999999999999999999999999999999999976543332110 0 00
Q ss_pred hhccccccC--CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 290 DLVEGDMEA--MNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 290 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......... .....+++++.+|+.+||+.||++|||++++++
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111111 122356789999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=358.65 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=195.8
Q ss_pred hhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeecCC----eeEEE
Q 046877 62 NFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ----NRLLA 137 (350)
Q Consensus 62 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 137 (350)
.+.+.||+|+||.||+|++. +..||+|+++... ........|+..+..++||||+++++++.+.+ ..++|
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~~-----g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKWR-----GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp EEEEEEECCSSSEEEEEEET-----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEC-----CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 45678999999999999863 2469999986432 22222344555666789999999999986543 57899
Q ss_pred EecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 138 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHED-----CSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 138 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
|||+++|+|.+++++ ..+++..+++++.|++.|++|||+. ..++|+||||||+||||+.++.+||+|||++...
T Consensus 80 ~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999999965 4689999999999999999999952 1369999999999999999999999999999876
Q ss_pred ccCcccc--eeeccccCCCccCcccccCCC------CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhh--------HH
Q 046877 213 TLNQRKT--IKTAIRGTKGYVAPEWFRKST------ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--------LT 276 (350)
Q Consensus 213 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~--------~~ 276 (350)
....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||.......... ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 5433221 223567999999999987543 5678999999999999999998885433221110 00
Q ss_pred HHHHHHhhcCCcchhccccc-cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 277 DWAFDCYRNGKLDDLVEGDM-EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
.........+... +.. ......+.+..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 239 ~~~~~~~~~~~~~----p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 239 EEMRKVVCEQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTTSCCC----CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccccC----CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0111111111110 010 111233567789999999999999999999999999987753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=350.19 Aligned_cols=269 Identities=23% Similarity=0.285 Sum_probs=199.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLA 137 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 137 (350)
.|++.+.||+|+||+||+|.+..++ +.||+|.+.... .....++.+|++++++++||||+++++++.+++..++|
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTG---EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCC---CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 3556788999999999999976654 569999985432 23356789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhc-CCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCc
Q 046877 138 YEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQ 216 (350)
Q Consensus 138 ~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 216 (350)
|||+.++.+..... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99998755544433 34668999999999999999999995 599999999999999999999999999998665432
Q ss_pred ccceeeccccCCCccCcccccCCC-CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc---
Q 046877 217 RKTIKTAIRGTKGYVAPEWFRKST-ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV--- 292 (350)
Q Consensus 217 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 292 (350)
.. .....||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+..+.....................
T Consensus 157 ~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp BC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 22 23456899999999987665 5789999999999999999999998655433221110000000000011000
Q ss_pred cccc---c-CCC-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcc
Q 046877 293 EGDM---E-AMN-----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEV 336 (350)
Q Consensus 293 ~~~~---~-~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~ 336 (350)
.... . ... ....+.++.+++.+||+.||++|||++++++ .++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000 0 000 1134578899999999999999999999986 35544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-51 Score=352.34 Aligned_cols=239 Identities=23% Similarity=0.412 Sum_probs=194.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccc------cHHHHHHHHHHHhcCC--CCceeeecceeecC
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQD------GEKEFKNEVIVIGQTH--HKNLVRLLGFCDEG 131 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~------~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~ 131 (350)
.|++.+.||+|+||.||+|.+..++ ..||+|.+...... ...++.+|+.++++++ ||||+++++++.+.
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCC---CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4667789999999999999976654 56999988643211 1234678999999986 89999999999999
Q ss_pred CeeEEEEecCCC-CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEeecccc
Q 046877 132 QNRLLAYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND-RYNARISDFGLA 209 (350)
Q Consensus 132 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~ 209 (350)
+..+++|||+.+ +++.+++..+..+++..++.++.|+++||+|||+ .+|+||||||+||+++. ++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 999999999976 5788888878889999999999999999999995 59999999999999985 579999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccCCCC-CCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCc
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTI-SAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 288 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
....... .....||+.|+|||++.+..+ +.++||||+||++|+|+||+.||...... ..+..
T Consensus 159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i-------------~~~~~ 221 (273)
T d1xwsa_ 159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------------IRGQV 221 (273)
T ss_dssp EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------------HHCCC
T ss_pred eeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH-------------hhccc
Confidence 8654322 234569999999999987665 56789999999999999999999743210 01110
Q ss_pred chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
..+..++.++.+++.+||+.||++|||++++++
T Consensus 222 ----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 ----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011134678999999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-49 Score=346.20 Aligned_cols=262 Identities=21% Similarity=0.252 Sum_probs=199.4
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|+..+.||+|+||+||+|++++ ++.||+|++.... ....+++.+|+.++++++||||+++++++.+.+..+++|
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNY----GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETT----SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ceeccEEecCCCcEEEEEEeCC----CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 4566889999999999998753 3569999986532 333578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
||+.++.+..+......+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||.+.........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 999998888888778889999999999999999999995 49999999999999999999999999999876543222
Q ss_pred ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhcc----
Q 046877 219 TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE---- 293 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 293 (350)
.....+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+................+.....
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 157 --YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred --cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 2344588999999998764 568999999999999999999999976544332111110000000000000000
Q ss_pred --------ccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 294 --------GDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 294 --------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...........+..+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001112234578999999999999999999999973
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=346.25 Aligned_cols=265 Identities=21% Similarity=0.256 Sum_probs=195.3
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcC---CCCceeeecceee----
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQT---HHKNLVRLLGFCD---- 129 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~---- 129 (350)
..|++.+.||+|+||+||+|.+..++ ++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTT--TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCEEEEEEEecccCeEEEEEEEECCC--CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 34667789999999999999875443 35689998864322 2233456677766655 8999999999884
Q ss_pred -cCCeeEEEEecCCCCChhhhh-cCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecc
Q 046877 130 -EGQNRLLAYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFG 207 (350)
Q Consensus 130 -~~~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 207 (350)
.....+++|||++++++.... .....+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 335678999999998775544 345678999999999999999999995 599999999999999999999999999
Q ss_pred cccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 208 LAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
++....... ......||+.|+|||++.+..++.++||||+||++|||+||+.||...+..+................
T Consensus 162 ~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 162 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp SCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 987654332 22456799999999999999999999999999999999999999986654432211111000000000
Q ss_pred cch------hc--cc--cccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 LDD------LV--EG--DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ~~~------~~--~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
+.. .. .. ..........++.+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00 00 0000111234678899999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=341.05 Aligned_cols=267 Identities=18% Similarity=0.211 Sum_probs=197.9
Q ss_pred HhhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecc--ccccHHHHHHHHHHHhcCCCCceeeecceeec------
Q 046877 59 ATDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV--FQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE------ 130 (350)
Q Consensus 59 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 130 (350)
..|++.+.||+|+||+||+|.+..+ ++.||+|++... ......++.+|++++++++|||++++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKT---GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTT---CCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCC---CCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 3456778899999999999997655 356999987543 23345678999999999999999999998754
Q ss_pred --CCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccc
Q 046877 131 --GQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGL 208 (350)
Q Consensus 131 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 208 (350)
+...+++|||+.++.+..+......+++..++.++.|+++||.|||+ .+|+||||||+|||++.++.+|++|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 35689999999988887777777889999999999999999999995 5999999999999999999999999999
Q ss_pred ccccccCccc--ceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 046877 209 AKLLTLNQRK--TIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 285 (350)
Q Consensus 209 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 285 (350)
+......... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.....................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9766533221 122334689999999998765 6899999999999999999999999865544432221111111110
Q ss_pred CCcchh--------ccccccCCCc-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 286 GKLDDL--------VEGDMEAMND-------IKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 286 ~~~~~~--------~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
...... .......... ...+..+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000000 0000000010 122457789999999999999999999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-47 Score=335.21 Aligned_cols=261 Identities=18% Similarity=0.211 Sum_probs=205.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 138 (350)
.|++.+.||+|+||.||+|.+..+ ++.||+|.+.... ....+.+|++.++.++ |+|++.+++++.+....++||
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTT---TEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCC---CCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 456778999999999999997665 3569999875432 2345788899999985 589999999999999999999
Q ss_pred ecCCCCChhhhhcCC-CCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----CCceEEeeccccccc
Q 046877 139 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND-----RYNARISDFGLAKLL 212 (350)
Q Consensus 139 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~~~~~ 212 (350)
||+ +++|.+++... ..++...+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++...
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999 57998888654 56899999999999999999999 669999999999999964 578999999999876
Q ss_pred ccCccc-----ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCC
Q 046877 213 TLNQRK-----TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 287 (350)
Q Consensus 213 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 287 (350)
...... .......||+.|+|||++.+..++.++||||||+++|||+||..||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 433211 122345799999999999999999999999999999999999999986554333222111111111111
Q ss_pred cchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcccC
Q 046877 288 LDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVVE 338 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~~ 338 (350)
..++. .++|+++.+++..||..+|++||+++.+.+.|+++++
T Consensus 237 ~~~l~---------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 237 LRELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hHHhc---------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 11211 1245789999999999999999999999999988764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-48 Score=339.12 Aligned_cols=260 Identities=19% Similarity=0.192 Sum_probs=196.2
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCc-eeeecceeecCCeeEEEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKN-LVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 138 (350)
+|++.+.||+|+||.||+|.+..++ +.||+|.+.... ...++..|+++++.++|+| |+.+..+..+.+..++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAG---EEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCC---CEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 3667789999999999999976654 569999876532 2345788999999997666 555566668888899999
Q ss_pred ecCCCCChhhhh-cCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEeeccccccccc
Q 046877 139 EFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLND---RYNARISDFGLAKLLTL 214 (350)
Q Consensus 139 e~~~~g~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~ 214 (350)
||+.+ +|...+ .....+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..+|++|||++.....
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99965 554444 456789999999999999999999995 59999999999999863 55799999999987654
Q ss_pred Cccc-----ceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcc
Q 046877 215 NQRK-----TIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 289 (350)
Q Consensus 215 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3221 12234579999999999999999999999999999999999999997654433221111111110011111
Q ss_pred hhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhccc
Q 046877 290 DLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQMLQEVV 337 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~~L~~~~ 337 (350)
.. ..++++++.+++.+||+.||++||+++++.+.|+++.
T Consensus 239 ~~---------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 239 VL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HH---------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred Hh---------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11 1135678999999999999999999999999988764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=344.37 Aligned_cols=255 Identities=20% Similarity=0.238 Sum_probs=205.0
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc----cccHHHHHHHHHHHhcCCC-CceeeecceeecCCee
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF----QDGEKEFKNEVIVIGQTHH-KNLVRLLGFCDEGQNR 134 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 134 (350)
.|++.+.||+|+||+||+|.......+++.||+|.++... ....+.+.+|++++++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 3778899999999999999876665667789999886432 2234568899999999965 8999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccccc
Q 046877 135 LLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTL 214 (350)
Q Consensus 135 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 214 (350)
+++|||+.+|+|.+++.....+.+..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 9999999999999999888888999999999999999999995 5999999999999999999999999999986654
Q ss_pred CcccceeeccccCCCccCcccccCC--CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCCcchhc
Q 046877 215 NQRKTIKTAIRGTKGYVAPEWFRKS--TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 292 (350)
Q Consensus 215 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
..... .....|++.|+|||.+.+. .++.++||||+||++|+|+||+.||............. ......
T Consensus 182 ~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~---~~~~~~------ 251 (322)
T d1vzoa_ 182 DETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKS------ 251 (322)
T ss_dssp GGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH---HHHHHC------
T ss_pred ccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcccC------
Confidence 33222 2345689999999999764 46889999999999999999999997665433321111 000000
Q ss_pred cccccCCCcHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046877 293 EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPT-----MRKVSQ 331 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~vl~ 331 (350)
....+..++.++.+++.+||+.||++||| ++|+++
T Consensus 252 ----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11122246789999999999999999994 788875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=344.19 Aligned_cols=266 Identities=21% Similarity=0.265 Sum_probs=195.6
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCceeeecceeec------CCe
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNLVRLLGFCDE------GQN 133 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 133 (350)
+|...+.||+|+||+||+|++..++ +.||+|++..... ...+|++++++++||||+++++++.. ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSG---ELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCC---CEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 3445678999999999999987653 5699999865432 23469999999999999999998843 345
Q ss_pred eEEEEecCCCCChhhh---hcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEeecccc
Q 046877 134 RLLAYEFLNNGTLASF---LFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NARISDFGLA 209 (350)
Q Consensus 134 ~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~ 209 (350)
.++||||++++.+..+ ......+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccch
Confidence 7899999987643333 345677899999999999999999999 66999999999999999765 8999999999
Q ss_pred cccccCcccceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------H
Q 046877 210 KLLTLNQRKTIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------F 280 (350)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~ 280 (350)
......... ....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+........ .
T Consensus 171 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 171 KQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp EECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 876543322 34568999999998865 47899999999999999999999999765543321111000 0
Q ss_pred HHhh----cCCcchhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcccC
Q 046877 281 DCYR----NGKLDDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVVE 338 (350)
Q Consensus 281 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~~ 338 (350)
.... ....................++++.+|+.+||+.||++|||++|+++ .++++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000 00111111111111112235678999999999999999999999985 4555543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=331.54 Aligned_cols=261 Identities=20% Similarity=0.251 Sum_probs=203.1
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCCeeEEEE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQNRLLAY 138 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 138 (350)
|++.+.||+|+||+||+|++..+ ++.||+|+++... .....++.+|+.+++.++||||+++++++.+....++++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTT---CCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CEeeeEEecCcCeEEEEEEECCC---CcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 55678899999999999997655 3569999986432 234578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccCccc
Q 046877 139 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLNQRK 218 (350)
Q Consensus 139 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 218 (350)
+++.+++|..++.....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||.+.........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999999999998888899999999999999999999995 49999999999999999999999999999876543322
Q ss_pred ceeeccccCCCccCcccccCCC-CCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc---CCcchhc--
Q 046877 219 TIKTAIRGTKGYVAPEWFRKST-ISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLDDLV-- 292 (350)
Q Consensus 219 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 292 (350)
.....++..|+|||.+.+.. ++.++||||+||++|+|++|+.||....+...... ........ .......
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK--RIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH--HHHHHHCCCCTTTCTTGGGS
T ss_pred --ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH--HHHhhcCCCChhhhhhhhhc
Confidence 23345678899999987664 68999999999999999999999754333222111 01111110 0100000
Q ss_pred ----------cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 293 ----------EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 293 ----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
............+..+.+|+.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111122345678899999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=340.63 Aligned_cols=264 Identities=23% Similarity=0.268 Sum_probs=193.7
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc--cccHHHHHHHHHHHhcCCCCceeeecceeecCC-----
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF--QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ----- 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 132 (350)
.|+..+.||+|+||+||+|.+..++ +.||+|++.... ....+++.+|+++|+.++||||+++++++...+
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTG---AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTC---CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4556788999999999999976654 569999986432 233457889999999999999999999997654
Q ss_pred -eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 133 -NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 133 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
..+++|||+ +.+|..+. +...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||++..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 569999999 55777766 45679999999999999999999995 5999999999999999999999999999986
Q ss_pred cccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH-----Hhhc
Q 046877 212 LTLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-----CYRN 285 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~-----~~~~ 285 (350)
..... +...+|+.|+|||++.+. .++.++||||+||++|+|++|+.||...+............. .+..
T Consensus 171 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 171 ADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 65332 345689999999998764 578999999999999999999999976654332211110000 0000
Q ss_pred CCc----------chhccccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhccc
Q 046877 286 GKL----------DDLVEGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVV 337 (350)
Q Consensus 286 ~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~ 337 (350)
... ........ .....+.++.+.+|+.+||..||++|||++++++ .|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000 00000000 0111234568899999999999999999999986 366554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=341.32 Aligned_cols=264 Identities=20% Similarity=0.227 Sum_probs=192.7
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccc-cccHHHHHHHHHHHhcCCCCceeeecceeecCC----eeE
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVF-QDGEKEFKNEVIVIGQTHHKNLVRLLGFCDEGQ----NRL 135 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~ 135 (350)
|++.+.||+|+||+||+|.+..++ +.||+|++.... ....+++.+|+.+|+.++||||+++++++.... ..+
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNK---VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTC---SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred eEEEEEEeeccCeEEEEEEECCCC---cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 556788999999999999976554 569999987543 233457889999999999999999999986543 234
Q ss_pred EEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeecccccccccC
Q 046877 136 LAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLLTLN 215 (350)
Q Consensus 136 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 215 (350)
++++|+.+|+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 87 ~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 55566778999999854 468999999999999999999995 49999999999999999999999999999876543
Q ss_pred ccc-ceeeccccCCCccCcccccC-CCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh-----cCCc
Q 046877 216 QRK-TIKTAIRGTKGYVAPEWFRK-STISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR-----NGKL 288 (350)
Q Consensus 216 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~ 288 (350)
... .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||......+............. ....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 222 12244568999999999854 4678899999999999999999999976554332211111000000 0000
Q ss_pred ----chhccccccCCC-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 289 ----DDLVEGDMEAMN-----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 289 ----~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
............ ....+.++.+++.+||+.||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 0123467899999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.2e-46 Score=331.43 Aligned_cols=257 Identities=20% Similarity=0.295 Sum_probs=195.8
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcC-CCCceeeecceeec--CCeeEE
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQT-HHKNLVRLLGFCDE--GQNRLL 136 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 136 (350)
.|++.+.||+|+||+||+|++..+ ++.||+|+++.. ..+++.+|+.+++.+ +||||+++++++.. ....++
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCC---CCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 467778999999999999997655 467999998643 356789999999999 59999999999874 456899
Q ss_pred EEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEeecccccccccC
Q 046877 137 AYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRY-NARISDFGLAKLLTLN 215 (350)
Q Consensus 137 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 215 (350)
+|||+.+++|..+. ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||++......
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999998764 46899999999999999999999 45999999999999998654 6999999999876543
Q ss_pred cccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHH-------HHHHHhhcCC
Q 046877 216 QRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD-------WAFDCYRNGK 287 (350)
Q Consensus 216 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~-------~~~~~~~~~~ 287 (350)
... ....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||....+........ ..........
T Consensus 184 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Ccc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 322 345689999999998765 57999999999999999999999997554432211100 0000000000
Q ss_pred ---c---chhc--------cccccCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 288 ---L---DDLV--------EGDMEAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 288 ---~---~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
. .... ............+.++.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 000111122345678999999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=333.48 Aligned_cols=259 Identities=22% Similarity=0.270 Sum_probs=187.3
Q ss_pred hhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceee------cCC
Q 046877 61 DNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCD------EGQ 132 (350)
Q Consensus 61 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~ 132 (350)
|++.+.||+|+||+||+|.+..++ ..||+|++..... ....++.+|+.+++.++||||+++++++. +..
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLD---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTT---EEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred eEEEEEeecCcCeEEEEEEECCCC---CEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 556678999999999999976653 5699999875432 33456889999999999999999999985 346
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
..|++|||+.++.+.. + ...+++..++.++.|++.|+.|||+ .+|+||||||+|||++.++.+|++|||++...
T Consensus 96 ~~~iv~Ey~~~~l~~~-~--~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQV-I--QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHHH-H--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHHh-h--hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 8899999998755544 4 3468899999999999999999995 59999999999999999999999999998866
Q ss_pred ccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHH---------------
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD--------------- 277 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~--------------- 277 (350)
..... .....+|+.|+|||++.+..++.++||||+||++|+|++|+.||...+.........
T Consensus 170 ~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 54322 234568999999999999999999999999999999999999997554322211100
Q ss_pred -HHHHHhhcC------Ccchhccccc---cCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046877 278 -WAFDCYRNG------KLDDLVEGDM---EAMNDIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ 331 (350)
Q Consensus 278 -~~~~~~~~~------~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~ 331 (350)
......... .......... ........+.++.+|+.+||..||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000100 0000010000 11112356788999999999999999999999973
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=336.52 Aligned_cols=277 Identities=24% Similarity=0.287 Sum_probs=199.5
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc--ccHHHHHHHHHHHhcCCCCceeeecceeecC-----C
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ--DGEKEFKNEVIVIGQTHHKNLVRLLGFCDEG-----Q 132 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 132 (350)
+|+..+.||+|+||+||+|.+..+ ++.||+|++..... ...+++.+|+.+++.++|||++++++++... .
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKT---GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTT---TEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CeEEEEEEecCCCeEEEEEEECCC---CCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 356678899999999999987655 46799999875432 2345788999999999999999999998533 3
Q ss_pred eeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEeeccccccc
Q 046877 133 NRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARISDFGLAKLL 212 (350)
Q Consensus 133 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 212 (350)
..+++++|+.+|+|.+++. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||++...
T Consensus 96 ~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred ceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence 4466677888999999985 4579999999999999999999995 59999999999999999999999999999765
Q ss_pred ccCcccceeeccccCCCccCcccccCC-CCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH-----HhhcC
Q 046877 213 TLNQRKTIKTAIRGTKGYVAPEWFRKS-TISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-----CYRNG 286 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~-----~~~~~ 286 (350)
.... ....|++.|+|||.+.+. .++.++||||+||++|+|++|..||...+............. .....
T Consensus 172 ~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 172 DDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp TGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred Cccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 4322 344588899999987765 468899999999999999999999976554332211100000 00000
Q ss_pred C---cchhccccccC--CC----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcccCCCCCCCCCCC
Q 046877 287 K---LDDLVEGDMEA--MN----DIKCVEKLLMISIWCIQEDPSLRPTMRKVSQ--MLQEVVEVDVPPNPSPF 348 (350)
Q Consensus 287 ~---~~~~~~~~~~~--~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~vl~--~L~~~~~~~~~~~~~~~ 348 (350)
. ........... .. ..+.+.++.+|+.+||+.||.+|||++|+++ .+++.......|...|+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~ 319 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY 319 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC
Confidence 0 00000000000 00 0124577899999999999999999999986 56665544433333333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-40 Score=299.82 Aligned_cols=276 Identities=20% Similarity=0.235 Sum_probs=192.9
Q ss_pred hhhhhhccCCCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-----------CCceeeeccee
Q 046877 60 TDNFKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-----------HKNLVRLLGFC 128 (350)
Q Consensus 60 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~ 128 (350)
+|++.+.||+|+||+||+|+...++ +.||+|+++... ...+.+.+|+++++.++ |+||+++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g---~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNN---THVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3677899999999999999976653 569999987542 23456788888888765 57899999887
Q ss_pred ec--CCeeEEEEecCCCCChhhh---hcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---
Q 046877 129 DE--GQNRLLAYEFLNNGTLASF---LFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYN--- 200 (350)
Q Consensus 129 ~~--~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~--- 200 (350)
.. ....+++++++..+..... ......+++..++.++.|++.|++|||+ ..+|+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence 54 4556677776655432222 2345677889999999999999999996 358999999999999986653
Q ss_pred ---eEEeecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHHHHHHHhCCCCCCcccchhhhhHHH
Q 046877 201 ---ARISDFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 277 (350)
Q Consensus 201 ---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~ 277 (350)
++++|||.+....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||.............
T Consensus 168 ~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 9999999997554322 34568999999999999999999999999999999999999997544322111100
Q ss_pred HHH---HH--------hhcCCc----------chhccc----------cccCCCcHHHHHHHHHHHHhccCCCCCCCCCH
Q 046877 278 WAF---DC--------YRNGKL----------DDLVEG----------DMEAMNDIKCVEKLLMISIWCIQEDPSLRPTM 326 (350)
Q Consensus 278 ~~~---~~--------~~~~~~----------~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 326 (350)
... .. ...+.. ...... ..........+.++.+|+.+||..||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 000 00 000000 000000 00122345678899999999999999999999
Q ss_pred HHHHH--HHhccc---CCCCCCCCC
Q 046877 327 RKVSQ--MLQEVV---EVDVPPNPS 346 (350)
Q Consensus 327 ~~vl~--~L~~~~---~~~~~~~~~ 346 (350)
+|+++ .++++. +...|+.|.
T Consensus 323 ~e~L~Hp~f~~~~~~~~~~~p~~~~ 347 (362)
T d1q8ya_ 323 GGLVNHPWLKDTLGMEEIRVPDREL 347 (362)
T ss_dssp HHHHTCGGGTTCTTCTTCCCTTSCT
T ss_pred HHHhcCcccCCCCCcccCCCCCccc
Confidence 99986 355443 444444443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.1e-23 Score=171.32 Aligned_cols=167 Identities=13% Similarity=0.111 Sum_probs=115.0
Q ss_pred hhhccCCCccceEEEEEEcCCCcceeEEEEEeeecccc------------------ccHHHHHHHHHHHhcCCCCceeee
Q 046877 63 FKEEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQ------------------DGEKEFKNEVIVIGQTHHKNLVRL 124 (350)
Q Consensus 63 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~ 124 (350)
+.+.||+|+||.||+|.+.+ +..||+|.+..... ........|...+..+.|++++..
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~----g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~ 79 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEK----FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 79 (191)
T ss_dssp EEEEEEECSSEEEEEEEETT----TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred hCCEeeeCcceEEEEEECCC----CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence 45789999999999998643 35699997642110 011234568888999999999887
Q ss_pred cceeecCCeeEEEEecCCCCChhhhhcCCCCcChhHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEe
Q 046877 125 LGFCDEGQNRLLAYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARVLLYLHEDCSSQIIHCDIKPQNILLNDRYNARIS 204 (350)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~ 204 (350)
+++.. .+++|||+++..+.. ++......++.|++++++|||+ .+++||||||+|||++++ .++|+
T Consensus 80 ~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEEC
T ss_pred EEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEE
Confidence 76532 379999999866543 3445567899999999999995 599999999999999976 48999
Q ss_pred ecccccccccCcccceeeccccCCCccCcccccCCCCCCCCcchhHHHH
Q 046877 205 DFGLAKLLTLNQRKTIKTAIRGTKGYVAPEWFRKSTISAKVDVYSFGVL 253 (350)
Q Consensus 205 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~ 253 (350)
|||.+.....+....... .+.. .-.+.+ ...|+.++|+||..--
T Consensus 145 DFG~a~~~~~~~~~~~l~---rd~~-~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWREILE---RDVR-NIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHHHHH---HHHH-HHHHHH-HHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHH---HHHH-HHHHHH-cCCCCCcccHHHHHHH
Confidence 999997654332111000 0000 000111 3567889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=3.5e-07 Score=76.10 Aligned_cols=133 Identities=15% Similarity=0.051 Sum_probs=88.7
Q ss_pred CCccceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCC-CCceeeecceeecCCeeEEEEecCCCCChh
Q 046877 69 RGSFGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTH-HKNLVRLLGFCDEGQNRLLAYEFLNNGTLA 147 (350)
Q Consensus 69 ~G~~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 147 (350)
.++.+.||+....+ ..+.+|............+.+|...++.+. +--+.+++.+..+++..+++|++++|.++.
T Consensus 24 G~s~~~v~rv~~~~-----~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 24 GMSPAKVYKLVGEN-----ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp CCSSSEEEEEECSS-----CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred CCCCCcEEEEEeCC-----CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccc
Confidence 34457899875322 236777765544444456778888877663 333567778888888999999999998876
Q ss_pred hhhcCCCCcChhHHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q 046877 148 SFLFGNLKPNWNLRTNIAFQIARVLLYLHEDC------------------------------------------------ 179 (350)
Q Consensus 148 ~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------------------------------------------------ 179 (350)
..... ......++.++++.++.||+..
T Consensus 99 ~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 99 EEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp HHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred ccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 54421 1123334555555566666210
Q ss_pred --------CCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 180 --------SSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 180 --------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
...++|+|+.|.||++++++..-++||+.+..
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877677999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.11 E-value=7e-06 Score=72.23 Aligned_cols=77 Identities=14% Similarity=0.148 Sum_probs=46.1
Q ss_pred hccCCCccceEEEEEEcCCCcceeEEEEEeeecc-------ccccHHHHHHHHHHHhcCC-C--CceeeecceeecCCee
Q 046877 65 EEVGRGSFGIIYKGVIQTTTTSTTAVAVKKLDRV-------FQDGEKEFKNEVIVIGQTH-H--KNLVRLLGFCDEGQNR 134 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~~~~~~vavk~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~ 134 (350)
+.||.|....||++....+ ++.+++|.-... .....++...|...++.+. + ..+.+++.+ +++..
T Consensus 32 ~eig~G~~N~vfrV~~~~~---~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~ 106 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEH---DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 106 (392)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EEeCCCceEeEEEEEeCCC---CeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCC
Confidence 5699999999999875433 345788864321 1112345566777777662 2 234444443 44566
Q ss_pred EEEEecCCCCCh
Q 046877 135 LLAYEFLNNGTL 146 (350)
Q Consensus 135 ~lv~e~~~~g~L 146 (350)
+++||++.+..+
T Consensus 107 ~lvmE~L~~~~~ 118 (392)
T d2pula1 107 VTVMEDLSHLKI 118 (392)
T ss_dssp EEEECCCTTSEE
T ss_pred EEEEeccCCccc
Confidence 789999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=5.7e-05 Score=61.79 Aligned_cols=129 Identities=16% Similarity=0.068 Sum_probs=79.2
Q ss_pred cCCCc-cceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCC--CceeeecceeecCCeeEEEEecCCC
Q 046877 67 VGRGS-FGIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHH--KNLVRLLGFCDEGQNRLLAYEFLNN 143 (350)
Q Consensus 67 lg~G~-~g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (350)
+..|. .+.||+...... ..+.+|..... ....+..|...++.+.. -.+.+++.+..+++..+++|++++|
T Consensus 18 ~~~G~s~~~v~r~~~~~~----~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGR----PVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECTTS----CCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeCCC----CEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 44444 367898864322 23667764332 23346777777776632 2356677777888889999999998
Q ss_pred CChhhhhcCCCCcChhHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 046877 144 GTLASFLFGNLKPNWNLRTNIAFQIARVLLYLH----------------------------------------------- 176 (350)
Q Consensus 144 g~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~Lh----------------------------------------------- 176 (350)
.++.... .. ....+.++.+.++-||
T Consensus 91 ~~~~~~~-----~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 91 QDLLSSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp EETTTSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccccccc-----cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 7664421 00 0111223333333333
Q ss_pred ----hc----CCCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 177 ----ED----CSSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 177 ----~~----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
+. ....++|+|+.|.||+++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 12347999999999999988777899998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.89 E-value=0.0014 Score=57.03 Aligned_cols=77 Identities=12% Similarity=0.207 Sum_probs=49.3
Q ss_pred hccCCCccceEEEEEEcCCC----cceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCce-eeecceeecCCeeEEEEe
Q 046877 65 EEVGRGSFGIIYKGVIQTTT----TSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL-VRLLGFCDEGQNRLLAYE 139 (350)
Q Consensus 65 ~~lg~G~~g~V~~~~~~~~~----~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 139 (350)
+.|+.|-.-.+|++...+.. .....+.+++... ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 45888888999998876432 1223466666542 2334456788888888743344 456666643 57899
Q ss_pred cCCCCChh
Q 046877 140 FLNNGTLA 147 (350)
Q Consensus 140 ~~~~g~L~ 147 (350)
|++|.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.70 E-value=0.0049 Score=51.94 Aligned_cols=132 Identities=12% Similarity=0.064 Sum_probs=72.7
Q ss_pred ceEEEEEEcCCCcceeEEEEEeeeccccccHHHHHHHHHHHhcCCCCce-----eeec--ceeecCCeeEEEEecCCCCC
Q 046877 73 GIIYKGVIQTTTTSTTAVAVKKLDRVFQDGEKEFKNEVIVIGQTHHKNL-----VRLL--GFCDEGQNRLLAYEFLNNGT 145 (350)
Q Consensus 73 g~V~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~--~~~~~~~~~~lv~e~~~~g~ 145 (350)
-.||++...+ +..+++|..... ....+++..|...+..|...++ +..- ..+..+...+.+++++.|..
T Consensus 36 N~vy~v~~~d----g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDED----RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTT----CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCC----CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 4688886533 344888876532 3346778888888777642222 1211 12345567788999988754
Q ss_pred hhh----hh--------------cC-----CCCcC-------------------hhHHHHHHHHHHHHHHHHHh----cC
Q 046877 146 LAS----FL--------------FG-----NLKPN-------------------WNLRTNIAFQIARVLLYLHE----DC 179 (350)
Q Consensus 146 L~~----~l--------------~~-----~~~~~-------------------~~~~~~~~~~i~~~l~~Lh~----~~ 179 (350)
+.. .. .. ....+ ......+...+...++.+.. ..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 321 00 00 01111 11111122222223333322 22
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEeecccccc
Q 046877 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAKL 211 (350)
Q Consensus 180 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 211 (350)
..+++|+|+.+.||+++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4578999999999999754 45899998863
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.83 E-value=0.05 Score=45.04 Aligned_cols=31 Identities=23% Similarity=0.339 Sum_probs=28.1
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEeeccccc
Q 046877 180 SSQIIHCDIKPQNILLNDRYNARISDFGLAK 210 (350)
Q Consensus 180 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 210 (350)
..+++|+|+.++|++++++...-+.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5679999999999999998877899999886
|